data_2lie_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lie _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -151.25 159.37 44.4 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.356 1.862 . . . . 0.0 109.424 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.44 140.65 58.89 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 121.562 -0.711 . . . . 0.0 112.243 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.45 -161.7 33.81 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.24 0.924 . . . . 0.0 114.426 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -98.44 126.75 44.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.187 0.995 . . . . 0.0 110.338 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -135.59 171.52 14.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.13 1.372 . . . . 0.0 112.701 -171.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.4 pt -124.82 153.62 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 126.329 1.852 . . . . 0.0 108.393 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.63 122.56 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -140.09 147.45 40.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.537 0.735 . . . . 0.0 111.393 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -75.62 136.7 40.46 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.918 -0.489 . . . . 0.0 111.117 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.7 tpt85 -66.28 -20.17 66.03 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -171.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.4 t . . . . . 0 N--CA 1.481 1.104 0 C-N-CA 124.809 1.244 . . . . 0.0 112.546 173.019 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.8 tp . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 121.325 0.583 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.7 144.12 30.45 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -169.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.79 132.38 53.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.653 1.181 . . . . 0.0 109.246 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.8 m -130.7 118.85 21.52 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.292 1.037 . . . . 0.0 111.139 -169.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -61.54 137.38 94.8 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 126.305 1.842 . . . . 0.0 112.513 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.57 -13.78 20.15 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.441 2.761 . . . . 0.0 114.926 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.25 8.15 84.03 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -153.58 161.95 41.72 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.811 1.644 . . . . 0.0 111.732 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -89.77 165.73 13.98 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.007 0.923 . . . . 0.0 111.586 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 49.57 38.54 15.02 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.773 1.629 . . . . 0.0 113.813 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.4 m -136.2 141.17 35.14 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 125.562 1.545 . . . . 0.0 111.322 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -45.55 154.98 0.51 Allowed 'Trans proline' 0 C--N 1.353 0.804 1 C-N-CA 126.167 4.578 . . . . 0.0 115.49 169.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.3 t -110.89 153.96 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.065 1.346 . . . . 0.0 110.118 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 m -128.13 172.51 10.92 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.695 1.598 . . . . 0.0 110.938 -169.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.97 144.71 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.692 1.197 . . . . 0.0 111.42 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -149.54 158.98 37.31 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 124.921 1.288 . . . . 0.0 111.872 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -63.24 130.35 28.41 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.279 1.986 . . . . 0.0 110.527 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.6 tp -63.28 136.3 57.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.373 1.069 . . . . 0.0 111.428 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -130.36 -26.87 2.26 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.192 1.797 . . . . 0.0 112.021 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.64 4.68 19.32 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.451 1.5 . . . . 0.0 114.175 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.4 p -65.74 159.45 25.09 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.783 1.291 . . . . 0.0 113.209 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -62.66 -19.1 63.5 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -68.55 -27.21 65.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.907 0.883 . . . . 0.0 112.324 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -102.38 -7.46 21.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.9 1.68 . . . . 0.0 113.197 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.64 146.37 28.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.452 1.101 . . . . 0.0 111.456 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -138.31 170.48 15.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.471 1.129 . . . . 0.0 111.858 -169.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.4 mt -121.2 136.0 59.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 127.294 2.238 . . . . 0.0 107.126 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.3 tp -137.18 124.44 21.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.274 1.43 . . . . 0.0 109.727 -170.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -141.84 140.21 32.88 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.605 0.762 . . . . 0.0 111.134 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.7 t -65.74 139.37 58.35 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.833 0.453 . . . . 0.0 110.988 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -115.19 -47.27 2.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.289 1.036 . . . . 0.0 111.595 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.37 109.48 3.73 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.308 1.043 . . . . 0.0 111.059 170.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -57.94 -27.58 63.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.828 0.851 . . . . 0.0 111.101 168.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -60.62 -21.28 62.54 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.127 2.171 . . . . 0.0 113.574 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -130.21 10.84 5.4 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.869 1.668 . . . . 0.0 112.737 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 46.36 28.51 0.72 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.967 2.107 . . . . 0.0 113.858 -168.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 p -89.71 140.03 29.98 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.85 -1.156 . . . . 0.0 112.424 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -135.26 142.93 46.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.137 1.775 . . . . 0.0 111.322 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.0 p -78.33 148.5 33.75 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.032 0.533 . . . . 0.0 110.767 172.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.2 mm -128.67 130.16 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.547 1.539 . . . . 0.0 109.807 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 m -144.8 149.65 43.72 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 126.208 1.803 . . . . 0.0 110.232 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.91 148.1 31.45 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.007 2.471 . . . . 0.0 111.143 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 m -66.18 -25.48 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 120.757 -1.215 . . . . 0.0 113.199 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.67 -21.82 65.61 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.762 0.696 . . . . 0.0 114.389 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.3 m -143.7 66.75 15.54 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 125.73 1.612 . . . . 0.0 111.047 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.23 -13.19 30.72 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.894 2.396 . . . . 0.0 113.678 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -76.55 4.69 8.73 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.046 1.738 . . . . 0.0 114.297 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.6 p -139.19 175.29 9.68 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.595 1.543 . . . . 0.0 112.579 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -138.53 171.49 14.28 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.357 1.463 . . . . 0.0 113.195 -169.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.8 mm -120.71 127.91 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.16 1.384 . . . . 0.0 110.364 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.84 -155.74 6.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.759 1.647 . . . . 0.0 110.968 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -143.25 145.06 32.41 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.492 1.146 . . . . 0.0 112.053 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.66 -162.99 10.97 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.428 1.49 . . . . 0.0 113.26 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.16 136.51 23.87 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.174 1.39 . . . . 0.0 113.054 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.77 -4.48 63.49 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.738 1.161 . . . . 0.0 114.268 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 48.54 54.71 10.09 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.425 1.89 . . . . 0.0 113.567 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.86 140.24 37.6 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 127.454 2.301 . . . . 0.0 107.674 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.28 141.21 46.51 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.076 1.184 . . . . 0.0 109.278 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.5 151.6 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.348 1.459 . . . . 0.0 111.681 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.3 t -76.91 134.6 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.115 0.966 . . . . 0.0 110.858 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -139.74 160.52 60.75 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.032 1.733 . . . . 0.0 111.825 -169.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.68 164.19 32.23 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.965 2.443 . . . . 0.0 111.983 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.71 120.51 6.73 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.43 2.087 . . . . 0.0 110.516 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -147.0 -90.91 0.09 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.0 0.92 . . . . 0.0 110.793 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -155.52 17.94 0.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.315 1.446 . . . . 0.0 113.096 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -67.36 136.33 54.62 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.486 -0.759 . . . . 0.0 111.99 -173.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.9 m -145.09 161.11 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.907 1.283 . . . . 0.0 112.545 -175.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -131.36 137.24 48.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.671 1.588 . . . . 0.0 110.737 169.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.1 m -68.49 129.67 40.6 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 169.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 44.3 mt -127.08 116.59 20.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.22 1.008 . . . . 0.0 108.693 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 m -131.6 128.29 38.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.813 0.845 . . . . 0.0 111.295 -169.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp -69.06 151.43 46.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.266 1.027 . . . . 0.0 112.147 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.6 p -129.02 -176.62 3.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.128 1.771 . . . . 0.0 111.465 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.2 p -60.34 -15.89 29.8 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.66 18.17 0.24 Allowed Glycine 0 CA--C 1.534 1.253 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.07 -150.39 8.33 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.15 1.357 . . . . 0.0 112.061 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -133.66 168.22 19.08 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.694 1.998 . . . . 0.0 111.693 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -130.0 148.71 51.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.257 2.223 . . . . 0.0 109.968 174.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.85 122.94 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.779 1.231 . . . . 0.0 109.563 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -137.96 160.4 39.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.73 1.212 . . . . 0.0 112.675 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.35 -24.38 66.42 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -172.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 124.93 -40.22 1.93 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.519 1.533 . . . . 0.0 113.077 -173.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -93.47 -3.05 53.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.298 1.439 . . . . 0.0 113.511 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 70.16 14.51 7.67 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.609 2.364 . . . . 0.0 113.413 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.2 p -72.75 -23.79 60.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.747 1.219 . . . . 0.0 112.703 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.3 m -146.02 172.66 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.91 1.684 . . . . 0.0 111.833 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.0 m -143.82 155.18 44.05 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.076 2.151 . . . . 0.0 111.214 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 38.0 m0 -73.1 140.58 47.23 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.938 -0.477 . . . . 0.0 111.848 169.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.3 p -153.56 170.71 20.14 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.225 1.41 . . . . 0.0 112.547 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.88 164.88 14.39 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.821 1.648 . . . . 0.0 110.068 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -99.62 -32.84 10.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.669 0.787 . . . . 0.0 111.623 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -143.83 -0.8 1.02 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.482 1.913 . . . . 0.0 114.196 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 50.31 27.49 2.72 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.125 2.17 . . . . 0.0 115.9 -172.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.2 p -79.4 160.0 26.85 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.901 -1.124 . . . . 0.0 112.663 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.71 138.55 58.46 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.606 0.762 . . . . 0.0 112.152 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.03 -0.3 89.86 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.658 1.123 . . . . 0.0 114.757 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -76.28 154.17 35.36 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.798 1.299 . . . . 0.0 113.169 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -81.77 122.73 28.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.058 -1.026 . . . . 0.0 110.71 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.12 151.43 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.094 0.958 . . . . 0.0 111.011 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.3 m -134.83 168.42 19.09 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.7 1.6 . . . . 0.0 111.283 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.2 mt -132.77 145.12 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.007 1.323 . . . . 0.0 109.268 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.6 -161.28 34.99 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 123.813 0.721 . . . . 0.0 112.529 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 149.16 17.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 117.828 0.814 . . . . 0.0 111.956 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.68 116.38 2.47 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.39 1.476 . . . . 0.0 113.934 -172.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.84 157.23 37.86 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.4 t -87.66 -12.98 43.84 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -133.64 -37.86 0.92 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.48 1.112 . . . . 0.0 113.44 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.4 p -104.81 2.18 29.85 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.857 1.263 . . . . 0.0 114.26 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.47 10.94 1.77 Allowed Glycine 0 CA--C 1.542 1.749 0 C-N-CA 125.888 1.708 . . . . 0.0 115.819 -176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -135.46 145.98 47.72 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.435 1.894 . . . . 0.0 111.225 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -138.06 178.51 7.07 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 126.949 2.1 . . . . 0.0 111.237 -168.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.31 138.09 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 124.169 0.987 . . . . 0.0 109.36 168.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.04 124.2 72.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 125.947 1.699 . . . . 0.0 107.215 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -147.93 152.5 37.65 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.535 1.134 . . . . 0.0 109.432 -170.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.74 155.58 38.94 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.046 -1.034 . . . . 0.0 112.909 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.133 1.773 . . . . 0.0 111.216 171.815 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 CA--C 1.543 0.683 0 CA-C-O 121.387 0.613 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 t -154.26 167.4 30.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.31 1.044 . . . . 0.0 110.087 173.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 125.06 22.7 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 122.091 -0.38 . . . . 0.0 111.506 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.2 -165.87 38.17 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -99.71 124.8 45.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.236 1.014 . . . . 0.0 110.087 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -134.2 170.02 16.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.28 1.432 . . . . 0.0 112.508 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 pt -125.07 152.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.242 1.817 . . . . 0.0 108.328 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.1 mt -128.94 119.33 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -137.85 147.8 44.83 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.279 0.631 . . . . 0.0 112.477 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -79.36 133.78 36.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.75 0.42 . . . . 0.0 111.234 -173.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -61.63 -21.78 64.68 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.187 1.395 . . . . 0.0 114.343 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.2 t . . . . . 0 N--CA 1.479 1.024 0 C-N-CA 123.976 0.91 . . . . 0.0 112.497 174.78 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 121.104 0.478 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.51 147.46 30.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.048 1.739 . . . . 0.0 114.287 -171.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.1 tp -60.25 136.73 58.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.207 1.403 . . . . 0.0 110.784 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 m -124.26 120.27 31.74 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.403 1.481 . . . . 0.0 111.473 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -63.62 133.3 95.48 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.764 1.626 . . . . 0.0 111.39 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.83 -11.48 21.82 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.077 2.518 . . . . 0.0 114.587 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.93 84.8 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 119.14 -0.811 . . . . 0.0 114.92 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -156.1 161.56 40.37 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.196 1.398 . . . . 0.0 112.036 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -88.96 164.51 15.08 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.131 0.972 . . . . 0.0 111.863 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 47.3 mmt-85 50.57 34.57 9.79 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.874 1.67 . . . . 0.0 113.986 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.8 m -132.29 138.9 33.29 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.848 1.659 . . . . 0.0 110.653 -169.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.99 154.74 12.58 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.685 3.59 . . . . 0.0 115.229 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -100.92 156.66 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.839 1.256 . . . . 0.0 110.642 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -126.98 178.24 6.11 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.675 1.59 . . . . 0.0 110.694 -170.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.98 148.96 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.911 1.284 . . . . 0.0 111.406 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.5 m -158.84 162.79 25.87 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 125.08 1.352 . . . . 0.0 112.76 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.67 127.62 16.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.53 2.153 . . . . 0.0 111.034 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.5 tp -65.2 140.22 58.73 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -137.26 10.64 3.01 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.986 1.315 . . . . 0.0 113.101 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.25 0.15 89.45 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.772 1.177 . . . . 0.0 114.948 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -64.66 142.51 58.4 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 118.678 1.239 . . . . 0.0 112.08 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.0 p -60.9 -14.13 20.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.037 1.335 . . . . 0.0 114.07 172.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.49 -21.55 64.6 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.201 -0.937 . . . . 0.0 112.626 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -118.28 9.5 12.54 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.975 1.31 . . . . 0.0 113.604 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -106.79 146.54 30.76 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.771 1.228 . . . . 0.0 110.894 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -138.94 173.96 11.01 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 122.478 1.133 . . . . 0.0 112.096 -168.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.7 mt -124.55 134.95 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 127.54 2.336 . . . . 0.0 106.948 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.02 124.88 22.6 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.376 1.47 . . . . 0.0 109.26 -170.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -146.39 139.32 25.52 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.069 0.548 . . . . 0.0 111.754 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 t -66.53 140.8 58.0 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.991 0.516 . . . . 0.0 111.592 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -114.85 -52.59 2.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.82 1.248 . . . . 0.0 111.223 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.86 110.32 5.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.77 1.228 . . . . 0.0 111.405 169.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.9 m -57.71 -24.7 58.19 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.956 0.903 . . . . 0.0 111.663 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -64.64 -21.97 66.86 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.009 2.124 . . . . 0.0 113.626 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.5 m -130.31 12.51 5.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.997 1.719 . . . . 0.0 112.686 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 42.95 35.33 0.73 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.623 1.969 . . . . 0.0 113.582 -169.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 p -87.58 139.28 30.7 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.76 -1.212 . . . . 0.0 111.709 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -135.94 143.57 44.99 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.57 1.548 . . . . 0.0 110.074 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.9 p -77.73 150.54 34.4 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.716 0.806 . . . . 0.0 110.793 173.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.9 mm -128.6 127.12 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.613 1.565 . . . . 0.0 109.44 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.6 m -143.79 148.11 41.39 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 125.835 1.654 . . . . 0.0 110.316 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.38 148.56 34.03 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.203 2.602 . . . . 0.0 111.172 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.5 m -66.79 -24.76 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.732 -1.23 . . . . 0.0 113.015 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.44 -23.9 74.34 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 123.938 0.78 . . . . 0.0 114.107 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.8 m -143.43 74.36 17.19 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 125.972 1.709 . . . . 0.0 110.368 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -61.81 -13.31 29.83 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.236 2.624 . . . . 0.0 113.192 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -89.38 9.58 25.68 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 128.52 2.728 . . . . 0.0 114.614 174.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.8 p -133.28 174.7 10.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.943 1.297 . . . . 0.0 112.009 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -141.36 170.07 16.42 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.882 1.273 . . . . 0.0 113.286 -170.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -120.48 128.95 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.164 1.386 . . . . 0.0 110.532 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.54 -159.61 8.22 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.652 1.596 . . . . 0.0 111.621 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -138.74 141.09 38.87 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.347 1.073 . . . . 0.0 111.956 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.78 -163.73 10.85 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.447 1.499 . . . . 0.0 113.425 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.77 140.14 19.9 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.045 1.338 . . . . 0.0 113.314 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.46 -4.74 73.62 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.686 1.136 . . . . 0.0 114.254 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 49.19 55.02 9.95 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.466 1.906 . . . . 0.0 114.333 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.8 149.05 70.8 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 126.103 1.761 . . . . 0.0 107.843 169.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.63 147.59 51.59 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.147 1.231 . . . . 0.0 109.877 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.26 153.02 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.74 1.616 . . . . 0.0 111.664 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.85 132.01 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.098 0.959 . . . . 0.0 111.158 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.3 mt -137.91 161.8 57.83 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 126.312 1.845 . . . . 0.0 112.053 -169.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.43 165.76 29.48 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.093 2.528 . . . . 0.0 111.944 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.6 123.02 9.1 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.446 2.097 . . . . 0.0 110.45 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -147.66 -88.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.719 0.808 . . . . 0.0 110.609 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -155.48 16.11 0.39 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.481 1.512 . . . . 0.0 112.954 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -65.9 132.7 49.28 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.502 -0.749 . . . . 0.0 111.936 -172.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.79 159.45 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.328 1.451 . . . . 0.0 111.522 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -129.3 145.98 51.27 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.157 1.383 . . . . 0.0 110.003 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.9 m -81.79 133.96 35.39 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.086 0.954 . . . . 0.0 109.735 173.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.45 132.7 54.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.041 1.336 . . . . 0.0 109.516 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 61.1 m -142.14 122.76 14.19 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.007 -1.058 . . . . 0.0 110.617 -173.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.5 mt -62.65 152.98 33.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.66 0.743 . . . . 0.0 112.65 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.9 p -126.17 -179.92 4.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.61 1.964 . . . . 0.0 109.808 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.5 m -61.38 -8.7 4.23 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.18 26.98 0.2 Allowed Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.229 0.919 . . . . 0.0 114.66 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.92 -151.72 11.02 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.946 1.26 . . . . 0.0 112.814 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -131.73 170.21 15.13 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.011 2.124 . . . . 0.0 112.113 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -137.31 152.8 50.15 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.292 2.637 . . . . 0.0 109.127 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.88 118.46 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.638 1.175 . . . . 0.0 109.176 -169.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -134.85 160.18 39.04 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -169.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -62.72 -25.98 68.45 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.626 1.97 . . . . 0.0 116.14 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 128.9 -32.99 3.17 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.054 1.312 . . . . 0.0 113.515 -173.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -113.72 9.86 17.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.298 1.839 . . . . 0.0 113.542 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 62.57 16.55 8.88 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.9 2.08 . . . . 0.0 113.98 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.8 p -70.2 -27.49 64.54 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.716 0.806 . . . . 0.0 112.437 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.0 m -146.0 173.13 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.466 1.506 . . . . 0.0 112.061 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 t -141.77 154.19 45.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.292 2.237 . . . . 0.0 109.596 172.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -69.66 144.31 52.93 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.696 -0.627 . . . . 0.0 110.688 169.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.0 p -155.03 168.59 26.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.498 1.119 . . . . 0.0 112.171 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.4 mt -113.94 163.76 14.69 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.119 1.767 . . . . 0.0 109.564 171.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -97.13 -33.69 11.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.925 0.89 . . . . 0.0 111.793 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -136.57 -6.49 1.97 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.969 2.108 . . . . 0.0 112.123 171.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.1 27.74 11.91 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.17 1.788 . . . . 0.0 114.268 -171.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.8 p -78.03 157.21 29.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.22 1.008 . . . . 0.0 111.995 172.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.48 139.39 58.5 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.235 -0.916 . . . . 0.0 111.736 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.26 0.74 90.05 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.712 1.148 . . . . 0.0 114.703 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.48 144.94 46.02 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.666 1.233 . . . . 0.0 112.834 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.49 120.49 21.79 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 173.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.82 149.8 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.571 0.7 . . . . 0.0 111.382 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 t -130.2 166.66 19.81 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.999 1.72 . . . . 0.0 111.677 -169.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.75 140.26 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.645 1.578 . . . . 0.0 109.184 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 171.32 -161.61 34.12 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 121.528 -0.733 . . . . 0.0 112.663 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.17 152.86 12.83 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 117.667 0.734 . . . . 0.0 111.715 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -51.88 109.28 0.35 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.418 1.487 . . . . 0.0 113.121 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.99 142.92 55.79 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.787 0.835 . . . . 0.0 113.163 -173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.0 t -60.07 -20.57 58.73 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -135.74 -40.26 0.7 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.947 1.299 . . . . 0.0 113.006 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.6 t -91.0 1.26 57.21 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -172.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.77 14.69 1.93 Allowed Glycine 0 CA--C 1.542 1.75 0 C-N-CA 125.115 1.34 . . . . 0.0 116.003 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.69 145.36 49.84 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.395 1.478 . . . . 0.0 111.476 -174.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -140.78 175.09 9.89 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.374 1.87 . . . . 0.0 110.613 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.48 141.03 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.123 1.369 . . . . 0.0 108.977 169.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 mp -121.31 124.37 71.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.649 1.58 . . . . 0.0 107.167 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -149.0 154.24 39.07 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.687 1.195 . . . . 0.0 109.181 -169.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -68.68 154.46 41.9 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.928 -1.107 . . . . 0.0 112.577 -177.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.324 1.85 . . . . 0.0 111.374 171.226 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.55 0.971 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 t -159.66 168.91 24.88 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.92 1.288 . . . . 0.0 110.269 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.27 139.67 57.32 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.811 -0.555 . . . . 0.0 111.995 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.76 -163.45 35.25 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.916 0.769 . . . . 0.0 114.51 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -95.1 124.0 38.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.959 0.903 . . . . 0.0 109.77 170.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -133.45 173.25 11.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.552 1.541 . . . . 0.0 112.026 -172.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.4 pt -126.37 152.26 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.95 1.7 . . . . 0.0 108.542 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 mt -123.54 122.95 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -137.74 146.7 44.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.512 0.725 . . . . 0.0 110.836 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -67.01 143.32 56.84 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -63.5 -23.54 67.44 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.882 -0.511 . . . . 0.0 112.212 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.469 0.487 0 C-N-CA 125.453 1.501 . . . . 0.0 108.391 168.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.2 tp . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 121.553 0.692 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.39 149.81 28.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.981 1.712 . . . . 0.0 115.041 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 tp -62.38 137.02 58.18 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.261 1.424 . . . . 0.0 110.384 169.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 m -127.61 120.39 28.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.799 1.24 . . . . 0.0 111.287 -174.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -66.18 135.52 95.05 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.095 1.358 . . . . 0.0 112.218 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.1 -13.41 21.22 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.339 2.693 . . . . 0.0 114.666 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.41 7.87 81.82 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.1 0.857 . . . . 0.0 115.035 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -154.77 164.65 38.48 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.239 1.816 . . . . 0.0 111.382 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -98.89 165.78 11.6 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.894 1.278 . . . . 0.0 111.435 -173.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 47.38 43.46 15.38 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.938 1.695 . . . . 0.0 113.494 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.6 m -139.33 137.99 19.9 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 126.381 1.872 . . . . 0.0 109.852 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.79 161.65 3.01 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.766 3.644 . . . . 0.0 115.597 173.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.46 148.55 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.875 1.27 . . . . 0.0 110.599 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 m -123.47 173.84 7.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.055 1.342 . . . . 0.0 111.039 -169.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.19 148.48 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.983 1.313 . . . . 0.0 111.533 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 m -154.34 160.21 31.16 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.153 0.981 . . . . 0.0 113.039 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.27 122.34 9.59 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.896 2.398 . . . . 0.0 110.575 170.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.58 136.54 57.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.379 1.471 . . . . 0.0 112.619 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -133.48 9.52 4.0 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.262 1.425 . . . . 0.0 112.41 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.82 8.09 60.1 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.147 1.356 . . . . 0.0 114.882 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.8 p -69.61 153.48 43.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 112.914 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -62.07 -17.7 58.36 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.93 -23.4 63.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.878 1.271 . . . . 0.0 112.544 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -118.27 4.82 11.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.063 1.745 . . . . 0.0 113.162 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.63 139.92 35.63 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.703 1.201 . . . . 0.0 110.774 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -133.74 171.08 14.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.756 1.265 . . . . 0.0 112.149 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.1 mt -125.88 135.53 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 127.571 2.349 . . . . 0.0 106.657 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.0 tp -136.2 126.3 26.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.113 1.365 . . . . 0.0 109.064 -170.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -142.22 140.63 32.36 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.795 0.838 . . . . 0.0 110.833 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.8 t -65.64 141.04 58.53 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.853 0.461 . . . . 0.0 111.006 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -112.11 -52.87 2.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.437 1.095 . . . . 0.0 110.743 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.97 109.28 4.68 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.591 1.156 . . . . 0.0 110.479 169.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.7 m -58.15 -25.25 61.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.948 0.899 . . . . 0.0 111.399 168.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -63.39 -21.52 66.33 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.0 2.12 . . . . 0.0 113.451 174.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.1 m -130.26 9.7 5.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.043 1.737 . . . . 0.0 113.105 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 45.52 33.32 1.32 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.765 2.026 . . . . 0.0 114.217 -169.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.8 p -87.72 143.15 27.31 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.79 -1.193 . . . . 0.0 112.073 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -140.43 140.23 35.39 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.287 1.435 . . . . 0.0 111.052 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.6 p -77.94 142.24 38.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.498 0.719 . . . . 0.0 111.079 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.1 mm -123.91 124.81 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.172 1.389 . . . . 0.0 109.836 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 m -142.31 145.7 36.31 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 125.437 1.495 . . . . 0.0 109.661 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.76 150.08 27.03 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.73 2.287 . . . . 0.0 111.274 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.5 t -65.05 -30.55 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 121.216 -0.927 . . . . 0.0 111.764 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.18 -11.11 82.82 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.3 m -155.49 63.67 3.74 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 125.525 1.53 . . . . 0.0 111.485 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -63.88 -19.24 66.5 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.994 3.129 . . . . 0.0 113.689 -173.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -68.11 -2.18 7.41 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 128.026 2.53 . . . . 0.0 114.553 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.4 m -132.24 166.58 21.54 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.602 1.961 . . . . 0.0 110.86 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -142.39 171.21 14.36 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.331 1.452 . . . . 0.0 112.946 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.27 126.26 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.837 1.255 . . . . 0.0 110.721 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.43 -158.98 7.91 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.475 1.512 . . . . 0.0 111.676 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -139.59 140.41 37.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.355 1.062 . . . . 0.0 111.555 -170.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.01 -166.06 12.75 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.284 1.421 . . . . 0.0 113.193 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.7 137.19 20.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.258 1.423 . . . . 0.0 113.159 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.9 -6.95 64.7 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.779 1.181 . . . . 0.0 114.183 -172.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 48.88 56.76 7.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.552 1.941 . . . . 0.0 114.216 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.95 151.57 78.22 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 126.292 1.837 . . . . 0.0 108.047 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.02 141.91 54.7 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 120.939 1.092 . . . . 0.0 109.626 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.27 152.71 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.372 1.469 . . . . 0.0 111.032 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 49.9 t -79.63 136.28 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.917 0.887 . . . . 0.0 111.07 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -140.84 165.19 31.32 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.674 1.99 . . . . 0.0 111.861 -170.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.64 176.43 2.27 Favored 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 123.558 2.838 . . . . 0.0 113.501 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.29 43.44 1.49 Allowed 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.78 2.987 . . . . 0.0 113.527 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -80.7 13.71 2.45 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.746 1.618 . . . . 0.0 114.407 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 70.74 44.69 0.62 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.714 2.405 . . . . 0.0 113.588 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -64.25 143.8 57.62 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.741 0.817 . . . . 0.0 111.273 169.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.6 m -141.86 156.21 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.403 1.081 . . . . 0.0 112.399 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -127.2 140.95 51.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.075 1.35 . . . . 0.0 111.176 170.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.8 m -78.88 127.04 31.5 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.741 1.216 . . . . 0.0 109.149 172.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.3 mt -115.39 128.64 56.2 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.809 0.843 . . . . 0.0 109.575 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.1 m -131.34 118.27 20.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.243 1.017 . . . . 0.0 110.189 -169.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.7 tp -66.03 145.73 55.52 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.761 -0.587 . . . . 0.0 111.17 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.0 p -127.55 175.35 8.32 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.963 1.705 . . . . 0.0 110.527 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.5 p -57.83 -16.51 11.85 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -155.06 23.74 0.6 Allowed Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.629 1.109 . . . . 0.0 114.565 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.95 -149.83 9.48 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.877 1.227 . . . . 0.0 112.607 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -134.0 171.11 14.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.186 2.194 . . . . 0.0 111.574 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -136.78 154.46 50.55 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.364 2.266 . . . . 0.0 109.95 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.5 mt -134.45 121.04 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.133 1.373 . . . . 0.0 109.355 -169.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -137.0 158.3 44.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.567 1.147 . . . . 0.0 112.614 -170.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.3 -33.38 75.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -171.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.21 -31.36 2.7 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.283 1.42 . . . . 0.0 113.772 -169.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -104.19 -2.21 26.07 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.539 1.536 . . . . 0.0 113.887 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 64.82 13.04 8.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.295 2.238 . . . . 0.0 114.128 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.4 p -69.98 -21.26 63.25 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.588 1.155 . . . . 0.0 112.824 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.89 169.6 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.486 1.515 . . . . 0.0 112.661 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.9 t -140.67 153.71 46.1 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.919 2.487 . . . . 0.0 109.66 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -69.9 144.8 52.35 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.455 -0.778 . . . . 0.0 110.137 168.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.7 p -149.34 171.6 16.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.378 1.071 . . . . 0.0 112.993 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.5 mt -125.15 165.7 17.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.108 1.763 . . . . 0.0 109.625 172.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -105.19 -32.71 8.53 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.904 0.882 . . . . 0.0 111.94 -169.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -140.24 -10.08 1.12 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.757 2.023 . . . . 0.0 112.662 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.68 27.13 12.15 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.569 1.548 . . . . 0.0 114.24 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.9 p -78.31 157.62 29.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.415 1.086 . . . . 0.0 111.807 170.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.87 141.57 58.73 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.259 -0.901 . . . . 0.0 112.161 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.27 4.96 89.22 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.5 1.048 . . . . 0.0 114.458 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -75.13 137.45 41.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.769 1.228 . . . . 0.0 112.402 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.41 128.28 35.15 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.508 -0.745 . . . . 0.0 110.569 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.5 t -64.23 150.71 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.229 0.612 . . . . 0.0 110.557 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.4 t -126.95 161.96 27.08 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.823 1.249 . . . . 0.0 111.796 -175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.7 mt -134.21 142.04 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.98 1.712 . . . . 0.0 108.78 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.84 -156.71 28.81 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 124.631 1.11 . . . . 0.0 110.716 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.77 166.43 1.91 Allowed 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.717 1.259 . . . . 0.0 111.685 169.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -56.35 157.01 5.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.06 0.944 . . . . 0.0 112.82 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.53 136.16 51.34 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.607 1.163 . . . . 0.0 112.312 -172.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.1 t -55.59 -26.84 45.98 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.254 1.822 . . . . 0.0 115.834 -169.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -130.16 -32.82 1.78 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.094 0.958 . . . . 0.0 113.385 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 96.6 p -103.87 -2.25 26.52 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.8 27.76 1.1 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 125.955 1.74 . . . . 0.0 114.859 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -147.64 142.1 26.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.765 2.026 . . . . 0.0 110.943 -169.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -140.74 175.75 9.36 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.956 1.702 . . . . 0.0 111.21 -168.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.55 140.16 26.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.735 1.214 . . . . 0.0 109.299 169.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.62 125.05 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 125.677 1.591 . . . . 0.0 107.354 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -148.98 153.62 38.2 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.8 1.24 . . . . 0.0 109.673 -171.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -67.9 155.22 39.9 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.998 -1.064 . . . . 0.0 112.882 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.328 1.851 . . . . 0.0 111.217 171.154 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 CA--C 1.549 0.94 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 t -159.92 168.21 26.24 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.215 1.406 . . . . 0.0 109.861 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.85 137.2 57.62 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.653 -0.654 . . . . 0.0 112.176 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.73 -162.88 35.41 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.968 0.794 . . . . 0.0 114.604 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -97.14 124.91 41.32 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.215 1.006 . . . . 0.0 109.978 172.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -133.88 173.11 11.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.637 1.575 . . . . 0.0 112.235 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.8 pt -125.88 151.66 32.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 126.051 1.74 . . . . 0.0 108.452 170.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 mt -124.64 119.17 55.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -137.63 148.11 45.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.776 0.83 . . . . 0.0 110.581 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -72.79 149.11 43.92 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.176 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -61.81 -24.94 67.19 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.686 -0.633 . . . . 0.0 112.569 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 N--CA 1.473 0.725 0 C-N-CA 125.545 1.538 . . . . 0.0 109.671 169.604 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 121.78 0.8 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.38 150.83 19.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -168.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.3 tp -60.45 135.63 57.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.806 1.242 . . . . 0.0 110.032 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -129.97 121.06 25.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.803 1.241 . . . . 0.0 111.247 -173.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -65.03 136.29 96.69 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.956 1.302 . . . . 0.0 112.458 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.07 -13.31 21.3 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.51 2.807 . . . . 0.0 114.688 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.01 7.42 80.68 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 124.223 0.916 . . . . 0.0 115.071 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -153.92 166.59 32.48 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.351 1.86 . . . . 0.0 111.299 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -102.57 166.64 10.41 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.743 1.217 . . . . 0.0 111.545 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 51.15 40.93 27.04 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.773 1.629 . . . . 0.0 112.425 -174.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.9 m -141.16 137.89 17.26 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 126.139 1.776 . . . . 0.0 110.47 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -52.71 158.17 6.49 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.736 3.624 . . . . 0.0 115.43 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 t -110.26 148.99 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.861 1.264 . . . . 0.0 110.74 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -121.66 176.5 5.68 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.216 1.407 . . . . 0.0 111.494 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.34 146.04 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.109 1.364 . . . . 0.0 111.647 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.1 m -153.79 163.06 25.13 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.469 1.108 . . . . 0.0 113.303 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -60.49 124.38 14.98 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.394 2.73 . . . . 0.0 110.418 168.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.46 136.21 57.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.33 1.052 . . . . 0.0 111.786 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -132.81 7.72 4.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.023 1.329 . . . . 0.0 112.449 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.53 9.61 58.78 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.92 1.247 . . . . 0.0 114.592 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.0 p -68.77 154.3 42.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.26 1.424 . . . . 0.0 112.729 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.4 p -62.54 -17.12 59.2 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -70.48 -24.41 62.86 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.858 1.263 . . . . 0.0 112.402 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.23 3.14 12.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.04 1.736 . . . . 0.0 113.235 -176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.89 140.26 32.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 110.558 171.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -134.15 171.31 14.41 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.763 1.268 . . . . 0.0 111.7 -169.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.4 mt -125.92 136.28 61.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 127.052 2.141 . . . . 0.0 106.566 -175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.6 tp -137.41 124.47 21.53 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.1 1.36 . . . . 0.0 108.901 -169.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -142.62 134.26 26.67 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.768 0.827 . . . . 0.0 110.946 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.3 t -63.78 137.03 57.88 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.998 0.519 . . . . 0.0 110.853 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -112.79 -47.38 3.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.324 1.05 . . . . 0.0 111.691 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.46 111.46 4.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.302 1.441 . . . . 0.0 110.708 170.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.2 m -58.99 -24.32 62.61 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.987 0.915 . . . . 0.0 111.533 168.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -64.18 -21.82 66.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.872 2.069 . . . . 0.0 113.522 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 m -130.33 11.75 5.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.684 1.594 . . . . 0.0 112.853 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 44.09 32.26 0.63 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.592 1.957 . . . . 0.0 113.509 -169.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 p -87.11 139.82 30.18 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.163 -0.96 . . . . 0.0 111.876 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -135.44 141.92 45.5 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.636 1.574 . . . . 0.0 110.978 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -77.5 145.72 36.82 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.808 0.443 . . . . 0.0 110.849 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.8 mm -127.14 126.73 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.32 1.448 . . . . 0.0 109.673 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 57.1 m -144.01 147.94 40.0 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 126.103 1.761 . . . . 0.0 109.578 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.63 149.93 24.11 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.887 2.392 . . . . 0.0 111.445 175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.91 -29.72 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.058 -1.026 . . . . 0.0 111.811 173.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.21 -13.97 81.12 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 115.424 0.929 . . . . 0.0 115.424 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.0 m -151.98 62.48 4.72 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 125.682 1.593 . . . . 0.0 111.536 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.13 -13.65 39.04 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.414 2.742 . . . . 0.0 114.034 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -73.18 6.33 2.86 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.425 1.89 . . . . 0.0 114.063 170.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -138.89 166.31 24.79 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.295 1.838 . . . . 0.0 111.088 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -136.56 171.23 14.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.348 1.459 . . . . 0.0 113.089 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.6 mm -120.9 130.62 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.143 1.377 . . . . 0.0 110.929 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.75 -156.15 6.9 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.917 1.722 . . . . 0.0 111.834 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -142.6 142.37 32.12 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.402 1.081 . . . . 0.0 111.518 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.22 -166.44 13.13 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.31 1.433 . . . . 0.0 113.401 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.2 138.65 20.13 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.085 1.354 . . . . 0.0 113.221 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.7 -6.57 67.58 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.724 1.154 . . . . 0.0 114.089 -172.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 49.67 56.54 7.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.578 1.951 . . . . 0.0 114.21 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.08 150.23 75.48 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 126.153 1.781 . . . . 0.0 108.127 169.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.94 142.38 56.73 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.192 1.261 . . . . 0.0 109.693 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.28 148.16 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.724 1.61 . . . . 0.0 111.096 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.73 138.8 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.938 0.895 . . . . 0.0 110.575 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.7 mt -140.53 161.74 53.05 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.31 1.844 . . . . 0.0 111.013 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.12 164.83 30.56 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.94 2.427 . . . . 0.0 111.879 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.23 119.55 6.07 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.528 2.152 . . . . 0.0 110.47 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -147.5 -89.6 0.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.821 0.848 . . . . 0.0 110.977 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -155.91 17.25 0.37 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.117 1.367 . . . . 0.0 113.235 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -67.56 135.86 53.61 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.525 -0.735 . . . . 0.0 112.075 -173.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.7 m -145.03 159.83 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.034 1.334 . . . . 0.0 112.646 -175.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -129.55 136.28 49.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.538 1.535 . . . . 0.0 110.925 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.3 m -74.35 128.98 36.91 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 109.437 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -118.01 125.81 51.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.175 0.99 . . . . 0.0 109.335 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.0 m -130.52 118.32 20.91 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.272 1.029 . . . . 0.0 111.155 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.99 148.39 51.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.641 0.776 . . . . 0.0 111.34 173.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.8 p -132.26 174.42 10.24 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.035 1.734 . . . . 0.0 110.35 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.8 m -61.67 -10.39 8.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.54 36.71 0.39 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.396 0.998 . . . . 0.0 113.944 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.24 -166.57 34.72 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.793 1.187 . . . . 0.0 112.708 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -121.23 166.83 13.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.484 1.914 . . . . 0.0 111.293 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -135.09 152.31 51.54 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.592 1.557 . . . . 0.0 110.454 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.58 117.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.136 1.374 . . . . 0.0 109.263 -169.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -136.48 157.73 46.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.66 1.184 . . . . 0.0 112.373 -169.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -63.72 -31.06 72.12 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -171.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.14 -26.14 3.27 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.313 1.435 . . . . 0.0 114.175 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -113.62 1.21 14.86 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.112 1.765 . . . . 0.0 114.0 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 64.32 12.87 7.57 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.453 2.301 . . . . 0.0 114.239 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.3 p -73.22 -22.37 60.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.163 0.985 . . . . 0.0 112.9 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 m -144.69 170.85 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.66 1.584 . . . . 0.0 112.437 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.5 t -144.27 150.43 37.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 129.215 3.006 . . . . 0.0 108.885 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.5 m0 -69.94 145.87 51.57 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.16 -0.962 . . . . 0.0 110.52 169.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.0 p -156.41 174.22 15.74 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.805 1.242 . . . . 0.0 112.575 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -120.35 171.87 8.21 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.144 1.777 . . . . 0.0 110.059 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -108.27 -31.83 7.72 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.968 1.307 . . . . 0.0 110.811 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -142.83 -13.34 0.75 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 127.425 2.29 . . . . 0.0 112.96 169.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.93 22.04 8.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.615 1.966 . . . . 0.0 114.729 -170.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.7 p -70.7 158.28 36.53 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.64 1.176 . . . . 0.0 111.944 170.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.56 136.84 57.44 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.244 -0.91 . . . . 0.0 111.886 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.09 0.74 89.67 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.644 1.116 . . . . 0.0 114.367 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -72.32 138.86 47.62 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.806 1.303 . . . . 0.0 112.584 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.9 125.41 28.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.463 0.705 . . . . 0.0 110.26 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.0 153.56 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.596 0.713 . . . . 0.0 110.315 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.1 m -135.34 165.19 26.03 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.193 1.397 . . . . 0.0 111.572 -172.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.8 mt -134.07 142.2 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.262 1.425 . . . . 0.0 108.96 -175.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.91 179.54 48.02 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 124.602 1.096 . . . . 0.0 111.496 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.48 -40.83 62.8 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.005 1.402 . . . . 0.0 114.274 -173.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -169.6 174.11 6.02 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.857 2.463 . . . . 0.0 111.61 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.27 150.63 39.52 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.574 1.149 . . . . 0.0 111.908 169.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -83.06 -7.02 59.7 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -169.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -142.38 -40.93 0.34 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.205 1.002 . . . . 0.0 112.524 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.9 p -95.3 3.54 54.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.432 1.493 . . . . 0.0 114.212 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.29 22.91 0.61 Allowed Glycine 0 CA--C 1.544 1.87 0 C-N-CA 125.818 1.675 . . . . 0.0 115.802 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -147.58 143.98 28.14 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.836 1.655 . . . . 0.0 111.066 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -136.45 175.54 9.52 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.398 1.879 . . . . 0.0 111.338 -169.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.45 137.76 25.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.653 1.181 . . . . 0.0 109.373 169.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -116.01 124.24 72.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 125.916 1.686 . . . . 0.0 107.14 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.6 153.09 38.98 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.845 1.258 . . . . 0.0 109.497 -171.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.08 155.4 39.63 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.008 -1.057 . . . . 0.0 112.803 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.3 t . . . . . 0 C--O 1.252 1.21 0 C-N-CA 126.121 1.769 . . . . 0.0 111.292 171.879 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 CA--C 1.543 0.699 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.6 t -161.58 170.46 19.78 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.302 1.841 . . . . 0.0 109.232 174.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.03 134.12 54.39 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.564 -0.71 . . . . 0.0 112.308 173.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.08 -161.24 34.2 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.114 0.864 . . . . 0.0 114.311 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -100.49 125.8 46.85 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.125 0.97 . . . . 0.0 110.213 173.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -134.86 172.76 12.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.537 1.535 . . . . 0.0 112.514 -170.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.97 154.69 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 126.461 1.904 . . . . 0.0 108.657 170.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 mt -129.92 118.92 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -141.61 153.37 44.73 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.68 0.792 . . . . 0.0 112.237 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -84.11 138.35 33.08 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.793 -0.567 . . . . 0.0 112.031 -172.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -63.36 -19.83 64.99 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.3 t . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 123.908 0.883 . . . . 0.0 112.319 173.174 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.9 tp . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 121.6 0.714 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.89 150.85 30.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.876 1.27 . . . . 0.0 113.12 -170.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.2 tp -61.44 139.56 58.19 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.256 1.022 . . . . 0.0 110.016 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.2 m -130.7 122.12 26.74 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.564 1.145 . . . . 0.0 111.584 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -64.24 135.52 96.37 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.637 1.175 . . . . 0.0 112.061 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.07 -13.68 21.2 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.428 2.752 . . . . 0.0 114.852 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.35 7.28 76.63 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.083 0.849 . . . . 0.0 114.957 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -156.01 164.46 38.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.583 1.553 . . . . 0.0 112.085 -174.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -90.77 164.47 14.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.442 1.097 . . . . 0.0 111.761 -174.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 49.48 39.38 16.59 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.843 1.657 . . . . 0.0 113.586 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.9 m -136.5 140.73 33.23 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.674 1.59 . . . . 0.0 111.198 -169.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -45.55 156.58 0.37 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 126.093 4.528 . . . . 0.0 115.277 169.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.92 150.74 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.719 1.207 . . . . 0.0 110.065 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.9 m -124.44 176.05 6.74 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.744 1.618 . . . . 0.0 110.265 -169.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.09 147.53 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.679 1.127 . . . . 0.0 112.1 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 m -150.84 160.83 31.63 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.94 1.296 . . . . 0.0 111.795 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -64.22 134.21 41.35 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.009 1.806 . . . . 0.0 111.613 170.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.6 tp -67.53 137.73 55.97 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.645 0.778 . . . . 0.0 111.515 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -138.29 8.81 2.7 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.864 1.265 . . . . 0.0 112.98 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.46 -7.07 58.89 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 125.058 1.313 . . . . 0.0 115.095 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -67.05 145.81 54.98 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.549 1.174 . . . . 0.0 111.827 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.4 p -60.33 -12.3 8.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.756 1.622 . . . . 0.0 114.96 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -68.66 -23.7 64.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.216 1.006 . . . . 0.0 112.36 174.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -114.76 4.5 14.98 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.573 1.549 . . . . 0.0 113.231 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.1 140.9 36.72 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.045 0.938 . . . . 0.0 111.126 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -134.14 170.56 15.49 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 122.83 1.3 . . . . 0.0 111.94 -169.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.58 135.34 62.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 127.485 2.314 . . . . 0.0 106.208 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.3 tp -136.62 124.17 22.24 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.044 1.338 . . . . 0.0 108.561 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -142.33 139.31 31.77 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.347 0.659 . . . . 0.0 111.048 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 t -64.59 138.55 58.47 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.966 0.506 . . . . 0.0 110.735 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -110.23 -53.03 2.72 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.453 1.101 . . . . 0.0 111.047 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.14 109.97 5.08 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.024 1.329 . . . . 0.0 110.648 169.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.4 m -57.73 -23.51 52.27 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.997 0.919 . . . . 0.0 111.748 168.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -65.21 -22.18 66.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.061 2.144 . . . . 0.0 113.439 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 m -130.32 12.03 5.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.145 1.778 . . . . 0.0 112.784 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 42.74 34.96 0.64 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.938 2.095 . . . . 0.0 113.412 -169.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -86.03 143.96 27.83 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 120.966 -1.084 . . . . 0.0 112.391 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -138.54 140.49 39.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.25 1.42 . . . . 0.0 111.068 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.8 p -77.84 146.36 35.75 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.206 0.603 . . . . 0.0 110.75 171.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.3 mm -130.79 120.46 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.284 1.433 . . . . 0.0 110.426 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.9 m -141.71 148.77 51.04 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.367 1.467 . . . . 0.0 110.343 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.08 148.34 24.49 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.841 2.361 . . . . 0.0 111.674 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.28 -31.12 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 121.198 -0.939 . . . . 0.0 111.881 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.74 -23.56 72.23 Favored Glycine 0 CA--C 1.539 1.543 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.1 m -144.43 60.66 7.92 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.315 1.446 . . . . 0.0 112.352 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.69 -12.1 26.96 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.502 2.801 . . . . 0.0 114.143 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -75.63 14.46 0.63 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.812 2.045 . . . . 0.0 113.336 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -142.32 171.61 13.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.995 2.118 . . . . 0.0 111.289 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -144.08 167.03 23.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.946 1.299 . . . . 0.0 112.027 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -118.38 131.74 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.517 1.127 . . . . 0.0 111.185 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -148.63 -157.72 7.69 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.952 1.739 . . . . 0.0 111.284 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -141.59 145.19 34.76 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.265 1.032 . . . . 0.0 111.802 -174.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.4 -164.22 11.75 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.491 1.52 . . . . 0.0 112.955 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.62 138.3 23.11 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.957 1.303 . . . . 0.0 113.045 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.63 -3.51 63.18 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.684 1.135 . . . . 0.0 114.322 -173.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 47.56 55.19 8.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.295 1.838 . . . . 0.0 113.713 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.91 138.76 31.49 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 127.693 2.397 . . . . 0.0 107.45 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.27 142.48 55.34 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 N-CA-C 109.206 -1.113 . . . . 0.0 109.206 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 m -133.27 151.08 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.139 1.376 . . . . 0.0 111.627 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.19 136.53 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.753 0.821 . . . . 0.0 110.783 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.9 mt -139.41 163.76 43.29 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 127.154 2.182 . . . . 0.0 110.286 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.16 159.31 53.67 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.153 1.902 . . . . 0.0 111.464 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -71.4 118.18 5.53 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.744 2.296 . . . . 0.0 110.294 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -145.47 -88.76 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.763 0.825 . . . . 0.0 111.018 -175.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -155.21 15.89 0.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.932 1.293 . . . . 0.0 113.387 -173.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -69.93 133.81 47.71 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.437 -0.789 . . . . 0.0 111.581 -175.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.0 m -141.8 160.99 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.422 1.089 . . . . 0.0 112.441 -174.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -129.06 134.85 48.27 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.339 1.456 . . . . 0.0 110.441 170.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.3 m -75.66 129.8 37.71 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.388 1.075 . . . . 0.0 109.406 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.1 mt -120.46 132.23 55.12 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.207 1.003 . . . . 0.0 109.786 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.1 m -133.2 118.26 18.42 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.194 0.998 . . . . 0.0 110.357 -170.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.28 137.27 58.23 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.862 1.265 . . . . 0.0 110.449 171.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 p -126.46 173.17 9.59 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.239 1.415 . . . . 0.0 111.798 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.4 m -58.13 -10.18 1.79 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.0 36.82 0.33 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.128 1.347 . . . . 0.0 113.251 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.78 -150.2 17.42 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.398 1.099 . . . . 0.0 114.148 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -132.83 169.59 16.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.949 2.499 . . . . 0.0 110.564 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -135.22 150.81 50.16 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.901 2.081 . . . . 0.0 109.451 171.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.1 mt -133.32 119.94 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.207 1.403 . . . . 0.0 109.515 -169.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -137.07 157.06 47.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.201 1.0 . . . . 0.0 112.552 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.09 -31.68 71.36 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.6 -40.28 1.63 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.798 1.666 . . . . 0.0 113.175 -172.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.3 -10.08 59.75 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.6 1.16 . . . . 0.0 113.946 173.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 67.39 12.95 9.18 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.798 2.039 . . . . 0.0 112.758 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.5 p -73.24 -23.97 60.42 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.281 1.432 . . . . 0.0 112.692 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.3 m -142.83 170.39 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.863 1.665 . . . . 0.0 112.025 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.4 t -142.15 151.81 42.6 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 128.903 2.881 . . . . 0.0 109.359 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -70.02 143.55 52.51 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 119.153 0.888 . . . . 0.0 111.29 169.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.6 p -152.08 170.81 19.03 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.822 1.249 . . . . 0.0 112.969 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.89 166.23 18.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.185 1.794 . . . . 0.0 110.111 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -109.02 -32.35 7.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.969 0.908 . . . . 0.0 111.689 -169.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -139.5 -10.89 1.21 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.436 1.894 . . . . 0.0 112.729 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.3 23.97 7.77 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.993 1.717 . . . . 0.0 114.685 -170.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.7 p -70.52 153.12 43.25 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.028 -1.045 . . . . 0.0 111.457 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.18 137.91 57.92 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.116 -0.99 . . . . 0.0 111.444 172.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.19 0.3 88.7 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.472 1.034 . . . . 0.0 114.251 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -69.56 142.38 53.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.873 1.337 . . . . 0.0 112.609 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.14 116.48 16.87 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.385 -0.822 . . . . 0.0 109.693 170.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.36 150.1 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.573 0.749 . . . . 0.0 111.59 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 57.5 m -129.81 169.54 15.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.591 1.556 . . . . 0.0 111.468 -169.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.6 mt -135.26 143.63 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.338 1.455 . . . . 0.0 108.862 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.35 179.12 47.49 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.672 1.13 . . . . 0.0 111.666 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.69 -41.98 61.84 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.092 1.446 . . . . 0.0 114.271 -172.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -168.81 172.28 7.93 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.915 2.486 . . . . 0.0 109.818 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.07 138.62 33.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.144 0.978 . . . . 0.0 112.436 169.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.0 t -62.97 -14.75 51.38 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -169.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.43 -36.89 0.43 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.38 1.072 . . . . 0.0 112.958 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.8 p -98.33 2.27 47.89 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.362 1.465 . . . . 0.0 114.529 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.33 12.64 1.76 Allowed Glycine 0 CA--C 1.544 1.86 0 C-N-CA 125.547 1.546 . . . . 0.0 116.202 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -135.48 145.34 47.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.22 1.808 . . . . 0.0 111.364 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -139.35 175.87 9.19 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.335 1.454 . . . . 0.0 111.98 -169.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.65 138.99 38.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.764 1.225 . . . . 0.0 109.421 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.5 125.74 74.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 125.404 1.481 . . . . 0.0 107.276 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -148.93 153.99 38.78 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.798 1.239 . . . . 0.0 109.304 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -67.49 155.86 38.05 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.094 -1.004 . . . . 0.0 112.827 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.073 1.749 . . . . 0.0 111.278 172.223 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.542 0.645 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 t -160.78 170.95 19.69 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.141 1.776 . . . . 0.0 109.414 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.22 133.1 49.92 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.631 -0.668 . . . . 0.0 111.656 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.25 -163.01 35.78 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.975 0.798 . . . . 0.0 114.183 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -98.63 125.64 43.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.826 0.851 . . . . 0.0 109.98 171.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -134.3 172.75 12.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.332 1.453 . . . . 0.0 112.284 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.0 pt -125.46 156.64 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 126.352 1.861 . . . . 0.0 109.058 171.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.8 mt -130.08 119.76 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -142.28 152.24 42.81 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.712 0.805 . . . . 0.0 112.346 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -84.3 137.81 33.25 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.871 -0.518 . . . . 0.0 111.736 -174.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -59.34 -19.54 47.41 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.3 t . . . . . 0 N--CA 1.478 0.929 0 C-N-CA 124.448 1.099 . . . . 0.0 112.834 175.923 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.6 tp . . . . . 0 N--CA 1.468 0.464 0 CA-C-O 121.171 0.51 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.98 148.2 26.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -59.3 135.25 57.59 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.006 1.323 . . . . 0.0 110.058 169.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 m -126.82 121.09 30.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.974 1.31 . . . . 0.0 110.877 -174.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -63.94 138.02 97.27 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.224 1.409 . . . . 0.0 111.913 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.03 -13.56 21.32 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.418 2.745 . . . . 0.0 114.845 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.87 4.43 72.42 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.481 1.039 . . . . 0.0 114.955 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.4 ptt-85 -156.14 172.95 17.55 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.294 1.838 . . . . 0.0 111.565 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -101.04 168.79 9.37 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.837 1.255 . . . . 0.0 111.396 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 50.04 35.08 9.15 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.002 2.121 . . . . 0.0 113.849 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.9 m -133.67 141.73 41.18 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.693 1.597 . . . . 0.0 111.274 -169.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -45.72 160.27 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.859 1 C-N-CA 126.174 4.582 . . . . 0.0 115.259 169.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.4 t -116.11 154.73 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.606 1.162 . . . . 0.0 109.964 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -128.5 172.04 11.52 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.429 1.492 . . . . 0.0 110.857 -169.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.61 149.23 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.902 1.281 . . . . 0.0 111.478 176.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 m -157.14 161.36 29.57 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.402 1.081 . . . . 0.0 113.122 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.04 122.28 11.42 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.779 2.986 . . . . 0.0 111.449 169.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.9 tp -59.01 138.45 57.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.2 1.0 . . . . 0.0 111.81 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -132.71 5.15 3.94 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.944 1.298 . . . . 0.0 112.756 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.6 7.33 60.96 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.784 1.183 . . . . 0.0 114.742 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.9 p -67.27 153.9 42.59 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.032 1.333 . . . . 0.0 112.541 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.7 p -62.49 -17.3 59.32 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -70.84 -22.3 62.34 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.552 1.141 . . . . 0.0 112.338 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.23 1.42 11.88 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.483 1.513 . . . . 0.0 113.638 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.34 146.08 27.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.522 1.129 . . . . 0.0 111.018 171.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -138.15 172.44 12.92 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.582 1.182 . . . . 0.0 111.901 -169.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.8 mt -119.6 136.79 55.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.847 2.459 . . . . 0.0 106.792 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.2 tp -135.99 128.21 29.98 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.132 1.373 . . . . 0.0 109.311 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.09 140.67 29.61 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.875 0.87 . . . . 0.0 110.785 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.9 t -66.01 140.31 58.28 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.726 0.41 . . . . 0.0 110.758 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -109.68 -52.73 2.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.544 1.138 . . . . 0.0 110.47 173.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.17 108.48 4.27 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.48 1.112 . . . . 0.0 110.691 169.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -57.44 -25.5 59.74 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.964 0.906 . . . . 0.0 111.56 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -62.85 -20.51 65.17 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.052 2.141 . . . . 0.0 113.535 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -130.23 9.01 5.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.132 1.773 . . . . 0.0 112.671 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 47.5 29.28 1.34 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.372 1.869 . . . . 0.0 114.325 -169.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.9 p -87.48 144.73 26.58 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.686 -1.259 . . . . 0.0 112.193 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -139.43 142.62 37.42 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.576 1.55 . . . . 0.0 111.288 -176.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.2 p -81.28 149.64 28.89 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.414 0.685 . . . . 0.0 110.882 171.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.5 mm -133.59 124.97 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.509 1.524 . . . . 0.0 110.481 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 m -142.83 153.27 60.86 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.889 1.676 . . . . 0.0 110.362 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.73 151.82 28.6 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.044 2.496 . . . . 0.0 111.199 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.9 -25.74 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.987 -1.071 . . . . 0.0 113.303 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.11 -18.19 54.25 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 123.927 0.775 . . . . 0.0 114.727 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.9 m -141.31 60.3 11.84 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 125.514 1.526 . . . . 0.0 111.536 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -62.22 -17.1 55.07 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.796 2.997 . . . . 0.0 113.286 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -72.15 9.47 0.97 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 128.191 2.596 . . . . 0.0 113.384 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 p -137.79 169.24 18.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.165 2.186 . . . . 0.0 111.095 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -143.73 164.6 29.99 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.001 1.32 . . . . 0.0 111.566 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -115.53 127.43 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.374 1.07 . . . . 0.0 111.154 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.49 -160.55 8.46 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.004 1.764 . . . . 0.0 111.367 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -142.93 147.88 35.98 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.251 1.026 . . . . 0.0 111.917 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -153.06 -159.12 8.88 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.531 1.539 . . . . 0.0 112.92 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.3 141.14 19.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.736 1.214 . . . . 0.0 113.077 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.7 -4.24 72.17 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.613 1.102 . . . . 0.0 114.359 -173.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 46.99 53.87 9.97 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.139 1.775 . . . . 0.0 113.625 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.32 138.53 32.44 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 127.6 2.36 . . . . 0.0 107.266 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.54 143.17 56.14 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 108.844 -1.252 . . . . 0.0 108.844 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.3 m -132.62 148.41 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.951 1.301 . . . . 0.0 110.818 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.2 t -75.54 137.16 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.547 0.739 . . . . 0.0 110.159 173.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.3 mt -142.92 164.68 30.65 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.702 2.001 . . . . 0.0 110.399 -171.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.87 155.59 43.58 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.216 1.944 . . . . 0.0 110.982 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.95 125.09 17.16 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.431 2.754 . . . . 0.0 112.684 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -145.12 -107.47 0.11 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.96 1.304 . . . . 0.0 109.107 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -143.56 20.06 1.85 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.174 1.789 . . . . 0.0 110.928 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -68.14 134.62 50.83 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.231 -0.918 . . . . 0.0 111.511 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.0 m -143.0 161.88 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.015 0.926 . . . . 0.0 112.065 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -129.96 134.36 47.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.017 1.327 . . . . 0.0 109.979 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.0 m -70.85 127.39 32.46 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.988 1.315 . . . . 0.0 108.743 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.1 mt -125.0 115.34 20.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.113 0.965 . . . . 0.0 109.027 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.7 m -136.62 133.68 36.55 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.49 0.716 . . . . 0.0 112.564 -169.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.9 tp -66.12 150.21 49.09 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.878 1.271 . . . . 0.0 112.602 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 p -136.89 175.81 9.28 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.663 1.585 . . . . 0.0 112.01 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.8 m -62.89 -4.97 2.44 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.75 19.64 0.21 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.455 1.026 . . . . 0.0 115.044 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.38 -156.87 28.32 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.682 1.135 . . . . 0.0 112.189 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.6 170.55 9.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.943 2.097 . . . . 0.0 110.91 174.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -132.21 149.52 52.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.828 1.651 . . . . 0.0 110.952 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.4 mt -135.11 117.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.164 1.386 . . . . 0.0 109.203 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -134.72 158.75 43.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.218 1.007 . . . . 0.0 111.942 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.03 -21.98 66.53 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -171.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.51 -40.28 1.83 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.375 1.464 . . . . 0.0 112.716 -170.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -98.26 5.22 48.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.329 1.451 . . . . 0.0 113.836 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 58.14 14.49 2.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.256 2.222 . . . . 0.0 114.221 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.3 p -72.97 -23.2 60.63 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.012 0.925 . . . . 0.0 112.547 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.0 m -143.79 173.01 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.768 1.627 . . . . 0.0 112.284 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.3 t -144.23 150.82 38.55 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.78 2.832 . . . . 0.0 109.106 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -70.24 145.03 51.65 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.115 -0.99 . . . . 0.0 111.372 169.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 99.3 p -153.63 173.28 16.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.715 1.206 . . . . 0.0 112.418 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.8 mt -126.39 174.1 8.85 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.128 1.771 . . . . 0.0 109.687 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -115.66 -33.5 5.17 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.996 0.918 . . . . 0.0 111.111 -170.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -141.52 -10.66 0.93 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.46 1.904 . . . . 0.0 112.946 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.84 22.37 6.98 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.96 1.704 . . . . 0.0 114.824 -170.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.5 p -70.94 158.02 37.18 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.115 0.966 . . . . 0.0 111.826 170.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.0 139.98 57.7 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.132 -0.98 . . . . 0.0 112.01 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.87 2.75 88.85 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.345 0.974 . . . . 0.0 114.064 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -69.93 139.09 52.86 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.651 1.225 . . . . 0.0 112.148 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.75 120.09 19.82 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.746 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.18 150.73 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.436 0.694 . . . . 0.0 111.202 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.2 m -130.33 167.71 18.08 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.058 1.343 . . . . 0.0 111.561 -171.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.3 mt -134.94 145.14 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.291 1.436 . . . . 0.0 108.753 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.4 -179.86 47.95 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 124.89 1.234 . . . . 0.0 111.231 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.39 -39.48 60.92 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.217 1.508 . . . . 0.0 113.849 -175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -169.96 175.4 5.14 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.889 2.476 . . . . 0.0 111.826 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.87 162.12 36.27 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.306 1.442 . . . . 0.0 111.687 169.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.4 t -92.7 -13.28 29.61 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -169.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -140.78 -32.49 0.57 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.541 1.137 . . . . 0.0 113.331 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.6 p -107.31 4.55 26.61 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.678 1.591 . . . . 0.0 114.045 -173.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.51 15.35 1.16 Allowed Glycine 0 CA--C 1.541 1.709 0 C-N-CA 126.348 1.928 . . . . 0.0 115.513 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -141.26 147.34 38.07 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.563 1.945 . . . . 0.0 110.353 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -141.1 177.48 8.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.21 1.804 . . . . 0.0 110.726 -169.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.23 142.61 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.025 0.93 . . . . 0.0 109.834 169.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.44 126.98 75.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.544 1.538 . . . . 0.0 107.053 173.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.91 153.84 38.58 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.908 1.283 . . . . 0.0 109.088 -170.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -66.78 155.06 39.22 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.049 -1.032 . . . . 0.0 112.53 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.2 t . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.991 1.716 . . . . 0.0 111.239 172.635 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 t -157.8 167.57 29.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.046 1.338 . . . . 0.0 110.207 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.14 135.6 53.79 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.928 -0.483 . . . . 0.0 111.275 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.6 -162.55 35.94 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 115.161 0.824 . . . . 0.0 115.161 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.96 119.7 35.93 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.946 1.298 . . . . 0.0 109.909 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -133.85 170.58 15.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.708 1.203 . . . . 0.0 112.468 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.8 pt -129.65 153.95 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 126.385 1.874 . . . . 0.0 108.763 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.7 mt -130.61 119.61 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -140.03 148.02 41.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.579 0.752 . . . . 0.0 111.639 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -75.72 137.46 40.64 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.592 -0.692 . . . . 0.0 111.213 -172.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -60.58 -29.23 69.05 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.39 1.076 . . . . 0.0 113.714 -175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 123.706 0.802 . . . . 0.0 111.669 178.766 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.8 mt . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 121.385 0.612 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.34 145.61 26.26 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.162 0.985 . . . . 0.0 112.44 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.51 132.18 50.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.922 0.889 . . . . 0.0 109.242 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.3 m -130.91 127.29 38.18 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.098 0.959 . . . . 0.0 110.826 -170.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.16 129.3 94.41 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.24 1.416 . . . . 0.0 111.142 -175.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.01 -11.08 19.72 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.078 2.519 . . . . 0.0 114.164 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.12 -4.28 52.08 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.5 1.047 . . . . 0.0 115.196 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -160.72 166.88 27.99 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.067 1.433 . . . . 0.0 113.035 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -89.17 161.97 16.17 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.109 1.764 . . . . 0.0 111.039 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 56.07 38.32 29.78 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.067 1.747 . . . . 0.0 113.783 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.7 m -141.86 140.91 20.63 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.401 1.88 . . . . 0.0 109.685 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.91 148.66 71.03 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.043 2.495 . . . . 0.0 113.717 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.65 157.61 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.061 1.344 . . . . 0.0 110.653 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -126.0 171.49 10.74 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.416 1.486 . . . . 0.0 111.115 -171.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -127.59 139.08 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 121.01 -1.056 . . . . 0.0 111.3 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -161.18 168.93 10.66 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.536 1.134 . . . . 0.0 113.161 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.83 152.8 12.76 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.604 3.536 . . . . 0.0 114.304 169.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.02 134.95 51.29 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.083 1.753 . . . . 0.0 110.094 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -130.88 -10.93 3.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.817 1.647 . . . . 0.0 113.68 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.99 -4.28 16.43 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.655 1.598 . . . . 0.0 114.395 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.0 t -63.07 165.13 7.41 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.036 1.418 . . . . 0.0 113.035 175.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.0 p -71.6 -15.18 62.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.66 1.184 . . . . 0.0 113.972 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.14 -31.33 72.49 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.417 1.008 . . . . 0.0 112.823 -178.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -113.22 4.84 16.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.356 1.462 . . . . 0.0 112.843 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.66 145.52 27.51 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.718 1.207 . . . . 0.0 111.614 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -141.48 174.12 10.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.646 1.212 . . . . 0.0 111.743 -169.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.7 mt -125.7 136.72 59.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.921 2.089 . . . . 0.0 107.357 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.3 tp -134.63 129.65 35.22 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.648 1.579 . . . . 0.0 108.816 -171.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.9 mtt85 -146.29 131.4 18.33 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.308 0.643 . . . . 0.0 110.64 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -64.33 138.0 58.2 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.401 0.546 . . . . 0.0 111.068 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -115.1 -47.78 2.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.332 1.053 . . . . 0.0 111.605 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.68 110.46 4.3 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.487 1.115 . . . . 0.0 111.476 170.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.9 m -59.51 -24.69 63.86 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.957 0.903 . . . . 0.0 111.412 168.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -63.96 -21.4 66.47 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.915 2.086 . . . . 0.0 113.495 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -130.18 9.28 5.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.674 1.59 . . . . 0.0 112.852 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 46.02 33.7 1.76 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.533 1.933 . . . . 0.0 113.55 -169.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.0 p -93.37 138.62 31.53 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.001 -1.062 . . . . 0.0 112.031 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -134.69 145.13 48.24 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.204 1.802 . . . . 0.0 110.789 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.7 p -77.98 152.75 32.95 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.854 -0.529 . . . . 0.0 110.958 171.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.1 mm -129.11 130.11 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.568 1.547 . . . . 0.0 109.045 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.8 m -142.99 145.98 35.34 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.628 1.571 . . . . 0.0 110.612 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.06 146.77 32.83 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.185 2.59 . . . . 0.0 111.102 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.84 -24.98 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.943 -1.098 . . . . 0.0 113.427 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.4 -22.15 63.17 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.743 0.687 . . . . 0.0 114.197 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.2 m -143.04 64.91 15.02 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 126.144 1.777 . . . . 0.0 110.473 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -63.76 -15.37 48.49 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.197 2.598 . . . . 0.0 113.364 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -71.94 0.3 9.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.229 1.811 . . . . 0.0 113.918 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m -131.01 173.63 10.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.916 1.686 . . . . 0.0 111.545 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -140.6 171.83 13.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.556 1.142 . . . . 0.0 113.474 -170.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.07 130.64 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.234 1.414 . . . . 0.0 110.587 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.14 -158.26 7.66 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.8 1.667 . . . . 0.0 111.513 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -142.42 145.35 33.71 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.351 1.075 . . . . 0.0 111.956 -173.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.62 -163.46 11.28 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.481 1.515 . . . . 0.0 112.942 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.83 138.17 24.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.904 1.281 . . . . 0.0 113.081 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.36 -6.78 61.52 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.821 1.2 . . . . 0.0 114.173 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 48.17 56.22 7.67 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.417 1.887 . . . . 0.0 114.177 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.02 149.2 67.7 Favored Pre-proline 0 C--O 1.239 0.512 0 C-N-CA 126.511 1.924 . . . . 0.0 107.896 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -69.76 146.01 58.89 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.338 1.358 . . . . 0.0 110.073 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.27 150.01 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.966 1.706 . . . . 0.0 111.274 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.81 134.66 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.085 0.954 . . . . 0.0 110.179 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.7 mt -137.74 162.46 54.39 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.79 1.636 . . . . 0.0 112.243 -169.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.75 167.85 21.83 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.267 2.645 . . . . 0.0 111.828 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.86 127.03 12.5 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.318 2.012 . . . . 0.0 110.676 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -149.78 -93.32 0.07 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.789 0.836 . . . . 0.0 110.541 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -155.4 18.14 0.41 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.908 1.683 . . . . 0.0 112.343 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -66.04 135.4 54.59 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.73 -0.606 . . . . 0.0 111.64 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -144.99 160.8 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.968 1.307 . . . . 0.0 111.756 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -130.32 144.24 51.26 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.53 1.532 . . . . 0.0 110.537 170.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.1 m -76.31 134.83 39.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.163 1.385 . . . . 0.0 109.409 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.21 125.62 50.54 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.413 1.085 . . . . 0.0 109.478 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.8 m -132.3 117.0 17.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.672 0.789 . . . . 0.0 110.246 -170.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 tp -66.16 146.72 54.31 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.181 0.592 . . . . 0.0 111.109 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.1 p -127.59 -177.97 4.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.593 1.557 . . . . 0.0 111.627 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.0 p -59.48 -13.57 9.37 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.13 25.85 0.19 Allowed Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.202 0.841 . . . . 0.0 115.202 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.55 -149.57 9.44 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.878 1.228 . . . . 0.0 112.273 -173.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -128.46 170.11 13.53 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.609 1.964 . . . . 0.0 111.781 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -137.05 153.59 50.57 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.976 2.511 . . . . 0.0 109.037 170.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.0 mt -133.56 127.88 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.807 1.243 . . . . 0.0 108.717 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -138.29 159.9 40.87 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.457 1.103 . . . . 0.0 112.734 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.45 -23.01 67.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 125.86 -39.51 2.02 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.97 1.272 . . . . 0.0 113.102 -171.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -98.66 1.58 46.38 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.889 1.675 . . . . 0.0 113.732 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.6 mmm-85 66.39 13.17 9.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.1 2.16 . . . . 0.0 113.655 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 72.8 p -74.84 -24.82 58.66 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.46 1.104 . . . . 0.0 112.683 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.2 m -143.46 174.25 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.738 1.615 . . . . 0.0 111.693 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 t -147.23 152.89 39.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.609 2.364 . . . . 0.0 110.176 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -70.01 143.43 52.57 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.543 -0.723 . . . . 0.0 111.413 171.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 81.3 p -153.26 172.14 17.45 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.807 1.243 . . . . 0.0 112.527 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -123.92 172.97 8.51 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.332 1.853 . . . . 0.0 110.207 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -119.44 -29.76 5.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.777 1.631 . . . . 0.0 112.065 -169.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -142.41 -8.7 0.86 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.995 1.718 . . . . 0.0 114.294 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.22 51.84 13.69 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.359 1.064 . . . . 0.0 113.649 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.5 p -126.99 167.1 16.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.887 0.875 . . . . 0.0 112.306 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -73.0 146.21 46.14 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.742 -1.224 . . . . 0.0 112.568 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.79 -8.49 69.21 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.44 1.019 . . . . 0.0 114.016 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -61.28 157.34 16.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.621 1.968 . . . . 0.0 112.602 169.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -109.11 124.87 51.48 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.424 1.089 . . . . 0.0 109.231 171.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -60.0 148.19 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.731 0.813 . . . . 0.0 111.886 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.2 m -130.91 168.22 17.68 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.734 1.614 . . . . 0.0 112.087 -170.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 80.8 mt -133.91 143.87 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.401 1.48 . . . . 0.0 109.712 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.49 179.79 48.79 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.036 1.303 . . . . 0.0 111.655 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.75 -40.54 54.95 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.248 1.524 . . . . 0.0 114.542 -172.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -171.92 173.41 4.46 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.057 2.943 . . . . 0.0 108.942 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.64 137.94 33.98 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.242 -0.911 . . . . 0.0 112.785 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.6 t -61.84 -21.02 64.29 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.73 1.612 . . . . 0.0 115.303 -170.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -134.18 -38.01 0.87 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.509 1.124 . . . . 0.0 113.312 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.3 p -98.19 4.06 48.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.152 1.381 . . . . 0.0 114.626 -171.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.53 14.25 1.03 Allowed Glycine 0 CA--C 1.544 1.892 0 C-N-CA 126.017 1.77 . . . . 0.0 115.9 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -134.53 150.66 50.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.88 1.672 . . . . 0.0 111.915 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -141.41 175.6 9.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.996 2.118 . . . . 0.0 110.795 -169.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.86 138.46 34.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 125.03 1.332 . . . . 0.0 108.814 169.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.8 123.5 71.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.716 1.606 . . . . 0.0 106.768 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -146.9 153.83 40.58 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.597 1.159 . . . . 0.0 109.168 -169.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -68.62 154.57 41.66 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.967 -1.083 . . . . 0.0 112.518 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.256 1.822 . . . . 0.0 111.405 171.902 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 t -159.7 168.43 25.98 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.084 1.354 . . . . 0.0 109.879 173.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.53 131.83 48.18 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.854 -0.529 . . . . 0.0 111.632 171.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.55 -168.49 41.34 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 114.643 0.617 . . . . 0.0 114.643 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -94.49 125.75 39.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.043 0.937 . . . . 0.0 109.793 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -132.73 166.15 22.87 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.709 1.604 . . . . 0.0 111.887 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.1 pt -117.69 151.1 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 125.489 1.516 . . . . 0.0 108.45 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.0 mt -130.33 113.43 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -136.47 143.39 43.82 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.439 1.095 . . . . 0.0 110.089 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -71.01 150.08 45.98 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.797 -0.564 . . . . 0.0 111.329 -172.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -63.83 -13.88 48.31 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.8 t . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 126.611 1.964 . . . . 0.0 108.889 169.729 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.657 0.742 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.53 150.12 21.44 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.827 1.651 . . . . 0.0 115.045 -168.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.77 134.99 57.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.18 0.992 . . . . 0.0 109.14 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.2 m -135.4 125.38 25.84 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.216 1.007 . . . . 0.0 111.301 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -67.0 140.42 96.04 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.551 1.94 . . . . 0.0 112.878 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.29 -15.64 17.89 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.705 2.937 . . . . 0.0 114.943 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.98 7.21 66.2 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.306 0.955 . . . . 0.0 115.076 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -156.97 167.04 31.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.515 1.926 . . . . 0.0 111.322 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -100.13 167.83 10.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.809 1.243 . . . . 0.0 111.267 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 50.85 38.91 21.12 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.672 1.589 . . . . 0.0 113.256 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.1 m -139.87 138.41 19.72 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 126.129 1.772 . . . . 0.0 110.557 -169.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.21 159.83 3.85 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.861 3.707 . . . . 0.0 115.542 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 t -114.0 149.64 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.107 1.363 . . . . 0.0 110.643 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 m -125.2 174.42 8.11 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.268 1.427 . . . . 0.0 110.909 -169.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.06 143.02 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.951 1.301 . . . . 0.0 111.365 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.3 m -152.99 162.51 26.21 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 124.302 1.041 . . . . 0.0 113.047 -173.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.34 150.57 40.62 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.446 2.764 . . . . 0.0 112.754 169.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.8 tp -108.14 134.19 51.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.864 1.266 . . . . 0.0 111.585 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -133.82 -26.88 1.52 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.823 2.049 . . . . 0.0 112.405 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.8 5.47 2.2 Favored Glycine 0 CA--C 1.537 1.464 0 N-CA-C 116.811 1.484 . . . . 0.0 116.811 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.3 p -72.83 165.28 25.19 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.899 1.849 . . . . 0.0 113.798 -175.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.3 m -70.04 -14.48 62.7 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -73.14 -25.34 60.79 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.974 0.91 . . . . 0.0 112.458 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.61 5.82 11.64 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.343 2.657 . . . . 0.0 112.23 -172.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.8 147.89 33.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.506 1.522 . . . . 0.0 110.257 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -134.96 171.66 14.1 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.886 1.326 . . . . 0.0 112.291 -168.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.3 mt -125.66 134.46 66.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 127.505 2.322 . . . . 0.0 106.249 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.4 tp -137.13 123.38 20.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.067 1.347 . . . . 0.0 109.624 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -142.81 140.03 31.17 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.495 0.718 . . . . 0.0 111.388 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.3 t -65.5 142.43 58.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.355 0.662 . . . . 0.0 111.451 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -117.19 -52.74 2.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.749 1.219 . . . . 0.0 111.823 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.2 111.24 5.32 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.3 1.04 . . . . 0.0 111.006 170.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.3 m -57.28 -24.35 54.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.887 0.875 . . . . 0.0 111.26 168.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -65.37 -21.6 66.7 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.924 2.089 . . . . 0.0 113.633 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.6 t -130.5 14.69 5.49 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.193 1.397 . . . . 0.0 112.898 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 43.89 34.56 0.92 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.24 1.816 . . . . 0.0 113.475 -169.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.1 p -88.0 143.23 27.21 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.995 -1.065 . . . . 0.0 112.106 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -139.17 143.22 38.04 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.328 1.451 . . . . 0.0 110.993 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.4 p -77.7 147.99 35.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.288 0.635 . . . . 0.0 110.723 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.0 mm -128.28 126.08 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.462 1.505 . . . . 0.0 109.397 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.0 m -143.34 146.46 36.24 Favored Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 125.791 1.637 . . . . 0.0 109.539 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.57 150.84 28.34 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.765 2.31 . . . . 0.0 111.53 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.49 -30.53 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 121.297 -0.877 . . . . 0.0 111.836 172.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.73 -14.89 78.99 Favored Glycine 0 CA--C 1.539 1.564 0 N-CA-C 115.595 0.998 . . . . 0.0 115.595 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.6 m -151.6 61.75 4.47 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 125.819 1.648 . . . . 0.0 111.56 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -62.8 -17.21 58.19 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 124.065 3.176 . . . . 0.0 113.669 -173.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -72.77 13.11 0.41 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 128.484 2.713 . . . . 0.0 114.238 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.8 p -141.46 171.34 14.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.731 2.012 . . . . 0.0 111.596 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -138.83 170.09 16.63 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.634 1.574 . . . . 0.0 112.469 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.71 129.88 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.865 1.266 . . . . 0.0 110.897 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.75 -156.15 6.82 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.83 1.681 . . . . 0.0 111.693 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -143.01 141.11 31.27 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.387 1.075 . . . . 0.0 111.526 -171.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.14 -166.78 13.0 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.36 1.457 . . . . 0.0 113.035 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.72 137.47 20.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.979 1.311 . . . . 0.0 113.164 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.32 -7.28 61.88 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.85 1.214 . . . . 0.0 114.094 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 48.69 56.32 7.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.575 1.95 . . . . 0.0 114.298 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.64 151.02 77.4 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 126.2 1.8 . . . . 0.0 108.201 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.57 142.16 57.91 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.269 1.313 . . . . 0.0 109.84 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.34 148.92 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.615 1.566 . . . . 0.0 111.123 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.87 139.47 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.838 0.855 . . . . 0.0 110.602 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.67 161.67 57.28 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.666 1.986 . . . . 0.0 110.944 -172.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -69.65 164.88 32.79 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.703 2.269 . . . . 0.0 111.482 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.0 123.44 10.02 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.455 2.103 . . . . 0.0 110.851 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -147.72 -91.34 0.08 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.245 1.018 . . . . 0.0 110.482 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -156.01 18.34 0.37 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.524 1.53 . . . . 0.0 112.955 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -68.2 136.13 53.11 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.544 -0.722 . . . . 0.0 112.125 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.7 m -145.19 161.55 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.06 1.344 . . . . 0.0 112.537 -174.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -131.49 136.79 48.2 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.964 1.706 . . . . 0.0 110.571 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.6 m -71.92 131.58 43.17 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.098 0.959 . . . . 0.0 108.717 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.1 mt -123.52 128.19 49.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.096 0.958 . . . . 0.0 109.424 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.1 m -133.63 120.35 20.56 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.772 0.829 . . . . 0.0 110.586 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.83 146.82 54.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.065 0.546 . . . . 0.0 111.246 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -126.43 178.85 5.6 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.585 1.554 . . . . 0.0 110.818 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.0 p -60.23 -14.98 20.54 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.75 33.66 0.36 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.659 1.124 . . . . 0.0 114.088 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.61 -154.46 24.23 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.927 1.251 . . . . 0.0 112.909 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -126.71 170.93 11.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.272 2.229 . . . . 0.0 111.119 174.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -135.44 151.05 50.04 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.361 2.264 . . . . 0.0 109.255 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.9 mt -132.94 125.3 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.921 1.289 . . . . 0.0 108.778 -170.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -138.12 157.67 45.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.598 1.159 . . . . 0.0 112.648 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -60.72 -32.98 72.21 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.38 -40.28 1.64 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.9 1.714 . . . . 0.0 113.298 -172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.65 -13.1 59.73 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.598 1.159 . . . . 0.0 113.585 171.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 69.99 13.85 7.86 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.221 2.208 . . . . 0.0 112.796 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.2 p -71.99 -21.53 61.55 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.84 1.656 . . . . 0.0 112.856 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.0 m -144.97 170.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.071 1.749 . . . . 0.0 111.754 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.3 t -141.23 156.47 45.9 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.255 1.822 . . . . 0.0 110.838 171.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -70.05 140.17 52.76 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.595 -0.691 . . . . 0.0 111.345 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.8 p -151.64 172.15 16.52 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.438 1.095 . . . . 0.0 112.498 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -117.34 174.73 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.137 1.775 . . . . 0.0 109.794 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -112.16 -31.88 6.73 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.977 1.311 . . . . 0.0 110.648 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -142.7 -13.3 0.76 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.546 2.338 . . . . 0.0 112.734 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.96 20.53 6.83 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.75 2.02 . . . . 0.0 114.78 -171.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.7 p -70.86 155.78 40.37 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.571 1.148 . . . . 0.0 111.921 171.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.12 137.22 58.04 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.408 -0.807 . . . . 0.0 112.457 172.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.14 -1.83 87.63 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.98 1.276 . . . . 0.0 114.455 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 139.01 45.81 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.75 1.275 . . . . 0.0 112.823 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.36 127.0 32.16 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.528 -0.732 . . . . 0.0 110.266 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.36 152.07 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.117 0.567 . . . . 0.0 110.426 175.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.7 m -130.34 161.98 30.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.574 1.549 . . . . 0.0 111.563 -173.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.0 mt -131.87 143.73 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.377 1.471 . . . . 0.0 108.84 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.44 -157.64 30.19 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 123.73 0.681 . . . . 0.0 112.236 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.16 159.99 4.07 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 117.832 0.816 . . . . 0.0 112.063 169.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.43 148.77 11.35 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.784 1.234 . . . . 0.0 112.229 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.8 138.93 53.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.988 1.315 . . . . 0.0 112.939 -170.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -60.07 -21.75 61.85 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -131.45 -39.93 1.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 85.9 p -98.59 3.78 48.01 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -173.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.43 -3.18 31.09 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.492 1.044 . . . . 0.0 115.02 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -121.45 154.88 35.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.941 1.696 . . . . 0.0 111.21 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -137.83 175.09 9.9 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.258 1.823 . . . . 0.0 111.155 -170.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.8 t -133.58 135.05 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.621 1.568 . . . . 0.0 107.956 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 47.6 mt -130.59 119.05 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -149.31 152.46 35.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.997 -168.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -68.93 154.4 42.11 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.167 -0.958 . . . . 0.0 112.587 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 C--O 1.254 1.311 0 C-N-CA 126.338 1.855 . . . . 0.0 111.422 172.324 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.714 0.769 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -157.49 167.49 30.05 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.494 1.118 . . . . 0.0 110.034 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.39 124.0 20.17 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.994 -0.441 . . . . 0.0 111.259 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.36 -166.05 37.83 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -101.53 123.91 46.33 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.198 0.999 . . . . 0.0 109.908 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.86 169.7 15.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.073 1.349 . . . . 0.0 112.454 -171.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.4 pt -123.52 152.01 28.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.992 1.717 . . . . 0.0 108.302 171.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.83 121.2 57.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -136.66 147.07 46.64 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.118 0.967 . . . . 0.0 111.022 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -73.62 148.11 43.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.828 -0.545 . . . . 0.0 110.832 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.7 tpt85 -64.61 -16.64 63.04 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.476 0.869 0 C-N-CA 126.084 1.754 . . . . 0.0 109.117 169.619 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.47 0.548 0 CA-C-O 121.13 0.49 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.24 151.15 24.46 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -167.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 tp -57.37 132.33 52.76 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.111 1.365 . . . . 0.0 109.778 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.0 m -130.47 124.82 32.88 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.929 0.892 . . . . 0.0 111.479 -170.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -61.11 128.87 90.05 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.14 1.376 . . . . 0.0 111.404 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.67 -11.36 20.3 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.326 2.684 . . . . 0.0 114.208 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.87 -5.15 50.25 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.456 1.027 . . . . 0.0 115.104 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -160.02 168.28 25.97 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.903 1.351 . . . . 0.0 113.067 -173.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -88.7 167.7 13.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.085 1.754 . . . . 0.0 111.394 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 48.92 40.42 16.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.678 1.991 . . . . 0.0 113.466 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.6 m -141.04 137.16 16.64 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 126.062 1.745 . . . . 0.0 110.03 -172.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.73 141.86 42.92 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.309 3.34 . . . . 0.0 114.547 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 t -84.74 149.15 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.398 1.079 . . . . 0.0 110.509 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 m -122.7 178.08 5.17 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.172 1.389 . . . . 0.0 110.595 -170.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.27 148.61 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.695 1.198 . . . . 0.0 111.253 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.4 p -155.11 159.01 32.15 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 123.539 0.736 . . . . 0.0 112.792 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.71 128.41 30.21 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.569 2.179 . . . . 0.0 111.213 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.92 131.51 49.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.391 1.076 . . . . 0.0 111.079 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -123.04 -19.36 6.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.587 1.155 . . . . 0.0 112.221 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.35 60.67 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.698 1.142 . . . . 0.0 113.261 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.5 t -67.74 162.26 24.21 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.066 1.346 . . . . 0.0 111.766 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.4 p -57.09 -18.74 15.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.62 1.168 . . . . 0.0 113.944 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.21 -32.88 74.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.685 1.194 . . . . 0.0 113.04 173.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -111.4 -0.65 16.23 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.42 146.48 24.73 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 122.33 1.062 . . . . 0.0 111.868 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -140.5 172.81 12.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.963 1.305 . . . . 0.0 111.427 -169.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.8 mt -123.03 135.19 63.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.072 2.149 . . . . 0.0 107.025 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.04 123.85 21.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.194 1.398 . . . . 0.0 109.17 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -144.03 139.96 29.28 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.461 0.705 . . . . 0.0 111.922 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 t -66.32 139.2 58.03 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.014 0.526 . . . . 0.0 111.651 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -114.58 -52.79 2.69 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.649 1.18 . . . . 0.0 111.303 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.85 109.95 4.93 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.614 1.165 . . . . 0.0 111.34 171.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.4 m -57.92 -24.58 58.43 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.877 0.871 . . . . 0.0 111.65 168.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -64.11 -22.57 66.99 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.129 2.171 . . . . 0.0 113.641 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.7 m -130.31 12.25 5.5 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.772 1.629 . . . . 0.0 112.671 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 43.99 35.35 1.13 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.595 1.958 . . . . 0.0 113.487 -168.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 p -89.45 140.43 29.52 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.836 -1.165 . . . . 0.0 112.028 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -136.55 144.73 44.37 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.03 1.732 . . . . 0.0 110.14 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.2 p -77.68 149.81 34.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.404 0.682 . . . . 0.0 110.667 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.0 mm -128.55 126.81 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.563 1.545 . . . . 0.0 109.184 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.1 m -144.77 142.9 19.53 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.348 1.459 . . . . 0.0 110.105 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.04 145.38 35.4 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.983 2.455 . . . . 0.0 111.114 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.6 m -66.01 -23.1 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.708 -1.245 . . . . 0.0 112.733 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.09 -9.69 81.87 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.675 1.131 . . . . 0.0 114.625 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.8 t -152.35 66.03 6.28 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.048 1.339 . . . . 0.0 110.883 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.99 -18.18 61.45 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.265 2.643 . . . . 0.0 112.949 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -78.61 5.22 11.5 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.406 2.282 . . . . 0.0 114.096 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 m -130.87 171.91 12.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.372 1.869 . . . . 0.0 111.182 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -138.7 173.59 11.42 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.39 1.476 . . . . 0.0 112.915 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.0 mm -121.67 129.79 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.232 1.413 . . . . 0.0 110.81 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.12 -156.85 7.13 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.76 1.648 . . . . 0.0 111.958 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -142.66 142.37 32.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.437 1.095 . . . . 0.0 111.646 -171.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.93 -165.13 12.0 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.303 1.43 . . . . 0.0 113.405 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.57 138.84 21.75 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.063 1.345 . . . . 0.0 113.217 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.69 -6.42 67.51 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.746 1.165 . . . . 0.0 114.097 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 49.04 57.78 6.08 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.373 1.869 . . . . 0.0 113.932 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.65 149.7 72.77 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 126.101 1.761 . . . . 0.0 108.13 169.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.75 144.4 53.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.242 1.294 . . . . 0.0 109.643 174.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.88 146.96 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.577 1.551 . . . . 0.0 110.945 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.9 t -76.22 137.99 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.567 0.747 . . . . 0.0 109.887 171.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.9 mt -140.21 162.97 47.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.946 1.699 . . . . 0.0 112.194 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.34 166.66 24.64 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.252 2.635 . . . . 0.0 111.71 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.44 126.81 11.92 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.311 2.007 . . . . 0.0 110.909 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -148.62 -106.18 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.604 1.161 . . . . 0.0 109.413 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -145.25 21.58 1.54 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.422 1.889 . . . . 0.0 110.59 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -66.73 133.5 50.31 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.226 -0.921 . . . . 0.0 111.774 -173.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.7 m -144.71 160.33 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.336 1.455 . . . . 0.0 111.994 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -130.06 145.66 51.69 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.611 1.564 . . . . 0.0 109.973 169.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -77.03 134.86 38.68 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.801 1.241 . . . . 0.0 109.583 171.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.66 126.06 51.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.644 1.177 . . . . 0.0 109.722 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.2 m -132.77 120.13 21.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.247 1.019 . . . . 0.0 110.284 -175.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 tp -65.33 146.6 54.72 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.203 0.601 . . . . 0.0 111.334 172.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 p -127.76 176.53 7.47 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.564 1.545 . . . . 0.0 111.497 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -60.51 -10.31 4.86 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.88 31.89 0.29 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.496 1.046 . . . . 0.0 114.064 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.38 -151.82 19.12 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.721 1.153 . . . . 0.0 113.02 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -131.64 170.22 15.07 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 128.007 2.523 . . . . 0.0 110.591 175.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -134.59 155.36 50.59 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.683 1.593 . . . . 0.0 111.076 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.1 mt -135.09 115.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.774 1.629 . . . . 0.0 108.98 -170.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -134.36 158.15 44.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.227 1.011 . . . . 0.0 112.866 -170.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -61.25 -18.1 56.72 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 120.27 -33.83 4.37 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.885 1.231 . . . . 0.0 113.279 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -107.94 5.73 26.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.477 1.911 . . . . 0.0 113.18 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.8 mmm-85 63.19 16.98 9.84 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.148 2.179 . . . . 0.0 113.998 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.8 p -74.71 -27.91 60.59 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.235 1.014 . . . . 0.0 112.799 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.7 m -143.19 175.27 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.314 1.446 . . . . 0.0 111.735 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -144.41 150.98 38.6 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 128.449 2.7 . . . . 0.0 109.675 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -71.0 145.01 50.26 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.583 -0.698 . . . . 0.0 111.517 169.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.5 p -152.32 176.42 11.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.552 1.141 . . . . 0.0 112.557 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -132.08 171.29 13.81 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.067 2.147 . . . . 0.0 109.861 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -111.68 -35.89 5.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.305 1.042 . . . . 0.0 111.159 -170.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -141.38 -10.95 0.94 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.079 2.152 . . . . 0.0 112.63 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.77 19.14 5.37 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.455 1.902 . . . . 0.0 115.134 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.6 p -70.69 157.81 37.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.319 1.047 . . . . 0.0 112.148 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.52 137.54 58.15 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.372 -0.83 . . . . 0.0 112.612 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.14 -1.22 89.06 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.536 1.065 . . . . 0.0 114.564 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -69.21 141.47 54.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.66 1.184 . . . . 0.0 112.501 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.91 128.88 34.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.579 0.752 . . . . 0.0 110.424 174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.08 151.62 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.429 0.692 . . . . 0.0 110.714 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.6 t -126.27 165.24 19.33 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.256 1.422 . . . . 0.0 111.539 -174.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.0 mt -135.68 140.48 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.608 1.563 . . . . 0.0 109.672 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.0 -179.49 48.9 Favored Glycine 0 N--CA 1.469 0.889 0 C-N-CA 124.9 1.238 . . . . 0.0 111.768 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.22 -41.05 62.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 119.034 1.417 . . . . 0.0 114.035 -173.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -168.62 172.17 8.25 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.809 2.444 . . . . 0.0 109.96 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.69 141.23 35.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.356 1.062 . . . . 0.0 112.547 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.5 t -60.43 -21.06 61.84 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -134.3 -38.4 0.85 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.3 p -96.65 5.36 50.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.347 1.459 . . . . 0.0 114.354 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.62 10.75 3.68 Favored Glycine 0 CA--C 1.542 1.764 0 C-N-CA 125.107 1.336 . . . . 0.0 115.658 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -136.22 149.1 48.4 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.85 2.06 . . . . 0.0 110.412 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -137.75 176.25 8.87 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.525 1.93 . . . . 0.0 112.022 -169.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.1 t -134.77 137.07 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.924 1.69 . . . . 0.0 108.509 171.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.94 123.75 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.06 154.19 38.92 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.651 1.18 . . . . 0.0 108.989 -170.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -68.75 154.75 41.4 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.682 -1.261 . . . . 0.0 112.594 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.394 1.878 . . . . 0.0 111.462 171.328 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 CA--C 1.542 0.657 0 CA-C-O 122.513 1.149 . . . . 0.0 114.031 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 t -160.08 170.07 22.03 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.662 1.585 . . . . 0.0 109.575 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 130.84 44.54 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.58 -0.7 . . . . 0.0 111.512 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.11 -163.02 36.52 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 121.623 -0.673 . . . . 0.0 114.627 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -98.41 124.33 43.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.049 0.939 . . . . 0.0 110.094 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -133.1 171.75 13.57 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.084 1.354 . . . . 0.0 112.679 -171.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.0 pt -125.72 153.32 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 126.368 1.867 . . . . 0.0 108.643 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mt -129.13 120.04 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -138.69 149.32 44.99 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.876 0.871 . . . . 0.0 111.326 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -75.65 144.51 41.65 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.98 -0.45 . . . . 0.0 110.648 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -62.13 -15.04 42.92 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.471 0.586 0 C-N-CA 125.37 1.468 . . . . 0.0 109.419 172.653 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.4 tp . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 121.366 0.603 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.96 149.52 22.54 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.934 1.294 . . . . 0.0 113.665 -171.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 tp -58.17 135.2 57.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.001 1.32 . . . . 0.0 110.081 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.6 m -127.38 127.11 43.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.793 1.237 . . . . 0.0 111.276 -174.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -66.9 132.23 93.89 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.762 0.825 . . . . 0.0 111.654 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.27 -10.34 22.38 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.1 2.534 . . . . 0.0 114.348 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.81 85.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 123.994 0.807 . . . . 0.0 114.64 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -148.53 150.89 34.16 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.94 1.696 . . . . 0.0 111.046 -171.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -90.67 159.55 16.33 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.588 1.155 . . . . 0.0 111.005 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 49.87 39.27 17.96 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.163 1.385 . . . . 0.0 112.969 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.3 m -135.03 137.52 27.27 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.907 1.683 . . . . 0.0 110.401 -169.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -53.41 152.92 18.97 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.514 3.476 . . . . 0.0 114.752 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.3 t -102.68 150.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.777 1.231 . . . . 0.0 110.801 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -122.76 172.85 8.13 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.159 1.383 . . . . 0.0 111.215 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.36 139.92 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.938 1.295 . . . . 0.0 111.352 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.9 m -151.76 166.06 16.06 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.401 1.081 . . . . 0.0 112.962 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.14 162.73 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 124.03 3.154 . . . . 0.0 114.113 169.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.5 tp -126.97 143.24 51.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.137 1.375 . . . . 0.0 111.485 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -145.68 -30.38 0.41 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.037 1.335 . . . . 0.0 113.579 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.94 -9.63 1.8 Allowed Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.259 1.409 . . . . 0.0 114.156 -174.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.4 t -64.21 140.35 58.86 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.825 1.313 . . . . 0.0 112.108 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -61.56 -12.63 16.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.584 1.554 . . . . 0.0 114.286 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.19 -22.49 65.73 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.162 -0.961 . . . . 0.0 112.027 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -106.69 1.78 25.32 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.998 1.719 . . . . 0.0 113.296 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.67 147.75 25.64 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.143 0.973 . . . . 0.0 111.489 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -141.31 169.77 16.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.54 1.136 . . . . 0.0 111.776 -169.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.18 138.79 42.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 126.729 2.012 . . . . 0.0 108.011 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.7 tp -136.84 127.94 27.83 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.847 1.659 . . . . 0.0 109.459 -173.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -143.5 142.28 31.09 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.895 0.878 . . . . 0.0 111.374 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.6 t -66.65 142.15 57.55 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.099 0.56 . . . . 0.0 111.176 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -115.18 -52.6 2.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.291 1.036 . . . . 0.0 111.522 174.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.73 110.64 4.99 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.648 1.179 . . . . 0.0 111.306 171.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.7 m -58.43 -24.43 60.18 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.938 0.895 . . . . 0.0 111.447 168.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -64.1 -21.62 66.6 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.998 2.119 . . . . 0.0 113.421 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 m -130.29 10.89 5.37 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.9 1.68 . . . . 0.0 113.021 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 44.5 33.93 1.0 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.491 1.916 . . . . 0.0 113.794 -169.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.1 p -89.63 144.61 25.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.859 0.864 . . . . 0.0 112.055 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -140.2 142.18 35.89 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.539 1.535 . . . . 0.0 110.838 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.0 p -77.83 146.61 35.62 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.012 0.525 . . . . 0.0 110.506 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.6 mm -128.02 125.93 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.402 1.481 . . . . 0.0 109.094 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.2 m -142.46 143.41 26.64 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 124.556 1.142 . . . . 0.0 110.391 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.93 140.7 42.66 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.061 2.507 . . . . 0.0 110.682 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.35 -25.65 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.27 -13.93 59.53 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.45 1.024 . . . . 0.0 114.752 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.5 m -140.45 61.44 16.41 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.421 1.488 . . . . 0.0 111.517 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -61.58 -17.43 54.12 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.659 2.906 . . . . 0.0 113.295 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -71.68 8.66 1.07 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 128.105 2.562 . . . . 0.0 114.079 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.9 m -141.1 172.19 13.02 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.504 2.321 . . . . 0.0 111.32 172.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -137.27 171.65 14.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.081 2.152 . . . . 0.0 112.045 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.97 124.28 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.805 1.242 . . . . 0.0 110.36 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.48 -160.89 8.51 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.806 1.67 . . . . 0.0 111.891 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -139.92 140.01 36.31 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.65 1.18 . . . . 0.0 111.449 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.46 -166.82 12.4 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.2 1.381 . . . . 0.0 113.384 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.0 137.95 20.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.073 1.349 . . . . 0.0 113.143 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.79 -7.08 62.86 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.735 1.159 . . . . 0.0 114.06 -172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 48.49 57.66 6.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.384 1.874 . . . . 0.0 113.829 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.87 149.74 71.39 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 126.176 1.79 . . . . 0.0 108.461 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.07 144.4 57.55 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.595 1.53 . . . . 0.0 110.042 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.38 145.6 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.73 1.612 . . . . 0.0 111.859 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.0 t -74.22 122.83 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.149 0.979 . . . . 0.0 110.346 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 mp -132.4 163.09 52.97 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.802 2.041 . . . . 0.0 110.481 -169.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.31 165.41 32.65 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.75 2.3 . . . . 0.0 111.97 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.3 126.12 20.52 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.04 2.494 . . . . 0.0 112.026 170.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -149.63 -90.75 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.087 0.955 . . . . 0.0 110.184 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -156.27 16.82 0.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.832 1.653 . . . . 0.0 112.513 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -66.27 132.6 48.77 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.324 0.65 . . . . 0.0 111.839 -171.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.0 m -144.21 160.69 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.093 1.357 . . . . 0.0 111.827 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -131.5 136.5 47.94 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.29 1.436 . . . . 0.0 110.411 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 61.7 m -72.73 132.87 44.2 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.542 1.137 . . . . 0.0 109.195 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.5 mt -124.17 73.68 1.25 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.844 0.857 . . . . 0.0 109.419 -174.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.0 m -74.59 125.27 28.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.369 1.067 . . . . 0.0 110.698 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 tp -69.05 146.4 52.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.267 0.627 . . . . 0.0 111.168 171.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 p -126.92 175.72 7.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.609 1.564 . . . . 0.0 111.009 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.1 m -59.72 -11.62 5.48 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.0 24.3 0.33 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.898 1.237 . . . . 0.0 114.42 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.19 -149.03 11.25 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 118.298 1.049 . . . . 0.0 112.895 -173.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -133.81 169.73 16.64 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.22 2.208 . . . . 0.0 111.894 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -136.14 145.89 46.31 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.082 2.153 . . . . 0.0 109.451 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -125.7 122.87 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.401 1.08 . . . . 0.0 108.914 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -139.27 157.68 45.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.344 1.058 . . . . 0.0 112.737 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -60.33 -29.74 69.08 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.914 1.686 . . . . 0.0 115.284 -173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 128.91 -40.07 1.76 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.892 1.711 . . . . 0.0 113.237 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -79.9 -10.25 59.76 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.653 1.181 . . . . 0.0 113.927 173.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 68.52 12.8 8.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.848 2.059 . . . . 0.0 112.837 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.8 p -74.12 -25.06 59.56 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.159 1.384 . . . . 0.0 112.512 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.2 m -144.31 171.35 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.908 1.683 . . . . 0.0 111.915 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.6 t -144.85 154.15 42.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.864 2.466 . . . . 0.0 109.938 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -69.95 145.45 51.88 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.62 -0.675 . . . . 0.0 111.603 170.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.9 p -150.32 177.04 10.33 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.112 0.965 . . . . 0.0 112.329 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.15 166.86 18.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.493 1.917 . . . . 0.0 109.354 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -110.01 -32.17 7.12 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.875 0.87 . . . . 0.0 112.023 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -139.94 -10.13 1.16 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.677 1.991 . . . . 0.0 112.644 170.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.18 24.29 7.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.82 1.648 . . . . 0.0 114.302 -169.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.3 p -73.45 154.85 39.79 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.783 -1.198 . . . . 0.0 111.0 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.45 142.83 58.03 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.154 -0.967 . . . . 0.0 112.001 173.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.43 5.8 89.12 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.667 1.127 . . . . 0.0 114.297 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -75.4 137.69 41.19 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.783 1.291 . . . . 0.0 112.61 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -72.94 123.91 24.41 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.5 -0.75 . . . . 0.0 110.167 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.0 t -60.92 149.39 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.564 0.746 . . . . 0.0 110.623 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.4 p -125.06 166.44 16.37 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.817 1.247 . . . . 0.0 112.384 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 84.8 mt -135.03 142.04 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.151 1.381 . . . . 0.0 109.185 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.37 177.96 46.65 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.728 1.156 . . . . 0.0 111.73 174.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.38 -40.15 48.86 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 119.087 1.443 . . . . 0.0 114.212 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -168.97 174.45 6.36 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.661 2.784 . . . . 0.0 110.734 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.92 141.23 38.49 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.183 0.993 . . . . 0.0 111.627 169.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.0 t -62.86 -21.09 65.71 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -169.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -137.94 -35.21 0.64 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p -97.52 3.46 50.66 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 114.19 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.95 17.83 1.23 Allowed Glycine 0 CA--C 1.542 1.767 0 C-N-CA 125.805 1.669 . . . . 0.0 115.805 -176.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -140.07 146.37 38.85 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.238 1.815 . . . . 0.0 110.766 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -140.4 175.85 9.26 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.812 1.245 . . . . 0.0 112.184 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.1 p -140.85 138.87 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.856 1.262 . . . . 0.0 109.409 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.18 125.92 74.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 125.785 1.634 . . . . 0.0 107.144 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -149.13 154.2 38.86 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.866 1.266 . . . . 0.0 109.101 -171.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -67.86 155.43 39.39 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.86 -1.15 . . . . 0.0 112.663 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.7 t . . . . . 0 C--O 1.252 1.227 0 C-N-CA 126.127 1.771 . . . . 0.0 111.28 171.853 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 m -151.44 159.41 44.22 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.296 1.839 . . . . 0.0 109.231 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.41 136.27 56.94 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.307 -0.871 . . . . 0.0 111.505 174.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.62 -164.77 37.55 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 114.788 0.675 . . . . 0.0 114.788 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -95.06 125.58 39.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.217 1.007 . . . . 0.0 110.213 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -134.62 172.26 13.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.694 1.598 . . . . 0.0 111.973 -172.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.2 pt -126.17 154.22 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.919 1.687 . . . . 0.0 108.535 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.9 mt -128.9 119.41 49.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -141.24 152.88 44.91 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.359 0.663 . . . . 0.0 111.655 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -88.43 133.32 34.15 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.029 -0.419 . . . . 0.0 111.289 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -62.52 -18.69 62.49 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.478 0.959 0 C-N-CA 124.298 1.039 . . . . 0.0 112.509 173.848 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.3 tp . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.389 0.614 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.25 149.62 28.93 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.503 1.521 . . . . 0.0 114.014 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.35 139.92 57.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.332 1.053 . . . . 0.0 109.598 169.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 m -132.34 123.41 26.76 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.216 1.006 . . . . 0.0 111.611 -174.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -60.18 129.65 88.74 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 126.4 1.88 . . . . 0.0 111.507 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.14 -3.86 14.19 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.736 2.957 . . . . 0.0 115.12 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.78 9.03 87.43 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 119.046 0.839 . . . . 0.0 114.702 -176.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -144.75 164.59 30.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.156 1.382 . . . . 0.0 112.476 -170.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -101.97 157.85 16.56 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.729 1.212 . . . . 0.0 109.841 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 49.27 33.72 5.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.022 1.329 . . . . 0.0 113.607 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.0 m -129.0 136.27 28.92 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 126.111 1.764 . . . . 0.0 110.083 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.6 149.18 19.11 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.771 3.647 . . . . 0.0 115.237 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.51 151.46 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.101 1.361 . . . . 0.0 110.819 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 m -122.14 175.78 6.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.22 1.408 . . . . 0.0 111.394 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.68 139.94 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.801 1.24 . . . . 0.0 111.516 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.0 m -152.68 166.43 15.4 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 124.249 1.02 . . . . 0.0 113.326 -171.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.7 161.32 6.15 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.652 2.901 . . . . 0.0 113.127 168.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.3 tp -121.84 138.44 54.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.461 1.104 . . . . 0.0 111.74 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -139.53 -37.18 0.5 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.744 2.018 . . . . 0.0 112.363 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.82 3.77 1.07 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.908 1.242 . . . . 0.0 115.334 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.7 t -63.44 153.84 34.04 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.476 1.638 . . . . 0.0 112.381 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.7 p -70.52 -11.16 60.75 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -75.16 -23.62 57.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.29 0.95 . . . . 0.0 112.209 175.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.72 3.55 11.66 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.33 2.652 . . . . 0.0 112.259 -170.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.46 148.88 32.18 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.337 1.455 . . . . 0.0 110.315 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -136.24 172.98 12.22 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.699 1.238 . . . . 0.0 112.537 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.1 mt -129.83 135.18 61.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 126.735 2.014 . . . . 0.0 106.709 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.5 tp -134.65 128.8 33.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.349 1.459 . . . . 0.0 109.472 -169.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -143.06 130.6 21.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.782 0.833 . . . . 0.0 110.383 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 t -64.02 138.49 58.48 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.485 0.584 . . . . 0.0 111.287 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -115.27 -51.86 2.69 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.32 1.048 . . . . 0.0 111.471 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.43 109.35 4.45 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.255 1.022 . . . . 0.0 111.127 170.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.9 m -58.03 -25.99 61.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.841 0.857 . . . . 0.0 111.141 168.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -62.79 -20.62 65.18 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.151 2.18 . . . . 0.0 113.598 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 t -130.42 9.98 5.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.684 1.593 . . . . 0.0 112.996 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 47.46 32.59 2.4 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.986 1.714 . . . . 0.0 114.087 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -90.24 140.72 29.41 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.857 -1.152 . . . . 0.0 112.362 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -138.32 145.09 40.78 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.865 1.666 . . . . 0.0 110.791 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.2 p -77.89 150.14 34.15 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.974 173.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 mm -124.54 127.75 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.374 1.47 . . . . 0.0 109.274 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.3 m -140.33 143.76 34.57 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.85 1.66 . . . . 0.0 110.22 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.87 147.24 30.57 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.121 2.548 . . . . 0.0 111.637 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.47 -29.89 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 121.122 -0.986 . . . . 0.0 111.882 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.75 -26.1 73.58 Favored Glycine 0 CA--C 1.538 1.506 0 O-C-N 121.705 -0.622 . . . . 0.0 114.448 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -145.64 64.95 10.91 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.508 1.523 . . . . 0.0 111.587 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.95 -13.65 36.35 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.505 2.803 . . . . 0.0 113.938 -174.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -73.7 10.04 1.24 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.926 2.09 . . . . 0.0 113.979 169.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.9 p -138.53 174.64 10.32 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.417 1.487 . . . . 0.0 112.389 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -142.11 168.25 20.2 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.942 1.297 . . . . 0.0 113.024 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -117.4 130.34 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.69 1.196 . . . . 0.0 110.849 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.35 -158.62 7.63 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.86 1.695 . . . . 0.0 111.69 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -142.25 141.95 32.55 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.452 1.101 . . . . 0.0 111.474 -173.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.39 -166.48 12.53 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.409 1.48 . . . . 0.0 113.184 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.45 138.15 22.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.016 1.326 . . . . 0.0 113.128 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.55 -6.56 63.06 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.731 1.158 . . . . 0.0 114.196 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 49.45 57.33 6.61 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.323 1.849 . . . . 0.0 113.976 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.7 149.34 71.73 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.327 1.851 . . . . 0.0 108.19 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.09 144.73 58.62 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.435 1.423 . . . . 0.0 109.712 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.35 150.01 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.782 1.633 . . . . 0.0 111.257 -176.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.83 136.28 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.262 0.625 . . . . 0.0 110.854 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.4 mt -134.63 158.3 75.39 Favored Pre-proline 0 C--O 1.239 0.549 0 C-N-CA 126.331 1.852 . . . . 0.0 111.65 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -60.59 164.89 12.42 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 122.649 2.233 . . . . 0.0 112.927 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.64 124.95 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.662 2.242 . . . . 0.0 110.665 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -147.99 -95.54 0.08 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.038 0.935 . . . . 0.0 110.354 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -155.24 21.06 0.42 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.163 1.785 . . . . 0.0 112.146 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -67.34 139.13 57.2 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.69 -0.631 . . . . 0.0 111.565 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.5 m -144.89 159.34 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.689 1.196 . . . . 0.0 112.047 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -128.76 148.67 50.87 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.528 1.531 . . . . 0.0 110.251 169.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 79.2 m -76.51 132.88 39.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.963 1.305 . . . . 0.0 109.209 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.41 115.98 22.51 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.391 1.077 . . . . 0.0 108.954 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 55.4 m -134.09 128.78 34.89 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.67 0.788 . . . . 0.0 110.968 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.8 mt -63.0 153.37 34.05 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 p -127.89 178.63 6.04 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.496 1.918 . . . . 0.0 110.057 170.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -61.56 -8.25 4.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.17 37.85 0.26 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.799 1.19 . . . . 0.0 113.578 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.57 -153.02 22.79 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.133 0.873 . . . . 0.0 113.231 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -132.26 169.25 16.73 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.718 2.407 . . . . 0.0 111.731 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -130.81 154.3 48.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.026 2.131 . . . . 0.0 110.295 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.4 mt -135.04 114.72 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.624 1.17 . . . . 0.0 109.176 -172.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -134.29 156.07 49.1 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.062 0.945 . . . . 0.0 112.312 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -61.63 -30.16 70.52 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -170.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.83 -40.5 1.6 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.855 1.693 . . . . 0.0 112.785 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -84.39 -5.64 59.3 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.966 1.307 . . . . 0.0 113.888 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 57.17 18.13 3.97 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.752 2.021 . . . . 0.0 113.415 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.5 p -72.07 -24.54 61.53 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.394 1.077 . . . . 0.0 112.259 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.3 m -143.75 173.92 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.943 1.697 . . . . 0.0 111.982 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 t -146.39 152.48 39.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.409 2.683 . . . . 0.0 109.979 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -70.57 144.78 51.13 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.385 -0.822 . . . . 0.0 111.8 170.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.6 p -152.88 174.76 13.69 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.067 1.347 . . . . 0.0 112.273 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -128.68 170.18 13.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.161 1.784 . . . . 0.0 110.199 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -109.03 -36.58 6.04 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.431 0.693 . . . . 0.0 111.864 -169.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -144.91 -0.15 0.92 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.091 1.756 . . . . 0.0 114.495 173.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.26 23.27 1.61 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.878 2.071 . . . . 0.0 116.122 -171.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.4 p -75.22 156.35 35.88 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.779 -1.201 . . . . 0.0 112.06 172.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.26 138.18 57.48 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.472 -0.767 . . . . 0.0 111.836 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.19 4.68 89.59 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.885 1.231 . . . . 0.0 114.422 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.6 146.96 30.95 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.198 1.499 . . . . 0.0 112.783 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -76.14 130.88 38.94 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.265 -0.897 . . . . 0.0 110.781 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.22 151.21 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.906 0.482 . . . . 0.0 110.453 173.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.8 m -129.9 164.45 24.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.464 1.506 . . . . 0.0 111.783 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.4 mt -133.56 143.27 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.305 1.442 . . . . 0.0 109.556 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.61 179.98 48.01 Favored Glycine 0 N--CA 1.471 0.976 0 C-N-CA 124.832 1.206 . . . . 0.0 111.745 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.79 -41.16 61.48 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 119.155 1.477 . . . . 0.0 114.27 -173.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -169.11 170.33 8.84 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.004 2.522 . . . . 0.0 109.906 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.42 130.61 23.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.155 0.982 . . . . 0.0 112.446 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.1 t -56.59 -28.75 61.04 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -122.36 -26.72 4.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.437 1.095 . . . . 0.0 113.856 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 72.9 p -116.48 0.02 12.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.757 1.223 . . . . 0.0 114.1 -171.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.14 33.88 0.65 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.619 2.057 . . . . 0.0 114.827 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 145.99 22.51 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.279 2.232 . . . . 0.0 110.597 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -143.3 175.72 9.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.422 1.489 . . . . 0.0 111.556 -168.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.4 p -139.44 138.9 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.488 1.115 . . . . 0.0 109.643 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.76 125.02 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 C-N-CA 125.984 1.714 . . . . 0.0 107.11 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -149.13 155.07 40.13 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.644 1.178 . . . . 0.0 109.08 -170.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -68.65 155.79 39.39 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.022 -1.049 . . . . 0.0 112.549 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.9 t . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.086 1.754 . . . . 0.0 111.301 171.856 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 122.41 1.1 . . . . 0.0 113.918 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.2 m -152.5 165.33 35.44 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.366 1.867 . . . . 0.0 109.228 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.78 130.59 44.08 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 121.5 -0.75 . . . . 0.0 110.958 169.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.06 -165.31 38.66 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 114.721 0.648 . . . . 0.0 114.721 -175.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -95.64 122.99 38.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.168 0.987 . . . . 0.0 110.304 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -133.98 174.74 10.15 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.246 1.418 . . . . 0.0 112.424 -172.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.0 pt -131.08 155.98 42.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 126.246 1.818 . . . . 0.0 108.936 171.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 mt -127.49 127.72 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -142.47 147.88 36.81 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.762 0.825 . . . . 0.0 111.564 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -78.06 133.44 37.91 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.92 -0.487 . . . . 0.0 111.043 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -60.91 -25.51 66.8 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.4 t . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 123.827 0.851 . . . . 0.0 112.36 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 121.449 0.642 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.81 150.25 29.25 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.4 tp -58.6 134.39 56.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.304 1.442 . . . . 0.0 109.529 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 m -127.07 125.28 41.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.741 1.216 . . . . 0.0 111.192 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.4 ' CE1' ' HG3' ' A' ' 79' ' ' PRO . 38.3 t80 -66.19 138.63 96.12 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.842 1.257 . . . . 0.0 112.094 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -76.56 -15.16 17.57 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.132 2.555 . . . . 0.0 114.911 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.31 3.72 69.23 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.535 1.064 . . . . 0.0 115.012 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -155.31 179.91 8.71 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.681 1.993 . . . . 0.0 110.756 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -110.42 170.64 7.95 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.939 1.295 . . . . 0.0 111.158 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 50.63 40.75 24.6 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.411 1.884 . . . . 0.0 112.83 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 m -140.87 141.59 24.95 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 126.14 1.776 . . . . 0.0 110.344 -169.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -52.95 163.31 2.13 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 125.293 3.995 . . . . 0.0 115.981 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.9 t -115.01 149.68 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.127 1.371 . . . . 0.0 110.857 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 m -127.8 176.0 7.9 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.301 1.441 . . . . 0.0 111.261 -168.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.7 m -123.43 156.29 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.965 -1.084 . . . . 0.0 112.045 170.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.3 m -153.0 167.05 14.15 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 124.946 1.298 . . . . 0.0 112.375 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.05 118.53 5.44 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.682 2.921 . . . . 0.0 111.671 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.63 134.76 52.96 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.789 -0.569 . . . . 0.0 111.842 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -138.61 3.42 2.29 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.566 1.546 . . . . 0.0 113.712 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.5 0.67 86.28 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.943 1.258 . . . . 0.0 115.033 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.7 t -63.29 147.41 51.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.402 1.601 . . . . 0.0 112.401 175.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.7 m -59.53 -13.51 9.35 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.325 1.45 . . . . 0.0 114.405 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.03 -26.16 63.91 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.162 0.892 . . . . 0.0 112.371 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -118.63 0.89 11.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.906 1.682 . . . . 0.0 114.45 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.16 145.48 27.96 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.617 1.167 . . . . 0.0 110.55 171.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -136.05 169.96 16.78 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 123.015 1.388 . . . . 0.0 112.546 -168.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.1 mt -117.54 137.15 52.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 128.578 2.751 . . . . 0.0 107.3 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.2 tp -134.65 128.99 34.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.573 1.549 . . . . 0.0 109.211 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -142.65 138.17 30.47 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.469 1.108 . . . . 0.0 110.732 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.8 t -67.81 141.26 56.55 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.947 0.499 . . . . 0.0 110.552 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -108.8 -51.25 2.91 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.623 1.169 . . . . 0.0 110.715 174.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.21 109.87 4.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.142 1.377 . . . . 0.0 110.595 169.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.9 m -56.96 -24.38 52.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.945 0.898 . . . . 0.0 111.745 168.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -65.21 -20.93 66.67 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.096 2.158 . . . . 0.0 113.589 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -130.8 14.59 5.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.838 1.655 . . . . 0.0 112.844 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 43.36 33.77 0.65 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.571 1.948 . . . . 0.0 114.113 -169.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -85.9 145.56 27.11 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.893 -1.129 . . . . 0.0 112.037 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -141.52 148.97 40.25 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.149 1.38 . . . . 0.0 111.58 -177.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.3 p -91.34 145.78 24.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.25 1.02 . . . . 0.0 110.641 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.8 mm -127.91 115.76 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.768 2.027 . . . . 0.0 110.257 -172.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.4 m -134.62 146.15 57.89 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 123.882 0.873 . . . . 0.0 110.712 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.4 ' HG3' ' CE1' ' A' ' 42' ' ' TYR . 62.2 Cg_endo -70.8 146.59 54.17 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.729 2.286 . . . . 0.0 109.92 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.31 -22.06 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.82 -11.13 54.27 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.554 1.073 . . . . 0.0 115.241 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.5 m -144.22 62.0 9.68 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.954 1.302 . . . . 0.0 111.795 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.49 -17.1 46.15 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.109 3.206 . . . . 0.0 113.846 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -71.65 19.02 0.07 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 128.653 2.781 . . . . 0.0 114.497 169.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.6 p -142.31 164.96 28.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.044 1.738 . . . . 0.0 112.226 171.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -143.83 140.37 29.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.568 1.547 . . . . 0.0 111.09 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.4 mm -85.04 132.25 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.79 -0.569 . . . . 0.0 111.086 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.1 -165.11 10.77 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.889 2.185 . . . . 0.0 112.021 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -144.04 141.62 30.2 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.387 1.075 . . . . 0.0 111.674 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.26 -163.55 11.05 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.319 1.438 . . . . 0.0 113.31 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.64 140.41 18.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.987 1.315 . . . . 0.0 113.207 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.93 -7.85 70.21 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.572 1.082 . . . . 0.0 114.012 -172.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 48.22 58.05 5.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.334 1.854 . . . . 0.0 113.853 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.2 m -133.25 149.25 72.03 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 126.272 1.829 . . . . 0.0 107.458 169.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.47 145.29 58.37 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.298 1.142 . . . . 0.0 109.395 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.06 172.06 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.581 1.952 . . . . 0.0 109.797 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -119.51 136.25 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.323 -0.861 . . . . 0.0 111.215 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -140.87 165.15 31.52 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 127.27 2.228 . . . . 0.0 110.474 -169.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -77.3 155.41 32.67 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.497 2.131 . . . . 0.0 111.643 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.39 124.85 12.61 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.194 3.263 . . . . 0.0 113.537 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -149.49 -88.85 0.08 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.616 1.166 . . . . 0.0 110.428 -176.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -154.89 8.84 0.31 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.23 1.412 . . . . 0.0 114.218 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.02 139.82 54.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.384 -0.822 . . . . 0.0 110.845 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.3 m -148.93 164.26 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.112 1.365 . . . . 0.0 111.417 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -129.47 131.36 46.67 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.121 1.369 . . . . 0.0 110.536 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.8 m -75.93 130.57 38.68 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.275 1.03 . . . . 0.0 109.559 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.7 mt -117.38 129.58 55.95 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.569 1.147 . . . . 0.0 109.447 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 m -137.02 129.29 29.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.093 0.957 . . . . 0.0 110.228 -170.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.2 mt -65.68 153.62 41.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.697 0.76 . . . . 0.0 113.025 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.1 p -127.78 -179.22 4.83 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.024 1.73 . . . . 0.0 110.274 170.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 75.7 p -60.89 -12.81 12.26 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.0 29.45 0.29 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.422 1.011 . . . . 0.0 114.658 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 176.95 -153.06 13.01 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 118.386 1.093 . . . . 0.0 113.25 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -131.58 169.74 15.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.108 2.163 . . . . 0.0 112.266 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -136.49 149.72 48.31 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.424 2.289 . . . . 0.0 109.462 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.9 mt -132.58 115.61 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.678 1.191 . . . . 0.0 109.106 -170.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -135.91 149.89 49.12 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.513 1.125 . . . . 0.0 111.649 -169.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -55.11 -34.12 63.43 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.082 0.953 . . . . 0.0 113.129 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.49 -29.83 2.85 Favored Glycine 0 N--CA 1.47 0.965 0 C-N-CA 125.856 1.693 . . . . 0.0 113.916 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -79.61 -6.02 56.23 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 60.59 12.92 3.88 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.474 2.31 . . . . 0.0 114.048 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.3 p -65.75 -28.19 68.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.837 2.055 . . . . 0.0 112.761 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.0 m -144.89 171.06 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.014 1.725 . . . . 0.0 112.135 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.2 t -146.15 156.02 43.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.413 2.685 . . . . 0.0 110.032 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -72.23 145.25 48.09 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.49 -0.756 . . . . 0.0 111.866 171.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.7 p -154.41 177.18 11.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.056 1.342 . . . . 0.0 112.232 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -118.96 169.52 9.82 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.644 1.578 . . . . 0.0 110.211 173.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -95.26 -33.32 12.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.354 0.662 . . . . 0.0 111.979 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -144.8 0.52 0.97 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.479 1.912 . . . . 0.0 114.42 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.08 26.54 3.88 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.864 2.066 . . . . 0.0 116.038 -172.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.5 p -82.6 160.16 22.57 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 120.965 -1.084 . . . . 0.0 112.246 172.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.14 141.46 58.76 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.303 -0.873 . . . . 0.0 111.93 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.28 1.19 89.52 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.178 0.894 . . . . 0.0 114.817 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -83.35 149.69 26.57 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.99 1.395 . . . . 0.0 113.45 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -74.87 136.76 41.5 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.312 -0.867 . . . . 0.0 111.056 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.0 t -70.34 154.54 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.106 0.479 . . . . 0.0 110.568 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -131.58 164.92 24.79 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.342 1.857 . . . . 0.0 111.343 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.6 mt -136.8 140.27 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.572 1.549 . . . . 0.0 109.638 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.99 177.96 47.14 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 125.056 1.312 . . . . 0.0 111.44 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.09 36.48 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.315 1.557 . . . . 0.0 114.553 -171.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -170.28 171.25 6.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.561 2.744 . . . . 0.0 108.968 176.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.0 127.21 21.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.766 0.826 . . . . 0.0 111.176 170.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.9 t -60.67 -14.17 19.15 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.258 1.823 . . . . 0.0 115.682 -170.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -128.65 -38.85 1.68 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.356 1.063 . . . . 0.0 113.185 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.3 p -111.96 2.99 17.19 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -171.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.37 13.83 0.53 Allowed Glycine 0 CA--C 1.539 1.537 0 N-CA-C 116.327 1.291 . . . . 0.0 116.327 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -134.68 147.84 50.2 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.255 2.027 . . . . 0.0 111.074 -172.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -139.8 176.01 9.1 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.491 1.516 . . . . 0.0 112.371 -168.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.3 t -135.82 139.14 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.101 1.36 . . . . 0.0 109.099 170.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.7 125.7 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 169.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.19 154.67 39.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.477 1.111 . . . . 0.0 109.56 -171.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -68.11 155.79 38.82 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.043 -1.036 . . . . 0.0 112.606 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.6 t . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.131 1.772 . . . . 0.0 111.31 171.584 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 CA--C 1.547 0.846 0 CA-C-O 122.377 1.084 . . . . 0.0 113.917 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.0 m -161.56 162.05 30.05 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.704 2.002 . . . . 0.0 109.222 177.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.15 137.11 58.13 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.544 -0.722 . . . . 0.0 111.923 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.79 -160.11 32.89 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 123.901 0.762 . . . . 0.0 114.937 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -98.48 122.62 41.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.919 1.288 . . . . 0.0 110.616 173.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -134.65 172.71 12.56 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.773 1.229 . . . . 0.0 112.698 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.44 154.25 38.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 126.458 1.903 . . . . 0.0 108.57 170.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.3 mt -124.97 126.91 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -141.26 150.38 42.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.05 0.54 . . . . 0.0 112.156 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -77.07 134.98 38.61 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.589 -0.694 . . . . 0.0 111.298 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -61.48 -28.32 69.21 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.48 1.07 0 C-N-CA 123.379 0.672 . . . . 0.0 112.042 -178.708 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.5 mt . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.964 0.411 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.76 141.66 36.1 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.601 1.16 . . . . 0.0 112.857 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.57 128.21 36.02 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.039 0.936 . . . . 0.0 108.789 169.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.0 m -128.37 115.0 17.56 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.055 0.942 . . . . 0.0 110.801 -170.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -59.89 135.19 90.03 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 126.934 2.094 . . . . 0.0 112.086 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.89 -11.45 19.89 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.289 2.659 . . . . 0.0 114.602 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.63 8.83 82.37 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-O 119.079 -0.845 . . . . 0.0 115.119 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -156.72 165.34 36.51 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.303 1.441 . . . . 0.0 112.134 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -87.74 166.6 14.52 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.436 1.095 . . . . 0.0 111.768 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 49.85 36.91 12.26 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.83 1.652 . . . . 0.0 113.839 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.8 m -135.97 138.55 27.97 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 126.228 1.811 . . . . 0.0 110.206 -169.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.3 160.57 4.63 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.94 3.76 . . . . 0.0 115.81 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.5 t -111.56 148.71 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.904 1.281 . . . . 0.0 110.724 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 m -123.36 167.24 14.06 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.256 1.422 . . . . 0.0 110.774 -169.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 p -121.48 138.25 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.167 0.987 . . . . 0.0 111.212 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.5 m -156.51 168.17 12.94 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 124.355 1.062 . . . . 0.0 112.882 -169.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.14 152.59 10.59 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.648 2.899 . . . . 0.0 114.286 169.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.4 tp -105.6 137.2 43.83 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.459 1.504 . . . . 0.0 110.45 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -135.23 -24.24 1.43 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.075 1.35 . . . . 0.0 112.751 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.18 5.83 9.35 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.199 1.381 . . . . 0.0 113.759 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 m -61.85 150.48 37.2 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.485 1.142 . . . . 0.0 111.532 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.2 p -61.8 -15.05 38.4 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -72.86 -24.01 60.82 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.355 1.062 . . . . 0.0 112.412 171.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -104.88 -9.33 18.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.519 1.927 . . . . 0.0 112.621 -174.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.62 142.0 34.5 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.596 1.158 . . . . 0.0 111.328 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -135.73 171.34 14.6 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.944 1.355 . . . . 0.0 112.111 -169.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.1 mt -126.17 136.45 60.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.024 2.13 . . . . 0.0 106.747 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.7 tp -136.84 126.53 25.46 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.948 1.299 . . . . 0.0 109.446 -169.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.2 mtp-105 -141.46 140.84 33.65 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.753 0.821 . . . . 0.0 111.121 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.0 t -65.24 141.56 58.59 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.908 0.483 . . . . 0.0 110.929 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -115.12 -51.27 2.72 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.434 1.094 . . . . 0.0 111.093 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.23 109.25 4.45 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.379 1.071 . . . . 0.0 110.996 169.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.2 m -59.18 -26.47 64.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.801 0.84 . . . . 0.0 111.166 168.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -60.99 -20.94 63.05 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.012 2.125 . . . . 0.0 113.398 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -130.26 6.32 4.91 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.308 1.843 . . . . 0.0 113.237 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 47.37 30.44 1.55 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.142 2.177 . . . . 0.0 114.281 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.0 p -90.6 143.58 26.6 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.25 -0.907 . . . . 0.0 112.367 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -139.31 141.64 37.71 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.683 1.593 . . . . 0.0 111.104 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.5 p -77.87 147.71 34.98 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.711 -0.618 . . . . 0.0 111.06 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.0 mm -129.26 127.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.421 1.488 . . . . 0.0 109.71 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.0 m -142.84 142.38 22.25 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.197 1.399 . . . . 0.0 110.355 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.1 145.39 31.05 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.217 2.611 . . . . 0.0 111.314 176.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.53 -28.22 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.311 -0.868 . . . . 0.0 111.769 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.55 -24.96 76.17 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 114.868 0.707 . . . . 0.0 114.868 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.9 m -148.17 65.51 8.83 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 125.429 1.492 . . . . 0.0 111.614 -176.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -64.13 -17.9 61.47 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.843 3.028 . . . . 0.0 113.669 -173.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -69.96 -2.62 13.04 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 127.688 2.395 . . . . 0.0 114.636 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.2 m -132.8 174.72 10.02 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.372 1.869 . . . . 0.0 111.686 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -141.27 172.66 12.37 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.371 1.469 . . . . 0.0 113.164 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -115.99 127.25 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.903 1.281 . . . . 0.0 110.413 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.56 -157.48 7.18 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.489 1.519 . . . . 0.0 111.35 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -141.99 142.24 32.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.135 0.974 . . . . 0.0 111.665 -171.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.94 -165.25 12.1 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.361 1.458 . . . . 0.0 113.466 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.59 135.15 23.44 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.265 1.426 . . . . 0.0 113.049 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.23 -8.64 59.08 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.969 1.271 . . . . 0.0 114.012 -172.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 49.29 56.16 8.23 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.485 1.914 . . . . 0.0 113.949 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.9 m -133.89 150.43 74.5 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 126.266 1.826 . . . . 0.0 108.065 169.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.01 142.71 52.02 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.225 1.283 . . . . 0.0 109.721 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.05 151.5 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.815 1.646 . . . . 0.0 111.536 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.14 132.18 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.074 0.95 . . . . 0.0 111.044 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.34 161.45 57.2 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.833 1.653 . . . . 0.0 112.193 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -65.04 174.06 5.26 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 123.277 2.652 . . . . 0.0 113.31 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.67 104.15 1.68 Allowed 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.779 2.319 . . . . 0.0 111.01 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -143.46 13.51 1.77 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.657 1.183 . . . . 0.0 113.356 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 70.37 40.88 1.07 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.913 2.485 . . . . 0.0 113.773 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -61.97 143.46 56.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.089 0.556 . . . . 0.0 110.887 169.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.92 156.55 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.206 1.002 . . . . 0.0 112.253 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -129.8 137.06 50.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.496 1.518 . . . . 0.0 110.448 172.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.9 m -71.0 134.23 46.98 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.698 1.199 . . . . 0.0 108.895 169.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.7 mt -126.24 73.93 1.41 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.878 0.871 . . . . 0.0 109.966 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.3 m -78.93 129.12 34.16 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.269 1.028 . . . . 0.0 111.116 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.7 tp -71.2 145.83 49.44 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.455 0.702 . . . . 0.0 111.226 171.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 p -124.55 -177.17 3.72 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.741 1.616 . . . . 0.0 111.719 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.2 p -59.04 -13.44 6.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.22 25.96 0.18 Allowed Glycine 0 CA--C 1.533 1.197 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 178.55 -149.25 8.87 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.023 1.296 . . . . 0.0 112.127 -173.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -131.77 168.44 17.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.286 1.834 . . . . 0.0 112.024 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -134.15 142.43 47.46 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.393 2.277 . . . . 0.0 109.515 174.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.1 mt -124.37 121.78 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.419 1.088 . . . . 0.0 109.231 -171.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -138.17 158.04 45.09 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.194 1.398 . . . . 0.0 112.68 -171.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -59.8 -18.18 41.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 125.23 -35.71 3.01 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.916 1.722 . . . . 0.0 112.623 -169.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -110.17 4.18 20.82 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.503 1.921 . . . . 0.0 113.557 -170.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? 57.39 21.6 7.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.858 2.063 . . . . 0.0 113.781 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.1 p -77.62 -30.58 52.35 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.391 -0.818 . . . . 0.0 112.02 175.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.1 m -148.07 155.81 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.667 1.587 . . . . 0.0 111.959 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.1 t -130.5 153.37 48.89 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.577 1.951 . . . . 0.0 111.248 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.3 m0 -69.88 139.57 53.05 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.289 0.635 . . . . 0.0 111.812 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 88.1 p -147.76 175.06 11.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.929 1.292 . . . . 0.0 111.909 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.43 151.33 46.35 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.53 1.532 . . . . 0.0 109.898 173.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -82.59 -33.56 27.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.179 0.992 . . . . 0.0 111.704 -169.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -138.93 -6.21 1.45 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.674 1.99 . . . . 0.0 112.634 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.79 32.36 14.78 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.852 1.661 . . . . 0.0 114.243 -170.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.3 p -81.58 156.63 25.1 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.26 1.024 . . . . 0.0 111.509 170.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.84 139.59 57.77 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.252 -0.905 . . . . 0.0 111.674 172.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.67 86.0 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.125 1.345 . . . . 0.0 114.718 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -79.64 144.65 33.57 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.929 1.292 . . . . 0.0 113.25 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -75.7 128.44 35.21 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.854 -1.154 . . . . 0.0 110.655 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.95 148.53 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.182 0.593 . . . . 0.0 110.799 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.7 t -126.07 160.83 29.04 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.812 1.245 . . . . 0.0 111.779 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.8 mt -134.22 140.86 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.823 1.649 . . . . 0.0 109.292 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 169.43 -159.73 32.69 Favored Glycine 0 N--CA 1.468 0.815 0 C-N-CA 123.776 0.703 . . . . 0.0 112.61 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.96 149.68 18.32 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 117.62 0.71 . . . . 0.0 111.764 169.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -52.63 119.09 4.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.482 1.513 . . . . 0.0 113.428 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.23 164.12 26.3 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.848 1.259 . . . . 0.0 114.174 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 t -93.65 -9.44 37.9 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.785 1.234 . . . . 0.0 114.229 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -142.11 -44.93 0.34 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.483 1.113 . . . . 0.0 113.028 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.8 p -91.61 1.93 56.81 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.6 5.09 6.07 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 126.414 1.959 . . . . 0.0 116.281 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -126.48 150.84 48.48 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.408 1.483 . . . . 0.0 112.252 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -142.16 175.98 9.33 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 127.389 2.276 . . . . 0.0 110.104 -169.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.65 139.7 28.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 124.354 1.062 . . . . 0.0 109.529 169.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -118.22 124.82 73.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 125.694 1.598 . . . . 0.0 107.15 174.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -147.74 153.44 39.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.644 1.178 . . . . 0.0 109.433 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.97 155.91 39.51 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.998 -1.064 . . . . 0.0 112.945 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 C--O 1.251 1.175 0 C-N-CA 126.221 1.808 . . . . 0.0 111.284 171.877 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 CA--C 1.544 0.719 0 CA-C-O 122.0 0.905 . . . . 0.0 113.165 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.1 m -151.45 159.53 44.15 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.668 1.987 . . . . 0.0 108.955 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.84 131.14 48.83 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.489 -0.757 . . . . 0.0 111.858 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.1 -163.11 36.86 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -100.56 126.93 47.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.128 0.971 . . . . 0.0 110.345 174.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.05 172.3 13.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.238 1.415 . . . . 0.0 112.292 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 pt -126.96 152.14 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.111 1.764 . . . . 0.0 108.518 172.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.1 mt -131.04 115.89 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -140.49 151.48 44.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.702 0.763 . . . . 0.0 112.408 -177.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -81.45 136.72 35.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.436 -173.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.8 mtp-105 -65.13 -18.22 65.12 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.9 t . . . . . 0 N--CA 1.478 0.929 0 C-N-CA 124.135 0.974 . . . . 0.0 112.375 173.114 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 121.771 0.796 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.31 151.42 24.77 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.676 -1.147 . . . . 0.0 113.718 -170.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.59 134.05 55.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.852 0.861 . . . . 0.0 108.897 168.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 85.6 m -134.54 126.05 28.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.864 0.865 . . . . 0.0 111.123 -170.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -60.49 130.3 89.93 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.518 1.927 . . . . 0.0 111.948 -176.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.32 -10.41 19.1 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.442 2.761 . . . . 0.0 114.465 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.53 -2.32 58.91 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.318 0.961 . . . . 0.0 115.152 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -160.28 171.22 19.54 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.082 1.353 . . . . 0.0 112.94 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -96.51 169.14 10.1 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.403 1.881 . . . . 0.0 111.121 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 mmt-85 52.13 32.51 10.61 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.113 1.765 . . . . 0.0 114.022 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.1 m -137.11 138.13 24.69 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.301 1.441 . . . . 0.0 110.731 -169.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.7 155.38 10.59 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.567 3.512 . . . . 0.0 114.847 172.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 t -105.03 153.81 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.867 1.267 . . . . 0.0 110.542 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 m -125.42 171.06 10.77 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.197 1.399 . . . . 0.0 110.186 -170.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.64 141.66 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.911 -1.118 . . . . 0.0 112.047 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.1 m -153.12 166.16 16.1 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.052 0.941 . . . . 0.0 112.327 -171.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.86 164.79 2.2 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.648 2.898 . . . . 0.0 113.564 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tt -127.59 141.8 51.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.729 1.211 . . . . 0.0 111.785 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -143.36 -13.6 0.69 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.43 -8.35 8.94 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.096 1.332 . . . . 0.0 114.347 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -63.44 157.86 22.21 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.895 1.348 . . . . 0.0 113.302 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 p -64.22 -11.91 35.64 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -66.53 -36.32 82.4 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.207 1.003 . . . . 0.0 112.161 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.81 6.4 11.49 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.58 147.27 24.04 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.793 0.806 . . . . 0.0 111.652 172.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -138.61 172.09 13.4 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.661 1.22 . . . . 0.0 112.306 -169.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.2 mt -120.77 135.47 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.498 2.319 . . . . 0.0 107.066 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.28 122.3 19.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.123 1.369 . . . . 0.0 109.544 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -140.92 137.98 33.52 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.309 0.644 . . . . 0.0 111.633 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.5 t -64.46 138.94 58.69 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.124 0.569 . . . . 0.0 111.151 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -115.17 -51.29 2.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.557 1.143 . . . . 0.0 111.339 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.52 109.96 4.81 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.583 1.153 . . . . 0.0 111.625 170.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.1 m -58.98 -23.72 62.02 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.025 0.93 . . . . 0.0 111.468 168.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.07 -21.69 66.62 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.075 2.15 . . . . 0.0 113.341 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -130.4 7.8 4.97 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.956 1.703 . . . . 0.0 113.002 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 46.56 34.87 2.6 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.667 1.987 . . . . 0.0 113.47 -168.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.6 p -92.34 142.76 27.1 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.531 -0.731 . . . . 0.0 112.275 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -138.73 144.15 39.37 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.86 1.664 . . . . 0.0 110.478 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.0 p -77.96 150.1 34.03 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.56 0.744 . . . . 0.0 111.018 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.8 mm -128.73 126.87 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 0.0 109.479 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 m -144.92 145.93 29.35 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.701 1.601 . . . . 0.0 110.51 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.27 145.41 34.49 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.832 2.354 . . . . 0.0 110.831 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.5 m -65.22 -24.69 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.004 -1.06 . . . . 0.0 113.119 177.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.65 -17.96 60.94 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.062 0.839 . . . . 0.0 114.61 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 42.5 m -144.1 62.14 9.99 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.434 1.494 . . . . 0.0 110.962 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -61.8 -18.59 61.59 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.013 3.142 . . . . 0.0 113.423 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -71.35 9.33 0.81 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 128.314 2.645 . . . . 0.0 114.148 169.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.1 p -138.44 172.53 12.75 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.886 1.675 . . . . 0.0 111.966 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -141.44 169.75 17.02 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.167 1.387 . . . . 0.0 112.837 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 mm -115.97 128.48 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.932 1.293 . . . . 0.0 110.567 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.37 -160.77 8.55 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.778 1.656 . . . . 0.0 111.926 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -140.27 139.63 35.56 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.443 1.097 . . . . 0.0 111.468 -172.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.18 -164.85 11.39 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.383 1.468 . . . . 0.0 113.208 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.3 139.38 19.16 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.928 1.291 . . . . 0.0 113.084 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.3 -7.72 66.63 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.825 1.202 . . . . 0.0 114.13 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 47.97 56.42 7.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.516 1.926 . . . . 0.0 113.974 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.71 150.96 76.17 Favored Pre-proline 0 C--O 1.24 0.571 0 C-N-CA 126.112 1.765 . . . . 0.0 108.386 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.87 142.67 58.11 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.23 1.286 . . . . 0.0 109.762 173.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.8 m -132.84 150.46 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.681 1.592 . . . . 0.0 111.354 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 t -83.26 132.92 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.764 0.826 . . . . 0.0 110.816 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.6 mt -138.39 162.33 54.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.982 1.713 . . . . 0.0 112.384 -169.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -61.1 167.19 9.48 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.824 2.349 . . . . 0.0 113.302 174.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.66 125.98 10.46 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.735 2.29 . . . . 0.0 110.216 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -146.95 -106.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.806 1.242 . . . . 0.0 109.304 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -145.22 21.55 1.55 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.518 1.927 . . . . 0.0 110.471 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -66.53 133.75 51.0 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.386 -0.821 . . . . 0.0 111.385 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.4 m -144.78 160.27 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.964 1.306 . . . . 0.0 111.812 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -130.84 148.77 52.66 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.406 1.482 . . . . 0.0 110.406 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.9 m -74.98 139.11 42.73 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.168 0.987 . . . . 0.0 109.262 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.59 73.92 1.22 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.143 0.977 . . . . 0.0 109.31 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 93.2 m -76.96 118.9 19.99 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.289 1.036 . . . . 0.0 110.594 -176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 tp -66.98 146.48 54.33 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.285 0.634 . . . . 0.0 111.156 170.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.2 p -125.42 -178.42 4.22 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.685 1.594 . . . . 0.0 111.233 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.0 t -60.26 -18.48 49.3 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -158.7 28.2 0.42 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.445 1.021 . . . . 0.0 114.465 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.63 -153.07 16.61 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.459 1.028 . . . . 0.0 113.018 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -133.1 168.71 18.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.87 2.068 . . . . 0.0 111.981 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -135.88 151.23 49.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.685 1.994 . . . . 0.0 110.412 171.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.7 mt -132.17 114.55 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.033 0.933 . . . . 0.0 109.949 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -135.47 156.43 48.91 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.199 1.0 . . . . 0.0 111.973 -169.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -60.35 -31.23 70.12 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.457 1.503 . . . . 0.0 114.829 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 133.09 -40.76 1.56 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.658 2.075 . . . . 0.0 112.797 -174.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -81.37 -6.45 58.93 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.676 1.19 . . . . 0.0 114.05 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 59.18 16.08 4.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.962 2.105 . . . . 0.0 113.999 -170.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.5 p -69.73 -23.39 63.39 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.871 1.268 . . . . 0.0 112.265 178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.7 m -144.27 170.01 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.101 1.76 . . . . 0.0 111.701 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 t -142.38 156.83 45.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.729 2.012 . . . . 0.0 110.676 173.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -70.9 138.72 50.38 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.234 0.614 . . . . 0.0 111.354 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.9 p -149.29 173.0 13.97 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.549 1.14 . . . . 0.0 112.504 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.1 mt -123.97 173.59 8.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.911 1.684 . . . . 0.0 109.879 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -111.41 -33.73 6.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.079 0.952 . . . . 0.0 111.459 -171.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -140.98 -9.49 1.01 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.646 1.978 . . . . 0.0 112.683 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.71 24.28 8.81 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.055 1.742 . . . . 0.0 114.784 -169.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 p -71.88 154.75 41.04 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.19 -0.944 . . . . 0.0 111.181 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.2 143.43 54.0 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.887 -1.133 . . . . 0.0 111.764 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.07 4.2 89.65 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.481 1.038 . . . . 0.0 114.153 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -73.56 142.58 46.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.825 1.313 . . . . 0.0 112.46 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -77.62 111.37 13.31 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.777 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 p -54.7 149.09 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.895 0.878 . . . . 0.0 111.434 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.7 t -130.55 168.63 16.76 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.561 1.544 . . . . 0.0 112.008 -169.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.8 mt -134.74 141.73 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.041 1.736 . . . . 0.0 108.866 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.91 -162.97 36.77 Favored Glycine 0 CA--C 1.526 0.722 0 O-C-N 121.52 -0.737 . . . . 0.0 112.283 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.61 153.56 10.15 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 117.631 0.715 . . . . 0.0 111.803 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -53.51 122.3 9.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.664 1.186 . . . . 0.0 113.039 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.69 173.68 7.81 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.228 1.411 . . . . 0.0 113.703 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 t -105.15 -5.06 21.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.821 1.248 . . . . 0.0 114.355 -172.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -148.44 -41.04 0.16 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.353 1.061 . . . . 0.0 112.821 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.2 p -96.91 4.98 51.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.376 1.47 . . . . 0.0 114.487 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.87 2.66 16.09 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.908 1.242 . . . . 0.0 115.575 -174.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -130.32 146.31 51.9 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.897 1.848 . . . . 0.0 111.134 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -136.97 174.36 10.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.875 1.27 . . . . 0.0 111.835 -168.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.5 p -138.53 139.14 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.757 1.223 . . . . 0.0 109.461 172.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.81 124.49 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 125.627 1.571 . . . . 0.0 107.067 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.98 153.78 38.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.856 -170.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -67.9 155.57 39.12 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.074 -1.016 . . . . 0.0 112.429 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.5 t . . . . . 0 C--O 1.252 1.205 0 C-N-CA 125.996 1.719 . . . . 0.0 111.228 172.429 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 t -159.94 170.1 22.07 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.29 1.436 . . . . 0.0 109.825 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 140.46 58.55 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 121.701 -0.625 . . . . 0.0 112.271 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.14 -162.37 33.15 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.203 0.906 . . . . 0.0 114.391 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -95.19 125.33 39.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.017 0.927 . . . . 0.0 110.174 170.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -134.19 170.87 15.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.367 1.467 . . . . 0.0 112.312 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.8 pt -123.9 151.55 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 126.119 1.768 . . . . 0.0 108.361 170.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.1 mt -128.18 120.12 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -139.94 149.83 43.79 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.743 0.817 . . . . 0.0 112.061 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -75.9 136.39 40.11 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.655 -0.653 . . . . 0.0 111.79 -174.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.4 tpt85 -65.76 -15.47 62.88 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 N--CA 1.478 0.95 0 C-N-CA 124.633 1.173 . . . . 0.0 112.489 172.721 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.1 tp . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.29 147.13 29.07 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.352 1.461 . . . . 0.0 114.547 -169.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.1 tp -58.16 136.18 57.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.232 1.013 . . . . 0.0 109.148 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.1 m -132.94 121.94 23.57 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.982 0.913 . . . . 0.0 111.373 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -60.01 130.96 89.27 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.526 2.331 . . . . 0.0 111.498 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.63 -8.58 19.44 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.6 2.866 . . . . 0.0 114.432 -177.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.02 -2.27 65.92 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.227 0.917 . . . . 0.0 114.958 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -156.46 169.85 23.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.084 1.354 . . . . 0.0 113.001 -173.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -99.46 159.28 15.13 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.345 1.858 . . . . 0.0 110.527 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 57.49 39.9 27.57 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.788 1.635 . . . . 0.0 113.402 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.1 m -142.22 139.2 17.49 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 125.963 1.705 . . . . 0.0 110.733 -172.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -52.96 156.95 8.79 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.869 3.713 . . . . 0.0 115.389 172.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 t -105.29 156.81 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.947 1.299 . . . . 0.0 110.711 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.6 m -127.94 170.16 13.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.715 1.606 . . . . 0.0 110.644 -171.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.1 140.16 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.843 1.257 . . . . 0.0 111.425 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.4 m -152.82 164.21 21.04 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 124.513 1.125 . . . . 0.0 112.758 -172.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -53.6 159.35 6.67 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.735 2.957 . . . . 0.0 113.604 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.2 tp -116.46 140.41 49.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.654 1.182 . . . . 0.0 111.725 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -140.68 -37.55 0.45 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.633 1.973 . . . . 0.0 112.517 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.11 3.58 1.21 Allowed Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.82 1.2 . . . . 0.0 115.374 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -62.39 154.68 27.4 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.535 1.667 . . . . 0.0 112.388 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.4 p -68.95 -14.79 63.25 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 173.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.57 -22.72 60.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.202 0.91 . . . . 0.0 112.343 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.73 6.4 11.56 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.111 2.564 . . . . 0.0 112.687 -169.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.17 149.51 37.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.966 1.306 . . . . 0.0 110.896 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -136.83 171.87 13.85 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 123.008 1.385 . . . . 0.0 112.856 -168.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.6 mt -120.2 135.33 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.948 2.499 . . . . 0.0 106.472 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.0 tp -135.73 126.21 26.84 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.116 1.366 . . . . 0.0 109.101 -172.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -142.82 139.59 30.99 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.634 0.773 . . . . 0.0 110.899 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.4 t -65.31 140.19 58.67 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.934 0.494 . . . . 0.0 110.874 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -109.84 -52.74 2.74 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.608 1.163 . . . . 0.0 110.62 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -145.18 106.86 4.25 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.721 1.208 . . . . 0.0 110.841 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 m -51.81 -31.81 28.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.204 1.802 . . . . 0.0 114.604 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 71' ' ' ASN . 3.2 p30 -73.71 -18.04 61.05 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.504 2.322 . . . . 0.0 114.151 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -117.51 6.37 12.54 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.923 1.689 . . . . 0.0 113.073 171.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 43.97 33.44 0.77 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.018 2.127 . . . . 0.0 114.267 -169.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -87.44 145.42 26.29 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.722 -1.236 . . . . 0.0 112.04 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -141.24 141.72 33.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.999 1.319 . . . . 0.0 111.422 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 p -80.46 146.58 31.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.76 0.824 . . . . 0.0 111.225 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.0 mm -130.16 122.26 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.45 1.5 . . . . 0.0 111.037 -171.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 m -142.04 147.66 45.37 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 125.256 1.423 . . . . 0.0 110.894 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.74 146.94 34.45 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.82 2.347 . . . . 0.0 110.977 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.0 m -65.6 -23.96 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.864 -1.148 . . . . 0.0 112.793 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.87 -6.58 72.12 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.6 1.095 . . . . 0.0 114.889 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.3 t -152.81 67.39 6.52 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 118.565 1.182 . . . . 0.0 111.867 176.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.16 -13.35 31.43 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.686 2.257 . . . . 0.0 113.103 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -78.16 11.26 2.41 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.473 1.909 . . . . 0.0 113.447 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.5 m -136.89 169.29 18.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.5 1.92 . . . . 0.0 111.783 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -141.61 167.18 22.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.353 1.461 . . . . 0.0 111.842 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.8 mm -119.18 130.98 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.665 1.186 . . . . 0.0 110.89 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.0 -158.86 8.26 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.722 1.629 . . . . 0.0 111.676 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -140.54 143.54 35.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.457 1.103 . . . . 0.0 111.792 -172.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.9 -165.34 12.16 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.394 1.474 . . . . 0.0 113.018 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.92 139.71 21.66 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.914 1.286 . . . . 0.0 113.185 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.12 -5.71 65.97 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.762 1.173 . . . . 0.0 114.18 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 48.38 55.85 8.31 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.6 1.96 . . . . 0.0 114.401 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.68 149.07 69.78 Favored Pre-proline 0 C--O 1.24 0.567 0 C-N-CA 126.291 1.837 . . . . 0.0 107.573 169.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.4 147.64 59.2 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.022 1.148 . . . . 0.0 109.802 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.32 149.93 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.743 1.617 . . . . 0.0 110.973 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.2 t -77.7 137.34 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.504 0.721 . . . . 0.0 110.368 173.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.9 mt -138.89 164.63 38.12 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.069 2.148 . . . . 0.0 110.677 -170.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.92 159.74 52.18 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 122.109 1.872 . . . . 0.0 111.178 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.23 119.84 6.57 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.031 2.487 . . . . 0.0 110.328 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -144.11 -88.46 0.12 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 110.752 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -156.09 14.59 0.33 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.102 1.361 . . . . 0.0 113.414 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -70.15 134.34 48.03 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.408 -0.808 . . . . 0.0 111.477 -174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.64 160.02 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.484 1.113 . . . . 0.0 112.344 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -128.07 135.07 49.32 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.989 1.316 . . . . 0.0 110.769 171.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.0 m -76.45 129.18 36.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.753 1.221 . . . . 0.0 109.391 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 42.4 mt -117.05 129.34 55.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.097 0.959 . . . . 0.0 109.793 -178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 m -133.27 118.03 18.07 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.649 1.18 . . . . 0.0 110.212 -169.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp -65.07 147.27 53.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.246 0.618 . . . . 0.0 111.335 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.3 p -129.06 -178.84 4.8 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.509 1.524 . . . . 0.0 111.686 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 64.3 p -59.05 -15.0 11.31 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.92 27.51 0.24 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.215 0.912 . . . . 0.0 114.64 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 174.42 -148.35 9.8 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.954 1.264 . . . . 0.0 112.155 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -131.8 172.12 12.69 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.936 2.095 . . . . 0.0 111.547 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -137.82 152.98 49.67 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.774 2.43 . . . . 0.0 109.526 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.7 mt -133.71 126.47 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.309 1.444 . . . . 0.0 108.824 -170.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -140.3 159.43 42.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.643 1.177 . . . . 0.0 113.14 -172.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.71 -24.17 67.54 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -169.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.9 -37.13 2.1 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.613 1.102 . . . . 0.0 113.032 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -117.38 12.17 14.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.478 1.911 . . . . 0.0 113.709 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 62.42 16.63 8.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.757 2.023 . . . . 0.0 114.185 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.9 p -72.16 -29.17 63.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.72 0.808 . . . . 0.0 112.534 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.0 m -145.85 177.45 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.494 1.517 . . . . 0.0 111.837 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t -148.97 153.05 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.648 2.379 . . . . 0.0 110.093 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -69.85 144.92 52.41 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.534 -0.729 . . . . 0.0 111.712 171.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 87.7 p -151.94 171.6 17.55 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.673 1.189 . . . . 0.0 112.734 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.4 mt -125.6 165.78 17.91 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.356 1.862 . . . . 0.0 110.015 174.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -104.8 -32.8 8.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.871 0.869 . . . . 0.0 112.144 -169.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -138.81 -8.33 1.4 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.661 1.984 . . . . 0.0 112.436 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.51 21.68 5.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.009 1.724 . . . . 0.0 114.621 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.2 p -73.08 154.13 40.53 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.961 -1.087 . . . . 0.0 111.683 171.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.65 142.82 58.26 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.299 -0.876 . . . . 0.0 112.263 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.05 1.68 90.08 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.904 1.24 . . . . 0.0 114.479 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.93 141.76 45.96 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.741 1.27 . . . . 0.0 112.776 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -76.22 117.86 18.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.23 -0.919 . . . . 0.0 110.312 173.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.88 148.29 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.804 0.842 . . . . 0.0 111.57 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 t -128.68 167.73 16.8 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.586 1.555 . . . . 0.0 111.781 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.7 mt -135.6 141.22 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.603 1.561 . . . . 0.0 109.582 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -179.41 179.86 48.82 Favored Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.944 1.259 . . . . 0.0 111.605 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.07 -40.41 58.29 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.221 1.51 . . . . 0.0 114.334 -173.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -171.63 173.14 4.75 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 128.844 2.858 . . . . 0.0 109.331 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.74 139.87 36.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.201 1.0 . . . . 0.0 112.629 169.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.6 t -60.98 -20.79 62.83 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -169.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -137.71 -38.88 0.58 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.465 1.106 . . . . 0.0 113.222 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 86.8 p -93.35 3.67 55.24 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.294 1.437 . . . . 0.0 114.606 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.23 15.66 1.37 Allowed Glycine 0 CA--C 1.543 1.799 0 C-N-CA 125.856 1.693 . . . . 0.0 115.763 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -134.73 152.46 51.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.916 1.686 . . . . 0.0 111.451 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -141.77 175.9 9.34 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.884 2.074 . . . . 0.0 110.594 -169.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.82 138.37 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 125.123 1.369 . . . . 0.0 108.588 170.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.77 123.29 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -149.0 154.01 38.73 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.922 1.289 . . . . 0.0 109.239 -171.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.58 155.85 39.2 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.907 -1.12 . . . . 0.0 112.701 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 C--O 1.252 1.211 0 C-N-CA 126.146 1.778 . . . . 0.0 111.276 171.415 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.7 m -149.69 163.16 38.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.315 1.846 . . . . 0.0 109.61 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.17 54.76 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.458 -0.776 . . . . 0.0 111.417 170.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.84 -164.3 36.9 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.914 0.768 . . . . 0.0 114.604 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -94.52 125.65 39.3 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.017 0.927 . . . . 0.0 110.232 170.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -134.64 171.12 14.79 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.428 1.491 . . . . 0.0 112.409 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.7 pt -125.38 152.42 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.173 1.789 . . . . 0.0 108.445 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.9 mt -128.72 119.85 50.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -140.25 148.96 42.25 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.696 0.798 . . . . 0.0 112.555 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -78.7 135.06 37.07 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.903 -0.498 . . . . 0.0 111.544 -174.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -59.59 -22.84 62.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.089 1.356 . . . . 0.0 114.139 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.6 t . . . . . 0 N--CA 1.481 1.094 0 C-N-CA 124.172 0.989 . . . . 0.0 112.866 175.204 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.8 tp . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 121.028 0.442 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.29 147.64 27.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.788 1.635 . . . . 0.0 114.203 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.4 tp -59.64 138.36 57.76 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.163 1.385 . . . . 0.0 110.863 170.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 m -130.42 126.52 37.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.102 0.961 . . . . 0.0 111.93 -171.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -61.25 130.51 91.66 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 126.319 1.848 . . . . 0.0 111.657 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.41 -6.49 16.39 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.707 2.938 . . . . 0.0 114.878 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.76 -2.29 62.07 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.832 -0.982 . . . . 0.0 115.082 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -160.22 169.75 22.59 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.919 1.359 . . . . 0.0 112.863 -172.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -95.17 167.55 11.3 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.894 1.677 . . . . 0.0 111.405 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.8 tpt85 47.49 40.71 11.77 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.11 2.164 . . . . 0.0 113.694 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.6 m -139.76 140.61 25.21 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 125.159 1.384 . . . . 0.0 111.83 -169.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -44.53 150.18 0.84 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 126.338 4.692 . . . . 0.0 115.424 169.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.57 155.84 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.145 1.378 . . . . 0.0 110.699 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -126.74 176.06 7.53 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.753 1.621 . . . . 0.0 111.082 -169.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.62 145.74 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.049 1.34 . . . . 0.0 111.452 176.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.6 m -151.22 159.67 33.19 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.938 1.295 . . . . 0.0 111.945 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.66 132.38 35.06 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.84 1.693 . . . . 0.0 110.758 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.69 138.73 57.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.161 1.384 . . . . 0.0 111.436 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -132.45 -22.34 2.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.946 1.298 . . . . 0.0 112.594 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.73 -1.82 32.12 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.944 1.735 . . . . 0.0 113.478 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.6 p -80.04 159.42 26.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.792 1.237 . . . . 0.0 113.076 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.3 m -60.19 -18.16 46.24 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.76 -35.26 80.0 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.04 0.936 . . . . 0.0 112.458 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.31 0.0 OUTLIER -120.47 14.06 11.89 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.16 149.69 23.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.267 1.027 . . . . 0.0 111.707 170.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -139.47 171.53 14.13 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.635 1.207 . . . . 0.0 113.131 -169.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.8 mt -120.8 137.04 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 127.721 2.408 . . . . 0.0 107.351 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.5 tp -137.0 125.61 23.73 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.487 1.515 . . . . 0.0 109.491 -171.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -142.88 135.69 27.92 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.08 0.952 . . . . 0.0 110.999 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -63.87 140.23 58.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.321 0.649 . . . . 0.0 111.37 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -112.06 -52.89 2.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.421 1.088 . . . . 0.0 111.25 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -147.89 117.34 6.98 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.13 . . . . 0.0 111.087 169.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -36.18 80.82 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 112.936 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -61.26 -17.35 53.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.927 2.091 . . . . 0.0 114.883 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 m -123.99 8.32 8.67 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.143 1.777 . . . . 0.0 113.624 172.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 43.36 33.56 0.62 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.31 1.844 . . . . 0.0 114.545 -169.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 p -89.25 144.81 25.82 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.386 -1.446 . . . . 0.0 112.316 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -139.71 140.82 36.91 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.357 1.463 . . . . 0.0 111.297 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.4 p -79.02 148.3 32.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.015 0.526 . . . . 0.0 110.858 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.13 129.9 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.524 1.53 . . . . 0.0 109.362 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.0 m -145.63 145.98 27.74 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.641 1.576 . . . . 0.0 110.622 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.19 145.91 35.52 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.999 2.466 . . . . 0.0 111.043 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.71 -25.78 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.925 -1.109 . . . . 0.0 113.057 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.87 -23.44 61.86 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 123.858 0.742 . . . . 0.0 114.388 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m -142.09 64.13 16.75 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.701 1.6 . . . . 0.0 111.112 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -61.3 -19.38 63.7 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.917 3.078 . . . . 0.0 113.244 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -71.19 9.0 0.82 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 128.234 2.614 . . . . 0.0 114.415 169.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.8 p -138.03 172.73 12.49 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.717 1.607 . . . . 0.0 112.345 173.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -137.98 171.6 14.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.917 1.687 . . . . 0.0 112.567 -171.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -120.39 126.7 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.15 1.38 . . . . 0.0 110.728 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.75 -158.59 7.6 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.874 1.702 . . . . 0.0 111.385 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -141.3 144.09 34.43 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.343 1.071 . . . . 0.0 111.763 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.84 -165.2 12.29 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.494 1.521 . . . . 0.0 113.059 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.24 138.92 25.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.003 1.321 . . . . 0.0 113.257 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.18 -1.63 67.62 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.607 1.099 . . . . 0.0 114.354 -173.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 48.52 55.67 8.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.236 1.815 . . . . 0.0 113.669 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.8 p -132.68 137.2 29.25 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 127.695 2.398 . . . . 0.0 107.479 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.31 143.29 47.76 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.112 -1.149 . . . . 0.0 109.112 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.13 147.13 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.178 1.391 . . . . 0.0 110.932 -172.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.64 138.87 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.423 0.689 . . . . 0.0 109.964 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.3 mt -142.31 163.55 38.8 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 125.826 1.65 . . . . 0.0 111.728 -169.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.92 165.77 30.02 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.05 2.5 . . . . 0.0 111.751 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.43 123.7 9.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.555 2.17 . . . . 0.0 110.924 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -147.07 -92.11 0.09 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.164 0.985 . . . . 0.0 110.511 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -154.53 17.47 0.46 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.563 1.545 . . . . 0.0 112.794 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -67.48 134.69 51.81 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.605 0.762 . . . . 0.0 111.92 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.5 m -145.73 161.45 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.059 1.344 . . . . 0.0 112.391 -175.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -129.75 138.19 50.96 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.466 1.506 . . . . 0.0 110.875 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.5 m -74.95 125.52 29.06 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.242 1.417 . . . . 0.0 109.228 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.1 mt -116.46 128.41 55.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 109.876 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.0 m -134.89 121.77 21.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.911 0.884 . . . . 0.0 110.858 -169.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 tp -67.92 148.24 51.38 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.262 0.625 . . . . 0.0 111.448 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 p -129.39 -176.67 3.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.93 1.692 . . . . 0.0 111.452 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.1 p -58.56 -17.71 23.86 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.68 29.37 0.24 Allowed Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.506 1.05 . . . . 0.0 114.017 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.48 -150.99 10.47 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.977 1.275 . . . . 0.0 112.172 -173.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -134.86 171.93 13.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.077 2.151 . . . . 0.0 111.536 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -137.83 154.49 49.51 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.52 1.928 . . . . 0.0 110.91 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 31.5 mt -135.32 118.53 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.084 1.354 . . . . 0.0 110.057 -169.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -134.9 157.96 45.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.218 1.007 . . . . 0.0 112.831 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -62.53 -26.76 68.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -169.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.48 -40.35 1.67 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.145 1.355 . . . . 0.0 113.143 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -98.54 1.5 46.6 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.643 1.577 . . . . 0.0 113.641 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 65.22 12.84 8.34 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.942 2.097 . . . . 0.0 113.738 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.2 p -73.49 -23.84 60.1 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.46 1.104 . . . . 0.0 112.812 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.6 m -143.3 173.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.552 1.541 . . . . 0.0 112.017 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 t -145.17 154.0 41.97 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.582 2.753 . . . . 0.0 109.767 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -72.32 145.24 47.94 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.401 -0.812 . . . . 0.0 111.491 170.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.0 p -154.84 162.14 41.21 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.362 1.065 . . . . 0.0 112.868 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.5 mt -109.91 170.55 8.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.797 1.639 . . . . 0.0 109.375 169.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -109.77 -31.74 7.33 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.224 1.01 . . . . 0.0 112.059 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -135.83 -10.11 2.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.756 2.022 . . . . 0.0 112.081 169.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.65 27.98 11.36 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.98 1.712 . . . . 0.0 113.939 -170.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.1 p -75.47 155.6 36.07 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.222 1.009 . . . . 0.0 111.657 170.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.26 136.54 55.99 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.244 -0.91 . . . . 0.0 111.427 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.03 0.75 88.93 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.466 1.031 . . . . 0.0 114.536 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -71.17 142.72 50.68 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.807 1.303 . . . . 0.0 112.73 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.1 119.87 19.85 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.302 -0.874 . . . . 0.0 110.06 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 p -62.47 150.34 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.521 0.729 . . . . 0.0 111.357 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.1 m -131.95 168.98 16.95 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.309 1.844 . . . . 0.0 111.293 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.6 mt -134.63 143.71 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.05 1.34 . . . . 0.0 109.379 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.28 179.33 47.53 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 124.819 1.2 . . . . 0.0 111.743 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.31 -42.65 61.33 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.963 1.382 . . . . 0.0 114.291 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -169.71 172.93 6.53 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.166 2.586 . . . . 0.0 109.559 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.51 135.02 33.05 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.168 0.987 . . . . 0.0 112.254 170.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.6 t -56.98 -24.56 54.32 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.273 1.829 . . . . 0.0 115.809 -169.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -130.83 -36.41 1.38 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.962 1.305 . . . . 0.0 112.826 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 t -96.3 1.14 51.71 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -171.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.83 26.37 0.77 Allowed Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.105 1.336 . . . . 0.0 115.948 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -145.92 149.7 34.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.17 1.788 . . . . 0.0 111.594 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -141.62 176.76 8.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.956 1.702 . . . . 0.0 111.826 -169.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.22 140.16 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.629 1.572 . . . . 0.0 108.807 169.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.18 123.59 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.98 153.32 37.77 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.599 1.16 . . . . 0.0 109.474 -170.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.09 155.01 40.47 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.945 -1.097 . . . . 0.0 112.736 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.3 t . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.317 1.847 . . . . 0.0 111.31 171.199 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.2 mt . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.5 m -148.53 162.9 38.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.696 1.998 . . . . 0.0 109.3 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.8 137.24 56.48 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.399 -0.813 . . . . 0.0 111.495 172.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.14 -162.94 36.15 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.312 0.885 . . . . 0.0 115.312 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -94.02 121.85 35.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.01 1.324 . . . . 0.0 110.282 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -133.5 170.49 15.42 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.483 1.113 . . . . 0.0 112.801 -173.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.26 154.74 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 126.353 1.861 . . . . 0.0 108.855 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.0 mt -130.24 120.15 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -145.49 160.53 41.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.777 0.831 . . . . 0.0 112.458 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -99.6 121.44 41.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.486 0.714 . . . . 0.0 110.871 -174.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -63.42 -14.73 53.54 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.8 t . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 124.324 1.049 . . . . 0.0 112.358 171.82 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.1 tp . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 121.343 0.592 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.96 153.07 21.86 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.621 1.169 . . . . 0.0 113.368 -171.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -62.1 136.15 57.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.608 1.163 . . . . 0.0 109.901 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.8 m -128.05 124.72 37.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.667 1.187 . . . . 0.0 111.644 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -68.27 136.18 91.28 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.149 0.98 . . . . 0.0 112.315 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.04 -13.16 19.41 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.547 2.831 . . . . 0.0 115.015 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.93 5.79 73.15 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.324 0.964 . . . . 0.0 115.191 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -157.0 167.57 30.07 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.051 1.741 . . . . 0.0 111.78 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -98.65 167.09 11.0 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.005 1.322 . . . . 0.0 111.453 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 47.78 43.36 16.95 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.642 1.977 . . . . 0.0 113.079 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.0 m -141.07 138.96 18.46 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 125.407 1.483 . . . . 0.0 111.272 -169.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -46.5 157.06 0.5 Allowed 'Trans proline' 0 C--N 1.354 0.852 1 C-N-CA 126.121 4.547 . . . . 0.0 115.306 169.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 t -117.43 149.68 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.384 1.474 . . . . 0.0 109.774 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 m -124.89 174.97 7.6 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.097 1.359 . . . . 0.0 110.429 -169.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 m -127.02 144.33 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 120.902 -1.124 . . . . 0.0 111.602 172.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.4 m -148.38 166.02 16.67 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.803 1.241 . . . . 0.0 112.462 -176.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.58 163.26 2.82 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.79 2.993 . . . . 0.0 113.469 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.2 tp -126.26 143.73 51.04 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.794 1.238 . . . . 0.0 111.552 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -147.98 -32.33 0.27 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.328 1.451 . . . . 0.0 113.434 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.26 -9.65 0.83 Allowed Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.358 1.456 . . . . 0.0 114.365 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -63.08 139.65 58.79 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.979 1.39 . . . . 0.0 111.916 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.7 p -63.99 -11.05 25.22 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.387 1.475 . . . . 0.0 114.353 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.99 -20.08 64.99 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.487 1.04 . . . . 0.0 112.095 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -109.07 3.94 22.56 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.482 1.913 . . . . 0.0 113.282 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.29 144.58 29.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.125 0.964 . . . . 0.0 111.687 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -139.54 173.66 11.31 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.899 1.333 . . . . 0.0 112.123 -169.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.0 mt -122.75 135.44 62.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 127.746 2.418 . . . . 0.0 106.745 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.0 tp -137.04 124.53 22.12 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.978 1.311 . . . . 0.0 109.379 -172.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -142.77 138.57 30.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.403 0.681 . . . . 0.0 111.196 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.8 t -64.53 139.41 58.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.967 0.507 . . . . 0.0 110.984 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -114.21 -51.01 2.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.528 1.131 . . . . 0.0 110.762 174.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.23 107.71 4.1 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.172 0.989 . . . . 0.0 111.208 169.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.6 m -58.27 -25.94 62.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.987 0.915 . . . . 0.0 111.311 168.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -62.24 -21.6 65.3 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.095 2.158 . . . . 0.0 113.399 173.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.4 m -130.37 9.1 5.11 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.913 1.685 . . . . 0.0 113.026 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 47.0 32.1 1.76 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.014 2.126 . . . . 0.0 114.23 -169.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 p -92.55 142.49 27.34 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.158 -0.964 . . . . 0.0 112.319 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -139.06 144.54 38.82 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.072 1.749 . . . . 0.0 110.653 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.0 p -77.85 148.5 34.64 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.182 0.593 . . . . 0.0 110.82 172.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 mm -128.17 126.86 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.572 1.549 . . . . 0.0 109.417 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.9 m -143.9 148.91 44.21 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 125.541 1.536 . . . . 0.0 109.785 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.51 150.76 28.47 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.031 2.487 . . . . 0.0 111.055 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.03 -26.38 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.023 -1.048 . . . . 0.0 113.552 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.84 -20.79 55.1 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.738 0.685 . . . . 0.0 114.485 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.6 m -142.39 61.13 11.23 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 125.635 1.574 . . . . 0.0 111.526 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -61.31 -17.16 51.39 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.69 2.926 . . . . 0.0 113.178 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -72.87 13.55 0.37 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 128.591 2.756 . . . . 0.0 113.481 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.8 p -144.0 170.13 16.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.428 2.291 . . . . 0.0 111.119 173.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -139.65 170.71 15.4 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.217 1.807 . . . . 0.0 111.979 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -117.1 126.79 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.732 1.213 . . . . 0.0 110.77 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.79 -158.67 7.63 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 126.072 1.796 . . . . 0.0 111.328 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -144.96 144.77 31.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.178 0.989 . . . . 0.0 111.897 -174.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.03 -161.13 9.83 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.573 1.558 . . . . 0.0 113.116 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.18 137.7 21.8 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.921 1.288 . . . . 0.0 113.018 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.56 -5.83 64.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.724 1.154 . . . . 0.0 114.248 -172.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 47.49 52.65 12.12 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.402 1.881 . . . . 0.0 113.719 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.84 141.39 41.51 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 127.213 2.205 . . . . 0.0 107.478 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.54 140.12 55.98 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 N-CA-C 108.944 -1.214 . . . . 0.0 108.944 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.53 148.02 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.327 1.451 . . . . 0.0 111.275 -175.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.0 t -77.26 137.42 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.577 0.751 . . . . 0.0 110.426 173.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -141.0 161.76 51.93 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.209 1.803 . . . . 0.0 110.799 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.32 162.5 38.33 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.555 2.17 . . . . 0.0 111.291 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.96 127.77 27.48 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.15 2.566 . . . . 0.0 113.02 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -149.3 -107.82 0.07 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.203 1.401 . . . . 0.0 108.994 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -143.83 21.22 1.8 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.535 1.934 . . . . 0.0 110.581 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -65.82 131.99 47.63 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.339 -0.85 . . . . 0.0 111.677 -173.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.5 m -143.56 161.24 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.437 1.495 . . . . 0.0 111.335 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -130.83 152.27 50.35 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.214 1.406 . . . . 0.0 110.135 169.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.4 m -77.03 135.58 38.66 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.158 1.383 . . . . 0.0 109.294 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -126.09 73.78 1.39 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.246 1.018 . . . . 0.0 109.137 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.8 m -83.92 127.16 33.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.3 1.04 . . . . 0.0 111.015 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 tp -69.58 147.36 50.83 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.727 0.811 . . . . 0.0 111.405 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.1 p -129.91 175.53 8.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.381 1.473 . . . . 0.0 111.791 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 75.9 p -62.88 -11.5 18.69 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.65 17.22 1.63 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.76 1.171 . . . . 0.0 115.291 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.63 -137.22 4.99 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 118.645 1.222 . . . . 0.0 112.498 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -133.6 169.07 17.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.421 2.288 . . . . 0.0 111.336 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -131.39 147.39 52.56 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.304 1.842 . . . . 0.0 110.43 172.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.8 mt -130.53 114.01 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.055 0.942 . . . . 0.0 110.022 -170.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -136.89 151.99 49.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.86 1.264 . . . . 0.0 111.433 -169.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.0 -31.37 62.99 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.55 -40.11 1.59 Allowed Glycine 0 N--CA 1.471 1.019 0 C-N-CA 125.221 1.391 . . . . 0.0 112.649 -171.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -79.77 -5.76 55.96 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.913 1.285 . . . . 0.0 114.214 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? 57.1 14.14 1.87 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 126.998 2.119 . . . . 0.0 114.26 -169.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.8 p -69.46 -26.54 64.63 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.625 1.97 . . . . 0.0 113.501 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.5 m -143.88 168.71 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.005 1.722 . . . . 0.0 111.322 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.6 t -140.93 156.88 46.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.157 1.783 . . . . 0.0 110.863 172.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -71.52 138.74 49.13 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.18 0.592 . . . . 0.0 111.148 170.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 98.3 p -147.94 172.97 13.35 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.344 1.058 . . . . 0.0 112.552 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.92 149.18 46.18 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.077 1.351 . . . . 0.0 110.001 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -82.55 -34.41 27.8 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.433 0.693 . . . . 0.0 111.285 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -141.0 -7.83 1.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.33 1.852 . . . . 0.0 112.785 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.45 28.16 13.25 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.816 1.646 . . . . 0.0 114.319 -170.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.0 p -76.81 157.84 31.26 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.987 -1.071 . . . . 0.0 111.39 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -71.24 144.51 50.05 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.074 -1.016 . . . . 0.0 112.036 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.11 0.83 84.1 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.423 1.011 . . . . 0.0 114.395 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -70.01 149.4 47.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.964 1.306 . . . . 0.0 112.579 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.91 114.22 21.52 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.991 -1.068 . . . . 0.0 109.774 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.7 p -56.96 146.09 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 111.353 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.3 t -124.94 165.8 17.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.99 1.316 . . . . 0.0 111.957 -169.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.8 mt -134.98 143.06 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.725 1.61 . . . . 0.0 108.81 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.66 -157.81 30.33 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.076 0.846 . . . . 0.0 111.85 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.54 157.51 5.15 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.664 0.732 . . . . 0.0 111.91 169.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -57.84 153.08 14.59 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.33 1.052 . . . . 0.0 112.691 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.24 171.24 7.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.911 1.685 . . . . 0.0 112.738 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.3 t -107.2 -3.45 19.81 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -170.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -145.82 -43.93 0.21 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.384 1.073 . . . . 0.0 112.536 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 86.2 p -95.48 -0.3 52.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.52 -3.71 27.76 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.5 1.524 . . . . 0.0 115.924 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -125.66 152.58 45.03 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.524 1.662 . . . . 0.0 111.541 -174.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -137.59 175.48 9.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.656 1.583 . . . . 0.0 111.947 -168.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.0 p -138.41 139.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.7 1.2 . . . . 0.0 109.857 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 mp -122.45 124.51 70.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.968 1.707 . . . . 0.0 106.95 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -149.07 154.03 38.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.104 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.24 155.16 40.28 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.102 -0.999 . . . . 0.0 112.62 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.6 t . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.077 1.751 . . . . 0.0 111.313 171.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.542 0.655 0 CA-C-O 121.572 0.701 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 t -154.18 169.53 23.38 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.945 1.298 . . . . 0.0 109.841 171.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.88 139.43 58.76 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 173.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.89 -161.34 32.29 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.267 0.937 . . . . 0.0 114.374 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -98.93 125.61 44.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.077 0.951 . . . . 0.0 110.111 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -134.28 172.47 12.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.572 1.549 . . . . 0.0 112.239 -171.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.4 pt -127.04 154.58 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 126.477 1.911 . . . . 0.0 108.62 171.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.66 123.77 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -141.36 150.22 42.15 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.362 0.665 . . . . 0.0 112.485 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -84.82 134.56 34.3 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.192 0.597 . . . . 0.0 111.635 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -64.83 -13.59 56.49 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.6 t . . . . . 0 N--CA 1.478 0.94 0 CA-C-N 119.447 1.022 . . . . 0.0 112.399 171.84 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.3 tp . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 121.213 0.53 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.72 145.17 29.73 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -169.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -59.39 130.95 49.42 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.803 1.241 . . . . 0.0 109.201 168.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.1 m -128.52 117.37 21.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.436 1.094 . . . . 0.0 110.909 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.87 134.3 89.77 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.512 1.925 . . . . 0.0 112.141 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.59 -10.46 18.68 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.497 2.798 . . . . 0.0 114.795 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.21 6.19 81.85 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 119.01 -0.883 . . . . 0.0 115.254 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -157.7 163.24 38.37 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.94 1.37 . . . . 0.0 112.241 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -90.8 165.62 13.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.318 1.047 . . . . 0.0 111.631 -175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 50.67 35.77 12.53 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.308 1.843 . . . . 0.0 113.707 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.0 m -134.06 138.96 31.78 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 125.385 1.474 . . . . 0.0 111.319 -169.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -46.62 153.15 1.32 Allowed 'Trans proline' 0 C--N 1.354 0.817 1 C-N-CA 125.973 4.449 . . . . 0.0 115.238 169.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.05 147.75 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.687 1.195 . . . . 0.0 110.388 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 m -120.95 173.02 7.5 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.377 1.471 . . . . 0.0 111.347 -168.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.47 143.91 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.875 1.27 . . . . 0.0 111.446 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.1 m -151.41 159.84 32.79 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.136 1.374 . . . . 0.0 111.478 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -62.55 132.95 40.22 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.241 1.961 . . . . 0.0 110.779 173.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.1 tp -63.79 137.28 57.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.284 1.034 . . . . 0.0 111.308 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -135.93 -24.03 1.32 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.298 1.439 . . . . 0.0 112.811 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.14 5.96 22.81 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.147 1.356 . . . . 0.0 114.037 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.3 t -62.48 147.93 47.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.425 1.113 . . . . 0.0 111.788 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.8 m -58.24 -20.29 40.81 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.097 0.959 . . . . 0.0 113.53 172.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.87 -20.98 65.18 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.927 0.891 . . . . 0.0 112.853 173.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -104.29 -1.54 26.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.145 1.778 . . . . 0.0 112.617 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.95 138.81 41.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.807 1.243 . . . . 0.0 111.517 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -136.0 170.43 16.02 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.745 1.218 . . . . 0.0 111.873 -169.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.0 mt -124.69 136.87 59.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 126.514 1.926 . . . . 0.0 107.358 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.6 tp -136.51 126.51 26.02 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.383 1.473 . . . . 0.0 109.506 -169.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -144.25 138.05 27.72 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.15 0.98 . . . . 0.0 110.788 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 t -63.84 141.87 58.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.933 0.493 . . . . 0.0 111.529 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -113.4 -52.27 2.77 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.505 1.122 . . . . 0.0 110.76 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.43 107.49 4.02 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.276 1.03 . . . . 0.0 110.971 169.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.1 m -57.96 -26.56 62.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.939 0.896 . . . . 0.0 111.369 168.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -61.7 -20.81 63.89 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.091 2.156 . . . . 0.0 113.664 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.8 m -130.36 9.39 5.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.242 1.817 . . . . 0.0 112.949 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 47.23 28.55 1.02 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.291 2.236 . . . . 0.0 114.734 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -88.53 142.33 27.79 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.592 -1.318 . . . . 0.0 112.443 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -138.45 141.7 39.47 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.932 1.693 . . . . 0.0 110.891 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.2 p -77.88 147.57 35.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.148 0.579 . . . . 0.0 110.758 172.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.6 mm -128.49 131.41 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.42 1.488 . . . . 0.0 109.507 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.1 m -144.54 148.33 39.75 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 125.918 1.687 . . . . 0.0 110.549 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.9 145.89 28.95 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.121 2.547 . . . . 0.0 111.322 173.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.34 -28.76 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 O-C-N 121.189 -0.945 . . . . 0.0 112.003 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.43 -25.3 74.63 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 123.738 0.685 . . . . 0.0 114.753 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.1 m -144.59 67.37 14.23 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.451 1.5 . . . . 0.0 111.554 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.82 -13.46 37.2 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.416 2.744 . . . . 0.0 113.658 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -73.99 1.99 9.68 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.976 1.71 . . . . 0.0 114.002 170.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m -132.74 173.56 11.23 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.7 1.6 . . . . 0.0 111.782 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -137.4 172.43 12.99 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.453 1.501 . . . . 0.0 112.775 -174.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.9 mm -119.28 123.02 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.098 1.359 . . . . 0.0 110.14 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.45 -161.43 9.75 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.981 1.753 . . . . 0.0 111.144 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -142.07 143.2 32.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.383 1.092 . . . . 0.0 111.703 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.68 -162.32 10.36 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.092 1.33 . . . . 0.0 113.35 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.08 137.71 21.2 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.17 1.388 . . . . 0.0 113.058 -177.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.48 -5.71 65.03 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.771 1.177 . . . . 0.0 114.167 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 47.99 55.91 7.99 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.256 1.822 . . . . 0.0 113.563 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.89 141.12 33.76 Favored Pre-proline 0 N--CA 1.468 0.457 0 C-N-CA 127.262 2.225 . . . . 0.0 107.658 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -66.43 144.18 72.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.142 1.228 . . . . 0.0 109.836 174.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.24 145.13 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.521 1.528 . . . . 0.0 111.992 -172.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.2 t -74.19 119.2 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.194 0.997 . . . . 0.0 110.361 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -129.95 164.64 39.07 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.842 2.057 . . . . 0.0 111.457 -169.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.04 166.34 27.03 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.154 2.569 . . . . 0.0 112.339 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.85 121.05 7.02 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.335 2.023 . . . . 0.0 110.374 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -148.11 -90.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.762 0.825 . . . . 0.0 110.827 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -155.81 17.75 0.38 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.648 1.579 . . . . 0.0 112.727 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -66.47 137.2 56.66 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.583 -0.698 . . . . 0.0 111.802 -174.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.0 m -144.53 160.46 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.788 1.235 . . . . 0.0 112.231 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -129.6 138.0 51.02 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.644 1.578 . . . . 0.0 110.145 169.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -71.4 127.51 32.8 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.67 1.188 . . . . 0.0 108.793 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.8 mt -125.92 115.76 20.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.192 0.997 . . . . 0.0 108.739 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.8 m -136.52 134.49 37.61 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.733 0.813 . . . . 0.0 111.261 -169.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.66 152.11 45.09 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.008 1.323 . . . . 0.0 112.14 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 p -131.61 -178.75 5.0 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.096 1.758 . . . . 0.0 111.373 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.6 p -60.54 -13.0 11.46 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.82 24.45 0.26 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.274 0.94 . . . . 0.0 114.885 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 176.02 -147.6 8.76 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.147 0.974 . . . . 0.0 113.112 -173.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -132.02 167.26 20.0 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.082 2.153 . . . . 0.0 111.233 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -122.27 155.12 36.57 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.923 2.089 . . . . 0.0 109.964 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mt -134.84 117.15 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.01 1.724 . . . . 0.0 108.276 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -134.91 157.21 47.44 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.732 1.213 . . . . 0.0 111.633 -173.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -60.96 -25.69 67.01 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.93 -40.36 1.66 Allowed Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.003 1.763 . . . . 0.0 112.425 -169.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -98.82 4.4 47.59 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 114.06 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 58.08 14.56 2.76 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.282 2.233 . . . . 0.0 114.352 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.4 p -71.13 -24.74 62.34 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.164 0.985 . . . . 0.0 112.597 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.78 172.9 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.867 1.667 . . . . 0.0 111.988 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.0 t -143.74 150.99 39.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.462 3.105 . . . . 0.0 108.816 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -73.51 144.84 45.99 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.41 -0.806 . . . . 0.0 111.507 170.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 93.1 p -154.07 173.98 15.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.447 1.099 . . . . 0.0 112.322 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.7 mt -121.11 170.51 9.48 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.841 2.056 . . . . 0.0 109.503 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -105.06 -33.87 8.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.025 0.93 . . . . 0.0 111.9 -169.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -139.33 -8.51 1.3 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.015 2.126 . . . . 0.0 112.456 170.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.8 24.53 10.87 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 126.211 1.805 . . . . 0.0 114.521 -171.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.5 p -73.26 158.76 34.55 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 111.736 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.72 142.91 54.86 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.21 -0.931 . . . . 0.0 112.009 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.02 6.23 85.74 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.659 1.123 . . . . 0.0 114.444 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.74 137.16 38.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.826 1.313 . . . . 0.0 112.498 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -71.95 134.35 45.91 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.369 -0.832 . . . . 0.0 110.834 174.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.48 155.59 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.462 0.649 . . . . 0.0 110.962 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.6 t -127.11 159.21 34.89 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.359 1.464 . . . . 0.0 110.91 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.97 137.07 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.468 1.507 . . . . 0.0 108.736 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 178.48 178.46 47.87 Favored Glycine 0 N--CA 1.471 0.976 0 C-N-CA 124.674 1.13 . . . . 0.0 111.44 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.87 -41.34 57.98 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.265 1.532 . . . . 0.0 114.19 -173.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -167.62 176.0 6.7 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.944 2.498 . . . . 0.0 111.382 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.12 140.08 35.95 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.332 1.053 . . . . 0.0 111.88 169.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.6 t -62.85 -22.59 66.79 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -171.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -134.01 -35.42 0.95 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.959 1.304 . . . . 0.0 113.076 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.0 t -97.8 2.8 49.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.812 1.245 . . . . 0.0 114.323 -171.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.91 17.6 1.26 Allowed Glycine 0 CA--C 1.544 1.865 0 C-N-CA 125.4 1.476 . . . . 0.0 116.27 -174.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -140.45 149.23 42.3 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.135 1.774 . . . . 0.0 112.142 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -140.89 178.17 7.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.717 2.007 . . . . 0.0 111.18 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.2 141.22 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.77 1.228 . . . . 0.0 109.286 169.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.33 123.62 71.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.575 1.55 . . . . 0.0 106.939 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -145.94 153.19 40.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.665 1.186 . . . . 0.0 109.482 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -67.45 155.28 39.41 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.04 -1.038 . . . . 0.0 112.774 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 77.1 t . . . . . 0 C--O 1.251 1.177 0 C-N-CA 126.171 1.789 . . . . 0.0 111.309 172.228 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 CA--C 1.547 0.853 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -160.76 169.28 23.07 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.095 1.358 . . . . 0.0 109.928 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.16 133.07 50.75 Favored 'General case' 0 CA--C 1.548 0.865 0 O-C-N 121.855 -0.528 . . . . 0.0 111.703 170.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.24 -164.99 37.95 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.841 0.734 . . . . 0.0 114.5 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -97.07 126.48 42.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.982 0.913 . . . . 0.0 110.318 171.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.15 172.05 13.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.56 1.544 . . . . 0.0 112.442 -170.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.6 pt -127.17 156.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.472 1.909 . . . . 0.0 108.763 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.8 mt -128.38 126.75 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.91 151.82 39.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.316 0.646 . . . . 0.0 111.735 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -86.2 138.36 31.93 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.75 -0.594 . . . . 0.0 112.038 -173.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.8 mmm180 -62.05 -19.08 62.52 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t . . . . . 0 N--CA 1.48 1.061 0 CA-C-N 119.269 0.941 . . . . 0.0 112.936 176.439 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 24.3 tp . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 121.15 0.5 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.78 141.23 36.48 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.574 1.149 . . . . 0.0 113.987 -169.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.415 HD13 ' CZ2' ' A' ' 63' ' ' TRP . 0.6 OUTLIER -60.99 125.04 22.28 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.326 1.45 . . . . 0.0 107.957 169.001 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.7 m -126.33 124.64 40.74 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.344 1.058 . . . . 0.0 112.054 -169.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.59 134.37 95.99 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.905 2.082 . . . . 0.0 111.885 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.83 -10.8 19.99 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.366 2.71 . . . . 0.0 114.462 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.89 6.16 76.38 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.962 -0.91 . . . . 0.0 115.262 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -157.17 166.66 32.59 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.005 1.402 . . . . 0.0 112.278 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -89.36 165.42 14.38 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.388 1.075 . . . . 0.0 111.828 -174.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 45.95 43.64 10.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.582 1.953 . . . . 0.0 113.497 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 m -138.31 139.01 23.91 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 125.507 1.523 . . . . 0.0 110.813 -169.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -45.84 157.81 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.881 1 C-N-CA 126.279 4.653 . . . . 0.0 115.483 169.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.15 151.02 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.316 1.446 . . . . 0.0 110.42 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 m -130.92 170.28 14.65 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.174 1.39 . . . . 0.0 110.339 -169.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.12 146.54 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.993 -1.067 . . . . 0.0 112.075 175.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -150.6 160.41 32.72 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.642 1.177 . . . . 0.0 112.223 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.06 128.03 27.39 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.46 2.774 . . . . 0.0 111.75 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 tp -64.11 136.22 57.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.481 0.713 . . . . 0.0 111.042 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -134.47 -26.89 1.39 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.206 1.403 . . . . 0.0 112.606 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.8 8.76 13.32 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.293 1.425 . . . . 0.0 113.938 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.5 t -66.98 160.13 27.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.596 1.198 . . . . 0.0 111.941 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.5 m -73.6 -16.28 61.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.088 0.955 . . . . 0.0 111.665 -176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.26 -16.73 58.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.064 1.745 . . . . 0.0 112.829 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -101.5 -5.45 25.19 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.02 1.728 . . . . 0.0 112.343 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.97 143.23 36.93 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.991 1.316 . . . . 0.0 111.735 -174.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.415 ' CZ2' HD13 ' A' ' 40' ' ' LEU . 90.3 m95 -136.4 168.12 20.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.542 1.163 . . . . 0.0 112.333 -169.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.2 mt -121.56 134.82 63.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.92 2.088 . . . . 0.0 106.654 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.1 tp -134.79 126.82 29.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.49 1.516 . . . . 0.0 109.655 -169.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -143.0 140.25 30.94 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.146 0.978 . . . . 0.0 110.894 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.7 t -65.92 140.23 58.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.707 0.403 . . . . 0.0 111.132 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -112.87 -51.2 2.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.414 1.086 . . . . 0.0 111.026 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.62 108.7 4.41 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.469 1.107 . . . . 0.0 110.93 169.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.1 m -58.08 -26.59 62.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.83 0.852 . . . . 0.0 111.188 168.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -61.36 -20.6 63.18 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.136 2.174 . . . . 0.0 113.51 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t -130.48 6.92 4.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.851 1.66 . . . . 0.0 113.401 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 48.1 31.29 2.44 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.26 1.824 . . . . 0.0 114.035 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -89.03 143.46 26.84 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.266 -0.896 . . . . 0.0 111.848 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -138.53 141.61 39.32 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.443 1.497 . . . . 0.0 110.795 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.9 p -78.02 147.44 34.82 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.092 0.557 . . . . 0.0 110.678 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.2 mm -127.63 128.09 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.48 1.512 . . . . 0.0 109.302 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.1 m -142.16 141.01 20.23 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.674 1.59 . . . . 0.0 110.5 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.09 143.41 32.33 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.853 2.369 . . . . 0.0 111.224 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.86 -28.8 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 121.297 -0.877 . . . . 0.0 111.631 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.17 -10.51 86.01 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.4 m -156.4 68.05 4.6 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.846 1.658 . . . . 0.0 110.469 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -63.55 -17.84 61.76 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.789 2.992 . . . . 0.0 113.5 -173.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -76.24 6.15 5.91 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 127.848 2.459 . . . . 0.0 114.657 171.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.7 m -131.23 175.31 9.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.977 1.711 . . . . 0.0 112.088 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -139.06 171.99 13.5 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.546 1.538 . . . . 0.0 113.28 -172.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.7 mm -120.17 130.79 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.272 1.429 . . . . 0.0 110.601 174.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.47 -157.63 7.34 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.645 1.593 . . . . 0.0 111.422 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -141.7 142.61 33.33 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.24 1.016 . . . . 0.0 111.848 -172.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.94 -163.21 10.57 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.247 1.403 . . . . 0.0 113.381 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.2 139.96 22.43 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.011 1.324 . . . . 0.0 113.136 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.46 -2.29 73.83 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.512 1.053 . . . . 0.0 114.292 -173.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 48.7 56.34 7.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.18 1.792 . . . . 0.0 113.41 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.7 p -133.83 136.88 27.34 Favored Pre-proline 0 C--O 1.238 0.49 0 C-N-CA 127.548 2.339 . . . . 0.0 107.751 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.75 142.77 59.13 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.202 1.268 . . . . 0.0 109.462 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.03 149.29 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.023 1.329 . . . . 0.0 111.472 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 t -76.22 134.93 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.851 0.861 . . . . 0.0 110.402 174.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.5 mt -141.17 161.62 52.27 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.649 1.58 . . . . 0.0 112.039 -169.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.9 165.65 29.18 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.062 2.508 . . . . 0.0 111.765 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.62 124.07 9.97 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.5 2.133 . . . . 0.0 110.702 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -148.01 -89.61 0.08 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.076 0.95 . . . . 0.0 110.592 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -154.82 15.95 0.43 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.431 1.493 . . . . 0.0 112.901 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -67.01 134.36 51.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.425 0.69 . . . . 0.0 111.906 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -144.92 161.03 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.949 1.3 . . . . 0.0 112.069 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -130.99 137.61 49.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.252 1.421 . . . . 0.0 110.762 169.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.9 m -72.19 131.74 43.17 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.899 1.28 . . . . 0.0 108.705 169.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.7 mt -121.94 73.49 1.09 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.071 0.938 . . . . 0.0 109.324 -176.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 93.3 m -73.42 119.47 17.7 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.755 1.222 . . . . 0.0 110.656 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.7 tp -68.41 147.63 51.8 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.077 0.551 . . . . 0.0 111.271 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.0 p -133.82 177.05 8.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.987 1.715 . . . . 0.0 110.515 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.9 m -59.88 -12.69 8.18 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.93 31.25 0.28 Allowed Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.761 1.172 . . . . 0.0 114.096 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.29 -160.62 34.22 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.976 1.274 . . . . 0.0 112.072 -174.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -127.92 172.11 11.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.255 1.822 . . . . 0.0 112.075 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -136.69 150.18 48.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.21 1.804 . . . . 0.0 110.099 170.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.1 mt -129.1 114.84 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.103 0.961 . . . . 0.0 109.516 -169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -134.8 155.74 50.08 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.124 0.969 . . . . 0.0 112.248 -169.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.86 -28.99 69.88 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.68 -40.6 1.61 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.063 1.792 . . . . 0.0 112.756 -172.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.08 -5.2 59.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.974 1.309 . . . . 0.0 113.983 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? 57.11 17.86 3.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.623 1.969 . . . . 0.0 113.374 -169.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 49.0 p -71.02 -24.46 62.37 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.195 0.998 . . . . 0.0 112.168 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.9 m -144.26 173.68 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.006 1.723 . . . . 0.0 112.162 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.4 t -146.14 154.81 42.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.481 2.712 . . . . 0.0 110.044 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -73.19 142.04 47.37 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.464 -0.773 . . . . 0.0 111.777 170.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 91.7 p -152.92 170.47 20.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.025 1.33 . . . . 0.0 112.63 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.81 156.06 31.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.954 1.302 . . . . 0.0 110.386 173.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -89.93 -31.47 17.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.281 0.632 . . . . 0.0 111.501 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -138.07 -4.12 1.74 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.556 1.542 . . . . 0.0 113.639 172.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.85 27.26 2.26 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.303 1.841 . . . . 0.0 114.452 -169.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.6 p -76.33 161.0 29.09 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.899 0.88 . . . . 0.0 111.471 174.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.72 142.39 51.47 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.911 -1.118 . . . . 0.0 111.359 169.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.41 5.79 82.79 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.322 0.963 . . . . 0.0 114.019 -173.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.53 140.57 49.95 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.906 1.283 . . . . 0.0 111.858 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.56 111.19 14.36 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 170.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.32 147.39 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.634 0.73 . . . . 0.0 111.175 172.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.3 m -134.22 171.54 14.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.76 1.624 . . . . 0.0 111.399 -169.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 70.0 mt -134.34 143.69 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.983 1.313 . . . . 0.0 109.231 -173.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.03 179.04 47.22 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.895 1.236 . . . . 0.0 111.65 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.47 -42.47 61.62 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.091 1.445 . . . . 0.0 114.266 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -169.3 174.28 6.18 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.266 2.626 . . . . 0.0 111.027 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -142.46 141.83 32.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.185 0.994 . . . . 0.0 111.866 169.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 t -66.26 -18.61 65.46 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -138.62 -43.66 0.49 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.194 0.998 . . . . 0.0 113.293 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.8 p -86.07 0.49 53.31 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.081 1.352 . . . . 0.0 114.381 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.95 19.68 0.96 Allowed Glycine 0 CA--C 1.541 1.666 0 C-N-CA 126.505 2.002 . . . . 0.0 116.622 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -144.94 149.78 35.83 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.069 1.935 . . . . 0.0 112.057 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -139.4 177.71 7.73 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.988 1.715 . . . . 0.0 112.368 -169.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.3 p -140.78 139.93 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.831 1.252 . . . . 0.0 109.607 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.17 125.87 74.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 125.821 1.648 . . . . 0.0 107.192 172.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -148.58 153.76 38.81 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.646 1.178 . . . . 0.0 109.46 -170.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -67.71 155.11 39.99 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.921 -1.112 . . . . 0.0 112.775 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.145 1.778 . . . . 0.0 111.323 171.908 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 CA--C 1.549 0.91 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.2 m -150.73 160.17 44.03 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.073 1.749 . . . . 0.0 109.382 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.52 131.14 45.66 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.652 -0.655 . . . . 0.0 111.362 171.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.93 -166.11 39.43 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -95.52 124.1 39.39 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.231 1.012 . . . . 0.0 110.037 172.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -133.17 171.83 13.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.098 1.359 . . . . 0.0 112.259 -173.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 pt -124.57 153.05 31.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.888 1.675 . . . . 0.0 108.431 170.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.7 mt -128.49 118.97 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -138.56 149.6 45.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.504 0.669 . . . . 0.0 112.212 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -77.6 136.58 38.27 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.04 -0.413 . . . . 0.0 111.463 -173.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -64.94 -24.28 67.47 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.3 t . . . . . 0 N--CA 1.481 1.104 0 C-N-CA 123.819 0.847 . . . . 0.0 112.489 -178.312 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.471 0.581 0 CA-C-O 121.095 0.474 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.46 142.86 33.86 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.445 1.098 . . . . 0.0 113.292 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.8 tp -56.74 135.76 55.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.857 0.863 . . . . 0.0 109.218 169.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 90.5 m -132.26 122.55 25.35 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.266 1.026 . . . . 0.0 110.827 -173.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -64.07 138.13 97.32 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 127.128 2.171 . . . . 0.0 111.907 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -74.06 -12.1 23.51 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.299 2.666 . . . . 0.0 114.933 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.29 7.26 86.94 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.006 0.812 . . . . 0.0 114.76 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -154.09 166.42 33.11 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.947 1.699 . . . . 0.0 111.764 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -93.83 164.69 13.02 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.936 0.894 . . . . 0.0 111.812 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.6 tpt85 46.68 40.12 8.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.816 2.046 . . . . 0.0 114.032 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.7 m -133.98 142.1 42.15 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.563 1.545 . . . . 0.0 111.057 -169.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -44.67 156.28 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.828 1 C-N-CA 126.003 4.469 . . . . 0.0 115.589 169.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.88 158.43 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.798 1.239 . . . . 0.0 110.207 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -128.71 170.28 13.48 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.698 1.599 . . . . 0.0 110.971 -169.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.8 p -125.49 142.29 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.833 1.253 . . . . 0.0 111.257 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 m -159.04 168.49 12.3 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.711 1.204 . . . . 0.0 113.004 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -49.97 161.56 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.677 3.585 . . . . 0.0 114.857 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.3 tp -123.01 132.26 54.05 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.739 1.216 . . . . 0.0 111.343 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -134.19 -29.27 1.27 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.922 2.089 . . . . 0.0 112.27 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.53 4.09 1.98 Allowed Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.642 1.417 . . . . 0.0 116.642 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -71.0 165.1 24.19 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.056 1.928 . . . . 0.0 113.391 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.2 m -69.02 -16.98 63.85 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.29 -24.84 62.23 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.022 0.828 . . . . 0.0 112.28 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.62 6.28 11.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.084 2.554 . . . . 0.0 112.409 -169.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.99 148.07 39.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.979 1.312 . . . . 0.0 110.745 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -137.51 174.02 11.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 122.69 1.233 . . . . 0.0 112.901 -168.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.8 mt -122.96 139.15 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.194 2.198 . . . . 0.0 107.09 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.7 tp -137.31 123.22 20.14 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.409 1.483 . . . . 0.0 109.044 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -144.13 138.34 28.12 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.507 0.723 . . . . 0.0 111.117 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.2 t -65.96 139.33 58.23 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.734 0.414 . . . . 0.0 111.002 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -111.93 -50.61 2.9 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.809 1.244 . . . . 0.0 110.282 174.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.01 106.9 3.97 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.432 1.093 . . . . 0.0 110.84 169.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.4 m -58.05 -25.5 61.3 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.959 0.903 . . . . 0.0 111.506 168.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -63.73 -20.99 66.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.022 2.129 . . . . 0.0 113.495 174.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -130.1 9.02 5.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.126 1.77 . . . . 0.0 112.644 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 45.87 32.69 1.36 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.422 2.289 . . . . 0.0 114.217 -169.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.5 p -91.62 140.95 29.23 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.919 -1.113 . . . . 0.0 112.091 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -136.84 144.89 43.86 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.878 1.671 . . . . 0.0 110.733 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.1 p -77.78 150.64 34.29 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.192 0.597 . . . . 0.0 110.965 170.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.9 mm -130.44 129.73 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.976 1.71 . . . . 0.0 108.519 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.1 p -151.98 155.09 33.4 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.171 0.988 . . . . 0.0 111.866 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.88 146.05 29.19 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.994 2.462 . . . . 0.0 110.841 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.49 -24.26 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.851 -1.156 . . . . 0.0 113.072 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.71 -19.54 57.89 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.033 0.825 . . . . 0.0 114.728 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.0 m -142.22 62.58 13.9 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 125.66 1.584 . . . . 0.0 111.266 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.36 -13.98 39.37 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.268 2.645 . . . . 0.0 113.491 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -74.08 6.84 3.1 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.293 1.837 . . . . 0.0 114.001 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -129.75 175.54 8.75 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.637 1.575 . . . . 0.0 111.331 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -141.0 167.96 20.94 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.618 1.567 . . . . 0.0 111.07 -172.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.7 mm -122.23 128.04 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.296 1.038 . . . . 0.0 110.552 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.77 -159.18 7.88 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.985 1.755 . . . . 0.0 111.243 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -143.83 148.32 35.36 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.595 1.197 . . . . 0.0 111.996 -174.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.51 -160.36 9.56 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.397 1.475 . . . . 0.0 112.968 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.46 138.35 27.68 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.832 1.253 . . . . 0.0 112.959 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.6 -3.59 63.32 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.612 1.101 . . . . 0.0 114.284 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 47.67 54.21 10.14 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.106 1.762 . . . . 0.0 113.602 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.98 138.44 30.68 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 127.53 2.332 . . . . 0.0 107.473 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.78 144.45 59.41 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.292 1.328 . . . . 0.0 109.284 174.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.01 149.87 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.253 1.421 . . . . 0.0 111.343 -174.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.96 134.26 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.01 0.924 . . . . 0.0 110.677 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.0 mt -139.23 162.1 53.86 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.586 1.555 . . . . 0.0 110.784 -172.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.69 161.14 45.02 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.34 2.027 . . . . 0.0 111.574 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.33 119.75 6.34 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.564 2.176 . . . . 0.0 110.307 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -146.49 -82.64 0.13 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.309 1.044 . . . . 0.0 110.793 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -154.72 10.48 0.35 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.005 1.322 . . . . 0.0 113.945 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -67.39 128.65 37.21 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.391 -0.818 . . . . 0.0 111.776 -175.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.4 m -143.6 163.76 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.757 1.623 . . . . 0.0 111.234 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -130.47 145.78 51.9 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.034 1.333 . . . . 0.0 110.332 171.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.2 m -74.94 134.96 41.43 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.848 1.259 . . . . 0.0 109.222 169.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.85 123.85 44.66 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.389 1.075 . . . . 0.0 109.49 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.3 m -135.09 127.17 29.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.952 0.901 . . . . 0.0 110.491 -169.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.1 153.24 41.41 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.795 0.807 . . . . 0.0 113.049 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.7 p -127.99 -177.45 4.13 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.422 1.889 . . . . 0.0 110.15 171.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.1 p -60.9 -14.59 23.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.61 30.71 0.26 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.51 1.052 . . . . 0.0 114.142 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.49 -149.78 9.61 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.795 1.188 . . . . 0.0 112.537 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -132.64 170.19 15.57 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.972 2.109 . . . . 0.0 112.358 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -134.73 152.12 51.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.306 2.643 . . . . 0.0 108.805 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.2 mt -132.46 125.13 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.826 1.251 . . . . 0.0 108.242 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -137.25 160.09 40.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.246 1.018 . . . . 0.0 112.342 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -63.67 -22.19 66.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 -170.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.87 -40.5 1.77 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.614 1.578 . . . . 0.0 112.725 -171.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -98.38 5.67 47.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.94 1.696 . . . . 0.0 113.401 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 57.11 18.04 3.86 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.156 2.182 . . . . 0.0 114.227 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p -74.37 -24.6 59.18 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.251 -0.905 . . . . 0.0 112.384 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.1 m -143.73 174.61 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.661 1.584 . . . . 0.0 112.104 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t -148.45 154.36 39.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.96 2.504 . . . . 0.0 110.111 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -70.29 143.59 52.02 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.386 -0.821 . . . . 0.0 111.802 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.1 p -151.54 172.46 15.97 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.154 1.382 . . . . 0.0 112.621 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.0 mt -128.81 177.59 6.96 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.338 1.855 . . . . 0.0 110.095 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -123.93 -31.93 3.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.258 1.423 . . . . 0.0 111.332 -169.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -143.41 -5.54 0.84 Allowed 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 173.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.17 34.61 17.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.692 1.597 . . . . 0.0 114.786 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.4 p -90.98 160.78 15.45 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.323 -0.861 . . . . 0.0 111.946 171.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.06 142.98 52.61 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.756 -1.215 . . . . 0.0 112.139 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.49 -0.5 87.83 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.535 1.064 . . . . 0.0 114.24 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -63.76 142.99 58.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.102 1.761 . . . . 0.0 112.443 174.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.54 116.78 24.05 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.144 -0.972 . . . . 0.0 109.759 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.3 p -58.82 152.92 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.24 1.016 . . . . 0.0 112.214 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.6 m -130.26 168.88 16.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.536 1.534 . . . . 0.0 111.767 -170.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.2 mt -136.65 143.38 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.217 1.407 . . . . 0.0 109.535 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 178.93 178.2 48.03 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.03 1.3 . . . . 0.0 111.905 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.59 -42.5 44.75 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 119.258 1.529 . . . . 0.0 114.562 -172.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -167.28 176.31 6.8 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 129.091 2.956 . . . . 0.0 108.374 172.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.53 137.93 35.87 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.228 -0.92 . . . . 0.0 112.364 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.2 t -59.93 -21.53 61.25 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.958 1.703 . . . . 0.0 115.218 -169.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -134.34 -36.51 0.89 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.399 1.08 . . . . 0.0 113.613 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -103.41 2.44 33.87 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.86 10.81 1.44 Allowed Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.294 1.426 . . . . 0.0 115.377 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -131.51 142.67 50.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.849 1.66 . . . . 0.0 109.921 -169.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -139.41 175.89 9.18 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.692 1.597 . . . . 0.0 111.85 -168.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.71 139.56 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.848 1.259 . . . . 0.0 109.403 169.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.42 125.49 73.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.731 1.613 . . . . 0.0 107.088 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.07 153.91 38.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.733 1.213 . . . . 0.0 108.974 -170.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -68.63 155.6 39.71 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.923 -1.111 . . . . 0.0 112.497 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.6 t . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.107 1.763 . . . . 0.0 111.279 171.807 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.72 -14.59 0.06 OUTLIER Glycine 0 CA--C 1.538 1.503 0 N-CA-C 115.795 1.078 . . . . 0.0 115.795 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -144.95 167.57 22.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.792 1.637 . . . . 0.0 111.567 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -154.6 145.45 22.52 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.915 1.286 . . . . 0.0 111.057 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -152.14 7.97 0.47 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.188 1.395 . . . . 0.0 113.641 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -74.99 -14.9 60.67 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -169.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -133.37 4.4 3.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.146 1.378 . . . . 0.0 114.008 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -156.84 157.34 34.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.075 1.35 . . . . 0.0 112.182 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.494 ' CG ' ' H ' ' A' ' 10' ' ' HIS . 8.3 t60 -147.45 -177.76 5.87 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.579 1.551 . . . . 0.0 111.144 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.494 ' H ' ' CG ' ' A' ' 9' ' ' HIS . 95.9 m-70 -131.12 171.03 13.74 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.098 1.759 . . . . 0.0 111.832 -176.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.8 p 44.63 34.09 1.07 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.698 1.999 . . . . 0.0 115.284 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.98 -19.6 0.06 OUTLIER Glycine 0 CA--C 1.539 1.546 0 C-N-CA 125.435 1.493 . . . . 0.0 114.545 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -129.05 16.64 6.2 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.966 1.706 . . . . 0.0 112.283 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 p -134.68 41.1 0.61 Allowed Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 126.075 1.75 . . . . 0.0 114.617 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -67.39 163.68 33.67 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.977 2.451 . . . . 0.0 113.011 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.03 24.41 2.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.726 1.21 . . . . 0.0 113.681 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.4 t -140.72 145.0 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.813 1.645 . . . . 0.0 110.484 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -148.88 11.36 0.84 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.4 1.48 . . . . 0.0 113.315 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt 59.13 169.09 0.06 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.102 2.161 . . . . 0.0 113.904 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -151.25 159.37 44.4 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.356 1.862 . . . . 0.0 109.424 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.44 140.65 58.89 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 121.562 -0.711 . . . . 0.0 112.243 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.45 -161.7 33.81 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.24 0.924 . . . . 0.0 114.426 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -98.44 126.75 44.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.187 0.995 . . . . 0.0 110.338 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -135.59 171.52 14.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.13 1.372 . . . . 0.0 112.701 -171.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.4 pt -124.82 153.62 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 126.329 1.852 . . . . 0.0 108.393 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.63 122.56 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -140.09 147.45 40.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.537 0.735 . . . . 0.0 111.393 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -75.62 136.7 40.46 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.918 -0.489 . . . . 0.0 111.117 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.7 tpt85 -66.28 -20.17 66.03 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -171.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.4 t -64.12 -24.26 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.809 1.244 . . . . 0.0 112.546 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.0 mt 60.88 170.63 0.1 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.906 2.082 . . . . 0.0 113.73 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.6 t -73.52 147.68 87.38 Favored Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 124.579 1.151 . . . . 0.0 111.876 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.2 -14.12 41.91 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.621 2.214 . . . . 0.0 112.828 169.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.2 tpt85 -70.52 -17.66 62.94 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.13 1.372 . . . . 0.0 113.123 169.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.84 22.81 22.47 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.474 1.511 . . . . 0.0 114.179 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -134.56 170.27 16.03 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.955 1.302 . . . . 0.0 111.844 -174.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -57.83 140.18 52.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.053 0.941 . . . . 0.0 111.692 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.28 78.09 1.14 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.451 1.501 . . . . 0.0 110.022 -171.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.7 144.12 30.45 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -169.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.79 132.38 53.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.653 1.181 . . . . 0.0 109.246 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.8 m -130.7 118.85 21.52 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.292 1.037 . . . . 0.0 111.139 -169.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -61.54 137.38 94.8 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 126.305 1.842 . . . . 0.0 112.513 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.57 -13.78 20.15 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.441 2.761 . . . . 0.0 114.926 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.25 8.15 84.03 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -153.58 161.95 41.72 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.811 1.644 . . . . 0.0 111.732 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -89.77 165.73 13.98 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.007 0.923 . . . . 0.0 111.586 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 49.57 38.54 15.02 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.773 1.629 . . . . 0.0 113.813 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.4 m -136.2 141.17 35.14 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 125.562 1.545 . . . . 0.0 111.322 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -45.55 154.98 0.51 Allowed 'Trans proline' 0 C--N 1.353 0.804 1 C-N-CA 126.167 4.578 . . . . 0.0 115.49 169.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.3 t -110.89 153.96 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.065 1.346 . . . . 0.0 110.118 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 m -128.13 172.51 10.92 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.695 1.598 . . . . 0.0 110.938 -169.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.97 144.71 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.692 1.197 . . . . 0.0 111.42 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -149.54 158.98 37.31 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 124.921 1.288 . . . . 0.0 111.872 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -63.24 130.35 28.41 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.279 1.986 . . . . 0.0 110.527 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.6 tp -63.28 136.3 57.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.373 1.069 . . . . 0.0 111.428 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -130.36 -26.87 2.26 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.192 1.797 . . . . 0.0 112.021 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.64 4.68 19.32 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.451 1.5 . . . . 0.0 114.175 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.4 p -65.74 159.45 25.09 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.783 1.291 . . . . 0.0 113.209 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -62.66 -19.1 63.5 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -68.55 -27.21 65.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.907 0.883 . . . . 0.0 112.324 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -102.38 -7.46 21.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.9 1.68 . . . . 0.0 113.197 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.64 146.37 28.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.452 1.101 . . . . 0.0 111.456 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -138.31 170.48 15.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.471 1.129 . . . . 0.0 111.858 -169.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.4 mt -121.2 136.0 59.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 127.294 2.238 . . . . 0.0 107.126 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.3 tp -137.18 124.44 21.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.274 1.43 . . . . 0.0 109.727 -170.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -141.84 140.21 32.88 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.605 0.762 . . . . 0.0 111.134 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.7 t -65.74 139.37 58.35 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.833 0.453 . . . . 0.0 110.988 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -115.19 -47.27 2.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.289 1.036 . . . . 0.0 111.595 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.37 109.48 3.73 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.308 1.043 . . . . 0.0 111.059 170.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -57.94 -27.58 63.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.828 0.851 . . . . 0.0 111.101 168.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -60.62 -21.28 62.54 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.127 2.171 . . . . 0.0 113.574 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -130.21 10.84 5.4 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.869 1.668 . . . . 0.0 112.737 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 46.36 28.51 0.72 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.967 2.107 . . . . 0.0 113.858 -168.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 p -89.71 140.03 29.98 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.85 -1.156 . . . . 0.0 112.424 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -135.26 142.93 46.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.137 1.775 . . . . 0.0 111.322 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.0 p -78.33 148.5 33.75 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.032 0.533 . . . . 0.0 110.767 172.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.2 mm -128.67 130.16 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.547 1.539 . . . . 0.0 109.807 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 m -144.8 149.65 43.72 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 126.208 1.803 . . . . 0.0 110.232 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.91 148.1 31.45 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.007 2.471 . . . . 0.0 111.143 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 m -66.18 -25.48 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 120.757 -1.215 . . . . 0.0 113.199 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.67 -21.82 65.61 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.762 0.696 . . . . 0.0 114.389 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.3 m -143.7 66.75 15.54 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 125.73 1.612 . . . . 0.0 111.047 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.23 -13.19 30.72 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.894 2.396 . . . . 0.0 113.678 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -76.55 4.69 8.73 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.046 1.738 . . . . 0.0 114.297 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.6 p -139.19 175.29 9.68 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.595 1.543 . . . . 0.0 112.579 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -138.53 171.49 14.28 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.357 1.463 . . . . 0.0 113.195 -169.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.8 mm -120.71 127.91 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.16 1.384 . . . . 0.0 110.364 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.84 -155.74 6.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.759 1.647 . . . . 0.0 110.968 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -143.25 145.06 32.41 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.492 1.146 . . . . 0.0 112.053 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.66 -162.99 10.97 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.428 1.49 . . . . 0.0 113.26 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.16 136.51 23.87 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.174 1.39 . . . . 0.0 113.054 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.77 -4.48 63.49 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.738 1.161 . . . . 0.0 114.268 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 48.54 54.71 10.09 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.425 1.89 . . . . 0.0 113.567 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.86 140.24 37.6 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 127.454 2.301 . . . . 0.0 107.674 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.28 141.21 46.51 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.076 1.184 . . . . 0.0 109.278 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.5 151.6 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.348 1.459 . . . . 0.0 111.681 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.3 t -76.91 134.6 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.115 0.966 . . . . 0.0 110.858 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -139.74 160.52 60.75 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.032 1.733 . . . . 0.0 111.825 -169.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.68 164.19 32.23 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.965 2.443 . . . . 0.0 111.983 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.71 120.51 6.73 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.43 2.087 . . . . 0.0 110.516 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -147.0 -90.91 0.09 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.0 0.92 . . . . 0.0 110.793 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -155.52 17.94 0.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.315 1.446 . . . . 0.0 113.096 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -67.36 136.33 54.62 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.486 -0.759 . . . . 0.0 111.99 -173.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.9 m -145.09 161.11 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.907 1.283 . . . . 0.0 112.545 -175.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -131.36 137.24 48.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.671 1.588 . . . . 0.0 110.737 169.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.1 m -68.49 129.67 40.6 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 169.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 44.3 mt -127.08 116.59 20.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.22 1.008 . . . . 0.0 108.693 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 m -131.6 128.29 38.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.813 0.845 . . . . 0.0 111.295 -169.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp -69.06 151.43 46.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.266 1.027 . . . . 0.0 112.147 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.6 p -129.02 -176.62 3.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.128 1.771 . . . . 0.0 111.465 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.2 p -60.34 -15.89 29.8 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.66 18.17 0.24 Allowed Glycine 0 CA--C 1.534 1.253 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.07 -150.39 8.33 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.15 1.357 . . . . 0.0 112.061 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -133.66 168.22 19.08 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.694 1.998 . . . . 0.0 111.693 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -130.0 148.71 51.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.257 2.223 . . . . 0.0 109.968 174.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.85 122.94 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.779 1.231 . . . . 0.0 109.563 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -137.96 160.4 39.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.73 1.212 . . . . 0.0 112.675 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.35 -24.38 66.42 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -172.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 124.93 -40.22 1.93 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.519 1.533 . . . . 0.0 113.077 -173.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -93.47 -3.05 53.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.298 1.439 . . . . 0.0 113.511 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 70.16 14.51 7.67 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.609 2.364 . . . . 0.0 113.413 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.2 p -72.75 -23.79 60.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.747 1.219 . . . . 0.0 112.703 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.3 m -146.02 172.66 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.91 1.684 . . . . 0.0 111.833 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.0 m -143.82 155.18 44.05 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.076 2.151 . . . . 0.0 111.214 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 38.0 m0 -73.1 140.58 47.23 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.938 -0.477 . . . . 0.0 111.848 169.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.3 p -153.56 170.71 20.14 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.225 1.41 . . . . 0.0 112.547 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.88 164.88 14.39 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.821 1.648 . . . . 0.0 110.068 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -99.62 -32.84 10.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.669 0.787 . . . . 0.0 111.623 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -143.83 -0.8 1.02 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.482 1.913 . . . . 0.0 114.196 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 50.31 27.49 2.72 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.125 2.17 . . . . 0.0 115.9 -172.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.2 p -79.4 160.0 26.85 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.901 -1.124 . . . . 0.0 112.663 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.71 138.55 58.46 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.606 0.762 . . . . 0.0 112.152 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.03 -0.3 89.86 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.658 1.123 . . . . 0.0 114.757 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -76.28 154.17 35.36 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.798 1.299 . . . . 0.0 113.169 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -81.77 122.73 28.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.058 -1.026 . . . . 0.0 110.71 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.12 151.43 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.094 0.958 . . . . 0.0 111.011 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.3 m -134.83 168.42 19.09 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.7 1.6 . . . . 0.0 111.283 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.2 mt -132.77 145.12 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.007 1.323 . . . . 0.0 109.268 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.6 -161.28 34.99 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 123.813 0.721 . . . . 0.0 112.529 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 149.16 17.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 117.828 0.814 . . . . 0.0 111.956 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.68 116.38 2.47 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.39 1.476 . . . . 0.0 113.934 -172.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.84 157.23 37.86 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.4 t -87.66 -12.98 43.84 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -133.64 -37.86 0.92 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.48 1.112 . . . . 0.0 113.44 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.4 p -104.81 2.18 29.85 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.857 1.263 . . . . 0.0 114.26 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.47 10.94 1.77 Allowed Glycine 0 CA--C 1.542 1.749 0 C-N-CA 125.888 1.708 . . . . 0.0 115.819 -176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -135.46 145.98 47.72 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.435 1.894 . . . . 0.0 111.225 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -138.06 178.51 7.07 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 126.949 2.1 . . . . 0.0 111.237 -168.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.31 138.09 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 124.169 0.987 . . . . 0.0 109.36 168.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.04 124.2 72.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 125.947 1.699 . . . . 0.0 107.215 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -147.93 152.5 37.65 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.535 1.134 . . . . 0.0 109.432 -170.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.74 155.58 38.94 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.046 -1.034 . . . . 0.0 112.909 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.133 1.773 . . . . 0.0 111.216 171.815 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.28 26.14 0.41 Allowed Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.272 0.939 . . . . 0.0 113.823 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -155.47 176.36 12.69 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.557 1.943 . . . . 0.0 111.266 -171.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -147.82 176.5 10.08 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.925 1.29 . . . . 0.0 112.255 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -154.94 165.69 35.92 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.889 1.276 . . . . 0.0 112.036 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -56.13 -17.34 6.9 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.132 1.773 . . . . 0.0 115.085 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -109.91 9.23 24.52 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.396 1.479 . . . . 0.0 113.407 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -134.5 -6.97 2.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.141 1.376 . . . . 0.0 114.191 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -131.41 -4.58 3.78 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.325 1.45 . . . . 0.0 113.992 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -128.04 7.58 6.07 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.977 1.311 . . . . 0.0 113.259 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 p -139.38 7.75 2.39 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.32 1.848 . . . . 0.0 113.527 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.46 16.51 0.17 Allowed Glycine 0 CA--C 1.539 1.553 0 C-N-CA 125.21 1.386 . . . . 0.0 114.963 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -143.72 21.91 1.8 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.338 1.455 . . . . 0.0 111.988 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.6 p -147.01 153.49 45.57 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.193 1.797 . . . . 0.0 111.733 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.15 164.02 33.9 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.198 2.599 . . . . 0.0 112.9 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.16 29.41 2.03 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.321 1.448 . . . . 0.0 112.615 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.55 144.41 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.817 1.647 . . . . 0.0 110.541 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.7 t -142.04 31.37 1.58 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 124.279 1.99 . . . . 0.0 114.375 -172.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.9 mt -62.67 169.78 2.91 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.717 2.007 . . . . 0.0 111.509 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 t -154.26 167.4 30.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.31 1.044 . . . . 0.0 110.087 173.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 125.06 22.7 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 122.091 -0.38 . . . . 0.0 111.506 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.2 -165.87 38.17 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -99.71 124.8 45.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.236 1.014 . . . . 0.0 110.087 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -134.2 170.02 16.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.28 1.432 . . . . 0.0 112.508 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 pt -125.07 152.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.242 1.817 . . . . 0.0 108.328 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.1 mt -128.94 119.33 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -137.85 147.8 44.83 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.279 0.631 . . . . 0.0 112.477 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -79.36 133.78 36.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.75 0.42 . . . . 0.0 111.234 -173.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -61.63 -21.78 64.68 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.187 1.395 . . . . 0.0 114.343 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.8 -24.15 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.976 0.91 . . . . 0.0 112.497 174.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.4 mt 62.02 168.19 0.11 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.085 2.154 . . . . 0.0 113.871 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.2 t -77.6 146.76 73.78 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 124.783 1.233 . . . . 0.0 112.411 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.99 -19.02 30.62 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.525 2.817 . . . . 0.0 113.536 168.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -66.29 -18.51 65.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.026 1.73 . . . . 0.0 113.2 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.72 22.94 24.78 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.028 1.775 . . . . 0.0 113.948 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -138.7 167.16 22.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.866 1.267 . . . . 0.0 112.066 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -56.38 136.47 53.65 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.154 0.981 . . . . 0.0 113.197 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.4 tp -111.6 80.64 1.34 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.456 1.903 . . . . 0.0 110.871 -169.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.51 147.46 30.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.048 1.739 . . . . 0.0 114.287 -171.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.1 tp -60.25 136.73 58.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.207 1.403 . . . . 0.0 110.784 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 m -124.26 120.27 31.74 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.403 1.481 . . . . 0.0 111.473 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -63.62 133.3 95.48 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.764 1.626 . . . . 0.0 111.39 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.83 -11.48 21.82 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.077 2.518 . . . . 0.0 114.587 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.93 84.8 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 119.14 -0.811 . . . . 0.0 114.92 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -156.1 161.56 40.37 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.196 1.398 . . . . 0.0 112.036 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -88.96 164.51 15.08 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.131 0.972 . . . . 0.0 111.863 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 47.3 mmt-85 50.57 34.57 9.79 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.874 1.67 . . . . 0.0 113.986 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.8 m -132.29 138.9 33.29 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.848 1.659 . . . . 0.0 110.653 -169.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.99 154.74 12.58 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.685 3.59 . . . . 0.0 115.229 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -100.92 156.66 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.839 1.256 . . . . 0.0 110.642 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -126.98 178.24 6.11 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.675 1.59 . . . . 0.0 110.694 -170.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.98 148.96 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.911 1.284 . . . . 0.0 111.406 176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.5 m -158.84 162.79 25.87 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 125.08 1.352 . . . . 0.0 112.76 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.67 127.62 16.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.53 2.153 . . . . 0.0 111.034 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.5 tp -65.2 140.22 58.73 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -137.26 10.64 3.01 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.986 1.315 . . . . 0.0 113.101 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.25 0.15 89.45 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.772 1.177 . . . . 0.0 114.948 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -64.66 142.51 58.4 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 118.678 1.239 . . . . 0.0 112.08 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.0 p -60.9 -14.13 20.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.037 1.335 . . . . 0.0 114.07 172.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.49 -21.55 64.6 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.201 -0.937 . . . . 0.0 112.626 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -118.28 9.5 12.54 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.975 1.31 . . . . 0.0 113.604 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -106.79 146.54 30.76 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.771 1.228 . . . . 0.0 110.894 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -138.94 173.96 11.01 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 122.478 1.133 . . . . 0.0 112.096 -168.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.7 mt -124.55 134.95 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 127.54 2.336 . . . . 0.0 106.948 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.02 124.88 22.6 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.376 1.47 . . . . 0.0 109.26 -170.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -146.39 139.32 25.52 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.069 0.548 . . . . 0.0 111.754 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 t -66.53 140.8 58.0 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.991 0.516 . . . . 0.0 111.592 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -114.85 -52.59 2.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.82 1.248 . . . . 0.0 111.223 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.86 110.32 5.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.77 1.228 . . . . 0.0 111.405 169.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.9 m -57.71 -24.7 58.19 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.956 0.903 . . . . 0.0 111.663 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -64.64 -21.97 66.86 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.009 2.124 . . . . 0.0 113.626 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.5 m -130.31 12.51 5.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.997 1.719 . . . . 0.0 112.686 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 42.95 35.33 0.73 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.623 1.969 . . . . 0.0 113.582 -169.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 p -87.58 139.28 30.7 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.76 -1.212 . . . . 0.0 111.709 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -135.94 143.57 44.99 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.57 1.548 . . . . 0.0 110.074 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.9 p -77.73 150.54 34.4 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.716 0.806 . . . . 0.0 110.793 173.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.9 mm -128.6 127.12 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.613 1.565 . . . . 0.0 109.44 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.6 m -143.79 148.11 41.39 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 125.835 1.654 . . . . 0.0 110.316 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.38 148.56 34.03 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.203 2.602 . . . . 0.0 111.172 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.5 m -66.79 -24.76 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.732 -1.23 . . . . 0.0 113.015 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.44 -23.9 74.34 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 123.938 0.78 . . . . 0.0 114.107 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.8 m -143.43 74.36 17.19 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 125.972 1.709 . . . . 0.0 110.368 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -61.81 -13.31 29.83 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.236 2.624 . . . . 0.0 113.192 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -89.38 9.58 25.68 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 128.52 2.728 . . . . 0.0 114.614 174.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.8 p -133.28 174.7 10.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.943 1.297 . . . . 0.0 112.009 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -141.36 170.07 16.42 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.882 1.273 . . . . 0.0 113.286 -170.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -120.48 128.95 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.164 1.386 . . . . 0.0 110.532 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.54 -159.61 8.22 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.652 1.596 . . . . 0.0 111.621 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -138.74 141.09 38.87 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.347 1.073 . . . . 0.0 111.956 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.78 -163.73 10.85 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.447 1.499 . . . . 0.0 113.425 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.77 140.14 19.9 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.045 1.338 . . . . 0.0 113.314 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.46 -4.74 73.62 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.686 1.136 . . . . 0.0 114.254 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 49.19 55.02 9.95 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.466 1.906 . . . . 0.0 114.333 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.8 149.05 70.8 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 126.103 1.761 . . . . 0.0 107.843 169.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.63 147.59 51.59 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.147 1.231 . . . . 0.0 109.877 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.26 153.02 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.74 1.616 . . . . 0.0 111.664 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.85 132.01 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.098 0.959 . . . . 0.0 111.158 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.3 mt -137.91 161.8 57.83 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 126.312 1.845 . . . . 0.0 112.053 -169.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.43 165.76 29.48 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.093 2.528 . . . . 0.0 111.944 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.6 123.02 9.1 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.446 2.097 . . . . 0.0 110.45 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -147.66 -88.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.719 0.808 . . . . 0.0 110.609 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -155.48 16.11 0.39 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.481 1.512 . . . . 0.0 112.954 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -65.9 132.7 49.28 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.502 -0.749 . . . . 0.0 111.936 -172.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.79 159.45 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.328 1.451 . . . . 0.0 111.522 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -129.3 145.98 51.27 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.157 1.383 . . . . 0.0 110.003 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.9 m -81.79 133.96 35.39 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.086 0.954 . . . . 0.0 109.735 173.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.45 132.7 54.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.041 1.336 . . . . 0.0 109.516 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 61.1 m -142.14 122.76 14.19 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.007 -1.058 . . . . 0.0 110.617 -173.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.5 mt -62.65 152.98 33.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.66 0.743 . . . . 0.0 112.65 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.9 p -126.17 -179.92 4.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.61 1.964 . . . . 0.0 109.808 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.5 m -61.38 -8.7 4.23 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.18 26.98 0.2 Allowed Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.229 0.919 . . . . 0.0 114.66 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.92 -151.72 11.02 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.946 1.26 . . . . 0.0 112.814 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -131.73 170.21 15.13 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.011 2.124 . . . . 0.0 112.113 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -137.31 152.8 50.15 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.292 2.637 . . . . 0.0 109.127 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.88 118.46 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.638 1.175 . . . . 0.0 109.176 -169.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -134.85 160.18 39.04 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -169.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -62.72 -25.98 68.45 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.626 1.97 . . . . 0.0 116.14 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 128.9 -32.99 3.17 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.054 1.312 . . . . 0.0 113.515 -173.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -113.72 9.86 17.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.298 1.839 . . . . 0.0 113.542 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 62.57 16.55 8.88 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.9 2.08 . . . . 0.0 113.98 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.8 p -70.2 -27.49 64.54 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.716 0.806 . . . . 0.0 112.437 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.0 m -146.0 173.13 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.466 1.506 . . . . 0.0 112.061 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 t -141.77 154.19 45.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.292 2.237 . . . . 0.0 109.596 172.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -69.66 144.31 52.93 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.696 -0.627 . . . . 0.0 110.688 169.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.0 p -155.03 168.59 26.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.498 1.119 . . . . 0.0 112.171 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.4 mt -113.94 163.76 14.69 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.119 1.767 . . . . 0.0 109.564 171.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -97.13 -33.69 11.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.925 0.89 . . . . 0.0 111.793 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -136.57 -6.49 1.97 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.969 2.108 . . . . 0.0 112.123 171.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.1 27.74 11.91 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.17 1.788 . . . . 0.0 114.268 -171.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.8 p -78.03 157.21 29.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.22 1.008 . . . . 0.0 111.995 172.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.48 139.39 58.5 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.235 -0.916 . . . . 0.0 111.736 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.26 0.74 90.05 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.712 1.148 . . . . 0.0 114.703 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.48 144.94 46.02 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.666 1.233 . . . . 0.0 112.834 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.49 120.49 21.79 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 173.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.82 149.8 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.571 0.7 . . . . 0.0 111.382 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 t -130.2 166.66 19.81 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.999 1.72 . . . . 0.0 111.677 -169.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.75 140.26 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.645 1.578 . . . . 0.0 109.184 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 171.32 -161.61 34.12 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 121.528 -0.733 . . . . 0.0 112.663 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.17 152.86 12.83 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 117.667 0.734 . . . . 0.0 111.715 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -51.88 109.28 0.35 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.418 1.487 . . . . 0.0 113.121 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.99 142.92 55.79 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.787 0.835 . . . . 0.0 113.163 -173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.0 t -60.07 -20.57 58.73 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -135.74 -40.26 0.7 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.947 1.299 . . . . 0.0 113.006 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.6 t -91.0 1.26 57.21 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -172.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.77 14.69 1.93 Allowed Glycine 0 CA--C 1.542 1.75 0 C-N-CA 125.115 1.34 . . . . 0.0 116.003 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.69 145.36 49.84 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.395 1.478 . . . . 0.0 111.476 -174.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -140.78 175.09 9.89 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.374 1.87 . . . . 0.0 110.613 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.48 141.03 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.123 1.369 . . . . 0.0 108.977 169.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 mp -121.31 124.37 71.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.649 1.58 . . . . 0.0 107.167 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -149.0 154.24 39.07 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.687 1.195 . . . . 0.0 109.181 -169.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -68.68 154.46 41.9 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.928 -1.107 . . . . 0.0 112.577 -177.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.324 1.85 . . . . 0.0 111.374 171.226 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 111.182 0.067 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.15 3.9 0.27 Allowed Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.311 1.285 . . . . 0.0 116.311 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -134.89 2.95 3.17 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.268 1.427 . . . . 0.0 113.387 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -156.36 179.53 9.16 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.696 1.998 . . . . 0.0 110.693 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -145.35 37.75 1.13 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.023 1.329 . . . . 0.0 112.076 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -133.81 157.89 44.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.901 1.28 . . . . 0.0 113.102 -170.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -145.55 165.08 29.68 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.482 1.513 . . . . 0.0 111.511 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -129.36 11.66 5.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.975 1.71 . . . . 0.0 112.396 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -154.01 168.56 26.03 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.356 2.262 . . . . 0.0 110.88 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -139.71 6.75 2.27 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.18 1.392 . . . . 0.0 113.686 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 m -66.24 -15.97 63.63 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.308 1.443 . . . . 0.0 114.84 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.93 18.77 0.48 Allowed Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.631 1.586 . . . . 0.0 113.906 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -148.52 172.59 14.25 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.375 2.27 . . . . 0.0 109.925 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.1 p -58.39 149.52 59.34 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -71.82 166.63 28.92 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.39 2.727 . . . . 0.0 112.607 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.5 19.13 5.25 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.822 1.249 . . . . 0.0 113.674 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.1 t -144.37 145.56 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.82 2.048 . . . . 0.0 109.758 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.0 t -149.02 12.36 0.85 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.085 1.354 . . . . 0.0 113.631 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.4 mt 55.91 178.71 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.478 1.911 . . . . 0.0 113.854 -172.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 t -159.66 168.91 24.88 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.92 1.288 . . . . 0.0 110.269 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.27 139.67 57.32 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.811 -0.555 . . . . 0.0 111.995 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.76 -163.45 35.25 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.916 0.769 . . . . 0.0 114.51 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -95.1 124.0 38.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.959 0.903 . . . . 0.0 109.77 170.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -133.45 173.25 11.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.552 1.541 . . . . 0.0 112.026 -172.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.4 pt -126.37 152.26 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.95 1.7 . . . . 0.0 108.542 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 mt -123.54 122.95 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -137.74 146.7 44.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.512 0.725 . . . . 0.0 110.836 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -67.01 143.32 56.84 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -63.5 -23.54 67.44 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.882 -0.511 . . . . 0.0 112.212 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.98 112.86 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.453 1.501 . . . . 0.0 108.391 168.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 mp -69.36 165.69 20.2 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.0 1.72 . . . . 0.0 111.968 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.6 p -62.77 161.84 25.74 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.629 1.172 . . . . 0.0 113.296 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -57.32 -23.32 54.01 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.278 2.652 . . . . 0.0 113.758 169.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.7 tpt85 -77.25 -17.02 58.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.057 1.743 . . . . 0.0 113.32 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.16 25.98 15.38 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.098 1.332 . . . . 0.0 113.933 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -124.24 159.45 30.16 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.118 1.367 . . . . 0.0 111.922 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.4 128.65 32.59 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.758 1.223 . . . . 0.0 110.915 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.2 tp -100.2 75.58 1.83 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.437 1.095 . . . . 0.0 111.211 -169.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.39 149.81 28.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.981 1.712 . . . . 0.0 115.041 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 tp -62.38 137.02 58.18 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.261 1.424 . . . . 0.0 110.384 169.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 m -127.61 120.39 28.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.799 1.24 . . . . 0.0 111.287 -174.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -66.18 135.52 95.05 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.095 1.358 . . . . 0.0 112.218 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.1 -13.41 21.22 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.339 2.693 . . . . 0.0 114.666 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.41 7.87 81.82 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.1 0.857 . . . . 0.0 115.035 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -154.77 164.65 38.48 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.239 1.816 . . . . 0.0 111.382 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -98.89 165.78 11.6 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.894 1.278 . . . . 0.0 111.435 -173.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 47.38 43.46 15.38 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.938 1.695 . . . . 0.0 113.494 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.6 m -139.33 137.99 19.9 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 126.381 1.872 . . . . 0.0 109.852 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.79 161.65 3.01 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.766 3.644 . . . . 0.0 115.597 173.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.46 148.55 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.875 1.27 . . . . 0.0 110.599 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 m -123.47 173.84 7.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.055 1.342 . . . . 0.0 111.039 -169.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.19 148.48 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.983 1.313 . . . . 0.0 111.533 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 m -154.34 160.21 31.16 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.153 0.981 . . . . 0.0 113.039 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.27 122.34 9.59 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.896 2.398 . . . . 0.0 110.575 170.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.58 136.54 57.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.379 1.471 . . . . 0.0 112.619 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -133.48 9.52 4.0 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.262 1.425 . . . . 0.0 112.41 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.82 8.09 60.1 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.147 1.356 . . . . 0.0 114.882 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.8 p -69.61 153.48 43.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 112.914 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -62.07 -17.7 58.36 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.93 -23.4 63.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.878 1.271 . . . . 0.0 112.544 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -118.27 4.82 11.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.063 1.745 . . . . 0.0 113.162 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.63 139.92 35.63 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.703 1.201 . . . . 0.0 110.774 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -133.74 171.08 14.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.756 1.265 . . . . 0.0 112.149 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.1 mt -125.88 135.53 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 127.571 2.349 . . . . 0.0 106.657 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.0 tp -136.2 126.3 26.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.113 1.365 . . . . 0.0 109.064 -170.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -142.22 140.63 32.36 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.795 0.838 . . . . 0.0 110.833 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.8 t -65.64 141.04 58.53 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.853 0.461 . . . . 0.0 111.006 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -112.11 -52.87 2.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.437 1.095 . . . . 0.0 110.743 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.97 109.28 4.68 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.591 1.156 . . . . 0.0 110.479 169.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.7 m -58.15 -25.25 61.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.948 0.899 . . . . 0.0 111.399 168.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -63.39 -21.52 66.33 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.0 2.12 . . . . 0.0 113.451 174.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.1 m -130.26 9.7 5.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.043 1.737 . . . . 0.0 113.105 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 45.52 33.32 1.32 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.765 2.026 . . . . 0.0 114.217 -169.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.8 p -87.72 143.15 27.31 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.79 -1.193 . . . . 0.0 112.073 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -140.43 140.23 35.39 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.287 1.435 . . . . 0.0 111.052 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.6 p -77.94 142.24 38.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.498 0.719 . . . . 0.0 111.079 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.1 mm -123.91 124.81 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.172 1.389 . . . . 0.0 109.836 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 m -142.31 145.7 36.31 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 125.437 1.495 . . . . 0.0 109.661 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.76 150.08 27.03 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.73 2.287 . . . . 0.0 111.274 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.5 t -65.05 -30.55 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 121.216 -0.927 . . . . 0.0 111.764 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.18 -11.11 82.82 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.3 m -155.49 63.67 3.74 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 125.525 1.53 . . . . 0.0 111.485 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -63.88 -19.24 66.5 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.994 3.129 . . . . 0.0 113.689 -173.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -68.11 -2.18 7.41 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 128.026 2.53 . . . . 0.0 114.553 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.4 m -132.24 166.58 21.54 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.602 1.961 . . . . 0.0 110.86 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -142.39 171.21 14.36 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.331 1.452 . . . . 0.0 112.946 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.27 126.26 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.837 1.255 . . . . 0.0 110.721 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.43 -158.98 7.91 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.475 1.512 . . . . 0.0 111.676 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -139.59 140.41 37.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.355 1.062 . . . . 0.0 111.555 -170.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.01 -166.06 12.75 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.284 1.421 . . . . 0.0 113.193 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.7 137.19 20.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.258 1.423 . . . . 0.0 113.159 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.9 -6.95 64.7 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.779 1.181 . . . . 0.0 114.183 -172.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 48.88 56.76 7.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.552 1.941 . . . . 0.0 114.216 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.95 151.57 78.22 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 126.292 1.837 . . . . 0.0 108.047 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.02 141.91 54.7 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 120.939 1.092 . . . . 0.0 109.626 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.27 152.71 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.372 1.469 . . . . 0.0 111.032 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 49.9 t -79.63 136.28 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.917 0.887 . . . . 0.0 111.07 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -140.84 165.19 31.32 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.674 1.99 . . . . 0.0 111.861 -170.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.64 176.43 2.27 Favored 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 123.558 2.838 . . . . 0.0 113.501 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.29 43.44 1.49 Allowed 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.78 2.987 . . . . 0.0 113.527 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -80.7 13.71 2.45 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.746 1.618 . . . . 0.0 114.407 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 70.74 44.69 0.62 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.714 2.405 . . . . 0.0 113.588 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -64.25 143.8 57.62 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.741 0.817 . . . . 0.0 111.273 169.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.6 m -141.86 156.21 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.403 1.081 . . . . 0.0 112.399 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -127.2 140.95 51.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.075 1.35 . . . . 0.0 111.176 170.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.8 m -78.88 127.04 31.5 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.741 1.216 . . . . 0.0 109.149 172.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.3 mt -115.39 128.64 56.2 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.809 0.843 . . . . 0.0 109.575 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.1 m -131.34 118.27 20.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.243 1.017 . . . . 0.0 110.189 -169.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.7 tp -66.03 145.73 55.52 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.761 -0.587 . . . . 0.0 111.17 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.0 p -127.55 175.35 8.32 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.963 1.705 . . . . 0.0 110.527 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.5 p -57.83 -16.51 11.85 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -155.06 23.74 0.6 Allowed Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.629 1.109 . . . . 0.0 114.565 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.95 -149.83 9.48 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.877 1.227 . . . . 0.0 112.607 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -134.0 171.11 14.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.186 2.194 . . . . 0.0 111.574 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -136.78 154.46 50.55 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.364 2.266 . . . . 0.0 109.95 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.5 mt -134.45 121.04 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.133 1.373 . . . . 0.0 109.355 -169.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -137.0 158.3 44.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.567 1.147 . . . . 0.0 112.614 -170.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.3 -33.38 75.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -171.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.21 -31.36 2.7 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.283 1.42 . . . . 0.0 113.772 -169.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -104.19 -2.21 26.07 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.539 1.536 . . . . 0.0 113.887 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 64.82 13.04 8.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.295 2.238 . . . . 0.0 114.128 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.4 p -69.98 -21.26 63.25 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.588 1.155 . . . . 0.0 112.824 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.89 169.6 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.486 1.515 . . . . 0.0 112.661 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.9 t -140.67 153.71 46.1 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.919 2.487 . . . . 0.0 109.66 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -69.9 144.8 52.35 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.455 -0.778 . . . . 0.0 110.137 168.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.7 p -149.34 171.6 16.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.378 1.071 . . . . 0.0 112.993 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.5 mt -125.15 165.7 17.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.108 1.763 . . . . 0.0 109.625 172.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -105.19 -32.71 8.53 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.904 0.882 . . . . 0.0 111.94 -169.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -140.24 -10.08 1.12 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.757 2.023 . . . . 0.0 112.662 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.68 27.13 12.15 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.569 1.548 . . . . 0.0 114.24 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.9 p -78.31 157.62 29.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.415 1.086 . . . . 0.0 111.807 170.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.87 141.57 58.73 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.259 -0.901 . . . . 0.0 112.161 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.27 4.96 89.22 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.5 1.048 . . . . 0.0 114.458 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -75.13 137.45 41.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.769 1.228 . . . . 0.0 112.402 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.41 128.28 35.15 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.508 -0.745 . . . . 0.0 110.569 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.5 t -64.23 150.71 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.229 0.612 . . . . 0.0 110.557 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.4 t -126.95 161.96 27.08 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.823 1.249 . . . . 0.0 111.796 -175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.7 mt -134.21 142.04 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.98 1.712 . . . . 0.0 108.78 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.84 -156.71 28.81 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 124.631 1.11 . . . . 0.0 110.716 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.77 166.43 1.91 Allowed 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.717 1.259 . . . . 0.0 111.685 169.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -56.35 157.01 5.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.06 0.944 . . . . 0.0 112.82 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.53 136.16 51.34 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.607 1.163 . . . . 0.0 112.312 -172.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.1 t -55.59 -26.84 45.98 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.254 1.822 . . . . 0.0 115.834 -169.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -130.16 -32.82 1.78 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.094 0.958 . . . . 0.0 113.385 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 96.6 p -103.87 -2.25 26.52 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.8 27.76 1.1 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 125.955 1.74 . . . . 0.0 114.859 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -147.64 142.1 26.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.765 2.026 . . . . 0.0 110.943 -169.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -140.74 175.75 9.36 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.956 1.702 . . . . 0.0 111.21 -168.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.55 140.16 26.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.735 1.214 . . . . 0.0 109.299 169.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.62 125.05 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 125.677 1.591 . . . . 0.0 107.354 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -148.98 153.62 38.2 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.8 1.24 . . . . 0.0 109.673 -171.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -67.9 155.22 39.9 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.998 -1.064 . . . . 0.0 112.882 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.328 1.851 . . . . 0.0 111.217 171.154 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.9 -171.53 40.33 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.676 1.131 . . . . 0.0 112.619 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -135.08 9.12 3.5 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.887 1.275 . . . . 0.0 113.276 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -156.93 179.62 9.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.212 1.805 . . . . 0.0 111.552 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -132.16 10.59 4.55 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.478 1.511 . . . . 0.0 113.469 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -73.18 -21.25 60.72 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.508 1.123 . . . . 0.0 113.889 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -141.12 5.72 1.92 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.407 1.483 . . . . 0.0 113.184 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -144.62 174.24 11.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.341 1.857 . . . . 0.0 111.426 -172.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -141.79 169.45 17.57 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.605 1.162 . . . . 0.0 111.633 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.4 m80 54.65 16.64 1.42 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.304 1.841 . . . . 0.0 115.0 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.4 m -136.78 19.29 3.05 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.692 1.997 . . . . 0.0 112.307 -172.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.56 -20.47 0.07 OUTLIER Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.906 1.717 . . . . 0.0 113.858 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -144.67 161.53 38.94 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.026 1.73 . . . . 0.0 111.224 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.4 p -153.27 159.05 32.66 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.848 1.659 . . . . 0.0 111.84 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -52.99 142.61 52.81 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.615 2.877 . . . . 0.0 114.165 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.59 31.36 0.98 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.623 1.169 . . . . 0.0 113.621 -176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.18 151.17 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.364 1.465 . . . . 0.0 110.609 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -141.63 -4.52 1.09 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.3 mt 58.37 173.67 0.06 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.855 2.062 . . . . 0.0 114.131 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 t -159.92 168.21 26.24 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.215 1.406 . . . . 0.0 109.861 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.85 137.2 57.62 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.653 -0.654 . . . . 0.0 112.176 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.73 -162.88 35.41 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.968 0.794 . . . . 0.0 114.604 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -97.14 124.91 41.32 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.215 1.006 . . . . 0.0 109.978 172.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -133.88 173.11 11.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.637 1.575 . . . . 0.0 112.235 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.8 pt -125.88 151.66 32.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 126.051 1.74 . . . . 0.0 108.452 170.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 mt -124.64 119.17 55.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -137.63 148.11 45.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.776 0.83 . . . . 0.0 110.581 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -72.79 149.11 43.92 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.176 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -61.81 -24.94 67.19 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.686 -0.633 . . . . 0.0 112.569 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.0 t -83.73 122.02 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.545 1.538 . . . . 0.0 109.671 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.96 168.39 17.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.812 1.645 . . . . 0.0 112.416 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.5 p -66.91 161.16 64.64 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.157 1.383 . . . . 0.0 113.159 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.1 -17.85 51.0 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.655 2.237 . . . . 0.0 113.096 169.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -73.93 -22.24 59.75 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.995 1.318 . . . . 0.0 112.781 169.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.67 24.33 9.39 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.156 1.36 . . . . 0.0 113.852 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.98 172.28 10.6 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.629 1.171 . . . . 0.0 111.903 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -54.69 144.75 21.05 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 121.409 -0.807 . . . . 0.0 110.584 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -119.85 83.11 1.99 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.828 1.251 . . . . 0.0 109.815 -168.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.38 150.83 19.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -168.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.3 tp -60.45 135.63 57.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.806 1.242 . . . . 0.0 110.032 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -129.97 121.06 25.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.803 1.241 . . . . 0.0 111.247 -173.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -65.03 136.29 96.69 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.956 1.302 . . . . 0.0 112.458 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.07 -13.31 21.3 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.51 2.807 . . . . 0.0 114.688 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.01 7.42 80.68 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 124.223 0.916 . . . . 0.0 115.071 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -153.92 166.59 32.48 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.351 1.86 . . . . 0.0 111.299 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -102.57 166.64 10.41 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.743 1.217 . . . . 0.0 111.545 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 51.15 40.93 27.04 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.773 1.629 . . . . 0.0 112.425 -174.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.9 m -141.16 137.89 17.26 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 126.139 1.776 . . . . 0.0 110.47 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -52.71 158.17 6.49 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.736 3.624 . . . . 0.0 115.43 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 t -110.26 148.99 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.861 1.264 . . . . 0.0 110.74 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -121.66 176.5 5.68 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.216 1.407 . . . . 0.0 111.494 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -131.34 146.04 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.109 1.364 . . . . 0.0 111.647 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.1 m -153.79 163.06 25.13 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.469 1.108 . . . . 0.0 113.303 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -60.49 124.38 14.98 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.394 2.73 . . . . 0.0 110.418 168.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.46 136.21 57.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.33 1.052 . . . . 0.0 111.786 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -132.81 7.72 4.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.023 1.329 . . . . 0.0 112.449 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.53 9.61 58.78 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.92 1.247 . . . . 0.0 114.592 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.0 p -68.77 154.3 42.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.26 1.424 . . . . 0.0 112.729 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.4 p -62.54 -17.12 59.2 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -70.48 -24.41 62.86 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.858 1.263 . . . . 0.0 112.402 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.23 3.14 12.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.04 1.736 . . . . 0.0 113.235 -176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.89 140.26 32.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 110.558 171.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -134.15 171.31 14.41 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.763 1.268 . . . . 0.0 111.7 -169.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.4 mt -125.92 136.28 61.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 127.052 2.141 . . . . 0.0 106.566 -175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.6 tp -137.41 124.47 21.53 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.1 1.36 . . . . 0.0 108.901 -169.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -142.62 134.26 26.67 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.768 0.827 . . . . 0.0 110.946 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.3 t -63.78 137.03 57.88 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.998 0.519 . . . . 0.0 110.853 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -112.79 -47.38 3.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.324 1.05 . . . . 0.0 111.691 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.46 111.46 4.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.302 1.441 . . . . 0.0 110.708 170.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.2 m -58.99 -24.32 62.61 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.987 0.915 . . . . 0.0 111.533 168.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -64.18 -21.82 66.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.872 2.069 . . . . 0.0 113.522 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 m -130.33 11.75 5.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.684 1.594 . . . . 0.0 112.853 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 44.09 32.26 0.63 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.592 1.957 . . . . 0.0 113.509 -169.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 p -87.11 139.82 30.18 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.163 -0.96 . . . . 0.0 111.876 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -135.44 141.92 45.5 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.636 1.574 . . . . 0.0 110.978 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -77.5 145.72 36.82 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.808 0.443 . . . . 0.0 110.849 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.8 mm -127.14 126.73 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.32 1.448 . . . . 0.0 109.673 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 57.1 m -144.01 147.94 40.0 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 126.103 1.761 . . . . 0.0 109.578 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.63 149.93 24.11 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.887 2.392 . . . . 0.0 111.445 175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.91 -29.72 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.058 -1.026 . . . . 0.0 111.811 173.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.21 -13.97 81.12 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 115.424 0.929 . . . . 0.0 115.424 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.0 m -151.98 62.48 4.72 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 125.682 1.593 . . . . 0.0 111.536 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.13 -13.65 39.04 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.414 2.742 . . . . 0.0 114.034 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -73.18 6.33 2.86 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.425 1.89 . . . . 0.0 114.063 170.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -138.89 166.31 24.79 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.295 1.838 . . . . 0.0 111.088 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -136.56 171.23 14.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.348 1.459 . . . . 0.0 113.089 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.6 mm -120.9 130.62 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.143 1.377 . . . . 0.0 110.929 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.75 -156.15 6.9 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.917 1.722 . . . . 0.0 111.834 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -142.6 142.37 32.12 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.402 1.081 . . . . 0.0 111.518 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.22 -166.44 13.13 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.31 1.433 . . . . 0.0 113.401 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.2 138.65 20.13 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.085 1.354 . . . . 0.0 113.221 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.7 -6.57 67.58 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.724 1.154 . . . . 0.0 114.089 -172.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 49.67 56.54 7.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.578 1.951 . . . . 0.0 114.21 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.08 150.23 75.48 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 126.153 1.781 . . . . 0.0 108.127 169.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.94 142.38 56.73 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.192 1.261 . . . . 0.0 109.693 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.28 148.16 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.724 1.61 . . . . 0.0 111.096 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.73 138.8 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.938 0.895 . . . . 0.0 110.575 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.7 mt -140.53 161.74 53.05 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.31 1.844 . . . . 0.0 111.013 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.12 164.83 30.56 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.94 2.427 . . . . 0.0 111.879 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.23 119.55 6.07 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.528 2.152 . . . . 0.0 110.47 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -147.5 -89.6 0.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.821 0.848 . . . . 0.0 110.977 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -155.91 17.25 0.37 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.117 1.367 . . . . 0.0 113.235 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -67.56 135.86 53.61 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.525 -0.735 . . . . 0.0 112.075 -173.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.7 m -145.03 159.83 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.034 1.334 . . . . 0.0 112.646 -175.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -129.55 136.28 49.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.538 1.535 . . . . 0.0 110.925 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.3 m -74.35 128.98 36.91 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 109.437 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -118.01 125.81 51.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.175 0.99 . . . . 0.0 109.335 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.0 m -130.52 118.32 20.91 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.272 1.029 . . . . 0.0 111.155 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.99 148.39 51.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.641 0.776 . . . . 0.0 111.34 173.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.8 p -132.26 174.42 10.24 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.035 1.734 . . . . 0.0 110.35 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.8 m -61.67 -10.39 8.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.54 36.71 0.39 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.396 0.998 . . . . 0.0 113.944 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.24 -166.57 34.72 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.793 1.187 . . . . 0.0 112.708 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -121.23 166.83 13.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.484 1.914 . . . . 0.0 111.293 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -135.09 152.31 51.54 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.592 1.557 . . . . 0.0 110.454 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.58 117.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.136 1.374 . . . . 0.0 109.263 -169.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -136.48 157.73 46.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.66 1.184 . . . . 0.0 112.373 -169.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -63.72 -31.06 72.12 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -171.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.14 -26.14 3.27 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.313 1.435 . . . . 0.0 114.175 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -113.62 1.21 14.86 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.112 1.765 . . . . 0.0 114.0 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 64.32 12.87 7.57 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.453 2.301 . . . . 0.0 114.239 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.3 p -73.22 -22.37 60.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.163 0.985 . . . . 0.0 112.9 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 m -144.69 170.85 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.66 1.584 . . . . 0.0 112.437 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.5 t -144.27 150.43 37.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 129.215 3.006 . . . . 0.0 108.885 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.5 m0 -69.94 145.87 51.57 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.16 -0.962 . . . . 0.0 110.52 169.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.0 p -156.41 174.22 15.74 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.805 1.242 . . . . 0.0 112.575 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -120.35 171.87 8.21 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.144 1.777 . . . . 0.0 110.059 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -108.27 -31.83 7.72 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.968 1.307 . . . . 0.0 110.811 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -142.83 -13.34 0.75 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 127.425 2.29 . . . . 0.0 112.96 169.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.93 22.04 8.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.615 1.966 . . . . 0.0 114.729 -170.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.7 p -70.7 158.28 36.53 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.64 1.176 . . . . 0.0 111.944 170.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.56 136.84 57.44 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.244 -0.91 . . . . 0.0 111.886 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.09 0.74 89.67 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.644 1.116 . . . . 0.0 114.367 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -72.32 138.86 47.62 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.806 1.303 . . . . 0.0 112.584 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.9 125.41 28.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.463 0.705 . . . . 0.0 110.26 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.0 153.56 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.596 0.713 . . . . 0.0 110.315 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.1 m -135.34 165.19 26.03 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.193 1.397 . . . . 0.0 111.572 -172.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.8 mt -134.07 142.2 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.262 1.425 . . . . 0.0 108.96 -175.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.91 179.54 48.02 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 124.602 1.096 . . . . 0.0 111.496 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.48 -40.83 62.8 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.005 1.402 . . . . 0.0 114.274 -173.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -169.6 174.11 6.02 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.857 2.463 . . . . 0.0 111.61 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.27 150.63 39.52 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.574 1.149 . . . . 0.0 111.908 169.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -83.06 -7.02 59.7 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -169.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -142.38 -40.93 0.34 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.205 1.002 . . . . 0.0 112.524 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.9 p -95.3 3.54 54.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.432 1.493 . . . . 0.0 114.212 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.29 22.91 0.61 Allowed Glycine 0 CA--C 1.544 1.87 0 C-N-CA 125.818 1.675 . . . . 0.0 115.802 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -147.58 143.98 28.14 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.836 1.655 . . . . 0.0 111.066 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -136.45 175.54 9.52 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.398 1.879 . . . . 0.0 111.338 -169.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.45 137.76 25.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.653 1.181 . . . . 0.0 109.373 169.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -116.01 124.24 72.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 125.916 1.686 . . . . 0.0 107.14 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.6 153.09 38.98 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.845 1.258 . . . . 0.0 109.497 -171.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.08 155.4 39.63 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.008 -1.057 . . . . 0.0 112.803 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.3 t . . . . . 0 C--O 1.252 1.21 0 C-N-CA 126.121 1.769 . . . . 0.0 111.292 171.879 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.98 175.02 47.28 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.398 0.999 . . . . 0.0 113.466 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -139.8 0.47 1.8 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.914 1.285 . . . . 0.0 113.621 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -151.88 157.42 41.83 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.964 1.706 . . . . 0.0 110.301 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.7 t60 52.72 25.41 3.76 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.866 1.666 . . . . 0.0 114.667 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -142.13 4.97 1.67 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.531 1.532 . . . . 0.0 113.119 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -59.54 -21.52 60.37 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.906 -1.121 . . . . 0.0 113.9 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -54.68 -15.2 1.68 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.162 2.185 . . . . 0.0 114.534 170.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -98.3 -5.6 32.66 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.469 1.508 . . . . 0.0 114.029 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -136.31 -5.36 2.07 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 t -142.03 155.09 45.41 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.471 1.508 . . . . 0.0 111.886 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.67 27.66 0.11 Allowed Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.203 1.382 . . . . 0.0 113.881 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -132.89 7.4 4.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.143 1.377 . . . . 0.0 113.575 -169.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.4 m -137.38 155.53 75.56 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 126.281 1.832 . . . . 0.0 111.563 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.79 160.62 47.47 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.046 2.497 . . . . 0.0 113.588 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.41 32.01 1.08 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.859 1.664 . . . . 0.0 111.985 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -137.62 167.04 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 126.597 1.959 . . . . 0.0 109.749 -169.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.0 t -127.63 18.99 6.78 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.68 1.592 . . . . 0.0 113.097 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.6 mt 62.29 164.88 0.1 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.012 2.525 . . . . 0.0 114.761 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.6 t -161.58 170.46 19.78 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.302 1.841 . . . . 0.0 109.232 174.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.03 134.12 54.39 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.564 -0.71 . . . . 0.0 112.308 173.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.08 -161.24 34.2 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.114 0.864 . . . . 0.0 114.311 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -100.49 125.8 46.85 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.125 0.97 . . . . 0.0 110.213 173.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -134.86 172.76 12.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.537 1.535 . . . . 0.0 112.514 -170.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.97 154.69 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 126.461 1.904 . . . . 0.0 108.657 170.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 mt -129.92 118.92 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -141.61 153.37 44.73 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.68 0.792 . . . . 0.0 112.237 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -84.11 138.35 33.08 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.793 -0.567 . . . . 0.0 112.031 -172.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -63.36 -19.83 64.99 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.3 t -66.09 -25.71 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.908 0.883 . . . . 0.0 112.319 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.5 mt 59.77 170.64 0.08 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.82 2.048 . . . . 0.0 113.748 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.0 t -73.68 145.24 84.24 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.222 1.009 . . . . 0.0 111.449 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -64.6 -13.26 37.86 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.027 2.485 . . . . 0.0 112.913 169.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 -68.61 -16.8 63.97 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.977 1.311 . . . . 0.0 112.811 169.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.72 25.2 21.21 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.584 1.564 . . . . 0.0 113.7 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -133.44 173.67 11.24 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.77 1.228 . . . . 0.0 111.382 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -54.93 156.28 3.88 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.427 -0.796 . . . . 0.0 111.589 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.9 tp -130.04 71.19 1.44 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.681 1.193 . . . . 0.0 110.151 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.89 150.85 30.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.876 1.27 . . . . 0.0 113.12 -170.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.2 tp -61.44 139.56 58.19 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.256 1.022 . . . . 0.0 110.016 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.2 m -130.7 122.12 26.74 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.564 1.145 . . . . 0.0 111.584 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -64.24 135.52 96.37 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.637 1.175 . . . . 0.0 112.061 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.07 -13.68 21.2 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.428 2.752 . . . . 0.0 114.852 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.35 7.28 76.63 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.083 0.849 . . . . 0.0 114.957 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -156.01 164.46 38.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.583 1.553 . . . . 0.0 112.085 -174.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -90.77 164.47 14.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.442 1.097 . . . . 0.0 111.761 -174.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 49.48 39.38 16.59 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.843 1.657 . . . . 0.0 113.586 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.9 m -136.5 140.73 33.23 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.674 1.59 . . . . 0.0 111.198 -169.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -45.55 156.58 0.37 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 126.093 4.528 . . . . 0.0 115.277 169.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.92 150.74 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.719 1.207 . . . . 0.0 110.065 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.9 m -124.44 176.05 6.74 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.744 1.618 . . . . 0.0 110.265 -169.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.09 147.53 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.679 1.127 . . . . 0.0 112.1 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 m -150.84 160.83 31.63 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.94 1.296 . . . . 0.0 111.795 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -64.22 134.21 41.35 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.009 1.806 . . . . 0.0 111.613 170.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.6 tp -67.53 137.73 55.97 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.645 0.778 . . . . 0.0 111.515 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -138.29 8.81 2.7 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.864 1.265 . . . . 0.0 112.98 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.46 -7.07 58.89 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 125.058 1.313 . . . . 0.0 115.095 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -67.05 145.81 54.98 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.549 1.174 . . . . 0.0 111.827 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.4 p -60.33 -12.3 8.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.756 1.622 . . . . 0.0 114.96 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -68.66 -23.7 64.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.216 1.006 . . . . 0.0 112.36 174.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -114.76 4.5 14.98 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.573 1.549 . . . . 0.0 113.231 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.1 140.9 36.72 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.045 0.938 . . . . 0.0 111.126 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -134.14 170.56 15.49 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 122.83 1.3 . . . . 0.0 111.94 -169.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.58 135.34 62.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 127.485 2.314 . . . . 0.0 106.208 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.3 tp -136.62 124.17 22.24 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.044 1.338 . . . . 0.0 108.561 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -142.33 139.31 31.77 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.347 0.659 . . . . 0.0 111.048 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 t -64.59 138.55 58.47 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.966 0.506 . . . . 0.0 110.735 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -110.23 -53.03 2.72 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.453 1.101 . . . . 0.0 111.047 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.14 109.97 5.08 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.024 1.329 . . . . 0.0 110.648 169.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.4 m -57.73 -23.51 52.27 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.997 0.919 . . . . 0.0 111.748 168.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -65.21 -22.18 66.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.061 2.144 . . . . 0.0 113.439 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 m -130.32 12.03 5.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.145 1.778 . . . . 0.0 112.784 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 42.74 34.96 0.64 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.938 2.095 . . . . 0.0 113.412 -169.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -86.03 143.96 27.83 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 120.966 -1.084 . . . . 0.0 112.391 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -138.54 140.49 39.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.25 1.42 . . . . 0.0 111.068 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.8 p -77.84 146.36 35.75 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.206 0.603 . . . . 0.0 110.75 171.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.3 mm -130.79 120.46 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.284 1.433 . . . . 0.0 110.426 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.9 m -141.71 148.77 51.04 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.367 1.467 . . . . 0.0 110.343 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.08 148.34 24.49 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.841 2.361 . . . . 0.0 111.674 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.28 -31.12 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 121.198 -0.939 . . . . 0.0 111.881 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.74 -23.56 72.23 Favored Glycine 0 CA--C 1.539 1.543 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.1 m -144.43 60.66 7.92 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.315 1.446 . . . . 0.0 112.352 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.69 -12.1 26.96 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.502 2.801 . . . . 0.0 114.143 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -75.63 14.46 0.63 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.812 2.045 . . . . 0.0 113.336 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -142.32 171.61 13.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.995 2.118 . . . . 0.0 111.289 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -144.08 167.03 23.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.946 1.299 . . . . 0.0 112.027 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -118.38 131.74 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.517 1.127 . . . . 0.0 111.185 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -148.63 -157.72 7.69 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.952 1.739 . . . . 0.0 111.284 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -141.59 145.19 34.76 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.265 1.032 . . . . 0.0 111.802 -174.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.4 -164.22 11.75 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.491 1.52 . . . . 0.0 112.955 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.62 138.3 23.11 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.957 1.303 . . . . 0.0 113.045 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.63 -3.51 63.18 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.684 1.135 . . . . 0.0 114.322 -173.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 47.56 55.19 8.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.295 1.838 . . . . 0.0 113.713 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.91 138.76 31.49 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 127.693 2.397 . . . . 0.0 107.45 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.27 142.48 55.34 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 N-CA-C 109.206 -1.113 . . . . 0.0 109.206 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 m -133.27 151.08 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.139 1.376 . . . . 0.0 111.627 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.19 136.53 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.753 0.821 . . . . 0.0 110.783 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.9 mt -139.41 163.76 43.29 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 127.154 2.182 . . . . 0.0 110.286 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.16 159.31 53.67 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.153 1.902 . . . . 0.0 111.464 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -71.4 118.18 5.53 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.744 2.296 . . . . 0.0 110.294 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -145.47 -88.76 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.763 0.825 . . . . 0.0 111.018 -175.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -155.21 15.89 0.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.932 1.293 . . . . 0.0 113.387 -173.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -69.93 133.81 47.71 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.437 -0.789 . . . . 0.0 111.581 -175.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.0 m -141.8 160.99 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.422 1.089 . . . . 0.0 112.441 -174.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -129.06 134.85 48.27 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.339 1.456 . . . . 0.0 110.441 170.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.3 m -75.66 129.8 37.71 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.388 1.075 . . . . 0.0 109.406 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.1 mt -120.46 132.23 55.12 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.207 1.003 . . . . 0.0 109.786 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.1 m -133.2 118.26 18.42 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.194 0.998 . . . . 0.0 110.357 -170.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.28 137.27 58.23 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.862 1.265 . . . . 0.0 110.449 171.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 p -126.46 173.17 9.59 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.239 1.415 . . . . 0.0 111.798 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.4 m -58.13 -10.18 1.79 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.0 36.82 0.33 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.128 1.347 . . . . 0.0 113.251 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.78 -150.2 17.42 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.398 1.099 . . . . 0.0 114.148 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -132.83 169.59 16.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.949 2.499 . . . . 0.0 110.564 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -135.22 150.81 50.16 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.901 2.081 . . . . 0.0 109.451 171.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.1 mt -133.32 119.94 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.207 1.403 . . . . 0.0 109.515 -169.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -137.07 157.06 47.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.201 1.0 . . . . 0.0 112.552 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.09 -31.68 71.36 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.6 -40.28 1.63 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.798 1.666 . . . . 0.0 113.175 -172.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.3 -10.08 59.75 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.6 1.16 . . . . 0.0 113.946 173.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 67.39 12.95 9.18 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.798 2.039 . . . . 0.0 112.758 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.5 p -73.24 -23.97 60.42 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.281 1.432 . . . . 0.0 112.692 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.3 m -142.83 170.39 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.863 1.665 . . . . 0.0 112.025 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.4 t -142.15 151.81 42.6 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 128.903 2.881 . . . . 0.0 109.359 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -70.02 143.55 52.51 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 119.153 0.888 . . . . 0.0 111.29 169.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.6 p -152.08 170.81 19.03 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.822 1.249 . . . . 0.0 112.969 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.89 166.23 18.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.185 1.794 . . . . 0.0 110.111 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -109.02 -32.35 7.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.969 0.908 . . . . 0.0 111.689 -169.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -139.5 -10.89 1.21 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.436 1.894 . . . . 0.0 112.729 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.3 23.97 7.77 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.993 1.717 . . . . 0.0 114.685 -170.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.7 p -70.52 153.12 43.25 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.028 -1.045 . . . . 0.0 111.457 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.18 137.91 57.92 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.116 -0.99 . . . . 0.0 111.444 172.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.19 0.3 88.7 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.472 1.034 . . . . 0.0 114.251 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -69.56 142.38 53.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.873 1.337 . . . . 0.0 112.609 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.14 116.48 16.87 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.385 -0.822 . . . . 0.0 109.693 170.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.36 150.1 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.573 0.749 . . . . 0.0 111.59 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 57.5 m -129.81 169.54 15.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.591 1.556 . . . . 0.0 111.468 -169.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.6 mt -135.26 143.63 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.338 1.455 . . . . 0.0 108.862 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.35 179.12 47.49 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.672 1.13 . . . . 0.0 111.666 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.69 -41.98 61.84 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.092 1.446 . . . . 0.0 114.271 -172.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -168.81 172.28 7.93 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.915 2.486 . . . . 0.0 109.818 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.07 138.62 33.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.144 0.978 . . . . 0.0 112.436 169.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.0 t -62.97 -14.75 51.38 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -169.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.43 -36.89 0.43 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.38 1.072 . . . . 0.0 112.958 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.8 p -98.33 2.27 47.89 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.362 1.465 . . . . 0.0 114.529 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.33 12.64 1.76 Allowed Glycine 0 CA--C 1.544 1.86 0 C-N-CA 125.547 1.546 . . . . 0.0 116.202 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -135.48 145.34 47.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.22 1.808 . . . . 0.0 111.364 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -139.35 175.87 9.19 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.335 1.454 . . . . 0.0 111.98 -169.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.65 138.99 38.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.764 1.225 . . . . 0.0 109.421 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.5 125.74 74.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 125.404 1.481 . . . . 0.0 107.276 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -148.93 153.99 38.78 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.798 1.239 . . . . 0.0 109.304 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -67.49 155.86 38.05 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.094 -1.004 . . . . 0.0 112.827 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.073 1.749 . . . . 0.0 111.278 172.223 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 119.234 -0.412 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.45 18.8 0.02 OUTLIER Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.595 0.998 . . . . 0.0 115.595 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.4 t60 52.11 26.2 3.71 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.163 1.785 . . . . 0.0 114.737 -173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -58.53 149.09 26.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.318 1.047 . . . . 0.0 111.528 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.8 m80 49.13 27.3 1.72 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.02 1.328 . . . . 0.0 113.924 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.5 p80 45.81 14.98 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 128.768 2.827 . . . . 0.0 116.48 -169.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -159.71 124.33 3.92 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.036 1.334 . . . . 0.0 111.836 -174.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -143.18 -2.26 1.01 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.909 1.284 . . . . 0.0 114.063 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -157.18 161.78 39.31 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.267 1.827 . . . . 0.0 110.29 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -60.99 -35.13 76.01 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.666 0.786 . . . . 0.0 112.787 175.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.4 m 50.45 28.67 3.46 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.384 1.873 . . . . 0.0 114.948 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.21 21.66 0.57 Allowed Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.405 1.479 . . . . 0.0 113.856 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.49 -16.47 60.78 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.241 1.416 . . . . 0.0 113.485 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -147.74 155.73 44.8 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.988 2.115 . . . . 0.0 111.219 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.56 167.85 24.29 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.837 2.358 . . . . 0.0 112.13 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.16 31.07 2.17 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.872 1.269 . . . . 0.0 112.288 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.74 150.91 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.697 1.599 . . . . 0.0 109.909 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 t -133.8 -4.22 2.86 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.436 1.094 . . . . 0.0 113.662 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.7 mt 63.62 165.41 0.13 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.796 2.438 . . . . 0.0 114.69 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 t -160.78 170.95 19.69 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.141 1.776 . . . . 0.0 109.414 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.22 133.1 49.92 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.631 -0.668 . . . . 0.0 111.656 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.25 -163.01 35.78 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.975 0.798 . . . . 0.0 114.183 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -98.63 125.64 43.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.826 0.851 . . . . 0.0 109.98 171.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -134.3 172.75 12.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.332 1.453 . . . . 0.0 112.284 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.0 pt -125.46 156.64 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 126.352 1.861 . . . . 0.0 109.058 171.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.8 mt -130.08 119.76 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -142.28 152.24 42.81 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.712 0.805 . . . . 0.0 112.346 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -84.3 137.81 33.25 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.871 -0.518 . . . . 0.0 111.736 -174.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -59.34 -19.54 47.41 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.3 t -67.3 -24.94 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.448 1.099 . . . . 0.0 112.834 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.35 168.61 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.575 1.95 . . . . 0.0 113.846 -170.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.0 p -73.84 159.36 84.45 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.212 1.005 . . . . 0.0 112.372 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.95 -15.31 43.36 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.456 2.104 . . . . 0.0 112.612 169.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -74.61 -17.22 60.74 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.516 1.526 . . . . 0.0 113.042 171.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.71 23.64 17.85 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.066 1.317 . . . . 0.0 113.897 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -131.98 173.76 10.87 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.721 1.208 . . . . 0.0 111.972 -174.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -55.83 142.62 34.3 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.228 -0.92 . . . . 0.0 111.21 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.6 tp -118.53 76.51 1.09 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.395 1.478 . . . . 0.0 109.737 -170.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.98 148.2 26.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -59.3 135.25 57.59 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.006 1.323 . . . . 0.0 110.058 169.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 m -126.82 121.09 30.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.974 1.31 . . . . 0.0 110.877 -174.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -63.94 138.02 97.27 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.224 1.409 . . . . 0.0 111.913 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.03 -13.56 21.32 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.418 2.745 . . . . 0.0 114.845 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.87 4.43 72.42 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.481 1.039 . . . . 0.0 114.955 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.4 ptt-85 -156.14 172.95 17.55 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.294 1.838 . . . . 0.0 111.565 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -101.04 168.79 9.37 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.837 1.255 . . . . 0.0 111.396 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 50.04 35.08 9.15 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.002 2.121 . . . . 0.0 113.849 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.9 m -133.67 141.73 41.18 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.693 1.597 . . . . 0.0 111.274 -169.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -45.72 160.27 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.859 1 C-N-CA 126.174 4.582 . . . . 0.0 115.259 169.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.4 t -116.11 154.73 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.606 1.162 . . . . 0.0 109.964 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -128.5 172.04 11.52 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.429 1.492 . . . . 0.0 110.857 -169.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.61 149.23 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.902 1.281 . . . . 0.0 111.478 176.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 m -157.14 161.36 29.57 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.402 1.081 . . . . 0.0 113.122 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.04 122.28 11.42 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.779 2.986 . . . . 0.0 111.449 169.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.9 tp -59.01 138.45 57.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.2 1.0 . . . . 0.0 111.81 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -132.71 5.15 3.94 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.944 1.298 . . . . 0.0 112.756 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.6 7.33 60.96 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.784 1.183 . . . . 0.0 114.742 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.9 p -67.27 153.9 42.59 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.032 1.333 . . . . 0.0 112.541 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.7 p -62.49 -17.3 59.32 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -70.84 -22.3 62.34 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.552 1.141 . . . . 0.0 112.338 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.23 1.42 11.88 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.483 1.513 . . . . 0.0 113.638 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.34 146.08 27.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.522 1.129 . . . . 0.0 111.018 171.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -138.15 172.44 12.92 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.582 1.182 . . . . 0.0 111.901 -169.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.8 mt -119.6 136.79 55.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.847 2.459 . . . . 0.0 106.792 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.2 tp -135.99 128.21 29.98 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.132 1.373 . . . . 0.0 109.311 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.09 140.67 29.61 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.875 0.87 . . . . 0.0 110.785 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.9 t -66.01 140.31 58.28 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.726 0.41 . . . . 0.0 110.758 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -109.68 -52.73 2.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.544 1.138 . . . . 0.0 110.47 173.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.17 108.48 4.27 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.48 1.112 . . . . 0.0 110.691 169.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -57.44 -25.5 59.74 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.964 0.906 . . . . 0.0 111.56 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -62.85 -20.51 65.17 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.052 2.141 . . . . 0.0 113.535 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -130.23 9.01 5.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.132 1.773 . . . . 0.0 112.671 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 47.5 29.28 1.34 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.372 1.869 . . . . 0.0 114.325 -169.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.9 p -87.48 144.73 26.58 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.686 -1.259 . . . . 0.0 112.193 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -139.43 142.62 37.42 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.576 1.55 . . . . 0.0 111.288 -176.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.2 p -81.28 149.64 28.89 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.414 0.685 . . . . 0.0 110.882 171.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.5 mm -133.59 124.97 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.509 1.524 . . . . 0.0 110.481 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 m -142.83 153.27 60.86 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.889 1.676 . . . . 0.0 110.362 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.73 151.82 28.6 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.044 2.496 . . . . 0.0 111.199 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.9 -25.74 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.987 -1.071 . . . . 0.0 113.303 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.11 -18.19 54.25 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 123.927 0.775 . . . . 0.0 114.727 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.9 m -141.31 60.3 11.84 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 125.514 1.526 . . . . 0.0 111.536 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -62.22 -17.1 55.07 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.796 2.997 . . . . 0.0 113.286 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -72.15 9.47 0.97 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 128.191 2.596 . . . . 0.0 113.384 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 p -137.79 169.24 18.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.165 2.186 . . . . 0.0 111.095 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -143.73 164.6 29.99 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.001 1.32 . . . . 0.0 111.566 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -115.53 127.43 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.374 1.07 . . . . 0.0 111.154 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.49 -160.55 8.46 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.004 1.764 . . . . 0.0 111.367 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -142.93 147.88 35.98 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.251 1.026 . . . . 0.0 111.917 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -153.06 -159.12 8.88 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.531 1.539 . . . . 0.0 112.92 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.3 141.14 19.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.736 1.214 . . . . 0.0 113.077 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.7 -4.24 72.17 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.613 1.102 . . . . 0.0 114.359 -173.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 46.99 53.87 9.97 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.139 1.775 . . . . 0.0 113.625 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.32 138.53 32.44 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 127.6 2.36 . . . . 0.0 107.266 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.54 143.17 56.14 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 108.844 -1.252 . . . . 0.0 108.844 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.3 m -132.62 148.41 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.951 1.301 . . . . 0.0 110.818 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.2 t -75.54 137.16 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.547 0.739 . . . . 0.0 110.159 173.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.3 mt -142.92 164.68 30.65 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.702 2.001 . . . . 0.0 110.399 -171.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.87 155.59 43.58 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.216 1.944 . . . . 0.0 110.982 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.95 125.09 17.16 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.431 2.754 . . . . 0.0 112.684 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -145.12 -107.47 0.11 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.96 1.304 . . . . 0.0 109.107 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -143.56 20.06 1.85 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.174 1.789 . . . . 0.0 110.928 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -68.14 134.62 50.83 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.231 -0.918 . . . . 0.0 111.511 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.0 m -143.0 161.88 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.015 0.926 . . . . 0.0 112.065 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -129.96 134.36 47.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.017 1.327 . . . . 0.0 109.979 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.0 m -70.85 127.39 32.46 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.988 1.315 . . . . 0.0 108.743 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.1 mt -125.0 115.34 20.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.113 0.965 . . . . 0.0 109.027 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.7 m -136.62 133.68 36.55 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.49 0.716 . . . . 0.0 112.564 -169.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.9 tp -66.12 150.21 49.09 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.878 1.271 . . . . 0.0 112.602 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 p -136.89 175.81 9.28 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.663 1.585 . . . . 0.0 112.01 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.8 m -62.89 -4.97 2.44 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.75 19.64 0.21 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.455 1.026 . . . . 0.0 115.044 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.38 -156.87 28.32 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.682 1.135 . . . . 0.0 112.189 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.6 170.55 9.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.943 2.097 . . . . 0.0 110.91 174.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -132.21 149.52 52.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.828 1.651 . . . . 0.0 110.952 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.4 mt -135.11 117.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.164 1.386 . . . . 0.0 109.203 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -134.72 158.75 43.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.218 1.007 . . . . 0.0 111.942 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.03 -21.98 66.53 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -171.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.51 -40.28 1.83 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.375 1.464 . . . . 0.0 112.716 -170.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -98.26 5.22 48.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.329 1.451 . . . . 0.0 113.836 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 58.14 14.49 2.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.256 2.222 . . . . 0.0 114.221 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.3 p -72.97 -23.2 60.63 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.012 0.925 . . . . 0.0 112.547 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.0 m -143.79 173.01 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.768 1.627 . . . . 0.0 112.284 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.3 t -144.23 150.82 38.55 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.78 2.832 . . . . 0.0 109.106 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -70.24 145.03 51.65 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.115 -0.99 . . . . 0.0 111.372 169.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 99.3 p -153.63 173.28 16.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.715 1.206 . . . . 0.0 112.418 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.8 mt -126.39 174.1 8.85 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.128 1.771 . . . . 0.0 109.687 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -115.66 -33.5 5.17 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.996 0.918 . . . . 0.0 111.111 -170.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -141.52 -10.66 0.93 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.46 1.904 . . . . 0.0 112.946 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.84 22.37 6.98 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.96 1.704 . . . . 0.0 114.824 -170.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.5 p -70.94 158.02 37.18 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.115 0.966 . . . . 0.0 111.826 170.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.0 139.98 57.7 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.132 -0.98 . . . . 0.0 112.01 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.87 2.75 88.85 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.345 0.974 . . . . 0.0 114.064 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -69.93 139.09 52.86 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.651 1.225 . . . . 0.0 112.148 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.75 120.09 19.82 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.746 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.18 150.73 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.436 0.694 . . . . 0.0 111.202 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.2 m -130.33 167.71 18.08 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.058 1.343 . . . . 0.0 111.561 -171.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.3 mt -134.94 145.14 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.291 1.436 . . . . 0.0 108.753 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.4 -179.86 47.95 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 124.89 1.234 . . . . 0.0 111.231 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.39 -39.48 60.92 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.217 1.508 . . . . 0.0 113.849 -175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -169.96 175.4 5.14 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.889 2.476 . . . . 0.0 111.826 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.87 162.12 36.27 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.306 1.442 . . . . 0.0 111.687 169.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.4 t -92.7 -13.28 29.61 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -169.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -140.78 -32.49 0.57 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.541 1.137 . . . . 0.0 113.331 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.6 p -107.31 4.55 26.61 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.678 1.591 . . . . 0.0 114.045 -173.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.51 15.35 1.16 Allowed Glycine 0 CA--C 1.541 1.709 0 C-N-CA 126.348 1.928 . . . . 0.0 115.513 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -141.26 147.34 38.07 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.563 1.945 . . . . 0.0 110.353 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -141.1 177.48 8.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.21 1.804 . . . . 0.0 110.726 -169.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.23 142.61 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.025 0.93 . . . . 0.0 109.834 169.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.44 126.98 75.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.544 1.538 . . . . 0.0 107.053 173.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.91 153.84 38.58 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.908 1.283 . . . . 0.0 109.088 -170.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -66.78 155.06 39.22 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.049 -1.032 . . . . 0.0 112.53 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.2 t . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.991 1.716 . . . . 0.0 111.239 172.635 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.78 175.5 41.51 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.669 1.128 . . . . 0.0 113.078 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -132.55 2.17 3.78 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.654 1.182 . . . . 0.0 114.032 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 50.06 28.8 3.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.188 1.795 . . . . 0.0 114.262 -174.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -70.44 -5.12 26.19 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.051 1.74 . . . . 0.0 114.487 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -147.16 157.45 43.61 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.218 1.807 . . . . 0.0 111.039 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -148.81 -3.3 0.46 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -60.69 -15.05 24.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.564 1.545 . . . . 0.0 114.581 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -118.53 10.55 12.63 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.848 1.659 . . . . 0.0 113.211 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -140.01 -28.27 0.74 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -177.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 m -132.88 5.56 3.91 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.268 1.427 . . . . 0.0 113.561 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.14 18.3 0.54 Allowed Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.011 1.291 . . . . 0.0 114.563 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -65.43 132.85 50.0 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.242 1.021 . . . . 0.0 112.317 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.8 t -159.57 -38.46 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.04 1.336 . . . . 0.0 114.182 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.56 169.87 2.89 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.034 2.489 . . . . 0.0 114.654 171.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 51.39 33.03 9.33 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.418 1.487 . . . . 0.0 113.901 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.03 145.21 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 125.404 1.482 . . . . 0.0 110.547 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 t -141.36 13.0 2.17 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -170.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.7 mt 58.66 177.98 0.07 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.641 1.976 . . . . 0.0 113.499 -175.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 t -157.8 167.57 29.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.046 1.338 . . . . 0.0 110.207 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.14 135.6 53.79 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.928 -0.483 . . . . 0.0 111.275 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.6 -162.55 35.94 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 115.161 0.824 . . . . 0.0 115.161 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.96 119.7 35.93 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.946 1.298 . . . . 0.0 109.909 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -133.85 170.58 15.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.708 1.203 . . . . 0.0 112.468 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.8 pt -129.65 153.95 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 126.385 1.874 . . . . 0.0 108.763 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.7 mt -130.61 119.61 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -140.03 148.02 41.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.579 0.752 . . . . 0.0 111.639 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -75.72 137.46 40.64 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.592 -0.692 . . . . 0.0 111.213 -172.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -60.58 -29.23 69.05 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.39 1.076 . . . . 0.0 113.714 -175.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.77 -37.38 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.706 0.802 . . . . 0.0 111.669 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tp 55.9 175.12 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.316 1.846 . . . . 0.0 114.437 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 t -72.76 139.68 80.63 Favored Pre-proline 0 N--CA 1.473 0.68 0 O-C-N 120.646 -1.284 . . . . 0.0 111.221 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -65.55 -15.49 49.77 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.917 2.411 . . . . 0.0 113.019 171.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.0 tpt85 -76.41 -17.01 59.56 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.817 1.247 . . . . 0.0 113.185 171.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.51 -3.53 56.4 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.898 1.713 . . . . 0.0 114.553 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -78.24 153.23 32.07 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.413 1.107 . . . . 0.0 111.519 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -65.16 159.92 22.44 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.619 -0.676 . . . . 0.0 112.034 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.8 mt -130.61 68.75 1.46 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.32 1.448 . . . . 0.0 110.661 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.34 145.61 26.26 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.162 0.985 . . . . 0.0 112.44 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.51 132.18 50.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.922 0.889 . . . . 0.0 109.242 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.3 m -130.91 127.29 38.18 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.098 0.959 . . . . 0.0 110.826 -170.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.16 129.3 94.41 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.24 1.416 . . . . 0.0 111.142 -175.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.01 -11.08 19.72 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.078 2.519 . . . . 0.0 114.164 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.12 -4.28 52.08 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.5 1.047 . . . . 0.0 115.196 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -160.72 166.88 27.99 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.067 1.433 . . . . 0.0 113.035 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -89.17 161.97 16.17 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.109 1.764 . . . . 0.0 111.039 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 56.07 38.32 29.78 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.067 1.747 . . . . 0.0 113.783 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.7 m -141.86 140.91 20.63 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.401 1.88 . . . . 0.0 109.685 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.91 148.66 71.03 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.043 2.495 . . . . 0.0 113.717 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.65 157.61 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.061 1.344 . . . . 0.0 110.653 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -126.0 171.49 10.74 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.416 1.486 . . . . 0.0 111.115 -171.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -127.59 139.08 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 121.01 -1.056 . . . . 0.0 111.3 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -161.18 168.93 10.66 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.536 1.134 . . . . 0.0 113.161 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.83 152.8 12.76 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.604 3.536 . . . . 0.0 114.304 169.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.02 134.95 51.29 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.083 1.753 . . . . 0.0 110.094 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -130.88 -10.93 3.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.817 1.647 . . . . 0.0 113.68 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.99 -4.28 16.43 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.655 1.598 . . . . 0.0 114.395 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.0 t -63.07 165.13 7.41 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.036 1.418 . . . . 0.0 113.035 175.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.0 p -71.6 -15.18 62.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.66 1.184 . . . . 0.0 113.972 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.14 -31.33 72.49 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.417 1.008 . . . . 0.0 112.823 -178.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -113.22 4.84 16.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.356 1.462 . . . . 0.0 112.843 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.66 145.52 27.51 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.718 1.207 . . . . 0.0 111.614 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -141.48 174.12 10.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.646 1.212 . . . . 0.0 111.743 -169.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.7 mt -125.7 136.72 59.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.921 2.089 . . . . 0.0 107.357 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.3 tp -134.63 129.65 35.22 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.648 1.579 . . . . 0.0 108.816 -171.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.9 mtt85 -146.29 131.4 18.33 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.308 0.643 . . . . 0.0 110.64 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -64.33 138.0 58.2 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.401 0.546 . . . . 0.0 111.068 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -115.1 -47.78 2.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.332 1.053 . . . . 0.0 111.605 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.68 110.46 4.3 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.487 1.115 . . . . 0.0 111.476 170.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.9 m -59.51 -24.69 63.86 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.957 0.903 . . . . 0.0 111.412 168.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -63.96 -21.4 66.47 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.915 2.086 . . . . 0.0 113.495 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -130.18 9.28 5.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.674 1.59 . . . . 0.0 112.852 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 46.02 33.7 1.76 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.533 1.933 . . . . 0.0 113.55 -169.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.0 p -93.37 138.62 31.53 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.001 -1.062 . . . . 0.0 112.031 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -134.69 145.13 48.24 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.204 1.802 . . . . 0.0 110.789 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.7 p -77.98 152.75 32.95 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.854 -0.529 . . . . 0.0 110.958 171.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.1 mm -129.11 130.11 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.568 1.547 . . . . 0.0 109.045 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.8 m -142.99 145.98 35.34 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.628 1.571 . . . . 0.0 110.612 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.06 146.77 32.83 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.185 2.59 . . . . 0.0 111.102 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.84 -24.98 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.943 -1.098 . . . . 0.0 113.427 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.4 -22.15 63.17 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.743 0.687 . . . . 0.0 114.197 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.2 m -143.04 64.91 15.02 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 126.144 1.777 . . . . 0.0 110.473 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -63.76 -15.37 48.49 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.197 2.598 . . . . 0.0 113.364 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -71.94 0.3 9.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.229 1.811 . . . . 0.0 113.918 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m -131.01 173.63 10.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.916 1.686 . . . . 0.0 111.545 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -140.6 171.83 13.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.556 1.142 . . . . 0.0 113.474 -170.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.07 130.64 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.234 1.414 . . . . 0.0 110.587 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.14 -158.26 7.66 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.8 1.667 . . . . 0.0 111.513 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -142.42 145.35 33.71 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.351 1.075 . . . . 0.0 111.956 -173.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.62 -163.46 11.28 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.481 1.515 . . . . 0.0 112.942 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.83 138.17 24.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.904 1.281 . . . . 0.0 113.081 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.36 -6.78 61.52 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.821 1.2 . . . . 0.0 114.173 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 48.17 56.22 7.67 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.417 1.887 . . . . 0.0 114.177 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.02 149.2 67.7 Favored Pre-proline 0 C--O 1.239 0.512 0 C-N-CA 126.511 1.924 . . . . 0.0 107.896 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -69.76 146.01 58.89 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.338 1.358 . . . . 0.0 110.073 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.27 150.01 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.966 1.706 . . . . 0.0 111.274 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.81 134.66 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.085 0.954 . . . . 0.0 110.179 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.7 mt -137.74 162.46 54.39 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.79 1.636 . . . . 0.0 112.243 -169.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.75 167.85 21.83 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.267 2.645 . . . . 0.0 111.828 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.86 127.03 12.5 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.318 2.012 . . . . 0.0 110.676 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -149.78 -93.32 0.07 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.789 0.836 . . . . 0.0 110.541 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -155.4 18.14 0.41 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.908 1.683 . . . . 0.0 112.343 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -66.04 135.4 54.59 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.73 -0.606 . . . . 0.0 111.64 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -144.99 160.8 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.968 1.307 . . . . 0.0 111.756 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -130.32 144.24 51.26 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.53 1.532 . . . . 0.0 110.537 170.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.1 m -76.31 134.83 39.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.163 1.385 . . . . 0.0 109.409 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.21 125.62 50.54 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.413 1.085 . . . . 0.0 109.478 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.8 m -132.3 117.0 17.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.672 0.789 . . . . 0.0 110.246 -170.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 tp -66.16 146.72 54.31 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.181 0.592 . . . . 0.0 111.109 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.1 p -127.59 -177.97 4.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.593 1.557 . . . . 0.0 111.627 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.0 p -59.48 -13.57 9.37 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.13 25.85 0.19 Allowed Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.202 0.841 . . . . 0.0 115.202 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.55 -149.57 9.44 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.878 1.228 . . . . 0.0 112.273 -173.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -128.46 170.11 13.53 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.609 1.964 . . . . 0.0 111.781 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -137.05 153.59 50.57 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.976 2.511 . . . . 0.0 109.037 170.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.0 mt -133.56 127.88 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.807 1.243 . . . . 0.0 108.717 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -138.29 159.9 40.87 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.457 1.103 . . . . 0.0 112.734 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.45 -23.01 67.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 125.86 -39.51 2.02 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.97 1.272 . . . . 0.0 113.102 -171.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -98.66 1.58 46.38 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.889 1.675 . . . . 0.0 113.732 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.6 mmm-85 66.39 13.17 9.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.1 2.16 . . . . 0.0 113.655 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 72.8 p -74.84 -24.82 58.66 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.46 1.104 . . . . 0.0 112.683 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.2 m -143.46 174.25 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.738 1.615 . . . . 0.0 111.693 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 t -147.23 152.89 39.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.609 2.364 . . . . 0.0 110.176 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -70.01 143.43 52.57 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.543 -0.723 . . . . 0.0 111.413 171.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 81.3 p -153.26 172.14 17.45 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.807 1.243 . . . . 0.0 112.527 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -123.92 172.97 8.51 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.332 1.853 . . . . 0.0 110.207 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -119.44 -29.76 5.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.777 1.631 . . . . 0.0 112.065 -169.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -142.41 -8.7 0.86 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.995 1.718 . . . . 0.0 114.294 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.22 51.84 13.69 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.359 1.064 . . . . 0.0 113.649 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.5 p -126.99 167.1 16.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.887 0.875 . . . . 0.0 112.306 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -73.0 146.21 46.14 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.742 -1.224 . . . . 0.0 112.568 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.79 -8.49 69.21 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.44 1.019 . . . . 0.0 114.016 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -61.28 157.34 16.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.621 1.968 . . . . 0.0 112.602 169.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -109.11 124.87 51.48 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.424 1.089 . . . . 0.0 109.231 171.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -60.0 148.19 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.731 0.813 . . . . 0.0 111.886 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.2 m -130.91 168.22 17.68 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.734 1.614 . . . . 0.0 112.087 -170.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 80.8 mt -133.91 143.87 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.401 1.48 . . . . 0.0 109.712 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.49 179.79 48.79 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.036 1.303 . . . . 0.0 111.655 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.75 -40.54 54.95 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.248 1.524 . . . . 0.0 114.542 -172.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -171.92 173.41 4.46 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.057 2.943 . . . . 0.0 108.942 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.64 137.94 33.98 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.242 -0.911 . . . . 0.0 112.785 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.6 t -61.84 -21.02 64.29 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.73 1.612 . . . . 0.0 115.303 -170.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -134.18 -38.01 0.87 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.509 1.124 . . . . 0.0 113.312 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.3 p -98.19 4.06 48.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.152 1.381 . . . . 0.0 114.626 -171.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.53 14.25 1.03 Allowed Glycine 0 CA--C 1.544 1.892 0 C-N-CA 126.017 1.77 . . . . 0.0 115.9 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -134.53 150.66 50.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.88 1.672 . . . . 0.0 111.915 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -141.41 175.6 9.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.996 2.118 . . . . 0.0 110.795 -169.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.86 138.46 34.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 125.03 1.332 . . . . 0.0 108.814 169.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.8 123.5 71.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.716 1.606 . . . . 0.0 106.768 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -146.9 153.83 40.58 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.597 1.159 . . . . 0.0 109.168 -169.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -68.62 154.57 41.66 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.967 -1.083 . . . . 0.0 112.518 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.256 1.822 . . . . 0.0 111.405 171.902 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.78 173.82 46.34 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.464 1.031 . . . . 0.0 112.996 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -133.25 7.97 3.96 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.102 1.361 . . . . 0.0 113.189 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -70.2 -15.68 62.97 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.786 1.634 . . . . 0.0 113.762 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -148.87 157.02 43.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.456 1.902 . . . . 0.0 110.706 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -144.57 163.88 32.59 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.639 1.576 . . . . 0.0 111.862 -174.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -123.4 3.1 9.1 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.873 1.269 . . . . 0.0 113.607 -175.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -143.43 160.5 40.46 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.374 1.869 . . . . 0.0 110.857 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -143.47 11.26 1.69 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.372 1.469 . . . . 0.0 112.85 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -152.97 168.39 25.98 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.478 1.911 . . . . 0.0 111.896 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.2 m -132.72 6.52 4.03 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.12 1.368 . . . . 0.0 113.348 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.98 176.14 43.95 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.911 1.72 . . . . 0.0 112.393 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -142.64 1.97 1.37 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.521 1.129 . . . . 0.0 113.691 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.4 m -145.0 159.35 50.15 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 126.154 1.782 . . . . 0.0 111.231 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.61 139.02 39.57 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.727 2.951 . . . . 0.0 113.747 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.79 27.79 1.19 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.805 1.242 . . . . 0.0 113.194 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 t -78.53 152.74 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.804 1.641 . . . . 0.0 110.501 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.2 t -134.1 6.28 3.62 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.5 mt 57.95 174.38 0.06 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.969 2.107 . . . . 0.0 113.746 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 t -159.7 168.43 25.98 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.084 1.354 . . . . 0.0 109.879 173.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.53 131.83 48.18 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.854 -0.529 . . . . 0.0 111.632 171.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.55 -168.49 41.34 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 114.643 0.617 . . . . 0.0 114.643 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -94.49 125.75 39.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.043 0.937 . . . . 0.0 109.793 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -132.73 166.15 22.87 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.709 1.604 . . . . 0.0 111.887 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.1 pt -117.69 151.1 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 125.489 1.516 . . . . 0.0 108.45 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.0 mt -130.33 113.43 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -136.47 143.39 43.82 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.439 1.095 . . . . 0.0 110.089 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -71.01 150.08 45.98 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.797 -0.564 . . . . 0.0 111.329 -172.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -63.83 -13.88 48.31 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.8 t -118.65 139.18 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.611 1.964 . . . . 0.0 108.889 169.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.9 mt -109.72 169.22 8.85 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.388 1.475 . . . . 0.0 113.398 -169.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.1 t -68.58 151.34 97.29 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.644 1.177 . . . . 0.0 111.889 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -61.35 -8.07 9.79 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.448 2.766 . . . . 0.0 113.833 169.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -62.1 -24.33 67.06 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.106 1.363 . . . . 0.0 112.302 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.54 30.38 27.36 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.844 1.212 . . . . 0.0 114.2 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.39 162.64 33.92 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.852 1.661 . . . . 0.0 110.294 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -54.34 142.02 28.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.618 0.767 . . . . 0.0 110.33 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -121.95 84.66 2.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.523 1.529 . . . . 0.0 110.684 -166.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.53 150.12 21.44 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.827 1.651 . . . . 0.0 115.045 -168.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.77 134.99 57.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.18 0.992 . . . . 0.0 109.14 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.2 m -135.4 125.38 25.84 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.216 1.007 . . . . 0.0 111.301 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -67.0 140.42 96.04 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.551 1.94 . . . . 0.0 112.878 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.29 -15.64 17.89 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.705 2.937 . . . . 0.0 114.943 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.98 7.21 66.2 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.306 0.955 . . . . 0.0 115.076 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -156.97 167.04 31.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.515 1.926 . . . . 0.0 111.322 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -100.13 167.83 10.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.809 1.243 . . . . 0.0 111.267 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 50.85 38.91 21.12 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.672 1.589 . . . . 0.0 113.256 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.1 m -139.87 138.41 19.72 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 126.129 1.772 . . . . 0.0 110.557 -169.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.21 159.83 3.85 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.861 3.707 . . . . 0.0 115.542 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 t -114.0 149.64 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.107 1.363 . . . . 0.0 110.643 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 m -125.2 174.42 8.11 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.268 1.427 . . . . 0.0 110.909 -169.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -127.06 143.02 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.951 1.301 . . . . 0.0 111.365 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.3 m -152.99 162.51 26.21 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 124.302 1.041 . . . . 0.0 113.047 -173.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.34 150.57 40.62 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.446 2.764 . . . . 0.0 112.754 169.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.8 tp -108.14 134.19 51.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.864 1.266 . . . . 0.0 111.585 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -133.82 -26.88 1.52 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.823 2.049 . . . . 0.0 112.405 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.8 5.47 2.2 Favored Glycine 0 CA--C 1.537 1.464 0 N-CA-C 116.811 1.484 . . . . 0.0 116.811 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.3 p -72.83 165.28 25.19 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.899 1.849 . . . . 0.0 113.798 -175.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.3 m -70.04 -14.48 62.7 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -73.14 -25.34 60.79 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.974 0.91 . . . . 0.0 112.458 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.61 5.82 11.64 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.343 2.657 . . . . 0.0 112.23 -172.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.8 147.89 33.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.506 1.522 . . . . 0.0 110.257 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -134.96 171.66 14.1 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.886 1.326 . . . . 0.0 112.291 -168.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.3 mt -125.66 134.46 66.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 127.505 2.322 . . . . 0.0 106.249 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.4 tp -137.13 123.38 20.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.067 1.347 . . . . 0.0 109.624 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -142.81 140.03 31.17 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.495 0.718 . . . . 0.0 111.388 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.3 t -65.5 142.43 58.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.355 0.662 . . . . 0.0 111.451 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -117.19 -52.74 2.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.749 1.219 . . . . 0.0 111.823 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.2 111.24 5.32 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.3 1.04 . . . . 0.0 111.006 170.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.3 m -57.28 -24.35 54.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.887 0.875 . . . . 0.0 111.26 168.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -65.37 -21.6 66.7 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.924 2.089 . . . . 0.0 113.633 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.6 t -130.5 14.69 5.49 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.193 1.397 . . . . 0.0 112.898 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 43.89 34.56 0.92 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.24 1.816 . . . . 0.0 113.475 -169.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.1 p -88.0 143.23 27.21 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.995 -1.065 . . . . 0.0 112.106 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -139.17 143.22 38.04 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.328 1.451 . . . . 0.0 110.993 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.4 p -77.7 147.99 35.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.288 0.635 . . . . 0.0 110.723 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.0 mm -128.28 126.08 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.462 1.505 . . . . 0.0 109.397 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.0 m -143.34 146.46 36.24 Favored Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 125.791 1.637 . . . . 0.0 109.539 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.57 150.84 28.34 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.765 2.31 . . . . 0.0 111.53 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.49 -30.53 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 121.297 -0.877 . . . . 0.0 111.836 172.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.73 -14.89 78.99 Favored Glycine 0 CA--C 1.539 1.564 0 N-CA-C 115.595 0.998 . . . . 0.0 115.595 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.6 m -151.6 61.75 4.47 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 125.819 1.648 . . . . 0.0 111.56 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -62.8 -17.21 58.19 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 124.065 3.176 . . . . 0.0 113.669 -173.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -72.77 13.11 0.41 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 128.484 2.713 . . . . 0.0 114.238 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.8 p -141.46 171.34 14.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.731 2.012 . . . . 0.0 111.596 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -138.83 170.09 16.63 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.634 1.574 . . . . 0.0 112.469 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.71 129.88 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.865 1.266 . . . . 0.0 110.897 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.75 -156.15 6.82 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.83 1.681 . . . . 0.0 111.693 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -143.01 141.11 31.27 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.387 1.075 . . . . 0.0 111.526 -171.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.14 -166.78 13.0 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.36 1.457 . . . . 0.0 113.035 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.72 137.47 20.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.979 1.311 . . . . 0.0 113.164 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.32 -7.28 61.88 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.85 1.214 . . . . 0.0 114.094 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 48.69 56.32 7.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.575 1.95 . . . . 0.0 114.298 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.64 151.02 77.4 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 126.2 1.8 . . . . 0.0 108.201 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.57 142.16 57.91 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.269 1.313 . . . . 0.0 109.84 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.34 148.92 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.615 1.566 . . . . 0.0 111.123 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.87 139.47 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.838 0.855 . . . . 0.0 110.602 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.67 161.67 57.28 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.666 1.986 . . . . 0.0 110.944 -172.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -69.65 164.88 32.79 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.703 2.269 . . . . 0.0 111.482 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.0 123.44 10.02 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.455 2.103 . . . . 0.0 110.851 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -147.72 -91.34 0.08 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.245 1.018 . . . . 0.0 110.482 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -156.01 18.34 0.37 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.524 1.53 . . . . 0.0 112.955 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -68.2 136.13 53.11 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.544 -0.722 . . . . 0.0 112.125 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.7 m -145.19 161.55 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.06 1.344 . . . . 0.0 112.537 -174.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -131.49 136.79 48.2 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.964 1.706 . . . . 0.0 110.571 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.6 m -71.92 131.58 43.17 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.098 0.959 . . . . 0.0 108.717 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.1 mt -123.52 128.19 49.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.096 0.958 . . . . 0.0 109.424 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.1 m -133.63 120.35 20.56 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.772 0.829 . . . . 0.0 110.586 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.83 146.82 54.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.065 0.546 . . . . 0.0 111.246 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -126.43 178.85 5.6 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.585 1.554 . . . . 0.0 110.818 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.0 p -60.23 -14.98 20.54 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.75 33.66 0.36 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.659 1.124 . . . . 0.0 114.088 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.61 -154.46 24.23 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.927 1.251 . . . . 0.0 112.909 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -126.71 170.93 11.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.272 2.229 . . . . 0.0 111.119 174.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -135.44 151.05 50.04 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.361 2.264 . . . . 0.0 109.255 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.9 mt -132.94 125.3 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.921 1.289 . . . . 0.0 108.778 -170.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -138.12 157.67 45.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.598 1.159 . . . . 0.0 112.648 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -60.72 -32.98 72.21 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.38 -40.28 1.64 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.9 1.714 . . . . 0.0 113.298 -172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.65 -13.1 59.73 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.598 1.159 . . . . 0.0 113.585 171.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 69.99 13.85 7.86 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.221 2.208 . . . . 0.0 112.796 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.2 p -71.99 -21.53 61.55 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.84 1.656 . . . . 0.0 112.856 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.0 m -144.97 170.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.071 1.749 . . . . 0.0 111.754 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.3 t -141.23 156.47 45.9 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.255 1.822 . . . . 0.0 110.838 171.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -70.05 140.17 52.76 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.595 -0.691 . . . . 0.0 111.345 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.8 p -151.64 172.15 16.52 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.438 1.095 . . . . 0.0 112.498 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -117.34 174.73 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.137 1.775 . . . . 0.0 109.794 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -112.16 -31.88 6.73 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.977 1.311 . . . . 0.0 110.648 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -142.7 -13.3 0.76 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.546 2.338 . . . . 0.0 112.734 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.96 20.53 6.83 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.75 2.02 . . . . 0.0 114.78 -171.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.7 p -70.86 155.78 40.37 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.571 1.148 . . . . 0.0 111.921 171.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.12 137.22 58.04 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.408 -0.807 . . . . 0.0 112.457 172.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.14 -1.83 87.63 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.98 1.276 . . . . 0.0 114.455 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 139.01 45.81 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.75 1.275 . . . . 0.0 112.823 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.36 127.0 32.16 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.528 -0.732 . . . . 0.0 110.266 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.36 152.07 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.117 0.567 . . . . 0.0 110.426 175.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.7 m -130.34 161.98 30.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.574 1.549 . . . . 0.0 111.563 -173.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.0 mt -131.87 143.73 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.377 1.471 . . . . 0.0 108.84 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.44 -157.64 30.19 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 123.73 0.681 . . . . 0.0 112.236 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.16 159.99 4.07 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 117.832 0.816 . . . . 0.0 112.063 169.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.43 148.77 11.35 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.784 1.234 . . . . 0.0 112.229 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.8 138.93 53.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.988 1.315 . . . . 0.0 112.939 -170.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -60.07 -21.75 61.85 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -131.45 -39.93 1.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 85.9 p -98.59 3.78 48.01 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -173.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.43 -3.18 31.09 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.492 1.044 . . . . 0.0 115.02 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -121.45 154.88 35.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.941 1.696 . . . . 0.0 111.21 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -137.83 175.09 9.9 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.258 1.823 . . . . 0.0 111.155 -170.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.8 t -133.58 135.05 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.621 1.568 . . . . 0.0 107.956 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 47.6 mt -130.59 119.05 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -149.31 152.46 35.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.997 -168.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -68.93 154.4 42.11 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.167 -0.958 . . . . 0.0 112.587 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 C--O 1.254 1.311 0 C-N-CA 126.338 1.855 . . . . 0.0 111.422 172.324 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.0 15.32 0.09 OUTLIER Glycine 0 CA--C 1.538 1.483 0 N-CA-C 115.719 1.048 . . . . 0.0 115.719 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 53.16 15.75 0.67 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.082 2.153 . . . . 0.0 116.164 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -145.06 19.13 1.6 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.049 1.739 . . . . 0.0 111.819 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -137.54 14.42 2.96 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.211 1.404 . . . . 0.0 113.203 -169.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -129.59 3.84 5.05 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.216 1.807 . . . . 0.0 113.377 -170.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -132.75 -13.36 2.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.949 1.699 . . . . 0.0 114.115 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -71.02 -9.81 58.68 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.587 1.155 . . . . 0.0 113.431 170.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -147.55 167.64 23.99 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.945 2.098 . . . . 0.0 111.179 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -155.54 167.05 31.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.397 1.479 . . . . 0.0 111.711 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 55.8 m -134.13 6.54 3.62 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.918 1.287 . . . . 0.0 113.933 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.9 29.4 0.42 Allowed Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.494 1.045 . . . . 0.0 114.536 -176.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -139.27 11.71 2.57 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.157 1.383 . . . . 0.0 113.295 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.1 m -63.59 157.91 62.75 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.723 1.209 . . . . 0.0 112.88 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.94 155.03 9.05 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.677 2.918 . . . . 0.0 114.042 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -133.25 24.08 4.14 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.012 1.325 . . . . 0.0 112.719 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.03 146.75 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.028 1.331 . . . . 0.0 110.646 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 t -150.65 33.64 0.62 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 123.304 1.526 . . . . 0.0 114.277 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.9 mt -57.28 161.0 3.54 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.496 1.519 . . . . 0.0 111.584 168.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -157.49 167.49 30.05 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.494 1.118 . . . . 0.0 110.034 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.39 124.0 20.17 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.994 -0.441 . . . . 0.0 111.259 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.36 -166.05 37.83 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -101.53 123.91 46.33 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.198 0.999 . . . . 0.0 109.908 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.86 169.7 15.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.073 1.349 . . . . 0.0 112.454 -171.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.4 pt -123.52 152.01 28.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.992 1.717 . . . . 0.0 108.302 171.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.83 121.2 57.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -136.66 147.07 46.64 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.118 0.967 . . . . 0.0 111.022 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -73.62 148.11 43.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.828 -0.545 . . . . 0.0 110.832 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.7 tpt85 -64.61 -16.64 63.04 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.77 140.43 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 126.084 1.754 . . . . 0.0 109.117 169.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 47.2 mt -109.99 167.52 10.11 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.284 1.433 . . . . 0.0 114.015 -168.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 t -69.74 151.04 96.55 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.814 1.246 . . . . 0.0 112.021 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.71 -9.71 12.25 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.578 2.852 . . . . 0.0 113.972 169.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -30.71 67.34 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.347 1.459 . . . . 0.0 112.127 169.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.49 21.95 25.47 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.939 1.257 . . . . 0.0 114.968 172.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -133.45 173.34 11.59 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.067 1.347 . . . . 0.0 111.056 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -54.33 148.17 12.17 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.505 0.722 . . . . 0.0 110.901 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -127.33 92.95 3.61 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.719 1.208 . . . . 0.0 109.949 -168.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.24 151.15 24.46 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -167.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 tp -57.37 132.33 52.76 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.111 1.365 . . . . 0.0 109.778 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.0 m -130.47 124.82 32.88 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.929 0.892 . . . . 0.0 111.479 -170.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -61.11 128.87 90.05 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.14 1.376 . . . . 0.0 111.404 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.67 -11.36 20.3 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.326 2.684 . . . . 0.0 114.208 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.87 -5.15 50.25 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.456 1.027 . . . . 0.0 115.104 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -160.02 168.28 25.97 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.903 1.351 . . . . 0.0 113.067 -173.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -88.7 167.7 13.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.085 1.754 . . . . 0.0 111.394 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 48.92 40.42 16.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.678 1.991 . . . . 0.0 113.466 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.6 m -141.04 137.16 16.64 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 126.062 1.745 . . . . 0.0 110.03 -172.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.73 141.86 42.92 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.309 3.34 . . . . 0.0 114.547 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 t -84.74 149.15 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.398 1.079 . . . . 0.0 110.509 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 m -122.7 178.08 5.17 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.172 1.389 . . . . 0.0 110.595 -170.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -130.27 148.61 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.695 1.198 . . . . 0.0 111.253 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.4 p -155.11 159.01 32.15 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 123.539 0.736 . . . . 0.0 112.792 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.71 128.41 30.21 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.569 2.179 . . . . 0.0 111.213 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.92 131.51 49.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.391 1.076 . . . . 0.0 111.079 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -123.04 -19.36 6.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.587 1.155 . . . . 0.0 112.221 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.35 60.67 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.698 1.142 . . . . 0.0 113.261 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.5 t -67.74 162.26 24.21 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.066 1.346 . . . . 0.0 111.766 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.4 p -57.09 -18.74 15.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.62 1.168 . . . . 0.0 113.944 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.21 -32.88 74.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.685 1.194 . . . . 0.0 113.04 173.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -111.4 -0.65 16.23 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.42 146.48 24.73 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 122.33 1.062 . . . . 0.0 111.868 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -140.5 172.81 12.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.963 1.305 . . . . 0.0 111.427 -169.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.8 mt -123.03 135.19 63.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.072 2.149 . . . . 0.0 107.025 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.04 123.85 21.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.194 1.398 . . . . 0.0 109.17 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -144.03 139.96 29.28 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.461 0.705 . . . . 0.0 111.922 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 t -66.32 139.2 58.03 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.014 0.526 . . . . 0.0 111.651 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -114.58 -52.79 2.69 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.649 1.18 . . . . 0.0 111.303 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.85 109.95 4.93 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.614 1.165 . . . . 0.0 111.34 171.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.4 m -57.92 -24.58 58.43 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.877 0.871 . . . . 0.0 111.65 168.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -64.11 -22.57 66.99 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.129 2.171 . . . . 0.0 113.641 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.7 m -130.31 12.25 5.5 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.772 1.629 . . . . 0.0 112.671 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 43.99 35.35 1.13 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.595 1.958 . . . . 0.0 113.487 -168.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 p -89.45 140.43 29.52 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.836 -1.165 . . . . 0.0 112.028 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -136.55 144.73 44.37 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.03 1.732 . . . . 0.0 110.14 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.2 p -77.68 149.81 34.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.404 0.682 . . . . 0.0 110.667 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.0 mm -128.55 126.81 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.563 1.545 . . . . 0.0 109.184 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.1 m -144.77 142.9 19.53 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.348 1.459 . . . . 0.0 110.105 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.04 145.38 35.4 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.983 2.455 . . . . 0.0 111.114 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.6 m -66.01 -23.1 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.708 -1.245 . . . . 0.0 112.733 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.09 -9.69 81.87 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.675 1.131 . . . . 0.0 114.625 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.8 t -152.35 66.03 6.28 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.048 1.339 . . . . 0.0 110.883 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.99 -18.18 61.45 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.265 2.643 . . . . 0.0 112.949 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -78.61 5.22 11.5 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.406 2.282 . . . . 0.0 114.096 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 m -130.87 171.91 12.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.372 1.869 . . . . 0.0 111.182 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -138.7 173.59 11.42 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.39 1.476 . . . . 0.0 112.915 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.0 mm -121.67 129.79 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.232 1.413 . . . . 0.0 110.81 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.12 -156.85 7.13 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.76 1.648 . . . . 0.0 111.958 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -142.66 142.37 32.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.437 1.095 . . . . 0.0 111.646 -171.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.93 -165.13 12.0 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.303 1.43 . . . . 0.0 113.405 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.57 138.84 21.75 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.063 1.345 . . . . 0.0 113.217 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.69 -6.42 67.51 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.746 1.165 . . . . 0.0 114.097 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 49.04 57.78 6.08 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.373 1.869 . . . . 0.0 113.932 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.65 149.7 72.77 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 126.101 1.761 . . . . 0.0 108.13 169.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.75 144.4 53.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.242 1.294 . . . . 0.0 109.643 174.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.88 146.96 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.577 1.551 . . . . 0.0 110.945 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.9 t -76.22 137.99 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.567 0.747 . . . . 0.0 109.887 171.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.9 mt -140.21 162.97 47.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.946 1.699 . . . . 0.0 112.194 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.34 166.66 24.64 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.252 2.635 . . . . 0.0 111.71 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.44 126.81 11.92 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.311 2.007 . . . . 0.0 110.909 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -148.62 -106.18 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.604 1.161 . . . . 0.0 109.413 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -145.25 21.58 1.54 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.422 1.889 . . . . 0.0 110.59 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -66.73 133.5 50.31 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.226 -0.921 . . . . 0.0 111.774 -173.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.7 m -144.71 160.33 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.336 1.455 . . . . 0.0 111.994 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -130.06 145.66 51.69 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.611 1.564 . . . . 0.0 109.973 169.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -77.03 134.86 38.68 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.801 1.241 . . . . 0.0 109.583 171.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.66 126.06 51.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.644 1.177 . . . . 0.0 109.722 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.2 m -132.77 120.13 21.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.247 1.019 . . . . 0.0 110.284 -175.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 tp -65.33 146.6 54.72 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.203 0.601 . . . . 0.0 111.334 172.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 p -127.76 176.53 7.47 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.564 1.545 . . . . 0.0 111.497 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -60.51 -10.31 4.86 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.88 31.89 0.29 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.496 1.046 . . . . 0.0 114.064 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.38 -151.82 19.12 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.721 1.153 . . . . 0.0 113.02 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -131.64 170.22 15.07 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 128.007 2.523 . . . . 0.0 110.591 175.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -134.59 155.36 50.59 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.683 1.593 . . . . 0.0 111.076 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.1 mt -135.09 115.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.774 1.629 . . . . 0.0 108.98 -170.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -134.36 158.15 44.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.227 1.011 . . . . 0.0 112.866 -170.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -61.25 -18.1 56.72 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 120.27 -33.83 4.37 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.885 1.231 . . . . 0.0 113.279 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -107.94 5.73 26.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.477 1.911 . . . . 0.0 113.18 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.8 mmm-85 63.19 16.98 9.84 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.148 2.179 . . . . 0.0 113.998 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.8 p -74.71 -27.91 60.59 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.235 1.014 . . . . 0.0 112.799 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.7 m -143.19 175.27 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.314 1.446 . . . . 0.0 111.735 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -144.41 150.98 38.6 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 128.449 2.7 . . . . 0.0 109.675 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -71.0 145.01 50.26 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.583 -0.698 . . . . 0.0 111.517 169.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.5 p -152.32 176.42 11.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.552 1.141 . . . . 0.0 112.557 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -132.08 171.29 13.81 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.067 2.147 . . . . 0.0 109.861 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -111.68 -35.89 5.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.305 1.042 . . . . 0.0 111.159 -170.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -141.38 -10.95 0.94 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.079 2.152 . . . . 0.0 112.63 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.77 19.14 5.37 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.455 1.902 . . . . 0.0 115.134 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.6 p -70.69 157.81 37.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.319 1.047 . . . . 0.0 112.148 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.52 137.54 58.15 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.372 -0.83 . . . . 0.0 112.612 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.14 -1.22 89.06 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.536 1.065 . . . . 0.0 114.564 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -69.21 141.47 54.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.66 1.184 . . . . 0.0 112.501 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.91 128.88 34.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.579 0.752 . . . . 0.0 110.424 174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.08 151.62 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.429 0.692 . . . . 0.0 110.714 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.6 t -126.27 165.24 19.33 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.256 1.422 . . . . 0.0 111.539 -174.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.0 mt -135.68 140.48 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.608 1.563 . . . . 0.0 109.672 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.0 -179.49 48.9 Favored Glycine 0 N--CA 1.469 0.889 0 C-N-CA 124.9 1.238 . . . . 0.0 111.768 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.22 -41.05 62.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 119.034 1.417 . . . . 0.0 114.035 -173.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -168.62 172.17 8.25 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.809 2.444 . . . . 0.0 109.96 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.69 141.23 35.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.356 1.062 . . . . 0.0 112.547 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.5 t -60.43 -21.06 61.84 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -134.3 -38.4 0.85 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.3 p -96.65 5.36 50.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.347 1.459 . . . . 0.0 114.354 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.62 10.75 3.68 Favored Glycine 0 CA--C 1.542 1.764 0 C-N-CA 125.107 1.336 . . . . 0.0 115.658 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -136.22 149.1 48.4 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.85 2.06 . . . . 0.0 110.412 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -137.75 176.25 8.87 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.525 1.93 . . . . 0.0 112.022 -169.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.1 t -134.77 137.07 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.924 1.69 . . . . 0.0 108.509 171.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.94 123.75 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.06 154.19 38.92 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.651 1.18 . . . . 0.0 108.989 -170.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -68.75 154.75 41.4 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.682 -1.261 . . . . 0.0 112.594 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.394 1.878 . . . . 0.0 111.462 171.328 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.76 178.46 45.6 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.736 1.16 . . . . 0.0 113.096 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -150.68 152.99 34.77 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.911 1.284 . . . . 0.0 111.866 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -147.3 159.64 43.43 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.847 1.659 . . . . 0.0 111.392 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -131.11 -6.88 3.88 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.819 1.248 . . . . 0.0 113.279 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -140.99 14.21 2.26 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.896 2.078 . . . . 0.0 113.099 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 44.79 30.86 0.58 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.818 2.447 . . . . 0.0 115.969 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -148.37 -177.85 5.99 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.347 1.459 . . . . 0.0 111.672 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.09 -0.3 1.02 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.1 p80 42.22 25.99 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.89 2.076 . . . . 0.0 115.996 -172.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.0 m 49.61 34.59 7.3 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.918 1.687 . . . . 0.0 114.012 -171.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.11 -156.71 8.27 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.458 1.504 . . . . 0.0 113.245 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.86 145.96 28.89 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.752 1.221 . . . . 0.0 111.409 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.9 m -151.18 164.23 20.95 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.964 1.706 . . . . 0.0 111.099 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.68 161.14 4.67 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.532 2.821 . . . . 0.0 114.403 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.51 33.26 3.02 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.246 1.418 . . . . 0.0 112.381 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.04 146.65 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.035 1.734 . . . . 0.0 109.914 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 t -135.19 12.57 3.56 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.525 1.53 . . . . 0.0 112.871 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.6 mt 63.01 168.03 0.13 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.674 2.39 . . . . 0.0 114.031 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 t -160.08 170.07 22.03 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.662 1.585 . . . . 0.0 109.575 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 130.84 44.54 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.58 -0.7 . . . . 0.0 111.512 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.11 -163.02 36.52 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 121.623 -0.673 . . . . 0.0 114.627 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -98.41 124.33 43.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.049 0.939 . . . . 0.0 110.094 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -133.1 171.75 13.57 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.084 1.354 . . . . 0.0 112.679 -171.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.0 pt -125.72 153.32 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 126.368 1.867 . . . . 0.0 108.643 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mt -129.13 120.04 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -138.69 149.32 44.99 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.876 0.871 . . . . 0.0 111.326 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -75.65 144.51 41.65 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.98 -0.45 . . . . 0.0 110.648 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -62.13 -15.04 42.92 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.18 102.03 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.37 1.468 . . . . 0.0 109.419 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.52 156.66 25.71 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.789 1.635 . . . . 0.0 111.568 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.8 p -74.39 159.62 83.17 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.42 -15.52 8.73 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.242 3.295 . . . . 0.0 115.412 170.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -28.75 69.35 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.506 1.922 . . . . 0.0 112.909 172.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.46 23.73 25.72 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.401 1.476 . . . . 0.0 114.387 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -135.44 162.01 33.84 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.313 1.445 . . . . 0.0 111.918 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -54.83 135.79 47.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.283 1.033 . . . . 0.0 110.966 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.4 tp -109.69 78.07 1.1 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.942 1.297 . . . . 0.0 111.386 -169.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.96 149.52 22.54 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.934 1.294 . . . . 0.0 113.665 -171.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 tp -58.17 135.2 57.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.001 1.32 . . . . 0.0 110.081 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.6 m -127.38 127.11 43.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.793 1.237 . . . . 0.0 111.276 -174.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -66.9 132.23 93.89 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.762 0.825 . . . . 0.0 111.654 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.27 -10.34 22.38 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.1 2.534 . . . . 0.0 114.348 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.81 85.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 123.994 0.807 . . . . 0.0 114.64 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -148.53 150.89 34.16 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.94 1.696 . . . . 0.0 111.046 -171.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -90.67 159.55 16.33 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.588 1.155 . . . . 0.0 111.005 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 49.87 39.27 17.96 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.163 1.385 . . . . 0.0 112.969 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.3 m -135.03 137.52 27.27 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.907 1.683 . . . . 0.0 110.401 -169.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -53.41 152.92 18.97 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.514 3.476 . . . . 0.0 114.752 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.3 t -102.68 150.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.777 1.231 . . . . 0.0 110.801 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -122.76 172.85 8.13 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.159 1.383 . . . . 0.0 111.215 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.36 139.92 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.938 1.295 . . . . 0.0 111.352 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.9 m -151.76 166.06 16.06 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.401 1.081 . . . . 0.0 112.962 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.14 162.73 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 124.03 3.154 . . . . 0.0 114.113 169.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.5 tp -126.97 143.24 51.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.137 1.375 . . . . 0.0 111.485 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -145.68 -30.38 0.41 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.037 1.335 . . . . 0.0 113.579 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.94 -9.63 1.8 Allowed Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.259 1.409 . . . . 0.0 114.156 -174.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.4 t -64.21 140.35 58.86 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.825 1.313 . . . . 0.0 112.108 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -61.56 -12.63 16.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.584 1.554 . . . . 0.0 114.286 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.19 -22.49 65.73 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.162 -0.961 . . . . 0.0 112.027 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -106.69 1.78 25.32 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.998 1.719 . . . . 0.0 113.296 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.67 147.75 25.64 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.143 0.973 . . . . 0.0 111.489 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -141.31 169.77 16.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.54 1.136 . . . . 0.0 111.776 -169.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.18 138.79 42.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 126.729 2.012 . . . . 0.0 108.011 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.7 tp -136.84 127.94 27.83 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.847 1.659 . . . . 0.0 109.459 -173.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -143.5 142.28 31.09 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.895 0.878 . . . . 0.0 111.374 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.6 t -66.65 142.15 57.55 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.099 0.56 . . . . 0.0 111.176 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -115.18 -52.6 2.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.291 1.036 . . . . 0.0 111.522 174.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.73 110.64 4.99 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.648 1.179 . . . . 0.0 111.306 171.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.7 m -58.43 -24.43 60.18 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.938 0.895 . . . . 0.0 111.447 168.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -64.1 -21.62 66.6 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.998 2.119 . . . . 0.0 113.421 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 m -130.29 10.89 5.37 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.9 1.68 . . . . 0.0 113.021 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 44.5 33.93 1.0 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.491 1.916 . . . . 0.0 113.794 -169.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.1 p -89.63 144.61 25.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.859 0.864 . . . . 0.0 112.055 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -140.2 142.18 35.89 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.539 1.535 . . . . 0.0 110.838 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.0 p -77.83 146.61 35.62 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.012 0.525 . . . . 0.0 110.506 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.6 mm -128.02 125.93 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.402 1.481 . . . . 0.0 109.094 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.2 m -142.46 143.41 26.64 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 124.556 1.142 . . . . 0.0 110.391 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.93 140.7 42.66 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.061 2.507 . . . . 0.0 110.682 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.35 -25.65 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.27 -13.93 59.53 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.45 1.024 . . . . 0.0 114.752 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.5 m -140.45 61.44 16.41 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.421 1.488 . . . . 0.0 111.517 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -61.58 -17.43 54.12 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.659 2.906 . . . . 0.0 113.295 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -71.68 8.66 1.07 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 128.105 2.562 . . . . 0.0 114.079 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.9 m -141.1 172.19 13.02 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.504 2.321 . . . . 0.0 111.32 172.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -137.27 171.65 14.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.081 2.152 . . . . 0.0 112.045 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.97 124.28 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.805 1.242 . . . . 0.0 110.36 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.48 -160.89 8.51 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.806 1.67 . . . . 0.0 111.891 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -139.92 140.01 36.31 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.65 1.18 . . . . 0.0 111.449 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.46 -166.82 12.4 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.2 1.381 . . . . 0.0 113.384 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.0 137.95 20.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.073 1.349 . . . . 0.0 113.143 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.79 -7.08 62.86 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.735 1.159 . . . . 0.0 114.06 -172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 48.49 57.66 6.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.384 1.874 . . . . 0.0 113.829 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.87 149.74 71.39 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 126.176 1.79 . . . . 0.0 108.461 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.07 144.4 57.55 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.595 1.53 . . . . 0.0 110.042 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.38 145.6 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.73 1.612 . . . . 0.0 111.859 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.0 t -74.22 122.83 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.149 0.979 . . . . 0.0 110.346 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 mp -132.4 163.09 52.97 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.802 2.041 . . . . 0.0 110.481 -169.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.31 165.41 32.65 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.75 2.3 . . . . 0.0 111.97 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.3 126.12 20.52 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.04 2.494 . . . . 0.0 112.026 170.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -149.63 -90.75 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.087 0.955 . . . . 0.0 110.184 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -156.27 16.82 0.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.832 1.653 . . . . 0.0 112.513 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -66.27 132.6 48.77 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.324 0.65 . . . . 0.0 111.839 -171.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.0 m -144.21 160.69 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.093 1.357 . . . . 0.0 111.827 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -131.5 136.5 47.94 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.29 1.436 . . . . 0.0 110.411 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 61.7 m -72.73 132.87 44.2 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.542 1.137 . . . . 0.0 109.195 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.5 mt -124.17 73.68 1.25 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.844 0.857 . . . . 0.0 109.419 -174.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.0 m -74.59 125.27 28.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.369 1.067 . . . . 0.0 110.698 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 tp -69.05 146.4 52.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.267 0.627 . . . . 0.0 111.168 171.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 p -126.92 175.72 7.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.609 1.564 . . . . 0.0 111.009 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.1 m -59.72 -11.62 5.48 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.0 24.3 0.33 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.898 1.237 . . . . 0.0 114.42 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.19 -149.03 11.25 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 118.298 1.049 . . . . 0.0 112.895 -173.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -133.81 169.73 16.64 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.22 2.208 . . . . 0.0 111.894 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -136.14 145.89 46.31 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.082 2.153 . . . . 0.0 109.451 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -125.7 122.87 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.401 1.08 . . . . 0.0 108.914 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -139.27 157.68 45.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.344 1.058 . . . . 0.0 112.737 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -60.33 -29.74 69.08 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.914 1.686 . . . . 0.0 115.284 -173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 128.91 -40.07 1.76 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.892 1.711 . . . . 0.0 113.237 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -79.9 -10.25 59.76 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.653 1.181 . . . . 0.0 113.927 173.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 68.52 12.8 8.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.848 2.059 . . . . 0.0 112.837 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.8 p -74.12 -25.06 59.56 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.159 1.384 . . . . 0.0 112.512 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.2 m -144.31 171.35 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.908 1.683 . . . . 0.0 111.915 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.6 t -144.85 154.15 42.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.864 2.466 . . . . 0.0 109.938 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -69.95 145.45 51.88 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.62 -0.675 . . . . 0.0 111.603 170.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.9 p -150.32 177.04 10.33 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.112 0.965 . . . . 0.0 112.329 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.15 166.86 18.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.493 1.917 . . . . 0.0 109.354 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -110.01 -32.17 7.12 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.875 0.87 . . . . 0.0 112.023 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -139.94 -10.13 1.16 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.677 1.991 . . . . 0.0 112.644 170.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.18 24.29 7.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.82 1.648 . . . . 0.0 114.302 -169.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.3 p -73.45 154.85 39.79 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.783 -1.198 . . . . 0.0 111.0 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.45 142.83 58.03 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.154 -0.967 . . . . 0.0 112.001 173.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.43 5.8 89.12 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.667 1.127 . . . . 0.0 114.297 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -75.4 137.69 41.19 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.783 1.291 . . . . 0.0 112.61 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -72.94 123.91 24.41 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.5 -0.75 . . . . 0.0 110.167 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.0 t -60.92 149.39 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.564 0.746 . . . . 0.0 110.623 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.4 p -125.06 166.44 16.37 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.817 1.247 . . . . 0.0 112.384 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 84.8 mt -135.03 142.04 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.151 1.381 . . . . 0.0 109.185 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.37 177.96 46.65 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.728 1.156 . . . . 0.0 111.73 174.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.38 -40.15 48.86 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 119.087 1.443 . . . . 0.0 114.212 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -168.97 174.45 6.36 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.661 2.784 . . . . 0.0 110.734 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.92 141.23 38.49 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.183 0.993 . . . . 0.0 111.627 169.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.0 t -62.86 -21.09 65.71 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -169.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -137.94 -35.21 0.64 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p -97.52 3.46 50.66 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 114.19 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.95 17.83 1.23 Allowed Glycine 0 CA--C 1.542 1.767 0 C-N-CA 125.805 1.669 . . . . 0.0 115.805 -176.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -140.07 146.37 38.85 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.238 1.815 . . . . 0.0 110.766 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -140.4 175.85 9.26 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.812 1.245 . . . . 0.0 112.184 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.1 p -140.85 138.87 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.856 1.262 . . . . 0.0 109.409 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.18 125.92 74.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 125.785 1.634 . . . . 0.0 107.144 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -149.13 154.2 38.86 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.866 1.266 . . . . 0.0 109.101 -171.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -67.86 155.43 39.39 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.86 -1.15 . . . . 0.0 112.663 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.7 t . . . . . 0 C--O 1.252 1.227 0 C-N-CA 126.127 1.771 . . . . 0.0 111.28 171.853 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.0 20.86 0.11 Allowed Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.754 1.169 . . . . 0.0 114.527 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -151.41 156.44 40.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.174 1.39 . . . . 0.0 111.895 -177.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -59.55 -17.0 28.9 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.344 1.858 . . . . 0.0 115.602 -174.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -111.63 2.66 17.41 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.882 1.273 . . . . 0.0 113.555 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -75.77 -12.42 60.18 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -134.68 -1.56 2.76 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.974 1.31 . . . . 0.0 113.642 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.0 m80 55.65 17.93 2.58 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.742 2.017 . . . . 0.0 116.097 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -125.7 13.4 8.03 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.8 1.64 . . . . 0.0 112.988 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -125.71 6.36 7.46 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.555 1.542 . . . . 0.0 113.049 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.7 p -133.66 -3.82 2.93 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.361 1.864 . . . . 0.0 113.672 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.51 172.92 40.04 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.843 1.687 . . . . 0.0 112.662 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -146.75 6.53 0.92 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.884 1.274 . . . . 0.0 113.337 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.0 m -147.48 162.21 32.97 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 125.92 1.688 . . . . 0.0 111.594 -172.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.13 158.25 5.33 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.969 3.112 . . . . 0.0 114.907 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.32 34.15 1.08 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -170.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 p -143.15 157.44 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 126.132 1.773 . . . . 0.0 111.25 -171.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.3 t -146.57 11.31 1.12 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -176.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.8 mt 60.05 166.85 0.07 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.198 2.199 . . . . 0.0 114.151 -174.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 m -151.44 159.41 44.22 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.296 1.839 . . . . 0.0 109.231 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.41 136.27 56.94 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.307 -0.871 . . . . 0.0 111.505 174.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.62 -164.77 37.55 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 114.788 0.675 . . . . 0.0 114.788 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -95.06 125.58 39.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.217 1.007 . . . . 0.0 110.213 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -134.62 172.26 13.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.694 1.598 . . . . 0.0 111.973 -172.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.2 pt -126.17 154.22 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.919 1.687 . . . . 0.0 108.535 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.9 mt -128.9 119.41 49.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -141.24 152.88 44.91 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.359 0.663 . . . . 0.0 111.655 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -88.43 133.32 34.15 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.029 -0.419 . . . . 0.0 111.289 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -62.52 -18.69 62.49 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t -61.6 -27.34 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.298 1.039 . . . . 0.0 112.509 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.4 mt 58.85 168.88 0.06 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.698 1.999 . . . . 0.0 113.496 -171.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.7 p -70.59 159.73 84.03 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 121.016 -1.053 . . . . 0.0 112.129 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.45 -16.85 48.46 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.898 2.399 . . . . 0.0 112.929 171.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -73.31 -18.22 61.22 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.424 1.49 . . . . 0.0 112.689 170.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.51 25.78 17.43 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.012 1.291 . . . . 0.0 113.512 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -127.22 169.31 13.62 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.095 1.358 . . . . 0.0 112.202 -175.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -58.33 144.04 42.84 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.594 1.158 . . . . 0.0 111.467 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.3 tp -125.06 73.2 1.28 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.876 1.27 . . . . 0.0 111.236 -169.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.25 149.62 28.93 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.503 1.521 . . . . 0.0 114.014 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.35 139.92 57.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.332 1.053 . . . . 0.0 109.598 169.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 m -132.34 123.41 26.76 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.216 1.006 . . . . 0.0 111.611 -174.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -60.18 129.65 88.74 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 126.4 1.88 . . . . 0.0 111.507 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.14 -3.86 14.19 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.736 2.957 . . . . 0.0 115.12 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.78 9.03 87.43 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 119.046 0.839 . . . . 0.0 114.702 -176.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -144.75 164.59 30.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.156 1.382 . . . . 0.0 112.476 -170.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -101.97 157.85 16.56 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.729 1.212 . . . . 0.0 109.841 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 49.27 33.72 5.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.022 1.329 . . . . 0.0 113.607 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.0 m -129.0 136.27 28.92 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 126.111 1.764 . . . . 0.0 110.083 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.6 149.18 19.11 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.771 3.647 . . . . 0.0 115.237 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.51 151.46 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.101 1.361 . . . . 0.0 110.819 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 m -122.14 175.78 6.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.22 1.408 . . . . 0.0 111.394 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.68 139.94 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.801 1.24 . . . . 0.0 111.516 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.0 m -152.68 166.43 15.4 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 124.249 1.02 . . . . 0.0 113.326 -171.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.7 161.32 6.15 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.652 2.901 . . . . 0.0 113.127 168.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.3 tp -121.84 138.44 54.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.461 1.104 . . . . 0.0 111.74 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -139.53 -37.18 0.5 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.744 2.018 . . . . 0.0 112.363 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.82 3.77 1.07 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.908 1.242 . . . . 0.0 115.334 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.7 t -63.44 153.84 34.04 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.476 1.638 . . . . 0.0 112.381 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.7 p -70.52 -11.16 60.75 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -75.16 -23.62 57.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.29 0.95 . . . . 0.0 112.209 175.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.72 3.55 11.66 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.33 2.652 . . . . 0.0 112.259 -170.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.46 148.88 32.18 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.337 1.455 . . . . 0.0 110.315 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -136.24 172.98 12.22 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.699 1.238 . . . . 0.0 112.537 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.1 mt -129.83 135.18 61.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 126.735 2.014 . . . . 0.0 106.709 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.5 tp -134.65 128.8 33.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.349 1.459 . . . . 0.0 109.472 -169.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -143.06 130.6 21.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.782 0.833 . . . . 0.0 110.383 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 t -64.02 138.49 58.48 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.485 0.584 . . . . 0.0 111.287 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -115.27 -51.86 2.69 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.32 1.048 . . . . 0.0 111.471 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.43 109.35 4.45 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.255 1.022 . . . . 0.0 111.127 170.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.9 m -58.03 -25.99 61.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.841 0.857 . . . . 0.0 111.141 168.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -62.79 -20.62 65.18 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.151 2.18 . . . . 0.0 113.598 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 t -130.42 9.98 5.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.684 1.593 . . . . 0.0 112.996 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 47.46 32.59 2.4 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.986 1.714 . . . . 0.0 114.087 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -90.24 140.72 29.41 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.857 -1.152 . . . . 0.0 112.362 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -138.32 145.09 40.78 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.865 1.666 . . . . 0.0 110.791 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.2 p -77.89 150.14 34.15 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.974 173.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 mm -124.54 127.75 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.374 1.47 . . . . 0.0 109.274 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.3 m -140.33 143.76 34.57 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.85 1.66 . . . . 0.0 110.22 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.87 147.24 30.57 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.121 2.548 . . . . 0.0 111.637 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.47 -29.89 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 121.122 -0.986 . . . . 0.0 111.882 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.75 -26.1 73.58 Favored Glycine 0 CA--C 1.538 1.506 0 O-C-N 121.705 -0.622 . . . . 0.0 114.448 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -145.64 64.95 10.91 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.508 1.523 . . . . 0.0 111.587 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.95 -13.65 36.35 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.505 2.803 . . . . 0.0 113.938 -174.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -73.7 10.04 1.24 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.926 2.09 . . . . 0.0 113.979 169.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.9 p -138.53 174.64 10.32 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.417 1.487 . . . . 0.0 112.389 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -142.11 168.25 20.2 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.942 1.297 . . . . 0.0 113.024 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -117.4 130.34 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.69 1.196 . . . . 0.0 110.849 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.35 -158.62 7.63 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.86 1.695 . . . . 0.0 111.69 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -142.25 141.95 32.55 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.452 1.101 . . . . 0.0 111.474 -173.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.39 -166.48 12.53 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.409 1.48 . . . . 0.0 113.184 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.45 138.15 22.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.016 1.326 . . . . 0.0 113.128 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.55 -6.56 63.06 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.731 1.158 . . . . 0.0 114.196 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 49.45 57.33 6.61 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.323 1.849 . . . . 0.0 113.976 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.7 149.34 71.73 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.327 1.851 . . . . 0.0 108.19 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.09 144.73 58.62 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.435 1.423 . . . . 0.0 109.712 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.35 150.01 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.782 1.633 . . . . 0.0 111.257 -176.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.83 136.28 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.262 0.625 . . . . 0.0 110.854 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.4 mt -134.63 158.3 75.39 Favored Pre-proline 0 C--O 1.239 0.549 0 C-N-CA 126.331 1.852 . . . . 0.0 111.65 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -60.59 164.89 12.42 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 122.649 2.233 . . . . 0.0 112.927 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.64 124.95 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.662 2.242 . . . . 0.0 110.665 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -147.99 -95.54 0.08 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.038 0.935 . . . . 0.0 110.354 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -155.24 21.06 0.42 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.163 1.785 . . . . 0.0 112.146 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -67.34 139.13 57.2 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.69 -0.631 . . . . 0.0 111.565 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.5 m -144.89 159.34 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.689 1.196 . . . . 0.0 112.047 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -128.76 148.67 50.87 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.528 1.531 . . . . 0.0 110.251 169.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 79.2 m -76.51 132.88 39.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.963 1.305 . . . . 0.0 109.209 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.41 115.98 22.51 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.391 1.077 . . . . 0.0 108.954 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 55.4 m -134.09 128.78 34.89 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.67 0.788 . . . . 0.0 110.968 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.8 mt -63.0 153.37 34.05 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 p -127.89 178.63 6.04 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.496 1.918 . . . . 0.0 110.057 170.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -61.56 -8.25 4.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.17 37.85 0.26 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.799 1.19 . . . . 0.0 113.578 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.57 -153.02 22.79 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.133 0.873 . . . . 0.0 113.231 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -132.26 169.25 16.73 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.718 2.407 . . . . 0.0 111.731 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -130.81 154.3 48.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.026 2.131 . . . . 0.0 110.295 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.4 mt -135.04 114.72 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.624 1.17 . . . . 0.0 109.176 -172.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -134.29 156.07 49.1 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.062 0.945 . . . . 0.0 112.312 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -61.63 -30.16 70.52 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -170.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.83 -40.5 1.6 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.855 1.693 . . . . 0.0 112.785 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -84.39 -5.64 59.3 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.966 1.307 . . . . 0.0 113.888 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 57.17 18.13 3.97 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.752 2.021 . . . . 0.0 113.415 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.5 p -72.07 -24.54 61.53 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.394 1.077 . . . . 0.0 112.259 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.3 m -143.75 173.92 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.943 1.697 . . . . 0.0 111.982 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 t -146.39 152.48 39.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.409 2.683 . . . . 0.0 109.979 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -70.57 144.78 51.13 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.385 -0.822 . . . . 0.0 111.8 170.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.6 p -152.88 174.76 13.69 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.067 1.347 . . . . 0.0 112.273 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -128.68 170.18 13.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.161 1.784 . . . . 0.0 110.199 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -109.03 -36.58 6.04 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.431 0.693 . . . . 0.0 111.864 -169.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -144.91 -0.15 0.92 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.091 1.756 . . . . 0.0 114.495 173.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.26 23.27 1.61 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.878 2.071 . . . . 0.0 116.122 -171.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.4 p -75.22 156.35 35.88 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.779 -1.201 . . . . 0.0 112.06 172.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.26 138.18 57.48 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.472 -0.767 . . . . 0.0 111.836 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.19 4.68 89.59 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.885 1.231 . . . . 0.0 114.422 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.6 146.96 30.95 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.198 1.499 . . . . 0.0 112.783 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -76.14 130.88 38.94 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.265 -0.897 . . . . 0.0 110.781 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.22 151.21 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.906 0.482 . . . . 0.0 110.453 173.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.8 m -129.9 164.45 24.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.464 1.506 . . . . 0.0 111.783 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.4 mt -133.56 143.27 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.305 1.442 . . . . 0.0 109.556 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.61 179.98 48.01 Favored Glycine 0 N--CA 1.471 0.976 0 C-N-CA 124.832 1.206 . . . . 0.0 111.745 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.79 -41.16 61.48 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 119.155 1.477 . . . . 0.0 114.27 -173.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -169.11 170.33 8.84 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.004 2.522 . . . . 0.0 109.906 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.42 130.61 23.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.155 0.982 . . . . 0.0 112.446 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.1 t -56.59 -28.75 61.04 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -122.36 -26.72 4.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.437 1.095 . . . . 0.0 113.856 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 72.9 p -116.48 0.02 12.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.757 1.223 . . . . 0.0 114.1 -171.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.14 33.88 0.65 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.619 2.057 . . . . 0.0 114.827 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 145.99 22.51 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.279 2.232 . . . . 0.0 110.597 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -143.3 175.72 9.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.422 1.489 . . . . 0.0 111.556 -168.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.4 p -139.44 138.9 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.488 1.115 . . . . 0.0 109.643 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.76 125.02 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 C-N-CA 125.984 1.714 . . . . 0.0 107.11 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -149.13 155.07 40.13 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.644 1.178 . . . . 0.0 109.08 -170.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -68.65 155.79 39.39 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.022 -1.049 . . . . 0.0 112.549 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.9 t . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.086 1.754 . . . . 0.0 111.301 171.856 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.83 3.69 0.97 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.262 0.934 . . . . 0.0 115.43 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -137.59 5.72 2.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.728 1.211 . . . . 0.0 114.034 -169.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -133.91 1.94 3.35 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.45 13.11 3.8 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.458 1.503 . . . . 0.0 113.443 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -132.88 20.28 4.15 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.902 1.681 . . . . 0.0 112.477 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -56.01 -18.9 10.64 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.618 1.567 . . . . 0.0 114.557 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -64.5 -24.75 67.72 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.553 1.541 . . . . 0.0 114.15 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -141.44 -8.61 0.98 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -138.59 172.58 12.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.908 1.683 . . . . 0.0 110.985 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.0 m 49.61 29.43 3.04 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.714 1.606 . . . . 0.0 114.811 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.69 -22.57 0.09 OUTLIER Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.566 1.079 . . . . 0.0 114.881 -171.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -128.39 0.24 5.66 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.975 1.31 . . . . 0.0 113.537 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.4 p -69.25 160.2 79.92 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.829 1.652 . . . . 0.0 112.907 172.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.4 144.88 38.61 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.952 3.101 . . . . 0.0 114.539 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.76 31.01 1.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.329 1.451 . . . . 0.0 112.249 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.19 151.22 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.938 1.295 . . . . 0.0 110.702 175.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -145.38 8.64 1.19 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt 62.03 161.13 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.508 2.323 . . . . 0.0 113.918 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.2 m -152.5 165.33 35.44 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.366 1.867 . . . . 0.0 109.228 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.78 130.59 44.08 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 121.5 -0.75 . . . . 0.0 110.958 169.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.06 -165.31 38.66 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 114.721 0.648 . . . . 0.0 114.721 -175.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -95.64 122.99 38.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.168 0.987 . . . . 0.0 110.304 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -133.98 174.74 10.15 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.246 1.418 . . . . 0.0 112.424 -172.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.0 pt -131.08 155.98 42.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 126.246 1.818 . . . . 0.0 108.936 171.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 mt -127.49 127.72 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -142.47 147.88 36.81 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.762 0.825 . . . . 0.0 111.564 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -78.06 133.44 37.91 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.92 -0.487 . . . . 0.0 111.043 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -60.91 -25.51 66.8 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.4 t -63.93 -36.42 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.827 0.851 . . . . 0.0 112.36 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mp 56.87 172.44 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.079 1.752 . . . . 0.0 115.308 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.3 t -87.61 139.2 31.47 Favored Pre-proline 0 N--CA 1.469 0.505 0 O-C-N 121.133 -0.979 . . . . 0.0 112.163 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.33 -15.98 12.51 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.993 3.129 . . . . 0.0 114.598 168.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.0 tpt85 -64.34 -19.16 65.27 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.14 1.776 . . . . 0.0 113.173 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.65 27.69 23.82 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.409 1.48 . . . . 0.0 113.709 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -140.06 152.56 46.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.897 1.279 . . . . 0.0 112.043 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -64.55 146.64 54.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.927 1.691 . . . . 0.0 113.363 -171.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.1 mt -115.48 75.79 0.96 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.144 1.778 . . . . 0.0 111.447 -175.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.81 150.25 29.25 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.4 tp -58.6 134.39 56.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.304 1.442 . . . . 0.0 109.529 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 m -127.07 125.28 41.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.741 1.216 . . . . 0.0 111.192 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.4 ' CE1' ' HG3' ' A' ' 79' ' ' PRO . 38.3 t80 -66.19 138.63 96.12 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.842 1.257 . . . . 0.0 112.094 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -76.56 -15.16 17.57 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.132 2.555 . . . . 0.0 114.911 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.31 3.72 69.23 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.535 1.064 . . . . 0.0 115.012 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -155.31 179.91 8.71 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.681 1.993 . . . . 0.0 110.756 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -110.42 170.64 7.95 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.939 1.295 . . . . 0.0 111.158 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 50.63 40.75 24.6 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.411 1.884 . . . . 0.0 112.83 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 m -140.87 141.59 24.95 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 126.14 1.776 . . . . 0.0 110.344 -169.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -52.95 163.31 2.13 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 125.293 3.995 . . . . 0.0 115.981 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.9 t -115.01 149.68 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.127 1.371 . . . . 0.0 110.857 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 m -127.8 176.0 7.9 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.301 1.441 . . . . 0.0 111.261 -168.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.7 m -123.43 156.29 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.965 -1.084 . . . . 0.0 112.045 170.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.3 m -153.0 167.05 14.15 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 124.946 1.298 . . . . 0.0 112.375 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.05 118.53 5.44 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.682 2.921 . . . . 0.0 111.671 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.63 134.76 52.96 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.789 -0.569 . . . . 0.0 111.842 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -138.61 3.42 2.29 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.566 1.546 . . . . 0.0 113.712 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.5 0.67 86.28 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.943 1.258 . . . . 0.0 115.033 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.7 t -63.29 147.41 51.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.402 1.601 . . . . 0.0 112.401 175.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.7 m -59.53 -13.51 9.35 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.325 1.45 . . . . 0.0 114.405 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.03 -26.16 63.91 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.162 0.892 . . . . 0.0 112.371 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -118.63 0.89 11.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.906 1.682 . . . . 0.0 114.45 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.16 145.48 27.96 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.617 1.167 . . . . 0.0 110.55 171.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -136.05 169.96 16.78 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 123.015 1.388 . . . . 0.0 112.546 -168.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.1 mt -117.54 137.15 52.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 128.578 2.751 . . . . 0.0 107.3 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.2 tp -134.65 128.99 34.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.573 1.549 . . . . 0.0 109.211 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -142.65 138.17 30.47 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.469 1.108 . . . . 0.0 110.732 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.8 t -67.81 141.26 56.55 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.947 0.499 . . . . 0.0 110.552 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -108.8 -51.25 2.91 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.623 1.169 . . . . 0.0 110.715 174.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.21 109.87 4.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.142 1.377 . . . . 0.0 110.595 169.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.9 m -56.96 -24.38 52.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.945 0.898 . . . . 0.0 111.745 168.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -65.21 -20.93 66.67 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.096 2.158 . . . . 0.0 113.589 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -130.8 14.59 5.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.838 1.655 . . . . 0.0 112.844 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 43.36 33.77 0.65 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.571 1.948 . . . . 0.0 114.113 -169.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -85.9 145.56 27.11 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.893 -1.129 . . . . 0.0 112.037 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -141.52 148.97 40.25 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.149 1.38 . . . . 0.0 111.58 -177.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.3 p -91.34 145.78 24.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.25 1.02 . . . . 0.0 110.641 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.8 mm -127.91 115.76 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.768 2.027 . . . . 0.0 110.257 -172.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.4 m -134.62 146.15 57.89 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 123.882 0.873 . . . . 0.0 110.712 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.4 ' HG3' ' CE1' ' A' ' 42' ' ' TYR . 62.2 Cg_endo -70.8 146.59 54.17 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.729 2.286 . . . . 0.0 109.92 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.31 -22.06 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.82 -11.13 54.27 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.554 1.073 . . . . 0.0 115.241 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.5 m -144.22 62.0 9.68 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.954 1.302 . . . . 0.0 111.795 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.49 -17.1 46.15 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.109 3.206 . . . . 0.0 113.846 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -71.65 19.02 0.07 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 128.653 2.781 . . . . 0.0 114.497 169.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.6 p -142.31 164.96 28.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.044 1.738 . . . . 0.0 112.226 171.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -143.83 140.37 29.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.568 1.547 . . . . 0.0 111.09 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.4 mm -85.04 132.25 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.79 -0.569 . . . . 0.0 111.086 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.1 -165.11 10.77 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.889 2.185 . . . . 0.0 112.021 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -144.04 141.62 30.2 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.387 1.075 . . . . 0.0 111.674 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.26 -163.55 11.05 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.319 1.438 . . . . 0.0 113.31 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.64 140.41 18.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.987 1.315 . . . . 0.0 113.207 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.93 -7.85 70.21 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.572 1.082 . . . . 0.0 114.012 -172.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 48.22 58.05 5.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.334 1.854 . . . . 0.0 113.853 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.2 m -133.25 149.25 72.03 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 126.272 1.829 . . . . 0.0 107.458 169.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.47 145.29 58.37 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.298 1.142 . . . . 0.0 109.395 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.06 172.06 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.581 1.952 . . . . 0.0 109.797 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -119.51 136.25 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.323 -0.861 . . . . 0.0 111.215 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -140.87 165.15 31.52 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 127.27 2.228 . . . . 0.0 110.474 -169.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -77.3 155.41 32.67 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.497 2.131 . . . . 0.0 111.643 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.39 124.85 12.61 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.194 3.263 . . . . 0.0 113.537 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -149.49 -88.85 0.08 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.616 1.166 . . . . 0.0 110.428 -176.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -154.89 8.84 0.31 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.23 1.412 . . . . 0.0 114.218 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.02 139.82 54.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.384 -0.822 . . . . 0.0 110.845 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.3 m -148.93 164.26 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.112 1.365 . . . . 0.0 111.417 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -129.47 131.36 46.67 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.121 1.369 . . . . 0.0 110.536 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.8 m -75.93 130.57 38.68 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.275 1.03 . . . . 0.0 109.559 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.7 mt -117.38 129.58 55.95 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.569 1.147 . . . . 0.0 109.447 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 m -137.02 129.29 29.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.093 0.957 . . . . 0.0 110.228 -170.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.2 mt -65.68 153.62 41.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.697 0.76 . . . . 0.0 113.025 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.1 p -127.78 -179.22 4.83 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.024 1.73 . . . . 0.0 110.274 170.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 75.7 p -60.89 -12.81 12.26 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.0 29.45 0.29 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.422 1.011 . . . . 0.0 114.658 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 176.95 -153.06 13.01 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 118.386 1.093 . . . . 0.0 113.25 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -131.58 169.74 15.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.108 2.163 . . . . 0.0 112.266 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -136.49 149.72 48.31 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.424 2.289 . . . . 0.0 109.462 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.9 mt -132.58 115.61 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.678 1.191 . . . . 0.0 109.106 -170.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -135.91 149.89 49.12 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.513 1.125 . . . . 0.0 111.649 -169.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -55.11 -34.12 63.43 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.082 0.953 . . . . 0.0 113.129 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.49 -29.83 2.85 Favored Glycine 0 N--CA 1.47 0.965 0 C-N-CA 125.856 1.693 . . . . 0.0 113.916 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -79.61 -6.02 56.23 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 60.59 12.92 3.88 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.474 2.31 . . . . 0.0 114.048 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.3 p -65.75 -28.19 68.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.837 2.055 . . . . 0.0 112.761 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.0 m -144.89 171.06 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.014 1.725 . . . . 0.0 112.135 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.2 t -146.15 156.02 43.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.413 2.685 . . . . 0.0 110.032 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -72.23 145.25 48.09 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.49 -0.756 . . . . 0.0 111.866 171.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.7 p -154.41 177.18 11.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.056 1.342 . . . . 0.0 112.232 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -118.96 169.52 9.82 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.644 1.578 . . . . 0.0 110.211 173.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -95.26 -33.32 12.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.354 0.662 . . . . 0.0 111.979 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -144.8 0.52 0.97 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.479 1.912 . . . . 0.0 114.42 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.08 26.54 3.88 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.864 2.066 . . . . 0.0 116.038 -172.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.5 p -82.6 160.16 22.57 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 120.965 -1.084 . . . . 0.0 112.246 172.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.14 141.46 58.76 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.303 -0.873 . . . . 0.0 111.93 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.28 1.19 89.52 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.178 0.894 . . . . 0.0 114.817 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -83.35 149.69 26.57 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.99 1.395 . . . . 0.0 113.45 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -74.87 136.76 41.5 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.312 -0.867 . . . . 0.0 111.056 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.0 t -70.34 154.54 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.106 0.479 . . . . 0.0 110.568 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -131.58 164.92 24.79 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.342 1.857 . . . . 0.0 111.343 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.6 mt -136.8 140.27 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.572 1.549 . . . . 0.0 109.638 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.99 177.96 47.14 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 125.056 1.312 . . . . 0.0 111.44 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.09 36.48 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.315 1.557 . . . . 0.0 114.553 -171.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -170.28 171.25 6.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.561 2.744 . . . . 0.0 108.968 176.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.0 127.21 21.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.766 0.826 . . . . 0.0 111.176 170.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.9 t -60.67 -14.17 19.15 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.258 1.823 . . . . 0.0 115.682 -170.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -128.65 -38.85 1.68 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.356 1.063 . . . . 0.0 113.185 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.3 p -111.96 2.99 17.19 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -171.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.37 13.83 0.53 Allowed Glycine 0 CA--C 1.539 1.537 0 N-CA-C 116.327 1.291 . . . . 0.0 116.327 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -134.68 147.84 50.2 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.255 2.027 . . . . 0.0 111.074 -172.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -139.8 176.01 9.1 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.491 1.516 . . . . 0.0 112.371 -168.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.3 t -135.82 139.14 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.101 1.36 . . . . 0.0 109.099 170.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.7 125.7 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 169.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.19 154.67 39.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.477 1.111 . . . . 0.0 109.56 -171.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -68.11 155.79 38.82 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.043 -1.036 . . . . 0.0 112.606 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.6 t . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.131 1.772 . . . . 0.0 111.31 171.584 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 110.784 -0.08 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.73 13.67 0.14 Allowed Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.372 0.909 . . . . 0.0 115.372 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.437 ' CG ' ' H ' ' A' ' 4' ' ' HIS . 21.0 t-80 -156.7 -175.31 5.36 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.187 1.795 . . . . 0.0 110.482 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.437 ' H ' ' CG ' ' A' ' 3' ' ' HIS . 94.2 m-70 -122.88 -1.56 8.86 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.699 1.6 . . . . 0.0 113.668 -174.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -140.77 168.49 19.67 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.321 1.849 . . . . 0.0 111.452 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -151.54 170.63 19.18 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.816 1.247 . . . . 0.0 111.34 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -142.43 -3.69 1.03 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.243 1.417 . . . . 0.0 114.643 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -134.98 -8.86 2.34 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.155 1.382 . . . . 0.0 113.809 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -130.06 -2.67 4.56 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.586 1.554 . . . . 0.0 113.766 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -149.83 163.03 39.12 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.419 1.487 . . . . 0.0 111.318 177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -144.56 144.28 31.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.613 1.565 . . . . 0.0 111.841 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.02 10.11 0.08 OUTLIER Glycine 0 CA--C 1.539 1.544 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -137.29 15.06 3.0 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.43 1.492 . . . . 0.0 112.302 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.501 ' H ' ' CD ' ' A' ' 15' ' ' PRO . 77.5 p -146.75 -23.48 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.606 1.962 . . . . 0.0 116.214 -174.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.501 ' CD ' ' H ' ' A' ' 14' ' ' SER . 87.7 Cg_exo -53.79 143.86 57.15 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 122.579 2.186 . . . . 0.0 113.836 169.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.59 15.52 1.61 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 t -146.75 147.46 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.427 1.891 . . . . 0.0 110.156 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.1 t -143.19 11.33 1.75 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.605 1.562 . . . . 0.0 113.303 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.7 mt 58.35 170.58 0.06 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.245 2.218 . . . . 0.0 113.917 -173.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.0 m -161.56 162.05 30.05 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.704 2.002 . . . . 0.0 109.222 177.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.15 137.11 58.13 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.544 -0.722 . . . . 0.0 111.923 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.79 -160.11 32.89 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 123.901 0.762 . . . . 0.0 114.937 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -98.48 122.62 41.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.919 1.288 . . . . 0.0 110.616 173.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -134.65 172.71 12.56 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.773 1.229 . . . . 0.0 112.698 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.44 154.25 38.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 126.458 1.903 . . . . 0.0 108.57 170.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.3 mt -124.97 126.91 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -141.26 150.38 42.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.05 0.54 . . . . 0.0 112.156 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -77.07 134.98 38.61 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.589 -0.694 . . . . 0.0 111.298 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -61.48 -28.32 69.21 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.41 -32.19 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.379 0.672 . . . . 0.0 112.042 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.5 mt 55.3 171.39 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.453 1.901 . . . . 0.0 114.208 -169.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.6 t -65.18 147.31 98.65 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 121.133 -0.979 . . . . 0.0 111.18 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.13 -22.05 18.32 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.319 2.679 . . . . 0.0 114.14 169.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -84.04 -14.32 50.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.846 1.258 . . . . 0.0 113.733 175.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.2 2.18 62.34 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.98 1.752 . . . . 0.0 114.289 -174.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -75.03 159.74 31.37 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.597 1.159 . . . . 0.0 112.203 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -61.97 156.03 22.16 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.805 0.842 . . . . 0.0 112.191 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.5 mt -130.65 66.84 1.51 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.48 1.512 . . . . 0.0 111.134 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.76 141.66 36.1 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.601 1.16 . . . . 0.0 112.857 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.57 128.21 36.02 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.039 0.936 . . . . 0.0 108.789 169.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.0 m -128.37 115.0 17.56 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.055 0.942 . . . . 0.0 110.801 -170.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -59.89 135.19 90.03 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 126.934 2.094 . . . . 0.0 112.086 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.89 -11.45 19.89 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.289 2.659 . . . . 0.0 114.602 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.63 8.83 82.37 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-O 119.079 -0.845 . . . . 0.0 115.119 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -156.72 165.34 36.51 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.303 1.441 . . . . 0.0 112.134 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -87.74 166.6 14.52 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.436 1.095 . . . . 0.0 111.768 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 49.85 36.91 12.26 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.83 1.652 . . . . 0.0 113.839 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.8 m -135.97 138.55 27.97 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 126.228 1.811 . . . . 0.0 110.206 -169.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.3 160.57 4.63 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.94 3.76 . . . . 0.0 115.81 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.5 t -111.56 148.71 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.904 1.281 . . . . 0.0 110.724 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 m -123.36 167.24 14.06 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.256 1.422 . . . . 0.0 110.774 -169.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 p -121.48 138.25 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.167 0.987 . . . . 0.0 111.212 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.5 m -156.51 168.17 12.94 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 124.355 1.062 . . . . 0.0 112.882 -169.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.14 152.59 10.59 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.648 2.899 . . . . 0.0 114.286 169.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.4 tp -105.6 137.2 43.83 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.459 1.504 . . . . 0.0 110.45 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -135.23 -24.24 1.43 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.075 1.35 . . . . 0.0 112.751 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.18 5.83 9.35 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.199 1.381 . . . . 0.0 113.759 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 m -61.85 150.48 37.2 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.485 1.142 . . . . 0.0 111.532 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.2 p -61.8 -15.05 38.4 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -72.86 -24.01 60.82 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.355 1.062 . . . . 0.0 112.412 171.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -104.88 -9.33 18.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.519 1.927 . . . . 0.0 112.621 -174.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.62 142.0 34.5 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.596 1.158 . . . . 0.0 111.328 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -135.73 171.34 14.6 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.944 1.355 . . . . 0.0 112.111 -169.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.1 mt -126.17 136.45 60.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.024 2.13 . . . . 0.0 106.747 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.7 tp -136.84 126.53 25.46 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.948 1.299 . . . . 0.0 109.446 -169.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.2 mtp-105 -141.46 140.84 33.65 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.753 0.821 . . . . 0.0 111.121 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.0 t -65.24 141.56 58.59 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.908 0.483 . . . . 0.0 110.929 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -115.12 -51.27 2.72 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.434 1.094 . . . . 0.0 111.093 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.23 109.25 4.45 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.379 1.071 . . . . 0.0 110.996 169.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.2 m -59.18 -26.47 64.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.801 0.84 . . . . 0.0 111.166 168.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -60.99 -20.94 63.05 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.012 2.125 . . . . 0.0 113.398 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -130.26 6.32 4.91 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.308 1.843 . . . . 0.0 113.237 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 47.37 30.44 1.55 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.142 2.177 . . . . 0.0 114.281 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.0 p -90.6 143.58 26.6 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.25 -0.907 . . . . 0.0 112.367 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -139.31 141.64 37.71 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.683 1.593 . . . . 0.0 111.104 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.5 p -77.87 147.71 34.98 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.711 -0.618 . . . . 0.0 111.06 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.0 mm -129.26 127.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.421 1.488 . . . . 0.0 109.71 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.0 m -142.84 142.38 22.25 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.197 1.399 . . . . 0.0 110.355 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.1 145.39 31.05 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.217 2.611 . . . . 0.0 111.314 176.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.53 -28.22 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.311 -0.868 . . . . 0.0 111.769 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.55 -24.96 76.17 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 114.868 0.707 . . . . 0.0 114.868 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.9 m -148.17 65.51 8.83 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 125.429 1.492 . . . . 0.0 111.614 -176.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -64.13 -17.9 61.47 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.843 3.028 . . . . 0.0 113.669 -173.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -69.96 -2.62 13.04 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 127.688 2.395 . . . . 0.0 114.636 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.2 m -132.8 174.72 10.02 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.372 1.869 . . . . 0.0 111.686 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -141.27 172.66 12.37 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.371 1.469 . . . . 0.0 113.164 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -115.99 127.25 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.903 1.281 . . . . 0.0 110.413 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.56 -157.48 7.18 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.489 1.519 . . . . 0.0 111.35 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -141.99 142.24 32.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.135 0.974 . . . . 0.0 111.665 -171.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.94 -165.25 12.1 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.361 1.458 . . . . 0.0 113.466 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.59 135.15 23.44 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.265 1.426 . . . . 0.0 113.049 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.23 -8.64 59.08 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.969 1.271 . . . . 0.0 114.012 -172.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 49.29 56.16 8.23 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.485 1.914 . . . . 0.0 113.949 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.9 m -133.89 150.43 74.5 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 126.266 1.826 . . . . 0.0 108.065 169.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.01 142.71 52.02 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.225 1.283 . . . . 0.0 109.721 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.05 151.5 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.815 1.646 . . . . 0.0 111.536 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.14 132.18 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.074 0.95 . . . . 0.0 111.044 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.34 161.45 57.2 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.833 1.653 . . . . 0.0 112.193 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -65.04 174.06 5.26 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 123.277 2.652 . . . . 0.0 113.31 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.67 104.15 1.68 Allowed 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.779 2.319 . . . . 0.0 111.01 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -143.46 13.51 1.77 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.657 1.183 . . . . 0.0 113.356 -177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 70.37 40.88 1.07 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.913 2.485 . . . . 0.0 113.773 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -61.97 143.46 56.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.089 0.556 . . . . 0.0 110.887 169.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.92 156.55 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.206 1.002 . . . . 0.0 112.253 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -129.8 137.06 50.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.496 1.518 . . . . 0.0 110.448 172.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.9 m -71.0 134.23 46.98 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.698 1.199 . . . . 0.0 108.895 169.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.7 mt -126.24 73.93 1.41 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.878 0.871 . . . . 0.0 109.966 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.3 m -78.93 129.12 34.16 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.269 1.028 . . . . 0.0 111.116 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.7 tp -71.2 145.83 49.44 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.455 0.702 . . . . 0.0 111.226 171.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 p -124.55 -177.17 3.72 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.741 1.616 . . . . 0.0 111.719 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.2 p -59.04 -13.44 6.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.22 25.96 0.18 Allowed Glycine 0 CA--C 1.533 1.197 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 178.55 -149.25 8.87 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.023 1.296 . . . . 0.0 112.127 -173.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -131.77 168.44 17.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.286 1.834 . . . . 0.0 112.024 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -134.15 142.43 47.46 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.393 2.277 . . . . 0.0 109.515 174.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.1 mt -124.37 121.78 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.419 1.088 . . . . 0.0 109.231 -171.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -138.17 158.04 45.09 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.194 1.398 . . . . 0.0 112.68 -171.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -59.8 -18.18 41.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 125.23 -35.71 3.01 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.916 1.722 . . . . 0.0 112.623 -169.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -110.17 4.18 20.82 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.503 1.921 . . . . 0.0 113.557 -170.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? 57.39 21.6 7.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.858 2.063 . . . . 0.0 113.781 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.1 p -77.62 -30.58 52.35 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.391 -0.818 . . . . 0.0 112.02 175.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.1 m -148.07 155.81 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.667 1.587 . . . . 0.0 111.959 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.1 t -130.5 153.37 48.89 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.577 1.951 . . . . 0.0 111.248 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.3 m0 -69.88 139.57 53.05 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.289 0.635 . . . . 0.0 111.812 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 88.1 p -147.76 175.06 11.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.929 1.292 . . . . 0.0 111.909 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.43 151.33 46.35 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.53 1.532 . . . . 0.0 109.898 173.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -82.59 -33.56 27.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.179 0.992 . . . . 0.0 111.704 -169.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -138.93 -6.21 1.45 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.674 1.99 . . . . 0.0 112.634 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.79 32.36 14.78 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.852 1.661 . . . . 0.0 114.243 -170.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.3 p -81.58 156.63 25.1 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.26 1.024 . . . . 0.0 111.509 170.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.84 139.59 57.77 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.252 -0.905 . . . . 0.0 111.674 172.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.67 86.0 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.125 1.345 . . . . 0.0 114.718 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -79.64 144.65 33.57 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.929 1.292 . . . . 0.0 113.25 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -75.7 128.44 35.21 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.854 -1.154 . . . . 0.0 110.655 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.95 148.53 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.182 0.593 . . . . 0.0 110.799 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.7 t -126.07 160.83 29.04 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.812 1.245 . . . . 0.0 111.779 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.8 mt -134.22 140.86 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.823 1.649 . . . . 0.0 109.292 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 169.43 -159.73 32.69 Favored Glycine 0 N--CA 1.468 0.815 0 C-N-CA 123.776 0.703 . . . . 0.0 112.61 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.96 149.68 18.32 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 117.62 0.71 . . . . 0.0 111.764 169.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -52.63 119.09 4.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.482 1.513 . . . . 0.0 113.428 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.23 164.12 26.3 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.848 1.259 . . . . 0.0 114.174 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 t -93.65 -9.44 37.9 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.785 1.234 . . . . 0.0 114.229 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -142.11 -44.93 0.34 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.483 1.113 . . . . 0.0 113.028 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.8 p -91.61 1.93 56.81 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.6 5.09 6.07 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 126.414 1.959 . . . . 0.0 116.281 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -126.48 150.84 48.48 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.408 1.483 . . . . 0.0 112.252 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -142.16 175.98 9.33 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 127.389 2.276 . . . . 0.0 110.104 -169.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.65 139.7 28.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 124.354 1.062 . . . . 0.0 109.529 169.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -118.22 124.82 73.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 125.694 1.598 . . . . 0.0 107.15 174.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -147.74 153.44 39.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.644 1.178 . . . . 0.0 109.433 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.97 155.91 39.51 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.998 -1.064 . . . . 0.0 112.945 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 C--O 1.251 1.175 0 C-N-CA 126.221 1.808 . . . . 0.0 111.284 171.877 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.423 0.154 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.16 22.14 0.3 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.301 0.953 . . . . 0.0 114.527 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -154.91 171.66 19.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.262 1.825 . . . . 0.0 111.306 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -139.14 0.53 1.94 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.876 1.27 . . . . 0.0 113.272 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -152.52 167.67 28.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.905 1.682 . . . . 0.0 111.43 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -149.24 154.61 39.33 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.121 1.368 . . . . 0.0 110.882 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -148.79 151.37 34.67 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.906 1.283 . . . . 0.0 111.168 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -154.45 164.63 38.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.709 1.603 . . . . 0.0 111.142 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -150.01 148.15 28.7 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.31 1.044 . . . . 0.0 111.51 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -156.3 -33.6 0.09 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.461 1.504 . . . . 0.0 112.128 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.9 p -150.17 173.9 13.4 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.337 1.855 . . . . 0.0 111.578 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.87 -21.82 0.03 OUTLIER Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.048 0.832 . . . . 0.0 114.773 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -139.34 162.43 35.03 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.066 1.747 . . . . 0.0 110.905 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.0 p -152.43 160.62 31.01 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 125.409 1.484 . . . . 0.0 111.544 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.43 148.27 34.49 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.52 2.813 . . . . 0.0 114.164 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.01 31.64 1.13 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.884 1.273 . . . . 0.0 112.651 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.19 143.21 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.547 1.539 . . . . 0.0 110.622 -172.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.7 p -129.26 1.87 5.15 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.064 1.746 . . . . 0.0 112.969 -171.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt 68.24 160.62 0.18 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 129.294 3.037 . . . . 0.0 113.165 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.1 m -151.45 159.53 44.15 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.668 1.987 . . . . 0.0 108.955 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.84 131.14 48.83 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.489 -0.757 . . . . 0.0 111.858 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.1 -163.11 36.86 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -100.56 126.93 47.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.128 0.971 . . . . 0.0 110.345 174.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.05 172.3 13.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.238 1.415 . . . . 0.0 112.292 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 pt -126.96 152.14 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.111 1.764 . . . . 0.0 108.518 172.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.1 mt -131.04 115.89 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -140.49 151.48 44.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.702 0.763 . . . . 0.0 112.408 -177.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -81.45 136.72 35.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.436 -173.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.8 mtp-105 -65.13 -18.22 65.12 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.9 t -66.23 -22.64 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.135 0.974 . . . . 0.0 112.375 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.4 mt 59.82 172.95 0.08 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.656 1.982 . . . . 0.0 113.718 -172.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.6 p -67.19 162.86 51.0 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.506 1.122 . . . . 0.0 112.024 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -68.23 -4.55 12.93 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 122.827 2.351 . . . . 0.0 112.961 170.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -100.76 -8.72 22.46 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.858 2.063 . . . . 0.0 113.32 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.4 24.42 28.81 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.489 1.042 . . . . 0.0 113.987 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.52 170.37 12.09 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.816 1.247 . . . . 0.0 111.836 -176.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -56.77 144.16 33.92 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.015 -1.053 . . . . 0.0 111.557 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.7 tp -125.11 72.98 1.26 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.328 1.451 . . . . 0.0 109.887 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.31 151.42 24.77 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.676 -1.147 . . . . 0.0 113.718 -170.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.59 134.05 55.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.852 0.861 . . . . 0.0 108.897 168.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 85.6 m -134.54 126.05 28.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.864 0.865 . . . . 0.0 111.123 -170.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -60.49 130.3 89.93 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.518 1.927 . . . . 0.0 111.948 -176.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.32 -10.41 19.1 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.442 2.761 . . . . 0.0 114.465 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.53 -2.32 58.91 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.318 0.961 . . . . 0.0 115.152 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -160.28 171.22 19.54 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.082 1.353 . . . . 0.0 112.94 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -96.51 169.14 10.1 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.403 1.881 . . . . 0.0 111.121 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 mmt-85 52.13 32.51 10.61 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.113 1.765 . . . . 0.0 114.022 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.1 m -137.11 138.13 24.69 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.301 1.441 . . . . 0.0 110.731 -169.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.7 155.38 10.59 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.567 3.512 . . . . 0.0 114.847 172.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 t -105.03 153.81 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.867 1.267 . . . . 0.0 110.542 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 m -125.42 171.06 10.77 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.197 1.399 . . . . 0.0 110.186 -170.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.64 141.66 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.911 -1.118 . . . . 0.0 112.047 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.1 m -153.12 166.16 16.1 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.052 0.941 . . . . 0.0 112.327 -171.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.86 164.79 2.2 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.648 2.898 . . . . 0.0 113.564 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tt -127.59 141.8 51.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.729 1.211 . . . . 0.0 111.785 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -143.36 -13.6 0.69 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.43 -8.35 8.94 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.096 1.332 . . . . 0.0 114.347 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -63.44 157.86 22.21 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.895 1.348 . . . . 0.0 113.302 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 p -64.22 -11.91 35.64 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -66.53 -36.32 82.4 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.207 1.003 . . . . 0.0 112.161 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.81 6.4 11.49 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.58 147.27 24.04 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.793 0.806 . . . . 0.0 111.652 172.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -138.61 172.09 13.4 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.661 1.22 . . . . 0.0 112.306 -169.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.2 mt -120.77 135.47 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.498 2.319 . . . . 0.0 107.066 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.28 122.3 19.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.123 1.369 . . . . 0.0 109.544 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -140.92 137.98 33.52 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.309 0.644 . . . . 0.0 111.633 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.5 t -64.46 138.94 58.69 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.124 0.569 . . . . 0.0 111.151 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -115.17 -51.29 2.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.557 1.143 . . . . 0.0 111.339 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.52 109.96 4.81 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.583 1.153 . . . . 0.0 111.625 170.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.1 m -58.98 -23.72 62.02 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.025 0.93 . . . . 0.0 111.468 168.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.07 -21.69 66.62 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.075 2.15 . . . . 0.0 113.341 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -130.4 7.8 4.97 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.956 1.703 . . . . 0.0 113.002 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 46.56 34.87 2.6 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.667 1.987 . . . . 0.0 113.47 -168.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.6 p -92.34 142.76 27.1 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.531 -0.731 . . . . 0.0 112.275 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -138.73 144.15 39.37 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.86 1.664 . . . . 0.0 110.478 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.0 p -77.96 150.1 34.03 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.56 0.744 . . . . 0.0 111.018 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.8 mm -128.73 126.87 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 0.0 109.479 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 m -144.92 145.93 29.35 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.701 1.601 . . . . 0.0 110.51 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.27 145.41 34.49 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.832 2.354 . . . . 0.0 110.831 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.5 m -65.22 -24.69 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.004 -1.06 . . . . 0.0 113.119 177.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.65 -17.96 60.94 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.062 0.839 . . . . 0.0 114.61 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 42.5 m -144.1 62.14 9.99 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.434 1.494 . . . . 0.0 110.962 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -61.8 -18.59 61.59 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.013 3.142 . . . . 0.0 113.423 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -71.35 9.33 0.81 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 128.314 2.645 . . . . 0.0 114.148 169.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.1 p -138.44 172.53 12.75 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.886 1.675 . . . . 0.0 111.966 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -141.44 169.75 17.02 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.167 1.387 . . . . 0.0 112.837 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 mm -115.97 128.48 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.932 1.293 . . . . 0.0 110.567 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.37 -160.77 8.55 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.778 1.656 . . . . 0.0 111.926 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -140.27 139.63 35.56 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.443 1.097 . . . . 0.0 111.468 -172.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.18 -164.85 11.39 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.383 1.468 . . . . 0.0 113.208 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.3 139.38 19.16 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.928 1.291 . . . . 0.0 113.084 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.3 -7.72 66.63 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.825 1.202 . . . . 0.0 114.13 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 47.97 56.42 7.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.516 1.926 . . . . 0.0 113.974 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.71 150.96 76.17 Favored Pre-proline 0 C--O 1.24 0.571 0 C-N-CA 126.112 1.765 . . . . 0.0 108.386 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.87 142.67 58.11 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.23 1.286 . . . . 0.0 109.762 173.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.8 m -132.84 150.46 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.681 1.592 . . . . 0.0 111.354 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 t -83.26 132.92 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.764 0.826 . . . . 0.0 110.816 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.6 mt -138.39 162.33 54.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.982 1.713 . . . . 0.0 112.384 -169.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -61.1 167.19 9.48 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.824 2.349 . . . . 0.0 113.302 174.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.66 125.98 10.46 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.735 2.29 . . . . 0.0 110.216 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -146.95 -106.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.806 1.242 . . . . 0.0 109.304 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -145.22 21.55 1.55 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.518 1.927 . . . . 0.0 110.471 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -66.53 133.75 51.0 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.386 -0.821 . . . . 0.0 111.385 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.4 m -144.78 160.27 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.964 1.306 . . . . 0.0 111.812 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -130.84 148.77 52.66 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.406 1.482 . . . . 0.0 110.406 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.9 m -74.98 139.11 42.73 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.168 0.987 . . . . 0.0 109.262 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.59 73.92 1.22 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.143 0.977 . . . . 0.0 109.31 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 93.2 m -76.96 118.9 19.99 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.289 1.036 . . . . 0.0 110.594 -176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 tp -66.98 146.48 54.33 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.285 0.634 . . . . 0.0 111.156 170.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.2 p -125.42 -178.42 4.22 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.685 1.594 . . . . 0.0 111.233 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.0 t -60.26 -18.48 49.3 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -158.7 28.2 0.42 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.445 1.021 . . . . 0.0 114.465 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.63 -153.07 16.61 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.459 1.028 . . . . 0.0 113.018 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -133.1 168.71 18.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.87 2.068 . . . . 0.0 111.981 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -135.88 151.23 49.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.685 1.994 . . . . 0.0 110.412 171.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.7 mt -132.17 114.55 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.033 0.933 . . . . 0.0 109.949 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -135.47 156.43 48.91 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.199 1.0 . . . . 0.0 111.973 -169.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -60.35 -31.23 70.12 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.457 1.503 . . . . 0.0 114.829 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 133.09 -40.76 1.56 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.658 2.075 . . . . 0.0 112.797 -174.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -81.37 -6.45 58.93 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.676 1.19 . . . . 0.0 114.05 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 59.18 16.08 4.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.962 2.105 . . . . 0.0 113.999 -170.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.5 p -69.73 -23.39 63.39 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.871 1.268 . . . . 0.0 112.265 178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.7 m -144.27 170.01 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.101 1.76 . . . . 0.0 111.701 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 t -142.38 156.83 45.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.729 2.012 . . . . 0.0 110.676 173.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -70.9 138.72 50.38 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.234 0.614 . . . . 0.0 111.354 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.9 p -149.29 173.0 13.97 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.549 1.14 . . . . 0.0 112.504 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.1 mt -123.97 173.59 8.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.911 1.684 . . . . 0.0 109.879 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -111.41 -33.73 6.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.079 0.952 . . . . 0.0 111.459 -171.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -140.98 -9.49 1.01 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.646 1.978 . . . . 0.0 112.683 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.71 24.28 8.81 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.055 1.742 . . . . 0.0 114.784 -169.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 p -71.88 154.75 41.04 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.19 -0.944 . . . . 0.0 111.181 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.2 143.43 54.0 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.887 -1.133 . . . . 0.0 111.764 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.07 4.2 89.65 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.481 1.038 . . . . 0.0 114.153 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -73.56 142.58 46.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.825 1.313 . . . . 0.0 112.46 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -77.62 111.37 13.31 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.777 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 p -54.7 149.09 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.895 0.878 . . . . 0.0 111.434 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.7 t -130.55 168.63 16.76 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.561 1.544 . . . . 0.0 112.008 -169.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.8 mt -134.74 141.73 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.041 1.736 . . . . 0.0 108.866 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.91 -162.97 36.77 Favored Glycine 0 CA--C 1.526 0.722 0 O-C-N 121.52 -0.737 . . . . 0.0 112.283 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.61 153.56 10.15 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 117.631 0.715 . . . . 0.0 111.803 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -53.51 122.3 9.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.664 1.186 . . . . 0.0 113.039 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.69 173.68 7.81 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.228 1.411 . . . . 0.0 113.703 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 t -105.15 -5.06 21.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.821 1.248 . . . . 0.0 114.355 -172.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -148.44 -41.04 0.16 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.353 1.061 . . . . 0.0 112.821 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.2 p -96.91 4.98 51.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.376 1.47 . . . . 0.0 114.487 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.87 2.66 16.09 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.908 1.242 . . . . 0.0 115.575 -174.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -130.32 146.31 51.9 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.897 1.848 . . . . 0.0 111.134 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -136.97 174.36 10.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.875 1.27 . . . . 0.0 111.835 -168.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.5 p -138.53 139.14 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.757 1.223 . . . . 0.0 109.461 172.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.81 124.49 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 125.627 1.571 . . . . 0.0 107.067 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.98 153.78 38.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.856 -170.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -67.9 155.57 39.12 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.074 -1.016 . . . . 0.0 112.429 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.5 t . . . . . 0 C--O 1.252 1.205 0 C-N-CA 125.996 1.719 . . . . 0.0 111.228 172.429 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.17 10.5 0.22 Allowed Glycine 0 CA--C 1.538 1.508 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 177.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -154.26 169.76 22.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.253 1.821 . . . . 0.0 110.258 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 55.52 16.41 1.84 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.85 2.06 . . . . 0.0 115.307 -175.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -140.03 -4.63 1.34 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.973 1.709 . . . . 0.0 113.214 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -153.76 156.55 37.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.827 1.651 . . . . 0.0 110.845 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -148.22 19.85 1.09 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -171.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -134.22 169.95 16.43 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 120.99 -1.069 . . . . 0.0 112.772 -171.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -67.71 164.25 19.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.823 0.849 . . . . 0.0 112.314 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -148.76 155.7 41.34 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.257 1.423 . . . . 0.0 111.524 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.7 p -151.13 158.67 44.3 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.804 1.242 . . . . 0.0 112.958 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.94 25.85 0.06 OUTLIER Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.325 0.964 . . . . 0.0 114.651 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -143.69 21.4 1.82 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.034 1.334 . . . . 0.0 112.73 -171.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.2 m -141.21 148.85 53.07 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 125.536 1.534 . . . . 0.0 111.372 -175.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -73.51 158.72 47.42 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.116 2.544 . . . . 0.0 112.589 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.99 29.35 1.49 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.31 1.444 . . . . 0.0 112.263 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.57 147.02 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.581 1.552 . . . . 0.0 110.374 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.7 t -133.83 8.73 3.85 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.5 mt 58.42 175.44 0.06 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.978 2.111 . . . . 0.0 113.967 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 t -159.94 170.1 22.07 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.29 1.436 . . . . 0.0 109.825 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 140.46 58.55 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 121.701 -0.625 . . . . 0.0 112.271 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.14 -162.37 33.15 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.203 0.906 . . . . 0.0 114.391 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -95.19 125.33 39.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.017 0.927 . . . . 0.0 110.174 170.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -134.19 170.87 15.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.367 1.467 . . . . 0.0 112.312 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.8 pt -123.9 151.55 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 126.119 1.768 . . . . 0.0 108.361 170.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.1 mt -128.18 120.12 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -139.94 149.83 43.79 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.743 0.817 . . . . 0.0 112.061 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -75.9 136.39 40.11 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.655 -0.653 . . . . 0.0 111.79 -174.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.4 tpt85 -65.76 -15.47 62.88 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.5 t -70.35 -20.66 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.633 1.173 . . . . 0.0 112.489 172.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 61.13 167.87 0.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.108 2.163 . . . . 0.0 112.569 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.0 t -65.8 150.02 96.82 Favored Pre-proline 0 CA--C 1.539 0.556 0 O-C-N 121.191 -0.943 . . . . 0.0 111.072 171.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.61 -14.89 42.64 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.87 2.38 . . . . 0.0 112.97 169.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -71.39 -15.32 62.36 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.403 1.481 . . . . 0.0 113.104 169.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.07 27.74 36.36 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.744 1.64 . . . . 0.0 113.792 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.83 166.1 19.7 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.25 1.42 . . . . 0.0 111.514 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.04 141.22 54.57 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.437 0.695 . . . . 0.0 111.572 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.1 tp -122.39 74.4 1.17 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.094 1.758 . . . . 0.0 109.2 -169.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.29 147.13 29.07 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.352 1.461 . . . . 0.0 114.547 -169.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.1 tp -58.16 136.18 57.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.232 1.013 . . . . 0.0 109.148 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.1 m -132.94 121.94 23.57 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.982 0.913 . . . . 0.0 111.373 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -60.01 130.96 89.27 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.526 2.331 . . . . 0.0 111.498 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.63 -8.58 19.44 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.6 2.866 . . . . 0.0 114.432 -177.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.02 -2.27 65.92 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.227 0.917 . . . . 0.0 114.958 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -156.46 169.85 23.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.084 1.354 . . . . 0.0 113.001 -173.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -99.46 159.28 15.13 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.345 1.858 . . . . 0.0 110.527 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 57.49 39.9 27.57 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.788 1.635 . . . . 0.0 113.402 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.1 m -142.22 139.2 17.49 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 125.963 1.705 . . . . 0.0 110.733 -172.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -52.96 156.95 8.79 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.869 3.713 . . . . 0.0 115.389 172.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 t -105.29 156.81 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.947 1.299 . . . . 0.0 110.711 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.6 m -127.94 170.16 13.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.715 1.606 . . . . 0.0 110.644 -171.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.1 140.16 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.843 1.257 . . . . 0.0 111.425 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.4 m -152.82 164.21 21.04 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 124.513 1.125 . . . . 0.0 112.758 -172.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -53.6 159.35 6.67 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.735 2.957 . . . . 0.0 113.604 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.2 tp -116.46 140.41 49.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.654 1.182 . . . . 0.0 111.725 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -140.68 -37.55 0.45 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.633 1.973 . . . . 0.0 112.517 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.11 3.58 1.21 Allowed Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.82 1.2 . . . . 0.0 115.374 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -62.39 154.68 27.4 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.535 1.667 . . . . 0.0 112.388 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.4 p -68.95 -14.79 63.25 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 173.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.57 -22.72 60.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.202 0.91 . . . . 0.0 112.343 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.73 6.4 11.56 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.111 2.564 . . . . 0.0 112.687 -169.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.17 149.51 37.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.966 1.306 . . . . 0.0 110.896 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -136.83 171.87 13.85 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 123.008 1.385 . . . . 0.0 112.856 -168.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.6 mt -120.2 135.33 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.948 2.499 . . . . 0.0 106.472 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.0 tp -135.73 126.21 26.84 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.116 1.366 . . . . 0.0 109.101 -172.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -142.82 139.59 30.99 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.634 0.773 . . . . 0.0 110.899 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.4 t -65.31 140.19 58.67 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.934 0.494 . . . . 0.0 110.874 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -109.84 -52.74 2.74 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.608 1.163 . . . . 0.0 110.62 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -145.18 106.86 4.25 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.721 1.208 . . . . 0.0 110.841 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 m -51.81 -31.81 28.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.204 1.802 . . . . 0.0 114.604 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 71' ' ' ASN . 3.2 p30 -73.71 -18.04 61.05 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.504 2.322 . . . . 0.0 114.151 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -117.51 6.37 12.54 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.923 1.689 . . . . 0.0 113.073 171.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 43.97 33.44 0.77 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.018 2.127 . . . . 0.0 114.267 -169.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -87.44 145.42 26.29 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.722 -1.236 . . . . 0.0 112.04 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -141.24 141.72 33.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.999 1.319 . . . . 0.0 111.422 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 p -80.46 146.58 31.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.76 0.824 . . . . 0.0 111.225 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.0 mm -130.16 122.26 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.45 1.5 . . . . 0.0 111.037 -171.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 m -142.04 147.66 45.37 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 125.256 1.423 . . . . 0.0 110.894 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.74 146.94 34.45 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.82 2.347 . . . . 0.0 110.977 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.0 m -65.6 -23.96 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.864 -1.148 . . . . 0.0 112.793 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.87 -6.58 72.12 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.6 1.095 . . . . 0.0 114.889 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.3 t -152.81 67.39 6.52 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 118.565 1.182 . . . . 0.0 111.867 176.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.16 -13.35 31.43 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.686 2.257 . . . . 0.0 113.103 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -78.16 11.26 2.41 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.473 1.909 . . . . 0.0 113.447 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.5 m -136.89 169.29 18.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.5 1.92 . . . . 0.0 111.783 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -141.61 167.18 22.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.353 1.461 . . . . 0.0 111.842 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.8 mm -119.18 130.98 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.665 1.186 . . . . 0.0 110.89 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.0 -158.86 8.26 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.722 1.629 . . . . 0.0 111.676 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -140.54 143.54 35.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.457 1.103 . . . . 0.0 111.792 -172.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.9 -165.34 12.16 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.394 1.474 . . . . 0.0 113.018 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.92 139.71 21.66 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.914 1.286 . . . . 0.0 113.185 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.12 -5.71 65.97 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.762 1.173 . . . . 0.0 114.18 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 48.38 55.85 8.31 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.6 1.96 . . . . 0.0 114.401 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.68 149.07 69.78 Favored Pre-proline 0 C--O 1.24 0.567 0 C-N-CA 126.291 1.837 . . . . 0.0 107.573 169.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.4 147.64 59.2 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.022 1.148 . . . . 0.0 109.802 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.32 149.93 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.743 1.617 . . . . 0.0 110.973 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.2 t -77.7 137.34 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.504 0.721 . . . . 0.0 110.368 173.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.9 mt -138.89 164.63 38.12 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.069 2.148 . . . . 0.0 110.677 -170.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.92 159.74 52.18 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 122.109 1.872 . . . . 0.0 111.178 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.23 119.84 6.57 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.031 2.487 . . . . 0.0 110.328 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -144.11 -88.46 0.12 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 110.752 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -156.09 14.59 0.33 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.102 1.361 . . . . 0.0 113.414 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -70.15 134.34 48.03 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.408 -0.808 . . . . 0.0 111.477 -174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.64 160.02 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.484 1.113 . . . . 0.0 112.344 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -128.07 135.07 49.32 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.989 1.316 . . . . 0.0 110.769 171.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.0 m -76.45 129.18 36.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.753 1.221 . . . . 0.0 109.391 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 42.4 mt -117.05 129.34 55.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.097 0.959 . . . . 0.0 109.793 -178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 m -133.27 118.03 18.07 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.649 1.18 . . . . 0.0 110.212 -169.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp -65.07 147.27 53.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.246 0.618 . . . . 0.0 111.335 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.3 p -129.06 -178.84 4.8 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.509 1.524 . . . . 0.0 111.686 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 64.3 p -59.05 -15.0 11.31 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.92 27.51 0.24 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.215 0.912 . . . . 0.0 114.64 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 174.42 -148.35 9.8 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.954 1.264 . . . . 0.0 112.155 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -131.8 172.12 12.69 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.936 2.095 . . . . 0.0 111.547 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -137.82 152.98 49.67 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.774 2.43 . . . . 0.0 109.526 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.7 mt -133.71 126.47 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.309 1.444 . . . . 0.0 108.824 -170.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -140.3 159.43 42.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.643 1.177 . . . . 0.0 113.14 -172.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.71 -24.17 67.54 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -169.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.9 -37.13 2.1 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.613 1.102 . . . . 0.0 113.032 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -117.38 12.17 14.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.478 1.911 . . . . 0.0 113.709 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 62.42 16.63 8.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.757 2.023 . . . . 0.0 114.185 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.9 p -72.16 -29.17 63.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.72 0.808 . . . . 0.0 112.534 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.0 m -145.85 177.45 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.494 1.517 . . . . 0.0 111.837 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t -148.97 153.05 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.648 2.379 . . . . 0.0 110.093 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -69.85 144.92 52.41 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.534 -0.729 . . . . 0.0 111.712 171.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 87.7 p -151.94 171.6 17.55 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.673 1.189 . . . . 0.0 112.734 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.4 mt -125.6 165.78 17.91 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.356 1.862 . . . . 0.0 110.015 174.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -104.8 -32.8 8.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.871 0.869 . . . . 0.0 112.144 -169.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -138.81 -8.33 1.4 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.661 1.984 . . . . 0.0 112.436 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.51 21.68 5.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.009 1.724 . . . . 0.0 114.621 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.2 p -73.08 154.13 40.53 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.961 -1.087 . . . . 0.0 111.683 171.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.65 142.82 58.26 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.299 -0.876 . . . . 0.0 112.263 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.05 1.68 90.08 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.904 1.24 . . . . 0.0 114.479 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.93 141.76 45.96 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.741 1.27 . . . . 0.0 112.776 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -76.22 117.86 18.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.23 -0.919 . . . . 0.0 110.312 173.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.88 148.29 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.804 0.842 . . . . 0.0 111.57 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 t -128.68 167.73 16.8 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.586 1.555 . . . . 0.0 111.781 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.7 mt -135.6 141.22 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.603 1.561 . . . . 0.0 109.582 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -179.41 179.86 48.82 Favored Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.944 1.259 . . . . 0.0 111.605 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.07 -40.41 58.29 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.221 1.51 . . . . 0.0 114.334 -173.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -171.63 173.14 4.75 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 128.844 2.858 . . . . 0.0 109.331 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.74 139.87 36.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.201 1.0 . . . . 0.0 112.629 169.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.6 t -60.98 -20.79 62.83 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -169.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -137.71 -38.88 0.58 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.465 1.106 . . . . 0.0 113.222 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 86.8 p -93.35 3.67 55.24 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.294 1.437 . . . . 0.0 114.606 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.23 15.66 1.37 Allowed Glycine 0 CA--C 1.543 1.799 0 C-N-CA 125.856 1.693 . . . . 0.0 115.763 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -134.73 152.46 51.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.916 1.686 . . . . 0.0 111.451 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -141.77 175.9 9.34 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.884 2.074 . . . . 0.0 110.594 -169.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.82 138.37 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 125.123 1.369 . . . . 0.0 108.588 170.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.77 123.29 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -149.0 154.01 38.73 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.922 1.289 . . . . 0.0 109.239 -171.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.58 155.85 39.2 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.907 -1.12 . . . . 0.0 112.701 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 C--O 1.252 1.211 0 C-N-CA 126.146 1.778 . . . . 0.0 111.276 171.415 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.01 174.87 42.92 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.526 1.06 . . . . 0.0 113.095 176.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -140.04 3.51 2.0 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.622 1.169 . . . . 0.0 113.548 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -61.3 -12.59 14.21 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.476 1.91 . . . . 0.0 115.077 -176.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -125.21 11.11 8.13 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.458 1.903 . . . . 0.0 112.608 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.4 m80 53.66 -167.76 0.07 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.854 2.062 . . . . 0.0 113.936 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -133.95 8.84 3.82 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.741 1.616 . . . . 0.0 112.943 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -152.52 170.61 19.74 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.373 1.869 . . . . 0.0 111.666 -173.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.0 p-80 -152.54 172.5 16.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.658 1.583 . . . . 0.0 111.749 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -147.58 162.65 38.67 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.948 1.299 . . . . 0.0 111.356 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.3 t -138.78 13.04 2.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.944 1.697 . . . . 0.0 112.677 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.99 25.54 2.23 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.709 1.623 . . . . 0.0 113.865 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.92 -13.36 61.66 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.997 1.319 . . . . 0.0 113.815 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.9 m 46.88 54.72 15.61 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 126.778 2.031 . . . . 0.0 115.134 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.41 179.61 4.92 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.567 2.844 . . . . 0.0 113.459 177.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 51.6 39.59 25.3 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.89 1.676 . . . . 0.0 113.593 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.8 t -59.1 138.75 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.05 1.34 . . . . 0.0 110.15 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 t -129.86 10.49 5.52 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -172.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt 60.16 170.85 0.08 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.429 2.292 . . . . 0.0 114.343 -177.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.7 m -149.69 163.16 38.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.315 1.846 . . . . 0.0 109.61 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.17 54.76 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.458 -0.776 . . . . 0.0 111.417 170.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.84 -164.3 36.9 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.914 0.768 . . . . 0.0 114.604 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -94.52 125.65 39.3 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.017 0.927 . . . . 0.0 110.232 170.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -134.64 171.12 14.79 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.428 1.491 . . . . 0.0 112.409 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.7 pt -125.38 152.42 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.173 1.789 . . . . 0.0 108.445 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.9 mt -128.72 119.85 50.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -140.25 148.96 42.25 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.696 0.798 . . . . 0.0 112.555 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -78.7 135.06 37.07 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.903 -0.498 . . . . 0.0 111.544 -174.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -59.59 -22.84 62.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.089 1.356 . . . . 0.0 114.139 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.56 -24.33 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.172 0.989 . . . . 0.0 112.866 175.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.6 mt 60.85 169.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.856 2.062 . . . . 0.0 113.867 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.9 p -75.37 160.6 79.44 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.331 1.052 . . . . 0.0 112.762 -175.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.2 -16.72 44.71 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.596 2.197 . . . . 0.0 112.694 170.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -76.19 -16.76 59.78 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.53 1.532 . . . . 0.0 113.094 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.72 22.2 19.13 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.249 1.404 . . . . 0.0 114.113 177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.38 172.08 12.61 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.895 1.278 . . . . 0.0 112.708 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -57.08 127.55 32.52 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.419 1.088 . . . . 0.0 111.447 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.8 tp -105.41 79.24 1.45 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.675 1.59 . . . . 0.0 110.016 -173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.29 147.64 27.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.788 1.635 . . . . 0.0 114.203 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.4 tp -59.64 138.36 57.76 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.163 1.385 . . . . 0.0 110.863 170.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 m -130.42 126.52 37.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.102 0.961 . . . . 0.0 111.93 -171.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -61.25 130.51 91.66 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 126.319 1.848 . . . . 0.0 111.657 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.41 -6.49 16.39 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.707 2.938 . . . . 0.0 114.878 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.76 -2.29 62.07 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.832 -0.982 . . . . 0.0 115.082 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -160.22 169.75 22.59 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.919 1.359 . . . . 0.0 112.863 -172.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -95.17 167.55 11.3 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.894 1.677 . . . . 0.0 111.405 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.8 tpt85 47.49 40.71 11.77 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.11 2.164 . . . . 0.0 113.694 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.6 m -139.76 140.61 25.21 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 125.159 1.384 . . . . 0.0 111.83 -169.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -44.53 150.18 0.84 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 126.338 4.692 . . . . 0.0 115.424 169.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.57 155.84 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.145 1.378 . . . . 0.0 110.699 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -126.74 176.06 7.53 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.753 1.621 . . . . 0.0 111.082 -169.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.62 145.74 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.049 1.34 . . . . 0.0 111.452 176.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.6 m -151.22 159.67 33.19 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.938 1.295 . . . . 0.0 111.945 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.66 132.38 35.06 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.84 1.693 . . . . 0.0 110.758 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.69 138.73 57.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.161 1.384 . . . . 0.0 111.436 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -132.45 -22.34 2.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.946 1.298 . . . . 0.0 112.594 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.73 -1.82 32.12 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.944 1.735 . . . . 0.0 113.478 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.6 p -80.04 159.42 26.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.792 1.237 . . . . 0.0 113.076 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.3 m -60.19 -18.16 46.24 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.76 -35.26 80.0 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.04 0.936 . . . . 0.0 112.458 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.31 0.0 OUTLIER -120.47 14.06 11.89 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.16 149.69 23.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.267 1.027 . . . . 0.0 111.707 170.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -139.47 171.53 14.13 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.635 1.207 . . . . 0.0 113.131 -169.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.8 mt -120.8 137.04 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 127.721 2.408 . . . . 0.0 107.351 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.5 tp -137.0 125.61 23.73 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.487 1.515 . . . . 0.0 109.491 -171.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -142.88 135.69 27.92 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.08 0.952 . . . . 0.0 110.999 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -63.87 140.23 58.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.321 0.649 . . . . 0.0 111.37 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -112.06 -52.89 2.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.421 1.088 . . . . 0.0 111.25 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -147.89 117.34 6.98 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.13 . . . . 0.0 111.087 169.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -36.18 80.82 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 112.936 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -61.26 -17.35 53.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.927 2.091 . . . . 0.0 114.883 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 m -123.99 8.32 8.67 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.143 1.777 . . . . 0.0 113.624 172.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 43.36 33.56 0.62 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.31 1.844 . . . . 0.0 114.545 -169.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 p -89.25 144.81 25.82 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.386 -1.446 . . . . 0.0 112.316 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -139.71 140.82 36.91 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.357 1.463 . . . . 0.0 111.297 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.4 p -79.02 148.3 32.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.015 0.526 . . . . 0.0 110.858 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.13 129.9 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.524 1.53 . . . . 0.0 109.362 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.0 m -145.63 145.98 27.74 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.641 1.576 . . . . 0.0 110.622 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.19 145.91 35.52 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.999 2.466 . . . . 0.0 111.043 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.71 -25.78 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.925 -1.109 . . . . 0.0 113.057 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.87 -23.44 61.86 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 123.858 0.742 . . . . 0.0 114.388 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m -142.09 64.13 16.75 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.701 1.6 . . . . 0.0 111.112 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -61.3 -19.38 63.7 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.917 3.078 . . . . 0.0 113.244 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -71.19 9.0 0.82 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 128.234 2.614 . . . . 0.0 114.415 169.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.8 p -138.03 172.73 12.49 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.717 1.607 . . . . 0.0 112.345 173.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -137.98 171.6 14.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.917 1.687 . . . . 0.0 112.567 -171.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -120.39 126.7 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.15 1.38 . . . . 0.0 110.728 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.75 -158.59 7.6 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.874 1.702 . . . . 0.0 111.385 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -141.3 144.09 34.43 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.343 1.071 . . . . 0.0 111.763 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.84 -165.2 12.29 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.494 1.521 . . . . 0.0 113.059 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.24 138.92 25.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.003 1.321 . . . . 0.0 113.257 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.18 -1.63 67.62 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.607 1.099 . . . . 0.0 114.354 -173.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 48.52 55.67 8.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.236 1.815 . . . . 0.0 113.669 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.8 p -132.68 137.2 29.25 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 127.695 2.398 . . . . 0.0 107.479 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.31 143.29 47.76 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.112 -1.149 . . . . 0.0 109.112 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.13 147.13 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.178 1.391 . . . . 0.0 110.932 -172.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.64 138.87 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.423 0.689 . . . . 0.0 109.964 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.3 mt -142.31 163.55 38.8 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 125.826 1.65 . . . . 0.0 111.728 -169.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.92 165.77 30.02 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.05 2.5 . . . . 0.0 111.751 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.43 123.7 9.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.555 2.17 . . . . 0.0 110.924 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -147.07 -92.11 0.09 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.164 0.985 . . . . 0.0 110.511 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -154.53 17.47 0.46 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.563 1.545 . . . . 0.0 112.794 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -67.48 134.69 51.81 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.605 0.762 . . . . 0.0 111.92 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.5 m -145.73 161.45 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.059 1.344 . . . . 0.0 112.391 -175.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -129.75 138.19 50.96 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.466 1.506 . . . . 0.0 110.875 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.5 m -74.95 125.52 29.06 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.242 1.417 . . . . 0.0 109.228 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.1 mt -116.46 128.41 55.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 109.876 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.0 m -134.89 121.77 21.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.911 0.884 . . . . 0.0 110.858 -169.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 tp -67.92 148.24 51.38 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.262 0.625 . . . . 0.0 111.448 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 p -129.39 -176.67 3.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.93 1.692 . . . . 0.0 111.452 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.1 p -58.56 -17.71 23.86 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.68 29.37 0.24 Allowed Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.506 1.05 . . . . 0.0 114.017 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.48 -150.99 10.47 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.977 1.275 . . . . 0.0 112.172 -173.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -134.86 171.93 13.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.077 2.151 . . . . 0.0 111.536 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -137.83 154.49 49.51 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.52 1.928 . . . . 0.0 110.91 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 31.5 mt -135.32 118.53 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.084 1.354 . . . . 0.0 110.057 -169.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -134.9 157.96 45.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.218 1.007 . . . . 0.0 112.831 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -62.53 -26.76 68.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -169.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.48 -40.35 1.67 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.145 1.355 . . . . 0.0 113.143 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -98.54 1.5 46.6 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.643 1.577 . . . . 0.0 113.641 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 65.22 12.84 8.34 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.942 2.097 . . . . 0.0 113.738 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.2 p -73.49 -23.84 60.1 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.46 1.104 . . . . 0.0 112.812 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.6 m -143.3 173.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.552 1.541 . . . . 0.0 112.017 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 t -145.17 154.0 41.97 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.582 2.753 . . . . 0.0 109.767 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -72.32 145.24 47.94 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.401 -0.812 . . . . 0.0 111.491 170.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.0 p -154.84 162.14 41.21 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.362 1.065 . . . . 0.0 112.868 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.5 mt -109.91 170.55 8.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.797 1.639 . . . . 0.0 109.375 169.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -109.77 -31.74 7.33 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.224 1.01 . . . . 0.0 112.059 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -135.83 -10.11 2.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.756 2.022 . . . . 0.0 112.081 169.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.65 27.98 11.36 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.98 1.712 . . . . 0.0 113.939 -170.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.1 p -75.47 155.6 36.07 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.222 1.009 . . . . 0.0 111.657 170.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.26 136.54 55.99 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.244 -0.91 . . . . 0.0 111.427 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.03 0.75 88.93 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.466 1.031 . . . . 0.0 114.536 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -71.17 142.72 50.68 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.807 1.303 . . . . 0.0 112.73 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.1 119.87 19.85 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.302 -0.874 . . . . 0.0 110.06 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 p -62.47 150.34 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.521 0.729 . . . . 0.0 111.357 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.1 m -131.95 168.98 16.95 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.309 1.844 . . . . 0.0 111.293 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.6 mt -134.63 143.71 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.05 1.34 . . . . 0.0 109.379 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.28 179.33 47.53 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 124.819 1.2 . . . . 0.0 111.743 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.31 -42.65 61.33 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.963 1.382 . . . . 0.0 114.291 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -169.71 172.93 6.53 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.166 2.586 . . . . 0.0 109.559 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.51 135.02 33.05 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.168 0.987 . . . . 0.0 112.254 170.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.6 t -56.98 -24.56 54.32 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.273 1.829 . . . . 0.0 115.809 -169.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -130.83 -36.41 1.38 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.962 1.305 . . . . 0.0 112.826 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 t -96.3 1.14 51.71 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -171.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.83 26.37 0.77 Allowed Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.105 1.336 . . . . 0.0 115.948 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -145.92 149.7 34.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.17 1.788 . . . . 0.0 111.594 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -141.62 176.76 8.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.956 1.702 . . . . 0.0 111.826 -169.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.22 140.16 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.629 1.572 . . . . 0.0 108.807 169.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.18 123.59 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.98 153.32 37.77 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.599 1.16 . . . . 0.0 109.474 -170.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.09 155.01 40.47 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.945 -1.097 . . . . 0.0 112.736 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.3 t . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.317 1.847 . . . . 0.0 111.31 171.199 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.98 -15.6 0.06 OUTLIER Glycine 0 CA--C 1.538 1.504 0 N-CA-C 115.656 1.022 . . . . 0.0 115.656 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -145.77 161.92 38.83 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.737 1.615 . . . . 0.0 111.221 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -142.15 161.96 36.67 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.701 1.6 . . . . 0.0 111.963 -174.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -147.99 161.64 40.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.011 1.324 . . . . 0.0 111.806 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -146.22 158.23 43.87 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.377 1.471 . . . . 0.0 112.106 -173.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -120.64 -7.2 9.65 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.41 1.484 . . . . 0.0 113.462 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -131.48 7.17 4.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.902 2.081 . . . . 0.0 113.353 -173.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -141.85 -9.88 0.91 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.489 1.516 . . . . 0.0 114.03 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -134.8 -21.04 1.72 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.255 1.422 . . . . 0.0 114.009 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.1 m -132.96 13.57 4.31 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.712 1.605 . . . . 0.0 112.72 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.51 -172.47 44.57 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.803 1.668 . . . . 0.0 112.307 -174.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -141.52 9.0 2.0 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.818 1.647 . . . . 0.0 113.441 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.0 m -149.72 165.66 17.06 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.278 1.831 . . . . 0.0 111.298 -169.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.92 147.83 24.73 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.606 2.87 . . . . 0.0 114.119 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.07 41.69 1.4 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.836 1.254 . . . . 0.0 112.276 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -140.68 161.18 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.191 1.796 . . . . 0.0 111.38 -170.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.0 p -109.71 9.31 24.93 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.478 1.511 . . . . 0.0 113.518 -170.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.2 mt 66.73 167.88 0.23 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.044 2.938 . . . . 0.0 113.523 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.5 m -148.53 162.9 38.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.696 1.998 . . . . 0.0 109.3 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.8 137.24 56.48 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.399 -0.813 . . . . 0.0 111.495 172.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.14 -162.94 36.15 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.312 0.885 . . . . 0.0 115.312 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -94.02 121.85 35.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.01 1.324 . . . . 0.0 110.282 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -133.5 170.49 15.42 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.483 1.113 . . . . 0.0 112.801 -173.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.26 154.74 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 126.353 1.861 . . . . 0.0 108.855 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.0 mt -130.24 120.15 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -145.49 160.53 41.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.777 0.831 . . . . 0.0 112.458 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -99.6 121.44 41.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.486 0.714 . . . . 0.0 110.871 -174.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -63.42 -14.73 53.54 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.8 t -60.57 -26.49 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.324 1.049 . . . . 0.0 112.358 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.4 mt 58.32 175.94 0.06 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.088 1.755 . . . . 0.0 112.666 -170.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.6 p -108.28 164.08 15.54 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 124.663 1.185 . . . . 0.0 113.514 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -55.68 -16.63 15.48 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 124.303 3.336 . . . . 0.0 115.18 169.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -63.75 -22.82 67.1 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.718 1.607 . . . . 0.0 112.604 171.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.7 24.79 37.45 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.528 1.537 . . . . 0.0 113.707 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -138.37 167.75 21.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.761 1.225 . . . . 0.0 112.179 -172.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.84 141.34 39.21 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.621 1.168 . . . . 0.0 111.519 173.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.1 tp -116.66 78.03 1.17 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.882 1.273 . . . . 0.0 110.414 -169.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.96 153.07 21.86 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.621 1.169 . . . . 0.0 113.368 -171.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -62.1 136.15 57.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.608 1.163 . . . . 0.0 109.901 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.8 m -128.05 124.72 37.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.667 1.187 . . . . 0.0 111.644 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -68.27 136.18 91.28 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.149 0.98 . . . . 0.0 112.315 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.04 -13.16 19.41 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.547 2.831 . . . . 0.0 115.015 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.93 5.79 73.15 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.324 0.964 . . . . 0.0 115.191 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -157.0 167.57 30.07 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.051 1.741 . . . . 0.0 111.78 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -98.65 167.09 11.0 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.005 1.322 . . . . 0.0 111.453 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 47.78 43.36 16.95 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.642 1.977 . . . . 0.0 113.079 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.0 m -141.07 138.96 18.46 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 125.407 1.483 . . . . 0.0 111.272 -169.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -46.5 157.06 0.5 Allowed 'Trans proline' 0 C--N 1.354 0.852 1 C-N-CA 126.121 4.547 . . . . 0.0 115.306 169.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 t -117.43 149.68 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.384 1.474 . . . . 0.0 109.774 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 m -124.89 174.97 7.6 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.097 1.359 . . . . 0.0 110.429 -169.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 m -127.02 144.33 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 120.902 -1.124 . . . . 0.0 111.602 172.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.4 m -148.38 166.02 16.67 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.803 1.241 . . . . 0.0 112.462 -176.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.58 163.26 2.82 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.79 2.993 . . . . 0.0 113.469 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.2 tp -126.26 143.73 51.04 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.794 1.238 . . . . 0.0 111.552 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -147.98 -32.33 0.27 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.328 1.451 . . . . 0.0 113.434 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.26 -9.65 0.83 Allowed Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.358 1.456 . . . . 0.0 114.365 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -63.08 139.65 58.79 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.979 1.39 . . . . 0.0 111.916 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.7 p -63.99 -11.05 25.22 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.387 1.475 . . . . 0.0 114.353 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.99 -20.08 64.99 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.487 1.04 . . . . 0.0 112.095 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -109.07 3.94 22.56 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.482 1.913 . . . . 0.0 113.282 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.29 144.58 29.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.125 0.964 . . . . 0.0 111.687 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -139.54 173.66 11.31 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.899 1.333 . . . . 0.0 112.123 -169.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.0 mt -122.75 135.44 62.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 127.746 2.418 . . . . 0.0 106.745 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.0 tp -137.04 124.53 22.12 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.978 1.311 . . . . 0.0 109.379 -172.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -142.77 138.57 30.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.403 0.681 . . . . 0.0 111.196 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.8 t -64.53 139.41 58.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.967 0.507 . . . . 0.0 110.984 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -114.21 -51.01 2.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.528 1.131 . . . . 0.0 110.762 174.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.23 107.71 4.1 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.172 0.989 . . . . 0.0 111.208 169.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.6 m -58.27 -25.94 62.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.987 0.915 . . . . 0.0 111.311 168.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -62.24 -21.6 65.3 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.095 2.158 . . . . 0.0 113.399 173.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.4 m -130.37 9.1 5.11 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.913 1.685 . . . . 0.0 113.026 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 47.0 32.1 1.76 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.014 2.126 . . . . 0.0 114.23 -169.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 p -92.55 142.49 27.34 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.158 -0.964 . . . . 0.0 112.319 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -139.06 144.54 38.82 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.072 1.749 . . . . 0.0 110.653 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.0 p -77.85 148.5 34.64 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.182 0.593 . . . . 0.0 110.82 172.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 mm -128.17 126.86 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.572 1.549 . . . . 0.0 109.417 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.9 m -143.9 148.91 44.21 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 125.541 1.536 . . . . 0.0 109.785 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.51 150.76 28.47 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.031 2.487 . . . . 0.0 111.055 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.03 -26.38 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.023 -1.048 . . . . 0.0 113.552 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.84 -20.79 55.1 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.738 0.685 . . . . 0.0 114.485 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.6 m -142.39 61.13 11.23 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 125.635 1.574 . . . . 0.0 111.526 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -61.31 -17.16 51.39 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.69 2.926 . . . . 0.0 113.178 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -72.87 13.55 0.37 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 128.591 2.756 . . . . 0.0 113.481 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.8 p -144.0 170.13 16.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.428 2.291 . . . . 0.0 111.119 173.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -139.65 170.71 15.4 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.217 1.807 . . . . 0.0 111.979 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -117.1 126.79 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.732 1.213 . . . . 0.0 110.77 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.79 -158.67 7.63 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 126.072 1.796 . . . . 0.0 111.328 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -144.96 144.77 31.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.178 0.989 . . . . 0.0 111.897 -174.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.03 -161.13 9.83 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.573 1.558 . . . . 0.0 113.116 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.18 137.7 21.8 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.921 1.288 . . . . 0.0 113.018 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.56 -5.83 64.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.724 1.154 . . . . 0.0 114.248 -172.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 47.49 52.65 12.12 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.402 1.881 . . . . 0.0 113.719 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.84 141.39 41.51 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 127.213 2.205 . . . . 0.0 107.478 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.54 140.12 55.98 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 N-CA-C 108.944 -1.214 . . . . 0.0 108.944 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.53 148.02 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.327 1.451 . . . . 0.0 111.275 -175.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.0 t -77.26 137.42 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.577 0.751 . . . . 0.0 110.426 173.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -141.0 161.76 51.93 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.209 1.803 . . . . 0.0 110.799 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.32 162.5 38.33 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.555 2.17 . . . . 0.0 111.291 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.96 127.77 27.48 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.15 2.566 . . . . 0.0 113.02 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -149.3 -107.82 0.07 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.203 1.401 . . . . 0.0 108.994 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -143.83 21.22 1.8 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.535 1.934 . . . . 0.0 110.581 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -65.82 131.99 47.63 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.339 -0.85 . . . . 0.0 111.677 -173.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.5 m -143.56 161.24 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.437 1.495 . . . . 0.0 111.335 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -130.83 152.27 50.35 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.214 1.406 . . . . 0.0 110.135 169.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.4 m -77.03 135.58 38.66 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.158 1.383 . . . . 0.0 109.294 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -126.09 73.78 1.39 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.246 1.018 . . . . 0.0 109.137 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.8 m -83.92 127.16 33.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.3 1.04 . . . . 0.0 111.015 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 tp -69.58 147.36 50.83 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.727 0.811 . . . . 0.0 111.405 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.1 p -129.91 175.53 8.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.381 1.473 . . . . 0.0 111.791 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 75.9 p -62.88 -11.5 18.69 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.65 17.22 1.63 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.76 1.171 . . . . 0.0 115.291 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.63 -137.22 4.99 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 118.645 1.222 . . . . 0.0 112.498 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -133.6 169.07 17.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.421 2.288 . . . . 0.0 111.336 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -131.39 147.39 52.56 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.304 1.842 . . . . 0.0 110.43 172.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.8 mt -130.53 114.01 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.055 0.942 . . . . 0.0 110.022 -170.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -136.89 151.99 49.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.86 1.264 . . . . 0.0 111.433 -169.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.0 -31.37 62.99 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.55 -40.11 1.59 Allowed Glycine 0 N--CA 1.471 1.019 0 C-N-CA 125.221 1.391 . . . . 0.0 112.649 -171.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -79.77 -5.76 55.96 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.913 1.285 . . . . 0.0 114.214 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? 57.1 14.14 1.87 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 126.998 2.119 . . . . 0.0 114.26 -169.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.8 p -69.46 -26.54 64.63 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.625 1.97 . . . . 0.0 113.501 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.5 m -143.88 168.71 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.005 1.722 . . . . 0.0 111.322 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.6 t -140.93 156.88 46.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.157 1.783 . . . . 0.0 110.863 172.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -71.52 138.74 49.13 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.18 0.592 . . . . 0.0 111.148 170.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 98.3 p -147.94 172.97 13.35 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.344 1.058 . . . . 0.0 112.552 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.92 149.18 46.18 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.077 1.351 . . . . 0.0 110.001 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -82.55 -34.41 27.8 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.433 0.693 . . . . 0.0 111.285 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -141.0 -7.83 1.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.33 1.852 . . . . 0.0 112.785 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.45 28.16 13.25 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.816 1.646 . . . . 0.0 114.319 -170.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.0 p -76.81 157.84 31.26 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.987 -1.071 . . . . 0.0 111.39 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -71.24 144.51 50.05 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.074 -1.016 . . . . 0.0 112.036 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.11 0.83 84.1 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.423 1.011 . . . . 0.0 114.395 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -70.01 149.4 47.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.964 1.306 . . . . 0.0 112.579 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.91 114.22 21.52 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.991 -1.068 . . . . 0.0 109.774 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.7 p -56.96 146.09 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 111.353 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.3 t -124.94 165.8 17.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.99 1.316 . . . . 0.0 111.957 -169.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.8 mt -134.98 143.06 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.725 1.61 . . . . 0.0 108.81 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.66 -157.81 30.33 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.076 0.846 . . . . 0.0 111.85 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.54 157.51 5.15 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.664 0.732 . . . . 0.0 111.91 169.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -57.84 153.08 14.59 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.33 1.052 . . . . 0.0 112.691 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.24 171.24 7.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.911 1.685 . . . . 0.0 112.738 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.3 t -107.2 -3.45 19.81 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -170.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -145.82 -43.93 0.21 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.384 1.073 . . . . 0.0 112.536 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 86.2 p -95.48 -0.3 52.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.52 -3.71 27.76 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.5 1.524 . . . . 0.0 115.924 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -125.66 152.58 45.03 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.524 1.662 . . . . 0.0 111.541 -174.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -137.59 175.48 9.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.656 1.583 . . . . 0.0 111.947 -168.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.0 p -138.41 139.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.7 1.2 . . . . 0.0 109.857 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 mp -122.45 124.51 70.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.968 1.707 . . . . 0.0 106.95 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -149.07 154.03 38.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.104 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.24 155.16 40.28 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.102 -0.999 . . . . 0.0 112.62 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.6 t . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.077 1.751 . . . . 0.0 111.313 171.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 tpp . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.9 173.89 45.44 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.907 1.241 . . . . 0.0 112.699 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.2 m80 57.57 6.22 0.4 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 127.019 2.127 . . . . 0.0 116.182 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -147.4 159.92 43.14 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.169 2.188 . . . . 0.0 110.802 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -133.61 -2.68 3.01 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.863 1.265 . . . . 0.0 113.771 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -155.54 152.67 29.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.327 1.851 . . . . 0.0 110.626 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -145.33 154.81 42.72 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.397 1.479 . . . . 0.0 111.743 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -141.17 2.1 1.67 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.938 1.295 . . . . 0.0 114.317 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -64.07 160.74 17.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.932 1.293 . . . . 0.0 113.15 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -65.79 -12.09 51.33 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.697 1.599 . . . . 0.0 114.989 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.8 t -55.16 153.35 6.88 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.314 1.446 . . . . 0.0 113.323 173.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.41 -175.7 43.98 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.978 1.275 . . . . 0.0 113.366 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -147.52 170.65 16.99 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.85 1.66 . . . . 0.0 111.905 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.2 m -138.87 151.68 68.84 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.228 1.411 . . . . 0.0 111.924 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.11 173.58 13.43 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.727 2.951 . . . . 0.0 112.471 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.34 27.31 9.75 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.872 1.269 . . . . 0.0 113.43 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -162.71 156.52 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 127.916 2.486 . . . . 0.0 110.707 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 t -149.97 29.8 0.73 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 123.58 1.657 . . . . 0.0 114.81 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -69.09 172.39 6.85 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.295 2.238 . . . . 0.0 111.826 169.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 t -154.18 169.53 23.38 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.945 1.298 . . . . 0.0 109.841 171.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.88 139.43 58.76 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 173.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.89 -161.34 32.29 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.267 0.937 . . . . 0.0 114.374 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -98.93 125.61 44.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.077 0.951 . . . . 0.0 110.111 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -134.28 172.47 12.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.572 1.549 . . . . 0.0 112.239 -171.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.4 pt -127.04 154.58 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 126.477 1.911 . . . . 0.0 108.62 171.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.66 123.77 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -141.36 150.22 42.15 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.362 0.665 . . . . 0.0 112.485 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -84.82 134.56 34.3 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.192 0.597 . . . . 0.0 111.635 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -64.83 -13.59 56.49 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.6 t -67.73 -24.68 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.447 1.022 . . . . 0.0 112.399 171.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mp 58.38 166.89 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.898 2.079 . . . . 0.0 113.97 -170.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.0 p -69.64 161.45 74.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 124.626 1.17 . . . . 0.0 112.362 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.96 -16.21 49.03 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.491 2.127 . . . . 0.0 113.004 170.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -74.29 -20.15 60.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.28 1.432 . . . . 0.0 112.894 169.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.5 24.42 14.03 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.004 1.287 . . . . 0.0 113.923 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -128.94 171.22 12.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.048 1.339 . . . . 0.0 112.259 -174.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -54.86 137.32 45.49 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.377 1.071 . . . . 0.0 111.367 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.3 tp -116.6 79.63 1.35 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.355 1.462 . . . . 0.0 110.27 -169.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.72 145.17 29.73 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -169.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -59.39 130.95 49.42 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.803 1.241 . . . . 0.0 109.201 168.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.1 m -128.52 117.37 21.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.436 1.094 . . . . 0.0 110.909 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.87 134.3 89.77 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.512 1.925 . . . . 0.0 112.141 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.59 -10.46 18.68 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.497 2.798 . . . . 0.0 114.795 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.21 6.19 81.85 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 119.01 -0.883 . . . . 0.0 115.254 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -157.7 163.24 38.37 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.94 1.37 . . . . 0.0 112.241 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -90.8 165.62 13.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.318 1.047 . . . . 0.0 111.631 -175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 50.67 35.77 12.53 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.308 1.843 . . . . 0.0 113.707 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.0 m -134.06 138.96 31.78 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 125.385 1.474 . . . . 0.0 111.319 -169.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -46.62 153.15 1.32 Allowed 'Trans proline' 0 C--N 1.354 0.817 1 C-N-CA 125.973 4.449 . . . . 0.0 115.238 169.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.05 147.75 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.687 1.195 . . . . 0.0 110.388 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 m -120.95 173.02 7.5 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.377 1.471 . . . . 0.0 111.347 -168.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.47 143.91 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.875 1.27 . . . . 0.0 111.446 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.1 m -151.41 159.84 32.79 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.136 1.374 . . . . 0.0 111.478 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -62.55 132.95 40.22 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.241 1.961 . . . . 0.0 110.779 173.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.1 tp -63.79 137.28 57.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.284 1.034 . . . . 0.0 111.308 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -135.93 -24.03 1.32 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.298 1.439 . . . . 0.0 112.811 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.14 5.96 22.81 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.147 1.356 . . . . 0.0 114.037 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.3 t -62.48 147.93 47.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.425 1.113 . . . . 0.0 111.788 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.8 m -58.24 -20.29 40.81 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.097 0.959 . . . . 0.0 113.53 172.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.87 -20.98 65.18 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.927 0.891 . . . . 0.0 112.853 173.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -104.29 -1.54 26.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.145 1.778 . . . . 0.0 112.617 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.95 138.81 41.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.807 1.243 . . . . 0.0 111.517 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -136.0 170.43 16.02 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.745 1.218 . . . . 0.0 111.873 -169.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.0 mt -124.69 136.87 59.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 126.514 1.926 . . . . 0.0 107.358 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.6 tp -136.51 126.51 26.02 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.383 1.473 . . . . 0.0 109.506 -169.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -144.25 138.05 27.72 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.15 0.98 . . . . 0.0 110.788 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 t -63.84 141.87 58.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.933 0.493 . . . . 0.0 111.529 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -113.4 -52.27 2.77 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.505 1.122 . . . . 0.0 110.76 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.43 107.49 4.02 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.276 1.03 . . . . 0.0 110.971 169.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.1 m -57.96 -26.56 62.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.939 0.896 . . . . 0.0 111.369 168.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -61.7 -20.81 63.89 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.091 2.156 . . . . 0.0 113.664 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.8 m -130.36 9.39 5.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.242 1.817 . . . . 0.0 112.949 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 47.23 28.55 1.02 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.291 2.236 . . . . 0.0 114.734 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -88.53 142.33 27.79 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.592 -1.318 . . . . 0.0 112.443 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -138.45 141.7 39.47 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.932 1.693 . . . . 0.0 110.891 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.2 p -77.88 147.57 35.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.148 0.579 . . . . 0.0 110.758 172.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.6 mm -128.49 131.41 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.42 1.488 . . . . 0.0 109.507 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.1 m -144.54 148.33 39.75 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 125.918 1.687 . . . . 0.0 110.549 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.9 145.89 28.95 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.121 2.547 . . . . 0.0 111.322 173.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.34 -28.76 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 O-C-N 121.189 -0.945 . . . . 0.0 112.003 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.43 -25.3 74.63 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 123.738 0.685 . . . . 0.0 114.753 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.1 m -144.59 67.37 14.23 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.451 1.5 . . . . 0.0 111.554 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.82 -13.46 37.2 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.416 2.744 . . . . 0.0 113.658 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -73.99 1.99 9.68 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.976 1.71 . . . . 0.0 114.002 170.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m -132.74 173.56 11.23 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.7 1.6 . . . . 0.0 111.782 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -137.4 172.43 12.99 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.453 1.501 . . . . 0.0 112.775 -174.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.9 mm -119.28 123.02 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.098 1.359 . . . . 0.0 110.14 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.45 -161.43 9.75 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.981 1.753 . . . . 0.0 111.144 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -142.07 143.2 32.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.383 1.092 . . . . 0.0 111.703 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.68 -162.32 10.36 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.092 1.33 . . . . 0.0 113.35 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.08 137.71 21.2 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.17 1.388 . . . . 0.0 113.058 -177.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.48 -5.71 65.03 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.771 1.177 . . . . 0.0 114.167 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 47.99 55.91 7.99 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.256 1.822 . . . . 0.0 113.563 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.89 141.12 33.76 Favored Pre-proline 0 N--CA 1.468 0.457 0 C-N-CA 127.262 2.225 . . . . 0.0 107.658 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -66.43 144.18 72.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.142 1.228 . . . . 0.0 109.836 174.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.24 145.13 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.521 1.528 . . . . 0.0 111.992 -172.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.2 t -74.19 119.2 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.194 0.997 . . . . 0.0 110.361 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -129.95 164.64 39.07 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.842 2.057 . . . . 0.0 111.457 -169.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.04 166.34 27.03 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.154 2.569 . . . . 0.0 112.339 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.85 121.05 7.02 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.335 2.023 . . . . 0.0 110.374 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -148.11 -90.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.762 0.825 . . . . 0.0 110.827 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -155.81 17.75 0.38 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.648 1.579 . . . . 0.0 112.727 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -66.47 137.2 56.66 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.583 -0.698 . . . . 0.0 111.802 -174.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.0 m -144.53 160.46 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.788 1.235 . . . . 0.0 112.231 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -129.6 138.0 51.02 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.644 1.578 . . . . 0.0 110.145 169.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -71.4 127.51 32.8 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.67 1.188 . . . . 0.0 108.793 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.8 mt -125.92 115.76 20.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.192 0.997 . . . . 0.0 108.739 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.8 m -136.52 134.49 37.61 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.733 0.813 . . . . 0.0 111.261 -169.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.66 152.11 45.09 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.008 1.323 . . . . 0.0 112.14 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 p -131.61 -178.75 5.0 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.096 1.758 . . . . 0.0 111.373 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.6 p -60.54 -13.0 11.46 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.82 24.45 0.26 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.274 0.94 . . . . 0.0 114.885 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 176.02 -147.6 8.76 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.147 0.974 . . . . 0.0 113.112 -173.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -132.02 167.26 20.0 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.082 2.153 . . . . 0.0 111.233 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -122.27 155.12 36.57 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.923 2.089 . . . . 0.0 109.964 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mt -134.84 117.15 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.01 1.724 . . . . 0.0 108.276 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -134.91 157.21 47.44 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.732 1.213 . . . . 0.0 111.633 -173.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -60.96 -25.69 67.01 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.93 -40.36 1.66 Allowed Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.003 1.763 . . . . 0.0 112.425 -169.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -98.82 4.4 47.59 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 114.06 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 58.08 14.56 2.76 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.282 2.233 . . . . 0.0 114.352 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.4 p -71.13 -24.74 62.34 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.164 0.985 . . . . 0.0 112.597 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.78 172.9 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.867 1.667 . . . . 0.0 111.988 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.0 t -143.74 150.99 39.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.462 3.105 . . . . 0.0 108.816 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -73.51 144.84 45.99 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.41 -0.806 . . . . 0.0 111.507 170.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 93.1 p -154.07 173.98 15.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.447 1.099 . . . . 0.0 112.322 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.7 mt -121.11 170.51 9.48 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.841 2.056 . . . . 0.0 109.503 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -105.06 -33.87 8.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.025 0.93 . . . . 0.0 111.9 -169.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -139.33 -8.51 1.3 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.015 2.126 . . . . 0.0 112.456 170.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.8 24.53 10.87 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 126.211 1.805 . . . . 0.0 114.521 -171.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.5 p -73.26 158.76 34.55 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 111.736 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.72 142.91 54.86 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.21 -0.931 . . . . 0.0 112.009 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.02 6.23 85.74 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.659 1.123 . . . . 0.0 114.444 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.74 137.16 38.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.826 1.313 . . . . 0.0 112.498 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -71.95 134.35 45.91 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.369 -0.832 . . . . 0.0 110.834 174.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.48 155.59 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.462 0.649 . . . . 0.0 110.962 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.6 t -127.11 159.21 34.89 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.359 1.464 . . . . 0.0 110.91 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.97 137.07 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.468 1.507 . . . . 0.0 108.736 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 178.48 178.46 47.87 Favored Glycine 0 N--CA 1.471 0.976 0 C-N-CA 124.674 1.13 . . . . 0.0 111.44 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.87 -41.34 57.98 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.265 1.532 . . . . 0.0 114.19 -173.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -167.62 176.0 6.7 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.944 2.498 . . . . 0.0 111.382 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.12 140.08 35.95 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.332 1.053 . . . . 0.0 111.88 169.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.6 t -62.85 -22.59 66.79 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -171.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -134.01 -35.42 0.95 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.959 1.304 . . . . 0.0 113.076 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.0 t -97.8 2.8 49.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.812 1.245 . . . . 0.0 114.323 -171.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.91 17.6 1.26 Allowed Glycine 0 CA--C 1.544 1.865 0 C-N-CA 125.4 1.476 . . . . 0.0 116.27 -174.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -140.45 149.23 42.3 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.135 1.774 . . . . 0.0 112.142 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -140.89 178.17 7.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.717 2.007 . . . . 0.0 111.18 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.2 141.22 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.77 1.228 . . . . 0.0 109.286 169.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.33 123.62 71.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.575 1.55 . . . . 0.0 106.939 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -145.94 153.19 40.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.665 1.186 . . . . 0.0 109.482 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -67.45 155.28 39.41 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.04 -1.038 . . . . 0.0 112.774 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 77.1 t . . . . . 0 C--O 1.251 1.177 0 C-N-CA 126.171 1.789 . . . . 0.0 111.309 172.228 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.44 174.95 43.38 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.331 0.967 . . . . 0.0 113.664 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -139.25 5.05 2.26 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.369 1.467 . . . . 0.0 113.909 -176.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -63.85 157.04 25.67 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.624 1.17 . . . . 0.0 112.761 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -149.65 159.78 44.05 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.252 1.421 . . . . 0.0 110.947 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -133.96 -3.89 2.82 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.159 1.384 . . . . 0.0 113.887 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -132.29 -9.4 3.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.679 1.192 . . . . 0.0 114.096 -175.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -149.68 134.2 17.54 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.28 1.432 . . . . 0.0 110.574 173.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -137.61 -8.33 1.67 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -62.45 -11.82 18.21 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.204 1.802 . . . . 0.0 114.761 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.3 m -130.57 18.38 5.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.213 1.805 . . . . 0.0 112.526 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.09 14.35 0.76 Allowed Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.671 1.129 . . . . 0.0 115.431 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -149.46 158.32 44.07 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.055 1.742 . . . . 0.0 110.98 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.7 p -151.76 161.53 29.28 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.195 1.398 . . . . 0.0 112.244 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.39 151.07 24.39 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.679 2.919 . . . . 0.0 114.596 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.77 23.44 4.28 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.431 1.492 . . . . 0.0 112.869 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 p -68.64 161.56 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.804 2.042 . . . . 0.0 111.097 171.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.2 t -144.66 12.17 1.47 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.7 mt 55.73 176.93 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.537 1.935 . . . . 0.0 113.828 -172.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -160.76 169.28 23.07 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.095 1.358 . . . . 0.0 109.928 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.16 133.07 50.75 Favored 'General case' 0 CA--C 1.548 0.865 0 O-C-N 121.855 -0.528 . . . . 0.0 111.703 170.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.24 -164.99 37.95 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.841 0.734 . . . . 0.0 114.5 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -97.07 126.48 42.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.982 0.913 . . . . 0.0 110.318 171.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.15 172.05 13.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.56 1.544 . . . . 0.0 112.442 -170.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.6 pt -127.17 156.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.472 1.909 . . . . 0.0 108.763 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.8 mt -128.38 126.75 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.91 151.82 39.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.316 0.646 . . . . 0.0 111.735 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -86.2 138.36 31.93 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.75 -0.594 . . . . 0.0 112.038 -173.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.8 mmm180 -62.05 -19.08 62.52 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.4 -24.41 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 119.269 0.941 . . . . 0.0 112.936 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 mp 58.59 166.35 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.684 1.994 . . . . 0.0 114.178 -170.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.7 t -73.28 145.99 86.21 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 124.392 1.077 . . . . 0.0 111.936 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.27 -19.49 28.06 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.611 2.874 . . . . 0.0 113.754 168.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -67.8 -18.7 64.94 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.848 1.659 . . . . 0.0 113.348 172.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.23 26.62 13.63 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.853 1.692 . . . . 0.0 113.983 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -134.32 160.58 37.49 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.727 1.211 . . . . 0.0 111.918 -171.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -54.67 129.37 36.42 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.086 1.355 . . . . 0.0 111.323 176.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 24.3 tp -98.73 79.89 2.48 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.731 1.213 . . . . 0.0 110.552 -172.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.78 141.23 36.48 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.574 1.149 . . . . 0.0 113.987 -169.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.415 HD13 ' CZ2' ' A' ' 63' ' ' TRP . 0.6 OUTLIER -60.99 125.04 22.28 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.326 1.45 . . . . 0.0 107.957 169.001 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.7 m -126.33 124.64 40.74 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.344 1.058 . . . . 0.0 112.054 -169.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.59 134.37 95.99 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.905 2.082 . . . . 0.0 111.885 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.83 -10.8 19.99 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.366 2.71 . . . . 0.0 114.462 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.89 6.16 76.38 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.962 -0.91 . . . . 0.0 115.262 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -157.17 166.66 32.59 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.005 1.402 . . . . 0.0 112.278 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -89.36 165.42 14.38 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.388 1.075 . . . . 0.0 111.828 -174.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 45.95 43.64 10.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.582 1.953 . . . . 0.0 113.497 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 m -138.31 139.01 23.91 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 125.507 1.523 . . . . 0.0 110.813 -169.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -45.84 157.81 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.881 1 C-N-CA 126.279 4.653 . . . . 0.0 115.483 169.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.15 151.02 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.316 1.446 . . . . 0.0 110.42 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 m -130.92 170.28 14.65 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.174 1.39 . . . . 0.0 110.339 -169.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.12 146.54 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.993 -1.067 . . . . 0.0 112.075 175.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -150.6 160.41 32.72 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.642 1.177 . . . . 0.0 112.223 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.06 128.03 27.39 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.46 2.774 . . . . 0.0 111.75 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 tp -64.11 136.22 57.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.481 0.713 . . . . 0.0 111.042 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -134.47 -26.89 1.39 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.206 1.403 . . . . 0.0 112.606 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.8 8.76 13.32 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.293 1.425 . . . . 0.0 113.938 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.5 t -66.98 160.13 27.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.596 1.198 . . . . 0.0 111.941 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.5 m -73.6 -16.28 61.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.088 0.955 . . . . 0.0 111.665 -176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.26 -16.73 58.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.064 1.745 . . . . 0.0 112.829 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -101.5 -5.45 25.19 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.02 1.728 . . . . 0.0 112.343 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.97 143.23 36.93 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.991 1.316 . . . . 0.0 111.735 -174.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.415 ' CZ2' HD13 ' A' ' 40' ' ' LEU . 90.3 m95 -136.4 168.12 20.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.542 1.163 . . . . 0.0 112.333 -169.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.2 mt -121.56 134.82 63.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.92 2.088 . . . . 0.0 106.654 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.1 tp -134.79 126.82 29.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.49 1.516 . . . . 0.0 109.655 -169.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -143.0 140.25 30.94 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.146 0.978 . . . . 0.0 110.894 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.7 t -65.92 140.23 58.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.707 0.403 . . . . 0.0 111.132 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -112.87 -51.2 2.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.414 1.086 . . . . 0.0 111.026 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.62 108.7 4.41 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.469 1.107 . . . . 0.0 110.93 169.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.1 m -58.08 -26.59 62.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.83 0.852 . . . . 0.0 111.188 168.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -61.36 -20.6 63.18 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.136 2.174 . . . . 0.0 113.51 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t -130.48 6.92 4.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.851 1.66 . . . . 0.0 113.401 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 48.1 31.29 2.44 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.26 1.824 . . . . 0.0 114.035 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -89.03 143.46 26.84 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.266 -0.896 . . . . 0.0 111.848 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -138.53 141.61 39.32 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.443 1.497 . . . . 0.0 110.795 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.9 p -78.02 147.44 34.82 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.092 0.557 . . . . 0.0 110.678 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.2 mm -127.63 128.09 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.48 1.512 . . . . 0.0 109.302 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.1 m -142.16 141.01 20.23 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.674 1.59 . . . . 0.0 110.5 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.09 143.41 32.33 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.853 2.369 . . . . 0.0 111.224 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.86 -28.8 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 121.297 -0.877 . . . . 0.0 111.631 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.17 -10.51 86.01 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.4 m -156.4 68.05 4.6 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.846 1.658 . . . . 0.0 110.469 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -63.55 -17.84 61.76 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.789 2.992 . . . . 0.0 113.5 -173.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -76.24 6.15 5.91 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 127.848 2.459 . . . . 0.0 114.657 171.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.7 m -131.23 175.31 9.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.977 1.711 . . . . 0.0 112.088 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -139.06 171.99 13.5 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.546 1.538 . . . . 0.0 113.28 -172.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.7 mm -120.17 130.79 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.272 1.429 . . . . 0.0 110.601 174.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.47 -157.63 7.34 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.645 1.593 . . . . 0.0 111.422 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -141.7 142.61 33.33 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.24 1.016 . . . . 0.0 111.848 -172.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.94 -163.21 10.57 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.247 1.403 . . . . 0.0 113.381 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.2 139.96 22.43 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.011 1.324 . . . . 0.0 113.136 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.46 -2.29 73.83 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.512 1.053 . . . . 0.0 114.292 -173.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 48.7 56.34 7.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.18 1.792 . . . . 0.0 113.41 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.7 p -133.83 136.88 27.34 Favored Pre-proline 0 C--O 1.238 0.49 0 C-N-CA 127.548 2.339 . . . . 0.0 107.751 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.75 142.77 59.13 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.202 1.268 . . . . 0.0 109.462 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.03 149.29 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.023 1.329 . . . . 0.0 111.472 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 t -76.22 134.93 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.851 0.861 . . . . 0.0 110.402 174.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.5 mt -141.17 161.62 52.27 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.649 1.58 . . . . 0.0 112.039 -169.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.9 165.65 29.18 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.062 2.508 . . . . 0.0 111.765 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.62 124.07 9.97 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.5 2.133 . . . . 0.0 110.702 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -148.01 -89.61 0.08 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.076 0.95 . . . . 0.0 110.592 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -154.82 15.95 0.43 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.431 1.493 . . . . 0.0 112.901 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -67.01 134.36 51.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.425 0.69 . . . . 0.0 111.906 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -144.92 161.03 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.949 1.3 . . . . 0.0 112.069 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -130.99 137.61 49.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.252 1.421 . . . . 0.0 110.762 169.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.9 m -72.19 131.74 43.17 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.899 1.28 . . . . 0.0 108.705 169.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.7 mt -121.94 73.49 1.09 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.071 0.938 . . . . 0.0 109.324 -176.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 93.3 m -73.42 119.47 17.7 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.755 1.222 . . . . 0.0 110.656 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.7 tp -68.41 147.63 51.8 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.077 0.551 . . . . 0.0 111.271 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.0 p -133.82 177.05 8.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.987 1.715 . . . . 0.0 110.515 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.9 m -59.88 -12.69 8.18 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.93 31.25 0.28 Allowed Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.761 1.172 . . . . 0.0 114.096 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.29 -160.62 34.22 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.976 1.274 . . . . 0.0 112.072 -174.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -127.92 172.11 11.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.255 1.822 . . . . 0.0 112.075 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -136.69 150.18 48.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.21 1.804 . . . . 0.0 110.099 170.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.1 mt -129.1 114.84 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.103 0.961 . . . . 0.0 109.516 -169.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -134.8 155.74 50.08 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.124 0.969 . . . . 0.0 112.248 -169.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.86 -28.99 69.88 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.68 -40.6 1.61 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.063 1.792 . . . . 0.0 112.756 -172.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.08 -5.2 59.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.974 1.309 . . . . 0.0 113.983 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? 57.11 17.86 3.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.623 1.969 . . . . 0.0 113.374 -169.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 49.0 p -71.02 -24.46 62.37 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.195 0.998 . . . . 0.0 112.168 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.9 m -144.26 173.68 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.006 1.723 . . . . 0.0 112.162 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.4 t -146.14 154.81 42.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.481 2.712 . . . . 0.0 110.044 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -73.19 142.04 47.37 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.464 -0.773 . . . . 0.0 111.777 170.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 91.7 p -152.92 170.47 20.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.025 1.33 . . . . 0.0 112.63 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.81 156.06 31.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.954 1.302 . . . . 0.0 110.386 173.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -89.93 -31.47 17.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.281 0.632 . . . . 0.0 111.501 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -138.07 -4.12 1.74 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.556 1.542 . . . . 0.0 113.639 172.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.85 27.26 2.26 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.303 1.841 . . . . 0.0 114.452 -169.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.6 p -76.33 161.0 29.09 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.899 0.88 . . . . 0.0 111.471 174.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.72 142.39 51.47 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.911 -1.118 . . . . 0.0 111.359 169.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.41 5.79 82.79 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.322 0.963 . . . . 0.0 114.019 -173.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.53 140.57 49.95 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.906 1.283 . . . . 0.0 111.858 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.56 111.19 14.36 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 170.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.32 147.39 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.634 0.73 . . . . 0.0 111.175 172.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.3 m -134.22 171.54 14.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.76 1.624 . . . . 0.0 111.399 -169.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 70.0 mt -134.34 143.69 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.983 1.313 . . . . 0.0 109.231 -173.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.03 179.04 47.22 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.895 1.236 . . . . 0.0 111.65 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.47 -42.47 61.62 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.091 1.445 . . . . 0.0 114.266 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -169.3 174.28 6.18 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.266 2.626 . . . . 0.0 111.027 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -142.46 141.83 32.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.185 0.994 . . . . 0.0 111.866 169.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 t -66.26 -18.61 65.46 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -138.62 -43.66 0.49 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.194 0.998 . . . . 0.0 113.293 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.8 p -86.07 0.49 53.31 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.081 1.352 . . . . 0.0 114.381 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.95 19.68 0.96 Allowed Glycine 0 CA--C 1.541 1.666 0 C-N-CA 126.505 2.002 . . . . 0.0 116.622 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -144.94 149.78 35.83 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.069 1.935 . . . . 0.0 112.057 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -139.4 177.71 7.73 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.988 1.715 . . . . 0.0 112.368 -169.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.3 p -140.78 139.93 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.831 1.252 . . . . 0.0 109.607 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.17 125.87 74.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 125.821 1.648 . . . . 0.0 107.192 172.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -148.58 153.76 38.81 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.646 1.178 . . . . 0.0 109.46 -170.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -67.71 155.11 39.99 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.921 -1.112 . . . . 0.0 112.775 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.145 1.778 . . . . 0.0 111.323 171.908 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 tpp . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -169.48 16.18 0.06 OUTLIER Glycine 0 CA--C 1.539 1.575 0 N-CA-C 116.154 1.222 . . . . 0.0 116.154 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -141.95 0.76 1.42 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 118.702 1.251 . . . . 0.0 113.996 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -142.42 162.01 36.56 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.22 1.408 . . . . 0.0 111.56 -177.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -138.26 16.19 2.79 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.94 1.296 . . . . 0.0 112.722 -173.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 62.52 2.54 0.93 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.194 2.197 . . . . 0.0 114.627 -169.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -149.33 172.34 15.05 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.917 2.087 . . . . 0.0 110.72 171.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -136.87 -4.62 1.96 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.197 1.399 . . . . 0.0 113.516 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -63.96 -19.31 65.05 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.297 1.439 . . . . 0.0 114.333 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -127.69 16.98 6.92 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.819 1.648 . . . . 0.0 112.221 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.8 m 55.24 -10.92 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 129.484 3.114 . . . . 0.0 119.088 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.84 14.23 0.03 OUTLIER Glycine 0 CA--C 1.537 1.45 0 N-CA-C 116.7 1.44 . . . . 0.0 116.7 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -140.58 168.07 20.67 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.058 1.429 . . . . 0.0 111.66 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.9 m -60.7 155.1 53.32 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 124.432 1.093 . . . . 0.0 112.542 174.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.0 134.78 43.37 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.639 2.893 . . . . 0.0 114.402 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.4 27.13 0.93 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.137 1.375 . . . . 0.0 112.69 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.19 151.41 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.738 1.215 . . . . 0.0 110.648 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 t -143.92 13.66 1.68 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.6 mt 59.62 166.9 0.06 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.286 2.235 . . . . 0.0 113.973 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.2 m -150.73 160.17 44.03 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.073 1.749 . . . . 0.0 109.382 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.52 131.14 45.66 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.652 -0.655 . . . . 0.0 111.362 171.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.93 -166.11 39.43 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -95.52 124.1 39.39 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.231 1.012 . . . . 0.0 110.037 172.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -133.17 171.83 13.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.098 1.359 . . . . 0.0 112.259 -173.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 pt -124.57 153.05 31.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.888 1.675 . . . . 0.0 108.431 170.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.7 mt -128.49 118.97 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -138.56 149.6 45.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.504 0.669 . . . . 0.0 112.212 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -77.6 136.58 38.27 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.04 -0.413 . . . . 0.0 111.463 -173.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -64.94 -24.28 67.47 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.3 t -65.98 -38.25 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.819 0.847 . . . . 0.0 112.489 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 73.3 mt 54.48 173.25 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.104 1.761 . . . . 0.0 114.66 -169.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.0 p -100.72 163.91 17.19 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.685 1.194 . . . . 0.0 112.068 176.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.2 -2.61 6.04 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.335 2.69 . . . . 0.0 114.363 170.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -73.41 -13.4 61.07 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.979 1.312 . . . . 0.0 113.967 172.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.25 14.1 75.17 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.431 172.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -133.05 167.31 20.54 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.974 1.309 . . . . 0.0 113.014 -175.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -60.78 156.3 17.41 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.802 1.241 . . . . 0.0 113.136 -175.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.3 mt -124.37 72.84 1.21 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.125 1.77 . . . . 0.0 109.8 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.46 142.86 33.86 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.445 1.098 . . . . 0.0 113.292 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.8 tp -56.74 135.76 55.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.857 0.863 . . . . 0.0 109.218 169.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 90.5 m -132.26 122.55 25.35 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.266 1.026 . . . . 0.0 110.827 -173.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -64.07 138.13 97.32 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 127.128 2.171 . . . . 0.0 111.907 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -74.06 -12.1 23.51 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.299 2.666 . . . . 0.0 114.933 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.29 7.26 86.94 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.006 0.812 . . . . 0.0 114.76 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -154.09 166.42 33.11 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.947 1.699 . . . . 0.0 111.764 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -93.83 164.69 13.02 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.936 0.894 . . . . 0.0 111.812 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.6 tpt85 46.68 40.12 8.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.816 2.046 . . . . 0.0 114.032 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.7 m -133.98 142.1 42.15 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.563 1.545 . . . . 0.0 111.057 -169.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -44.67 156.28 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.828 1 C-N-CA 126.003 4.469 . . . . 0.0 115.589 169.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.88 158.43 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.798 1.239 . . . . 0.0 110.207 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -128.71 170.28 13.48 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.698 1.599 . . . . 0.0 110.971 -169.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.8 p -125.49 142.29 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.833 1.253 . . . . 0.0 111.257 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 m -159.04 168.49 12.3 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.711 1.204 . . . . 0.0 113.004 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -49.97 161.56 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.677 3.585 . . . . 0.0 114.857 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.3 tp -123.01 132.26 54.05 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.739 1.216 . . . . 0.0 111.343 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -134.19 -29.27 1.27 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.922 2.089 . . . . 0.0 112.27 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.53 4.09 1.98 Allowed Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.642 1.417 . . . . 0.0 116.642 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -71.0 165.1 24.19 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.056 1.928 . . . . 0.0 113.391 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.2 m -69.02 -16.98 63.85 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.29 -24.84 62.23 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.022 0.828 . . . . 0.0 112.28 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.62 6.28 11.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.084 2.554 . . . . 0.0 112.409 -169.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.99 148.07 39.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.979 1.312 . . . . 0.0 110.745 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -137.51 174.02 11.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 122.69 1.233 . . . . 0.0 112.901 -168.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.8 mt -122.96 139.15 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.194 2.198 . . . . 0.0 107.09 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.7 tp -137.31 123.22 20.14 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.409 1.483 . . . . 0.0 109.044 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -144.13 138.34 28.12 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.507 0.723 . . . . 0.0 111.117 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.2 t -65.96 139.33 58.23 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.734 0.414 . . . . 0.0 111.002 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -111.93 -50.61 2.9 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.809 1.244 . . . . 0.0 110.282 174.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.01 106.9 3.97 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.432 1.093 . . . . 0.0 110.84 169.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.4 m -58.05 -25.5 61.3 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.959 0.903 . . . . 0.0 111.506 168.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -63.73 -20.99 66.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.022 2.129 . . . . 0.0 113.495 174.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -130.1 9.02 5.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.126 1.77 . . . . 0.0 112.644 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 45.87 32.69 1.36 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.422 2.289 . . . . 0.0 114.217 -169.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.5 p -91.62 140.95 29.23 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.919 -1.113 . . . . 0.0 112.091 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -136.84 144.89 43.86 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.878 1.671 . . . . 0.0 110.733 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.1 p -77.78 150.64 34.29 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.192 0.597 . . . . 0.0 110.965 170.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.9 mm -130.44 129.73 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.976 1.71 . . . . 0.0 108.519 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.1 p -151.98 155.09 33.4 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.171 0.988 . . . . 0.0 111.866 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.88 146.05 29.19 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.994 2.462 . . . . 0.0 110.841 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.49 -24.26 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.851 -1.156 . . . . 0.0 113.072 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.71 -19.54 57.89 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.033 0.825 . . . . 0.0 114.728 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.0 m -142.22 62.58 13.9 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 125.66 1.584 . . . . 0.0 111.266 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.36 -13.98 39.37 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.268 2.645 . . . . 0.0 113.491 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -74.08 6.84 3.1 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.293 1.837 . . . . 0.0 114.001 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -129.75 175.54 8.75 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.637 1.575 . . . . 0.0 111.331 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -141.0 167.96 20.94 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.618 1.567 . . . . 0.0 111.07 -172.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.7 mm -122.23 128.04 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.296 1.038 . . . . 0.0 110.552 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.77 -159.18 7.88 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.985 1.755 . . . . 0.0 111.243 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -143.83 148.32 35.36 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.595 1.197 . . . . 0.0 111.996 -174.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.51 -160.36 9.56 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.397 1.475 . . . . 0.0 112.968 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.46 138.35 27.68 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.832 1.253 . . . . 0.0 112.959 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.6 -3.59 63.32 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.612 1.101 . . . . 0.0 114.284 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 47.67 54.21 10.14 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.106 1.762 . . . . 0.0 113.602 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.98 138.44 30.68 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 127.53 2.332 . . . . 0.0 107.473 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.78 144.45 59.41 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.292 1.328 . . . . 0.0 109.284 174.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.01 149.87 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.253 1.421 . . . . 0.0 111.343 -174.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.96 134.26 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.01 0.924 . . . . 0.0 110.677 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.0 mt -139.23 162.1 53.86 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.586 1.555 . . . . 0.0 110.784 -172.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.69 161.14 45.02 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.34 2.027 . . . . 0.0 111.574 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.33 119.75 6.34 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.564 2.176 . . . . 0.0 110.307 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -146.49 -82.64 0.13 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.309 1.044 . . . . 0.0 110.793 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -154.72 10.48 0.35 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.005 1.322 . . . . 0.0 113.945 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -67.39 128.65 37.21 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.391 -0.818 . . . . 0.0 111.776 -175.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.4 m -143.6 163.76 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.757 1.623 . . . . 0.0 111.234 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -130.47 145.78 51.9 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.034 1.333 . . . . 0.0 110.332 171.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.2 m -74.94 134.96 41.43 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.848 1.259 . . . . 0.0 109.222 169.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.85 123.85 44.66 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.389 1.075 . . . . 0.0 109.49 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.3 m -135.09 127.17 29.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.952 0.901 . . . . 0.0 110.491 -169.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.1 153.24 41.41 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.795 0.807 . . . . 0.0 113.049 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.7 p -127.99 -177.45 4.13 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.422 1.889 . . . . 0.0 110.15 171.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.1 p -60.9 -14.59 23.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.61 30.71 0.26 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.51 1.052 . . . . 0.0 114.142 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.49 -149.78 9.61 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.795 1.188 . . . . 0.0 112.537 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -132.64 170.19 15.57 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.972 2.109 . . . . 0.0 112.358 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -134.73 152.12 51.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.306 2.643 . . . . 0.0 108.805 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.2 mt -132.46 125.13 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.826 1.251 . . . . 0.0 108.242 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -137.25 160.09 40.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.246 1.018 . . . . 0.0 112.342 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -63.67 -22.19 66.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 -170.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.87 -40.5 1.77 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.614 1.578 . . . . 0.0 112.725 -171.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -98.38 5.67 47.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.94 1.696 . . . . 0.0 113.401 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 57.11 18.04 3.86 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.156 2.182 . . . . 0.0 114.227 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p -74.37 -24.6 59.18 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.251 -0.905 . . . . 0.0 112.384 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.1 m -143.73 174.61 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.661 1.584 . . . . 0.0 112.104 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t -148.45 154.36 39.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.96 2.504 . . . . 0.0 110.111 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -70.29 143.59 52.02 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.386 -0.821 . . . . 0.0 111.802 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.1 p -151.54 172.46 15.97 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.154 1.382 . . . . 0.0 112.621 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.0 mt -128.81 177.59 6.96 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.338 1.855 . . . . 0.0 110.095 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -123.93 -31.93 3.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.258 1.423 . . . . 0.0 111.332 -169.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -143.41 -5.54 0.84 Allowed 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 173.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.17 34.61 17.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.692 1.597 . . . . 0.0 114.786 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.4 p -90.98 160.78 15.45 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.323 -0.861 . . . . 0.0 111.946 171.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.06 142.98 52.61 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.756 -1.215 . . . . 0.0 112.139 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.49 -0.5 87.83 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.535 1.064 . . . . 0.0 114.24 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -63.76 142.99 58.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.102 1.761 . . . . 0.0 112.443 174.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.54 116.78 24.05 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.144 -0.972 . . . . 0.0 109.759 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.3 p -58.82 152.92 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.24 1.016 . . . . 0.0 112.214 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.6 m -130.26 168.88 16.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.536 1.534 . . . . 0.0 111.767 -170.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.2 mt -136.65 143.38 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.217 1.407 . . . . 0.0 109.535 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 178.93 178.2 48.03 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.03 1.3 . . . . 0.0 111.905 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.59 -42.5 44.75 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 119.258 1.529 . . . . 0.0 114.562 -172.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -167.28 176.31 6.8 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 129.091 2.956 . . . . 0.0 108.374 172.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.53 137.93 35.87 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.228 -0.92 . . . . 0.0 112.364 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.2 t -59.93 -21.53 61.25 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.958 1.703 . . . . 0.0 115.218 -169.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -134.34 -36.51 0.89 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.399 1.08 . . . . 0.0 113.613 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -103.41 2.44 33.87 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.86 10.81 1.44 Allowed Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.294 1.426 . . . . 0.0 115.377 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -131.51 142.67 50.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.849 1.66 . . . . 0.0 109.921 -169.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -139.41 175.89 9.18 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.692 1.597 . . . . 0.0 111.85 -168.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.71 139.56 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.848 1.259 . . . . 0.0 109.403 169.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.42 125.49 73.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.731 1.613 . . . . 0.0 107.088 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.07 153.91 38.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.733 1.213 . . . . 0.0 108.974 -170.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -68.63 155.6 39.71 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.923 -1.111 . . . . 0.0 112.497 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.6 t . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.107 1.763 . . . . 0.0 111.279 171.807 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -151.25 159.37 44.4 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.356 1.862 . . . . 0.0 109.424 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.44 140.65 58.89 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 121.562 -0.711 . . . . 0.0 112.243 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.45 -161.7 33.81 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.24 0.924 . . . . 0.0 114.426 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -98.44 126.75 44.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.187 0.995 . . . . 0.0 110.338 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -135.59 171.52 14.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.13 1.372 . . . . 0.0 112.701 -171.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.4 pt -124.82 153.62 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 126.329 1.852 . . . . 0.0 108.393 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.63 122.56 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -140.09 147.45 40.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.537 0.735 . . . . 0.0 111.393 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -75.62 136.7 40.46 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.918 -0.489 . . . . 0.0 111.117 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.7 tpt85 -66.28 -20.17 66.03 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -171.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.4 t . . . . . 0 N--CA 1.481 1.104 0 C-N-CA 124.809 1.244 . . . . 0.0 112.546 173.019 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.8 tp . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 121.325 0.583 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.7 144.12 30.45 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -169.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.79 132.38 53.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.653 1.181 . . . . 0.0 109.246 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.8 m -130.7 118.85 21.52 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.292 1.037 . . . . 0.0 111.139 -169.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -61.54 137.38 94.8 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 126.305 1.842 . . . . 0.0 112.513 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.57 -13.78 20.15 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.441 2.761 . . . . 0.0 114.926 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.25 8.15 84.03 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -153.58 161.95 41.72 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.811 1.644 . . . . 0.0 111.732 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -89.77 165.73 13.98 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.007 0.923 . . . . 0.0 111.586 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 49.57 38.54 15.02 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.773 1.629 . . . . 0.0 113.813 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.4 m -136.2 141.17 35.14 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 125.562 1.545 . . . . 0.0 111.322 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -45.55 154.98 0.51 Allowed 'Trans proline' 0 C--N 1.353 0.804 1 C-N-CA 126.167 4.578 . . . . 0.0 115.49 169.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.3 t -110.89 153.96 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.065 1.346 . . . . 0.0 110.118 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 m -128.13 172.51 10.92 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.695 1.598 . . . . 0.0 110.938 -169.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.97 144.71 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.692 1.197 . . . . 0.0 111.42 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -149.54 158.98 37.31 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 124.921 1.288 . . . . 0.0 111.872 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -63.24 130.35 28.41 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.279 1.986 . . . . 0.0 110.527 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.6 tp -63.28 136.3 57.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.373 1.069 . . . . 0.0 111.428 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -130.36 -26.87 2.26 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.192 1.797 . . . . 0.0 112.021 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.64 4.68 19.32 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.451 1.5 . . . . 0.0 114.175 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.4 p -65.74 159.45 25.09 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.783 1.291 . . . . 0.0 113.209 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -62.66 -19.1 63.5 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -68.55 -27.21 65.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.907 0.883 . . . . 0.0 112.324 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -102.38 -7.46 21.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.9 1.68 . . . . 0.0 113.197 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.64 146.37 28.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.452 1.101 . . . . 0.0 111.456 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -138.31 170.48 15.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.471 1.129 . . . . 0.0 111.858 -169.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.4 mt -121.2 136.0 59.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 127.294 2.238 . . . . 0.0 107.126 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.3 tp -137.18 124.44 21.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.274 1.43 . . . . 0.0 109.727 -170.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -141.84 140.21 32.88 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.605 0.762 . . . . 0.0 111.134 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.7 t -65.74 139.37 58.35 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.833 0.453 . . . . 0.0 110.988 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -115.19 -47.27 2.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.289 1.036 . . . . 0.0 111.595 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.37 109.48 3.73 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.308 1.043 . . . . 0.0 111.059 170.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -57.94 -27.58 63.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.828 0.851 . . . . 0.0 111.101 168.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -60.62 -21.28 62.54 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.127 2.171 . . . . 0.0 113.574 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -130.21 10.84 5.4 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.869 1.668 . . . . 0.0 112.737 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 46.36 28.51 0.72 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.967 2.107 . . . . 0.0 113.858 -168.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 p -89.71 140.03 29.98 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.85 -1.156 . . . . 0.0 112.424 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -135.26 142.93 46.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.137 1.775 . . . . 0.0 111.322 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.0 p -78.33 148.5 33.75 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.032 0.533 . . . . 0.0 110.767 172.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.2 mm -128.67 130.16 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.547 1.539 . . . . 0.0 109.807 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 m -144.8 149.65 43.72 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 126.208 1.803 . . . . 0.0 110.232 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.91 148.1 31.45 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.007 2.471 . . . . 0.0 111.143 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 m -66.18 -25.48 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 120.757 -1.215 . . . . 0.0 113.199 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.67 -21.82 65.61 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.762 0.696 . . . . 0.0 114.389 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.3 m -143.7 66.75 15.54 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 125.73 1.612 . . . . 0.0 111.047 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.23 -13.19 30.72 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.894 2.396 . . . . 0.0 113.678 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -76.55 4.69 8.73 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.046 1.738 . . . . 0.0 114.297 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.6 p -139.19 175.29 9.68 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.595 1.543 . . . . 0.0 112.579 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -138.53 171.49 14.28 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.357 1.463 . . . . 0.0 113.195 -169.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.8 mm -120.71 127.91 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.16 1.384 . . . . 0.0 110.364 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.84 -155.74 6.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.759 1.647 . . . . 0.0 110.968 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -143.25 145.06 32.41 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.492 1.146 . . . . 0.0 112.053 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.66 -162.99 10.97 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.428 1.49 . . . . 0.0 113.26 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.16 136.51 23.87 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.174 1.39 . . . . 0.0 113.054 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.77 -4.48 63.49 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.738 1.161 . . . . 0.0 114.268 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 48.54 54.71 10.09 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.425 1.89 . . . . 0.0 113.567 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.86 140.24 37.6 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 127.454 2.301 . . . . 0.0 107.674 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.28 141.21 46.51 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.076 1.184 . . . . 0.0 109.278 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.5 151.6 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.348 1.459 . . . . 0.0 111.681 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.3 t -76.91 134.6 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.115 0.966 . . . . 0.0 110.858 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -139.74 160.52 60.75 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.032 1.733 . . . . 0.0 111.825 -169.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.68 164.19 32.23 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.965 2.443 . . . . 0.0 111.983 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.71 120.51 6.73 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.43 2.087 . . . . 0.0 110.516 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -147.0 -90.91 0.09 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.0 0.92 . . . . 0.0 110.793 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -155.52 17.94 0.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.315 1.446 . . . . 0.0 113.096 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -67.36 136.33 54.62 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.486 -0.759 . . . . 0.0 111.99 -173.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.9 m -145.09 161.11 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.907 1.283 . . . . 0.0 112.545 -175.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -131.36 137.24 48.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.671 1.588 . . . . 0.0 110.737 169.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.1 m -68.49 129.67 40.6 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 169.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 44.3 mt -127.08 116.59 20.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.22 1.008 . . . . 0.0 108.693 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 m -131.6 128.29 38.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.813 0.845 . . . . 0.0 111.295 -169.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp -69.06 151.43 46.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.266 1.027 . . . . 0.0 112.147 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.6 p -129.02 -176.62 3.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.128 1.771 . . . . 0.0 111.465 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.2 p -60.34 -15.89 29.8 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.66 18.17 0.24 Allowed Glycine 0 CA--C 1.534 1.253 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.07 -150.39 8.33 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.15 1.357 . . . . 0.0 112.061 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -133.66 168.22 19.08 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.694 1.998 . . . . 0.0 111.693 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -130.0 148.71 51.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.257 2.223 . . . . 0.0 109.968 174.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.85 122.94 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.779 1.231 . . . . 0.0 109.563 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -137.96 160.4 39.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.73 1.212 . . . . 0.0 112.675 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.35 -24.38 66.42 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -172.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 124.93 -40.22 1.93 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.519 1.533 . . . . 0.0 113.077 -173.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -93.47 -3.05 53.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.298 1.439 . . . . 0.0 113.511 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 70.16 14.51 7.67 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.609 2.364 . . . . 0.0 113.413 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.2 p -72.75 -23.79 60.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.747 1.219 . . . . 0.0 112.703 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.3 m -146.02 172.66 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.91 1.684 . . . . 0.0 111.833 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.0 m -143.82 155.18 44.05 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.076 2.151 . . . . 0.0 111.214 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 38.0 m0 -73.1 140.58 47.23 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.938 -0.477 . . . . 0.0 111.848 169.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.3 p -153.56 170.71 20.14 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.225 1.41 . . . . 0.0 112.547 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.88 164.88 14.39 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.821 1.648 . . . . 0.0 110.068 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -99.62 -32.84 10.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.669 0.787 . . . . 0.0 111.623 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -143.83 -0.8 1.02 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.482 1.913 . . . . 0.0 114.196 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 50.31 27.49 2.72 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.125 2.17 . . . . 0.0 115.9 -172.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.2 p -79.4 160.0 26.85 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.901 -1.124 . . . . 0.0 112.663 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.71 138.55 58.46 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.606 0.762 . . . . 0.0 112.152 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.03 -0.3 89.86 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.658 1.123 . . . . 0.0 114.757 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -76.28 154.17 35.36 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.798 1.299 . . . . 0.0 113.169 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -81.77 122.73 28.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.058 -1.026 . . . . 0.0 110.71 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.12 151.43 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.094 0.958 . . . . 0.0 111.011 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.3 m -134.83 168.42 19.09 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.7 1.6 . . . . 0.0 111.283 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.2 mt -132.77 145.12 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.007 1.323 . . . . 0.0 109.268 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.6 -161.28 34.99 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 123.813 0.721 . . . . 0.0 112.529 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 149.16 17.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 117.828 0.814 . . . . 0.0 111.956 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.68 116.38 2.47 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.39 1.476 . . . . 0.0 113.934 -172.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.84 157.23 37.86 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.4 t -87.66 -12.98 43.84 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -133.64 -37.86 0.92 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.48 1.112 . . . . 0.0 113.44 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.4 p -104.81 2.18 29.85 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.857 1.263 . . . . 0.0 114.26 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.47 10.94 1.77 Allowed Glycine 0 CA--C 1.542 1.749 0 C-N-CA 125.888 1.708 . . . . 0.0 115.819 -176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -135.46 145.98 47.72 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.435 1.894 . . . . 0.0 111.225 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -138.06 178.51 7.07 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 126.949 2.1 . . . . 0.0 111.237 -168.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.31 138.09 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 124.169 0.987 . . . . 0.0 109.36 168.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.04 124.2 72.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 125.947 1.699 . . . . 0.0 107.215 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -147.93 152.5 37.65 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.535 1.134 . . . . 0.0 109.432 -170.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.74 155.58 38.94 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.046 -1.034 . . . . 0.0 112.909 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.133 1.773 . . . . 0.0 111.216 171.815 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 CA--C 1.543 0.683 0 CA-C-O 121.387 0.613 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 t -154.26 167.4 30.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.31 1.044 . . . . 0.0 110.087 173.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 125.06 22.7 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 122.091 -0.38 . . . . 0.0 111.506 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.2 -165.87 38.17 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -99.71 124.8 45.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.236 1.014 . . . . 0.0 110.087 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -134.2 170.02 16.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.28 1.432 . . . . 0.0 112.508 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 pt -125.07 152.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.242 1.817 . . . . 0.0 108.328 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.1 mt -128.94 119.33 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -137.85 147.8 44.83 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.279 0.631 . . . . 0.0 112.477 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -79.36 133.78 36.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.75 0.42 . . . . 0.0 111.234 -173.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -61.63 -21.78 64.68 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.187 1.395 . . . . 0.0 114.343 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.2 t . . . . . 0 N--CA 1.479 1.024 0 C-N-CA 123.976 0.91 . . . . 0.0 112.497 174.78 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 121.104 0.478 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.51 147.46 30.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.048 1.739 . . . . 0.0 114.287 -171.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.1 tp -60.25 136.73 58.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.207 1.403 . . . . 0.0 110.784 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 m -124.26 120.27 31.74 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.403 1.481 . . . . 0.0 111.473 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -63.62 133.3 95.48 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.764 1.626 . . . . 0.0 111.39 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.83 -11.48 21.82 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.077 2.518 . . . . 0.0 114.587 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.93 84.8 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 119.14 -0.811 . . . . 0.0 114.92 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -156.1 161.56 40.37 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.196 1.398 . . . . 0.0 112.036 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -88.96 164.51 15.08 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.131 0.972 . . . . 0.0 111.863 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 47.3 mmt-85 50.57 34.57 9.79 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.874 1.67 . . . . 0.0 113.986 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.8 m -132.29 138.9 33.29 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.848 1.659 . . . . 0.0 110.653 -169.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.99 154.74 12.58 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.685 3.59 . . . . 0.0 115.229 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -100.92 156.66 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.839 1.256 . . . . 0.0 110.642 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 52' ' ' VAL . 2.9 m -126.98 178.24 6.11 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.675 1.59 . . . . 0.0 110.694 -170.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -134.98 148.96 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.911 1.284 . . . . 0.0 111.406 176.604 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.5 m -158.84 162.79 25.87 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 125.08 1.352 . . . . 0.0 112.76 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.67 127.62 16.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.53 2.153 . . . . 0.0 111.034 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.5 tp -65.2 140.22 58.73 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -137.26 10.64 3.01 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.986 1.315 . . . . 0.0 113.101 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.25 0.15 89.45 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.772 1.177 . . . . 0.0 114.948 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -64.66 142.51 58.4 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 118.678 1.239 . . . . 0.0 112.08 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.0 p -60.9 -14.13 20.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.037 1.335 . . . . 0.0 114.07 172.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.49 -21.55 64.6 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.201 -0.937 . . . . 0.0 112.626 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -118.28 9.5 12.54 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.975 1.31 . . . . 0.0 113.604 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -106.79 146.54 30.76 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.771 1.228 . . . . 0.0 110.894 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -138.94 173.96 11.01 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 122.478 1.133 . . . . 0.0 112.096 -168.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.7 mt -124.55 134.95 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 127.54 2.336 . . . . 0.0 106.948 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.02 124.88 22.6 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.376 1.47 . . . . 0.0 109.26 -170.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -146.39 139.32 25.52 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.069 0.548 . . . . 0.0 111.754 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 t -66.53 140.8 58.0 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.991 0.516 . . . . 0.0 111.592 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -114.85 -52.59 2.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.82 1.248 . . . . 0.0 111.223 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.86 110.32 5.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.77 1.228 . . . . 0.0 111.405 169.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.9 m -57.71 -24.7 58.19 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.956 0.903 . . . . 0.0 111.663 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -64.64 -21.97 66.86 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.009 2.124 . . . . 0.0 113.626 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.5 m -130.31 12.51 5.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.997 1.719 . . . . 0.0 112.686 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 42.95 35.33 0.73 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.623 1.969 . . . . 0.0 113.582 -169.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 p -87.58 139.28 30.7 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.76 -1.212 . . . . 0.0 111.709 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -135.94 143.57 44.99 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.57 1.548 . . . . 0.0 110.074 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.9 p -77.73 150.54 34.4 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.716 0.806 . . . . 0.0 110.793 173.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.9 mm -128.6 127.12 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.613 1.565 . . . . 0.0 109.44 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.6 m -143.79 148.11 41.39 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 125.835 1.654 . . . . 0.0 110.316 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.38 148.56 34.03 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.203 2.602 . . . . 0.0 111.172 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.5 m -66.79 -24.76 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.732 -1.23 . . . . 0.0 113.015 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.44 -23.9 74.34 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 123.938 0.78 . . . . 0.0 114.107 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.8 m -143.43 74.36 17.19 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 125.972 1.709 . . . . 0.0 110.368 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -61.81 -13.31 29.83 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.236 2.624 . . . . 0.0 113.192 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -89.38 9.58 25.68 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 128.52 2.728 . . . . 0.0 114.614 174.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.8 p -133.28 174.7 10.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.943 1.297 . . . . 0.0 112.009 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -141.36 170.07 16.42 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.882 1.273 . . . . 0.0 113.286 -170.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -120.48 128.95 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.164 1.386 . . . . 0.0 110.532 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.54 -159.61 8.22 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.652 1.596 . . . . 0.0 111.621 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -138.74 141.09 38.87 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.347 1.073 . . . . 0.0 111.956 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.78 -163.73 10.85 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.447 1.499 . . . . 0.0 113.425 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.77 140.14 19.9 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.045 1.338 . . . . 0.0 113.314 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.46 -4.74 73.62 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.686 1.136 . . . . 0.0 114.254 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 49.19 55.02 9.95 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.466 1.906 . . . . 0.0 114.333 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.8 149.05 70.8 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 126.103 1.761 . . . . 0.0 107.843 169.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.63 147.59 51.59 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.147 1.231 . . . . 0.0 109.877 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.26 153.02 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.74 1.616 . . . . 0.0 111.664 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.85 132.01 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.098 0.959 . . . . 0.0 111.158 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.3 mt -137.91 161.8 57.83 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 126.312 1.845 . . . . 0.0 112.053 -169.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.43 165.76 29.48 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.093 2.528 . . . . 0.0 111.944 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.6 123.02 9.1 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.446 2.097 . . . . 0.0 110.45 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -147.66 -88.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.719 0.808 . . . . 0.0 110.609 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -155.48 16.11 0.39 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.481 1.512 . . . . 0.0 112.954 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -65.9 132.7 49.28 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.502 -0.749 . . . . 0.0 111.936 -172.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.79 159.45 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.328 1.451 . . . . 0.0 111.522 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -129.3 145.98 51.27 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.157 1.383 . . . . 0.0 110.003 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.9 m -81.79 133.96 35.39 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.086 0.954 . . . . 0.0 109.735 173.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.45 132.7 54.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.041 1.336 . . . . 0.0 109.516 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 61.1 m -142.14 122.76 14.19 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.007 -1.058 . . . . 0.0 110.617 -173.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.5 mt -62.65 152.98 33.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.66 0.743 . . . . 0.0 112.65 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.9 p -126.17 -179.92 4.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.61 1.964 . . . . 0.0 109.808 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.5 m -61.38 -8.7 4.23 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.18 26.98 0.2 Allowed Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.229 0.919 . . . . 0.0 114.66 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.92 -151.72 11.02 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.946 1.26 . . . . 0.0 112.814 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -131.73 170.21 15.13 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.011 2.124 . . . . 0.0 112.113 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -137.31 152.8 50.15 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.292 2.637 . . . . 0.0 109.127 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.88 118.46 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.638 1.175 . . . . 0.0 109.176 -169.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -134.85 160.18 39.04 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -169.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -62.72 -25.98 68.45 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.626 1.97 . . . . 0.0 116.14 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 128.9 -32.99 3.17 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.054 1.312 . . . . 0.0 113.515 -173.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -113.72 9.86 17.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.298 1.839 . . . . 0.0 113.542 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 62.57 16.55 8.88 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.9 2.08 . . . . 0.0 113.98 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.8 p -70.2 -27.49 64.54 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.716 0.806 . . . . 0.0 112.437 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.0 m -146.0 173.13 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.466 1.506 . . . . 0.0 112.061 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 t -141.77 154.19 45.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.292 2.237 . . . . 0.0 109.596 172.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -69.66 144.31 52.93 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.696 -0.627 . . . . 0.0 110.688 169.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.0 p -155.03 168.59 26.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.498 1.119 . . . . 0.0 112.171 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.4 mt -113.94 163.76 14.69 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.119 1.767 . . . . 0.0 109.564 171.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -97.13 -33.69 11.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.925 0.89 . . . . 0.0 111.793 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -136.57 -6.49 1.97 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.969 2.108 . . . . 0.0 112.123 171.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.1 27.74 11.91 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.17 1.788 . . . . 0.0 114.268 -171.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.8 p -78.03 157.21 29.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.22 1.008 . . . . 0.0 111.995 172.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.48 139.39 58.5 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.235 -0.916 . . . . 0.0 111.736 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.26 0.74 90.05 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.712 1.148 . . . . 0.0 114.703 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.48 144.94 46.02 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.666 1.233 . . . . 0.0 112.834 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.49 120.49 21.79 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 173.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.82 149.8 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.571 0.7 . . . . 0.0 111.382 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 t -130.2 166.66 19.81 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.999 1.72 . . . . 0.0 111.677 -169.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.75 140.26 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.645 1.578 . . . . 0.0 109.184 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 171.32 -161.61 34.12 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 121.528 -0.733 . . . . 0.0 112.663 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.17 152.86 12.83 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 117.667 0.734 . . . . 0.0 111.715 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -51.88 109.28 0.35 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.418 1.487 . . . . 0.0 113.121 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.99 142.92 55.79 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.787 0.835 . . . . 0.0 113.163 -173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.0 t -60.07 -20.57 58.73 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -135.74 -40.26 0.7 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.947 1.299 . . . . 0.0 113.006 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.6 t -91.0 1.26 57.21 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -172.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.77 14.69 1.93 Allowed Glycine 0 CA--C 1.542 1.75 0 C-N-CA 125.115 1.34 . . . . 0.0 116.003 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.69 145.36 49.84 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.395 1.478 . . . . 0.0 111.476 -174.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -140.78 175.09 9.89 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.374 1.87 . . . . 0.0 110.613 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.48 141.03 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.123 1.369 . . . . 0.0 108.977 169.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 mp -121.31 124.37 71.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.649 1.58 . . . . 0.0 107.167 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -149.0 154.24 39.07 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.687 1.195 . . . . 0.0 109.181 -169.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -68.68 154.46 41.9 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.928 -1.107 . . . . 0.0 112.577 -177.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.324 1.85 . . . . 0.0 111.374 171.226 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.55 0.971 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 t -159.66 168.91 24.88 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.92 1.288 . . . . 0.0 110.269 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.27 139.67 57.32 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.811 -0.555 . . . . 0.0 111.995 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.76 -163.45 35.25 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.916 0.769 . . . . 0.0 114.51 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -95.1 124.0 38.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.959 0.903 . . . . 0.0 109.77 170.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -133.45 173.25 11.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.552 1.541 . . . . 0.0 112.026 -172.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.4 pt -126.37 152.26 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.95 1.7 . . . . 0.0 108.542 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 mt -123.54 122.95 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -137.74 146.7 44.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.512 0.725 . . . . 0.0 110.836 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -67.01 143.32 56.84 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -63.5 -23.54 67.44 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.882 -0.511 . . . . 0.0 112.212 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.469 0.487 0 C-N-CA 125.453 1.501 . . . . 0.0 108.391 168.981 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.2 tp . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 121.553 0.692 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.39 149.81 28.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.981 1.712 . . . . 0.0 115.041 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 tp -62.38 137.02 58.18 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.261 1.424 . . . . 0.0 110.384 169.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 m -127.61 120.39 28.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.799 1.24 . . . . 0.0 111.287 -174.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -66.18 135.52 95.05 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.095 1.358 . . . . 0.0 112.218 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.1 -13.41 21.22 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.339 2.693 . . . . 0.0 114.666 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.41 7.87 81.82 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.1 0.857 . . . . 0.0 115.035 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -154.77 164.65 38.48 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.239 1.816 . . . . 0.0 111.382 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -98.89 165.78 11.6 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.894 1.278 . . . . 0.0 111.435 -173.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 47.38 43.46 15.38 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.938 1.695 . . . . 0.0 113.494 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.6 m -139.33 137.99 19.9 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 126.381 1.872 . . . . 0.0 109.852 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.79 161.65 3.01 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.766 3.644 . . . . 0.0 115.597 173.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.46 148.55 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.875 1.27 . . . . 0.0 110.599 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 m -123.47 173.84 7.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.055 1.342 . . . . 0.0 111.039 -169.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.19 148.48 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.983 1.313 . . . . 0.0 111.533 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 m -154.34 160.21 31.16 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.153 0.981 . . . . 0.0 113.039 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.27 122.34 9.59 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.896 2.398 . . . . 0.0 110.575 170.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.58 136.54 57.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.379 1.471 . . . . 0.0 112.619 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -133.48 9.52 4.0 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.262 1.425 . . . . 0.0 112.41 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.82 8.09 60.1 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.147 1.356 . . . . 0.0 114.882 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.8 p -69.61 153.48 43.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 112.914 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -62.07 -17.7 58.36 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.93 -23.4 63.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.878 1.271 . . . . 0.0 112.544 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -118.27 4.82 11.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.063 1.745 . . . . 0.0 113.162 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.63 139.92 35.63 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.703 1.201 . . . . 0.0 110.774 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -133.74 171.08 14.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.756 1.265 . . . . 0.0 112.149 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.1 mt -125.88 135.53 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 127.571 2.349 . . . . 0.0 106.657 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.0 tp -136.2 126.3 26.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.113 1.365 . . . . 0.0 109.064 -170.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -142.22 140.63 32.36 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.795 0.838 . . . . 0.0 110.833 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.8 t -65.64 141.04 58.53 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.853 0.461 . . . . 0.0 111.006 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -112.11 -52.87 2.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.437 1.095 . . . . 0.0 110.743 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.97 109.28 4.68 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.591 1.156 . . . . 0.0 110.479 169.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.7 m -58.15 -25.25 61.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.948 0.899 . . . . 0.0 111.399 168.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -63.39 -21.52 66.33 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.0 2.12 . . . . 0.0 113.451 174.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.1 m -130.26 9.7 5.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.043 1.737 . . . . 0.0 113.105 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 45.52 33.32 1.32 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.765 2.026 . . . . 0.0 114.217 -169.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.8 p -87.72 143.15 27.31 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.79 -1.193 . . . . 0.0 112.073 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -140.43 140.23 35.39 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.287 1.435 . . . . 0.0 111.052 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.6 p -77.94 142.24 38.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.498 0.719 . . . . 0.0 111.079 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.1 mm -123.91 124.81 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.172 1.389 . . . . 0.0 109.836 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 m -142.31 145.7 36.31 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 125.437 1.495 . . . . 0.0 109.661 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.76 150.08 27.03 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.73 2.287 . . . . 0.0 111.274 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.5 t -65.05 -30.55 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 121.216 -0.927 . . . . 0.0 111.764 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.18 -11.11 82.82 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.3 m -155.49 63.67 3.74 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 125.525 1.53 . . . . 0.0 111.485 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -63.88 -19.24 66.5 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.994 3.129 . . . . 0.0 113.689 -173.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -68.11 -2.18 7.41 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 128.026 2.53 . . . . 0.0 114.553 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.4 m -132.24 166.58 21.54 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.602 1.961 . . . . 0.0 110.86 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -142.39 171.21 14.36 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.331 1.452 . . . . 0.0 112.946 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.27 126.26 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.837 1.255 . . . . 0.0 110.721 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.43 -158.98 7.91 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.475 1.512 . . . . 0.0 111.676 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -139.59 140.41 37.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.355 1.062 . . . . 0.0 111.555 -170.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.01 -166.06 12.75 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.284 1.421 . . . . 0.0 113.193 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.7 137.19 20.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.258 1.423 . . . . 0.0 113.159 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.9 -6.95 64.7 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.779 1.181 . . . . 0.0 114.183 -172.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 48.88 56.76 7.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.552 1.941 . . . . 0.0 114.216 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.95 151.57 78.22 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 126.292 1.837 . . . . 0.0 108.047 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.02 141.91 54.7 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 120.939 1.092 . . . . 0.0 109.626 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.27 152.71 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.372 1.469 . . . . 0.0 111.032 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 49.9 t -79.63 136.28 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.917 0.887 . . . . 0.0 111.07 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -140.84 165.19 31.32 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.674 1.99 . . . . 0.0 111.861 -170.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.64 176.43 2.27 Favored 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 123.558 2.838 . . . . 0.0 113.501 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.29 43.44 1.49 Allowed 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.78 2.987 . . . . 0.0 113.527 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -80.7 13.71 2.45 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.746 1.618 . . . . 0.0 114.407 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 70.74 44.69 0.62 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.714 2.405 . . . . 0.0 113.588 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -64.25 143.8 57.62 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.741 0.817 . . . . 0.0 111.273 169.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.6 m -141.86 156.21 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.403 1.081 . . . . 0.0 112.399 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -127.2 140.95 51.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.075 1.35 . . . . 0.0 111.176 170.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.8 m -78.88 127.04 31.5 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.741 1.216 . . . . 0.0 109.149 172.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.3 mt -115.39 128.64 56.2 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.809 0.843 . . . . 0.0 109.575 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.1 m -131.34 118.27 20.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.243 1.017 . . . . 0.0 110.189 -169.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.7 tp -66.03 145.73 55.52 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.761 -0.587 . . . . 0.0 111.17 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.0 p -127.55 175.35 8.32 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.963 1.705 . . . . 0.0 110.527 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.5 p -57.83 -16.51 11.85 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -155.06 23.74 0.6 Allowed Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.629 1.109 . . . . 0.0 114.565 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.95 -149.83 9.48 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.877 1.227 . . . . 0.0 112.607 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -134.0 171.11 14.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.186 2.194 . . . . 0.0 111.574 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -136.78 154.46 50.55 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.364 2.266 . . . . 0.0 109.95 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.5 mt -134.45 121.04 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.133 1.373 . . . . 0.0 109.355 -169.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -137.0 158.3 44.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.567 1.147 . . . . 0.0 112.614 -170.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.3 -33.38 75.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -171.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.21 -31.36 2.7 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.283 1.42 . . . . 0.0 113.772 -169.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -104.19 -2.21 26.07 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.539 1.536 . . . . 0.0 113.887 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 64.82 13.04 8.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.295 2.238 . . . . 0.0 114.128 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.4 p -69.98 -21.26 63.25 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.588 1.155 . . . . 0.0 112.824 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.89 169.6 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.486 1.515 . . . . 0.0 112.661 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.9 t -140.67 153.71 46.1 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.919 2.487 . . . . 0.0 109.66 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -69.9 144.8 52.35 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.455 -0.778 . . . . 0.0 110.137 168.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.7 p -149.34 171.6 16.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.378 1.071 . . . . 0.0 112.993 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.5 mt -125.15 165.7 17.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.108 1.763 . . . . 0.0 109.625 172.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -105.19 -32.71 8.53 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.904 0.882 . . . . 0.0 111.94 -169.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -140.24 -10.08 1.12 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.757 2.023 . . . . 0.0 112.662 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.68 27.13 12.15 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.569 1.548 . . . . 0.0 114.24 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.9 p -78.31 157.62 29.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.415 1.086 . . . . 0.0 111.807 170.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.87 141.57 58.73 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.259 -0.901 . . . . 0.0 112.161 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.27 4.96 89.22 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.5 1.048 . . . . 0.0 114.458 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -75.13 137.45 41.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.769 1.228 . . . . 0.0 112.402 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.41 128.28 35.15 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.508 -0.745 . . . . 0.0 110.569 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.5 t -64.23 150.71 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.229 0.612 . . . . 0.0 110.557 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.4 t -126.95 161.96 27.08 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.823 1.249 . . . . 0.0 111.796 -175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.7 mt -134.21 142.04 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.98 1.712 . . . . 0.0 108.78 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.84 -156.71 28.81 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 124.631 1.11 . . . . 0.0 110.716 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.77 166.43 1.91 Allowed 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.717 1.259 . . . . 0.0 111.685 169.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -56.35 157.01 5.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.06 0.944 . . . . 0.0 112.82 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.53 136.16 51.34 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.607 1.163 . . . . 0.0 112.312 -172.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.1 t -55.59 -26.84 45.98 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.254 1.822 . . . . 0.0 115.834 -169.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -130.16 -32.82 1.78 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.094 0.958 . . . . 0.0 113.385 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 96.6 p -103.87 -2.25 26.52 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.8 27.76 1.1 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 125.955 1.74 . . . . 0.0 114.859 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -147.64 142.1 26.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.765 2.026 . . . . 0.0 110.943 -169.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -140.74 175.75 9.36 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.956 1.702 . . . . 0.0 111.21 -168.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.55 140.16 26.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.735 1.214 . . . . 0.0 109.299 169.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.62 125.05 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 125.677 1.591 . . . . 0.0 107.354 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -148.98 153.62 38.2 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.8 1.24 . . . . 0.0 109.673 -171.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -67.9 155.22 39.9 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.998 -1.064 . . . . 0.0 112.882 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.328 1.851 . . . . 0.0 111.217 171.154 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 CA--C 1.549 0.94 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 t -159.92 168.21 26.24 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.215 1.406 . . . . 0.0 109.861 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.85 137.2 57.62 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.653 -0.654 . . . . 0.0 112.176 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.73 -162.88 35.41 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.968 0.794 . . . . 0.0 114.604 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -97.14 124.91 41.32 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.215 1.006 . . . . 0.0 109.978 172.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -133.88 173.11 11.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.637 1.575 . . . . 0.0 112.235 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.8 pt -125.88 151.66 32.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 126.051 1.74 . . . . 0.0 108.452 170.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 mt -124.64 119.17 55.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -137.63 148.11 45.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.776 0.83 . . . . 0.0 110.581 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -72.79 149.11 43.92 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.176 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -61.81 -24.94 67.19 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.686 -0.633 . . . . 0.0 112.569 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 N--CA 1.473 0.725 0 C-N-CA 125.545 1.538 . . . . 0.0 109.671 169.604 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 121.78 0.8 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.38 150.83 19.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -168.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.3 tp -60.45 135.63 57.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.806 1.242 . . . . 0.0 110.032 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -129.97 121.06 25.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.803 1.241 . . . . 0.0 111.247 -173.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -65.03 136.29 96.69 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.956 1.302 . . . . 0.0 112.458 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.07 -13.31 21.3 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.51 2.807 . . . . 0.0 114.688 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.01 7.42 80.68 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 124.223 0.916 . . . . 0.0 115.071 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -153.92 166.59 32.48 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.351 1.86 . . . . 0.0 111.299 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -102.57 166.64 10.41 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.743 1.217 . . . . 0.0 111.545 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 51.15 40.93 27.04 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.773 1.629 . . . . 0.0 112.425 -174.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.9 m -141.16 137.89 17.26 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 126.139 1.776 . . . . 0.0 110.47 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -52.71 158.17 6.49 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.736 3.624 . . . . 0.0 115.43 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 t -110.26 148.99 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.861 1.264 . . . . 0.0 110.74 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 52' ' ' VAL . 1.3 m -121.66 176.5 5.68 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.216 1.407 . . . . 0.0 111.494 -169.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.461 ' H ' HG22 ' A' ' 51' ' ' THR . 0.3 OUTLIER -131.34 146.04 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.109 1.364 . . . . 0.0 111.647 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.1 m -153.79 163.06 25.13 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.469 1.108 . . . . 0.0 113.303 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -60.49 124.38 14.98 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.394 2.73 . . . . 0.0 110.418 168.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.46 136.21 57.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.33 1.052 . . . . 0.0 111.786 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -132.81 7.72 4.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.023 1.329 . . . . 0.0 112.449 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.53 9.61 58.78 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.92 1.247 . . . . 0.0 114.592 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.0 p -68.77 154.3 42.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.26 1.424 . . . . 0.0 112.729 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.4 p -62.54 -17.12 59.2 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -70.48 -24.41 62.86 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.858 1.263 . . . . 0.0 112.402 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.23 3.14 12.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.04 1.736 . . . . 0.0 113.235 -176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.89 140.26 32.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 110.558 171.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -134.15 171.31 14.41 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.763 1.268 . . . . 0.0 111.7 -169.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.4 mt -125.92 136.28 61.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 127.052 2.141 . . . . 0.0 106.566 -175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.6 tp -137.41 124.47 21.53 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.1 1.36 . . . . 0.0 108.901 -169.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -142.62 134.26 26.67 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.768 0.827 . . . . 0.0 110.946 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.3 t -63.78 137.03 57.88 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.998 0.519 . . . . 0.0 110.853 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -112.79 -47.38 3.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.324 1.05 . . . . 0.0 111.691 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.46 111.46 4.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.302 1.441 . . . . 0.0 110.708 170.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.2 m -58.99 -24.32 62.61 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.987 0.915 . . . . 0.0 111.533 168.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -64.18 -21.82 66.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.872 2.069 . . . . 0.0 113.522 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 m -130.33 11.75 5.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.684 1.594 . . . . 0.0 112.853 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 44.09 32.26 0.63 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.592 1.957 . . . . 0.0 113.509 -169.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 p -87.11 139.82 30.18 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.163 -0.96 . . . . 0.0 111.876 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -135.44 141.92 45.5 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.636 1.574 . . . . 0.0 110.978 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -77.5 145.72 36.82 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.808 0.443 . . . . 0.0 110.849 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.8 mm -127.14 126.73 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.32 1.448 . . . . 0.0 109.673 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 57.1 m -144.01 147.94 40.0 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 126.103 1.761 . . . . 0.0 109.578 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.63 149.93 24.11 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.887 2.392 . . . . 0.0 111.445 175.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.91 -29.72 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.058 -1.026 . . . . 0.0 111.811 173.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.21 -13.97 81.12 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 115.424 0.929 . . . . 0.0 115.424 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.0 m -151.98 62.48 4.72 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 125.682 1.593 . . . . 0.0 111.536 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.13 -13.65 39.04 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.414 2.742 . . . . 0.0 114.034 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -73.18 6.33 2.86 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.425 1.89 . . . . 0.0 114.063 170.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -138.89 166.31 24.79 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.295 1.838 . . . . 0.0 111.088 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -136.56 171.23 14.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.348 1.459 . . . . 0.0 113.089 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.6 mm -120.9 130.62 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.143 1.377 . . . . 0.0 110.929 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.75 -156.15 6.9 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.917 1.722 . . . . 0.0 111.834 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -142.6 142.37 32.12 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.402 1.081 . . . . 0.0 111.518 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.22 -166.44 13.13 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.31 1.433 . . . . 0.0 113.401 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.2 138.65 20.13 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.085 1.354 . . . . 0.0 113.221 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.7 -6.57 67.58 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.724 1.154 . . . . 0.0 114.089 -172.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 49.67 56.54 7.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.578 1.951 . . . . 0.0 114.21 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.08 150.23 75.48 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 126.153 1.781 . . . . 0.0 108.127 169.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.94 142.38 56.73 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.192 1.261 . . . . 0.0 109.693 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.28 148.16 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.724 1.61 . . . . 0.0 111.096 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.73 138.8 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.938 0.895 . . . . 0.0 110.575 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.7 mt -140.53 161.74 53.05 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.31 1.844 . . . . 0.0 111.013 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.12 164.83 30.56 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.94 2.427 . . . . 0.0 111.879 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.23 119.55 6.07 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.528 2.152 . . . . 0.0 110.47 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -147.5 -89.6 0.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.821 0.848 . . . . 0.0 110.977 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -155.91 17.25 0.37 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.117 1.367 . . . . 0.0 113.235 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -67.56 135.86 53.61 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.525 -0.735 . . . . 0.0 112.075 -173.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.7 m -145.03 159.83 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.034 1.334 . . . . 0.0 112.646 -175.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -129.55 136.28 49.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.538 1.535 . . . . 0.0 110.925 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.3 m -74.35 128.98 36.91 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 109.437 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -118.01 125.81 51.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.175 0.99 . . . . 0.0 109.335 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.0 m -130.52 118.32 20.91 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.272 1.029 . . . . 0.0 111.155 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.99 148.39 51.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.641 0.776 . . . . 0.0 111.34 173.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.8 p -132.26 174.42 10.24 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.035 1.734 . . . . 0.0 110.35 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.8 m -61.67 -10.39 8.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.54 36.71 0.39 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.396 0.998 . . . . 0.0 113.944 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.24 -166.57 34.72 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.793 1.187 . . . . 0.0 112.708 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -121.23 166.83 13.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.484 1.914 . . . . 0.0 111.293 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -135.09 152.31 51.54 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.592 1.557 . . . . 0.0 110.454 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.58 117.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.136 1.374 . . . . 0.0 109.263 -169.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -136.48 157.73 46.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.66 1.184 . . . . 0.0 112.373 -169.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -63.72 -31.06 72.12 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -171.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.14 -26.14 3.27 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.313 1.435 . . . . 0.0 114.175 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -113.62 1.21 14.86 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.112 1.765 . . . . 0.0 114.0 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 64.32 12.87 7.57 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.453 2.301 . . . . 0.0 114.239 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.3 p -73.22 -22.37 60.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.163 0.985 . . . . 0.0 112.9 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 m -144.69 170.85 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.66 1.584 . . . . 0.0 112.437 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.5 t -144.27 150.43 37.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 129.215 3.006 . . . . 0.0 108.885 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.5 m0 -69.94 145.87 51.57 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.16 -0.962 . . . . 0.0 110.52 169.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.0 p -156.41 174.22 15.74 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.805 1.242 . . . . 0.0 112.575 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -120.35 171.87 8.21 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.144 1.777 . . . . 0.0 110.059 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -108.27 -31.83 7.72 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.968 1.307 . . . . 0.0 110.811 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -142.83 -13.34 0.75 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 127.425 2.29 . . . . 0.0 112.96 169.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.93 22.04 8.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.615 1.966 . . . . 0.0 114.729 -170.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.7 p -70.7 158.28 36.53 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.64 1.176 . . . . 0.0 111.944 170.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.56 136.84 57.44 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.244 -0.91 . . . . 0.0 111.886 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.09 0.74 89.67 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.644 1.116 . . . . 0.0 114.367 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -72.32 138.86 47.62 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.806 1.303 . . . . 0.0 112.584 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.9 125.41 28.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.463 0.705 . . . . 0.0 110.26 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.0 153.56 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.596 0.713 . . . . 0.0 110.315 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.1 m -135.34 165.19 26.03 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.193 1.397 . . . . 0.0 111.572 -172.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.8 mt -134.07 142.2 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.262 1.425 . . . . 0.0 108.96 -175.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.91 179.54 48.02 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 124.602 1.096 . . . . 0.0 111.496 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.48 -40.83 62.8 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.005 1.402 . . . . 0.0 114.274 -173.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -169.6 174.11 6.02 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.857 2.463 . . . . 0.0 111.61 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.27 150.63 39.52 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.574 1.149 . . . . 0.0 111.908 169.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -83.06 -7.02 59.7 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -169.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -142.38 -40.93 0.34 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.205 1.002 . . . . 0.0 112.524 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.9 p -95.3 3.54 54.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.432 1.493 . . . . 0.0 114.212 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.29 22.91 0.61 Allowed Glycine 0 CA--C 1.544 1.87 0 C-N-CA 125.818 1.675 . . . . 0.0 115.802 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -147.58 143.98 28.14 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.836 1.655 . . . . 0.0 111.066 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -136.45 175.54 9.52 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.398 1.879 . . . . 0.0 111.338 -169.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.45 137.76 25.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.653 1.181 . . . . 0.0 109.373 169.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -116.01 124.24 72.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 125.916 1.686 . . . . 0.0 107.14 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.6 153.09 38.98 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.845 1.258 . . . . 0.0 109.497 -171.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.08 155.4 39.63 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.008 -1.057 . . . . 0.0 112.803 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.3 t . . . . . 0 C--O 1.252 1.21 0 C-N-CA 126.121 1.769 . . . . 0.0 111.292 171.879 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 CA--C 1.543 0.699 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.6 t -161.58 170.46 19.78 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.302 1.841 . . . . 0.0 109.232 174.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.03 134.12 54.39 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.564 -0.71 . . . . 0.0 112.308 173.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.08 -161.24 34.2 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.114 0.864 . . . . 0.0 114.311 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -100.49 125.8 46.85 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.125 0.97 . . . . 0.0 110.213 173.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -134.86 172.76 12.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.537 1.535 . . . . 0.0 112.514 -170.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.97 154.69 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 126.461 1.904 . . . . 0.0 108.657 170.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 mt -129.92 118.92 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -141.61 153.37 44.73 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.68 0.792 . . . . 0.0 112.237 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -84.11 138.35 33.08 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.793 -0.567 . . . . 0.0 112.031 -172.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -63.36 -19.83 64.99 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.3 t . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 123.908 0.883 . . . . 0.0 112.319 173.174 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.9 tp . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 121.6 0.714 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.89 150.85 30.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.876 1.27 . . . . 0.0 113.12 -170.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.2 tp -61.44 139.56 58.19 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.256 1.022 . . . . 0.0 110.016 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.2 m -130.7 122.12 26.74 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.564 1.145 . . . . 0.0 111.584 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -64.24 135.52 96.37 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.637 1.175 . . . . 0.0 112.061 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.07 -13.68 21.2 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.428 2.752 . . . . 0.0 114.852 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.35 7.28 76.63 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.083 0.849 . . . . 0.0 114.957 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -156.01 164.46 38.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.583 1.553 . . . . 0.0 112.085 -174.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -90.77 164.47 14.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.442 1.097 . . . . 0.0 111.761 -174.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 49.48 39.38 16.59 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.843 1.657 . . . . 0.0 113.586 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.9 m -136.5 140.73 33.23 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.674 1.59 . . . . 0.0 111.198 -169.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -45.55 156.58 0.37 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 126.093 4.528 . . . . 0.0 115.277 169.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.92 150.74 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.719 1.207 . . . . 0.0 110.065 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.9 m -124.44 176.05 6.74 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.744 1.618 . . . . 0.0 110.265 -169.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.09 147.53 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.679 1.127 . . . . 0.0 112.1 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 m -150.84 160.83 31.63 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.94 1.296 . . . . 0.0 111.795 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -64.22 134.21 41.35 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.009 1.806 . . . . 0.0 111.613 170.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.6 tp -67.53 137.73 55.97 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.645 0.778 . . . . 0.0 111.515 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -138.29 8.81 2.7 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.864 1.265 . . . . 0.0 112.98 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.46 -7.07 58.89 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 125.058 1.313 . . . . 0.0 115.095 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -67.05 145.81 54.98 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.549 1.174 . . . . 0.0 111.827 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.4 p -60.33 -12.3 8.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.756 1.622 . . . . 0.0 114.96 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -68.66 -23.7 64.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.216 1.006 . . . . 0.0 112.36 174.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -114.76 4.5 14.98 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.573 1.549 . . . . 0.0 113.231 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.1 140.9 36.72 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.045 0.938 . . . . 0.0 111.126 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -134.14 170.56 15.49 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 122.83 1.3 . . . . 0.0 111.94 -169.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.58 135.34 62.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 127.485 2.314 . . . . 0.0 106.208 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.3 tp -136.62 124.17 22.24 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.044 1.338 . . . . 0.0 108.561 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -142.33 139.31 31.77 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.347 0.659 . . . . 0.0 111.048 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 t -64.59 138.55 58.47 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.966 0.506 . . . . 0.0 110.735 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -110.23 -53.03 2.72 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.453 1.101 . . . . 0.0 111.047 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.14 109.97 5.08 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.024 1.329 . . . . 0.0 110.648 169.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.4 m -57.73 -23.51 52.27 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.997 0.919 . . . . 0.0 111.748 168.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -65.21 -22.18 66.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.061 2.144 . . . . 0.0 113.439 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 m -130.32 12.03 5.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.145 1.778 . . . . 0.0 112.784 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 42.74 34.96 0.64 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.938 2.095 . . . . 0.0 113.412 -169.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -86.03 143.96 27.83 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 120.966 -1.084 . . . . 0.0 112.391 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -138.54 140.49 39.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.25 1.42 . . . . 0.0 111.068 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.8 p -77.84 146.36 35.75 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.206 0.603 . . . . 0.0 110.75 171.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.3 mm -130.79 120.46 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.284 1.433 . . . . 0.0 110.426 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.9 m -141.71 148.77 51.04 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.367 1.467 . . . . 0.0 110.343 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.08 148.34 24.49 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.841 2.361 . . . . 0.0 111.674 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.28 -31.12 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 121.198 -0.939 . . . . 0.0 111.881 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.74 -23.56 72.23 Favored Glycine 0 CA--C 1.539 1.543 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.1 m -144.43 60.66 7.92 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.315 1.446 . . . . 0.0 112.352 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.69 -12.1 26.96 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.502 2.801 . . . . 0.0 114.143 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -75.63 14.46 0.63 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.812 2.045 . . . . 0.0 113.336 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -142.32 171.61 13.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.995 2.118 . . . . 0.0 111.289 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -144.08 167.03 23.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.946 1.299 . . . . 0.0 112.027 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -118.38 131.74 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.517 1.127 . . . . 0.0 111.185 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -148.63 -157.72 7.69 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.952 1.739 . . . . 0.0 111.284 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -141.59 145.19 34.76 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.265 1.032 . . . . 0.0 111.802 -174.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.4 -164.22 11.75 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.491 1.52 . . . . 0.0 112.955 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.62 138.3 23.11 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.957 1.303 . . . . 0.0 113.045 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.63 -3.51 63.18 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.684 1.135 . . . . 0.0 114.322 -173.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 47.56 55.19 8.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.295 1.838 . . . . 0.0 113.713 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.91 138.76 31.49 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 127.693 2.397 . . . . 0.0 107.45 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.27 142.48 55.34 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 N-CA-C 109.206 -1.113 . . . . 0.0 109.206 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 m -133.27 151.08 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.139 1.376 . . . . 0.0 111.627 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.19 136.53 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.753 0.821 . . . . 0.0 110.783 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.9 mt -139.41 163.76 43.29 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 127.154 2.182 . . . . 0.0 110.286 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.16 159.31 53.67 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.153 1.902 . . . . 0.0 111.464 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -71.4 118.18 5.53 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.744 2.296 . . . . 0.0 110.294 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -145.47 -88.76 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.763 0.825 . . . . 0.0 111.018 -175.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -155.21 15.89 0.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.932 1.293 . . . . 0.0 113.387 -173.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -69.93 133.81 47.71 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.437 -0.789 . . . . 0.0 111.581 -175.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.0 m -141.8 160.99 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.422 1.089 . . . . 0.0 112.441 -174.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -129.06 134.85 48.27 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.339 1.456 . . . . 0.0 110.441 170.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.3 m -75.66 129.8 37.71 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.388 1.075 . . . . 0.0 109.406 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.1 mt -120.46 132.23 55.12 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.207 1.003 . . . . 0.0 109.786 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.1 m -133.2 118.26 18.42 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.194 0.998 . . . . 0.0 110.357 -170.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.28 137.27 58.23 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.862 1.265 . . . . 0.0 110.449 171.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 p -126.46 173.17 9.59 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.239 1.415 . . . . 0.0 111.798 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.4 m -58.13 -10.18 1.79 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.0 36.82 0.33 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.128 1.347 . . . . 0.0 113.251 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.78 -150.2 17.42 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.398 1.099 . . . . 0.0 114.148 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -132.83 169.59 16.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.949 2.499 . . . . 0.0 110.564 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -135.22 150.81 50.16 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.901 2.081 . . . . 0.0 109.451 171.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.1 mt -133.32 119.94 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.207 1.403 . . . . 0.0 109.515 -169.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -137.07 157.06 47.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.201 1.0 . . . . 0.0 112.552 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.09 -31.68 71.36 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.6 -40.28 1.63 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.798 1.666 . . . . 0.0 113.175 -172.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.3 -10.08 59.75 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.6 1.16 . . . . 0.0 113.946 173.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 67.39 12.95 9.18 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.798 2.039 . . . . 0.0 112.758 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.5 p -73.24 -23.97 60.42 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.281 1.432 . . . . 0.0 112.692 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.3 m -142.83 170.39 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.863 1.665 . . . . 0.0 112.025 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.4 t -142.15 151.81 42.6 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 128.903 2.881 . . . . 0.0 109.359 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -70.02 143.55 52.51 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 119.153 0.888 . . . . 0.0 111.29 169.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.6 p -152.08 170.81 19.03 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.822 1.249 . . . . 0.0 112.969 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.89 166.23 18.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.185 1.794 . . . . 0.0 110.111 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -109.02 -32.35 7.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.969 0.908 . . . . 0.0 111.689 -169.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -139.5 -10.89 1.21 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.436 1.894 . . . . 0.0 112.729 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.3 23.97 7.77 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.993 1.717 . . . . 0.0 114.685 -170.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.7 p -70.52 153.12 43.25 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.028 -1.045 . . . . 0.0 111.457 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.18 137.91 57.92 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.116 -0.99 . . . . 0.0 111.444 172.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.19 0.3 88.7 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.472 1.034 . . . . 0.0 114.251 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -69.56 142.38 53.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.873 1.337 . . . . 0.0 112.609 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.14 116.48 16.87 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.385 -0.822 . . . . 0.0 109.693 170.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.36 150.1 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.573 0.749 . . . . 0.0 111.59 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 57.5 m -129.81 169.54 15.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.591 1.556 . . . . 0.0 111.468 -169.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.6 mt -135.26 143.63 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.338 1.455 . . . . 0.0 108.862 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.35 179.12 47.49 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.672 1.13 . . . . 0.0 111.666 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.69 -41.98 61.84 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.092 1.446 . . . . 0.0 114.271 -172.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -168.81 172.28 7.93 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.915 2.486 . . . . 0.0 109.818 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.07 138.62 33.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.144 0.978 . . . . 0.0 112.436 169.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.0 t -62.97 -14.75 51.38 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -169.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.43 -36.89 0.43 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.38 1.072 . . . . 0.0 112.958 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.8 p -98.33 2.27 47.89 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.362 1.465 . . . . 0.0 114.529 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.33 12.64 1.76 Allowed Glycine 0 CA--C 1.544 1.86 0 C-N-CA 125.547 1.546 . . . . 0.0 116.202 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -135.48 145.34 47.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.22 1.808 . . . . 0.0 111.364 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -139.35 175.87 9.19 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.335 1.454 . . . . 0.0 111.98 -169.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.65 138.99 38.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.764 1.225 . . . . 0.0 109.421 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.5 125.74 74.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 125.404 1.481 . . . . 0.0 107.276 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -148.93 153.99 38.78 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.798 1.239 . . . . 0.0 109.304 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -67.49 155.86 38.05 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.094 -1.004 . . . . 0.0 112.827 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.073 1.749 . . . . 0.0 111.278 172.223 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.542 0.645 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 t -160.78 170.95 19.69 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.141 1.776 . . . . 0.0 109.414 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.22 133.1 49.92 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.631 -0.668 . . . . 0.0 111.656 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.25 -163.01 35.78 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.975 0.798 . . . . 0.0 114.183 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -98.63 125.64 43.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.826 0.851 . . . . 0.0 109.98 171.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -134.3 172.75 12.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.332 1.453 . . . . 0.0 112.284 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.0 pt -125.46 156.64 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 126.352 1.861 . . . . 0.0 109.058 171.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.8 mt -130.08 119.76 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -142.28 152.24 42.81 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.712 0.805 . . . . 0.0 112.346 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -84.3 137.81 33.25 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.871 -0.518 . . . . 0.0 111.736 -174.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -59.34 -19.54 47.41 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.3 t . . . . . 0 N--CA 1.478 0.929 0 C-N-CA 124.448 1.099 . . . . 0.0 112.834 175.923 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.6 tp . . . . . 0 N--CA 1.468 0.464 0 CA-C-O 121.171 0.51 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.98 148.2 26.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -59.3 135.25 57.59 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.006 1.323 . . . . 0.0 110.058 169.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 m -126.82 121.09 30.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.974 1.31 . . . . 0.0 110.877 -174.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -63.94 138.02 97.27 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.224 1.409 . . . . 0.0 111.913 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.03 -13.56 21.32 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.418 2.745 . . . . 0.0 114.845 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.87 4.43 72.42 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.481 1.039 . . . . 0.0 114.955 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.4 ptt-85 -156.14 172.95 17.55 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.294 1.838 . . . . 0.0 111.565 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -101.04 168.79 9.37 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.837 1.255 . . . . 0.0 111.396 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 50.04 35.08 9.15 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.002 2.121 . . . . 0.0 113.849 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.9 m -133.67 141.73 41.18 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.693 1.597 . . . . 0.0 111.274 -169.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -45.72 160.27 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.859 1 C-N-CA 126.174 4.582 . . . . 0.0 115.259 169.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.4 t -116.11 154.73 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.606 1.162 . . . . 0.0 109.964 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -128.5 172.04 11.52 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.429 1.492 . . . . 0.0 110.857 -169.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.61 149.23 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.902 1.281 . . . . 0.0 111.478 176.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 m -157.14 161.36 29.57 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.402 1.081 . . . . 0.0 113.122 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.04 122.28 11.42 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.779 2.986 . . . . 0.0 111.449 169.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.9 tp -59.01 138.45 57.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.2 1.0 . . . . 0.0 111.81 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -132.71 5.15 3.94 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.944 1.298 . . . . 0.0 112.756 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.6 7.33 60.96 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.784 1.183 . . . . 0.0 114.742 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.9 p -67.27 153.9 42.59 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.032 1.333 . . . . 0.0 112.541 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.7 p -62.49 -17.3 59.32 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -70.84 -22.3 62.34 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.552 1.141 . . . . 0.0 112.338 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.23 1.42 11.88 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.483 1.513 . . . . 0.0 113.638 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.34 146.08 27.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.522 1.129 . . . . 0.0 111.018 171.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -138.15 172.44 12.92 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.582 1.182 . . . . 0.0 111.901 -169.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.8 mt -119.6 136.79 55.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.847 2.459 . . . . 0.0 106.792 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.2 tp -135.99 128.21 29.98 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.132 1.373 . . . . 0.0 109.311 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.09 140.67 29.61 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.875 0.87 . . . . 0.0 110.785 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.9 t -66.01 140.31 58.28 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.726 0.41 . . . . 0.0 110.758 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -109.68 -52.73 2.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.544 1.138 . . . . 0.0 110.47 173.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.17 108.48 4.27 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.48 1.112 . . . . 0.0 110.691 169.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -57.44 -25.5 59.74 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.964 0.906 . . . . 0.0 111.56 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -62.85 -20.51 65.17 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.052 2.141 . . . . 0.0 113.535 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -130.23 9.01 5.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.132 1.773 . . . . 0.0 112.671 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 47.5 29.28 1.34 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.372 1.869 . . . . 0.0 114.325 -169.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.9 p -87.48 144.73 26.58 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.686 -1.259 . . . . 0.0 112.193 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -139.43 142.62 37.42 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.576 1.55 . . . . 0.0 111.288 -176.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.2 p -81.28 149.64 28.89 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.414 0.685 . . . . 0.0 110.882 171.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.5 mm -133.59 124.97 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.509 1.524 . . . . 0.0 110.481 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 m -142.83 153.27 60.86 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.889 1.676 . . . . 0.0 110.362 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.73 151.82 28.6 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.044 2.496 . . . . 0.0 111.199 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.9 -25.74 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.987 -1.071 . . . . 0.0 113.303 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.11 -18.19 54.25 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 123.927 0.775 . . . . 0.0 114.727 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.9 m -141.31 60.3 11.84 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 125.514 1.526 . . . . 0.0 111.536 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -62.22 -17.1 55.07 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.796 2.997 . . . . 0.0 113.286 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -72.15 9.47 0.97 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 128.191 2.596 . . . . 0.0 113.384 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 p -137.79 169.24 18.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.165 2.186 . . . . 0.0 111.095 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -143.73 164.6 29.99 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.001 1.32 . . . . 0.0 111.566 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -115.53 127.43 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.374 1.07 . . . . 0.0 111.154 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.49 -160.55 8.46 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.004 1.764 . . . . 0.0 111.367 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -142.93 147.88 35.98 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.251 1.026 . . . . 0.0 111.917 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -153.06 -159.12 8.88 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.531 1.539 . . . . 0.0 112.92 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.3 141.14 19.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.736 1.214 . . . . 0.0 113.077 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.7 -4.24 72.17 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.613 1.102 . . . . 0.0 114.359 -173.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 46.99 53.87 9.97 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.139 1.775 . . . . 0.0 113.625 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.32 138.53 32.44 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 127.6 2.36 . . . . 0.0 107.266 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.54 143.17 56.14 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 108.844 -1.252 . . . . 0.0 108.844 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.3 m -132.62 148.41 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.951 1.301 . . . . 0.0 110.818 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.2 t -75.54 137.16 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.547 0.739 . . . . 0.0 110.159 173.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.3 mt -142.92 164.68 30.65 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.702 2.001 . . . . 0.0 110.399 -171.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.87 155.59 43.58 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.216 1.944 . . . . 0.0 110.982 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.95 125.09 17.16 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.431 2.754 . . . . 0.0 112.684 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -145.12 -107.47 0.11 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.96 1.304 . . . . 0.0 109.107 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -143.56 20.06 1.85 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.174 1.789 . . . . 0.0 110.928 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -68.14 134.62 50.83 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.231 -0.918 . . . . 0.0 111.511 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.0 m -143.0 161.88 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.015 0.926 . . . . 0.0 112.065 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -129.96 134.36 47.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.017 1.327 . . . . 0.0 109.979 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.0 m -70.85 127.39 32.46 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.988 1.315 . . . . 0.0 108.743 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.1 mt -125.0 115.34 20.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.113 0.965 . . . . 0.0 109.027 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.7 m -136.62 133.68 36.55 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.49 0.716 . . . . 0.0 112.564 -169.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.9 tp -66.12 150.21 49.09 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.878 1.271 . . . . 0.0 112.602 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 p -136.89 175.81 9.28 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.663 1.585 . . . . 0.0 112.01 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.8 m -62.89 -4.97 2.44 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.75 19.64 0.21 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.455 1.026 . . . . 0.0 115.044 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.38 -156.87 28.32 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.682 1.135 . . . . 0.0 112.189 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.6 170.55 9.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.943 2.097 . . . . 0.0 110.91 174.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -132.21 149.52 52.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.828 1.651 . . . . 0.0 110.952 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.4 mt -135.11 117.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.164 1.386 . . . . 0.0 109.203 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -134.72 158.75 43.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.218 1.007 . . . . 0.0 111.942 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.03 -21.98 66.53 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -171.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.51 -40.28 1.83 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.375 1.464 . . . . 0.0 112.716 -170.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -98.26 5.22 48.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.329 1.451 . . . . 0.0 113.836 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 58.14 14.49 2.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.256 2.222 . . . . 0.0 114.221 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.3 p -72.97 -23.2 60.63 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.012 0.925 . . . . 0.0 112.547 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.0 m -143.79 173.01 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.768 1.627 . . . . 0.0 112.284 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.3 t -144.23 150.82 38.55 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.78 2.832 . . . . 0.0 109.106 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -70.24 145.03 51.65 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.115 -0.99 . . . . 0.0 111.372 169.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 99.3 p -153.63 173.28 16.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.715 1.206 . . . . 0.0 112.418 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.8 mt -126.39 174.1 8.85 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.128 1.771 . . . . 0.0 109.687 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -115.66 -33.5 5.17 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.996 0.918 . . . . 0.0 111.111 -170.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -141.52 -10.66 0.93 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.46 1.904 . . . . 0.0 112.946 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.84 22.37 6.98 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.96 1.704 . . . . 0.0 114.824 -170.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.5 p -70.94 158.02 37.18 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.115 0.966 . . . . 0.0 111.826 170.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.0 139.98 57.7 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.132 -0.98 . . . . 0.0 112.01 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.87 2.75 88.85 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.345 0.974 . . . . 0.0 114.064 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -69.93 139.09 52.86 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.651 1.225 . . . . 0.0 112.148 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.75 120.09 19.82 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.746 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.18 150.73 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.436 0.694 . . . . 0.0 111.202 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.2 m -130.33 167.71 18.08 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.058 1.343 . . . . 0.0 111.561 -171.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.3 mt -134.94 145.14 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.291 1.436 . . . . 0.0 108.753 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.4 -179.86 47.95 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 124.89 1.234 . . . . 0.0 111.231 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.39 -39.48 60.92 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.217 1.508 . . . . 0.0 113.849 -175.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -169.96 175.4 5.14 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.889 2.476 . . . . 0.0 111.826 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.87 162.12 36.27 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.306 1.442 . . . . 0.0 111.687 169.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.4 t -92.7 -13.28 29.61 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -169.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -140.78 -32.49 0.57 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.541 1.137 . . . . 0.0 113.331 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.6 p -107.31 4.55 26.61 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.678 1.591 . . . . 0.0 114.045 -173.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.51 15.35 1.16 Allowed Glycine 0 CA--C 1.541 1.709 0 C-N-CA 126.348 1.928 . . . . 0.0 115.513 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -141.26 147.34 38.07 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.563 1.945 . . . . 0.0 110.353 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -141.1 177.48 8.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.21 1.804 . . . . 0.0 110.726 -169.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.23 142.61 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.025 0.93 . . . . 0.0 109.834 169.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.44 126.98 75.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.544 1.538 . . . . 0.0 107.053 173.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.91 153.84 38.58 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.908 1.283 . . . . 0.0 109.088 -170.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -66.78 155.06 39.22 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.049 -1.032 . . . . 0.0 112.53 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.2 t . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.991 1.716 . . . . 0.0 111.239 172.635 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 t -157.8 167.57 29.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.046 1.338 . . . . 0.0 110.207 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.14 135.6 53.79 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.928 -0.483 . . . . 0.0 111.275 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.6 -162.55 35.94 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 115.161 0.824 . . . . 0.0 115.161 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.96 119.7 35.93 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.946 1.298 . . . . 0.0 109.909 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -133.85 170.58 15.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.708 1.203 . . . . 0.0 112.468 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.8 pt -129.65 153.95 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 126.385 1.874 . . . . 0.0 108.763 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.7 mt -130.61 119.61 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -140.03 148.02 41.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.579 0.752 . . . . 0.0 111.639 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -75.72 137.46 40.64 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.592 -0.692 . . . . 0.0 111.213 -172.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -60.58 -29.23 69.05 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.39 1.076 . . . . 0.0 113.714 -175.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 123.706 0.802 . . . . 0.0 111.669 178.766 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.8 mt . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 121.385 0.612 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.34 145.61 26.26 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.162 0.985 . . . . 0.0 112.44 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.51 132.18 50.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.922 0.889 . . . . 0.0 109.242 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.3 m -130.91 127.29 38.18 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.098 0.959 . . . . 0.0 110.826 -170.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.16 129.3 94.41 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.24 1.416 . . . . 0.0 111.142 -175.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.01 -11.08 19.72 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.078 2.519 . . . . 0.0 114.164 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.12 -4.28 52.08 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.5 1.047 . . . . 0.0 115.196 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -160.72 166.88 27.99 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.067 1.433 . . . . 0.0 113.035 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -89.17 161.97 16.17 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.109 1.764 . . . . 0.0 111.039 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 56.07 38.32 29.78 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.067 1.747 . . . . 0.0 113.783 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.7 m -141.86 140.91 20.63 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.401 1.88 . . . . 0.0 109.685 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.91 148.66 71.03 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.043 2.495 . . . . 0.0 113.717 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.65 157.61 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.061 1.344 . . . . 0.0 110.653 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -126.0 171.49 10.74 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.416 1.486 . . . . 0.0 111.115 -171.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -127.59 139.08 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 121.01 -1.056 . . . . 0.0 111.3 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -161.18 168.93 10.66 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.536 1.134 . . . . 0.0 113.161 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.83 152.8 12.76 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.604 3.536 . . . . 0.0 114.304 169.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.02 134.95 51.29 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.083 1.753 . . . . 0.0 110.094 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -130.88 -10.93 3.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.817 1.647 . . . . 0.0 113.68 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.99 -4.28 16.43 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.655 1.598 . . . . 0.0 114.395 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.0 t -63.07 165.13 7.41 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.036 1.418 . . . . 0.0 113.035 175.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.0 p -71.6 -15.18 62.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.66 1.184 . . . . 0.0 113.972 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.14 -31.33 72.49 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.417 1.008 . . . . 0.0 112.823 -178.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -113.22 4.84 16.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.356 1.462 . . . . 0.0 112.843 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.66 145.52 27.51 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.718 1.207 . . . . 0.0 111.614 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -141.48 174.12 10.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.646 1.212 . . . . 0.0 111.743 -169.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.7 mt -125.7 136.72 59.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.921 2.089 . . . . 0.0 107.357 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.3 tp -134.63 129.65 35.22 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.648 1.579 . . . . 0.0 108.816 -171.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.9 mtt85 -146.29 131.4 18.33 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.308 0.643 . . . . 0.0 110.64 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -64.33 138.0 58.2 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.401 0.546 . . . . 0.0 111.068 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -115.1 -47.78 2.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.332 1.053 . . . . 0.0 111.605 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.68 110.46 4.3 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.487 1.115 . . . . 0.0 111.476 170.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.9 m -59.51 -24.69 63.86 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.957 0.903 . . . . 0.0 111.412 168.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -63.96 -21.4 66.47 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.915 2.086 . . . . 0.0 113.495 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -130.18 9.28 5.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.674 1.59 . . . . 0.0 112.852 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 46.02 33.7 1.76 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.533 1.933 . . . . 0.0 113.55 -169.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.0 p -93.37 138.62 31.53 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.001 -1.062 . . . . 0.0 112.031 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -134.69 145.13 48.24 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.204 1.802 . . . . 0.0 110.789 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.7 p -77.98 152.75 32.95 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.854 -0.529 . . . . 0.0 110.958 171.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.1 mm -129.11 130.11 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.568 1.547 . . . . 0.0 109.045 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.8 m -142.99 145.98 35.34 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.628 1.571 . . . . 0.0 110.612 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.06 146.77 32.83 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.185 2.59 . . . . 0.0 111.102 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.84 -24.98 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.943 -1.098 . . . . 0.0 113.427 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.4 -22.15 63.17 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.743 0.687 . . . . 0.0 114.197 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.2 m -143.04 64.91 15.02 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 126.144 1.777 . . . . 0.0 110.473 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -63.76 -15.37 48.49 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.197 2.598 . . . . 0.0 113.364 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -71.94 0.3 9.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.229 1.811 . . . . 0.0 113.918 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m -131.01 173.63 10.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.916 1.686 . . . . 0.0 111.545 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -140.6 171.83 13.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.556 1.142 . . . . 0.0 113.474 -170.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.07 130.64 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.234 1.414 . . . . 0.0 110.587 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.14 -158.26 7.66 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.8 1.667 . . . . 0.0 111.513 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -142.42 145.35 33.71 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.351 1.075 . . . . 0.0 111.956 -173.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.62 -163.46 11.28 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.481 1.515 . . . . 0.0 112.942 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.83 138.17 24.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.904 1.281 . . . . 0.0 113.081 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.36 -6.78 61.52 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.821 1.2 . . . . 0.0 114.173 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 48.17 56.22 7.67 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.417 1.887 . . . . 0.0 114.177 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.02 149.2 67.7 Favored Pre-proline 0 C--O 1.239 0.512 0 C-N-CA 126.511 1.924 . . . . 0.0 107.896 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -69.76 146.01 58.89 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.338 1.358 . . . . 0.0 110.073 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.27 150.01 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.966 1.706 . . . . 0.0 111.274 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.81 134.66 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.085 0.954 . . . . 0.0 110.179 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.7 mt -137.74 162.46 54.39 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.79 1.636 . . . . 0.0 112.243 -169.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.75 167.85 21.83 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.267 2.645 . . . . 0.0 111.828 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.86 127.03 12.5 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.318 2.012 . . . . 0.0 110.676 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -149.78 -93.32 0.07 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.789 0.836 . . . . 0.0 110.541 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -155.4 18.14 0.41 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.908 1.683 . . . . 0.0 112.343 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -66.04 135.4 54.59 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.73 -0.606 . . . . 0.0 111.64 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -144.99 160.8 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.968 1.307 . . . . 0.0 111.756 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -130.32 144.24 51.26 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.53 1.532 . . . . 0.0 110.537 170.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.1 m -76.31 134.83 39.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.163 1.385 . . . . 0.0 109.409 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.21 125.62 50.54 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.413 1.085 . . . . 0.0 109.478 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.8 m -132.3 117.0 17.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.672 0.789 . . . . 0.0 110.246 -170.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 tp -66.16 146.72 54.31 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.181 0.592 . . . . 0.0 111.109 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.1 p -127.59 -177.97 4.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.593 1.557 . . . . 0.0 111.627 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.0 p -59.48 -13.57 9.37 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.13 25.85 0.19 Allowed Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.202 0.841 . . . . 0.0 115.202 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.55 -149.57 9.44 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.878 1.228 . . . . 0.0 112.273 -173.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -128.46 170.11 13.53 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.609 1.964 . . . . 0.0 111.781 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -137.05 153.59 50.57 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.976 2.511 . . . . 0.0 109.037 170.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.0 mt -133.56 127.88 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.807 1.243 . . . . 0.0 108.717 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -138.29 159.9 40.87 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.457 1.103 . . . . 0.0 112.734 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.45 -23.01 67.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 125.86 -39.51 2.02 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.97 1.272 . . . . 0.0 113.102 -171.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -98.66 1.58 46.38 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.889 1.675 . . . . 0.0 113.732 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.6 mmm-85 66.39 13.17 9.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.1 2.16 . . . . 0.0 113.655 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 72.8 p -74.84 -24.82 58.66 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.46 1.104 . . . . 0.0 112.683 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.2 m -143.46 174.25 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.738 1.615 . . . . 0.0 111.693 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 t -147.23 152.89 39.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.609 2.364 . . . . 0.0 110.176 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -70.01 143.43 52.57 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.543 -0.723 . . . . 0.0 111.413 171.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 81.3 p -153.26 172.14 17.45 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.807 1.243 . . . . 0.0 112.527 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -123.92 172.97 8.51 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.332 1.853 . . . . 0.0 110.207 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -119.44 -29.76 5.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.777 1.631 . . . . 0.0 112.065 -169.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -142.41 -8.7 0.86 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.995 1.718 . . . . 0.0 114.294 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.22 51.84 13.69 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.359 1.064 . . . . 0.0 113.649 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.5 p -126.99 167.1 16.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.887 0.875 . . . . 0.0 112.306 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -73.0 146.21 46.14 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.742 -1.224 . . . . 0.0 112.568 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.79 -8.49 69.21 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.44 1.019 . . . . 0.0 114.016 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -61.28 157.34 16.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.621 1.968 . . . . 0.0 112.602 169.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -109.11 124.87 51.48 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.424 1.089 . . . . 0.0 109.231 171.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -60.0 148.19 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.731 0.813 . . . . 0.0 111.886 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.2 m -130.91 168.22 17.68 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.734 1.614 . . . . 0.0 112.087 -170.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 80.8 mt -133.91 143.87 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.401 1.48 . . . . 0.0 109.712 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.49 179.79 48.79 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.036 1.303 . . . . 0.0 111.655 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.75 -40.54 54.95 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.248 1.524 . . . . 0.0 114.542 -172.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -171.92 173.41 4.46 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.057 2.943 . . . . 0.0 108.942 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.64 137.94 33.98 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.242 -0.911 . . . . 0.0 112.785 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.6 t -61.84 -21.02 64.29 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.73 1.612 . . . . 0.0 115.303 -170.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -134.18 -38.01 0.87 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.509 1.124 . . . . 0.0 113.312 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.3 p -98.19 4.06 48.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.152 1.381 . . . . 0.0 114.626 -171.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.53 14.25 1.03 Allowed Glycine 0 CA--C 1.544 1.892 0 C-N-CA 126.017 1.77 . . . . 0.0 115.9 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -134.53 150.66 50.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.88 1.672 . . . . 0.0 111.915 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -141.41 175.6 9.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.996 2.118 . . . . 0.0 110.795 -169.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.86 138.46 34.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 125.03 1.332 . . . . 0.0 108.814 169.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.8 123.5 71.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.716 1.606 . . . . 0.0 106.768 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -146.9 153.83 40.58 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.597 1.159 . . . . 0.0 109.168 -169.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -68.62 154.57 41.66 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.967 -1.083 . . . . 0.0 112.518 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.256 1.822 . . . . 0.0 111.405 171.902 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 t -159.7 168.43 25.98 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.084 1.354 . . . . 0.0 109.879 173.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.53 131.83 48.18 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.854 -0.529 . . . . 0.0 111.632 171.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.55 -168.49 41.34 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 114.643 0.617 . . . . 0.0 114.643 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -94.49 125.75 39.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.043 0.937 . . . . 0.0 109.793 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -132.73 166.15 22.87 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.709 1.604 . . . . 0.0 111.887 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.1 pt -117.69 151.1 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 125.489 1.516 . . . . 0.0 108.45 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.0 mt -130.33 113.43 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -136.47 143.39 43.82 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.439 1.095 . . . . 0.0 110.089 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -71.01 150.08 45.98 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.797 -0.564 . . . . 0.0 111.329 -172.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -63.83 -13.88 48.31 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.8 t . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 126.611 1.964 . . . . 0.0 108.889 169.729 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.657 0.742 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.53 150.12 21.44 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.827 1.651 . . . . 0.0 115.045 -168.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.77 134.99 57.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.18 0.992 . . . . 0.0 109.14 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.2 m -135.4 125.38 25.84 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.216 1.007 . . . . 0.0 111.301 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -67.0 140.42 96.04 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.551 1.94 . . . . 0.0 112.878 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.29 -15.64 17.89 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.705 2.937 . . . . 0.0 114.943 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.98 7.21 66.2 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.306 0.955 . . . . 0.0 115.076 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -156.97 167.04 31.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.515 1.926 . . . . 0.0 111.322 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -100.13 167.83 10.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.809 1.243 . . . . 0.0 111.267 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 50.85 38.91 21.12 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.672 1.589 . . . . 0.0 113.256 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.1 m -139.87 138.41 19.72 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 126.129 1.772 . . . . 0.0 110.557 -169.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.21 159.83 3.85 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.861 3.707 . . . . 0.0 115.542 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 t -114.0 149.64 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.107 1.363 . . . . 0.0 110.643 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 52' ' ' VAL . 2.8 m -125.2 174.42 8.11 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.268 1.427 . . . . 0.0 110.909 -169.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 51' ' ' THR . 0.3 OUTLIER -127.06 143.02 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.951 1.301 . . . . 0.0 111.365 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.3 m -152.99 162.51 26.21 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 124.302 1.041 . . . . 0.0 113.047 -173.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.34 150.57 40.62 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.446 2.764 . . . . 0.0 112.754 169.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.8 tp -108.14 134.19 51.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.864 1.266 . . . . 0.0 111.585 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -133.82 -26.88 1.52 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.823 2.049 . . . . 0.0 112.405 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.8 5.47 2.2 Favored Glycine 0 CA--C 1.537 1.464 0 N-CA-C 116.811 1.484 . . . . 0.0 116.811 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.3 p -72.83 165.28 25.19 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.899 1.849 . . . . 0.0 113.798 -175.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.3 m -70.04 -14.48 62.7 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -73.14 -25.34 60.79 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.974 0.91 . . . . 0.0 112.458 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.61 5.82 11.64 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.343 2.657 . . . . 0.0 112.23 -172.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.8 147.89 33.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.506 1.522 . . . . 0.0 110.257 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -134.96 171.66 14.1 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.886 1.326 . . . . 0.0 112.291 -168.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.3 mt -125.66 134.46 66.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 127.505 2.322 . . . . 0.0 106.249 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.4 tp -137.13 123.38 20.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.067 1.347 . . . . 0.0 109.624 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -142.81 140.03 31.17 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.495 0.718 . . . . 0.0 111.388 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.3 t -65.5 142.43 58.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.355 0.662 . . . . 0.0 111.451 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -117.19 -52.74 2.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.749 1.219 . . . . 0.0 111.823 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.2 111.24 5.32 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.3 1.04 . . . . 0.0 111.006 170.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.3 m -57.28 -24.35 54.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.887 0.875 . . . . 0.0 111.26 168.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -65.37 -21.6 66.7 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.924 2.089 . . . . 0.0 113.633 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.6 t -130.5 14.69 5.49 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.193 1.397 . . . . 0.0 112.898 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 43.89 34.56 0.92 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.24 1.816 . . . . 0.0 113.475 -169.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.1 p -88.0 143.23 27.21 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.995 -1.065 . . . . 0.0 112.106 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -139.17 143.22 38.04 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.328 1.451 . . . . 0.0 110.993 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.4 p -77.7 147.99 35.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.288 0.635 . . . . 0.0 110.723 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.0 mm -128.28 126.08 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.462 1.505 . . . . 0.0 109.397 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.0 m -143.34 146.46 36.24 Favored Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 125.791 1.637 . . . . 0.0 109.539 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.57 150.84 28.34 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.765 2.31 . . . . 0.0 111.53 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.49 -30.53 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 121.297 -0.877 . . . . 0.0 111.836 172.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.73 -14.89 78.99 Favored Glycine 0 CA--C 1.539 1.564 0 N-CA-C 115.595 0.998 . . . . 0.0 115.595 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.6 m -151.6 61.75 4.47 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 125.819 1.648 . . . . 0.0 111.56 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -62.8 -17.21 58.19 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 124.065 3.176 . . . . 0.0 113.669 -173.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -72.77 13.11 0.41 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 128.484 2.713 . . . . 0.0 114.238 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.8 p -141.46 171.34 14.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.731 2.012 . . . . 0.0 111.596 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -138.83 170.09 16.63 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.634 1.574 . . . . 0.0 112.469 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.71 129.88 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.865 1.266 . . . . 0.0 110.897 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.75 -156.15 6.82 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.83 1.681 . . . . 0.0 111.693 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -143.01 141.11 31.27 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.387 1.075 . . . . 0.0 111.526 -171.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.14 -166.78 13.0 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.36 1.457 . . . . 0.0 113.035 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.72 137.47 20.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.979 1.311 . . . . 0.0 113.164 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.32 -7.28 61.88 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.85 1.214 . . . . 0.0 114.094 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 48.69 56.32 7.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.575 1.95 . . . . 0.0 114.298 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.64 151.02 77.4 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 126.2 1.8 . . . . 0.0 108.201 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.57 142.16 57.91 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.269 1.313 . . . . 0.0 109.84 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.34 148.92 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.615 1.566 . . . . 0.0 111.123 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.87 139.47 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.838 0.855 . . . . 0.0 110.602 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.67 161.67 57.28 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.666 1.986 . . . . 0.0 110.944 -172.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -69.65 164.88 32.79 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.703 2.269 . . . . 0.0 111.482 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.0 123.44 10.02 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.455 2.103 . . . . 0.0 110.851 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -147.72 -91.34 0.08 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.245 1.018 . . . . 0.0 110.482 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -156.01 18.34 0.37 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.524 1.53 . . . . 0.0 112.955 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -68.2 136.13 53.11 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.544 -0.722 . . . . 0.0 112.125 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.7 m -145.19 161.55 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.06 1.344 . . . . 0.0 112.537 -174.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -131.49 136.79 48.2 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.964 1.706 . . . . 0.0 110.571 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.6 m -71.92 131.58 43.17 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.098 0.959 . . . . 0.0 108.717 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.1 mt -123.52 128.19 49.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.096 0.958 . . . . 0.0 109.424 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.1 m -133.63 120.35 20.56 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.772 0.829 . . . . 0.0 110.586 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.83 146.82 54.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.065 0.546 . . . . 0.0 111.246 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -126.43 178.85 5.6 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.585 1.554 . . . . 0.0 110.818 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.0 p -60.23 -14.98 20.54 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.75 33.66 0.36 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.659 1.124 . . . . 0.0 114.088 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.61 -154.46 24.23 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.927 1.251 . . . . 0.0 112.909 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -126.71 170.93 11.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.272 2.229 . . . . 0.0 111.119 174.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -135.44 151.05 50.04 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.361 2.264 . . . . 0.0 109.255 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.9 mt -132.94 125.3 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.921 1.289 . . . . 0.0 108.778 -170.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -138.12 157.67 45.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.598 1.159 . . . . 0.0 112.648 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -60.72 -32.98 72.21 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -174.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.38 -40.28 1.64 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.9 1.714 . . . . 0.0 113.298 -172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.65 -13.1 59.73 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.598 1.159 . . . . 0.0 113.585 171.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 69.99 13.85 7.86 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.221 2.208 . . . . 0.0 112.796 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.2 p -71.99 -21.53 61.55 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.84 1.656 . . . . 0.0 112.856 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.0 m -144.97 170.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.071 1.749 . . . . 0.0 111.754 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.3 t -141.23 156.47 45.9 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.255 1.822 . . . . 0.0 110.838 171.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -70.05 140.17 52.76 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.595 -0.691 . . . . 0.0 111.345 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.8 p -151.64 172.15 16.52 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.438 1.095 . . . . 0.0 112.498 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -117.34 174.73 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.137 1.775 . . . . 0.0 109.794 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -112.16 -31.88 6.73 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.977 1.311 . . . . 0.0 110.648 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -142.7 -13.3 0.76 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.546 2.338 . . . . 0.0 112.734 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.96 20.53 6.83 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.75 2.02 . . . . 0.0 114.78 -171.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.7 p -70.86 155.78 40.37 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.571 1.148 . . . . 0.0 111.921 171.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.12 137.22 58.04 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.408 -0.807 . . . . 0.0 112.457 172.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.14 -1.83 87.63 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.98 1.276 . . . . 0.0 114.455 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 139.01 45.81 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.75 1.275 . . . . 0.0 112.823 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.36 127.0 32.16 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.528 -0.732 . . . . 0.0 110.266 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.36 152.07 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.117 0.567 . . . . 0.0 110.426 175.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.7 m -130.34 161.98 30.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.574 1.549 . . . . 0.0 111.563 -173.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.0 mt -131.87 143.73 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.377 1.471 . . . . 0.0 108.84 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.44 -157.64 30.19 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 123.73 0.681 . . . . 0.0 112.236 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.16 159.99 4.07 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 117.832 0.816 . . . . 0.0 112.063 169.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.43 148.77 11.35 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.784 1.234 . . . . 0.0 112.229 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.8 138.93 53.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.988 1.315 . . . . 0.0 112.939 -170.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -60.07 -21.75 61.85 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -131.45 -39.93 1.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 85.9 p -98.59 3.78 48.01 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -173.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.43 -3.18 31.09 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.492 1.044 . . . . 0.0 115.02 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -121.45 154.88 35.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.941 1.696 . . . . 0.0 111.21 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -137.83 175.09 9.9 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.258 1.823 . . . . 0.0 111.155 -170.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.8 t -133.58 135.05 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.621 1.568 . . . . 0.0 107.956 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 47.6 mt -130.59 119.05 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -149.31 152.46 35.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.997 -168.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -68.93 154.4 42.11 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.167 -0.958 . . . . 0.0 112.587 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 C--O 1.254 1.311 0 C-N-CA 126.338 1.855 . . . . 0.0 111.422 172.324 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.714 0.769 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -157.49 167.49 30.05 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.494 1.118 . . . . 0.0 110.034 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.39 124.0 20.17 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.994 -0.441 . . . . 0.0 111.259 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.36 -166.05 37.83 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -101.53 123.91 46.33 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.198 0.999 . . . . 0.0 109.908 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.86 169.7 15.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.073 1.349 . . . . 0.0 112.454 -171.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.4 pt -123.52 152.01 28.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.992 1.717 . . . . 0.0 108.302 171.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.83 121.2 57.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -136.66 147.07 46.64 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.118 0.967 . . . . 0.0 111.022 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -73.62 148.11 43.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.828 -0.545 . . . . 0.0 110.832 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.7 tpt85 -64.61 -16.64 63.04 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.476 0.869 0 C-N-CA 126.084 1.754 . . . . 0.0 109.117 169.619 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.47 0.548 0 CA-C-O 121.13 0.49 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.24 151.15 24.46 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -167.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 tp -57.37 132.33 52.76 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.111 1.365 . . . . 0.0 109.778 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.0 m -130.47 124.82 32.88 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.929 0.892 . . . . 0.0 111.479 -170.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -61.11 128.87 90.05 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.14 1.376 . . . . 0.0 111.404 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.67 -11.36 20.3 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.326 2.684 . . . . 0.0 114.208 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.87 -5.15 50.25 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.456 1.027 . . . . 0.0 115.104 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -160.02 168.28 25.97 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.903 1.351 . . . . 0.0 113.067 -173.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -88.7 167.7 13.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.085 1.754 . . . . 0.0 111.394 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 48.92 40.42 16.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.678 1.991 . . . . 0.0 113.466 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.6 m -141.04 137.16 16.64 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 126.062 1.745 . . . . 0.0 110.03 -172.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.73 141.86 42.92 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.309 3.34 . . . . 0.0 114.547 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 t -84.74 149.15 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.398 1.079 . . . . 0.0 110.509 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 52' ' ' VAL . 1.4 m -122.7 178.08 5.17 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.172 1.389 . . . . 0.0 110.595 -170.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.473 ' H ' HG22 ' A' ' 51' ' ' THR . 0.3 OUTLIER -130.27 148.61 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.695 1.198 . . . . 0.0 111.253 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.4 p -155.11 159.01 32.15 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 123.539 0.736 . . . . 0.0 112.792 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.71 128.41 30.21 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.569 2.179 . . . . 0.0 111.213 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.92 131.51 49.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.391 1.076 . . . . 0.0 111.079 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -123.04 -19.36 6.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.587 1.155 . . . . 0.0 112.221 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.35 60.67 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.698 1.142 . . . . 0.0 113.261 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.5 t -67.74 162.26 24.21 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.066 1.346 . . . . 0.0 111.766 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.4 p -57.09 -18.74 15.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.62 1.168 . . . . 0.0 113.944 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.21 -32.88 74.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.685 1.194 . . . . 0.0 113.04 173.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -111.4 -0.65 16.23 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.42 146.48 24.73 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 122.33 1.062 . . . . 0.0 111.868 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -140.5 172.81 12.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.963 1.305 . . . . 0.0 111.427 -169.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.8 mt -123.03 135.19 63.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.072 2.149 . . . . 0.0 107.025 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.04 123.85 21.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.194 1.398 . . . . 0.0 109.17 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -144.03 139.96 29.28 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.461 0.705 . . . . 0.0 111.922 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 t -66.32 139.2 58.03 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.014 0.526 . . . . 0.0 111.651 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -114.58 -52.79 2.69 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.649 1.18 . . . . 0.0 111.303 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.85 109.95 4.93 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.614 1.165 . . . . 0.0 111.34 171.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.4 m -57.92 -24.58 58.43 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.877 0.871 . . . . 0.0 111.65 168.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -64.11 -22.57 66.99 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.129 2.171 . . . . 0.0 113.641 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.7 m -130.31 12.25 5.5 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.772 1.629 . . . . 0.0 112.671 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 43.99 35.35 1.13 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.595 1.958 . . . . 0.0 113.487 -168.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 p -89.45 140.43 29.52 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.836 -1.165 . . . . 0.0 112.028 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -136.55 144.73 44.37 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.03 1.732 . . . . 0.0 110.14 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.2 p -77.68 149.81 34.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.404 0.682 . . . . 0.0 110.667 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.0 mm -128.55 126.81 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.563 1.545 . . . . 0.0 109.184 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.1 m -144.77 142.9 19.53 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.348 1.459 . . . . 0.0 110.105 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.04 145.38 35.4 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.983 2.455 . . . . 0.0 111.114 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.6 m -66.01 -23.1 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.708 -1.245 . . . . 0.0 112.733 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.09 -9.69 81.87 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.675 1.131 . . . . 0.0 114.625 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.8 t -152.35 66.03 6.28 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.048 1.339 . . . . 0.0 110.883 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.99 -18.18 61.45 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.265 2.643 . . . . 0.0 112.949 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -78.61 5.22 11.5 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.406 2.282 . . . . 0.0 114.096 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 m -130.87 171.91 12.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.372 1.869 . . . . 0.0 111.182 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -138.7 173.59 11.42 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.39 1.476 . . . . 0.0 112.915 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.0 mm -121.67 129.79 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.232 1.413 . . . . 0.0 110.81 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.12 -156.85 7.13 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.76 1.648 . . . . 0.0 111.958 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -142.66 142.37 32.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.437 1.095 . . . . 0.0 111.646 -171.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.93 -165.13 12.0 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.303 1.43 . . . . 0.0 113.405 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.57 138.84 21.75 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.063 1.345 . . . . 0.0 113.217 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.69 -6.42 67.51 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.746 1.165 . . . . 0.0 114.097 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 49.04 57.78 6.08 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.373 1.869 . . . . 0.0 113.932 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.65 149.7 72.77 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 126.101 1.761 . . . . 0.0 108.13 169.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.75 144.4 53.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.242 1.294 . . . . 0.0 109.643 174.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.88 146.96 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.577 1.551 . . . . 0.0 110.945 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.9 t -76.22 137.99 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.567 0.747 . . . . 0.0 109.887 171.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.9 mt -140.21 162.97 47.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.946 1.699 . . . . 0.0 112.194 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.34 166.66 24.64 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.252 2.635 . . . . 0.0 111.71 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.44 126.81 11.92 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.311 2.007 . . . . 0.0 110.909 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -148.62 -106.18 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.604 1.161 . . . . 0.0 109.413 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -145.25 21.58 1.54 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.422 1.889 . . . . 0.0 110.59 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -66.73 133.5 50.31 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.226 -0.921 . . . . 0.0 111.774 -173.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.7 m -144.71 160.33 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.336 1.455 . . . . 0.0 111.994 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -130.06 145.66 51.69 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.611 1.564 . . . . 0.0 109.973 169.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -77.03 134.86 38.68 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.801 1.241 . . . . 0.0 109.583 171.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.66 126.06 51.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.644 1.177 . . . . 0.0 109.722 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.2 m -132.77 120.13 21.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.247 1.019 . . . . 0.0 110.284 -175.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 tp -65.33 146.6 54.72 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.203 0.601 . . . . 0.0 111.334 172.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 p -127.76 176.53 7.47 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.564 1.545 . . . . 0.0 111.497 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -60.51 -10.31 4.86 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.88 31.89 0.29 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.496 1.046 . . . . 0.0 114.064 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.38 -151.82 19.12 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.721 1.153 . . . . 0.0 113.02 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -131.64 170.22 15.07 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 128.007 2.523 . . . . 0.0 110.591 175.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -134.59 155.36 50.59 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.683 1.593 . . . . 0.0 111.076 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.1 mt -135.09 115.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.774 1.629 . . . . 0.0 108.98 -170.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -134.36 158.15 44.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.227 1.011 . . . . 0.0 112.866 -170.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -61.25 -18.1 56.72 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 120.27 -33.83 4.37 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.885 1.231 . . . . 0.0 113.279 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -107.94 5.73 26.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.477 1.911 . . . . 0.0 113.18 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.8 mmm-85 63.19 16.98 9.84 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.148 2.179 . . . . 0.0 113.998 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.8 p -74.71 -27.91 60.59 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.235 1.014 . . . . 0.0 112.799 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.7 m -143.19 175.27 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.314 1.446 . . . . 0.0 111.735 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -144.41 150.98 38.6 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 128.449 2.7 . . . . 0.0 109.675 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -71.0 145.01 50.26 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.583 -0.698 . . . . 0.0 111.517 169.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.5 p -152.32 176.42 11.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.552 1.141 . . . . 0.0 112.557 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -132.08 171.29 13.81 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.067 2.147 . . . . 0.0 109.861 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -111.68 -35.89 5.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.305 1.042 . . . . 0.0 111.159 -170.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -141.38 -10.95 0.94 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.079 2.152 . . . . 0.0 112.63 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.77 19.14 5.37 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.455 1.902 . . . . 0.0 115.134 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.6 p -70.69 157.81 37.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.319 1.047 . . . . 0.0 112.148 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.52 137.54 58.15 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.372 -0.83 . . . . 0.0 112.612 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.14 -1.22 89.06 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.536 1.065 . . . . 0.0 114.564 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -69.21 141.47 54.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.66 1.184 . . . . 0.0 112.501 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.91 128.88 34.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.579 0.752 . . . . 0.0 110.424 174.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.08 151.62 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.429 0.692 . . . . 0.0 110.714 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.6 t -126.27 165.24 19.33 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.256 1.422 . . . . 0.0 111.539 -174.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.0 mt -135.68 140.48 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.608 1.563 . . . . 0.0 109.672 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.0 -179.49 48.9 Favored Glycine 0 N--CA 1.469 0.889 0 C-N-CA 124.9 1.238 . . . . 0.0 111.768 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.22 -41.05 62.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 119.034 1.417 . . . . 0.0 114.035 -173.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -168.62 172.17 8.25 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.809 2.444 . . . . 0.0 109.96 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.69 141.23 35.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.356 1.062 . . . . 0.0 112.547 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.5 t -60.43 -21.06 61.84 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -134.3 -38.4 0.85 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.3 p -96.65 5.36 50.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.347 1.459 . . . . 0.0 114.354 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.62 10.75 3.68 Favored Glycine 0 CA--C 1.542 1.764 0 C-N-CA 125.107 1.336 . . . . 0.0 115.658 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -136.22 149.1 48.4 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.85 2.06 . . . . 0.0 110.412 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -137.75 176.25 8.87 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.525 1.93 . . . . 0.0 112.022 -169.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.1 t -134.77 137.07 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.924 1.69 . . . . 0.0 108.509 171.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.94 123.75 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.06 154.19 38.92 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.651 1.18 . . . . 0.0 108.989 -170.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -68.75 154.75 41.4 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.682 -1.261 . . . . 0.0 112.594 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.394 1.878 . . . . 0.0 111.462 171.328 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 CA--C 1.542 0.657 0 CA-C-O 122.513 1.149 . . . . 0.0 114.031 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 t -160.08 170.07 22.03 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.662 1.585 . . . . 0.0 109.575 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 130.84 44.54 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.58 -0.7 . . . . 0.0 111.512 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.11 -163.02 36.52 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 121.623 -0.673 . . . . 0.0 114.627 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -98.41 124.33 43.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.049 0.939 . . . . 0.0 110.094 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -133.1 171.75 13.57 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.084 1.354 . . . . 0.0 112.679 -171.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.0 pt -125.72 153.32 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 126.368 1.867 . . . . 0.0 108.643 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mt -129.13 120.04 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -138.69 149.32 44.99 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.876 0.871 . . . . 0.0 111.326 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -75.65 144.51 41.65 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.98 -0.45 . . . . 0.0 110.648 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -62.13 -15.04 42.92 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.471 0.586 0 C-N-CA 125.37 1.468 . . . . 0.0 109.419 172.653 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.4 tp . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 121.366 0.603 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.96 149.52 22.54 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.934 1.294 . . . . 0.0 113.665 -171.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 tp -58.17 135.2 57.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.001 1.32 . . . . 0.0 110.081 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.6 m -127.38 127.11 43.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.793 1.237 . . . . 0.0 111.276 -174.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -66.9 132.23 93.89 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.762 0.825 . . . . 0.0 111.654 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.27 -10.34 22.38 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.1 2.534 . . . . 0.0 114.348 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.81 85.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 123.994 0.807 . . . . 0.0 114.64 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -148.53 150.89 34.16 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.94 1.696 . . . . 0.0 111.046 -171.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -90.67 159.55 16.33 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.588 1.155 . . . . 0.0 111.005 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 49.87 39.27 17.96 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.163 1.385 . . . . 0.0 112.969 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.3 m -135.03 137.52 27.27 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.907 1.683 . . . . 0.0 110.401 -169.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -53.41 152.92 18.97 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.514 3.476 . . . . 0.0 114.752 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.3 t -102.68 150.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.777 1.231 . . . . 0.0 110.801 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -122.76 172.85 8.13 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.159 1.383 . . . . 0.0 111.215 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.36 139.92 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.938 1.295 . . . . 0.0 111.352 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.9 m -151.76 166.06 16.06 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.401 1.081 . . . . 0.0 112.962 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.14 162.73 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 124.03 3.154 . . . . 0.0 114.113 169.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.5 tp -126.97 143.24 51.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.137 1.375 . . . . 0.0 111.485 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -145.68 -30.38 0.41 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.037 1.335 . . . . 0.0 113.579 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.94 -9.63 1.8 Allowed Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.259 1.409 . . . . 0.0 114.156 -174.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.4 t -64.21 140.35 58.86 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.825 1.313 . . . . 0.0 112.108 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -61.56 -12.63 16.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.584 1.554 . . . . 0.0 114.286 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.19 -22.49 65.73 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.162 -0.961 . . . . 0.0 112.027 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -106.69 1.78 25.32 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.998 1.719 . . . . 0.0 113.296 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.67 147.75 25.64 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.143 0.973 . . . . 0.0 111.489 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -141.31 169.77 16.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.54 1.136 . . . . 0.0 111.776 -169.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.18 138.79 42.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 126.729 2.012 . . . . 0.0 108.011 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.7 tp -136.84 127.94 27.83 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.847 1.659 . . . . 0.0 109.459 -173.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -143.5 142.28 31.09 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.895 0.878 . . . . 0.0 111.374 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.6 t -66.65 142.15 57.55 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.099 0.56 . . . . 0.0 111.176 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -115.18 -52.6 2.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.291 1.036 . . . . 0.0 111.522 174.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.73 110.64 4.99 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.648 1.179 . . . . 0.0 111.306 171.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.7 m -58.43 -24.43 60.18 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.938 0.895 . . . . 0.0 111.447 168.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -64.1 -21.62 66.6 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.998 2.119 . . . . 0.0 113.421 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 m -130.29 10.89 5.37 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.9 1.68 . . . . 0.0 113.021 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 44.5 33.93 1.0 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.491 1.916 . . . . 0.0 113.794 -169.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.1 p -89.63 144.61 25.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.859 0.864 . . . . 0.0 112.055 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -140.2 142.18 35.89 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.539 1.535 . . . . 0.0 110.838 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.0 p -77.83 146.61 35.62 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.012 0.525 . . . . 0.0 110.506 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.6 mm -128.02 125.93 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.402 1.481 . . . . 0.0 109.094 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.2 m -142.46 143.41 26.64 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 124.556 1.142 . . . . 0.0 110.391 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.93 140.7 42.66 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.061 2.507 . . . . 0.0 110.682 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.35 -25.65 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.27 -13.93 59.53 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.45 1.024 . . . . 0.0 114.752 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.5 m -140.45 61.44 16.41 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.421 1.488 . . . . 0.0 111.517 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -61.58 -17.43 54.12 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.659 2.906 . . . . 0.0 113.295 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -71.68 8.66 1.07 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 128.105 2.562 . . . . 0.0 114.079 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.9 m -141.1 172.19 13.02 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.504 2.321 . . . . 0.0 111.32 172.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -137.27 171.65 14.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.081 2.152 . . . . 0.0 112.045 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.97 124.28 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.805 1.242 . . . . 0.0 110.36 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.48 -160.89 8.51 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.806 1.67 . . . . 0.0 111.891 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -139.92 140.01 36.31 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.65 1.18 . . . . 0.0 111.449 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.46 -166.82 12.4 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.2 1.381 . . . . 0.0 113.384 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.0 137.95 20.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.073 1.349 . . . . 0.0 113.143 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.79 -7.08 62.86 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.735 1.159 . . . . 0.0 114.06 -172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 48.49 57.66 6.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.384 1.874 . . . . 0.0 113.829 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.87 149.74 71.39 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 126.176 1.79 . . . . 0.0 108.461 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.07 144.4 57.55 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.595 1.53 . . . . 0.0 110.042 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.38 145.6 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.73 1.612 . . . . 0.0 111.859 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.0 t -74.22 122.83 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.149 0.979 . . . . 0.0 110.346 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 mp -132.4 163.09 52.97 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.802 2.041 . . . . 0.0 110.481 -169.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.31 165.41 32.65 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.75 2.3 . . . . 0.0 111.97 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.3 126.12 20.52 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.04 2.494 . . . . 0.0 112.026 170.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -149.63 -90.75 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.087 0.955 . . . . 0.0 110.184 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -156.27 16.82 0.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.832 1.653 . . . . 0.0 112.513 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -66.27 132.6 48.77 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.324 0.65 . . . . 0.0 111.839 -171.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.0 m -144.21 160.69 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.093 1.357 . . . . 0.0 111.827 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -131.5 136.5 47.94 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.29 1.436 . . . . 0.0 110.411 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 61.7 m -72.73 132.87 44.2 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.542 1.137 . . . . 0.0 109.195 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.5 mt -124.17 73.68 1.25 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.844 0.857 . . . . 0.0 109.419 -174.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.0 m -74.59 125.27 28.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.369 1.067 . . . . 0.0 110.698 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 tp -69.05 146.4 52.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.267 0.627 . . . . 0.0 111.168 171.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 p -126.92 175.72 7.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.609 1.564 . . . . 0.0 111.009 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.1 m -59.72 -11.62 5.48 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.0 24.3 0.33 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.898 1.237 . . . . 0.0 114.42 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.19 -149.03 11.25 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 118.298 1.049 . . . . 0.0 112.895 -173.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -133.81 169.73 16.64 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.22 2.208 . . . . 0.0 111.894 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -136.14 145.89 46.31 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.082 2.153 . . . . 0.0 109.451 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -125.7 122.87 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.401 1.08 . . . . 0.0 108.914 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -139.27 157.68 45.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.344 1.058 . . . . 0.0 112.737 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -60.33 -29.74 69.08 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.914 1.686 . . . . 0.0 115.284 -173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 128.91 -40.07 1.76 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.892 1.711 . . . . 0.0 113.237 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -79.9 -10.25 59.76 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.653 1.181 . . . . 0.0 113.927 173.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 68.52 12.8 8.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.848 2.059 . . . . 0.0 112.837 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.8 p -74.12 -25.06 59.56 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.159 1.384 . . . . 0.0 112.512 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.2 m -144.31 171.35 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.908 1.683 . . . . 0.0 111.915 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.6 t -144.85 154.15 42.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.864 2.466 . . . . 0.0 109.938 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -69.95 145.45 51.88 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.62 -0.675 . . . . 0.0 111.603 170.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.9 p -150.32 177.04 10.33 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.112 0.965 . . . . 0.0 112.329 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.15 166.86 18.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.493 1.917 . . . . 0.0 109.354 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -110.01 -32.17 7.12 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.875 0.87 . . . . 0.0 112.023 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -139.94 -10.13 1.16 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.677 1.991 . . . . 0.0 112.644 170.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.18 24.29 7.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.82 1.648 . . . . 0.0 114.302 -169.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.3 p -73.45 154.85 39.79 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.783 -1.198 . . . . 0.0 111.0 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.45 142.83 58.03 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.154 -0.967 . . . . 0.0 112.001 173.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.43 5.8 89.12 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.667 1.127 . . . . 0.0 114.297 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -75.4 137.69 41.19 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.783 1.291 . . . . 0.0 112.61 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -72.94 123.91 24.41 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.5 -0.75 . . . . 0.0 110.167 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.0 t -60.92 149.39 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.564 0.746 . . . . 0.0 110.623 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.4 p -125.06 166.44 16.37 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.817 1.247 . . . . 0.0 112.384 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 84.8 mt -135.03 142.04 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.151 1.381 . . . . 0.0 109.185 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.37 177.96 46.65 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.728 1.156 . . . . 0.0 111.73 174.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.38 -40.15 48.86 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 119.087 1.443 . . . . 0.0 114.212 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -168.97 174.45 6.36 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.661 2.784 . . . . 0.0 110.734 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.92 141.23 38.49 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.183 0.993 . . . . 0.0 111.627 169.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.0 t -62.86 -21.09 65.71 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -169.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -137.94 -35.21 0.64 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p -97.52 3.46 50.66 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 114.19 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.95 17.83 1.23 Allowed Glycine 0 CA--C 1.542 1.767 0 C-N-CA 125.805 1.669 . . . . 0.0 115.805 -176.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -140.07 146.37 38.85 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.238 1.815 . . . . 0.0 110.766 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -140.4 175.85 9.26 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.812 1.245 . . . . 0.0 112.184 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.1 p -140.85 138.87 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.856 1.262 . . . . 0.0 109.409 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.18 125.92 74.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 125.785 1.634 . . . . 0.0 107.144 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -149.13 154.2 38.86 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.866 1.266 . . . . 0.0 109.101 -171.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -67.86 155.43 39.39 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.86 -1.15 . . . . 0.0 112.663 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.7 t . . . . . 0 C--O 1.252 1.227 0 C-N-CA 126.127 1.771 . . . . 0.0 111.28 171.853 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 m -151.44 159.41 44.22 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.296 1.839 . . . . 0.0 109.231 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.41 136.27 56.94 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.307 -0.871 . . . . 0.0 111.505 174.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.62 -164.77 37.55 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 114.788 0.675 . . . . 0.0 114.788 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -95.06 125.58 39.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.217 1.007 . . . . 0.0 110.213 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -134.62 172.26 13.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.694 1.598 . . . . 0.0 111.973 -172.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.2 pt -126.17 154.22 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.919 1.687 . . . . 0.0 108.535 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.9 mt -128.9 119.41 49.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -141.24 152.88 44.91 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.359 0.663 . . . . 0.0 111.655 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -88.43 133.32 34.15 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.029 -0.419 . . . . 0.0 111.289 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -62.52 -18.69 62.49 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.478 0.959 0 C-N-CA 124.298 1.039 . . . . 0.0 112.509 173.848 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.3 tp . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.389 0.614 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.25 149.62 28.93 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.503 1.521 . . . . 0.0 114.014 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.35 139.92 57.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.332 1.053 . . . . 0.0 109.598 169.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 m -132.34 123.41 26.76 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.216 1.006 . . . . 0.0 111.611 -174.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -60.18 129.65 88.74 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 126.4 1.88 . . . . 0.0 111.507 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.14 -3.86 14.19 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.736 2.957 . . . . 0.0 115.12 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.78 9.03 87.43 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 119.046 0.839 . . . . 0.0 114.702 -176.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -144.75 164.59 30.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.156 1.382 . . . . 0.0 112.476 -170.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -101.97 157.85 16.56 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.729 1.212 . . . . 0.0 109.841 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 49.27 33.72 5.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.022 1.329 . . . . 0.0 113.607 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.0 m -129.0 136.27 28.92 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 126.111 1.764 . . . . 0.0 110.083 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.6 149.18 19.11 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.771 3.647 . . . . 0.0 115.237 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.51 151.46 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.101 1.361 . . . . 0.0 110.819 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 m -122.14 175.78 6.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.22 1.408 . . . . 0.0 111.394 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.68 139.94 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.801 1.24 . . . . 0.0 111.516 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.0 m -152.68 166.43 15.4 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 124.249 1.02 . . . . 0.0 113.326 -171.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.7 161.32 6.15 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.652 2.901 . . . . 0.0 113.127 168.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.3 tp -121.84 138.44 54.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.461 1.104 . . . . 0.0 111.74 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -139.53 -37.18 0.5 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.744 2.018 . . . . 0.0 112.363 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.82 3.77 1.07 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.908 1.242 . . . . 0.0 115.334 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.7 t -63.44 153.84 34.04 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.476 1.638 . . . . 0.0 112.381 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.7 p -70.52 -11.16 60.75 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -75.16 -23.62 57.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.29 0.95 . . . . 0.0 112.209 175.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.72 3.55 11.66 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.33 2.652 . . . . 0.0 112.259 -170.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.46 148.88 32.18 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.337 1.455 . . . . 0.0 110.315 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -136.24 172.98 12.22 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.699 1.238 . . . . 0.0 112.537 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.1 mt -129.83 135.18 61.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 126.735 2.014 . . . . 0.0 106.709 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.5 tp -134.65 128.8 33.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.349 1.459 . . . . 0.0 109.472 -169.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -143.06 130.6 21.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.782 0.833 . . . . 0.0 110.383 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 t -64.02 138.49 58.48 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.485 0.584 . . . . 0.0 111.287 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -115.27 -51.86 2.69 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.32 1.048 . . . . 0.0 111.471 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.43 109.35 4.45 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.255 1.022 . . . . 0.0 111.127 170.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.9 m -58.03 -25.99 61.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.841 0.857 . . . . 0.0 111.141 168.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -62.79 -20.62 65.18 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.151 2.18 . . . . 0.0 113.598 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 t -130.42 9.98 5.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.684 1.593 . . . . 0.0 112.996 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 47.46 32.59 2.4 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.986 1.714 . . . . 0.0 114.087 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -90.24 140.72 29.41 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.857 -1.152 . . . . 0.0 112.362 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -138.32 145.09 40.78 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.865 1.666 . . . . 0.0 110.791 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.2 p -77.89 150.14 34.15 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.974 173.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 mm -124.54 127.75 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.374 1.47 . . . . 0.0 109.274 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.3 m -140.33 143.76 34.57 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.85 1.66 . . . . 0.0 110.22 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.87 147.24 30.57 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.121 2.548 . . . . 0.0 111.637 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.47 -29.89 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 121.122 -0.986 . . . . 0.0 111.882 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.75 -26.1 73.58 Favored Glycine 0 CA--C 1.538 1.506 0 O-C-N 121.705 -0.622 . . . . 0.0 114.448 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -145.64 64.95 10.91 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.508 1.523 . . . . 0.0 111.587 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.95 -13.65 36.35 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.505 2.803 . . . . 0.0 113.938 -174.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -73.7 10.04 1.24 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.926 2.09 . . . . 0.0 113.979 169.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.9 p -138.53 174.64 10.32 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.417 1.487 . . . . 0.0 112.389 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -142.11 168.25 20.2 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.942 1.297 . . . . 0.0 113.024 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -117.4 130.34 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.69 1.196 . . . . 0.0 110.849 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.35 -158.62 7.63 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.86 1.695 . . . . 0.0 111.69 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -142.25 141.95 32.55 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.452 1.101 . . . . 0.0 111.474 -173.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.39 -166.48 12.53 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.409 1.48 . . . . 0.0 113.184 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.45 138.15 22.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.016 1.326 . . . . 0.0 113.128 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.55 -6.56 63.06 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.731 1.158 . . . . 0.0 114.196 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 49.45 57.33 6.61 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.323 1.849 . . . . 0.0 113.976 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.7 149.34 71.73 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.327 1.851 . . . . 0.0 108.19 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.09 144.73 58.62 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.435 1.423 . . . . 0.0 109.712 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.35 150.01 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.782 1.633 . . . . 0.0 111.257 -176.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.83 136.28 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.262 0.625 . . . . 0.0 110.854 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.4 mt -134.63 158.3 75.39 Favored Pre-proline 0 C--O 1.239 0.549 0 C-N-CA 126.331 1.852 . . . . 0.0 111.65 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -60.59 164.89 12.42 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 122.649 2.233 . . . . 0.0 112.927 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.64 124.95 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.662 2.242 . . . . 0.0 110.665 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -147.99 -95.54 0.08 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.038 0.935 . . . . 0.0 110.354 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -155.24 21.06 0.42 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.163 1.785 . . . . 0.0 112.146 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -67.34 139.13 57.2 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.69 -0.631 . . . . 0.0 111.565 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.5 m -144.89 159.34 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.689 1.196 . . . . 0.0 112.047 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -128.76 148.67 50.87 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.528 1.531 . . . . 0.0 110.251 169.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 79.2 m -76.51 132.88 39.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.963 1.305 . . . . 0.0 109.209 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.41 115.98 22.51 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.391 1.077 . . . . 0.0 108.954 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 55.4 m -134.09 128.78 34.89 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.67 0.788 . . . . 0.0 110.968 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.8 mt -63.0 153.37 34.05 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 p -127.89 178.63 6.04 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.496 1.918 . . . . 0.0 110.057 170.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -61.56 -8.25 4.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.17 37.85 0.26 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.799 1.19 . . . . 0.0 113.578 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.57 -153.02 22.79 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.133 0.873 . . . . 0.0 113.231 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -132.26 169.25 16.73 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.718 2.407 . . . . 0.0 111.731 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -130.81 154.3 48.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.026 2.131 . . . . 0.0 110.295 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.4 mt -135.04 114.72 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.624 1.17 . . . . 0.0 109.176 -172.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -134.29 156.07 49.1 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.062 0.945 . . . . 0.0 112.312 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -61.63 -30.16 70.52 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -170.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.83 -40.5 1.6 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.855 1.693 . . . . 0.0 112.785 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -84.39 -5.64 59.3 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.966 1.307 . . . . 0.0 113.888 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 57.17 18.13 3.97 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.752 2.021 . . . . 0.0 113.415 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.5 p -72.07 -24.54 61.53 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.394 1.077 . . . . 0.0 112.259 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.3 m -143.75 173.92 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.943 1.697 . . . . 0.0 111.982 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 t -146.39 152.48 39.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.409 2.683 . . . . 0.0 109.979 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -70.57 144.78 51.13 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.385 -0.822 . . . . 0.0 111.8 170.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.6 p -152.88 174.76 13.69 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.067 1.347 . . . . 0.0 112.273 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -128.68 170.18 13.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.161 1.784 . . . . 0.0 110.199 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -109.03 -36.58 6.04 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.431 0.693 . . . . 0.0 111.864 -169.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -144.91 -0.15 0.92 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.091 1.756 . . . . 0.0 114.495 173.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.26 23.27 1.61 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.878 2.071 . . . . 0.0 116.122 -171.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.4 p -75.22 156.35 35.88 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.779 -1.201 . . . . 0.0 112.06 172.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.26 138.18 57.48 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.472 -0.767 . . . . 0.0 111.836 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.19 4.68 89.59 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.885 1.231 . . . . 0.0 114.422 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.6 146.96 30.95 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.198 1.499 . . . . 0.0 112.783 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -76.14 130.88 38.94 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.265 -0.897 . . . . 0.0 110.781 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.22 151.21 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.906 0.482 . . . . 0.0 110.453 173.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.8 m -129.9 164.45 24.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.464 1.506 . . . . 0.0 111.783 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.4 mt -133.56 143.27 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.305 1.442 . . . . 0.0 109.556 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.61 179.98 48.01 Favored Glycine 0 N--CA 1.471 0.976 0 C-N-CA 124.832 1.206 . . . . 0.0 111.745 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.79 -41.16 61.48 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 119.155 1.477 . . . . 0.0 114.27 -173.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -169.11 170.33 8.84 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.004 2.522 . . . . 0.0 109.906 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.42 130.61 23.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.155 0.982 . . . . 0.0 112.446 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.1 t -56.59 -28.75 61.04 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -122.36 -26.72 4.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.437 1.095 . . . . 0.0 113.856 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 72.9 p -116.48 0.02 12.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.757 1.223 . . . . 0.0 114.1 -171.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.14 33.88 0.65 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.619 2.057 . . . . 0.0 114.827 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 145.99 22.51 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.279 2.232 . . . . 0.0 110.597 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -143.3 175.72 9.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.422 1.489 . . . . 0.0 111.556 -168.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.4 p -139.44 138.9 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.488 1.115 . . . . 0.0 109.643 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.76 125.02 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 C-N-CA 125.984 1.714 . . . . 0.0 107.11 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -149.13 155.07 40.13 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.644 1.178 . . . . 0.0 109.08 -170.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -68.65 155.79 39.39 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.022 -1.049 . . . . 0.0 112.549 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.9 t . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.086 1.754 . . . . 0.0 111.301 171.856 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 122.41 1.1 . . . . 0.0 113.918 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.2 m -152.5 165.33 35.44 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.366 1.867 . . . . 0.0 109.228 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.78 130.59 44.08 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 121.5 -0.75 . . . . 0.0 110.958 169.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.06 -165.31 38.66 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 114.721 0.648 . . . . 0.0 114.721 -175.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -95.64 122.99 38.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.168 0.987 . . . . 0.0 110.304 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -133.98 174.74 10.15 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.246 1.418 . . . . 0.0 112.424 -172.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.0 pt -131.08 155.98 42.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 126.246 1.818 . . . . 0.0 108.936 171.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 mt -127.49 127.72 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -142.47 147.88 36.81 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.762 0.825 . . . . 0.0 111.564 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -78.06 133.44 37.91 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.92 -0.487 . . . . 0.0 111.043 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -60.91 -25.51 66.8 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.4 t . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 123.827 0.851 . . . . 0.0 112.36 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 121.449 0.642 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.81 150.25 29.25 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.4 tp -58.6 134.39 56.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.304 1.442 . . . . 0.0 109.529 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 m -127.07 125.28 41.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.741 1.216 . . . . 0.0 111.192 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 79' ' ' PRO . 38.3 t80 -66.19 138.63 96.12 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.842 1.257 . . . . 0.0 112.094 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -76.56 -15.16 17.57 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.132 2.555 . . . . 0.0 114.911 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.31 3.72 69.23 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.535 1.064 . . . . 0.0 115.012 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -155.31 179.91 8.71 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.681 1.993 . . . . 0.0 110.756 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -110.42 170.64 7.95 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.939 1.295 . . . . 0.0 111.158 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 50.63 40.75 24.6 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.411 1.884 . . . . 0.0 112.83 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 m -140.87 141.59 24.95 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 126.14 1.776 . . . . 0.0 110.344 -169.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -52.95 163.31 2.13 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 125.293 3.995 . . . . 0.0 115.981 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.9 t -115.01 149.68 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.127 1.371 . . . . 0.0 110.857 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 m -127.8 176.0 7.9 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.301 1.441 . . . . 0.0 111.261 -168.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.7 m -123.43 156.29 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.965 -1.084 . . . . 0.0 112.045 170.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.3 m -153.0 167.05 14.15 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 124.946 1.298 . . . . 0.0 112.375 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.05 118.53 5.44 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.682 2.921 . . . . 0.0 111.671 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.63 134.76 52.96 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.789 -0.569 . . . . 0.0 111.842 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -138.61 3.42 2.29 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.566 1.546 . . . . 0.0 113.712 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.5 0.67 86.28 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.943 1.258 . . . . 0.0 115.033 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.7 t -63.29 147.41 51.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.402 1.601 . . . . 0.0 112.401 175.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.7 m -59.53 -13.51 9.35 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.325 1.45 . . . . 0.0 114.405 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.03 -26.16 63.91 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.162 0.892 . . . . 0.0 112.371 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -118.63 0.89 11.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.906 1.682 . . . . 0.0 114.45 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.16 145.48 27.96 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.617 1.167 . . . . 0.0 110.55 171.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -136.05 169.96 16.78 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 123.015 1.388 . . . . 0.0 112.546 -168.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.1 mt -117.54 137.15 52.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 128.578 2.751 . . . . 0.0 107.3 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.2 tp -134.65 128.99 34.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.573 1.549 . . . . 0.0 109.211 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -142.65 138.17 30.47 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.469 1.108 . . . . 0.0 110.732 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.8 t -67.81 141.26 56.55 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.947 0.499 . . . . 0.0 110.552 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -108.8 -51.25 2.91 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.623 1.169 . . . . 0.0 110.715 174.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.21 109.87 4.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.142 1.377 . . . . 0.0 110.595 169.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.9 m -56.96 -24.38 52.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.945 0.898 . . . . 0.0 111.745 168.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -65.21 -20.93 66.67 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.096 2.158 . . . . 0.0 113.589 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -130.8 14.59 5.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.838 1.655 . . . . 0.0 112.844 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 43.36 33.77 0.65 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.571 1.948 . . . . 0.0 114.113 -169.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -85.9 145.56 27.11 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.893 -1.129 . . . . 0.0 112.037 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -141.52 148.97 40.25 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.149 1.38 . . . . 0.0 111.58 -177.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.3 p -91.34 145.78 24.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.25 1.02 . . . . 0.0 110.641 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.8 mm -127.91 115.76 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.768 2.027 . . . . 0.0 110.257 -172.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.4 m -134.62 146.15 57.89 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 123.882 0.873 . . . . 0.0 110.712 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HG3' ' CE1' ' A' ' 42' ' ' TYR . 62.2 Cg_endo -70.8 146.59 54.17 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.729 2.286 . . . . 0.0 109.92 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.31 -22.06 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.82 -11.13 54.27 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.554 1.073 . . . . 0.0 115.241 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.5 m -144.22 62.0 9.68 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.954 1.302 . . . . 0.0 111.795 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.49 -17.1 46.15 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.109 3.206 . . . . 0.0 113.846 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -71.65 19.02 0.07 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 128.653 2.781 . . . . 0.0 114.497 169.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.6 p -142.31 164.96 28.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.044 1.738 . . . . 0.0 112.226 171.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -143.83 140.37 29.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.568 1.547 . . . . 0.0 111.09 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.4 mm -85.04 132.25 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.79 -0.569 . . . . 0.0 111.086 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.1 -165.11 10.77 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.889 2.185 . . . . 0.0 112.021 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -144.04 141.62 30.2 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.387 1.075 . . . . 0.0 111.674 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.26 -163.55 11.05 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.319 1.438 . . . . 0.0 113.31 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.64 140.41 18.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.987 1.315 . . . . 0.0 113.207 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.93 -7.85 70.21 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.572 1.082 . . . . 0.0 114.012 -172.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 48.22 58.05 5.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.334 1.854 . . . . 0.0 113.853 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.2 m -133.25 149.25 72.03 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 126.272 1.829 . . . . 0.0 107.458 169.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.47 145.29 58.37 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.298 1.142 . . . . 0.0 109.395 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.06 172.06 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.581 1.952 . . . . 0.0 109.797 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -119.51 136.25 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.323 -0.861 . . . . 0.0 111.215 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -140.87 165.15 31.52 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 127.27 2.228 . . . . 0.0 110.474 -169.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -77.3 155.41 32.67 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.497 2.131 . . . . 0.0 111.643 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.39 124.85 12.61 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.194 3.263 . . . . 0.0 113.537 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -149.49 -88.85 0.08 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.616 1.166 . . . . 0.0 110.428 -176.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -154.89 8.84 0.31 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.23 1.412 . . . . 0.0 114.218 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.02 139.82 54.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.384 -0.822 . . . . 0.0 110.845 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.3 m -148.93 164.26 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.112 1.365 . . . . 0.0 111.417 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -129.47 131.36 46.67 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.121 1.369 . . . . 0.0 110.536 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.8 m -75.93 130.57 38.68 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.275 1.03 . . . . 0.0 109.559 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.7 mt -117.38 129.58 55.95 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.569 1.147 . . . . 0.0 109.447 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 m -137.02 129.29 29.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.093 0.957 . . . . 0.0 110.228 -170.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.2 mt -65.68 153.62 41.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.697 0.76 . . . . 0.0 113.025 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.1 p -127.78 -179.22 4.83 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.024 1.73 . . . . 0.0 110.274 170.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 75.7 p -60.89 -12.81 12.26 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.0 29.45 0.29 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.422 1.011 . . . . 0.0 114.658 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 176.95 -153.06 13.01 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 118.386 1.093 . . . . 0.0 113.25 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -131.58 169.74 15.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.108 2.163 . . . . 0.0 112.266 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -136.49 149.72 48.31 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.424 2.289 . . . . 0.0 109.462 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.9 mt -132.58 115.61 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.678 1.191 . . . . 0.0 109.106 -170.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -135.91 149.89 49.12 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.513 1.125 . . . . 0.0 111.649 -169.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -55.11 -34.12 63.43 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.082 0.953 . . . . 0.0 113.129 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.49 -29.83 2.85 Favored Glycine 0 N--CA 1.47 0.965 0 C-N-CA 125.856 1.693 . . . . 0.0 113.916 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -79.61 -6.02 56.23 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 60.59 12.92 3.88 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.474 2.31 . . . . 0.0 114.048 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.3 p -65.75 -28.19 68.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.837 2.055 . . . . 0.0 112.761 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.0 m -144.89 171.06 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.014 1.725 . . . . 0.0 112.135 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.2 t -146.15 156.02 43.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.413 2.685 . . . . 0.0 110.032 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -72.23 145.25 48.09 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.49 -0.756 . . . . 0.0 111.866 171.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.7 p -154.41 177.18 11.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.056 1.342 . . . . 0.0 112.232 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -118.96 169.52 9.82 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.644 1.578 . . . . 0.0 110.211 173.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -95.26 -33.32 12.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.354 0.662 . . . . 0.0 111.979 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -144.8 0.52 0.97 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.479 1.912 . . . . 0.0 114.42 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.08 26.54 3.88 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.864 2.066 . . . . 0.0 116.038 -172.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.5 p -82.6 160.16 22.57 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 120.965 -1.084 . . . . 0.0 112.246 172.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.14 141.46 58.76 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.303 -0.873 . . . . 0.0 111.93 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.28 1.19 89.52 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.178 0.894 . . . . 0.0 114.817 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -83.35 149.69 26.57 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.99 1.395 . . . . 0.0 113.45 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -74.87 136.76 41.5 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.312 -0.867 . . . . 0.0 111.056 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.0 t -70.34 154.54 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.106 0.479 . . . . 0.0 110.568 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -131.58 164.92 24.79 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.342 1.857 . . . . 0.0 111.343 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.6 mt -136.8 140.27 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.572 1.549 . . . . 0.0 109.638 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.99 177.96 47.14 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 125.056 1.312 . . . . 0.0 111.44 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.09 36.48 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.315 1.557 . . . . 0.0 114.553 -171.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -170.28 171.25 6.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.561 2.744 . . . . 0.0 108.968 176.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.0 127.21 21.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.766 0.826 . . . . 0.0 111.176 170.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.9 t -60.67 -14.17 19.15 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.258 1.823 . . . . 0.0 115.682 -170.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -128.65 -38.85 1.68 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.356 1.063 . . . . 0.0 113.185 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.3 p -111.96 2.99 17.19 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -171.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.37 13.83 0.53 Allowed Glycine 0 CA--C 1.539 1.537 0 N-CA-C 116.327 1.291 . . . . 0.0 116.327 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -134.68 147.84 50.2 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.255 2.027 . . . . 0.0 111.074 -172.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -139.8 176.01 9.1 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.491 1.516 . . . . 0.0 112.371 -168.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.3 t -135.82 139.14 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.101 1.36 . . . . 0.0 109.099 170.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.7 125.7 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 169.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.19 154.67 39.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.477 1.111 . . . . 0.0 109.56 -171.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -68.11 155.79 38.82 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.043 -1.036 . . . . 0.0 112.606 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.6 t . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.131 1.772 . . . . 0.0 111.31 171.584 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 CA--C 1.547 0.846 0 CA-C-O 122.377 1.084 . . . . 0.0 113.917 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.0 m -161.56 162.05 30.05 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.704 2.002 . . . . 0.0 109.222 177.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.15 137.11 58.13 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.544 -0.722 . . . . 0.0 111.923 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.79 -160.11 32.89 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 123.901 0.762 . . . . 0.0 114.937 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -98.48 122.62 41.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.919 1.288 . . . . 0.0 110.616 173.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -134.65 172.71 12.56 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.773 1.229 . . . . 0.0 112.698 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.44 154.25 38.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 126.458 1.903 . . . . 0.0 108.57 170.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.3 mt -124.97 126.91 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -141.26 150.38 42.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.05 0.54 . . . . 0.0 112.156 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -77.07 134.98 38.61 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.589 -0.694 . . . . 0.0 111.298 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -61.48 -28.32 69.21 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.48 1.07 0 C-N-CA 123.379 0.672 . . . . 0.0 112.042 -178.708 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.5 mt . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.964 0.411 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.76 141.66 36.1 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.601 1.16 . . . . 0.0 112.857 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.57 128.21 36.02 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.039 0.936 . . . . 0.0 108.789 169.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.0 m -128.37 115.0 17.56 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.055 0.942 . . . . 0.0 110.801 -170.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -59.89 135.19 90.03 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 126.934 2.094 . . . . 0.0 112.086 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.89 -11.45 19.89 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.289 2.659 . . . . 0.0 114.602 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.63 8.83 82.37 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-O 119.079 -0.845 . . . . 0.0 115.119 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -156.72 165.34 36.51 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.303 1.441 . . . . 0.0 112.134 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -87.74 166.6 14.52 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.436 1.095 . . . . 0.0 111.768 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 49.85 36.91 12.26 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.83 1.652 . . . . 0.0 113.839 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.8 m -135.97 138.55 27.97 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 126.228 1.811 . . . . 0.0 110.206 -169.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.3 160.57 4.63 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.94 3.76 . . . . 0.0 115.81 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.5 t -111.56 148.71 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.904 1.281 . . . . 0.0 110.724 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 m -123.36 167.24 14.06 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.256 1.422 . . . . 0.0 110.774 -169.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 p -121.48 138.25 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.167 0.987 . . . . 0.0 111.212 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.5 m -156.51 168.17 12.94 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 124.355 1.062 . . . . 0.0 112.882 -169.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.14 152.59 10.59 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.648 2.899 . . . . 0.0 114.286 169.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.4 tp -105.6 137.2 43.83 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.459 1.504 . . . . 0.0 110.45 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -135.23 -24.24 1.43 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.075 1.35 . . . . 0.0 112.751 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.18 5.83 9.35 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.199 1.381 . . . . 0.0 113.759 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 m -61.85 150.48 37.2 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.485 1.142 . . . . 0.0 111.532 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.2 p -61.8 -15.05 38.4 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -72.86 -24.01 60.82 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.355 1.062 . . . . 0.0 112.412 171.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -104.88 -9.33 18.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.519 1.927 . . . . 0.0 112.621 -174.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.62 142.0 34.5 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.596 1.158 . . . . 0.0 111.328 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -135.73 171.34 14.6 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.944 1.355 . . . . 0.0 112.111 -169.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.1 mt -126.17 136.45 60.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.024 2.13 . . . . 0.0 106.747 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.7 tp -136.84 126.53 25.46 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.948 1.299 . . . . 0.0 109.446 -169.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.2 mtp-105 -141.46 140.84 33.65 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.753 0.821 . . . . 0.0 111.121 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.0 t -65.24 141.56 58.59 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.908 0.483 . . . . 0.0 110.929 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -115.12 -51.27 2.72 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.434 1.094 . . . . 0.0 111.093 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.23 109.25 4.45 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.379 1.071 . . . . 0.0 110.996 169.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.2 m -59.18 -26.47 64.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.801 0.84 . . . . 0.0 111.166 168.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -60.99 -20.94 63.05 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.012 2.125 . . . . 0.0 113.398 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -130.26 6.32 4.91 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.308 1.843 . . . . 0.0 113.237 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 47.37 30.44 1.55 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.142 2.177 . . . . 0.0 114.281 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.0 p -90.6 143.58 26.6 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.25 -0.907 . . . . 0.0 112.367 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -139.31 141.64 37.71 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.683 1.593 . . . . 0.0 111.104 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.5 p -77.87 147.71 34.98 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.711 -0.618 . . . . 0.0 111.06 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.0 mm -129.26 127.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.421 1.488 . . . . 0.0 109.71 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.0 m -142.84 142.38 22.25 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.197 1.399 . . . . 0.0 110.355 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.1 145.39 31.05 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.217 2.611 . . . . 0.0 111.314 176.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.53 -28.22 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.311 -0.868 . . . . 0.0 111.769 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.55 -24.96 76.17 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 114.868 0.707 . . . . 0.0 114.868 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.9 m -148.17 65.51 8.83 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 125.429 1.492 . . . . 0.0 111.614 -176.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -64.13 -17.9 61.47 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.843 3.028 . . . . 0.0 113.669 -173.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -69.96 -2.62 13.04 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 127.688 2.395 . . . . 0.0 114.636 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.2 m -132.8 174.72 10.02 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.372 1.869 . . . . 0.0 111.686 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -141.27 172.66 12.37 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.371 1.469 . . . . 0.0 113.164 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -115.99 127.25 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.903 1.281 . . . . 0.0 110.413 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.56 -157.48 7.18 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.489 1.519 . . . . 0.0 111.35 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -141.99 142.24 32.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.135 0.974 . . . . 0.0 111.665 -171.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.94 -165.25 12.1 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.361 1.458 . . . . 0.0 113.466 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.59 135.15 23.44 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.265 1.426 . . . . 0.0 113.049 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.23 -8.64 59.08 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.969 1.271 . . . . 0.0 114.012 -172.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 49.29 56.16 8.23 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.485 1.914 . . . . 0.0 113.949 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.9 m -133.89 150.43 74.5 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 126.266 1.826 . . . . 0.0 108.065 169.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.01 142.71 52.02 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.225 1.283 . . . . 0.0 109.721 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.05 151.5 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.815 1.646 . . . . 0.0 111.536 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.14 132.18 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.074 0.95 . . . . 0.0 111.044 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.34 161.45 57.2 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.833 1.653 . . . . 0.0 112.193 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -65.04 174.06 5.26 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 123.277 2.652 . . . . 0.0 113.31 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.67 104.15 1.68 Allowed 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.779 2.319 . . . . 0.0 111.01 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.405 ' HB3' ' CE2' ' A' ' 103' ' ' TYR . 65.2 t30 -143.46 13.51 1.77 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.657 1.183 . . . . 0.0 113.356 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 70.37 40.88 1.07 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.913 2.485 . . . . 0.0 113.773 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.405 ' CE2' ' HB3' ' A' ' 101' ' ' ASN . 90.7 m-85 -61.97 143.46 56.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.089 0.556 . . . . 0.0 110.887 169.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.92 156.55 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.206 1.002 . . . . 0.0 112.253 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -129.8 137.06 50.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.496 1.518 . . . . 0.0 110.448 172.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.9 m -71.0 134.23 46.98 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.698 1.199 . . . . 0.0 108.895 169.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.7 mt -126.24 73.93 1.41 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.878 0.871 . . . . 0.0 109.966 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.3 m -78.93 129.12 34.16 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.269 1.028 . . . . 0.0 111.116 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.7 tp -71.2 145.83 49.44 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.455 0.702 . . . . 0.0 111.226 171.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 p -124.55 -177.17 3.72 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.741 1.616 . . . . 0.0 111.719 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.2 p -59.04 -13.44 6.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.22 25.96 0.18 Allowed Glycine 0 CA--C 1.533 1.197 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 178.55 -149.25 8.87 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.023 1.296 . . . . 0.0 112.127 -173.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -131.77 168.44 17.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.286 1.834 . . . . 0.0 112.024 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -134.15 142.43 47.46 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.393 2.277 . . . . 0.0 109.515 174.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.1 mt -124.37 121.78 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.419 1.088 . . . . 0.0 109.231 -171.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -138.17 158.04 45.09 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.194 1.398 . . . . 0.0 112.68 -171.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -59.8 -18.18 41.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 125.23 -35.71 3.01 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.916 1.722 . . . . 0.0 112.623 -169.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -110.17 4.18 20.82 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.503 1.921 . . . . 0.0 113.557 -170.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? 57.39 21.6 7.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.858 2.063 . . . . 0.0 113.781 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.1 p -77.62 -30.58 52.35 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.391 -0.818 . . . . 0.0 112.02 175.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.1 m -148.07 155.81 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.667 1.587 . . . . 0.0 111.959 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.1 t -130.5 153.37 48.89 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.577 1.951 . . . . 0.0 111.248 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.3 m0 -69.88 139.57 53.05 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.289 0.635 . . . . 0.0 111.812 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 88.1 p -147.76 175.06 11.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.929 1.292 . . . . 0.0 111.909 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.43 151.33 46.35 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.53 1.532 . . . . 0.0 109.898 173.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -82.59 -33.56 27.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.179 0.992 . . . . 0.0 111.704 -169.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -138.93 -6.21 1.45 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.674 1.99 . . . . 0.0 112.634 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.79 32.36 14.78 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.852 1.661 . . . . 0.0 114.243 -170.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.3 p -81.58 156.63 25.1 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.26 1.024 . . . . 0.0 111.509 170.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.84 139.59 57.77 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.252 -0.905 . . . . 0.0 111.674 172.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.67 86.0 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.125 1.345 . . . . 0.0 114.718 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -79.64 144.65 33.57 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.929 1.292 . . . . 0.0 113.25 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -75.7 128.44 35.21 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.854 -1.154 . . . . 0.0 110.655 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.95 148.53 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.182 0.593 . . . . 0.0 110.799 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.7 t -126.07 160.83 29.04 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.812 1.245 . . . . 0.0 111.779 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.8 mt -134.22 140.86 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.823 1.649 . . . . 0.0 109.292 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 169.43 -159.73 32.69 Favored Glycine 0 N--CA 1.468 0.815 0 C-N-CA 123.776 0.703 . . . . 0.0 112.61 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.96 149.68 18.32 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 117.62 0.71 . . . . 0.0 111.764 169.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -52.63 119.09 4.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.482 1.513 . . . . 0.0 113.428 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.23 164.12 26.3 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.848 1.259 . . . . 0.0 114.174 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 t -93.65 -9.44 37.9 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.785 1.234 . . . . 0.0 114.229 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -142.11 -44.93 0.34 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.483 1.113 . . . . 0.0 113.028 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.8 p -91.61 1.93 56.81 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.6 5.09 6.07 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 126.414 1.959 . . . . 0.0 116.281 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -126.48 150.84 48.48 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.408 1.483 . . . . 0.0 112.252 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -142.16 175.98 9.33 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 127.389 2.276 . . . . 0.0 110.104 -169.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.65 139.7 28.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 124.354 1.062 . . . . 0.0 109.529 169.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -118.22 124.82 73.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 125.694 1.598 . . . . 0.0 107.15 174.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -147.74 153.44 39.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.644 1.178 . . . . 0.0 109.433 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.97 155.91 39.51 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.998 -1.064 . . . . 0.0 112.945 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 C--O 1.251 1.175 0 C-N-CA 126.221 1.808 . . . . 0.0 111.284 171.877 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 CA--C 1.544 0.719 0 CA-C-O 122.0 0.905 . . . . 0.0 113.165 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.1 m -151.45 159.53 44.15 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.668 1.987 . . . . 0.0 108.955 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.84 131.14 48.83 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.489 -0.757 . . . . 0.0 111.858 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.1 -163.11 36.86 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -100.56 126.93 47.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.128 0.971 . . . . 0.0 110.345 174.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.05 172.3 13.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.238 1.415 . . . . 0.0 112.292 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 pt -126.96 152.14 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.111 1.764 . . . . 0.0 108.518 172.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.1 mt -131.04 115.89 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -140.49 151.48 44.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.702 0.763 . . . . 0.0 112.408 -177.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -81.45 136.72 35.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.436 -173.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.8 mtp-105 -65.13 -18.22 65.12 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.9 t . . . . . 0 N--CA 1.478 0.929 0 C-N-CA 124.135 0.974 . . . . 0.0 112.375 173.114 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 121.771 0.796 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.31 151.42 24.77 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.676 -1.147 . . . . 0.0 113.718 -170.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.59 134.05 55.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.852 0.861 . . . . 0.0 108.897 168.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 85.6 m -134.54 126.05 28.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.864 0.865 . . . . 0.0 111.123 -170.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -60.49 130.3 89.93 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.518 1.927 . . . . 0.0 111.948 -176.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.32 -10.41 19.1 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.442 2.761 . . . . 0.0 114.465 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.53 -2.32 58.91 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.318 0.961 . . . . 0.0 115.152 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -160.28 171.22 19.54 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.082 1.353 . . . . 0.0 112.94 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -96.51 169.14 10.1 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.403 1.881 . . . . 0.0 111.121 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 mmt-85 52.13 32.51 10.61 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.113 1.765 . . . . 0.0 114.022 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.1 m -137.11 138.13 24.69 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.301 1.441 . . . . 0.0 110.731 -169.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.7 155.38 10.59 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.567 3.512 . . . . 0.0 114.847 172.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 t -105.03 153.81 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.867 1.267 . . . . 0.0 110.542 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 m -125.42 171.06 10.77 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.197 1.399 . . . . 0.0 110.186 -170.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.64 141.66 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.911 -1.118 . . . . 0.0 112.047 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.1 m -153.12 166.16 16.1 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.052 0.941 . . . . 0.0 112.327 -171.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.86 164.79 2.2 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.648 2.898 . . . . 0.0 113.564 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tt -127.59 141.8 51.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.729 1.211 . . . . 0.0 111.785 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -143.36 -13.6 0.69 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.43 -8.35 8.94 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.096 1.332 . . . . 0.0 114.347 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -63.44 157.86 22.21 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.895 1.348 . . . . 0.0 113.302 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 p -64.22 -11.91 35.64 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -66.53 -36.32 82.4 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.207 1.003 . . . . 0.0 112.161 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.81 6.4 11.49 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.58 147.27 24.04 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.793 0.806 . . . . 0.0 111.652 172.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -138.61 172.09 13.4 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.661 1.22 . . . . 0.0 112.306 -169.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.2 mt -120.77 135.47 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.498 2.319 . . . . 0.0 107.066 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.28 122.3 19.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.123 1.369 . . . . 0.0 109.544 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -140.92 137.98 33.52 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.309 0.644 . . . . 0.0 111.633 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.5 t -64.46 138.94 58.69 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.124 0.569 . . . . 0.0 111.151 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -115.17 -51.29 2.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.557 1.143 . . . . 0.0 111.339 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.52 109.96 4.81 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.583 1.153 . . . . 0.0 111.625 170.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.1 m -58.98 -23.72 62.02 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.025 0.93 . . . . 0.0 111.468 168.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.07 -21.69 66.62 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.075 2.15 . . . . 0.0 113.341 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -130.4 7.8 4.97 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.956 1.703 . . . . 0.0 113.002 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 46.56 34.87 2.6 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.667 1.987 . . . . 0.0 113.47 -168.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.6 p -92.34 142.76 27.1 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.531 -0.731 . . . . 0.0 112.275 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -138.73 144.15 39.37 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.86 1.664 . . . . 0.0 110.478 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.0 p -77.96 150.1 34.03 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.56 0.744 . . . . 0.0 111.018 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.8 mm -128.73 126.87 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 0.0 109.479 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 m -144.92 145.93 29.35 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.701 1.601 . . . . 0.0 110.51 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.27 145.41 34.49 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.832 2.354 . . . . 0.0 110.831 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.5 m -65.22 -24.69 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.004 -1.06 . . . . 0.0 113.119 177.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.65 -17.96 60.94 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.062 0.839 . . . . 0.0 114.61 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 42.5 m -144.1 62.14 9.99 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.434 1.494 . . . . 0.0 110.962 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -61.8 -18.59 61.59 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.013 3.142 . . . . 0.0 113.423 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -71.35 9.33 0.81 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 128.314 2.645 . . . . 0.0 114.148 169.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.1 p -138.44 172.53 12.75 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.886 1.675 . . . . 0.0 111.966 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -141.44 169.75 17.02 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.167 1.387 . . . . 0.0 112.837 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 mm -115.97 128.48 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.932 1.293 . . . . 0.0 110.567 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.37 -160.77 8.55 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.778 1.656 . . . . 0.0 111.926 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -140.27 139.63 35.56 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.443 1.097 . . . . 0.0 111.468 -172.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.18 -164.85 11.39 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.383 1.468 . . . . 0.0 113.208 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.3 139.38 19.16 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.928 1.291 . . . . 0.0 113.084 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.3 -7.72 66.63 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.825 1.202 . . . . 0.0 114.13 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 47.97 56.42 7.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.516 1.926 . . . . 0.0 113.974 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.71 150.96 76.17 Favored Pre-proline 0 C--O 1.24 0.571 0 C-N-CA 126.112 1.765 . . . . 0.0 108.386 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.87 142.67 58.11 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.23 1.286 . . . . 0.0 109.762 173.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.8 m -132.84 150.46 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.681 1.592 . . . . 0.0 111.354 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 t -83.26 132.92 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.764 0.826 . . . . 0.0 110.816 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.6 mt -138.39 162.33 54.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.982 1.713 . . . . 0.0 112.384 -169.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -61.1 167.19 9.48 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.824 2.349 . . . . 0.0 113.302 174.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.66 125.98 10.46 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.735 2.29 . . . . 0.0 110.216 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -146.95 -106.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.806 1.242 . . . . 0.0 109.304 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -145.22 21.55 1.55 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.518 1.927 . . . . 0.0 110.471 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -66.53 133.75 51.0 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.386 -0.821 . . . . 0.0 111.385 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.4 m -144.78 160.27 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.964 1.306 . . . . 0.0 111.812 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -130.84 148.77 52.66 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.406 1.482 . . . . 0.0 110.406 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.9 m -74.98 139.11 42.73 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.168 0.987 . . . . 0.0 109.262 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.59 73.92 1.22 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.143 0.977 . . . . 0.0 109.31 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 93.2 m -76.96 118.9 19.99 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.289 1.036 . . . . 0.0 110.594 -176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 tp -66.98 146.48 54.33 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.285 0.634 . . . . 0.0 111.156 170.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.2 p -125.42 -178.42 4.22 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.685 1.594 . . . . 0.0 111.233 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.0 t -60.26 -18.48 49.3 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -158.7 28.2 0.42 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.445 1.021 . . . . 0.0 114.465 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.63 -153.07 16.61 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.459 1.028 . . . . 0.0 113.018 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -133.1 168.71 18.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.87 2.068 . . . . 0.0 111.981 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -135.88 151.23 49.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.685 1.994 . . . . 0.0 110.412 171.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.7 mt -132.17 114.55 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.033 0.933 . . . . 0.0 109.949 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -135.47 156.43 48.91 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.199 1.0 . . . . 0.0 111.973 -169.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -60.35 -31.23 70.12 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.457 1.503 . . . . 0.0 114.829 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 133.09 -40.76 1.56 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.658 2.075 . . . . 0.0 112.797 -174.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -81.37 -6.45 58.93 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.676 1.19 . . . . 0.0 114.05 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 59.18 16.08 4.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.962 2.105 . . . . 0.0 113.999 -170.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.5 p -69.73 -23.39 63.39 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.871 1.268 . . . . 0.0 112.265 178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.7 m -144.27 170.01 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.101 1.76 . . . . 0.0 111.701 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 t -142.38 156.83 45.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.729 2.012 . . . . 0.0 110.676 173.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -70.9 138.72 50.38 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.234 0.614 . . . . 0.0 111.354 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.9 p -149.29 173.0 13.97 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.549 1.14 . . . . 0.0 112.504 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.1 mt -123.97 173.59 8.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.911 1.684 . . . . 0.0 109.879 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -111.41 -33.73 6.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.079 0.952 . . . . 0.0 111.459 -171.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -140.98 -9.49 1.01 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.646 1.978 . . . . 0.0 112.683 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.71 24.28 8.81 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.055 1.742 . . . . 0.0 114.784 -169.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 p -71.88 154.75 41.04 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.19 -0.944 . . . . 0.0 111.181 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.2 143.43 54.0 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.887 -1.133 . . . . 0.0 111.764 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.07 4.2 89.65 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.481 1.038 . . . . 0.0 114.153 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -73.56 142.58 46.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.825 1.313 . . . . 0.0 112.46 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -77.62 111.37 13.31 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.777 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 p -54.7 149.09 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.895 0.878 . . . . 0.0 111.434 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.7 t -130.55 168.63 16.76 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.561 1.544 . . . . 0.0 112.008 -169.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.8 mt -134.74 141.73 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.041 1.736 . . . . 0.0 108.866 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.91 -162.97 36.77 Favored Glycine 0 CA--C 1.526 0.722 0 O-C-N 121.52 -0.737 . . . . 0.0 112.283 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.61 153.56 10.15 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 117.631 0.715 . . . . 0.0 111.803 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -53.51 122.3 9.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.664 1.186 . . . . 0.0 113.039 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.69 173.68 7.81 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.228 1.411 . . . . 0.0 113.703 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 t -105.15 -5.06 21.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.821 1.248 . . . . 0.0 114.355 -172.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -148.44 -41.04 0.16 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.353 1.061 . . . . 0.0 112.821 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.2 p -96.91 4.98 51.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.376 1.47 . . . . 0.0 114.487 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.87 2.66 16.09 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.908 1.242 . . . . 0.0 115.575 -174.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -130.32 146.31 51.9 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.897 1.848 . . . . 0.0 111.134 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -136.97 174.36 10.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.875 1.27 . . . . 0.0 111.835 -168.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.5 p -138.53 139.14 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.757 1.223 . . . . 0.0 109.461 172.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.81 124.49 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 125.627 1.571 . . . . 0.0 107.067 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.98 153.78 38.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.856 -170.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -67.9 155.57 39.12 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.074 -1.016 . . . . 0.0 112.429 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.5 t . . . . . 0 C--O 1.252 1.205 0 C-N-CA 125.996 1.719 . . . . 0.0 111.228 172.429 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 t -159.94 170.1 22.07 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.29 1.436 . . . . 0.0 109.825 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 140.46 58.55 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 121.701 -0.625 . . . . 0.0 112.271 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.14 -162.37 33.15 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.203 0.906 . . . . 0.0 114.391 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -95.19 125.33 39.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.017 0.927 . . . . 0.0 110.174 170.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -134.19 170.87 15.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.367 1.467 . . . . 0.0 112.312 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.8 pt -123.9 151.55 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 126.119 1.768 . . . . 0.0 108.361 170.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.1 mt -128.18 120.12 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -139.94 149.83 43.79 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.743 0.817 . . . . 0.0 112.061 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -75.9 136.39 40.11 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.655 -0.653 . . . . 0.0 111.79 -174.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.4 tpt85 -65.76 -15.47 62.88 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 N--CA 1.478 0.95 0 C-N-CA 124.633 1.173 . . . . 0.0 112.489 172.721 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.1 tp . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.29 147.13 29.07 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.352 1.461 . . . . 0.0 114.547 -169.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.1 tp -58.16 136.18 57.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.232 1.013 . . . . 0.0 109.148 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.1 m -132.94 121.94 23.57 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.982 0.913 . . . . 0.0 111.373 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -60.01 130.96 89.27 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.526 2.331 . . . . 0.0 111.498 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.63 -8.58 19.44 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.6 2.866 . . . . 0.0 114.432 -177.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.02 -2.27 65.92 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.227 0.917 . . . . 0.0 114.958 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -156.46 169.85 23.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.084 1.354 . . . . 0.0 113.001 -173.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -99.46 159.28 15.13 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.345 1.858 . . . . 0.0 110.527 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 57.49 39.9 27.57 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.788 1.635 . . . . 0.0 113.402 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.1 m -142.22 139.2 17.49 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 125.963 1.705 . . . . 0.0 110.733 -172.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -52.96 156.95 8.79 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.869 3.713 . . . . 0.0 115.389 172.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 t -105.29 156.81 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.947 1.299 . . . . 0.0 110.711 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.6 m -127.94 170.16 13.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.715 1.606 . . . . 0.0 110.644 -171.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.1 140.16 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.843 1.257 . . . . 0.0 111.425 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.4 m -152.82 164.21 21.04 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 124.513 1.125 . . . . 0.0 112.758 -172.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -53.6 159.35 6.67 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.735 2.957 . . . . 0.0 113.604 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.2 tp -116.46 140.41 49.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.654 1.182 . . . . 0.0 111.725 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -140.68 -37.55 0.45 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.633 1.973 . . . . 0.0 112.517 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.11 3.58 1.21 Allowed Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.82 1.2 . . . . 0.0 115.374 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -62.39 154.68 27.4 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.535 1.667 . . . . 0.0 112.388 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.4 p -68.95 -14.79 63.25 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 173.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.57 -22.72 60.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.202 0.91 . . . . 0.0 112.343 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.73 6.4 11.56 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.111 2.564 . . . . 0.0 112.687 -169.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.17 149.51 37.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.966 1.306 . . . . 0.0 110.896 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -136.83 171.87 13.85 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 123.008 1.385 . . . . 0.0 112.856 -168.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.6 mt -120.2 135.33 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.948 2.499 . . . . 0.0 106.472 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.0 tp -135.73 126.21 26.84 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.116 1.366 . . . . 0.0 109.101 -172.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -142.82 139.59 30.99 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.634 0.773 . . . . 0.0 110.899 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.4 t -65.31 140.19 58.67 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.934 0.494 . . . . 0.0 110.874 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -109.84 -52.74 2.74 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.608 1.163 . . . . 0.0 110.62 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -145.18 106.86 4.25 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.721 1.208 . . . . 0.0 110.841 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 m -51.81 -31.81 28.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.204 1.802 . . . . 0.0 114.604 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 71' ' ' ASN . 3.2 p30 -73.71 -18.04 61.05 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.504 2.322 . . . . 0.0 114.151 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -117.51 6.37 12.54 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.923 1.689 . . . . 0.0 113.073 171.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 43.97 33.44 0.77 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.018 2.127 . . . . 0.0 114.267 -169.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -87.44 145.42 26.29 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.722 -1.236 . . . . 0.0 112.04 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -141.24 141.72 33.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.999 1.319 . . . . 0.0 111.422 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 p -80.46 146.58 31.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.76 0.824 . . . . 0.0 111.225 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.0 mm -130.16 122.26 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.45 1.5 . . . . 0.0 111.037 -171.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 m -142.04 147.66 45.37 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 125.256 1.423 . . . . 0.0 110.894 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.74 146.94 34.45 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.82 2.347 . . . . 0.0 110.977 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.0 m -65.6 -23.96 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.864 -1.148 . . . . 0.0 112.793 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.87 -6.58 72.12 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.6 1.095 . . . . 0.0 114.889 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.3 t -152.81 67.39 6.52 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 118.565 1.182 . . . . 0.0 111.867 176.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.16 -13.35 31.43 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.686 2.257 . . . . 0.0 113.103 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -78.16 11.26 2.41 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.473 1.909 . . . . 0.0 113.447 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.5 m -136.89 169.29 18.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.5 1.92 . . . . 0.0 111.783 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -141.61 167.18 22.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.353 1.461 . . . . 0.0 111.842 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.8 mm -119.18 130.98 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.665 1.186 . . . . 0.0 110.89 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.0 -158.86 8.26 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.722 1.629 . . . . 0.0 111.676 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -140.54 143.54 35.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.457 1.103 . . . . 0.0 111.792 -172.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.9 -165.34 12.16 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.394 1.474 . . . . 0.0 113.018 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.92 139.71 21.66 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.914 1.286 . . . . 0.0 113.185 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.12 -5.71 65.97 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.762 1.173 . . . . 0.0 114.18 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 48.38 55.85 8.31 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.6 1.96 . . . . 0.0 114.401 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.68 149.07 69.78 Favored Pre-proline 0 C--O 1.24 0.567 0 C-N-CA 126.291 1.837 . . . . 0.0 107.573 169.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.4 147.64 59.2 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.022 1.148 . . . . 0.0 109.802 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.32 149.93 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.743 1.617 . . . . 0.0 110.973 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.2 t -77.7 137.34 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.504 0.721 . . . . 0.0 110.368 173.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.9 mt -138.89 164.63 38.12 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.069 2.148 . . . . 0.0 110.677 -170.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.92 159.74 52.18 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 122.109 1.872 . . . . 0.0 111.178 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.23 119.84 6.57 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.031 2.487 . . . . 0.0 110.328 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -144.11 -88.46 0.12 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 110.752 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -156.09 14.59 0.33 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.102 1.361 . . . . 0.0 113.414 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -70.15 134.34 48.03 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.408 -0.808 . . . . 0.0 111.477 -174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.64 160.02 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.484 1.113 . . . . 0.0 112.344 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -128.07 135.07 49.32 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.989 1.316 . . . . 0.0 110.769 171.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.0 m -76.45 129.18 36.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.753 1.221 . . . . 0.0 109.391 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 42.4 mt -117.05 129.34 55.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.097 0.959 . . . . 0.0 109.793 -178.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 m -133.27 118.03 18.07 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.649 1.18 . . . . 0.0 110.212 -169.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp -65.07 147.27 53.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.246 0.618 . . . . 0.0 111.335 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.3 p -129.06 -178.84 4.8 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.509 1.524 . . . . 0.0 111.686 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 64.3 p -59.05 -15.0 11.31 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.92 27.51 0.24 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.215 0.912 . . . . 0.0 114.64 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 174.42 -148.35 9.8 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.954 1.264 . . . . 0.0 112.155 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -131.8 172.12 12.69 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.936 2.095 . . . . 0.0 111.547 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -137.82 152.98 49.67 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.774 2.43 . . . . 0.0 109.526 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.7 mt -133.71 126.47 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.309 1.444 . . . . 0.0 108.824 -170.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -140.3 159.43 42.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.643 1.177 . . . . 0.0 113.14 -172.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.71 -24.17 67.54 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -169.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.9 -37.13 2.1 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.613 1.102 . . . . 0.0 113.032 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -117.38 12.17 14.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.478 1.911 . . . . 0.0 113.709 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 62.42 16.63 8.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.757 2.023 . . . . 0.0 114.185 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.9 p -72.16 -29.17 63.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.72 0.808 . . . . 0.0 112.534 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.0 m -145.85 177.45 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.494 1.517 . . . . 0.0 111.837 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t -148.97 153.05 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.648 2.379 . . . . 0.0 110.093 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -69.85 144.92 52.41 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.534 -0.729 . . . . 0.0 111.712 171.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 87.7 p -151.94 171.6 17.55 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.673 1.189 . . . . 0.0 112.734 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.4 mt -125.6 165.78 17.91 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.356 1.862 . . . . 0.0 110.015 174.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -104.8 -32.8 8.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.871 0.869 . . . . 0.0 112.144 -169.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -138.81 -8.33 1.4 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.661 1.984 . . . . 0.0 112.436 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.51 21.68 5.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.009 1.724 . . . . 0.0 114.621 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.2 p -73.08 154.13 40.53 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.961 -1.087 . . . . 0.0 111.683 171.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.65 142.82 58.26 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.299 -0.876 . . . . 0.0 112.263 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.05 1.68 90.08 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.904 1.24 . . . . 0.0 114.479 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.93 141.76 45.96 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.741 1.27 . . . . 0.0 112.776 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -76.22 117.86 18.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.23 -0.919 . . . . 0.0 110.312 173.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.88 148.29 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.804 0.842 . . . . 0.0 111.57 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 t -128.68 167.73 16.8 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.586 1.555 . . . . 0.0 111.781 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.7 mt -135.6 141.22 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.603 1.561 . . . . 0.0 109.582 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -179.41 179.86 48.82 Favored Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.944 1.259 . . . . 0.0 111.605 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.07 -40.41 58.29 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.221 1.51 . . . . 0.0 114.334 -173.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -171.63 173.14 4.75 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 128.844 2.858 . . . . 0.0 109.331 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.74 139.87 36.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.201 1.0 . . . . 0.0 112.629 169.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.6 t -60.98 -20.79 62.83 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -169.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -137.71 -38.88 0.58 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.465 1.106 . . . . 0.0 113.222 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 86.8 p -93.35 3.67 55.24 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.294 1.437 . . . . 0.0 114.606 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.23 15.66 1.37 Allowed Glycine 0 CA--C 1.543 1.799 0 C-N-CA 125.856 1.693 . . . . 0.0 115.763 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -134.73 152.46 51.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.916 1.686 . . . . 0.0 111.451 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -141.77 175.9 9.34 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.884 2.074 . . . . 0.0 110.594 -169.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.82 138.37 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 125.123 1.369 . . . . 0.0 108.588 170.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.77 123.29 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -149.0 154.01 38.73 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.922 1.289 . . . . 0.0 109.239 -171.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.58 155.85 39.2 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.907 -1.12 . . . . 0.0 112.701 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 C--O 1.252 1.211 0 C-N-CA 126.146 1.778 . . . . 0.0 111.276 171.415 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.7 m -149.69 163.16 38.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.315 1.846 . . . . 0.0 109.61 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.17 54.76 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.458 -0.776 . . . . 0.0 111.417 170.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.84 -164.3 36.9 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.914 0.768 . . . . 0.0 114.604 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -94.52 125.65 39.3 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.017 0.927 . . . . 0.0 110.232 170.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -134.64 171.12 14.79 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.428 1.491 . . . . 0.0 112.409 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.7 pt -125.38 152.42 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.173 1.789 . . . . 0.0 108.445 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.9 mt -128.72 119.85 50.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -140.25 148.96 42.25 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.696 0.798 . . . . 0.0 112.555 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -78.7 135.06 37.07 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.903 -0.498 . . . . 0.0 111.544 -174.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -59.59 -22.84 62.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.089 1.356 . . . . 0.0 114.139 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.6 t . . . . . 0 N--CA 1.481 1.094 0 C-N-CA 124.172 0.989 . . . . 0.0 112.866 175.204 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.8 tp . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 121.028 0.442 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.29 147.64 27.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.788 1.635 . . . . 0.0 114.203 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.4 tp -59.64 138.36 57.76 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.163 1.385 . . . . 0.0 110.863 170.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 m -130.42 126.52 37.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.102 0.961 . . . . 0.0 111.93 -171.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -61.25 130.51 91.66 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 126.319 1.848 . . . . 0.0 111.657 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.41 -6.49 16.39 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.707 2.938 . . . . 0.0 114.878 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.76 -2.29 62.07 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.832 -0.982 . . . . 0.0 115.082 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -160.22 169.75 22.59 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.919 1.359 . . . . 0.0 112.863 -172.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -95.17 167.55 11.3 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.894 1.677 . . . . 0.0 111.405 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.8 tpt85 47.49 40.71 11.77 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.11 2.164 . . . . 0.0 113.694 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.6 m -139.76 140.61 25.21 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 125.159 1.384 . . . . 0.0 111.83 -169.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -44.53 150.18 0.84 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 126.338 4.692 . . . . 0.0 115.424 169.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.57 155.84 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.145 1.378 . . . . 0.0 110.699 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 52' ' ' VAL . 2.9 m -126.74 176.06 7.53 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.753 1.621 . . . . 0.0 111.082 -169.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -130.62 145.74 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.049 1.34 . . . . 0.0 111.452 176.162 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.6 m -151.22 159.67 33.19 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.938 1.295 . . . . 0.0 111.945 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.66 132.38 35.06 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.84 1.693 . . . . 0.0 110.758 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.69 138.73 57.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.161 1.384 . . . . 0.0 111.436 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -132.45 -22.34 2.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.946 1.298 . . . . 0.0 112.594 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.73 -1.82 32.12 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.944 1.735 . . . . 0.0 113.478 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.6 p -80.04 159.42 26.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.792 1.237 . . . . 0.0 113.076 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.3 m -60.19 -18.16 46.24 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.76 -35.26 80.0 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.04 0.936 . . . . 0.0 112.458 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.31 0.0 OUTLIER -120.47 14.06 11.89 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.16 149.69 23.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.267 1.027 . . . . 0.0 111.707 170.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -139.47 171.53 14.13 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.635 1.207 . . . . 0.0 113.131 -169.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.8 mt -120.8 137.04 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 127.721 2.408 . . . . 0.0 107.351 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.5 tp -137.0 125.61 23.73 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.487 1.515 . . . . 0.0 109.491 -171.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -142.88 135.69 27.92 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.08 0.952 . . . . 0.0 110.999 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -63.87 140.23 58.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.321 0.649 . . . . 0.0 111.37 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -112.06 -52.89 2.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.421 1.088 . . . . 0.0 111.25 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -147.89 117.34 6.98 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.13 . . . . 0.0 111.087 169.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -36.18 80.82 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 112.936 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -61.26 -17.35 53.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.927 2.091 . . . . 0.0 114.883 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 m -123.99 8.32 8.67 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.143 1.777 . . . . 0.0 113.624 172.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 43.36 33.56 0.62 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.31 1.844 . . . . 0.0 114.545 -169.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 p -89.25 144.81 25.82 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.386 -1.446 . . . . 0.0 112.316 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -139.71 140.82 36.91 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.357 1.463 . . . . 0.0 111.297 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.4 p -79.02 148.3 32.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.015 0.526 . . . . 0.0 110.858 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.13 129.9 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.524 1.53 . . . . 0.0 109.362 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.0 m -145.63 145.98 27.74 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.641 1.576 . . . . 0.0 110.622 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.19 145.91 35.52 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.999 2.466 . . . . 0.0 111.043 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.71 -25.78 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.925 -1.109 . . . . 0.0 113.057 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.87 -23.44 61.86 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 123.858 0.742 . . . . 0.0 114.388 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m -142.09 64.13 16.75 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.701 1.6 . . . . 0.0 111.112 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -61.3 -19.38 63.7 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.917 3.078 . . . . 0.0 113.244 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -71.19 9.0 0.82 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 128.234 2.614 . . . . 0.0 114.415 169.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.8 p -138.03 172.73 12.49 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.717 1.607 . . . . 0.0 112.345 173.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -137.98 171.6 14.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.917 1.687 . . . . 0.0 112.567 -171.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -120.39 126.7 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.15 1.38 . . . . 0.0 110.728 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.75 -158.59 7.6 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.874 1.702 . . . . 0.0 111.385 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -141.3 144.09 34.43 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.343 1.071 . . . . 0.0 111.763 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.84 -165.2 12.29 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.494 1.521 . . . . 0.0 113.059 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.24 138.92 25.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.003 1.321 . . . . 0.0 113.257 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.18 -1.63 67.62 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.607 1.099 . . . . 0.0 114.354 -173.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 48.52 55.67 8.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.236 1.815 . . . . 0.0 113.669 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.8 p -132.68 137.2 29.25 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 127.695 2.398 . . . . 0.0 107.479 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.31 143.29 47.76 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.112 -1.149 . . . . 0.0 109.112 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.13 147.13 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.178 1.391 . . . . 0.0 110.932 -172.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.64 138.87 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.423 0.689 . . . . 0.0 109.964 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.3 mt -142.31 163.55 38.8 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 125.826 1.65 . . . . 0.0 111.728 -169.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.92 165.77 30.02 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.05 2.5 . . . . 0.0 111.751 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.43 123.7 9.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.555 2.17 . . . . 0.0 110.924 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -147.07 -92.11 0.09 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.164 0.985 . . . . 0.0 110.511 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -154.53 17.47 0.46 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.563 1.545 . . . . 0.0 112.794 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -67.48 134.69 51.81 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.605 0.762 . . . . 0.0 111.92 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.5 m -145.73 161.45 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.059 1.344 . . . . 0.0 112.391 -175.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -129.75 138.19 50.96 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.466 1.506 . . . . 0.0 110.875 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.5 m -74.95 125.52 29.06 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.242 1.417 . . . . 0.0 109.228 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.1 mt -116.46 128.41 55.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 109.876 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.0 m -134.89 121.77 21.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.911 0.884 . . . . 0.0 110.858 -169.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 tp -67.92 148.24 51.38 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.262 0.625 . . . . 0.0 111.448 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 p -129.39 -176.67 3.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.93 1.692 . . . . 0.0 111.452 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.1 p -58.56 -17.71 23.86 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.68 29.37 0.24 Allowed Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.506 1.05 . . . . 0.0 114.017 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.48 -150.99 10.47 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.977 1.275 . . . . 0.0 112.172 -173.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -134.86 171.93 13.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.077 2.151 . . . . 0.0 111.536 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -137.83 154.49 49.51 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.52 1.928 . . . . 0.0 110.91 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 31.5 mt -135.32 118.53 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.084 1.354 . . . . 0.0 110.057 -169.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -134.9 157.96 45.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.218 1.007 . . . . 0.0 112.831 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -62.53 -26.76 68.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -169.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.48 -40.35 1.67 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.145 1.355 . . . . 0.0 113.143 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -98.54 1.5 46.6 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.643 1.577 . . . . 0.0 113.641 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 65.22 12.84 8.34 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.942 2.097 . . . . 0.0 113.738 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.2 p -73.49 -23.84 60.1 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.46 1.104 . . . . 0.0 112.812 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.6 m -143.3 173.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.552 1.541 . . . . 0.0 112.017 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 t -145.17 154.0 41.97 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.582 2.753 . . . . 0.0 109.767 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -72.32 145.24 47.94 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.401 -0.812 . . . . 0.0 111.491 170.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.0 p -154.84 162.14 41.21 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.362 1.065 . . . . 0.0 112.868 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.5 mt -109.91 170.55 8.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.797 1.639 . . . . 0.0 109.375 169.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -109.77 -31.74 7.33 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.224 1.01 . . . . 0.0 112.059 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -135.83 -10.11 2.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.756 2.022 . . . . 0.0 112.081 169.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.65 27.98 11.36 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.98 1.712 . . . . 0.0 113.939 -170.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.1 p -75.47 155.6 36.07 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.222 1.009 . . . . 0.0 111.657 170.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.26 136.54 55.99 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.244 -0.91 . . . . 0.0 111.427 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.03 0.75 88.93 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.466 1.031 . . . . 0.0 114.536 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -71.17 142.72 50.68 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.807 1.303 . . . . 0.0 112.73 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.1 119.87 19.85 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.302 -0.874 . . . . 0.0 110.06 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 p -62.47 150.34 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.521 0.729 . . . . 0.0 111.357 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.1 m -131.95 168.98 16.95 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.309 1.844 . . . . 0.0 111.293 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.6 mt -134.63 143.71 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.05 1.34 . . . . 0.0 109.379 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.28 179.33 47.53 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 124.819 1.2 . . . . 0.0 111.743 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.31 -42.65 61.33 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.963 1.382 . . . . 0.0 114.291 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -169.71 172.93 6.53 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.166 2.586 . . . . 0.0 109.559 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.51 135.02 33.05 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.168 0.987 . . . . 0.0 112.254 170.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.6 t -56.98 -24.56 54.32 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.273 1.829 . . . . 0.0 115.809 -169.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -130.83 -36.41 1.38 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.962 1.305 . . . . 0.0 112.826 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 t -96.3 1.14 51.71 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -171.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.83 26.37 0.77 Allowed Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.105 1.336 . . . . 0.0 115.948 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -145.92 149.7 34.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.17 1.788 . . . . 0.0 111.594 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -141.62 176.76 8.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.956 1.702 . . . . 0.0 111.826 -169.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.22 140.16 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.629 1.572 . . . . 0.0 108.807 169.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.18 123.59 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.98 153.32 37.77 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.599 1.16 . . . . 0.0 109.474 -170.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.09 155.01 40.47 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.945 -1.097 . . . . 0.0 112.736 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.3 t . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.317 1.847 . . . . 0.0 111.31 171.199 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.2 mt . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.5 m -148.53 162.9 38.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.696 1.998 . . . . 0.0 109.3 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.8 137.24 56.48 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.399 -0.813 . . . . 0.0 111.495 172.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.14 -162.94 36.15 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.312 0.885 . . . . 0.0 115.312 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -94.02 121.85 35.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.01 1.324 . . . . 0.0 110.282 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -133.5 170.49 15.42 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.483 1.113 . . . . 0.0 112.801 -173.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.26 154.74 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 126.353 1.861 . . . . 0.0 108.855 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.0 mt -130.24 120.15 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -145.49 160.53 41.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.777 0.831 . . . . 0.0 112.458 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -99.6 121.44 41.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.486 0.714 . . . . 0.0 110.871 -174.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -63.42 -14.73 53.54 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.8 t . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 124.324 1.049 . . . . 0.0 112.358 171.82 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.1 tp . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 121.343 0.592 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.96 153.07 21.86 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.621 1.169 . . . . 0.0 113.368 -171.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -62.1 136.15 57.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.608 1.163 . . . . 0.0 109.901 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.8 m -128.05 124.72 37.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.667 1.187 . . . . 0.0 111.644 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -68.27 136.18 91.28 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.149 0.98 . . . . 0.0 112.315 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.04 -13.16 19.41 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.547 2.831 . . . . 0.0 115.015 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.93 5.79 73.15 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.324 0.964 . . . . 0.0 115.191 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -157.0 167.57 30.07 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.051 1.741 . . . . 0.0 111.78 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -98.65 167.09 11.0 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.005 1.322 . . . . 0.0 111.453 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 47.78 43.36 16.95 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.642 1.977 . . . . 0.0 113.079 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.0 m -141.07 138.96 18.46 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 125.407 1.483 . . . . 0.0 111.272 -169.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -46.5 157.06 0.5 Allowed 'Trans proline' 0 C--N 1.354 0.852 1 C-N-CA 126.121 4.547 . . . . 0.0 115.306 169.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 t -117.43 149.68 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.384 1.474 . . . . 0.0 109.774 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 m -124.89 174.97 7.6 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.097 1.359 . . . . 0.0 110.429 -169.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 m -127.02 144.33 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 120.902 -1.124 . . . . 0.0 111.602 172.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.4 m -148.38 166.02 16.67 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.803 1.241 . . . . 0.0 112.462 -176.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.58 163.26 2.82 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.79 2.993 . . . . 0.0 113.469 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.2 tp -126.26 143.73 51.04 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.794 1.238 . . . . 0.0 111.552 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -147.98 -32.33 0.27 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.328 1.451 . . . . 0.0 113.434 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.26 -9.65 0.83 Allowed Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.358 1.456 . . . . 0.0 114.365 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -63.08 139.65 58.79 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.979 1.39 . . . . 0.0 111.916 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.7 p -63.99 -11.05 25.22 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.387 1.475 . . . . 0.0 114.353 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.99 -20.08 64.99 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.487 1.04 . . . . 0.0 112.095 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -109.07 3.94 22.56 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.482 1.913 . . . . 0.0 113.282 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.29 144.58 29.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.125 0.964 . . . . 0.0 111.687 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -139.54 173.66 11.31 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.899 1.333 . . . . 0.0 112.123 -169.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.0 mt -122.75 135.44 62.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 127.746 2.418 . . . . 0.0 106.745 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.0 tp -137.04 124.53 22.12 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.978 1.311 . . . . 0.0 109.379 -172.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -142.77 138.57 30.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.403 0.681 . . . . 0.0 111.196 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.8 t -64.53 139.41 58.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.967 0.507 . . . . 0.0 110.984 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -114.21 -51.01 2.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.528 1.131 . . . . 0.0 110.762 174.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.23 107.71 4.1 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.172 0.989 . . . . 0.0 111.208 169.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.6 m -58.27 -25.94 62.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.987 0.915 . . . . 0.0 111.311 168.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -62.24 -21.6 65.3 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.095 2.158 . . . . 0.0 113.399 173.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.4 m -130.37 9.1 5.11 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.913 1.685 . . . . 0.0 113.026 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 47.0 32.1 1.76 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.014 2.126 . . . . 0.0 114.23 -169.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 p -92.55 142.49 27.34 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.158 -0.964 . . . . 0.0 112.319 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -139.06 144.54 38.82 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.072 1.749 . . . . 0.0 110.653 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.0 p -77.85 148.5 34.64 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.182 0.593 . . . . 0.0 110.82 172.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 mm -128.17 126.86 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.572 1.549 . . . . 0.0 109.417 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.9 m -143.9 148.91 44.21 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 125.541 1.536 . . . . 0.0 109.785 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.51 150.76 28.47 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.031 2.487 . . . . 0.0 111.055 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.03 -26.38 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.023 -1.048 . . . . 0.0 113.552 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.84 -20.79 55.1 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.738 0.685 . . . . 0.0 114.485 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.6 m -142.39 61.13 11.23 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 125.635 1.574 . . . . 0.0 111.526 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -61.31 -17.16 51.39 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.69 2.926 . . . . 0.0 113.178 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -72.87 13.55 0.37 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 128.591 2.756 . . . . 0.0 113.481 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.8 p -144.0 170.13 16.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.428 2.291 . . . . 0.0 111.119 173.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -139.65 170.71 15.4 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.217 1.807 . . . . 0.0 111.979 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -117.1 126.79 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.732 1.213 . . . . 0.0 110.77 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.79 -158.67 7.63 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 126.072 1.796 . . . . 0.0 111.328 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -144.96 144.77 31.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.178 0.989 . . . . 0.0 111.897 -174.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.03 -161.13 9.83 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.573 1.558 . . . . 0.0 113.116 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.18 137.7 21.8 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.921 1.288 . . . . 0.0 113.018 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.56 -5.83 64.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.724 1.154 . . . . 0.0 114.248 -172.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 47.49 52.65 12.12 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.402 1.881 . . . . 0.0 113.719 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.84 141.39 41.51 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 127.213 2.205 . . . . 0.0 107.478 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.54 140.12 55.98 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 N-CA-C 108.944 -1.214 . . . . 0.0 108.944 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.53 148.02 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.327 1.451 . . . . 0.0 111.275 -175.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.0 t -77.26 137.42 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.577 0.751 . . . . 0.0 110.426 173.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -141.0 161.76 51.93 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.209 1.803 . . . . 0.0 110.799 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.32 162.5 38.33 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.555 2.17 . . . . 0.0 111.291 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.96 127.77 27.48 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.15 2.566 . . . . 0.0 113.02 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -149.3 -107.82 0.07 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.203 1.401 . . . . 0.0 108.994 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -143.83 21.22 1.8 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.535 1.934 . . . . 0.0 110.581 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -65.82 131.99 47.63 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.339 -0.85 . . . . 0.0 111.677 -173.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.5 m -143.56 161.24 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.437 1.495 . . . . 0.0 111.335 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -130.83 152.27 50.35 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.214 1.406 . . . . 0.0 110.135 169.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.4 m -77.03 135.58 38.66 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.158 1.383 . . . . 0.0 109.294 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -126.09 73.78 1.39 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.246 1.018 . . . . 0.0 109.137 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.8 m -83.92 127.16 33.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.3 1.04 . . . . 0.0 111.015 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 tp -69.58 147.36 50.83 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.727 0.811 . . . . 0.0 111.405 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.1 p -129.91 175.53 8.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.381 1.473 . . . . 0.0 111.791 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 75.9 p -62.88 -11.5 18.69 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.65 17.22 1.63 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.76 1.171 . . . . 0.0 115.291 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.63 -137.22 4.99 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 118.645 1.222 . . . . 0.0 112.498 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -133.6 169.07 17.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.421 2.288 . . . . 0.0 111.336 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -131.39 147.39 52.56 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.304 1.842 . . . . 0.0 110.43 172.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.8 mt -130.53 114.01 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.055 0.942 . . . . 0.0 110.022 -170.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -136.89 151.99 49.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.86 1.264 . . . . 0.0 111.433 -169.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.0 -31.37 62.99 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.55 -40.11 1.59 Allowed Glycine 0 N--CA 1.471 1.019 0 C-N-CA 125.221 1.391 . . . . 0.0 112.649 -171.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -79.77 -5.76 55.96 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.913 1.285 . . . . 0.0 114.214 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? 57.1 14.14 1.87 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 126.998 2.119 . . . . 0.0 114.26 -169.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.8 p -69.46 -26.54 64.63 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.625 1.97 . . . . 0.0 113.501 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.5 m -143.88 168.71 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.005 1.722 . . . . 0.0 111.322 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.6 t -140.93 156.88 46.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.157 1.783 . . . . 0.0 110.863 172.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -71.52 138.74 49.13 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.18 0.592 . . . . 0.0 111.148 170.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 98.3 p -147.94 172.97 13.35 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.344 1.058 . . . . 0.0 112.552 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.92 149.18 46.18 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.077 1.351 . . . . 0.0 110.001 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -82.55 -34.41 27.8 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.433 0.693 . . . . 0.0 111.285 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -141.0 -7.83 1.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.33 1.852 . . . . 0.0 112.785 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.45 28.16 13.25 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.816 1.646 . . . . 0.0 114.319 -170.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.0 p -76.81 157.84 31.26 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.987 -1.071 . . . . 0.0 111.39 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -71.24 144.51 50.05 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.074 -1.016 . . . . 0.0 112.036 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.11 0.83 84.1 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.423 1.011 . . . . 0.0 114.395 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -70.01 149.4 47.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.964 1.306 . . . . 0.0 112.579 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.91 114.22 21.52 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.991 -1.068 . . . . 0.0 109.774 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.7 p -56.96 146.09 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 111.353 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.3 t -124.94 165.8 17.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.99 1.316 . . . . 0.0 111.957 -169.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.8 mt -134.98 143.06 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.725 1.61 . . . . 0.0 108.81 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.66 -157.81 30.33 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.076 0.846 . . . . 0.0 111.85 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.54 157.51 5.15 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.664 0.732 . . . . 0.0 111.91 169.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -57.84 153.08 14.59 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.33 1.052 . . . . 0.0 112.691 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.24 171.24 7.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.911 1.685 . . . . 0.0 112.738 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.3 t -107.2 -3.45 19.81 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -170.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -145.82 -43.93 0.21 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.384 1.073 . . . . 0.0 112.536 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 86.2 p -95.48 -0.3 52.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.52 -3.71 27.76 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.5 1.524 . . . . 0.0 115.924 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -125.66 152.58 45.03 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.524 1.662 . . . . 0.0 111.541 -174.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -137.59 175.48 9.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.656 1.583 . . . . 0.0 111.947 -168.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.0 p -138.41 139.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.7 1.2 . . . . 0.0 109.857 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 mp -122.45 124.51 70.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.968 1.707 . . . . 0.0 106.95 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -149.07 154.03 38.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.104 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.24 155.16 40.28 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.102 -0.999 . . . . 0.0 112.62 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.6 t . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.077 1.751 . . . . 0.0 111.313 171.989 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.542 0.655 0 CA-C-O 121.572 0.701 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 t -154.18 169.53 23.38 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.945 1.298 . . . . 0.0 109.841 171.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.88 139.43 58.76 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 173.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.89 -161.34 32.29 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.267 0.937 . . . . 0.0 114.374 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -98.93 125.61 44.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.077 0.951 . . . . 0.0 110.111 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -134.28 172.47 12.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.572 1.549 . . . . 0.0 112.239 -171.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.4 pt -127.04 154.58 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 126.477 1.911 . . . . 0.0 108.62 171.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.66 123.77 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -141.36 150.22 42.15 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.362 0.665 . . . . 0.0 112.485 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -84.82 134.56 34.3 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.192 0.597 . . . . 0.0 111.635 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -64.83 -13.59 56.49 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.6 t . . . . . 0 N--CA 1.478 0.94 0 CA-C-N 119.447 1.022 . . . . 0.0 112.399 171.84 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.3 tp . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 121.213 0.53 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.72 145.17 29.73 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -169.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -59.39 130.95 49.42 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.803 1.241 . . . . 0.0 109.201 168.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.1 m -128.52 117.37 21.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.436 1.094 . . . . 0.0 110.909 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.87 134.3 89.77 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.512 1.925 . . . . 0.0 112.141 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.59 -10.46 18.68 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.497 2.798 . . . . 0.0 114.795 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.21 6.19 81.85 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 119.01 -0.883 . . . . 0.0 115.254 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -157.7 163.24 38.37 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.94 1.37 . . . . 0.0 112.241 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -90.8 165.62 13.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.318 1.047 . . . . 0.0 111.631 -175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 50.67 35.77 12.53 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.308 1.843 . . . . 0.0 113.707 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.0 m -134.06 138.96 31.78 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 125.385 1.474 . . . . 0.0 111.319 -169.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -46.62 153.15 1.32 Allowed 'Trans proline' 0 C--N 1.354 0.817 1 C-N-CA 125.973 4.449 . . . . 0.0 115.238 169.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.05 147.75 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.687 1.195 . . . . 0.0 110.388 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 m -120.95 173.02 7.5 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.377 1.471 . . . . 0.0 111.347 -168.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.47 143.91 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.875 1.27 . . . . 0.0 111.446 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.1 m -151.41 159.84 32.79 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.136 1.374 . . . . 0.0 111.478 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -62.55 132.95 40.22 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.241 1.961 . . . . 0.0 110.779 173.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.1 tp -63.79 137.28 57.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.284 1.034 . . . . 0.0 111.308 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -135.93 -24.03 1.32 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.298 1.439 . . . . 0.0 112.811 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.14 5.96 22.81 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.147 1.356 . . . . 0.0 114.037 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.3 t -62.48 147.93 47.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.425 1.113 . . . . 0.0 111.788 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.8 m -58.24 -20.29 40.81 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.097 0.959 . . . . 0.0 113.53 172.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.87 -20.98 65.18 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.927 0.891 . . . . 0.0 112.853 173.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -104.29 -1.54 26.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.145 1.778 . . . . 0.0 112.617 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.95 138.81 41.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.807 1.243 . . . . 0.0 111.517 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -136.0 170.43 16.02 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.745 1.218 . . . . 0.0 111.873 -169.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.0 mt -124.69 136.87 59.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 126.514 1.926 . . . . 0.0 107.358 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.6 tp -136.51 126.51 26.02 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.383 1.473 . . . . 0.0 109.506 -169.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -144.25 138.05 27.72 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.15 0.98 . . . . 0.0 110.788 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 t -63.84 141.87 58.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.933 0.493 . . . . 0.0 111.529 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -113.4 -52.27 2.77 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.505 1.122 . . . . 0.0 110.76 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.43 107.49 4.02 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.276 1.03 . . . . 0.0 110.971 169.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.1 m -57.96 -26.56 62.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.939 0.896 . . . . 0.0 111.369 168.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -61.7 -20.81 63.89 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.091 2.156 . . . . 0.0 113.664 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.8 m -130.36 9.39 5.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.242 1.817 . . . . 0.0 112.949 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 47.23 28.55 1.02 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.291 2.236 . . . . 0.0 114.734 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -88.53 142.33 27.79 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.592 -1.318 . . . . 0.0 112.443 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -138.45 141.7 39.47 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.932 1.693 . . . . 0.0 110.891 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.2 p -77.88 147.57 35.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.148 0.579 . . . . 0.0 110.758 172.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.6 mm -128.49 131.41 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.42 1.488 . . . . 0.0 109.507 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.1 m -144.54 148.33 39.75 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 125.918 1.687 . . . . 0.0 110.549 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.9 145.89 28.95 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.121 2.547 . . . . 0.0 111.322 173.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.34 -28.76 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 O-C-N 121.189 -0.945 . . . . 0.0 112.003 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.43 -25.3 74.63 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 123.738 0.685 . . . . 0.0 114.753 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.1 m -144.59 67.37 14.23 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.451 1.5 . . . . 0.0 111.554 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.82 -13.46 37.2 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.416 2.744 . . . . 0.0 113.658 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -73.99 1.99 9.68 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.976 1.71 . . . . 0.0 114.002 170.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m -132.74 173.56 11.23 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.7 1.6 . . . . 0.0 111.782 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -137.4 172.43 12.99 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.453 1.501 . . . . 0.0 112.775 -174.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.9 mm -119.28 123.02 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.098 1.359 . . . . 0.0 110.14 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.45 -161.43 9.75 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.981 1.753 . . . . 0.0 111.144 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -142.07 143.2 32.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.383 1.092 . . . . 0.0 111.703 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.68 -162.32 10.36 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.092 1.33 . . . . 0.0 113.35 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.08 137.71 21.2 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.17 1.388 . . . . 0.0 113.058 -177.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.48 -5.71 65.03 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.771 1.177 . . . . 0.0 114.167 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 47.99 55.91 7.99 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.256 1.822 . . . . 0.0 113.563 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.89 141.12 33.76 Favored Pre-proline 0 N--CA 1.468 0.457 0 C-N-CA 127.262 2.225 . . . . 0.0 107.658 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -66.43 144.18 72.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.142 1.228 . . . . 0.0 109.836 174.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.24 145.13 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.521 1.528 . . . . 0.0 111.992 -172.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.2 t -74.19 119.2 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.194 0.997 . . . . 0.0 110.361 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -129.95 164.64 39.07 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.842 2.057 . . . . 0.0 111.457 -169.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.04 166.34 27.03 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.154 2.569 . . . . 0.0 112.339 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.85 121.05 7.02 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.335 2.023 . . . . 0.0 110.374 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -148.11 -90.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.762 0.825 . . . . 0.0 110.827 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -155.81 17.75 0.38 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.648 1.579 . . . . 0.0 112.727 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -66.47 137.2 56.66 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.583 -0.698 . . . . 0.0 111.802 -174.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.0 m -144.53 160.46 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.788 1.235 . . . . 0.0 112.231 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -129.6 138.0 51.02 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.644 1.578 . . . . 0.0 110.145 169.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -71.4 127.51 32.8 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.67 1.188 . . . . 0.0 108.793 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.8 mt -125.92 115.76 20.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.192 0.997 . . . . 0.0 108.739 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.8 m -136.52 134.49 37.61 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.733 0.813 . . . . 0.0 111.261 -169.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.66 152.11 45.09 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.008 1.323 . . . . 0.0 112.14 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 p -131.61 -178.75 5.0 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.096 1.758 . . . . 0.0 111.373 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.6 p -60.54 -13.0 11.46 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.82 24.45 0.26 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.274 0.94 . . . . 0.0 114.885 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 176.02 -147.6 8.76 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.147 0.974 . . . . 0.0 113.112 -173.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -132.02 167.26 20.0 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.082 2.153 . . . . 0.0 111.233 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -122.27 155.12 36.57 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.923 2.089 . . . . 0.0 109.964 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mt -134.84 117.15 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.01 1.724 . . . . 0.0 108.276 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -134.91 157.21 47.44 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.732 1.213 . . . . 0.0 111.633 -173.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -60.96 -25.69 67.01 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.93 -40.36 1.66 Allowed Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.003 1.763 . . . . 0.0 112.425 -169.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -98.82 4.4 47.59 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 114.06 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 58.08 14.56 2.76 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.282 2.233 . . . . 0.0 114.352 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.4 p -71.13 -24.74 62.34 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.164 0.985 . . . . 0.0 112.597 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.78 172.9 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.867 1.667 . . . . 0.0 111.988 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.0 t -143.74 150.99 39.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.462 3.105 . . . . 0.0 108.816 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -73.51 144.84 45.99 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.41 -0.806 . . . . 0.0 111.507 170.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 93.1 p -154.07 173.98 15.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.447 1.099 . . . . 0.0 112.322 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.7 mt -121.11 170.51 9.48 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.841 2.056 . . . . 0.0 109.503 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -105.06 -33.87 8.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.025 0.93 . . . . 0.0 111.9 -169.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -139.33 -8.51 1.3 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.015 2.126 . . . . 0.0 112.456 170.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.8 24.53 10.87 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 126.211 1.805 . . . . 0.0 114.521 -171.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.5 p -73.26 158.76 34.55 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 111.736 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.72 142.91 54.86 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.21 -0.931 . . . . 0.0 112.009 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.02 6.23 85.74 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.659 1.123 . . . . 0.0 114.444 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.74 137.16 38.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.826 1.313 . . . . 0.0 112.498 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -71.95 134.35 45.91 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.369 -0.832 . . . . 0.0 110.834 174.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.48 155.59 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.462 0.649 . . . . 0.0 110.962 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.6 t -127.11 159.21 34.89 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.359 1.464 . . . . 0.0 110.91 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.97 137.07 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.468 1.507 . . . . 0.0 108.736 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 178.48 178.46 47.87 Favored Glycine 0 N--CA 1.471 0.976 0 C-N-CA 124.674 1.13 . . . . 0.0 111.44 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.87 -41.34 57.98 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.265 1.532 . . . . 0.0 114.19 -173.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -167.62 176.0 6.7 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.944 2.498 . . . . 0.0 111.382 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.12 140.08 35.95 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.332 1.053 . . . . 0.0 111.88 169.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.6 t -62.85 -22.59 66.79 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -171.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -134.01 -35.42 0.95 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.959 1.304 . . . . 0.0 113.076 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.0 t -97.8 2.8 49.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.812 1.245 . . . . 0.0 114.323 -171.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.91 17.6 1.26 Allowed Glycine 0 CA--C 1.544 1.865 0 C-N-CA 125.4 1.476 . . . . 0.0 116.27 -174.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -140.45 149.23 42.3 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.135 1.774 . . . . 0.0 112.142 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -140.89 178.17 7.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.717 2.007 . . . . 0.0 111.18 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.2 141.22 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.77 1.228 . . . . 0.0 109.286 169.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.33 123.62 71.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.575 1.55 . . . . 0.0 106.939 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -145.94 153.19 40.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.665 1.186 . . . . 0.0 109.482 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -67.45 155.28 39.41 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.04 -1.038 . . . . 0.0 112.774 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 77.1 t . . . . . 0 C--O 1.251 1.177 0 C-N-CA 126.171 1.789 . . . . 0.0 111.309 172.228 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 CA--C 1.547 0.853 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -160.76 169.28 23.07 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.095 1.358 . . . . 0.0 109.928 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.16 133.07 50.75 Favored 'General case' 0 CA--C 1.548 0.865 0 O-C-N 121.855 -0.528 . . . . 0.0 111.703 170.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.24 -164.99 37.95 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.841 0.734 . . . . 0.0 114.5 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -97.07 126.48 42.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.982 0.913 . . . . 0.0 110.318 171.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.15 172.05 13.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.56 1.544 . . . . 0.0 112.442 -170.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.6 pt -127.17 156.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.472 1.909 . . . . 0.0 108.763 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.8 mt -128.38 126.75 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.91 151.82 39.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.316 0.646 . . . . 0.0 111.735 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -86.2 138.36 31.93 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.75 -0.594 . . . . 0.0 112.038 -173.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.8 mmm180 -62.05 -19.08 62.52 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t . . . . . 0 N--CA 1.48 1.061 0 CA-C-N 119.269 0.941 . . . . 0.0 112.936 176.439 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 24.3 tp . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 121.15 0.5 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.78 141.23 36.48 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.574 1.149 . . . . 0.0 113.987 -169.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.561 HD12 ' CZ2' ' A' ' 63' ' ' TRP . 0.6 OUTLIER -60.99 125.04 22.28 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.326 1.45 . . . . 0.0 107.957 169.001 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.406 ' N ' HD13 ' A' ' 40' ' ' LEU . 87.7 m -126.33 124.64 40.74 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.344 1.058 . . . . 0.0 112.054 -169.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.59 134.37 95.99 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.905 2.082 . . . . 0.0 111.885 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.83 -10.8 19.99 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.366 2.71 . . . . 0.0 114.462 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.89 6.16 76.38 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.962 -0.91 . . . . 0.0 115.262 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -157.17 166.66 32.59 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.005 1.402 . . . . 0.0 112.278 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -89.36 165.42 14.38 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.388 1.075 . . . . 0.0 111.828 -174.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 45.95 43.64 10.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.582 1.953 . . . . 0.0 113.497 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 m -138.31 139.01 23.91 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 125.507 1.523 . . . . 0.0 110.813 -169.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -45.84 157.81 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.881 1 C-N-CA 126.279 4.653 . . . . 0.0 115.483 169.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.15 151.02 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.316 1.446 . . . . 0.0 110.42 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 m -130.92 170.28 14.65 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.174 1.39 . . . . 0.0 110.339 -169.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.12 146.54 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.993 -1.067 . . . . 0.0 112.075 175.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -150.6 160.41 32.72 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.642 1.177 . . . . 0.0 112.223 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.06 128.03 27.39 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.46 2.774 . . . . 0.0 111.75 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 tp -64.11 136.22 57.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.481 0.713 . . . . 0.0 111.042 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -134.47 -26.89 1.39 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.206 1.403 . . . . 0.0 112.606 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.8 8.76 13.32 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.293 1.425 . . . . 0.0 113.938 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.5 t -66.98 160.13 27.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.596 1.198 . . . . 0.0 111.941 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.5 m -73.6 -16.28 61.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.088 0.955 . . . . 0.0 111.665 -176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.26 -16.73 58.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.064 1.745 . . . . 0.0 112.829 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -101.5 -5.45 25.19 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.02 1.728 . . . . 0.0 112.343 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.97 143.23 36.93 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.991 1.316 . . . . 0.0 111.735 -174.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.561 ' CZ2' HD12 ' A' ' 40' ' ' LEU . 90.3 m95 -136.4 168.12 20.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.542 1.163 . . . . 0.0 112.333 -169.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.2 mt -121.56 134.82 63.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.92 2.088 . . . . 0.0 106.654 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.1 tp -134.79 126.82 29.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.49 1.516 . . . . 0.0 109.655 -169.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -143.0 140.25 30.94 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.146 0.978 . . . . 0.0 110.894 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.7 t -65.92 140.23 58.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.707 0.403 . . . . 0.0 111.132 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -112.87 -51.2 2.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.414 1.086 . . . . 0.0 111.026 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.62 108.7 4.41 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.469 1.107 . . . . 0.0 110.93 169.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.1 m -58.08 -26.59 62.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.83 0.852 . . . . 0.0 111.188 168.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -61.36 -20.6 63.18 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.136 2.174 . . . . 0.0 113.51 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t -130.48 6.92 4.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.851 1.66 . . . . 0.0 113.401 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 48.1 31.29 2.44 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.26 1.824 . . . . 0.0 114.035 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -89.03 143.46 26.84 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.266 -0.896 . . . . 0.0 111.848 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -138.53 141.61 39.32 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.443 1.497 . . . . 0.0 110.795 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.9 p -78.02 147.44 34.82 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.092 0.557 . . . . 0.0 110.678 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.2 mm -127.63 128.09 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.48 1.512 . . . . 0.0 109.302 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.1 m -142.16 141.01 20.23 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.674 1.59 . . . . 0.0 110.5 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.09 143.41 32.33 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.853 2.369 . . . . 0.0 111.224 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.86 -28.8 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 121.297 -0.877 . . . . 0.0 111.631 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.17 -10.51 86.01 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.4 m -156.4 68.05 4.6 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.846 1.658 . . . . 0.0 110.469 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -63.55 -17.84 61.76 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.789 2.992 . . . . 0.0 113.5 -173.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -76.24 6.15 5.91 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 127.848 2.459 . . . . 0.0 114.657 171.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.7 m -131.23 175.31 9.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.977 1.711 . . . . 0.0 112.088 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -139.06 171.99 13.5 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.546 1.538 . . . . 0.0 113.28 -172.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.7 mm -120.17 130.79 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.272 1.429 . . . . 0.0 110.601 174.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.47 -157.63 7.34 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.645 1.593 . . . . 0.0 111.422 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -141.7 142.61 33.33 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.24 1.016 . . . . 0.0 111.848 -172.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.94 -163.21 10.57 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.247 1.403 . . . . 0.0 113.381 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.2 139.96 22.43 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.011 1.324 . . . . 0.0 113.136 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.46 -2.29 73.83 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.512 1.053 . . . . 0.0 114.292 -173.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 48.7 56.34 7.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.18 1.792 . . . . 0.0 113.41 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.7 p -133.83 136.88 27.34 Favored Pre-proline 0 C--O 1.238 0.49 0 C-N-CA 127.548 2.339 . . . . 0.0 107.751 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.75 142.77 59.13 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.202 1.268 . . . . 0.0 109.462 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.03 149.29 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.023 1.329 . . . . 0.0 111.472 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 t -76.22 134.93 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.851 0.861 . . . . 0.0 110.402 174.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.5 mt -141.17 161.62 52.27 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.649 1.58 . . . . 0.0 112.039 -169.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.9 165.65 29.18 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.062 2.508 . . . . 0.0 111.765 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.62 124.07 9.97 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.5 2.133 . . . . 0.0 110.702 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -148.01 -89.61 0.08 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.076 0.95 . . . . 0.0 110.592 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -154.82 15.95 0.43 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.431 1.493 . . . . 0.0 112.901 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -67.01 134.36 51.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.425 0.69 . . . . 0.0 111.906 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -144.92 161.03 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.949 1.3 . . . . 0.0 112.069 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -130.99 137.61 49.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.252 1.421 . . . . 0.0 110.762 169.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.9 m -72.19 131.74 43.17 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.899 1.28 . . . . 0.0 108.705 169.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.7 mt -121.94 73.49 1.09 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.071 0.938 . . . . 0.0 109.324 -176.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 93.3 m -73.42 119.47 17.7 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.755 1.222 . . . . 0.0 110.656 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.7 tp -68.41 147.63 51.8 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.077 0.551 . . . . 0.0 111.271 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.0 p -133.82 177.05 8.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.987 1.715 . . . . 0.0 110.515 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.9 m -59.88 -12.69 8.18 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.93 31.25 0.28 Allowed Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.761 1.172 . . . . 0.0 114.096 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.29 -160.62 34.22 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.976 1.274 . . . . 0.0 112.072 -174.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -127.92 172.11 11.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.255 1.822 . . . . 0.0 112.075 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -136.69 150.18 48.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.21 1.804 . . . . 0.0 110.099 170.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.1 mt -129.1 114.84 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.103 0.961 . . . . 0.0 109.516 -169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -134.8 155.74 50.08 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.124 0.969 . . . . 0.0 112.248 -169.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.86 -28.99 69.88 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.68 -40.6 1.61 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.063 1.792 . . . . 0.0 112.756 -172.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.08 -5.2 59.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.974 1.309 . . . . 0.0 113.983 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? 57.11 17.86 3.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.623 1.969 . . . . 0.0 113.374 -169.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 49.0 p -71.02 -24.46 62.37 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.195 0.998 . . . . 0.0 112.168 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.9 m -144.26 173.68 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.006 1.723 . . . . 0.0 112.162 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.4 t -146.14 154.81 42.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.481 2.712 . . . . 0.0 110.044 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -73.19 142.04 47.37 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.464 -0.773 . . . . 0.0 111.777 170.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 91.7 p -152.92 170.47 20.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.025 1.33 . . . . 0.0 112.63 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.81 156.06 31.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.954 1.302 . . . . 0.0 110.386 173.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -89.93 -31.47 17.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.281 0.632 . . . . 0.0 111.501 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -138.07 -4.12 1.74 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.556 1.542 . . . . 0.0 113.639 172.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.85 27.26 2.26 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.303 1.841 . . . . 0.0 114.452 -169.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.6 p -76.33 161.0 29.09 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.899 0.88 . . . . 0.0 111.471 174.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.72 142.39 51.47 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.911 -1.118 . . . . 0.0 111.359 169.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.41 5.79 82.79 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.322 0.963 . . . . 0.0 114.019 -173.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.53 140.57 49.95 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.906 1.283 . . . . 0.0 111.858 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.56 111.19 14.36 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 170.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.32 147.39 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.634 0.73 . . . . 0.0 111.175 172.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.3 m -134.22 171.54 14.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.76 1.624 . . . . 0.0 111.399 -169.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 70.0 mt -134.34 143.69 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.983 1.313 . . . . 0.0 109.231 -173.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.03 179.04 47.22 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.895 1.236 . . . . 0.0 111.65 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.47 -42.47 61.62 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.091 1.445 . . . . 0.0 114.266 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -169.3 174.28 6.18 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.266 2.626 . . . . 0.0 111.027 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -142.46 141.83 32.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.185 0.994 . . . . 0.0 111.866 169.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 t -66.26 -18.61 65.46 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -138.62 -43.66 0.49 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.194 0.998 . . . . 0.0 113.293 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.8 p -86.07 0.49 53.31 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.081 1.352 . . . . 0.0 114.381 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.95 19.68 0.96 Allowed Glycine 0 CA--C 1.541 1.666 0 C-N-CA 126.505 2.002 . . . . 0.0 116.622 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -144.94 149.78 35.83 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.069 1.935 . . . . 0.0 112.057 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -139.4 177.71 7.73 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.988 1.715 . . . . 0.0 112.368 -169.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.3 p -140.78 139.93 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.831 1.252 . . . . 0.0 109.607 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.17 125.87 74.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 125.821 1.648 . . . . 0.0 107.192 172.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -148.58 153.76 38.81 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.646 1.178 . . . . 0.0 109.46 -170.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -67.71 155.11 39.99 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.921 -1.112 . . . . 0.0 112.775 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.145 1.778 . . . . 0.0 111.323 171.908 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 CA--C 1.549 0.91 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.2 m -150.73 160.17 44.03 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.073 1.749 . . . . 0.0 109.382 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.52 131.14 45.66 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.652 -0.655 . . . . 0.0 111.362 171.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.93 -166.11 39.43 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -95.52 124.1 39.39 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.231 1.012 . . . . 0.0 110.037 172.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -133.17 171.83 13.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.098 1.359 . . . . 0.0 112.259 -173.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 pt -124.57 153.05 31.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.888 1.675 . . . . 0.0 108.431 170.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.7 mt -128.49 118.97 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -138.56 149.6 45.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.504 0.669 . . . . 0.0 112.212 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -77.6 136.58 38.27 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.04 -0.413 . . . . 0.0 111.463 -173.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -64.94 -24.28 67.47 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.3 t . . . . . 0 N--CA 1.481 1.104 0 C-N-CA 123.819 0.847 . . . . 0.0 112.489 -178.312 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.471 0.581 0 CA-C-O 121.095 0.474 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.46 142.86 33.86 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.445 1.098 . . . . 0.0 113.292 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.8 tp -56.74 135.76 55.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.857 0.863 . . . . 0.0 109.218 169.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 90.5 m -132.26 122.55 25.35 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.266 1.026 . . . . 0.0 110.827 -173.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -64.07 138.13 97.32 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 127.128 2.171 . . . . 0.0 111.907 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -74.06 -12.1 23.51 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.299 2.666 . . . . 0.0 114.933 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.29 7.26 86.94 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.006 0.812 . . . . 0.0 114.76 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -154.09 166.42 33.11 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.947 1.699 . . . . 0.0 111.764 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -93.83 164.69 13.02 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.936 0.894 . . . . 0.0 111.812 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.6 tpt85 46.68 40.12 8.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.816 2.046 . . . . 0.0 114.032 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.7 m -133.98 142.1 42.15 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.563 1.545 . . . . 0.0 111.057 -169.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -44.67 156.28 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.828 1 C-N-CA 126.003 4.469 . . . . 0.0 115.589 169.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.88 158.43 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.798 1.239 . . . . 0.0 110.207 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -128.71 170.28 13.48 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.698 1.599 . . . . 0.0 110.971 -169.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.8 p -125.49 142.29 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.833 1.253 . . . . 0.0 111.257 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 m -159.04 168.49 12.3 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.711 1.204 . . . . 0.0 113.004 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -49.97 161.56 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.677 3.585 . . . . 0.0 114.857 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.3 tp -123.01 132.26 54.05 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.739 1.216 . . . . 0.0 111.343 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -134.19 -29.27 1.27 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.922 2.089 . . . . 0.0 112.27 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.53 4.09 1.98 Allowed Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.642 1.417 . . . . 0.0 116.642 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -71.0 165.1 24.19 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.056 1.928 . . . . 0.0 113.391 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.2 m -69.02 -16.98 63.85 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.29 -24.84 62.23 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.022 0.828 . . . . 0.0 112.28 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.62 6.28 11.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.084 2.554 . . . . 0.0 112.409 -169.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.99 148.07 39.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.979 1.312 . . . . 0.0 110.745 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -137.51 174.02 11.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 122.69 1.233 . . . . 0.0 112.901 -168.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.8 mt -122.96 139.15 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.194 2.198 . . . . 0.0 107.09 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.7 tp -137.31 123.22 20.14 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.409 1.483 . . . . 0.0 109.044 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -144.13 138.34 28.12 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.507 0.723 . . . . 0.0 111.117 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.2 t -65.96 139.33 58.23 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.734 0.414 . . . . 0.0 111.002 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -111.93 -50.61 2.9 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.809 1.244 . . . . 0.0 110.282 174.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.01 106.9 3.97 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.432 1.093 . . . . 0.0 110.84 169.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.4 m -58.05 -25.5 61.3 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.959 0.903 . . . . 0.0 111.506 168.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -63.73 -20.99 66.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.022 2.129 . . . . 0.0 113.495 174.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -130.1 9.02 5.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.126 1.77 . . . . 0.0 112.644 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 45.87 32.69 1.36 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.422 2.289 . . . . 0.0 114.217 -169.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.5 p -91.62 140.95 29.23 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.919 -1.113 . . . . 0.0 112.091 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -136.84 144.89 43.86 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.878 1.671 . . . . 0.0 110.733 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.1 p -77.78 150.64 34.29 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.192 0.597 . . . . 0.0 110.965 170.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.9 mm -130.44 129.73 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.976 1.71 . . . . 0.0 108.519 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.1 p -151.98 155.09 33.4 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.171 0.988 . . . . 0.0 111.866 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.88 146.05 29.19 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.994 2.462 . . . . 0.0 110.841 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.49 -24.26 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.851 -1.156 . . . . 0.0 113.072 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.71 -19.54 57.89 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.033 0.825 . . . . 0.0 114.728 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.0 m -142.22 62.58 13.9 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 125.66 1.584 . . . . 0.0 111.266 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.36 -13.98 39.37 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.268 2.645 . . . . 0.0 113.491 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -74.08 6.84 3.1 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.293 1.837 . . . . 0.0 114.001 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -129.75 175.54 8.75 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.637 1.575 . . . . 0.0 111.331 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -141.0 167.96 20.94 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.618 1.567 . . . . 0.0 111.07 -172.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.7 mm -122.23 128.04 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.296 1.038 . . . . 0.0 110.552 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.77 -159.18 7.88 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.985 1.755 . . . . 0.0 111.243 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -143.83 148.32 35.36 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.595 1.197 . . . . 0.0 111.996 -174.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.51 -160.36 9.56 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.397 1.475 . . . . 0.0 112.968 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.46 138.35 27.68 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.832 1.253 . . . . 0.0 112.959 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.6 -3.59 63.32 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.612 1.101 . . . . 0.0 114.284 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 47.67 54.21 10.14 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.106 1.762 . . . . 0.0 113.602 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.98 138.44 30.68 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 127.53 2.332 . . . . 0.0 107.473 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.78 144.45 59.41 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.292 1.328 . . . . 0.0 109.284 174.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.01 149.87 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.253 1.421 . . . . 0.0 111.343 -174.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.96 134.26 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.01 0.924 . . . . 0.0 110.677 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.0 mt -139.23 162.1 53.86 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.586 1.555 . . . . 0.0 110.784 -172.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.69 161.14 45.02 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.34 2.027 . . . . 0.0 111.574 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.33 119.75 6.34 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.564 2.176 . . . . 0.0 110.307 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -146.49 -82.64 0.13 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.309 1.044 . . . . 0.0 110.793 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -154.72 10.48 0.35 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.005 1.322 . . . . 0.0 113.945 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -67.39 128.65 37.21 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.391 -0.818 . . . . 0.0 111.776 -175.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.4 m -143.6 163.76 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.757 1.623 . . . . 0.0 111.234 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -130.47 145.78 51.9 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.034 1.333 . . . . 0.0 110.332 171.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.2 m -74.94 134.96 41.43 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.848 1.259 . . . . 0.0 109.222 169.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.85 123.85 44.66 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.389 1.075 . . . . 0.0 109.49 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.3 m -135.09 127.17 29.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.952 0.901 . . . . 0.0 110.491 -169.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.1 153.24 41.41 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.795 0.807 . . . . 0.0 113.049 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.7 p -127.99 -177.45 4.13 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.422 1.889 . . . . 0.0 110.15 171.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.1 p -60.9 -14.59 23.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.61 30.71 0.26 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.51 1.052 . . . . 0.0 114.142 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.49 -149.78 9.61 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.795 1.188 . . . . 0.0 112.537 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -132.64 170.19 15.57 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.972 2.109 . . . . 0.0 112.358 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -134.73 152.12 51.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.306 2.643 . . . . 0.0 108.805 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.2 mt -132.46 125.13 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.826 1.251 . . . . 0.0 108.242 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -137.25 160.09 40.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.246 1.018 . . . . 0.0 112.342 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -63.67 -22.19 66.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 -170.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.87 -40.5 1.77 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.614 1.578 . . . . 0.0 112.725 -171.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -98.38 5.67 47.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.94 1.696 . . . . 0.0 113.401 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 57.11 18.04 3.86 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.156 2.182 . . . . 0.0 114.227 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p -74.37 -24.6 59.18 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.251 -0.905 . . . . 0.0 112.384 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.1 m -143.73 174.61 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.661 1.584 . . . . 0.0 112.104 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t -148.45 154.36 39.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.96 2.504 . . . . 0.0 110.111 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -70.29 143.59 52.02 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.386 -0.821 . . . . 0.0 111.802 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.1 p -151.54 172.46 15.97 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.154 1.382 . . . . 0.0 112.621 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.0 mt -128.81 177.59 6.96 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.338 1.855 . . . . 0.0 110.095 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -123.93 -31.93 3.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.258 1.423 . . . . 0.0 111.332 -169.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -143.41 -5.54 0.84 Allowed 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 173.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.17 34.61 17.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.692 1.597 . . . . 0.0 114.786 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.4 p -90.98 160.78 15.45 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.323 -0.861 . . . . 0.0 111.946 171.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.06 142.98 52.61 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.756 -1.215 . . . . 0.0 112.139 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.49 -0.5 87.83 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.535 1.064 . . . . 0.0 114.24 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -63.76 142.99 58.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.102 1.761 . . . . 0.0 112.443 174.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.54 116.78 24.05 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.144 -0.972 . . . . 0.0 109.759 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.3 p -58.82 152.92 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.24 1.016 . . . . 0.0 112.214 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.6 m -130.26 168.88 16.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.536 1.534 . . . . 0.0 111.767 -170.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.2 mt -136.65 143.38 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.217 1.407 . . . . 0.0 109.535 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 178.93 178.2 48.03 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.03 1.3 . . . . 0.0 111.905 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.59 -42.5 44.75 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 119.258 1.529 . . . . 0.0 114.562 -172.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -167.28 176.31 6.8 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 129.091 2.956 . . . . 0.0 108.374 172.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.53 137.93 35.87 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.228 -0.92 . . . . 0.0 112.364 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.2 t -59.93 -21.53 61.25 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.958 1.703 . . . . 0.0 115.218 -169.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -134.34 -36.51 0.89 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.399 1.08 . . . . 0.0 113.613 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -103.41 2.44 33.87 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.86 10.81 1.44 Allowed Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.294 1.426 . . . . 0.0 115.377 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -131.51 142.67 50.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.849 1.66 . . . . 0.0 109.921 -169.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -139.41 175.89 9.18 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.692 1.597 . . . . 0.0 111.85 -168.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.71 139.56 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.848 1.259 . . . . 0.0 109.403 169.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.42 125.49 73.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.731 1.613 . . . . 0.0 107.088 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.07 153.91 38.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.733 1.213 . . . . 0.0 108.974 -170.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -68.63 155.6 39.71 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.923 -1.111 . . . . 0.0 112.497 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.6 t . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.107 1.763 . . . . 0.0 111.279 171.807 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.72 -14.59 0.06 OUTLIER Glycine 0 CA--C 1.538 1.503 0 N-CA-C 115.795 1.078 . . . . 0.0 115.795 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -144.95 167.57 22.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.792 1.637 . . . . 0.0 111.567 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -154.6 145.45 22.52 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.915 1.286 . . . . 0.0 111.057 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -152.14 7.97 0.47 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.188 1.395 . . . . 0.0 113.641 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -74.99 -14.9 60.67 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -169.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -133.37 4.4 3.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.146 1.378 . . . . 0.0 114.008 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -156.84 157.34 34.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.075 1.35 . . . . 0.0 112.182 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.453 ' CG ' ' H ' ' A' ' 10' ' ' HIS . 8.3 t60 -147.45 -177.76 5.87 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.579 1.551 . . . . 0.0 111.144 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.453 ' H ' ' CG ' ' A' ' 9' ' ' HIS . 95.9 m-70 -131.12 171.03 13.74 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.098 1.759 . . . . 0.0 111.832 -176.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.8 p 44.63 34.09 1.07 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.698 1.999 . . . . 0.0 115.284 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.98 -19.6 0.06 OUTLIER Glycine 0 CA--C 1.539 1.546 0 C-N-CA 125.435 1.493 . . . . 0.0 114.545 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -129.05 16.64 6.2 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.966 1.706 . . . . 0.0 112.283 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 p -134.68 41.1 0.61 Allowed Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 126.075 1.75 . . . . 0.0 114.617 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -67.39 163.68 33.67 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.977 2.451 . . . . 0.0 113.011 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.03 24.41 2.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.726 1.21 . . . . 0.0 113.681 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.4 t -140.72 145.0 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.813 1.645 . . . . 0.0 110.484 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -148.88 11.36 0.84 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.4 1.48 . . . . 0.0 113.315 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt 59.13 169.09 0.06 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.102 2.161 . . . . 0.0 113.904 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -151.25 159.37 44.4 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.356 1.862 . . . . 0.0 109.424 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.44 140.65 58.89 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 121.562 -0.711 . . . . 0.0 112.243 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.45 -161.7 33.81 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.24 0.924 . . . . 0.0 114.426 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -98.44 126.75 44.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.187 0.995 . . . . 0.0 110.338 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -135.59 171.52 14.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.13 1.372 . . . . 0.0 112.701 -171.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.4 pt -124.82 153.62 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 126.329 1.852 . . . . 0.0 108.393 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.63 122.56 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -140.09 147.45 40.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.537 0.735 . . . . 0.0 111.393 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -75.62 136.7 40.46 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.918 -0.489 . . . . 0.0 111.117 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.7 tpt85 -66.28 -20.17 66.03 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -171.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.4 t -64.12 -24.26 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.809 1.244 . . . . 0.0 112.546 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.0 mt 60.88 170.63 0.1 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.906 2.082 . . . . 0.0 113.73 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.6 t -73.52 147.68 87.38 Favored Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 124.579 1.151 . . . . 0.0 111.876 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.2 -14.12 41.91 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.621 2.214 . . . . 0.0 112.828 169.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.2 tpt85 -70.52 -17.66 62.94 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.13 1.372 . . . . 0.0 113.123 169.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.84 22.81 22.47 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.474 1.511 . . . . 0.0 114.179 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -134.56 170.27 16.03 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.955 1.302 . . . . 0.0 111.844 -174.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -57.83 140.18 52.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.053 0.941 . . . . 0.0 111.692 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.28 78.09 1.14 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.451 1.501 . . . . 0.0 110.022 -171.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.7 144.12 30.45 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -169.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.79 132.38 53.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.653 1.181 . . . . 0.0 109.246 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.8 m -130.7 118.85 21.52 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.292 1.037 . . . . 0.0 111.139 -169.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -61.54 137.38 94.8 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 126.305 1.842 . . . . 0.0 112.513 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.57 -13.78 20.15 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.441 2.761 . . . . 0.0 114.926 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.25 8.15 84.03 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -153.58 161.95 41.72 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.811 1.644 . . . . 0.0 111.732 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -89.77 165.73 13.98 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.007 0.923 . . . . 0.0 111.586 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 49.57 38.54 15.02 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.773 1.629 . . . . 0.0 113.813 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.4 m -136.2 141.17 35.14 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 125.562 1.545 . . . . 0.0 111.322 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -45.55 154.98 0.51 Allowed 'Trans proline' 0 C--N 1.353 0.804 1 C-N-CA 126.167 4.578 . . . . 0.0 115.49 169.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.3 t -110.89 153.96 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.065 1.346 . . . . 0.0 110.118 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 m -128.13 172.51 10.92 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.695 1.598 . . . . 0.0 110.938 -169.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.97 144.71 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.692 1.197 . . . . 0.0 111.42 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -149.54 158.98 37.31 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 124.921 1.288 . . . . 0.0 111.872 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -63.24 130.35 28.41 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.279 1.986 . . . . 0.0 110.527 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.6 tp -63.28 136.3 57.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.373 1.069 . . . . 0.0 111.428 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -130.36 -26.87 2.26 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.192 1.797 . . . . 0.0 112.021 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.64 4.68 19.32 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.451 1.5 . . . . 0.0 114.175 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.4 p -65.74 159.45 25.09 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.783 1.291 . . . . 0.0 113.209 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -62.66 -19.1 63.5 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -68.55 -27.21 65.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.907 0.883 . . . . 0.0 112.324 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -102.38 -7.46 21.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.9 1.68 . . . . 0.0 113.197 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.64 146.37 28.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.452 1.101 . . . . 0.0 111.456 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -138.31 170.48 15.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.471 1.129 . . . . 0.0 111.858 -169.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.4 mt -121.2 136.0 59.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 127.294 2.238 . . . . 0.0 107.126 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.3 tp -137.18 124.44 21.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.274 1.43 . . . . 0.0 109.727 -170.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -141.84 140.21 32.88 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.605 0.762 . . . . 0.0 111.134 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.7 t -65.74 139.37 58.35 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.833 0.453 . . . . 0.0 110.988 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -115.19 -47.27 2.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.289 1.036 . . . . 0.0 111.595 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.37 109.48 3.73 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.308 1.043 . . . . 0.0 111.059 170.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -57.94 -27.58 63.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.828 0.851 . . . . 0.0 111.101 168.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -60.62 -21.28 62.54 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.127 2.171 . . . . 0.0 113.574 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -130.21 10.84 5.4 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.869 1.668 . . . . 0.0 112.737 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 46.36 28.51 0.72 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.967 2.107 . . . . 0.0 113.858 -168.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 p -89.71 140.03 29.98 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.85 -1.156 . . . . 0.0 112.424 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -135.26 142.93 46.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.137 1.775 . . . . 0.0 111.322 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.0 p -78.33 148.5 33.75 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.032 0.533 . . . . 0.0 110.767 172.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.2 mm -128.67 130.16 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.547 1.539 . . . . 0.0 109.807 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 m -144.8 149.65 43.72 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 126.208 1.803 . . . . 0.0 110.232 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.91 148.1 31.45 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.007 2.471 . . . . 0.0 111.143 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 m -66.18 -25.48 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 120.757 -1.215 . . . . 0.0 113.199 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.67 -21.82 65.61 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.762 0.696 . . . . 0.0 114.389 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.3 m -143.7 66.75 15.54 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 125.73 1.612 . . . . 0.0 111.047 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.23 -13.19 30.72 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.894 2.396 . . . . 0.0 113.678 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -76.55 4.69 8.73 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.046 1.738 . . . . 0.0 114.297 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.6 p -139.19 175.29 9.68 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.595 1.543 . . . . 0.0 112.579 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -138.53 171.49 14.28 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.357 1.463 . . . . 0.0 113.195 -169.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.8 mm -120.71 127.91 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.16 1.384 . . . . 0.0 110.364 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.84 -155.74 6.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.759 1.647 . . . . 0.0 110.968 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -143.25 145.06 32.41 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.492 1.146 . . . . 0.0 112.053 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.66 -162.99 10.97 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.428 1.49 . . . . 0.0 113.26 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.16 136.51 23.87 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.174 1.39 . . . . 0.0 113.054 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.77 -4.48 63.49 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.738 1.161 . . . . 0.0 114.268 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 48.54 54.71 10.09 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.425 1.89 . . . . 0.0 113.567 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.86 140.24 37.6 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 127.454 2.301 . . . . 0.0 107.674 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.28 141.21 46.51 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.076 1.184 . . . . 0.0 109.278 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.5 151.6 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.348 1.459 . . . . 0.0 111.681 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.3 t -76.91 134.6 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.115 0.966 . . . . 0.0 110.858 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -139.74 160.52 60.75 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.032 1.733 . . . . 0.0 111.825 -169.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.68 164.19 32.23 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.965 2.443 . . . . 0.0 111.983 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.71 120.51 6.73 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.43 2.087 . . . . 0.0 110.516 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -147.0 -90.91 0.09 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.0 0.92 . . . . 0.0 110.793 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -155.52 17.94 0.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.315 1.446 . . . . 0.0 113.096 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -67.36 136.33 54.62 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.486 -0.759 . . . . 0.0 111.99 -173.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.9 m -145.09 161.11 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.907 1.283 . . . . 0.0 112.545 -175.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -131.36 137.24 48.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.671 1.588 . . . . 0.0 110.737 169.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.1 m -68.49 129.67 40.6 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 169.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 44.3 mt -127.08 116.59 20.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.22 1.008 . . . . 0.0 108.693 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 m -131.6 128.29 38.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.813 0.845 . . . . 0.0 111.295 -169.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp -69.06 151.43 46.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.266 1.027 . . . . 0.0 112.147 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.6 p -129.02 -176.62 3.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.128 1.771 . . . . 0.0 111.465 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.2 p -60.34 -15.89 29.8 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.66 18.17 0.24 Allowed Glycine 0 CA--C 1.534 1.253 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.07 -150.39 8.33 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.15 1.357 . . . . 0.0 112.061 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -133.66 168.22 19.08 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.694 1.998 . . . . 0.0 111.693 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -130.0 148.71 51.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.257 2.223 . . . . 0.0 109.968 174.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.85 122.94 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.779 1.231 . . . . 0.0 109.563 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -137.96 160.4 39.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.73 1.212 . . . . 0.0 112.675 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.35 -24.38 66.42 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -172.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 124.93 -40.22 1.93 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.519 1.533 . . . . 0.0 113.077 -173.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -93.47 -3.05 53.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.298 1.439 . . . . 0.0 113.511 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 70.16 14.51 7.67 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.609 2.364 . . . . 0.0 113.413 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.2 p -72.75 -23.79 60.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.747 1.219 . . . . 0.0 112.703 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.3 m -146.02 172.66 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.91 1.684 . . . . 0.0 111.833 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.0 m -143.82 155.18 44.05 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.076 2.151 . . . . 0.0 111.214 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 38.0 m0 -73.1 140.58 47.23 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.938 -0.477 . . . . 0.0 111.848 169.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.3 p -153.56 170.71 20.14 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.225 1.41 . . . . 0.0 112.547 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.88 164.88 14.39 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.821 1.648 . . . . 0.0 110.068 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -99.62 -32.84 10.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.669 0.787 . . . . 0.0 111.623 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -143.83 -0.8 1.02 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.482 1.913 . . . . 0.0 114.196 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 50.31 27.49 2.72 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.125 2.17 . . . . 0.0 115.9 -172.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.2 p -79.4 160.0 26.85 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.901 -1.124 . . . . 0.0 112.663 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.71 138.55 58.46 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.606 0.762 . . . . 0.0 112.152 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.03 -0.3 89.86 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.658 1.123 . . . . 0.0 114.757 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -76.28 154.17 35.36 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.798 1.299 . . . . 0.0 113.169 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -81.77 122.73 28.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.058 -1.026 . . . . 0.0 110.71 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.12 151.43 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.094 0.958 . . . . 0.0 111.011 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.3 m -134.83 168.42 19.09 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.7 1.6 . . . . 0.0 111.283 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.2 mt -132.77 145.12 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.007 1.323 . . . . 0.0 109.268 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.6 -161.28 34.99 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 123.813 0.721 . . . . 0.0 112.529 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 149.16 17.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 117.828 0.814 . . . . 0.0 111.956 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.68 116.38 2.47 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.39 1.476 . . . . 0.0 113.934 -172.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.84 157.23 37.86 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.4 t -87.66 -12.98 43.84 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -133.64 -37.86 0.92 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.48 1.112 . . . . 0.0 113.44 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.4 p -104.81 2.18 29.85 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.857 1.263 . . . . 0.0 114.26 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.47 10.94 1.77 Allowed Glycine 0 CA--C 1.542 1.749 0 C-N-CA 125.888 1.708 . . . . 0.0 115.819 -176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -135.46 145.98 47.72 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.435 1.894 . . . . 0.0 111.225 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -138.06 178.51 7.07 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 126.949 2.1 . . . . 0.0 111.237 -168.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.31 138.09 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 124.169 0.987 . . . . 0.0 109.36 168.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.04 124.2 72.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 125.947 1.699 . . . . 0.0 107.215 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -147.93 152.5 37.65 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.535 1.134 . . . . 0.0 109.432 -170.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.74 155.58 38.94 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.046 -1.034 . . . . 0.0 112.909 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.133 1.773 . . . . 0.0 111.216 171.815 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.28 26.14 0.41 Allowed Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.272 0.939 . . . . 0.0 113.823 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -155.47 176.36 12.69 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.557 1.943 . . . . 0.0 111.266 -171.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -147.82 176.5 10.08 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.925 1.29 . . . . 0.0 112.255 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -154.94 165.69 35.92 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.889 1.276 . . . . 0.0 112.036 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -56.13 -17.34 6.9 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.132 1.773 . . . . 0.0 115.085 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -109.91 9.23 24.52 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.396 1.479 . . . . 0.0 113.407 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -134.5 -6.97 2.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.141 1.376 . . . . 0.0 114.191 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -131.41 -4.58 3.78 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.325 1.45 . . . . 0.0 113.992 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -128.04 7.58 6.07 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.977 1.311 . . . . 0.0 113.259 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 p -139.38 7.75 2.39 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.32 1.848 . . . . 0.0 113.527 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.46 16.51 0.17 Allowed Glycine 0 CA--C 1.539 1.553 0 C-N-CA 125.21 1.386 . . . . 0.0 114.963 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -143.72 21.91 1.8 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.338 1.455 . . . . 0.0 111.988 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.6 p -147.01 153.49 45.57 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.193 1.797 . . . . 0.0 111.733 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.15 164.02 33.9 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.198 2.599 . . . . 0.0 112.9 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.16 29.41 2.03 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.321 1.448 . . . . 0.0 112.615 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.55 144.41 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.817 1.647 . . . . 0.0 110.541 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.7 t -142.04 31.37 1.58 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 124.279 1.99 . . . . 0.0 114.375 -172.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.9 mt -62.67 169.78 2.91 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.717 2.007 . . . . 0.0 111.509 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 t -154.26 167.4 30.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.31 1.044 . . . . 0.0 110.087 173.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 125.06 22.7 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 122.091 -0.38 . . . . 0.0 111.506 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.2 -165.87 38.17 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -99.71 124.8 45.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.236 1.014 . . . . 0.0 110.087 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -134.2 170.02 16.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.28 1.432 . . . . 0.0 112.508 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 pt -125.07 152.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.242 1.817 . . . . 0.0 108.328 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.1 mt -128.94 119.33 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -137.85 147.8 44.83 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.279 0.631 . . . . 0.0 112.477 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -79.36 133.78 36.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.75 0.42 . . . . 0.0 111.234 -173.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -61.63 -21.78 64.68 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.187 1.395 . . . . 0.0 114.343 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.8 -24.15 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.976 0.91 . . . . 0.0 112.497 174.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.4 mt 62.02 168.19 0.11 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.085 2.154 . . . . 0.0 113.871 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.2 t -77.6 146.76 73.78 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 124.783 1.233 . . . . 0.0 112.411 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.99 -19.02 30.62 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.525 2.817 . . . . 0.0 113.536 168.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -66.29 -18.51 65.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.026 1.73 . . . . 0.0 113.2 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.72 22.94 24.78 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.028 1.775 . . . . 0.0 113.948 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -138.7 167.16 22.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.866 1.267 . . . . 0.0 112.066 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -56.38 136.47 53.65 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.154 0.981 . . . . 0.0 113.197 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.4 tp -111.6 80.64 1.34 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.456 1.903 . . . . 0.0 110.871 -169.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.51 147.46 30.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.048 1.739 . . . . 0.0 114.287 -171.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.1 tp -60.25 136.73 58.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.207 1.403 . . . . 0.0 110.784 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 m -124.26 120.27 31.74 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.403 1.481 . . . . 0.0 111.473 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -63.62 133.3 95.48 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.764 1.626 . . . . 0.0 111.39 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.83 -11.48 21.82 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.077 2.518 . . . . 0.0 114.587 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.93 84.8 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 119.14 -0.811 . . . . 0.0 114.92 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -156.1 161.56 40.37 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.196 1.398 . . . . 0.0 112.036 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -88.96 164.51 15.08 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.131 0.972 . . . . 0.0 111.863 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 47.3 mmt-85 50.57 34.57 9.79 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.874 1.67 . . . . 0.0 113.986 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.8 m -132.29 138.9 33.29 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.848 1.659 . . . . 0.0 110.653 -169.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.99 154.74 12.58 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.685 3.59 . . . . 0.0 115.229 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -100.92 156.66 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.839 1.256 . . . . 0.0 110.642 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 52' ' ' VAL . 2.9 m -126.98 178.24 6.11 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.675 1.59 . . . . 0.0 110.694 -170.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -134.98 148.96 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.911 1.284 . . . . 0.0 111.406 176.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.5 m -158.84 162.79 25.87 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 125.08 1.352 . . . . 0.0 112.76 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.67 127.62 16.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.53 2.153 . . . . 0.0 111.034 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.5 tp -65.2 140.22 58.73 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -137.26 10.64 3.01 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.986 1.315 . . . . 0.0 113.101 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.25 0.15 89.45 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.772 1.177 . . . . 0.0 114.948 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -64.66 142.51 58.4 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 118.678 1.239 . . . . 0.0 112.08 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.0 p -60.9 -14.13 20.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.037 1.335 . . . . 0.0 114.07 172.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.49 -21.55 64.6 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.201 -0.937 . . . . 0.0 112.626 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -118.28 9.5 12.54 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.975 1.31 . . . . 0.0 113.604 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -106.79 146.54 30.76 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.771 1.228 . . . . 0.0 110.894 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -138.94 173.96 11.01 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 122.478 1.133 . . . . 0.0 112.096 -168.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.7 mt -124.55 134.95 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 127.54 2.336 . . . . 0.0 106.948 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.02 124.88 22.6 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.376 1.47 . . . . 0.0 109.26 -170.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -146.39 139.32 25.52 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.069 0.548 . . . . 0.0 111.754 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 t -66.53 140.8 58.0 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.991 0.516 . . . . 0.0 111.592 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -114.85 -52.59 2.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.82 1.248 . . . . 0.0 111.223 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.86 110.32 5.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.77 1.228 . . . . 0.0 111.405 169.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.9 m -57.71 -24.7 58.19 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.956 0.903 . . . . 0.0 111.663 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -64.64 -21.97 66.86 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.009 2.124 . . . . 0.0 113.626 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.5 m -130.31 12.51 5.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.997 1.719 . . . . 0.0 112.686 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 42.95 35.33 0.73 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.623 1.969 . . . . 0.0 113.582 -169.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 p -87.58 139.28 30.7 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.76 -1.212 . . . . 0.0 111.709 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -135.94 143.57 44.99 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.57 1.548 . . . . 0.0 110.074 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.9 p -77.73 150.54 34.4 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.716 0.806 . . . . 0.0 110.793 173.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.9 mm -128.6 127.12 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.613 1.565 . . . . 0.0 109.44 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.6 m -143.79 148.11 41.39 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 125.835 1.654 . . . . 0.0 110.316 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.38 148.56 34.03 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.203 2.602 . . . . 0.0 111.172 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.5 m -66.79 -24.76 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.732 -1.23 . . . . 0.0 113.015 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.44 -23.9 74.34 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 123.938 0.78 . . . . 0.0 114.107 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.8 m -143.43 74.36 17.19 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 125.972 1.709 . . . . 0.0 110.368 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -61.81 -13.31 29.83 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.236 2.624 . . . . 0.0 113.192 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -89.38 9.58 25.68 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 128.52 2.728 . . . . 0.0 114.614 174.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.8 p -133.28 174.7 10.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.943 1.297 . . . . 0.0 112.009 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -141.36 170.07 16.42 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.882 1.273 . . . . 0.0 113.286 -170.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -120.48 128.95 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.164 1.386 . . . . 0.0 110.532 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.54 -159.61 8.22 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.652 1.596 . . . . 0.0 111.621 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -138.74 141.09 38.87 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.347 1.073 . . . . 0.0 111.956 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.78 -163.73 10.85 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.447 1.499 . . . . 0.0 113.425 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.77 140.14 19.9 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.045 1.338 . . . . 0.0 113.314 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.46 -4.74 73.62 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.686 1.136 . . . . 0.0 114.254 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 49.19 55.02 9.95 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.466 1.906 . . . . 0.0 114.333 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.8 149.05 70.8 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 126.103 1.761 . . . . 0.0 107.843 169.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.63 147.59 51.59 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.147 1.231 . . . . 0.0 109.877 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.26 153.02 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.74 1.616 . . . . 0.0 111.664 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.85 132.01 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.098 0.959 . . . . 0.0 111.158 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.3 mt -137.91 161.8 57.83 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 126.312 1.845 . . . . 0.0 112.053 -169.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.43 165.76 29.48 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.093 2.528 . . . . 0.0 111.944 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.6 123.02 9.1 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.446 2.097 . . . . 0.0 110.45 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -147.66 -88.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.719 0.808 . . . . 0.0 110.609 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -155.48 16.11 0.39 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.481 1.512 . . . . 0.0 112.954 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -65.9 132.7 49.28 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.502 -0.749 . . . . 0.0 111.936 -172.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.79 159.45 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.328 1.451 . . . . 0.0 111.522 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -129.3 145.98 51.27 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.157 1.383 . . . . 0.0 110.003 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.9 m -81.79 133.96 35.39 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.086 0.954 . . . . 0.0 109.735 173.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.45 132.7 54.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.041 1.336 . . . . 0.0 109.516 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 61.1 m -142.14 122.76 14.19 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.007 -1.058 . . . . 0.0 110.617 -173.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.5 mt -62.65 152.98 33.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.66 0.743 . . . . 0.0 112.65 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.9 p -126.17 -179.92 4.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.61 1.964 . . . . 0.0 109.808 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.5 m -61.38 -8.7 4.23 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.18 26.98 0.2 Allowed Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.229 0.919 . . . . 0.0 114.66 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.92 -151.72 11.02 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.946 1.26 . . . . 0.0 112.814 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -131.73 170.21 15.13 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.011 2.124 . . . . 0.0 112.113 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -137.31 152.8 50.15 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.292 2.637 . . . . 0.0 109.127 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.88 118.46 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.638 1.175 . . . . 0.0 109.176 -169.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -134.85 160.18 39.04 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -169.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -62.72 -25.98 68.45 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.626 1.97 . . . . 0.0 116.14 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 128.9 -32.99 3.17 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.054 1.312 . . . . 0.0 113.515 -173.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -113.72 9.86 17.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.298 1.839 . . . . 0.0 113.542 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 62.57 16.55 8.88 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.9 2.08 . . . . 0.0 113.98 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.8 p -70.2 -27.49 64.54 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.716 0.806 . . . . 0.0 112.437 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.0 m -146.0 173.13 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.466 1.506 . . . . 0.0 112.061 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 t -141.77 154.19 45.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.292 2.237 . . . . 0.0 109.596 172.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -69.66 144.31 52.93 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.696 -0.627 . . . . 0.0 110.688 169.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.0 p -155.03 168.59 26.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.498 1.119 . . . . 0.0 112.171 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.4 mt -113.94 163.76 14.69 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.119 1.767 . . . . 0.0 109.564 171.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -97.13 -33.69 11.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.925 0.89 . . . . 0.0 111.793 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -136.57 -6.49 1.97 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.969 2.108 . . . . 0.0 112.123 171.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.1 27.74 11.91 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.17 1.788 . . . . 0.0 114.268 -171.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.8 p -78.03 157.21 29.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.22 1.008 . . . . 0.0 111.995 172.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.48 139.39 58.5 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.235 -0.916 . . . . 0.0 111.736 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.26 0.74 90.05 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.712 1.148 . . . . 0.0 114.703 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.48 144.94 46.02 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.666 1.233 . . . . 0.0 112.834 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.49 120.49 21.79 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 173.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.82 149.8 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.571 0.7 . . . . 0.0 111.382 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 t -130.2 166.66 19.81 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.999 1.72 . . . . 0.0 111.677 -169.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.75 140.26 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.645 1.578 . . . . 0.0 109.184 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 171.32 -161.61 34.12 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 121.528 -0.733 . . . . 0.0 112.663 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.17 152.86 12.83 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 117.667 0.734 . . . . 0.0 111.715 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -51.88 109.28 0.35 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.418 1.487 . . . . 0.0 113.121 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.99 142.92 55.79 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.787 0.835 . . . . 0.0 113.163 -173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.0 t -60.07 -20.57 58.73 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -135.74 -40.26 0.7 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.947 1.299 . . . . 0.0 113.006 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.6 t -91.0 1.26 57.21 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -172.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.77 14.69 1.93 Allowed Glycine 0 CA--C 1.542 1.75 0 C-N-CA 125.115 1.34 . . . . 0.0 116.003 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.69 145.36 49.84 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.395 1.478 . . . . 0.0 111.476 -174.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -140.78 175.09 9.89 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.374 1.87 . . . . 0.0 110.613 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.48 141.03 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.123 1.369 . . . . 0.0 108.977 169.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 mp -121.31 124.37 71.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.649 1.58 . . . . 0.0 107.167 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -149.0 154.24 39.07 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.687 1.195 . . . . 0.0 109.181 -169.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -68.68 154.46 41.9 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.928 -1.107 . . . . 0.0 112.577 -177.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.324 1.85 . . . . 0.0 111.374 171.226 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 111.182 0.067 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.15 3.9 0.27 Allowed Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.311 1.285 . . . . 0.0 116.311 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -134.89 2.95 3.17 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.268 1.427 . . . . 0.0 113.387 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -156.36 179.53 9.16 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.696 1.998 . . . . 0.0 110.693 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -145.35 37.75 1.13 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.023 1.329 . . . . 0.0 112.076 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -133.81 157.89 44.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.901 1.28 . . . . 0.0 113.102 -170.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -145.55 165.08 29.68 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.482 1.513 . . . . 0.0 111.511 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -129.36 11.66 5.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.975 1.71 . . . . 0.0 112.396 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -154.01 168.56 26.03 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.356 2.262 . . . . 0.0 110.88 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -139.71 6.75 2.27 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.18 1.392 . . . . 0.0 113.686 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 m -66.24 -15.97 63.63 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.308 1.443 . . . . 0.0 114.84 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.93 18.77 0.48 Allowed Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.631 1.586 . . . . 0.0 113.906 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -148.52 172.59 14.25 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.375 2.27 . . . . 0.0 109.925 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.1 p -58.39 149.52 59.34 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -71.82 166.63 28.92 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.39 2.727 . . . . 0.0 112.607 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.5 19.13 5.25 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.822 1.249 . . . . 0.0 113.674 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.1 t -144.37 145.56 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.82 2.048 . . . . 0.0 109.758 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.0 t -149.02 12.36 0.85 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.085 1.354 . . . . 0.0 113.631 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.4 mt 55.91 178.71 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.478 1.911 . . . . 0.0 113.854 -172.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 t -159.66 168.91 24.88 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.92 1.288 . . . . 0.0 110.269 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.27 139.67 57.32 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.811 -0.555 . . . . 0.0 111.995 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.76 -163.45 35.25 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.916 0.769 . . . . 0.0 114.51 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -95.1 124.0 38.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.959 0.903 . . . . 0.0 109.77 170.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -133.45 173.25 11.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.552 1.541 . . . . 0.0 112.026 -172.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.4 pt -126.37 152.26 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.95 1.7 . . . . 0.0 108.542 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 mt -123.54 122.95 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -137.74 146.7 44.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.512 0.725 . . . . 0.0 110.836 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -67.01 143.32 56.84 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -63.5 -23.54 67.44 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.882 -0.511 . . . . 0.0 112.212 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.98 112.86 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.453 1.501 . . . . 0.0 108.391 168.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 mp -69.36 165.69 20.2 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.0 1.72 . . . . 0.0 111.968 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.6 p -62.77 161.84 25.74 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.629 1.172 . . . . 0.0 113.296 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -57.32 -23.32 54.01 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.278 2.652 . . . . 0.0 113.758 169.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.7 tpt85 -77.25 -17.02 58.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.057 1.743 . . . . 0.0 113.32 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.16 25.98 15.38 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.098 1.332 . . . . 0.0 113.933 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -124.24 159.45 30.16 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.118 1.367 . . . . 0.0 111.922 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.4 128.65 32.59 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.758 1.223 . . . . 0.0 110.915 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.2 tp -100.2 75.58 1.83 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.437 1.095 . . . . 0.0 111.211 -169.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.39 149.81 28.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.981 1.712 . . . . 0.0 115.041 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 tp -62.38 137.02 58.18 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.261 1.424 . . . . 0.0 110.384 169.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 m -127.61 120.39 28.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.799 1.24 . . . . 0.0 111.287 -174.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -66.18 135.52 95.05 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.095 1.358 . . . . 0.0 112.218 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.1 -13.41 21.22 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.339 2.693 . . . . 0.0 114.666 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.41 7.87 81.82 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.1 0.857 . . . . 0.0 115.035 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -154.77 164.65 38.48 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.239 1.816 . . . . 0.0 111.382 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -98.89 165.78 11.6 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.894 1.278 . . . . 0.0 111.435 -173.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 47.38 43.46 15.38 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.938 1.695 . . . . 0.0 113.494 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.6 m -139.33 137.99 19.9 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 126.381 1.872 . . . . 0.0 109.852 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.79 161.65 3.01 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.766 3.644 . . . . 0.0 115.597 173.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.46 148.55 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.875 1.27 . . . . 0.0 110.599 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 m -123.47 173.84 7.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.055 1.342 . . . . 0.0 111.039 -169.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.19 148.48 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.983 1.313 . . . . 0.0 111.533 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 m -154.34 160.21 31.16 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.153 0.981 . . . . 0.0 113.039 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.27 122.34 9.59 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.896 2.398 . . . . 0.0 110.575 170.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.58 136.54 57.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.379 1.471 . . . . 0.0 112.619 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -133.48 9.52 4.0 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.262 1.425 . . . . 0.0 112.41 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.82 8.09 60.1 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.147 1.356 . . . . 0.0 114.882 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.8 p -69.61 153.48 43.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 112.914 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -62.07 -17.7 58.36 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.93 -23.4 63.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.878 1.271 . . . . 0.0 112.544 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -118.27 4.82 11.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.063 1.745 . . . . 0.0 113.162 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.63 139.92 35.63 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.703 1.201 . . . . 0.0 110.774 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -133.74 171.08 14.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.756 1.265 . . . . 0.0 112.149 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.1 mt -125.88 135.53 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 127.571 2.349 . . . . 0.0 106.657 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.0 tp -136.2 126.3 26.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.113 1.365 . . . . 0.0 109.064 -170.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -142.22 140.63 32.36 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.795 0.838 . . . . 0.0 110.833 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.8 t -65.64 141.04 58.53 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.853 0.461 . . . . 0.0 111.006 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -112.11 -52.87 2.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.437 1.095 . . . . 0.0 110.743 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.97 109.28 4.68 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.591 1.156 . . . . 0.0 110.479 169.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.7 m -58.15 -25.25 61.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.948 0.899 . . . . 0.0 111.399 168.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -63.39 -21.52 66.33 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.0 2.12 . . . . 0.0 113.451 174.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.1 m -130.26 9.7 5.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.043 1.737 . . . . 0.0 113.105 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 45.52 33.32 1.32 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.765 2.026 . . . . 0.0 114.217 -169.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.8 p -87.72 143.15 27.31 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.79 -1.193 . . . . 0.0 112.073 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -140.43 140.23 35.39 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.287 1.435 . . . . 0.0 111.052 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.6 p -77.94 142.24 38.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.498 0.719 . . . . 0.0 111.079 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.1 mm -123.91 124.81 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.172 1.389 . . . . 0.0 109.836 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 m -142.31 145.7 36.31 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 125.437 1.495 . . . . 0.0 109.661 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.76 150.08 27.03 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.73 2.287 . . . . 0.0 111.274 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.5 t -65.05 -30.55 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 121.216 -0.927 . . . . 0.0 111.764 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.18 -11.11 82.82 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.3 m -155.49 63.67 3.74 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 125.525 1.53 . . . . 0.0 111.485 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -63.88 -19.24 66.5 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.994 3.129 . . . . 0.0 113.689 -173.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -68.11 -2.18 7.41 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 128.026 2.53 . . . . 0.0 114.553 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.4 m -132.24 166.58 21.54 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.602 1.961 . . . . 0.0 110.86 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -142.39 171.21 14.36 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.331 1.452 . . . . 0.0 112.946 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.27 126.26 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.837 1.255 . . . . 0.0 110.721 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.43 -158.98 7.91 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.475 1.512 . . . . 0.0 111.676 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -139.59 140.41 37.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.355 1.062 . . . . 0.0 111.555 -170.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.01 -166.06 12.75 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.284 1.421 . . . . 0.0 113.193 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.7 137.19 20.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.258 1.423 . . . . 0.0 113.159 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.9 -6.95 64.7 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.779 1.181 . . . . 0.0 114.183 -172.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 48.88 56.76 7.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.552 1.941 . . . . 0.0 114.216 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.95 151.57 78.22 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 126.292 1.837 . . . . 0.0 108.047 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.02 141.91 54.7 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 120.939 1.092 . . . . 0.0 109.626 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.27 152.71 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.372 1.469 . . . . 0.0 111.032 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 49.9 t -79.63 136.28 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.917 0.887 . . . . 0.0 111.07 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -140.84 165.19 31.32 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.674 1.99 . . . . 0.0 111.861 -170.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.64 176.43 2.27 Favored 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 123.558 2.838 . . . . 0.0 113.501 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.29 43.44 1.49 Allowed 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.78 2.987 . . . . 0.0 113.527 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -80.7 13.71 2.45 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.746 1.618 . . . . 0.0 114.407 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 70.74 44.69 0.62 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.714 2.405 . . . . 0.0 113.588 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -64.25 143.8 57.62 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.741 0.817 . . . . 0.0 111.273 169.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.6 m -141.86 156.21 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.403 1.081 . . . . 0.0 112.399 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -127.2 140.95 51.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.075 1.35 . . . . 0.0 111.176 170.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.8 m -78.88 127.04 31.5 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.741 1.216 . . . . 0.0 109.149 172.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.3 mt -115.39 128.64 56.2 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.809 0.843 . . . . 0.0 109.575 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.1 m -131.34 118.27 20.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.243 1.017 . . . . 0.0 110.189 -169.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.7 tp -66.03 145.73 55.52 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.761 -0.587 . . . . 0.0 111.17 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.0 p -127.55 175.35 8.32 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.963 1.705 . . . . 0.0 110.527 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.5 p -57.83 -16.51 11.85 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -155.06 23.74 0.6 Allowed Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.629 1.109 . . . . 0.0 114.565 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.95 -149.83 9.48 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.877 1.227 . . . . 0.0 112.607 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -134.0 171.11 14.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.186 2.194 . . . . 0.0 111.574 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -136.78 154.46 50.55 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.364 2.266 . . . . 0.0 109.95 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.5 mt -134.45 121.04 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.133 1.373 . . . . 0.0 109.355 -169.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -137.0 158.3 44.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.567 1.147 . . . . 0.0 112.614 -170.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.3 -33.38 75.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -171.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.21 -31.36 2.7 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.283 1.42 . . . . 0.0 113.772 -169.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -104.19 -2.21 26.07 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.539 1.536 . . . . 0.0 113.887 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 64.82 13.04 8.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.295 2.238 . . . . 0.0 114.128 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.4 p -69.98 -21.26 63.25 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.588 1.155 . . . . 0.0 112.824 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.89 169.6 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.486 1.515 . . . . 0.0 112.661 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.9 t -140.67 153.71 46.1 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.919 2.487 . . . . 0.0 109.66 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -69.9 144.8 52.35 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.455 -0.778 . . . . 0.0 110.137 168.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.7 p -149.34 171.6 16.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.378 1.071 . . . . 0.0 112.993 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.5 mt -125.15 165.7 17.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.108 1.763 . . . . 0.0 109.625 172.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -105.19 -32.71 8.53 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.904 0.882 . . . . 0.0 111.94 -169.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -140.24 -10.08 1.12 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.757 2.023 . . . . 0.0 112.662 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.68 27.13 12.15 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.569 1.548 . . . . 0.0 114.24 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.9 p -78.31 157.62 29.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.415 1.086 . . . . 0.0 111.807 170.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.87 141.57 58.73 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.259 -0.901 . . . . 0.0 112.161 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.27 4.96 89.22 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.5 1.048 . . . . 0.0 114.458 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -75.13 137.45 41.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.769 1.228 . . . . 0.0 112.402 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.41 128.28 35.15 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.508 -0.745 . . . . 0.0 110.569 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.5 t -64.23 150.71 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.229 0.612 . . . . 0.0 110.557 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.4 t -126.95 161.96 27.08 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.823 1.249 . . . . 0.0 111.796 -175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.7 mt -134.21 142.04 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.98 1.712 . . . . 0.0 108.78 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.84 -156.71 28.81 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 124.631 1.11 . . . . 0.0 110.716 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.77 166.43 1.91 Allowed 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.717 1.259 . . . . 0.0 111.685 169.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -56.35 157.01 5.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.06 0.944 . . . . 0.0 112.82 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.53 136.16 51.34 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.607 1.163 . . . . 0.0 112.312 -172.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.1 t -55.59 -26.84 45.98 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.254 1.822 . . . . 0.0 115.834 -169.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -130.16 -32.82 1.78 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.094 0.958 . . . . 0.0 113.385 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 96.6 p -103.87 -2.25 26.52 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.8 27.76 1.1 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 125.955 1.74 . . . . 0.0 114.859 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -147.64 142.1 26.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.765 2.026 . . . . 0.0 110.943 -169.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -140.74 175.75 9.36 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.956 1.702 . . . . 0.0 111.21 -168.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.55 140.16 26.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.735 1.214 . . . . 0.0 109.299 169.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.62 125.05 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 125.677 1.591 . . . . 0.0 107.354 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -148.98 153.62 38.2 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.8 1.24 . . . . 0.0 109.673 -171.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -67.9 155.22 39.9 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.998 -1.064 . . . . 0.0 112.882 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.328 1.851 . . . . 0.0 111.217 171.154 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.9 -171.53 40.33 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.676 1.131 . . . . 0.0 112.619 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -135.08 9.12 3.5 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.887 1.275 . . . . 0.0 113.276 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -156.93 179.62 9.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.212 1.805 . . . . 0.0 111.552 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -132.16 10.59 4.55 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.478 1.511 . . . . 0.0 113.469 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -73.18 -21.25 60.72 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.508 1.123 . . . . 0.0 113.889 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -141.12 5.72 1.92 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.407 1.483 . . . . 0.0 113.184 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -144.62 174.24 11.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.341 1.857 . . . . 0.0 111.426 -172.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -141.79 169.45 17.57 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.605 1.162 . . . . 0.0 111.633 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.4 m80 54.65 16.64 1.42 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.304 1.841 . . . . 0.0 115.0 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.4 m -136.78 19.29 3.05 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.692 1.997 . . . . 0.0 112.307 -172.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.56 -20.47 0.07 OUTLIER Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.906 1.717 . . . . 0.0 113.858 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -144.67 161.53 38.94 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.026 1.73 . . . . 0.0 111.224 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.4 p -153.27 159.05 32.66 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.848 1.659 . . . . 0.0 111.84 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -52.99 142.61 52.81 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.615 2.877 . . . . 0.0 114.165 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.59 31.36 0.98 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.623 1.169 . . . . 0.0 113.621 -176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.18 151.17 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.364 1.465 . . . . 0.0 110.609 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -141.63 -4.52 1.09 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.3 mt 58.37 173.67 0.06 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.855 2.062 . . . . 0.0 114.131 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 t -159.92 168.21 26.24 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.215 1.406 . . . . 0.0 109.861 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.85 137.2 57.62 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.653 -0.654 . . . . 0.0 112.176 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.73 -162.88 35.41 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.968 0.794 . . . . 0.0 114.604 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -97.14 124.91 41.32 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.215 1.006 . . . . 0.0 109.978 172.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -133.88 173.11 11.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.637 1.575 . . . . 0.0 112.235 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.8 pt -125.88 151.66 32.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 126.051 1.74 . . . . 0.0 108.452 170.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 mt -124.64 119.17 55.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -137.63 148.11 45.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.776 0.83 . . . . 0.0 110.581 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -72.79 149.11 43.92 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.176 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -61.81 -24.94 67.19 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.686 -0.633 . . . . 0.0 112.569 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.0 t -83.73 122.02 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.545 1.538 . . . . 0.0 109.671 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.96 168.39 17.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.812 1.645 . . . . 0.0 112.416 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.5 p -66.91 161.16 64.64 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.157 1.383 . . . . 0.0 113.159 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.1 -17.85 51.0 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.655 2.237 . . . . 0.0 113.096 169.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -73.93 -22.24 59.75 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.995 1.318 . . . . 0.0 112.781 169.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.67 24.33 9.39 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.156 1.36 . . . . 0.0 113.852 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.98 172.28 10.6 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.629 1.171 . . . . 0.0 111.903 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -54.69 144.75 21.05 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 121.409 -0.807 . . . . 0.0 110.584 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -119.85 83.11 1.99 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.828 1.251 . . . . 0.0 109.815 -168.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.38 150.83 19.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -168.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.3 tp -60.45 135.63 57.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.806 1.242 . . . . 0.0 110.032 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -129.97 121.06 25.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.803 1.241 . . . . 0.0 111.247 -173.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -65.03 136.29 96.69 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.956 1.302 . . . . 0.0 112.458 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.07 -13.31 21.3 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.51 2.807 . . . . 0.0 114.688 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.01 7.42 80.68 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 124.223 0.916 . . . . 0.0 115.071 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -153.92 166.59 32.48 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.351 1.86 . . . . 0.0 111.299 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -102.57 166.64 10.41 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.743 1.217 . . . . 0.0 111.545 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 51.15 40.93 27.04 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.773 1.629 . . . . 0.0 112.425 -174.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.9 m -141.16 137.89 17.26 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 126.139 1.776 . . . . 0.0 110.47 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -52.71 158.17 6.49 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.736 3.624 . . . . 0.0 115.43 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 t -110.26 148.99 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.861 1.264 . . . . 0.0 110.74 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 52' ' ' VAL . 1.3 m -121.66 176.5 5.68 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.216 1.407 . . . . 0.0 111.494 -169.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.461 ' H ' HG22 ' A' ' 51' ' ' THR . 0.3 OUTLIER -131.34 146.04 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.109 1.364 . . . . 0.0 111.647 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.1 m -153.79 163.06 25.13 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.469 1.108 . . . . 0.0 113.303 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -60.49 124.38 14.98 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.394 2.73 . . . . 0.0 110.418 168.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.46 136.21 57.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.33 1.052 . . . . 0.0 111.786 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -132.81 7.72 4.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.023 1.329 . . . . 0.0 112.449 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.53 9.61 58.78 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.92 1.247 . . . . 0.0 114.592 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.0 p -68.77 154.3 42.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.26 1.424 . . . . 0.0 112.729 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.4 p -62.54 -17.12 59.2 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -70.48 -24.41 62.86 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.858 1.263 . . . . 0.0 112.402 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.23 3.14 12.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.04 1.736 . . . . 0.0 113.235 -176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.89 140.26 32.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 110.558 171.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -134.15 171.31 14.41 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.763 1.268 . . . . 0.0 111.7 -169.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.4 mt -125.92 136.28 61.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 127.052 2.141 . . . . 0.0 106.566 -175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.6 tp -137.41 124.47 21.53 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.1 1.36 . . . . 0.0 108.901 -169.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -142.62 134.26 26.67 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.768 0.827 . . . . 0.0 110.946 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.3 t -63.78 137.03 57.88 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.998 0.519 . . . . 0.0 110.853 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -112.79 -47.38 3.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.324 1.05 . . . . 0.0 111.691 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.46 111.46 4.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.302 1.441 . . . . 0.0 110.708 170.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.2 m -58.99 -24.32 62.61 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.987 0.915 . . . . 0.0 111.533 168.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -64.18 -21.82 66.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.872 2.069 . . . . 0.0 113.522 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 m -130.33 11.75 5.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.684 1.594 . . . . 0.0 112.853 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 44.09 32.26 0.63 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.592 1.957 . . . . 0.0 113.509 -169.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 p -87.11 139.82 30.18 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.163 -0.96 . . . . 0.0 111.876 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -135.44 141.92 45.5 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.636 1.574 . . . . 0.0 110.978 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -77.5 145.72 36.82 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.808 0.443 . . . . 0.0 110.849 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.8 mm -127.14 126.73 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.32 1.448 . . . . 0.0 109.673 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 57.1 m -144.01 147.94 40.0 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 126.103 1.761 . . . . 0.0 109.578 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.63 149.93 24.11 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.887 2.392 . . . . 0.0 111.445 175.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.91 -29.72 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.058 -1.026 . . . . 0.0 111.811 173.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.21 -13.97 81.12 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 115.424 0.929 . . . . 0.0 115.424 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.0 m -151.98 62.48 4.72 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 125.682 1.593 . . . . 0.0 111.536 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.13 -13.65 39.04 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.414 2.742 . . . . 0.0 114.034 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -73.18 6.33 2.86 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.425 1.89 . . . . 0.0 114.063 170.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -138.89 166.31 24.79 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.295 1.838 . . . . 0.0 111.088 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -136.56 171.23 14.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.348 1.459 . . . . 0.0 113.089 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.6 mm -120.9 130.62 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.143 1.377 . . . . 0.0 110.929 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.75 -156.15 6.9 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.917 1.722 . . . . 0.0 111.834 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -142.6 142.37 32.12 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.402 1.081 . . . . 0.0 111.518 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.22 -166.44 13.13 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.31 1.433 . . . . 0.0 113.401 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.2 138.65 20.13 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.085 1.354 . . . . 0.0 113.221 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.7 -6.57 67.58 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.724 1.154 . . . . 0.0 114.089 -172.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 49.67 56.54 7.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.578 1.951 . . . . 0.0 114.21 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.08 150.23 75.48 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 126.153 1.781 . . . . 0.0 108.127 169.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.94 142.38 56.73 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.192 1.261 . . . . 0.0 109.693 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.28 148.16 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.724 1.61 . . . . 0.0 111.096 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.73 138.8 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.938 0.895 . . . . 0.0 110.575 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.7 mt -140.53 161.74 53.05 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.31 1.844 . . . . 0.0 111.013 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.12 164.83 30.56 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.94 2.427 . . . . 0.0 111.879 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.23 119.55 6.07 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.528 2.152 . . . . 0.0 110.47 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -147.5 -89.6 0.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.821 0.848 . . . . 0.0 110.977 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -155.91 17.25 0.37 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.117 1.367 . . . . 0.0 113.235 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -67.56 135.86 53.61 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.525 -0.735 . . . . 0.0 112.075 -173.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.7 m -145.03 159.83 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.034 1.334 . . . . 0.0 112.646 -175.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -129.55 136.28 49.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.538 1.535 . . . . 0.0 110.925 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.3 m -74.35 128.98 36.91 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 109.437 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -118.01 125.81 51.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.175 0.99 . . . . 0.0 109.335 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.0 m -130.52 118.32 20.91 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.272 1.029 . . . . 0.0 111.155 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.99 148.39 51.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.641 0.776 . . . . 0.0 111.34 173.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.8 p -132.26 174.42 10.24 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.035 1.734 . . . . 0.0 110.35 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.8 m -61.67 -10.39 8.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.54 36.71 0.39 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.396 0.998 . . . . 0.0 113.944 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.24 -166.57 34.72 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.793 1.187 . . . . 0.0 112.708 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -121.23 166.83 13.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.484 1.914 . . . . 0.0 111.293 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -135.09 152.31 51.54 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.592 1.557 . . . . 0.0 110.454 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.58 117.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.136 1.374 . . . . 0.0 109.263 -169.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -136.48 157.73 46.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.66 1.184 . . . . 0.0 112.373 -169.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -63.72 -31.06 72.12 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -171.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.14 -26.14 3.27 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.313 1.435 . . . . 0.0 114.175 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -113.62 1.21 14.86 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.112 1.765 . . . . 0.0 114.0 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 64.32 12.87 7.57 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.453 2.301 . . . . 0.0 114.239 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.3 p -73.22 -22.37 60.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.163 0.985 . . . . 0.0 112.9 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 m -144.69 170.85 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.66 1.584 . . . . 0.0 112.437 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.5 t -144.27 150.43 37.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 129.215 3.006 . . . . 0.0 108.885 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.5 m0 -69.94 145.87 51.57 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.16 -0.962 . . . . 0.0 110.52 169.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.0 p -156.41 174.22 15.74 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.805 1.242 . . . . 0.0 112.575 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -120.35 171.87 8.21 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.144 1.777 . . . . 0.0 110.059 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -108.27 -31.83 7.72 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.968 1.307 . . . . 0.0 110.811 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -142.83 -13.34 0.75 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 127.425 2.29 . . . . 0.0 112.96 169.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.93 22.04 8.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.615 1.966 . . . . 0.0 114.729 -170.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.7 p -70.7 158.28 36.53 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.64 1.176 . . . . 0.0 111.944 170.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.56 136.84 57.44 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.244 -0.91 . . . . 0.0 111.886 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.09 0.74 89.67 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.644 1.116 . . . . 0.0 114.367 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -72.32 138.86 47.62 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.806 1.303 . . . . 0.0 112.584 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.9 125.41 28.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.463 0.705 . . . . 0.0 110.26 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.0 153.56 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.596 0.713 . . . . 0.0 110.315 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.1 m -135.34 165.19 26.03 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.193 1.397 . . . . 0.0 111.572 -172.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.8 mt -134.07 142.2 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.262 1.425 . . . . 0.0 108.96 -175.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.91 179.54 48.02 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 124.602 1.096 . . . . 0.0 111.496 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.48 -40.83 62.8 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.005 1.402 . . . . 0.0 114.274 -173.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -169.6 174.11 6.02 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.857 2.463 . . . . 0.0 111.61 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.27 150.63 39.52 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.574 1.149 . . . . 0.0 111.908 169.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -83.06 -7.02 59.7 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -169.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -142.38 -40.93 0.34 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.205 1.002 . . . . 0.0 112.524 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.9 p -95.3 3.54 54.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.432 1.493 . . . . 0.0 114.212 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.29 22.91 0.61 Allowed Glycine 0 CA--C 1.544 1.87 0 C-N-CA 125.818 1.675 . . . . 0.0 115.802 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -147.58 143.98 28.14 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.836 1.655 . . . . 0.0 111.066 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -136.45 175.54 9.52 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.398 1.879 . . . . 0.0 111.338 -169.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.45 137.76 25.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.653 1.181 . . . . 0.0 109.373 169.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -116.01 124.24 72.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 125.916 1.686 . . . . 0.0 107.14 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.6 153.09 38.98 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.845 1.258 . . . . 0.0 109.497 -171.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.08 155.4 39.63 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.008 -1.057 . . . . 0.0 112.803 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.3 t . . . . . 0 C--O 1.252 1.21 0 C-N-CA 126.121 1.769 . . . . 0.0 111.292 171.879 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.98 175.02 47.28 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.398 0.999 . . . . 0.0 113.466 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -139.8 0.47 1.8 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.914 1.285 . . . . 0.0 113.621 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -151.88 157.42 41.83 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.964 1.706 . . . . 0.0 110.301 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.7 t60 52.72 25.41 3.76 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.866 1.666 . . . . 0.0 114.667 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -142.13 4.97 1.67 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.531 1.532 . . . . 0.0 113.119 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -59.54 -21.52 60.37 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.906 -1.121 . . . . 0.0 113.9 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -54.68 -15.2 1.68 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.162 2.185 . . . . 0.0 114.534 170.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -98.3 -5.6 32.66 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.469 1.508 . . . . 0.0 114.029 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -136.31 -5.36 2.07 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 t -142.03 155.09 45.41 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.471 1.508 . . . . 0.0 111.886 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.67 27.66 0.11 Allowed Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.203 1.382 . . . . 0.0 113.881 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -132.89 7.4 4.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.143 1.377 . . . . 0.0 113.575 -169.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.4 m -137.38 155.53 75.56 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 126.281 1.832 . . . . 0.0 111.563 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.79 160.62 47.47 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.046 2.497 . . . . 0.0 113.588 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.41 32.01 1.08 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.859 1.664 . . . . 0.0 111.985 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -137.62 167.04 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 126.597 1.959 . . . . 0.0 109.749 -169.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.0 t -127.63 18.99 6.78 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.68 1.592 . . . . 0.0 113.097 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.6 mt 62.29 164.88 0.1 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.012 2.525 . . . . 0.0 114.761 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.6 t -161.58 170.46 19.78 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.302 1.841 . . . . 0.0 109.232 174.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.03 134.12 54.39 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.564 -0.71 . . . . 0.0 112.308 173.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.08 -161.24 34.2 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.114 0.864 . . . . 0.0 114.311 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -100.49 125.8 46.85 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.125 0.97 . . . . 0.0 110.213 173.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -134.86 172.76 12.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.537 1.535 . . . . 0.0 112.514 -170.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.97 154.69 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 126.461 1.904 . . . . 0.0 108.657 170.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 mt -129.92 118.92 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -141.61 153.37 44.73 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.68 0.792 . . . . 0.0 112.237 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -84.11 138.35 33.08 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.793 -0.567 . . . . 0.0 112.031 -172.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -63.36 -19.83 64.99 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.3 t -66.09 -25.71 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.908 0.883 . . . . 0.0 112.319 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.5 mt 59.77 170.64 0.08 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.82 2.048 . . . . 0.0 113.748 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.0 t -73.68 145.24 84.24 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.222 1.009 . . . . 0.0 111.449 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -64.6 -13.26 37.86 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.027 2.485 . . . . 0.0 112.913 169.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 -68.61 -16.8 63.97 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.977 1.311 . . . . 0.0 112.811 169.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.72 25.2 21.21 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.584 1.564 . . . . 0.0 113.7 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -133.44 173.67 11.24 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.77 1.228 . . . . 0.0 111.382 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -54.93 156.28 3.88 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.427 -0.796 . . . . 0.0 111.589 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.9 tp -130.04 71.19 1.44 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.681 1.193 . . . . 0.0 110.151 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.89 150.85 30.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.876 1.27 . . . . 0.0 113.12 -170.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.2 tp -61.44 139.56 58.19 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.256 1.022 . . . . 0.0 110.016 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.2 m -130.7 122.12 26.74 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.564 1.145 . . . . 0.0 111.584 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -64.24 135.52 96.37 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.637 1.175 . . . . 0.0 112.061 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.07 -13.68 21.2 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.428 2.752 . . . . 0.0 114.852 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.35 7.28 76.63 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.083 0.849 . . . . 0.0 114.957 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -156.01 164.46 38.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.583 1.553 . . . . 0.0 112.085 -174.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -90.77 164.47 14.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.442 1.097 . . . . 0.0 111.761 -174.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 49.48 39.38 16.59 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.843 1.657 . . . . 0.0 113.586 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.9 m -136.5 140.73 33.23 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.674 1.59 . . . . 0.0 111.198 -169.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -45.55 156.58 0.37 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 126.093 4.528 . . . . 0.0 115.277 169.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.92 150.74 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.719 1.207 . . . . 0.0 110.065 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.9 m -124.44 176.05 6.74 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.744 1.618 . . . . 0.0 110.265 -169.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.09 147.53 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.679 1.127 . . . . 0.0 112.1 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 m -150.84 160.83 31.63 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.94 1.296 . . . . 0.0 111.795 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -64.22 134.21 41.35 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.009 1.806 . . . . 0.0 111.613 170.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.6 tp -67.53 137.73 55.97 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.645 0.778 . . . . 0.0 111.515 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -138.29 8.81 2.7 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.864 1.265 . . . . 0.0 112.98 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.46 -7.07 58.89 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 125.058 1.313 . . . . 0.0 115.095 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -67.05 145.81 54.98 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.549 1.174 . . . . 0.0 111.827 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.4 p -60.33 -12.3 8.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.756 1.622 . . . . 0.0 114.96 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -68.66 -23.7 64.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.216 1.006 . . . . 0.0 112.36 174.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -114.76 4.5 14.98 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.573 1.549 . . . . 0.0 113.231 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.1 140.9 36.72 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.045 0.938 . . . . 0.0 111.126 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -134.14 170.56 15.49 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 122.83 1.3 . . . . 0.0 111.94 -169.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.58 135.34 62.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 127.485 2.314 . . . . 0.0 106.208 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.3 tp -136.62 124.17 22.24 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.044 1.338 . . . . 0.0 108.561 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -142.33 139.31 31.77 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.347 0.659 . . . . 0.0 111.048 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 t -64.59 138.55 58.47 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.966 0.506 . . . . 0.0 110.735 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -110.23 -53.03 2.72 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.453 1.101 . . . . 0.0 111.047 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.14 109.97 5.08 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.024 1.329 . . . . 0.0 110.648 169.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.4 m -57.73 -23.51 52.27 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.997 0.919 . . . . 0.0 111.748 168.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -65.21 -22.18 66.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.061 2.144 . . . . 0.0 113.439 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 m -130.32 12.03 5.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.145 1.778 . . . . 0.0 112.784 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 42.74 34.96 0.64 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.938 2.095 . . . . 0.0 113.412 -169.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -86.03 143.96 27.83 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 120.966 -1.084 . . . . 0.0 112.391 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -138.54 140.49 39.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.25 1.42 . . . . 0.0 111.068 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.8 p -77.84 146.36 35.75 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.206 0.603 . . . . 0.0 110.75 171.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.3 mm -130.79 120.46 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.284 1.433 . . . . 0.0 110.426 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.9 m -141.71 148.77 51.04 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.367 1.467 . . . . 0.0 110.343 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.08 148.34 24.49 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.841 2.361 . . . . 0.0 111.674 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.28 -31.12 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 121.198 -0.939 . . . . 0.0 111.881 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.74 -23.56 72.23 Favored Glycine 0 CA--C 1.539 1.543 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.1 m -144.43 60.66 7.92 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.315 1.446 . . . . 0.0 112.352 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.69 -12.1 26.96 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.502 2.801 . . . . 0.0 114.143 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -75.63 14.46 0.63 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.812 2.045 . . . . 0.0 113.336 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -142.32 171.61 13.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.995 2.118 . . . . 0.0 111.289 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -144.08 167.03 23.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.946 1.299 . . . . 0.0 112.027 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -118.38 131.74 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.517 1.127 . . . . 0.0 111.185 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -148.63 -157.72 7.69 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.952 1.739 . . . . 0.0 111.284 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -141.59 145.19 34.76 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.265 1.032 . . . . 0.0 111.802 -174.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.4 -164.22 11.75 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.491 1.52 . . . . 0.0 112.955 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.62 138.3 23.11 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.957 1.303 . . . . 0.0 113.045 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.63 -3.51 63.18 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.684 1.135 . . . . 0.0 114.322 -173.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 47.56 55.19 8.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.295 1.838 . . . . 0.0 113.713 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.91 138.76 31.49 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 127.693 2.397 . . . . 0.0 107.45 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.27 142.48 55.34 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 N-CA-C 109.206 -1.113 . . . . 0.0 109.206 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 m -133.27 151.08 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.139 1.376 . . . . 0.0 111.627 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.19 136.53 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.753 0.821 . . . . 0.0 110.783 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.9 mt -139.41 163.76 43.29 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 127.154 2.182 . . . . 0.0 110.286 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.16 159.31 53.67 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.153 1.902 . . . . 0.0 111.464 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -71.4 118.18 5.53 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.744 2.296 . . . . 0.0 110.294 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -145.47 -88.76 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.763 0.825 . . . . 0.0 111.018 -175.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -155.21 15.89 0.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.932 1.293 . . . . 0.0 113.387 -173.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -69.93 133.81 47.71 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.437 -0.789 . . . . 0.0 111.581 -175.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.0 m -141.8 160.99 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.422 1.089 . . . . 0.0 112.441 -174.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -129.06 134.85 48.27 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.339 1.456 . . . . 0.0 110.441 170.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.3 m -75.66 129.8 37.71 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.388 1.075 . . . . 0.0 109.406 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.1 mt -120.46 132.23 55.12 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.207 1.003 . . . . 0.0 109.786 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.1 m -133.2 118.26 18.42 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.194 0.998 . . . . 0.0 110.357 -170.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.28 137.27 58.23 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.862 1.265 . . . . 0.0 110.449 171.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 p -126.46 173.17 9.59 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.239 1.415 . . . . 0.0 111.798 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.4 m -58.13 -10.18 1.79 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.0 36.82 0.33 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.128 1.347 . . . . 0.0 113.251 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.78 -150.2 17.42 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.398 1.099 . . . . 0.0 114.148 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -132.83 169.59 16.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.949 2.499 . . . . 0.0 110.564 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -135.22 150.81 50.16 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.901 2.081 . . . . 0.0 109.451 171.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.1 mt -133.32 119.94 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.207 1.403 . . . . 0.0 109.515 -169.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -137.07 157.06 47.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.201 1.0 . . . . 0.0 112.552 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.09 -31.68 71.36 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.6 -40.28 1.63 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.798 1.666 . . . . 0.0 113.175 -172.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.3 -10.08 59.75 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.6 1.16 . . . . 0.0 113.946 173.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 67.39 12.95 9.18 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.798 2.039 . . . . 0.0 112.758 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.5 p -73.24 -23.97 60.42 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.281 1.432 . . . . 0.0 112.692 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.3 m -142.83 170.39 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.863 1.665 . . . . 0.0 112.025 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.4 t -142.15 151.81 42.6 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 128.903 2.881 . . . . 0.0 109.359 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -70.02 143.55 52.51 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 119.153 0.888 . . . . 0.0 111.29 169.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.6 p -152.08 170.81 19.03 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.822 1.249 . . . . 0.0 112.969 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.89 166.23 18.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.185 1.794 . . . . 0.0 110.111 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -109.02 -32.35 7.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.969 0.908 . . . . 0.0 111.689 -169.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -139.5 -10.89 1.21 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.436 1.894 . . . . 0.0 112.729 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.3 23.97 7.77 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.993 1.717 . . . . 0.0 114.685 -170.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.7 p -70.52 153.12 43.25 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.028 -1.045 . . . . 0.0 111.457 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.18 137.91 57.92 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.116 -0.99 . . . . 0.0 111.444 172.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.19 0.3 88.7 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.472 1.034 . . . . 0.0 114.251 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -69.56 142.38 53.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.873 1.337 . . . . 0.0 112.609 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.14 116.48 16.87 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.385 -0.822 . . . . 0.0 109.693 170.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.36 150.1 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.573 0.749 . . . . 0.0 111.59 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 57.5 m -129.81 169.54 15.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.591 1.556 . . . . 0.0 111.468 -169.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.6 mt -135.26 143.63 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.338 1.455 . . . . 0.0 108.862 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.35 179.12 47.49 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.672 1.13 . . . . 0.0 111.666 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.69 -41.98 61.84 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.092 1.446 . . . . 0.0 114.271 -172.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -168.81 172.28 7.93 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.915 2.486 . . . . 0.0 109.818 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.07 138.62 33.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.144 0.978 . . . . 0.0 112.436 169.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.0 t -62.97 -14.75 51.38 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -169.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.43 -36.89 0.43 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.38 1.072 . . . . 0.0 112.958 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.8 p -98.33 2.27 47.89 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.362 1.465 . . . . 0.0 114.529 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.33 12.64 1.76 Allowed Glycine 0 CA--C 1.544 1.86 0 C-N-CA 125.547 1.546 . . . . 0.0 116.202 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -135.48 145.34 47.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.22 1.808 . . . . 0.0 111.364 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -139.35 175.87 9.19 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.335 1.454 . . . . 0.0 111.98 -169.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.65 138.99 38.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.764 1.225 . . . . 0.0 109.421 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.5 125.74 74.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 125.404 1.481 . . . . 0.0 107.276 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -148.93 153.99 38.78 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.798 1.239 . . . . 0.0 109.304 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -67.49 155.86 38.05 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.094 -1.004 . . . . 0.0 112.827 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.073 1.749 . . . . 0.0 111.278 172.223 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 119.234 -0.412 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.45 18.8 0.02 OUTLIER Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.595 0.998 . . . . 0.0 115.595 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.4 t60 52.11 26.2 3.71 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.163 1.785 . . . . 0.0 114.737 -173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -58.53 149.09 26.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.318 1.047 . . . . 0.0 111.528 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.8 m80 49.13 27.3 1.72 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.02 1.328 . . . . 0.0 113.924 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.5 p80 45.81 14.98 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 128.768 2.827 . . . . 0.0 116.48 -169.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -159.71 124.33 3.92 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.036 1.334 . . . . 0.0 111.836 -174.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -143.18 -2.26 1.01 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.909 1.284 . . . . 0.0 114.063 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.422 ' CD2' ' H ' ' A' ' 11' ' ' SER . 26.5 t60 -157.18 161.78 39.31 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.267 1.827 . . . . 0.0 110.29 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -60.99 -35.13 76.01 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.666 0.786 . . . . 0.0 112.787 175.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.422 ' H ' ' CD2' ' A' ' 9' ' ' HIS . 49.4 m 50.45 28.67 3.46 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.384 1.873 . . . . 0.0 114.948 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.21 21.66 0.57 Allowed Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.405 1.479 . . . . 0.0 113.856 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.49 -16.47 60.78 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.241 1.416 . . . . 0.0 113.485 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -147.74 155.73 44.8 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.988 2.115 . . . . 0.0 111.219 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.56 167.85 24.29 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.837 2.358 . . . . 0.0 112.13 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.16 31.07 2.17 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.872 1.269 . . . . 0.0 112.288 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.74 150.91 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.697 1.599 . . . . 0.0 109.909 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 t -133.8 -4.22 2.86 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.436 1.094 . . . . 0.0 113.662 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.7 mt 63.62 165.41 0.13 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.796 2.438 . . . . 0.0 114.69 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 t -160.78 170.95 19.69 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.141 1.776 . . . . 0.0 109.414 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.22 133.1 49.92 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.631 -0.668 . . . . 0.0 111.656 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.25 -163.01 35.78 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.975 0.798 . . . . 0.0 114.183 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -98.63 125.64 43.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.826 0.851 . . . . 0.0 109.98 171.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -134.3 172.75 12.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.332 1.453 . . . . 0.0 112.284 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.0 pt -125.46 156.64 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 126.352 1.861 . . . . 0.0 109.058 171.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.8 mt -130.08 119.76 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -142.28 152.24 42.81 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.712 0.805 . . . . 0.0 112.346 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -84.3 137.81 33.25 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.871 -0.518 . . . . 0.0 111.736 -174.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -59.34 -19.54 47.41 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.3 t -67.3 -24.94 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.448 1.099 . . . . 0.0 112.834 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.35 168.61 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.575 1.95 . . . . 0.0 113.846 -170.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.0 p -73.84 159.36 84.45 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.212 1.005 . . . . 0.0 112.372 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.95 -15.31 43.36 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.456 2.104 . . . . 0.0 112.612 169.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -74.61 -17.22 60.74 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.516 1.526 . . . . 0.0 113.042 171.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.71 23.64 17.85 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.066 1.317 . . . . 0.0 113.897 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -131.98 173.76 10.87 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.721 1.208 . . . . 0.0 111.972 -174.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -55.83 142.62 34.3 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.228 -0.92 . . . . 0.0 111.21 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.6 tp -118.53 76.51 1.09 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.395 1.478 . . . . 0.0 109.737 -170.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.98 148.2 26.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -59.3 135.25 57.59 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.006 1.323 . . . . 0.0 110.058 169.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 m -126.82 121.09 30.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.974 1.31 . . . . 0.0 110.877 -174.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -63.94 138.02 97.27 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.224 1.409 . . . . 0.0 111.913 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.03 -13.56 21.32 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.418 2.745 . . . . 0.0 114.845 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.87 4.43 72.42 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.481 1.039 . . . . 0.0 114.955 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.4 ptt-85 -156.14 172.95 17.55 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.294 1.838 . . . . 0.0 111.565 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -101.04 168.79 9.37 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.837 1.255 . . . . 0.0 111.396 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 50.04 35.08 9.15 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.002 2.121 . . . . 0.0 113.849 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.9 m -133.67 141.73 41.18 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.693 1.597 . . . . 0.0 111.274 -169.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -45.72 160.27 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.859 1 C-N-CA 126.174 4.582 . . . . 0.0 115.259 169.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.4 t -116.11 154.73 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.606 1.162 . . . . 0.0 109.964 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -128.5 172.04 11.52 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.429 1.492 . . . . 0.0 110.857 -169.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.61 149.23 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.902 1.281 . . . . 0.0 111.478 176.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 m -157.14 161.36 29.57 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.402 1.081 . . . . 0.0 113.122 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.04 122.28 11.42 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.779 2.986 . . . . 0.0 111.449 169.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.9 tp -59.01 138.45 57.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.2 1.0 . . . . 0.0 111.81 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -132.71 5.15 3.94 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.944 1.298 . . . . 0.0 112.756 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.6 7.33 60.96 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.784 1.183 . . . . 0.0 114.742 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.9 p -67.27 153.9 42.59 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.032 1.333 . . . . 0.0 112.541 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.7 p -62.49 -17.3 59.32 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -70.84 -22.3 62.34 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.552 1.141 . . . . 0.0 112.338 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.23 1.42 11.88 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.483 1.513 . . . . 0.0 113.638 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.34 146.08 27.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.522 1.129 . . . . 0.0 111.018 171.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -138.15 172.44 12.92 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.582 1.182 . . . . 0.0 111.901 -169.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.8 mt -119.6 136.79 55.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.847 2.459 . . . . 0.0 106.792 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.2 tp -135.99 128.21 29.98 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.132 1.373 . . . . 0.0 109.311 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.09 140.67 29.61 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.875 0.87 . . . . 0.0 110.785 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.9 t -66.01 140.31 58.28 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.726 0.41 . . . . 0.0 110.758 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -109.68 -52.73 2.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.544 1.138 . . . . 0.0 110.47 173.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.17 108.48 4.27 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.48 1.112 . . . . 0.0 110.691 169.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -57.44 -25.5 59.74 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.964 0.906 . . . . 0.0 111.56 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -62.85 -20.51 65.17 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.052 2.141 . . . . 0.0 113.535 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -130.23 9.01 5.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.132 1.773 . . . . 0.0 112.671 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 47.5 29.28 1.34 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.372 1.869 . . . . 0.0 114.325 -169.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.9 p -87.48 144.73 26.58 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.686 -1.259 . . . . 0.0 112.193 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -139.43 142.62 37.42 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.576 1.55 . . . . 0.0 111.288 -176.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.2 p -81.28 149.64 28.89 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.414 0.685 . . . . 0.0 110.882 171.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.5 mm -133.59 124.97 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.509 1.524 . . . . 0.0 110.481 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 m -142.83 153.27 60.86 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.889 1.676 . . . . 0.0 110.362 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.73 151.82 28.6 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.044 2.496 . . . . 0.0 111.199 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.9 -25.74 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.987 -1.071 . . . . 0.0 113.303 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.11 -18.19 54.25 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 123.927 0.775 . . . . 0.0 114.727 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.9 m -141.31 60.3 11.84 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 125.514 1.526 . . . . 0.0 111.536 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -62.22 -17.1 55.07 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.796 2.997 . . . . 0.0 113.286 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -72.15 9.47 0.97 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 128.191 2.596 . . . . 0.0 113.384 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 p -137.79 169.24 18.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.165 2.186 . . . . 0.0 111.095 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -143.73 164.6 29.99 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.001 1.32 . . . . 0.0 111.566 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -115.53 127.43 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.374 1.07 . . . . 0.0 111.154 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.49 -160.55 8.46 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.004 1.764 . . . . 0.0 111.367 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -142.93 147.88 35.98 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.251 1.026 . . . . 0.0 111.917 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -153.06 -159.12 8.88 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.531 1.539 . . . . 0.0 112.92 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.3 141.14 19.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.736 1.214 . . . . 0.0 113.077 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.7 -4.24 72.17 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.613 1.102 . . . . 0.0 114.359 -173.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 46.99 53.87 9.97 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.139 1.775 . . . . 0.0 113.625 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.32 138.53 32.44 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 127.6 2.36 . . . . 0.0 107.266 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.54 143.17 56.14 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 108.844 -1.252 . . . . 0.0 108.844 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.3 m -132.62 148.41 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.951 1.301 . . . . 0.0 110.818 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.2 t -75.54 137.16 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.547 0.739 . . . . 0.0 110.159 173.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.3 mt -142.92 164.68 30.65 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.702 2.001 . . . . 0.0 110.399 -171.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.87 155.59 43.58 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.216 1.944 . . . . 0.0 110.982 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.95 125.09 17.16 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.431 2.754 . . . . 0.0 112.684 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -145.12 -107.47 0.11 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.96 1.304 . . . . 0.0 109.107 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -143.56 20.06 1.85 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.174 1.789 . . . . 0.0 110.928 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -68.14 134.62 50.83 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.231 -0.918 . . . . 0.0 111.511 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.0 m -143.0 161.88 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.015 0.926 . . . . 0.0 112.065 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -129.96 134.36 47.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.017 1.327 . . . . 0.0 109.979 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.0 m -70.85 127.39 32.46 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.988 1.315 . . . . 0.0 108.743 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.1 mt -125.0 115.34 20.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.113 0.965 . . . . 0.0 109.027 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.7 m -136.62 133.68 36.55 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.49 0.716 . . . . 0.0 112.564 -169.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.9 tp -66.12 150.21 49.09 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.878 1.271 . . . . 0.0 112.602 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 p -136.89 175.81 9.28 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.663 1.585 . . . . 0.0 112.01 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.8 m -62.89 -4.97 2.44 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.75 19.64 0.21 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.455 1.026 . . . . 0.0 115.044 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.38 -156.87 28.32 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.682 1.135 . . . . 0.0 112.189 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.6 170.55 9.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.943 2.097 . . . . 0.0 110.91 174.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -132.21 149.52 52.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.828 1.651 . . . . 0.0 110.952 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.4 mt -135.11 117.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.164 1.386 . . . . 0.0 109.203 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -134.72 158.75 43.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.218 1.007 . . . . 0.0 111.942 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.03 -21.98 66.53 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -171.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.51 -40.28 1.83 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.375 1.464 . . . . 0.0 112.716 -170.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -98.26 5.22 48.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.329 1.451 . . . . 0.0 113.836 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 58.14 14.49 2.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.256 2.222 . . . . 0.0 114.221 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.3 p -72.97 -23.2 60.63 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.012 0.925 . . . . 0.0 112.547 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.0 m -143.79 173.01 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.768 1.627 . . . . 0.0 112.284 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.3 t -144.23 150.82 38.55 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.78 2.832 . . . . 0.0 109.106 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -70.24 145.03 51.65 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.115 -0.99 . . . . 0.0 111.372 169.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 99.3 p -153.63 173.28 16.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.715 1.206 . . . . 0.0 112.418 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.8 mt -126.39 174.1 8.85 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.128 1.771 . . . . 0.0 109.687 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -115.66 -33.5 5.17 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.996 0.918 . . . . 0.0 111.111 -170.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -141.52 -10.66 0.93 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.46 1.904 . . . . 0.0 112.946 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.84 22.37 6.98 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.96 1.704 . . . . 0.0 114.824 -170.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.5 p -70.94 158.02 37.18 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.115 0.966 . . . . 0.0 111.826 170.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.0 139.98 57.7 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.132 -0.98 . . . . 0.0 112.01 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.87 2.75 88.85 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.345 0.974 . . . . 0.0 114.064 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -69.93 139.09 52.86 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.651 1.225 . . . . 0.0 112.148 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.75 120.09 19.82 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.746 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.18 150.73 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.436 0.694 . . . . 0.0 111.202 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.2 m -130.33 167.71 18.08 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.058 1.343 . . . . 0.0 111.561 -171.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.3 mt -134.94 145.14 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.291 1.436 . . . . 0.0 108.753 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.4 -179.86 47.95 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 124.89 1.234 . . . . 0.0 111.231 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.39 -39.48 60.92 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.217 1.508 . . . . 0.0 113.849 -175.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -169.96 175.4 5.14 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.889 2.476 . . . . 0.0 111.826 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.87 162.12 36.27 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.306 1.442 . . . . 0.0 111.687 169.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.4 t -92.7 -13.28 29.61 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -169.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -140.78 -32.49 0.57 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.541 1.137 . . . . 0.0 113.331 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.6 p -107.31 4.55 26.61 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.678 1.591 . . . . 0.0 114.045 -173.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.51 15.35 1.16 Allowed Glycine 0 CA--C 1.541 1.709 0 C-N-CA 126.348 1.928 . . . . 0.0 115.513 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -141.26 147.34 38.07 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.563 1.945 . . . . 0.0 110.353 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -141.1 177.48 8.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.21 1.804 . . . . 0.0 110.726 -169.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.23 142.61 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.025 0.93 . . . . 0.0 109.834 169.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.44 126.98 75.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.544 1.538 . . . . 0.0 107.053 173.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.91 153.84 38.58 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.908 1.283 . . . . 0.0 109.088 -170.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -66.78 155.06 39.22 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.049 -1.032 . . . . 0.0 112.53 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.2 t . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.991 1.716 . . . . 0.0 111.239 172.635 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.78 175.5 41.51 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.669 1.128 . . . . 0.0 113.078 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -132.55 2.17 3.78 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.654 1.182 . . . . 0.0 114.032 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 50.06 28.8 3.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.188 1.795 . . . . 0.0 114.262 -174.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -70.44 -5.12 26.19 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.051 1.74 . . . . 0.0 114.487 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -147.16 157.45 43.61 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.218 1.807 . . . . 0.0 111.039 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -148.81 -3.3 0.46 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -60.69 -15.05 24.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.564 1.545 . . . . 0.0 114.581 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -118.53 10.55 12.63 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.848 1.659 . . . . 0.0 113.211 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -140.01 -28.27 0.74 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -177.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 m -132.88 5.56 3.91 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.268 1.427 . . . . 0.0 113.561 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.14 18.3 0.54 Allowed Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.011 1.291 . . . . 0.0 114.563 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -65.43 132.85 50.0 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.242 1.021 . . . . 0.0 112.317 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.427 ' H ' ' CD ' ' A' ' 15' ' ' PRO . 21.8 t -159.57 -38.46 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.04 1.336 . . . . 0.0 114.182 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.427 ' CD ' ' H ' ' A' ' 14' ' ' SER . 51.7 Cg_exo -58.56 169.87 2.89 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.034 2.489 . . . . 0.0 114.654 171.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 51.39 33.03 9.33 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.418 1.487 . . . . 0.0 113.901 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.03 145.21 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 125.404 1.482 . . . . 0.0 110.547 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 t -141.36 13.0 2.17 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -170.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.7 mt 58.66 177.98 0.07 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.641 1.976 . . . . 0.0 113.499 -175.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 t -157.8 167.57 29.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.046 1.338 . . . . 0.0 110.207 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.14 135.6 53.79 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.928 -0.483 . . . . 0.0 111.275 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.6 -162.55 35.94 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 115.161 0.824 . . . . 0.0 115.161 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.96 119.7 35.93 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.946 1.298 . . . . 0.0 109.909 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -133.85 170.58 15.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.708 1.203 . . . . 0.0 112.468 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.8 pt -129.65 153.95 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 126.385 1.874 . . . . 0.0 108.763 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.7 mt -130.61 119.61 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -140.03 148.02 41.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.579 0.752 . . . . 0.0 111.639 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -75.72 137.46 40.64 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.592 -0.692 . . . . 0.0 111.213 -172.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -60.58 -29.23 69.05 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.39 1.076 . . . . 0.0 113.714 -175.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.77 -37.38 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.706 0.802 . . . . 0.0 111.669 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tp 55.9 175.12 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.316 1.846 . . . . 0.0 114.437 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 t -72.76 139.68 80.63 Favored Pre-proline 0 N--CA 1.473 0.68 0 O-C-N 120.646 -1.284 . . . . 0.0 111.221 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -65.55 -15.49 49.77 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.917 2.411 . . . . 0.0 113.019 171.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.0 tpt85 -76.41 -17.01 59.56 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.817 1.247 . . . . 0.0 113.185 171.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.51 -3.53 56.4 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.898 1.713 . . . . 0.0 114.553 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -78.24 153.23 32.07 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.413 1.107 . . . . 0.0 111.519 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -65.16 159.92 22.44 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.619 -0.676 . . . . 0.0 112.034 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.8 mt -130.61 68.75 1.46 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.32 1.448 . . . . 0.0 110.661 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.34 145.61 26.26 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.162 0.985 . . . . 0.0 112.44 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.51 132.18 50.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.922 0.889 . . . . 0.0 109.242 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.3 m -130.91 127.29 38.18 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.098 0.959 . . . . 0.0 110.826 -170.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.16 129.3 94.41 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.24 1.416 . . . . 0.0 111.142 -175.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.01 -11.08 19.72 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.078 2.519 . . . . 0.0 114.164 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.12 -4.28 52.08 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.5 1.047 . . . . 0.0 115.196 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -160.72 166.88 27.99 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.067 1.433 . . . . 0.0 113.035 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -89.17 161.97 16.17 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.109 1.764 . . . . 0.0 111.039 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 56.07 38.32 29.78 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.067 1.747 . . . . 0.0 113.783 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.7 m -141.86 140.91 20.63 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.401 1.88 . . . . 0.0 109.685 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.91 148.66 71.03 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.043 2.495 . . . . 0.0 113.717 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.65 157.61 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.061 1.344 . . . . 0.0 110.653 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -126.0 171.49 10.74 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.416 1.486 . . . . 0.0 111.115 -171.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -127.59 139.08 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 121.01 -1.056 . . . . 0.0 111.3 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -161.18 168.93 10.66 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.536 1.134 . . . . 0.0 113.161 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.83 152.8 12.76 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.604 3.536 . . . . 0.0 114.304 169.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.02 134.95 51.29 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.083 1.753 . . . . 0.0 110.094 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -130.88 -10.93 3.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.817 1.647 . . . . 0.0 113.68 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.99 -4.28 16.43 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.655 1.598 . . . . 0.0 114.395 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.0 t -63.07 165.13 7.41 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.036 1.418 . . . . 0.0 113.035 175.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.0 p -71.6 -15.18 62.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.66 1.184 . . . . 0.0 113.972 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.14 -31.33 72.49 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.417 1.008 . . . . 0.0 112.823 -178.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -113.22 4.84 16.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.356 1.462 . . . . 0.0 112.843 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.66 145.52 27.51 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.718 1.207 . . . . 0.0 111.614 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -141.48 174.12 10.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.646 1.212 . . . . 0.0 111.743 -169.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.7 mt -125.7 136.72 59.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.921 2.089 . . . . 0.0 107.357 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.3 tp -134.63 129.65 35.22 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.648 1.579 . . . . 0.0 108.816 -171.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.9 mtt85 -146.29 131.4 18.33 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.308 0.643 . . . . 0.0 110.64 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -64.33 138.0 58.2 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.401 0.546 . . . . 0.0 111.068 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -115.1 -47.78 2.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.332 1.053 . . . . 0.0 111.605 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.68 110.46 4.3 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.487 1.115 . . . . 0.0 111.476 170.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.9 m -59.51 -24.69 63.86 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.957 0.903 . . . . 0.0 111.412 168.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -63.96 -21.4 66.47 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.915 2.086 . . . . 0.0 113.495 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -130.18 9.28 5.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.674 1.59 . . . . 0.0 112.852 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 46.02 33.7 1.76 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.533 1.933 . . . . 0.0 113.55 -169.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.0 p -93.37 138.62 31.53 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.001 -1.062 . . . . 0.0 112.031 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -134.69 145.13 48.24 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.204 1.802 . . . . 0.0 110.789 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.7 p -77.98 152.75 32.95 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.854 -0.529 . . . . 0.0 110.958 171.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.1 mm -129.11 130.11 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.568 1.547 . . . . 0.0 109.045 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.8 m -142.99 145.98 35.34 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.628 1.571 . . . . 0.0 110.612 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.06 146.77 32.83 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.185 2.59 . . . . 0.0 111.102 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.84 -24.98 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.943 -1.098 . . . . 0.0 113.427 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.4 -22.15 63.17 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.743 0.687 . . . . 0.0 114.197 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.2 m -143.04 64.91 15.02 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 126.144 1.777 . . . . 0.0 110.473 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -63.76 -15.37 48.49 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.197 2.598 . . . . 0.0 113.364 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -71.94 0.3 9.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.229 1.811 . . . . 0.0 113.918 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m -131.01 173.63 10.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.916 1.686 . . . . 0.0 111.545 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -140.6 171.83 13.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.556 1.142 . . . . 0.0 113.474 -170.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.07 130.64 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.234 1.414 . . . . 0.0 110.587 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.14 -158.26 7.66 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.8 1.667 . . . . 0.0 111.513 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -142.42 145.35 33.71 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.351 1.075 . . . . 0.0 111.956 -173.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.62 -163.46 11.28 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.481 1.515 . . . . 0.0 112.942 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.83 138.17 24.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.904 1.281 . . . . 0.0 113.081 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.36 -6.78 61.52 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.821 1.2 . . . . 0.0 114.173 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 48.17 56.22 7.67 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.417 1.887 . . . . 0.0 114.177 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.02 149.2 67.7 Favored Pre-proline 0 C--O 1.239 0.512 0 C-N-CA 126.511 1.924 . . . . 0.0 107.896 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -69.76 146.01 58.89 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.338 1.358 . . . . 0.0 110.073 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.27 150.01 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.966 1.706 . . . . 0.0 111.274 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.81 134.66 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.085 0.954 . . . . 0.0 110.179 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.7 mt -137.74 162.46 54.39 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.79 1.636 . . . . 0.0 112.243 -169.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.75 167.85 21.83 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.267 2.645 . . . . 0.0 111.828 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.86 127.03 12.5 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.318 2.012 . . . . 0.0 110.676 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -149.78 -93.32 0.07 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.789 0.836 . . . . 0.0 110.541 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -155.4 18.14 0.41 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.908 1.683 . . . . 0.0 112.343 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -66.04 135.4 54.59 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.73 -0.606 . . . . 0.0 111.64 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -144.99 160.8 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.968 1.307 . . . . 0.0 111.756 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -130.32 144.24 51.26 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.53 1.532 . . . . 0.0 110.537 170.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.1 m -76.31 134.83 39.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.163 1.385 . . . . 0.0 109.409 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.21 125.62 50.54 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.413 1.085 . . . . 0.0 109.478 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.8 m -132.3 117.0 17.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.672 0.789 . . . . 0.0 110.246 -170.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 tp -66.16 146.72 54.31 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.181 0.592 . . . . 0.0 111.109 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.1 p -127.59 -177.97 4.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.593 1.557 . . . . 0.0 111.627 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.0 p -59.48 -13.57 9.37 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.13 25.85 0.19 Allowed Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.202 0.841 . . . . 0.0 115.202 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.55 -149.57 9.44 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.878 1.228 . . . . 0.0 112.273 -173.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -128.46 170.11 13.53 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.609 1.964 . . . . 0.0 111.781 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -137.05 153.59 50.57 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.976 2.511 . . . . 0.0 109.037 170.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.0 mt -133.56 127.88 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.807 1.243 . . . . 0.0 108.717 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -138.29 159.9 40.87 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.457 1.103 . . . . 0.0 112.734 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.45 -23.01 67.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 125.86 -39.51 2.02 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.97 1.272 . . . . 0.0 113.102 -171.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -98.66 1.58 46.38 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.889 1.675 . . . . 0.0 113.732 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.6 mmm-85 66.39 13.17 9.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.1 2.16 . . . . 0.0 113.655 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 72.8 p -74.84 -24.82 58.66 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.46 1.104 . . . . 0.0 112.683 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.2 m -143.46 174.25 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.738 1.615 . . . . 0.0 111.693 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 t -147.23 152.89 39.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.609 2.364 . . . . 0.0 110.176 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -70.01 143.43 52.57 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.543 -0.723 . . . . 0.0 111.413 171.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 81.3 p -153.26 172.14 17.45 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.807 1.243 . . . . 0.0 112.527 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -123.92 172.97 8.51 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.332 1.853 . . . . 0.0 110.207 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -119.44 -29.76 5.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.777 1.631 . . . . 0.0 112.065 -169.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -142.41 -8.7 0.86 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.995 1.718 . . . . 0.0 114.294 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.22 51.84 13.69 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.359 1.064 . . . . 0.0 113.649 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.5 p -126.99 167.1 16.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.887 0.875 . . . . 0.0 112.306 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -73.0 146.21 46.14 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.742 -1.224 . . . . 0.0 112.568 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.79 -8.49 69.21 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.44 1.019 . . . . 0.0 114.016 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -61.28 157.34 16.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.621 1.968 . . . . 0.0 112.602 169.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -109.11 124.87 51.48 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.424 1.089 . . . . 0.0 109.231 171.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -60.0 148.19 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.731 0.813 . . . . 0.0 111.886 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.2 m -130.91 168.22 17.68 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.734 1.614 . . . . 0.0 112.087 -170.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 80.8 mt -133.91 143.87 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.401 1.48 . . . . 0.0 109.712 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.49 179.79 48.79 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.036 1.303 . . . . 0.0 111.655 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.75 -40.54 54.95 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.248 1.524 . . . . 0.0 114.542 -172.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -171.92 173.41 4.46 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.057 2.943 . . . . 0.0 108.942 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.64 137.94 33.98 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.242 -0.911 . . . . 0.0 112.785 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.6 t -61.84 -21.02 64.29 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.73 1.612 . . . . 0.0 115.303 -170.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -134.18 -38.01 0.87 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.509 1.124 . . . . 0.0 113.312 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.3 p -98.19 4.06 48.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.152 1.381 . . . . 0.0 114.626 -171.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.53 14.25 1.03 Allowed Glycine 0 CA--C 1.544 1.892 0 C-N-CA 126.017 1.77 . . . . 0.0 115.9 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -134.53 150.66 50.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.88 1.672 . . . . 0.0 111.915 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -141.41 175.6 9.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.996 2.118 . . . . 0.0 110.795 -169.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.86 138.46 34.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 125.03 1.332 . . . . 0.0 108.814 169.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.8 123.5 71.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.716 1.606 . . . . 0.0 106.768 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -146.9 153.83 40.58 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.597 1.159 . . . . 0.0 109.168 -169.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -68.62 154.57 41.66 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.967 -1.083 . . . . 0.0 112.518 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.256 1.822 . . . . 0.0 111.405 171.902 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.78 173.82 46.34 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.464 1.031 . . . . 0.0 112.996 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -133.25 7.97 3.96 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.102 1.361 . . . . 0.0 113.189 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -70.2 -15.68 62.97 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.786 1.634 . . . . 0.0 113.762 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -148.87 157.02 43.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.456 1.902 . . . . 0.0 110.706 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -144.57 163.88 32.59 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.639 1.576 . . . . 0.0 111.862 -174.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -123.4 3.1 9.1 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.873 1.269 . . . . 0.0 113.607 -175.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -143.43 160.5 40.46 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.374 1.869 . . . . 0.0 110.857 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -143.47 11.26 1.69 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.372 1.469 . . . . 0.0 112.85 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -152.97 168.39 25.98 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.478 1.911 . . . . 0.0 111.896 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.2 m -132.72 6.52 4.03 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.12 1.368 . . . . 0.0 113.348 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.98 176.14 43.95 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.911 1.72 . . . . 0.0 112.393 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -142.64 1.97 1.37 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.521 1.129 . . . . 0.0 113.691 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.4 m -145.0 159.35 50.15 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 126.154 1.782 . . . . 0.0 111.231 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.61 139.02 39.57 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.727 2.951 . . . . 0.0 113.747 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.79 27.79 1.19 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.805 1.242 . . . . 0.0 113.194 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 t -78.53 152.74 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.804 1.641 . . . . 0.0 110.501 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.2 t -134.1 6.28 3.62 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.5 mt 57.95 174.38 0.06 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.969 2.107 . . . . 0.0 113.746 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 t -159.7 168.43 25.98 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.084 1.354 . . . . 0.0 109.879 173.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.53 131.83 48.18 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.854 -0.529 . . . . 0.0 111.632 171.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.55 -168.49 41.34 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 114.643 0.617 . . . . 0.0 114.643 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -94.49 125.75 39.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.043 0.937 . . . . 0.0 109.793 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -132.73 166.15 22.87 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.709 1.604 . . . . 0.0 111.887 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.1 pt -117.69 151.1 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 125.489 1.516 . . . . 0.0 108.45 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.0 mt -130.33 113.43 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -136.47 143.39 43.82 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.439 1.095 . . . . 0.0 110.089 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -71.01 150.08 45.98 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.797 -0.564 . . . . 0.0 111.329 -172.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -63.83 -13.88 48.31 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.8 t -118.65 139.18 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.611 1.964 . . . . 0.0 108.889 169.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.9 mt -109.72 169.22 8.85 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.388 1.475 . . . . 0.0 113.398 -169.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.1 t -68.58 151.34 97.29 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.644 1.177 . . . . 0.0 111.889 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -61.35 -8.07 9.79 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.448 2.766 . . . . 0.0 113.833 169.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -62.1 -24.33 67.06 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.106 1.363 . . . . 0.0 112.302 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.54 30.38 27.36 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.844 1.212 . . . . 0.0 114.2 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.39 162.64 33.92 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.852 1.661 . . . . 0.0 110.294 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -54.34 142.02 28.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.618 0.767 . . . . 0.0 110.33 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -121.95 84.66 2.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.523 1.529 . . . . 0.0 110.684 -166.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.53 150.12 21.44 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.827 1.651 . . . . 0.0 115.045 -168.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.77 134.99 57.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.18 0.992 . . . . 0.0 109.14 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.2 m -135.4 125.38 25.84 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.216 1.007 . . . . 0.0 111.301 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -67.0 140.42 96.04 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.551 1.94 . . . . 0.0 112.878 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.29 -15.64 17.89 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.705 2.937 . . . . 0.0 114.943 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.98 7.21 66.2 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.306 0.955 . . . . 0.0 115.076 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -156.97 167.04 31.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.515 1.926 . . . . 0.0 111.322 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -100.13 167.83 10.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.809 1.243 . . . . 0.0 111.267 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 50.85 38.91 21.12 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.672 1.589 . . . . 0.0 113.256 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.1 m -139.87 138.41 19.72 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 126.129 1.772 . . . . 0.0 110.557 -169.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.21 159.83 3.85 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.861 3.707 . . . . 0.0 115.542 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 t -114.0 149.64 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.107 1.363 . . . . 0.0 110.643 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 52' ' ' VAL . 2.8 m -125.2 174.42 8.11 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.268 1.427 . . . . 0.0 110.909 -169.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 51' ' ' THR . 0.3 OUTLIER -127.06 143.02 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.951 1.301 . . . . 0.0 111.365 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.3 m -152.99 162.51 26.21 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 124.302 1.041 . . . . 0.0 113.047 -173.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.34 150.57 40.62 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.446 2.764 . . . . 0.0 112.754 169.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.8 tp -108.14 134.19 51.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.864 1.266 . . . . 0.0 111.585 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -133.82 -26.88 1.52 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.823 2.049 . . . . 0.0 112.405 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.8 5.47 2.2 Favored Glycine 0 CA--C 1.537 1.464 0 N-CA-C 116.811 1.484 . . . . 0.0 116.811 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.3 p -72.83 165.28 25.19 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.899 1.849 . . . . 0.0 113.798 -175.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.3 m -70.04 -14.48 62.7 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -73.14 -25.34 60.79 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.974 0.91 . . . . 0.0 112.458 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.61 5.82 11.64 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.343 2.657 . . . . 0.0 112.23 -172.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.8 147.89 33.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.506 1.522 . . . . 0.0 110.257 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -134.96 171.66 14.1 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.886 1.326 . . . . 0.0 112.291 -168.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.3 mt -125.66 134.46 66.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 127.505 2.322 . . . . 0.0 106.249 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.4 tp -137.13 123.38 20.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.067 1.347 . . . . 0.0 109.624 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -142.81 140.03 31.17 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.495 0.718 . . . . 0.0 111.388 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.3 t -65.5 142.43 58.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.355 0.662 . . . . 0.0 111.451 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -117.19 -52.74 2.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.749 1.219 . . . . 0.0 111.823 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.2 111.24 5.32 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.3 1.04 . . . . 0.0 111.006 170.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.3 m -57.28 -24.35 54.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.887 0.875 . . . . 0.0 111.26 168.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -65.37 -21.6 66.7 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.924 2.089 . . . . 0.0 113.633 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.6 t -130.5 14.69 5.49 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.193 1.397 . . . . 0.0 112.898 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 43.89 34.56 0.92 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.24 1.816 . . . . 0.0 113.475 -169.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.1 p -88.0 143.23 27.21 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.995 -1.065 . . . . 0.0 112.106 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -139.17 143.22 38.04 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.328 1.451 . . . . 0.0 110.993 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.4 p -77.7 147.99 35.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.288 0.635 . . . . 0.0 110.723 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.0 mm -128.28 126.08 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.462 1.505 . . . . 0.0 109.397 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.0 m -143.34 146.46 36.24 Favored Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 125.791 1.637 . . . . 0.0 109.539 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.57 150.84 28.34 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.765 2.31 . . . . 0.0 111.53 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.49 -30.53 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 121.297 -0.877 . . . . 0.0 111.836 172.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.73 -14.89 78.99 Favored Glycine 0 CA--C 1.539 1.564 0 N-CA-C 115.595 0.998 . . . . 0.0 115.595 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.6 m -151.6 61.75 4.47 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 125.819 1.648 . . . . 0.0 111.56 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -62.8 -17.21 58.19 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 124.065 3.176 . . . . 0.0 113.669 -173.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -72.77 13.11 0.41 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 128.484 2.713 . . . . 0.0 114.238 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.8 p -141.46 171.34 14.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.731 2.012 . . . . 0.0 111.596 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -138.83 170.09 16.63 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.634 1.574 . . . . 0.0 112.469 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.71 129.88 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.865 1.266 . . . . 0.0 110.897 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.75 -156.15 6.82 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.83 1.681 . . . . 0.0 111.693 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -143.01 141.11 31.27 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.387 1.075 . . . . 0.0 111.526 -171.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.14 -166.78 13.0 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.36 1.457 . . . . 0.0 113.035 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.72 137.47 20.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.979 1.311 . . . . 0.0 113.164 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.32 -7.28 61.88 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.85 1.214 . . . . 0.0 114.094 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 48.69 56.32 7.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.575 1.95 . . . . 0.0 114.298 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.64 151.02 77.4 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 126.2 1.8 . . . . 0.0 108.201 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.57 142.16 57.91 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.269 1.313 . . . . 0.0 109.84 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.34 148.92 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.615 1.566 . . . . 0.0 111.123 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.87 139.47 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.838 0.855 . . . . 0.0 110.602 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.67 161.67 57.28 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.666 1.986 . . . . 0.0 110.944 -172.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -69.65 164.88 32.79 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.703 2.269 . . . . 0.0 111.482 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.0 123.44 10.02 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.455 2.103 . . . . 0.0 110.851 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -147.72 -91.34 0.08 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.245 1.018 . . . . 0.0 110.482 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -156.01 18.34 0.37 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.524 1.53 . . . . 0.0 112.955 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -68.2 136.13 53.11 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.544 -0.722 . . . . 0.0 112.125 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.7 m -145.19 161.55 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.06 1.344 . . . . 0.0 112.537 -174.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -131.49 136.79 48.2 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.964 1.706 . . . . 0.0 110.571 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.6 m -71.92 131.58 43.17 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.098 0.959 . . . . 0.0 108.717 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.1 mt -123.52 128.19 49.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.096 0.958 . . . . 0.0 109.424 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.1 m -133.63 120.35 20.56 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.772 0.829 . . . . 0.0 110.586 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.83 146.82 54.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.065 0.546 . . . . 0.0 111.246 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -126.43 178.85 5.6 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.585 1.554 . . . . 0.0 110.818 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.0 p -60.23 -14.98 20.54 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.75 33.66 0.36 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.659 1.124 . . . . 0.0 114.088 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.61 -154.46 24.23 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.927 1.251 . . . . 0.0 112.909 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -126.71 170.93 11.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.272 2.229 . . . . 0.0 111.119 174.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -135.44 151.05 50.04 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.361 2.264 . . . . 0.0 109.255 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.9 mt -132.94 125.3 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.921 1.289 . . . . 0.0 108.778 -170.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -138.12 157.67 45.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.598 1.159 . . . . 0.0 112.648 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -60.72 -32.98 72.21 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -174.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.38 -40.28 1.64 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.9 1.714 . . . . 0.0 113.298 -172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.65 -13.1 59.73 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.598 1.159 . . . . 0.0 113.585 171.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 69.99 13.85 7.86 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.221 2.208 . . . . 0.0 112.796 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.2 p -71.99 -21.53 61.55 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.84 1.656 . . . . 0.0 112.856 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.0 m -144.97 170.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.071 1.749 . . . . 0.0 111.754 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.3 t -141.23 156.47 45.9 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.255 1.822 . . . . 0.0 110.838 171.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -70.05 140.17 52.76 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.595 -0.691 . . . . 0.0 111.345 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.8 p -151.64 172.15 16.52 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.438 1.095 . . . . 0.0 112.498 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -117.34 174.73 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.137 1.775 . . . . 0.0 109.794 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -112.16 -31.88 6.73 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.977 1.311 . . . . 0.0 110.648 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -142.7 -13.3 0.76 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.546 2.338 . . . . 0.0 112.734 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.96 20.53 6.83 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.75 2.02 . . . . 0.0 114.78 -171.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.7 p -70.86 155.78 40.37 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.571 1.148 . . . . 0.0 111.921 171.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.12 137.22 58.04 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.408 -0.807 . . . . 0.0 112.457 172.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.14 -1.83 87.63 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.98 1.276 . . . . 0.0 114.455 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 139.01 45.81 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.75 1.275 . . . . 0.0 112.823 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.36 127.0 32.16 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.528 -0.732 . . . . 0.0 110.266 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.36 152.07 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.117 0.567 . . . . 0.0 110.426 175.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.7 m -130.34 161.98 30.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.574 1.549 . . . . 0.0 111.563 -173.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.0 mt -131.87 143.73 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.377 1.471 . . . . 0.0 108.84 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.44 -157.64 30.19 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 123.73 0.681 . . . . 0.0 112.236 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.16 159.99 4.07 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 117.832 0.816 . . . . 0.0 112.063 169.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.43 148.77 11.35 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.784 1.234 . . . . 0.0 112.229 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.8 138.93 53.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.988 1.315 . . . . 0.0 112.939 -170.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -60.07 -21.75 61.85 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -131.45 -39.93 1.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 85.9 p -98.59 3.78 48.01 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -173.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.43 -3.18 31.09 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.492 1.044 . . . . 0.0 115.02 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -121.45 154.88 35.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.941 1.696 . . . . 0.0 111.21 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -137.83 175.09 9.9 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.258 1.823 . . . . 0.0 111.155 -170.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.8 t -133.58 135.05 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.621 1.568 . . . . 0.0 107.956 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 47.6 mt -130.59 119.05 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -149.31 152.46 35.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.997 -168.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -68.93 154.4 42.11 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.167 -0.958 . . . . 0.0 112.587 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 C--O 1.254 1.311 0 C-N-CA 126.338 1.855 . . . . 0.0 111.422 172.324 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.0 15.32 0.09 OUTLIER Glycine 0 CA--C 1.538 1.483 0 N-CA-C 115.719 1.048 . . . . 0.0 115.719 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 53.16 15.75 0.67 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.082 2.153 . . . . 0.0 116.164 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -145.06 19.13 1.6 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.049 1.739 . . . . 0.0 111.819 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -137.54 14.42 2.96 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.211 1.404 . . . . 0.0 113.203 -169.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -129.59 3.84 5.05 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.216 1.807 . . . . 0.0 113.377 -170.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -132.75 -13.36 2.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.949 1.699 . . . . 0.0 114.115 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -71.02 -9.81 58.68 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.587 1.155 . . . . 0.0 113.431 170.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -147.55 167.64 23.99 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.945 2.098 . . . . 0.0 111.179 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -155.54 167.05 31.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.397 1.479 . . . . 0.0 111.711 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 55.8 m -134.13 6.54 3.62 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.918 1.287 . . . . 0.0 113.933 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.9 29.4 0.42 Allowed Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.494 1.045 . . . . 0.0 114.536 -176.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -139.27 11.71 2.57 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.157 1.383 . . . . 0.0 113.295 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.1 m -63.59 157.91 62.75 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.723 1.209 . . . . 0.0 112.88 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.94 155.03 9.05 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.677 2.918 . . . . 0.0 114.042 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -133.25 24.08 4.14 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.012 1.325 . . . . 0.0 112.719 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.03 146.75 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.028 1.331 . . . . 0.0 110.646 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 t -150.65 33.64 0.62 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 123.304 1.526 . . . . 0.0 114.277 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.9 mt -57.28 161.0 3.54 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.496 1.519 . . . . 0.0 111.584 168.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -157.49 167.49 30.05 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.494 1.118 . . . . 0.0 110.034 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.39 124.0 20.17 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.994 -0.441 . . . . 0.0 111.259 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.36 -166.05 37.83 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -101.53 123.91 46.33 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.198 0.999 . . . . 0.0 109.908 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.86 169.7 15.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.073 1.349 . . . . 0.0 112.454 -171.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.4 pt -123.52 152.01 28.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.992 1.717 . . . . 0.0 108.302 171.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.83 121.2 57.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -136.66 147.07 46.64 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.118 0.967 . . . . 0.0 111.022 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -73.62 148.11 43.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.828 -0.545 . . . . 0.0 110.832 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.7 tpt85 -64.61 -16.64 63.04 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.77 140.43 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 126.084 1.754 . . . . 0.0 109.117 169.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 47.2 mt -109.99 167.52 10.11 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.284 1.433 . . . . 0.0 114.015 -168.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 t -69.74 151.04 96.55 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.814 1.246 . . . . 0.0 112.021 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.71 -9.71 12.25 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.578 2.852 . . . . 0.0 113.972 169.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -30.71 67.34 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.347 1.459 . . . . 0.0 112.127 169.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.49 21.95 25.47 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.939 1.257 . . . . 0.0 114.968 172.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -133.45 173.34 11.59 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.067 1.347 . . . . 0.0 111.056 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -54.33 148.17 12.17 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.505 0.722 . . . . 0.0 110.901 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -127.33 92.95 3.61 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.719 1.208 . . . . 0.0 109.949 -168.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.24 151.15 24.46 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -167.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 tp -57.37 132.33 52.76 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.111 1.365 . . . . 0.0 109.778 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.0 m -130.47 124.82 32.88 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.929 0.892 . . . . 0.0 111.479 -170.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -61.11 128.87 90.05 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.14 1.376 . . . . 0.0 111.404 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.67 -11.36 20.3 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.326 2.684 . . . . 0.0 114.208 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.87 -5.15 50.25 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.456 1.027 . . . . 0.0 115.104 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -160.02 168.28 25.97 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.903 1.351 . . . . 0.0 113.067 -173.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -88.7 167.7 13.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.085 1.754 . . . . 0.0 111.394 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 48.92 40.42 16.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.678 1.991 . . . . 0.0 113.466 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.6 m -141.04 137.16 16.64 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 126.062 1.745 . . . . 0.0 110.03 -172.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.73 141.86 42.92 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.309 3.34 . . . . 0.0 114.547 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 t -84.74 149.15 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.398 1.079 . . . . 0.0 110.509 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 52' ' ' VAL . 1.4 m -122.7 178.08 5.17 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.172 1.389 . . . . 0.0 110.595 -170.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.473 ' H ' HG22 ' A' ' 51' ' ' THR . 0.3 OUTLIER -130.27 148.61 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.695 1.198 . . . . 0.0 111.253 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.4 p -155.11 159.01 32.15 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 123.539 0.736 . . . . 0.0 112.792 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.71 128.41 30.21 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.569 2.179 . . . . 0.0 111.213 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.92 131.51 49.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.391 1.076 . . . . 0.0 111.079 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -123.04 -19.36 6.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.587 1.155 . . . . 0.0 112.221 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.35 60.67 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.698 1.142 . . . . 0.0 113.261 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.5 t -67.74 162.26 24.21 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.066 1.346 . . . . 0.0 111.766 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.4 p -57.09 -18.74 15.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.62 1.168 . . . . 0.0 113.944 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.21 -32.88 74.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.685 1.194 . . . . 0.0 113.04 173.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -111.4 -0.65 16.23 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.42 146.48 24.73 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 122.33 1.062 . . . . 0.0 111.868 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -140.5 172.81 12.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.963 1.305 . . . . 0.0 111.427 -169.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.8 mt -123.03 135.19 63.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.072 2.149 . . . . 0.0 107.025 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.04 123.85 21.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.194 1.398 . . . . 0.0 109.17 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -144.03 139.96 29.28 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.461 0.705 . . . . 0.0 111.922 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 t -66.32 139.2 58.03 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.014 0.526 . . . . 0.0 111.651 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -114.58 -52.79 2.69 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.649 1.18 . . . . 0.0 111.303 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.85 109.95 4.93 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.614 1.165 . . . . 0.0 111.34 171.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.4 m -57.92 -24.58 58.43 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.877 0.871 . . . . 0.0 111.65 168.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -64.11 -22.57 66.99 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.129 2.171 . . . . 0.0 113.641 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.7 m -130.31 12.25 5.5 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.772 1.629 . . . . 0.0 112.671 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 43.99 35.35 1.13 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.595 1.958 . . . . 0.0 113.487 -168.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 p -89.45 140.43 29.52 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.836 -1.165 . . . . 0.0 112.028 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -136.55 144.73 44.37 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.03 1.732 . . . . 0.0 110.14 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.2 p -77.68 149.81 34.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.404 0.682 . . . . 0.0 110.667 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.0 mm -128.55 126.81 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.563 1.545 . . . . 0.0 109.184 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.1 m -144.77 142.9 19.53 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.348 1.459 . . . . 0.0 110.105 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.04 145.38 35.4 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.983 2.455 . . . . 0.0 111.114 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.6 m -66.01 -23.1 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.708 -1.245 . . . . 0.0 112.733 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.09 -9.69 81.87 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.675 1.131 . . . . 0.0 114.625 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.8 t -152.35 66.03 6.28 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.048 1.339 . . . . 0.0 110.883 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.99 -18.18 61.45 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.265 2.643 . . . . 0.0 112.949 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -78.61 5.22 11.5 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.406 2.282 . . . . 0.0 114.096 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 m -130.87 171.91 12.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.372 1.869 . . . . 0.0 111.182 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -138.7 173.59 11.42 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.39 1.476 . . . . 0.0 112.915 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.0 mm -121.67 129.79 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.232 1.413 . . . . 0.0 110.81 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.12 -156.85 7.13 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.76 1.648 . . . . 0.0 111.958 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -142.66 142.37 32.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.437 1.095 . . . . 0.0 111.646 -171.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.93 -165.13 12.0 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.303 1.43 . . . . 0.0 113.405 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.57 138.84 21.75 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.063 1.345 . . . . 0.0 113.217 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.69 -6.42 67.51 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.746 1.165 . . . . 0.0 114.097 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 49.04 57.78 6.08 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.373 1.869 . . . . 0.0 113.932 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.65 149.7 72.77 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 126.101 1.761 . . . . 0.0 108.13 169.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.75 144.4 53.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.242 1.294 . . . . 0.0 109.643 174.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.88 146.96 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.577 1.551 . . . . 0.0 110.945 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.9 t -76.22 137.99 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.567 0.747 . . . . 0.0 109.887 171.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.9 mt -140.21 162.97 47.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.946 1.699 . . . . 0.0 112.194 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.34 166.66 24.64 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.252 2.635 . . . . 0.0 111.71 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.44 126.81 11.92 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.311 2.007 . . . . 0.0 110.909 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -148.62 -106.18 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.604 1.161 . . . . 0.0 109.413 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -145.25 21.58 1.54 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.422 1.889 . . . . 0.0 110.59 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -66.73 133.5 50.31 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.226 -0.921 . . . . 0.0 111.774 -173.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.7 m -144.71 160.33 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.336 1.455 . . . . 0.0 111.994 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -130.06 145.66 51.69 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.611 1.564 . . . . 0.0 109.973 169.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -77.03 134.86 38.68 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.801 1.241 . . . . 0.0 109.583 171.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.66 126.06 51.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.644 1.177 . . . . 0.0 109.722 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.2 m -132.77 120.13 21.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.247 1.019 . . . . 0.0 110.284 -175.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 tp -65.33 146.6 54.72 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.203 0.601 . . . . 0.0 111.334 172.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 p -127.76 176.53 7.47 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.564 1.545 . . . . 0.0 111.497 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -60.51 -10.31 4.86 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.88 31.89 0.29 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.496 1.046 . . . . 0.0 114.064 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.38 -151.82 19.12 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.721 1.153 . . . . 0.0 113.02 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -131.64 170.22 15.07 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 128.007 2.523 . . . . 0.0 110.591 175.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -134.59 155.36 50.59 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.683 1.593 . . . . 0.0 111.076 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.1 mt -135.09 115.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.774 1.629 . . . . 0.0 108.98 -170.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -134.36 158.15 44.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.227 1.011 . . . . 0.0 112.866 -170.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -61.25 -18.1 56.72 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 120.27 -33.83 4.37 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.885 1.231 . . . . 0.0 113.279 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -107.94 5.73 26.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.477 1.911 . . . . 0.0 113.18 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.8 mmm-85 63.19 16.98 9.84 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.148 2.179 . . . . 0.0 113.998 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.8 p -74.71 -27.91 60.59 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.235 1.014 . . . . 0.0 112.799 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.7 m -143.19 175.27 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.314 1.446 . . . . 0.0 111.735 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -144.41 150.98 38.6 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 128.449 2.7 . . . . 0.0 109.675 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -71.0 145.01 50.26 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.583 -0.698 . . . . 0.0 111.517 169.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.5 p -152.32 176.42 11.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.552 1.141 . . . . 0.0 112.557 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -132.08 171.29 13.81 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.067 2.147 . . . . 0.0 109.861 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -111.68 -35.89 5.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.305 1.042 . . . . 0.0 111.159 -170.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -141.38 -10.95 0.94 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.079 2.152 . . . . 0.0 112.63 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.77 19.14 5.37 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.455 1.902 . . . . 0.0 115.134 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.6 p -70.69 157.81 37.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.319 1.047 . . . . 0.0 112.148 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.52 137.54 58.15 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.372 -0.83 . . . . 0.0 112.612 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.14 -1.22 89.06 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.536 1.065 . . . . 0.0 114.564 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -69.21 141.47 54.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.66 1.184 . . . . 0.0 112.501 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.91 128.88 34.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.579 0.752 . . . . 0.0 110.424 174.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.08 151.62 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.429 0.692 . . . . 0.0 110.714 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.6 t -126.27 165.24 19.33 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.256 1.422 . . . . 0.0 111.539 -174.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.0 mt -135.68 140.48 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.608 1.563 . . . . 0.0 109.672 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.0 -179.49 48.9 Favored Glycine 0 N--CA 1.469 0.889 0 C-N-CA 124.9 1.238 . . . . 0.0 111.768 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.22 -41.05 62.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 119.034 1.417 . . . . 0.0 114.035 -173.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -168.62 172.17 8.25 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.809 2.444 . . . . 0.0 109.96 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.69 141.23 35.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.356 1.062 . . . . 0.0 112.547 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.5 t -60.43 -21.06 61.84 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -134.3 -38.4 0.85 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.3 p -96.65 5.36 50.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.347 1.459 . . . . 0.0 114.354 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.62 10.75 3.68 Favored Glycine 0 CA--C 1.542 1.764 0 C-N-CA 125.107 1.336 . . . . 0.0 115.658 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -136.22 149.1 48.4 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.85 2.06 . . . . 0.0 110.412 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -137.75 176.25 8.87 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.525 1.93 . . . . 0.0 112.022 -169.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.1 t -134.77 137.07 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.924 1.69 . . . . 0.0 108.509 171.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.94 123.75 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.06 154.19 38.92 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.651 1.18 . . . . 0.0 108.989 -170.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -68.75 154.75 41.4 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.682 -1.261 . . . . 0.0 112.594 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.394 1.878 . . . . 0.0 111.462 171.328 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.76 178.46 45.6 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.736 1.16 . . . . 0.0 113.096 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -150.68 152.99 34.77 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.911 1.284 . . . . 0.0 111.866 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -147.3 159.64 43.43 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.847 1.659 . . . . 0.0 111.392 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -131.11 -6.88 3.88 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.819 1.248 . . . . 0.0 113.279 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -140.99 14.21 2.26 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.896 2.078 . . . . 0.0 113.099 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 44.79 30.86 0.58 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.818 2.447 . . . . 0.0 115.969 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -148.37 -177.85 5.99 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.347 1.459 . . . . 0.0 111.672 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.09 -0.3 1.02 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.1 p80 42.22 25.99 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.89 2.076 . . . . 0.0 115.996 -172.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.0 m 49.61 34.59 7.3 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.918 1.687 . . . . 0.0 114.012 -171.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.11 -156.71 8.27 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.458 1.504 . . . . 0.0 113.245 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.86 145.96 28.89 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.752 1.221 . . . . 0.0 111.409 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.9 m -151.18 164.23 20.95 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.964 1.706 . . . . 0.0 111.099 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.68 161.14 4.67 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.532 2.821 . . . . 0.0 114.403 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.51 33.26 3.02 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.246 1.418 . . . . 0.0 112.381 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.04 146.65 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.035 1.734 . . . . 0.0 109.914 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 t -135.19 12.57 3.56 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.525 1.53 . . . . 0.0 112.871 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.6 mt 63.01 168.03 0.13 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.674 2.39 . . . . 0.0 114.031 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 t -160.08 170.07 22.03 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.662 1.585 . . . . 0.0 109.575 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 130.84 44.54 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.58 -0.7 . . . . 0.0 111.512 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.11 -163.02 36.52 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 121.623 -0.673 . . . . 0.0 114.627 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -98.41 124.33 43.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.049 0.939 . . . . 0.0 110.094 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -133.1 171.75 13.57 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.084 1.354 . . . . 0.0 112.679 -171.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.0 pt -125.72 153.32 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 126.368 1.867 . . . . 0.0 108.643 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mt -129.13 120.04 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -138.69 149.32 44.99 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.876 0.871 . . . . 0.0 111.326 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -75.65 144.51 41.65 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.98 -0.45 . . . . 0.0 110.648 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -62.13 -15.04 42.92 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.18 102.03 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.37 1.468 . . . . 0.0 109.419 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.52 156.66 25.71 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.789 1.635 . . . . 0.0 111.568 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.8 p -74.39 159.62 83.17 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.42 -15.52 8.73 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.242 3.295 . . . . 0.0 115.412 170.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -28.75 69.35 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.506 1.922 . . . . 0.0 112.909 172.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.46 23.73 25.72 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.401 1.476 . . . . 0.0 114.387 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -135.44 162.01 33.84 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.313 1.445 . . . . 0.0 111.918 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -54.83 135.79 47.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.283 1.033 . . . . 0.0 110.966 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.4 tp -109.69 78.07 1.1 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.942 1.297 . . . . 0.0 111.386 -169.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.96 149.52 22.54 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.934 1.294 . . . . 0.0 113.665 -171.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 tp -58.17 135.2 57.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.001 1.32 . . . . 0.0 110.081 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.6 m -127.38 127.11 43.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.793 1.237 . . . . 0.0 111.276 -174.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -66.9 132.23 93.89 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.762 0.825 . . . . 0.0 111.654 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.27 -10.34 22.38 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.1 2.534 . . . . 0.0 114.348 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.81 85.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 123.994 0.807 . . . . 0.0 114.64 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -148.53 150.89 34.16 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.94 1.696 . . . . 0.0 111.046 -171.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -90.67 159.55 16.33 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.588 1.155 . . . . 0.0 111.005 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 49.87 39.27 17.96 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.163 1.385 . . . . 0.0 112.969 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.3 m -135.03 137.52 27.27 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.907 1.683 . . . . 0.0 110.401 -169.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -53.41 152.92 18.97 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.514 3.476 . . . . 0.0 114.752 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.3 t -102.68 150.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.777 1.231 . . . . 0.0 110.801 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -122.76 172.85 8.13 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.159 1.383 . . . . 0.0 111.215 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.36 139.92 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.938 1.295 . . . . 0.0 111.352 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.9 m -151.76 166.06 16.06 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.401 1.081 . . . . 0.0 112.962 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.14 162.73 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 124.03 3.154 . . . . 0.0 114.113 169.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.5 tp -126.97 143.24 51.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.137 1.375 . . . . 0.0 111.485 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -145.68 -30.38 0.41 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.037 1.335 . . . . 0.0 113.579 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.94 -9.63 1.8 Allowed Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.259 1.409 . . . . 0.0 114.156 -174.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.4 t -64.21 140.35 58.86 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.825 1.313 . . . . 0.0 112.108 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -61.56 -12.63 16.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.584 1.554 . . . . 0.0 114.286 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.19 -22.49 65.73 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.162 -0.961 . . . . 0.0 112.027 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -106.69 1.78 25.32 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.998 1.719 . . . . 0.0 113.296 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.67 147.75 25.64 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.143 0.973 . . . . 0.0 111.489 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -141.31 169.77 16.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.54 1.136 . . . . 0.0 111.776 -169.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.18 138.79 42.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 126.729 2.012 . . . . 0.0 108.011 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.7 tp -136.84 127.94 27.83 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.847 1.659 . . . . 0.0 109.459 -173.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -143.5 142.28 31.09 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.895 0.878 . . . . 0.0 111.374 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.6 t -66.65 142.15 57.55 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.099 0.56 . . . . 0.0 111.176 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -115.18 -52.6 2.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.291 1.036 . . . . 0.0 111.522 174.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.73 110.64 4.99 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.648 1.179 . . . . 0.0 111.306 171.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.7 m -58.43 -24.43 60.18 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.938 0.895 . . . . 0.0 111.447 168.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -64.1 -21.62 66.6 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.998 2.119 . . . . 0.0 113.421 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 m -130.29 10.89 5.37 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.9 1.68 . . . . 0.0 113.021 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 44.5 33.93 1.0 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.491 1.916 . . . . 0.0 113.794 -169.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.1 p -89.63 144.61 25.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.859 0.864 . . . . 0.0 112.055 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -140.2 142.18 35.89 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.539 1.535 . . . . 0.0 110.838 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.0 p -77.83 146.61 35.62 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.012 0.525 . . . . 0.0 110.506 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.6 mm -128.02 125.93 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.402 1.481 . . . . 0.0 109.094 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.2 m -142.46 143.41 26.64 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 124.556 1.142 . . . . 0.0 110.391 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.93 140.7 42.66 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.061 2.507 . . . . 0.0 110.682 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.35 -25.65 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.27 -13.93 59.53 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.45 1.024 . . . . 0.0 114.752 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.5 m -140.45 61.44 16.41 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.421 1.488 . . . . 0.0 111.517 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -61.58 -17.43 54.12 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.659 2.906 . . . . 0.0 113.295 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -71.68 8.66 1.07 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 128.105 2.562 . . . . 0.0 114.079 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.9 m -141.1 172.19 13.02 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.504 2.321 . . . . 0.0 111.32 172.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -137.27 171.65 14.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.081 2.152 . . . . 0.0 112.045 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.97 124.28 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.805 1.242 . . . . 0.0 110.36 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.48 -160.89 8.51 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.806 1.67 . . . . 0.0 111.891 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -139.92 140.01 36.31 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.65 1.18 . . . . 0.0 111.449 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.46 -166.82 12.4 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.2 1.381 . . . . 0.0 113.384 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.0 137.95 20.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.073 1.349 . . . . 0.0 113.143 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.79 -7.08 62.86 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.735 1.159 . . . . 0.0 114.06 -172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 48.49 57.66 6.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.384 1.874 . . . . 0.0 113.829 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.87 149.74 71.39 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 126.176 1.79 . . . . 0.0 108.461 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.07 144.4 57.55 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.595 1.53 . . . . 0.0 110.042 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.38 145.6 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.73 1.612 . . . . 0.0 111.859 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.0 t -74.22 122.83 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.149 0.979 . . . . 0.0 110.346 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 mp -132.4 163.09 52.97 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.802 2.041 . . . . 0.0 110.481 -169.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.31 165.41 32.65 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.75 2.3 . . . . 0.0 111.97 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.3 126.12 20.52 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.04 2.494 . . . . 0.0 112.026 170.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -149.63 -90.75 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.087 0.955 . . . . 0.0 110.184 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -156.27 16.82 0.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.832 1.653 . . . . 0.0 112.513 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -66.27 132.6 48.77 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.324 0.65 . . . . 0.0 111.839 -171.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.0 m -144.21 160.69 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.093 1.357 . . . . 0.0 111.827 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -131.5 136.5 47.94 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.29 1.436 . . . . 0.0 110.411 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 61.7 m -72.73 132.87 44.2 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.542 1.137 . . . . 0.0 109.195 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.5 mt -124.17 73.68 1.25 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.844 0.857 . . . . 0.0 109.419 -174.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.0 m -74.59 125.27 28.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.369 1.067 . . . . 0.0 110.698 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 tp -69.05 146.4 52.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.267 0.627 . . . . 0.0 111.168 171.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 p -126.92 175.72 7.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.609 1.564 . . . . 0.0 111.009 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.1 m -59.72 -11.62 5.48 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.0 24.3 0.33 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.898 1.237 . . . . 0.0 114.42 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.19 -149.03 11.25 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 118.298 1.049 . . . . 0.0 112.895 -173.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -133.81 169.73 16.64 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.22 2.208 . . . . 0.0 111.894 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -136.14 145.89 46.31 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.082 2.153 . . . . 0.0 109.451 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -125.7 122.87 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.401 1.08 . . . . 0.0 108.914 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -139.27 157.68 45.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.344 1.058 . . . . 0.0 112.737 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -60.33 -29.74 69.08 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.914 1.686 . . . . 0.0 115.284 -173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 128.91 -40.07 1.76 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.892 1.711 . . . . 0.0 113.237 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -79.9 -10.25 59.76 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.653 1.181 . . . . 0.0 113.927 173.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 68.52 12.8 8.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.848 2.059 . . . . 0.0 112.837 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.8 p -74.12 -25.06 59.56 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.159 1.384 . . . . 0.0 112.512 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.2 m -144.31 171.35 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.908 1.683 . . . . 0.0 111.915 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.6 t -144.85 154.15 42.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.864 2.466 . . . . 0.0 109.938 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -69.95 145.45 51.88 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.62 -0.675 . . . . 0.0 111.603 170.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.9 p -150.32 177.04 10.33 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.112 0.965 . . . . 0.0 112.329 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.15 166.86 18.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.493 1.917 . . . . 0.0 109.354 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -110.01 -32.17 7.12 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.875 0.87 . . . . 0.0 112.023 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -139.94 -10.13 1.16 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.677 1.991 . . . . 0.0 112.644 170.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.18 24.29 7.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.82 1.648 . . . . 0.0 114.302 -169.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.3 p -73.45 154.85 39.79 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.783 -1.198 . . . . 0.0 111.0 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.45 142.83 58.03 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.154 -0.967 . . . . 0.0 112.001 173.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.43 5.8 89.12 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.667 1.127 . . . . 0.0 114.297 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -75.4 137.69 41.19 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.783 1.291 . . . . 0.0 112.61 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -72.94 123.91 24.41 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.5 -0.75 . . . . 0.0 110.167 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.0 t -60.92 149.39 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.564 0.746 . . . . 0.0 110.623 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.4 p -125.06 166.44 16.37 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.817 1.247 . . . . 0.0 112.384 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 84.8 mt -135.03 142.04 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.151 1.381 . . . . 0.0 109.185 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.37 177.96 46.65 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.728 1.156 . . . . 0.0 111.73 174.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.38 -40.15 48.86 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 119.087 1.443 . . . . 0.0 114.212 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -168.97 174.45 6.36 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.661 2.784 . . . . 0.0 110.734 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.92 141.23 38.49 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.183 0.993 . . . . 0.0 111.627 169.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.0 t -62.86 -21.09 65.71 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -169.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -137.94 -35.21 0.64 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p -97.52 3.46 50.66 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 114.19 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.95 17.83 1.23 Allowed Glycine 0 CA--C 1.542 1.767 0 C-N-CA 125.805 1.669 . . . . 0.0 115.805 -176.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -140.07 146.37 38.85 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.238 1.815 . . . . 0.0 110.766 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -140.4 175.85 9.26 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.812 1.245 . . . . 0.0 112.184 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.1 p -140.85 138.87 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.856 1.262 . . . . 0.0 109.409 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.18 125.92 74.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 125.785 1.634 . . . . 0.0 107.144 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -149.13 154.2 38.86 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.866 1.266 . . . . 0.0 109.101 -171.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -67.86 155.43 39.39 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.86 -1.15 . . . . 0.0 112.663 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.7 t . . . . . 0 C--O 1.252 1.227 0 C-N-CA 126.127 1.771 . . . . 0.0 111.28 171.853 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.0 20.86 0.11 Allowed Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.754 1.169 . . . . 0.0 114.527 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -151.41 156.44 40.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.174 1.39 . . . . 0.0 111.895 -177.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -59.55 -17.0 28.9 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.344 1.858 . . . . 0.0 115.602 -174.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -111.63 2.66 17.41 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.882 1.273 . . . . 0.0 113.555 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -75.77 -12.42 60.18 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -134.68 -1.56 2.76 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.974 1.31 . . . . 0.0 113.642 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.0 m80 55.65 17.93 2.58 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.742 2.017 . . . . 0.0 116.097 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -125.7 13.4 8.03 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.8 1.64 . . . . 0.0 112.988 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -125.71 6.36 7.46 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.555 1.542 . . . . 0.0 113.049 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.7 p -133.66 -3.82 2.93 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.361 1.864 . . . . 0.0 113.672 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.51 172.92 40.04 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.843 1.687 . . . . 0.0 112.662 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -146.75 6.53 0.92 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.884 1.274 . . . . 0.0 113.337 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.0 m -147.48 162.21 32.97 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 125.92 1.688 . . . . 0.0 111.594 -172.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.13 158.25 5.33 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.969 3.112 . . . . 0.0 114.907 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.32 34.15 1.08 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -170.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 p -143.15 157.44 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 126.132 1.773 . . . . 0.0 111.25 -171.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.3 t -146.57 11.31 1.12 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.8 mt 60.05 166.85 0.07 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.198 2.199 . . . . 0.0 114.151 -174.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 m -151.44 159.41 44.22 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.296 1.839 . . . . 0.0 109.231 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.41 136.27 56.94 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.307 -0.871 . . . . 0.0 111.505 174.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.62 -164.77 37.55 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 114.788 0.675 . . . . 0.0 114.788 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -95.06 125.58 39.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.217 1.007 . . . . 0.0 110.213 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -134.62 172.26 13.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.694 1.598 . . . . 0.0 111.973 -172.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.2 pt -126.17 154.22 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.919 1.687 . . . . 0.0 108.535 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.9 mt -128.9 119.41 49.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -141.24 152.88 44.91 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.359 0.663 . . . . 0.0 111.655 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -88.43 133.32 34.15 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.029 -0.419 . . . . 0.0 111.289 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -62.52 -18.69 62.49 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t -61.6 -27.34 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.298 1.039 . . . . 0.0 112.509 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.4 mt 58.85 168.88 0.06 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.698 1.999 . . . . 0.0 113.496 -171.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.7 p -70.59 159.73 84.03 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 121.016 -1.053 . . . . 0.0 112.129 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.45 -16.85 48.46 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.898 2.399 . . . . 0.0 112.929 171.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -73.31 -18.22 61.22 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.424 1.49 . . . . 0.0 112.689 170.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.51 25.78 17.43 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.012 1.291 . . . . 0.0 113.512 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -127.22 169.31 13.62 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.095 1.358 . . . . 0.0 112.202 -175.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -58.33 144.04 42.84 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.594 1.158 . . . . 0.0 111.467 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.3 tp -125.06 73.2 1.28 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.876 1.27 . . . . 0.0 111.236 -169.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.25 149.62 28.93 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.503 1.521 . . . . 0.0 114.014 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.35 139.92 57.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.332 1.053 . . . . 0.0 109.598 169.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 m -132.34 123.41 26.76 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.216 1.006 . . . . 0.0 111.611 -174.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -60.18 129.65 88.74 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 126.4 1.88 . . . . 0.0 111.507 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.14 -3.86 14.19 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.736 2.957 . . . . 0.0 115.12 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.78 9.03 87.43 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 119.046 0.839 . . . . 0.0 114.702 -176.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -144.75 164.59 30.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.156 1.382 . . . . 0.0 112.476 -170.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -101.97 157.85 16.56 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.729 1.212 . . . . 0.0 109.841 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 49.27 33.72 5.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.022 1.329 . . . . 0.0 113.607 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.0 m -129.0 136.27 28.92 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 126.111 1.764 . . . . 0.0 110.083 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.6 149.18 19.11 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.771 3.647 . . . . 0.0 115.237 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.51 151.46 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.101 1.361 . . . . 0.0 110.819 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 m -122.14 175.78 6.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.22 1.408 . . . . 0.0 111.394 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.68 139.94 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.801 1.24 . . . . 0.0 111.516 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.0 m -152.68 166.43 15.4 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 124.249 1.02 . . . . 0.0 113.326 -171.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.7 161.32 6.15 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.652 2.901 . . . . 0.0 113.127 168.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.3 tp -121.84 138.44 54.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.461 1.104 . . . . 0.0 111.74 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -139.53 -37.18 0.5 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.744 2.018 . . . . 0.0 112.363 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.82 3.77 1.07 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.908 1.242 . . . . 0.0 115.334 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.7 t -63.44 153.84 34.04 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.476 1.638 . . . . 0.0 112.381 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.7 p -70.52 -11.16 60.75 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -75.16 -23.62 57.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.29 0.95 . . . . 0.0 112.209 175.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.72 3.55 11.66 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.33 2.652 . . . . 0.0 112.259 -170.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.46 148.88 32.18 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.337 1.455 . . . . 0.0 110.315 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -136.24 172.98 12.22 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.699 1.238 . . . . 0.0 112.537 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.1 mt -129.83 135.18 61.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 126.735 2.014 . . . . 0.0 106.709 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.5 tp -134.65 128.8 33.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.349 1.459 . . . . 0.0 109.472 -169.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -143.06 130.6 21.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.782 0.833 . . . . 0.0 110.383 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 t -64.02 138.49 58.48 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.485 0.584 . . . . 0.0 111.287 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -115.27 -51.86 2.69 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.32 1.048 . . . . 0.0 111.471 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.43 109.35 4.45 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.255 1.022 . . . . 0.0 111.127 170.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.9 m -58.03 -25.99 61.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.841 0.857 . . . . 0.0 111.141 168.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -62.79 -20.62 65.18 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.151 2.18 . . . . 0.0 113.598 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 t -130.42 9.98 5.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.684 1.593 . . . . 0.0 112.996 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 47.46 32.59 2.4 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.986 1.714 . . . . 0.0 114.087 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -90.24 140.72 29.41 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.857 -1.152 . . . . 0.0 112.362 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -138.32 145.09 40.78 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.865 1.666 . . . . 0.0 110.791 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.2 p -77.89 150.14 34.15 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.974 173.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 mm -124.54 127.75 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.374 1.47 . . . . 0.0 109.274 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.3 m -140.33 143.76 34.57 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.85 1.66 . . . . 0.0 110.22 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.87 147.24 30.57 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.121 2.548 . . . . 0.0 111.637 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.47 -29.89 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 121.122 -0.986 . . . . 0.0 111.882 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.75 -26.1 73.58 Favored Glycine 0 CA--C 1.538 1.506 0 O-C-N 121.705 -0.622 . . . . 0.0 114.448 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -145.64 64.95 10.91 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.508 1.523 . . . . 0.0 111.587 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.95 -13.65 36.35 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.505 2.803 . . . . 0.0 113.938 -174.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -73.7 10.04 1.24 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.926 2.09 . . . . 0.0 113.979 169.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.9 p -138.53 174.64 10.32 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.417 1.487 . . . . 0.0 112.389 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -142.11 168.25 20.2 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.942 1.297 . . . . 0.0 113.024 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -117.4 130.34 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.69 1.196 . . . . 0.0 110.849 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.35 -158.62 7.63 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.86 1.695 . . . . 0.0 111.69 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -142.25 141.95 32.55 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.452 1.101 . . . . 0.0 111.474 -173.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.39 -166.48 12.53 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.409 1.48 . . . . 0.0 113.184 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.45 138.15 22.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.016 1.326 . . . . 0.0 113.128 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.55 -6.56 63.06 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.731 1.158 . . . . 0.0 114.196 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 49.45 57.33 6.61 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.323 1.849 . . . . 0.0 113.976 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.7 149.34 71.73 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.327 1.851 . . . . 0.0 108.19 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.09 144.73 58.62 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.435 1.423 . . . . 0.0 109.712 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.35 150.01 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.782 1.633 . . . . 0.0 111.257 -176.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.83 136.28 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.262 0.625 . . . . 0.0 110.854 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.4 mt -134.63 158.3 75.39 Favored Pre-proline 0 C--O 1.239 0.549 0 C-N-CA 126.331 1.852 . . . . 0.0 111.65 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -60.59 164.89 12.42 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 122.649 2.233 . . . . 0.0 112.927 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.64 124.95 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.662 2.242 . . . . 0.0 110.665 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -147.99 -95.54 0.08 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.038 0.935 . . . . 0.0 110.354 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -155.24 21.06 0.42 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.163 1.785 . . . . 0.0 112.146 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -67.34 139.13 57.2 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.69 -0.631 . . . . 0.0 111.565 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.5 m -144.89 159.34 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.689 1.196 . . . . 0.0 112.047 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -128.76 148.67 50.87 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.528 1.531 . . . . 0.0 110.251 169.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 79.2 m -76.51 132.88 39.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.963 1.305 . . . . 0.0 109.209 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.41 115.98 22.51 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.391 1.077 . . . . 0.0 108.954 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 55.4 m -134.09 128.78 34.89 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.67 0.788 . . . . 0.0 110.968 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.8 mt -63.0 153.37 34.05 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 p -127.89 178.63 6.04 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.496 1.918 . . . . 0.0 110.057 170.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -61.56 -8.25 4.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.17 37.85 0.26 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.799 1.19 . . . . 0.0 113.578 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.57 -153.02 22.79 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.133 0.873 . . . . 0.0 113.231 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -132.26 169.25 16.73 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.718 2.407 . . . . 0.0 111.731 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -130.81 154.3 48.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.026 2.131 . . . . 0.0 110.295 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.4 mt -135.04 114.72 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.624 1.17 . . . . 0.0 109.176 -172.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -134.29 156.07 49.1 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.062 0.945 . . . . 0.0 112.312 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -61.63 -30.16 70.52 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -170.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.83 -40.5 1.6 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.855 1.693 . . . . 0.0 112.785 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -84.39 -5.64 59.3 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.966 1.307 . . . . 0.0 113.888 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 57.17 18.13 3.97 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.752 2.021 . . . . 0.0 113.415 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.5 p -72.07 -24.54 61.53 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.394 1.077 . . . . 0.0 112.259 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.3 m -143.75 173.92 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.943 1.697 . . . . 0.0 111.982 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 t -146.39 152.48 39.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.409 2.683 . . . . 0.0 109.979 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -70.57 144.78 51.13 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.385 -0.822 . . . . 0.0 111.8 170.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.6 p -152.88 174.76 13.69 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.067 1.347 . . . . 0.0 112.273 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -128.68 170.18 13.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.161 1.784 . . . . 0.0 110.199 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -109.03 -36.58 6.04 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.431 0.693 . . . . 0.0 111.864 -169.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -144.91 -0.15 0.92 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.091 1.756 . . . . 0.0 114.495 173.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.26 23.27 1.61 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.878 2.071 . . . . 0.0 116.122 -171.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.4 p -75.22 156.35 35.88 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.779 -1.201 . . . . 0.0 112.06 172.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.26 138.18 57.48 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.472 -0.767 . . . . 0.0 111.836 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.19 4.68 89.59 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.885 1.231 . . . . 0.0 114.422 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.6 146.96 30.95 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.198 1.499 . . . . 0.0 112.783 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -76.14 130.88 38.94 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.265 -0.897 . . . . 0.0 110.781 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.22 151.21 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.906 0.482 . . . . 0.0 110.453 173.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.8 m -129.9 164.45 24.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.464 1.506 . . . . 0.0 111.783 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.4 mt -133.56 143.27 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.305 1.442 . . . . 0.0 109.556 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.61 179.98 48.01 Favored Glycine 0 N--CA 1.471 0.976 0 C-N-CA 124.832 1.206 . . . . 0.0 111.745 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.79 -41.16 61.48 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 119.155 1.477 . . . . 0.0 114.27 -173.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -169.11 170.33 8.84 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.004 2.522 . . . . 0.0 109.906 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.42 130.61 23.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.155 0.982 . . . . 0.0 112.446 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.1 t -56.59 -28.75 61.04 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -122.36 -26.72 4.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.437 1.095 . . . . 0.0 113.856 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 72.9 p -116.48 0.02 12.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.757 1.223 . . . . 0.0 114.1 -171.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.14 33.88 0.65 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.619 2.057 . . . . 0.0 114.827 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 145.99 22.51 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.279 2.232 . . . . 0.0 110.597 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -143.3 175.72 9.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.422 1.489 . . . . 0.0 111.556 -168.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.4 p -139.44 138.9 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.488 1.115 . . . . 0.0 109.643 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.76 125.02 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 C-N-CA 125.984 1.714 . . . . 0.0 107.11 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -149.13 155.07 40.13 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.644 1.178 . . . . 0.0 109.08 -170.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -68.65 155.79 39.39 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.022 -1.049 . . . . 0.0 112.549 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.9 t . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.086 1.754 . . . . 0.0 111.301 171.856 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.83 3.69 0.97 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.262 0.934 . . . . 0.0 115.43 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -137.59 5.72 2.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.728 1.211 . . . . 0.0 114.034 -169.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -133.91 1.94 3.35 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.45 13.11 3.8 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.458 1.503 . . . . 0.0 113.443 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -132.88 20.28 4.15 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.902 1.681 . . . . 0.0 112.477 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -56.01 -18.9 10.64 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.618 1.567 . . . . 0.0 114.557 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -64.5 -24.75 67.72 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.553 1.541 . . . . 0.0 114.15 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -141.44 -8.61 0.98 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -138.59 172.58 12.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.908 1.683 . . . . 0.0 110.985 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.0 m 49.61 29.43 3.04 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.714 1.606 . . . . 0.0 114.811 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.69 -22.57 0.09 OUTLIER Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.566 1.079 . . . . 0.0 114.881 -171.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -128.39 0.24 5.66 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.975 1.31 . . . . 0.0 113.537 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.4 p -69.25 160.2 79.92 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.829 1.652 . . . . 0.0 112.907 172.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.4 144.88 38.61 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.952 3.101 . . . . 0.0 114.539 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.76 31.01 1.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.329 1.451 . . . . 0.0 112.249 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.19 151.22 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.938 1.295 . . . . 0.0 110.702 175.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -145.38 8.64 1.19 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt 62.03 161.13 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.508 2.323 . . . . 0.0 113.918 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.2 m -152.5 165.33 35.44 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.366 1.867 . . . . 0.0 109.228 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.78 130.59 44.08 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 121.5 -0.75 . . . . 0.0 110.958 169.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.06 -165.31 38.66 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 114.721 0.648 . . . . 0.0 114.721 -175.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -95.64 122.99 38.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.168 0.987 . . . . 0.0 110.304 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -133.98 174.74 10.15 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.246 1.418 . . . . 0.0 112.424 -172.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.0 pt -131.08 155.98 42.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 126.246 1.818 . . . . 0.0 108.936 171.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 mt -127.49 127.72 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -142.47 147.88 36.81 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.762 0.825 . . . . 0.0 111.564 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -78.06 133.44 37.91 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.92 -0.487 . . . . 0.0 111.043 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -60.91 -25.51 66.8 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.4 t -63.93 -36.42 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.827 0.851 . . . . 0.0 112.36 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mp 56.87 172.44 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.079 1.752 . . . . 0.0 115.308 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.3 t -87.61 139.2 31.47 Favored Pre-proline 0 N--CA 1.469 0.505 0 O-C-N 121.133 -0.979 . . . . 0.0 112.163 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.33 -15.98 12.51 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.993 3.129 . . . . 0.0 114.598 168.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.0 tpt85 -64.34 -19.16 65.27 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.14 1.776 . . . . 0.0 113.173 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.65 27.69 23.82 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.409 1.48 . . . . 0.0 113.709 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -140.06 152.56 46.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.897 1.279 . . . . 0.0 112.043 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -64.55 146.64 54.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.927 1.691 . . . . 0.0 113.363 -171.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.1 mt -115.48 75.79 0.96 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.144 1.778 . . . . 0.0 111.447 -175.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.81 150.25 29.25 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.4 tp -58.6 134.39 56.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.304 1.442 . . . . 0.0 109.529 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 m -127.07 125.28 41.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.741 1.216 . . . . 0.0 111.192 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 79' ' ' PRO . 38.3 t80 -66.19 138.63 96.12 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.842 1.257 . . . . 0.0 112.094 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -76.56 -15.16 17.57 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.132 2.555 . . . . 0.0 114.911 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.31 3.72 69.23 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.535 1.064 . . . . 0.0 115.012 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -155.31 179.91 8.71 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.681 1.993 . . . . 0.0 110.756 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -110.42 170.64 7.95 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.939 1.295 . . . . 0.0 111.158 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 50.63 40.75 24.6 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.411 1.884 . . . . 0.0 112.83 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 m -140.87 141.59 24.95 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 126.14 1.776 . . . . 0.0 110.344 -169.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -52.95 163.31 2.13 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 125.293 3.995 . . . . 0.0 115.981 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.9 t -115.01 149.68 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.127 1.371 . . . . 0.0 110.857 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 m -127.8 176.0 7.9 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.301 1.441 . . . . 0.0 111.261 -168.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.7 m -123.43 156.29 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.965 -1.084 . . . . 0.0 112.045 170.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.3 m -153.0 167.05 14.15 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 124.946 1.298 . . . . 0.0 112.375 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.05 118.53 5.44 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.682 2.921 . . . . 0.0 111.671 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.63 134.76 52.96 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.789 -0.569 . . . . 0.0 111.842 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -138.61 3.42 2.29 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.566 1.546 . . . . 0.0 113.712 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.5 0.67 86.28 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.943 1.258 . . . . 0.0 115.033 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.7 t -63.29 147.41 51.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.402 1.601 . . . . 0.0 112.401 175.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.7 m -59.53 -13.51 9.35 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.325 1.45 . . . . 0.0 114.405 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.03 -26.16 63.91 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.162 0.892 . . . . 0.0 112.371 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -118.63 0.89 11.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.906 1.682 . . . . 0.0 114.45 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.16 145.48 27.96 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.617 1.167 . . . . 0.0 110.55 171.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -136.05 169.96 16.78 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 123.015 1.388 . . . . 0.0 112.546 -168.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.1 mt -117.54 137.15 52.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 128.578 2.751 . . . . 0.0 107.3 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.2 tp -134.65 128.99 34.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.573 1.549 . . . . 0.0 109.211 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -142.65 138.17 30.47 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.469 1.108 . . . . 0.0 110.732 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.8 t -67.81 141.26 56.55 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.947 0.499 . . . . 0.0 110.552 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -108.8 -51.25 2.91 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.623 1.169 . . . . 0.0 110.715 174.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.21 109.87 4.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.142 1.377 . . . . 0.0 110.595 169.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.9 m -56.96 -24.38 52.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.945 0.898 . . . . 0.0 111.745 168.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -65.21 -20.93 66.67 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.096 2.158 . . . . 0.0 113.589 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -130.8 14.59 5.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.838 1.655 . . . . 0.0 112.844 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 43.36 33.77 0.65 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.571 1.948 . . . . 0.0 114.113 -169.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -85.9 145.56 27.11 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.893 -1.129 . . . . 0.0 112.037 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -141.52 148.97 40.25 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.149 1.38 . . . . 0.0 111.58 -177.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.3 p -91.34 145.78 24.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.25 1.02 . . . . 0.0 110.641 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.8 mm -127.91 115.76 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.768 2.027 . . . . 0.0 110.257 -172.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.4 m -134.62 146.15 57.89 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 123.882 0.873 . . . . 0.0 110.712 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HG3' ' CE1' ' A' ' 42' ' ' TYR . 62.2 Cg_endo -70.8 146.59 54.17 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.729 2.286 . . . . 0.0 109.92 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.31 -22.06 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.82 -11.13 54.27 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.554 1.073 . . . . 0.0 115.241 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.5 m -144.22 62.0 9.68 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.954 1.302 . . . . 0.0 111.795 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.49 -17.1 46.15 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.109 3.206 . . . . 0.0 113.846 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -71.65 19.02 0.07 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 128.653 2.781 . . . . 0.0 114.497 169.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.6 p -142.31 164.96 28.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.044 1.738 . . . . 0.0 112.226 171.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -143.83 140.37 29.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.568 1.547 . . . . 0.0 111.09 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.4 mm -85.04 132.25 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.79 -0.569 . . . . 0.0 111.086 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.1 -165.11 10.77 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.889 2.185 . . . . 0.0 112.021 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -144.04 141.62 30.2 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.387 1.075 . . . . 0.0 111.674 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.26 -163.55 11.05 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.319 1.438 . . . . 0.0 113.31 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.64 140.41 18.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.987 1.315 . . . . 0.0 113.207 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.93 -7.85 70.21 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.572 1.082 . . . . 0.0 114.012 -172.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 48.22 58.05 5.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.334 1.854 . . . . 0.0 113.853 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.2 m -133.25 149.25 72.03 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 126.272 1.829 . . . . 0.0 107.458 169.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.47 145.29 58.37 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.298 1.142 . . . . 0.0 109.395 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.06 172.06 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.581 1.952 . . . . 0.0 109.797 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -119.51 136.25 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.323 -0.861 . . . . 0.0 111.215 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -140.87 165.15 31.52 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 127.27 2.228 . . . . 0.0 110.474 -169.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -77.3 155.41 32.67 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.497 2.131 . . . . 0.0 111.643 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.39 124.85 12.61 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.194 3.263 . . . . 0.0 113.537 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -149.49 -88.85 0.08 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.616 1.166 . . . . 0.0 110.428 -176.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -154.89 8.84 0.31 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.23 1.412 . . . . 0.0 114.218 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.02 139.82 54.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.384 -0.822 . . . . 0.0 110.845 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.3 m -148.93 164.26 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.112 1.365 . . . . 0.0 111.417 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -129.47 131.36 46.67 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.121 1.369 . . . . 0.0 110.536 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.8 m -75.93 130.57 38.68 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.275 1.03 . . . . 0.0 109.559 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.7 mt -117.38 129.58 55.95 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.569 1.147 . . . . 0.0 109.447 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 m -137.02 129.29 29.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.093 0.957 . . . . 0.0 110.228 -170.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.2 mt -65.68 153.62 41.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.697 0.76 . . . . 0.0 113.025 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.1 p -127.78 -179.22 4.83 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.024 1.73 . . . . 0.0 110.274 170.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 75.7 p -60.89 -12.81 12.26 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.0 29.45 0.29 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.422 1.011 . . . . 0.0 114.658 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 176.95 -153.06 13.01 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 118.386 1.093 . . . . 0.0 113.25 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -131.58 169.74 15.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.108 2.163 . . . . 0.0 112.266 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -136.49 149.72 48.31 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.424 2.289 . . . . 0.0 109.462 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.9 mt -132.58 115.61 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.678 1.191 . . . . 0.0 109.106 -170.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -135.91 149.89 49.12 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.513 1.125 . . . . 0.0 111.649 -169.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -55.11 -34.12 63.43 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.082 0.953 . . . . 0.0 113.129 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.49 -29.83 2.85 Favored Glycine 0 N--CA 1.47 0.965 0 C-N-CA 125.856 1.693 . . . . 0.0 113.916 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -79.61 -6.02 56.23 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 60.59 12.92 3.88 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.474 2.31 . . . . 0.0 114.048 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.3 p -65.75 -28.19 68.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.837 2.055 . . . . 0.0 112.761 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.0 m -144.89 171.06 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.014 1.725 . . . . 0.0 112.135 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.2 t -146.15 156.02 43.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.413 2.685 . . . . 0.0 110.032 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -72.23 145.25 48.09 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.49 -0.756 . . . . 0.0 111.866 171.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.7 p -154.41 177.18 11.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.056 1.342 . . . . 0.0 112.232 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -118.96 169.52 9.82 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.644 1.578 . . . . 0.0 110.211 173.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -95.26 -33.32 12.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.354 0.662 . . . . 0.0 111.979 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -144.8 0.52 0.97 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.479 1.912 . . . . 0.0 114.42 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.08 26.54 3.88 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.864 2.066 . . . . 0.0 116.038 -172.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.5 p -82.6 160.16 22.57 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 120.965 -1.084 . . . . 0.0 112.246 172.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.14 141.46 58.76 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.303 -0.873 . . . . 0.0 111.93 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.28 1.19 89.52 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.178 0.894 . . . . 0.0 114.817 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -83.35 149.69 26.57 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.99 1.395 . . . . 0.0 113.45 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -74.87 136.76 41.5 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.312 -0.867 . . . . 0.0 111.056 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.0 t -70.34 154.54 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.106 0.479 . . . . 0.0 110.568 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -131.58 164.92 24.79 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.342 1.857 . . . . 0.0 111.343 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.6 mt -136.8 140.27 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.572 1.549 . . . . 0.0 109.638 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.99 177.96 47.14 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 125.056 1.312 . . . . 0.0 111.44 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.09 36.48 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.315 1.557 . . . . 0.0 114.553 -171.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -170.28 171.25 6.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.561 2.744 . . . . 0.0 108.968 176.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.0 127.21 21.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.766 0.826 . . . . 0.0 111.176 170.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.9 t -60.67 -14.17 19.15 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.258 1.823 . . . . 0.0 115.682 -170.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -128.65 -38.85 1.68 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.356 1.063 . . . . 0.0 113.185 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.3 p -111.96 2.99 17.19 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -171.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.37 13.83 0.53 Allowed Glycine 0 CA--C 1.539 1.537 0 N-CA-C 116.327 1.291 . . . . 0.0 116.327 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -134.68 147.84 50.2 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.255 2.027 . . . . 0.0 111.074 -172.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -139.8 176.01 9.1 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.491 1.516 . . . . 0.0 112.371 -168.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.3 t -135.82 139.14 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.101 1.36 . . . . 0.0 109.099 170.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.7 125.7 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 169.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.19 154.67 39.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.477 1.111 . . . . 0.0 109.56 -171.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -68.11 155.79 38.82 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.043 -1.036 . . . . 0.0 112.606 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.6 t . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.131 1.772 . . . . 0.0 111.31 171.584 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 110.784 -0.08 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.73 13.67 0.14 Allowed Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.372 0.909 . . . . 0.0 115.372 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -156.7 -175.31 5.36 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.187 1.795 . . . . 0.0 110.482 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -122.88 -1.56 8.86 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.699 1.6 . . . . 0.0 113.668 -174.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -140.77 168.49 19.67 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.321 1.849 . . . . 0.0 111.452 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -151.54 170.63 19.18 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.816 1.247 . . . . 0.0 111.34 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -142.43 -3.69 1.03 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.243 1.417 . . . . 0.0 114.643 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -134.98 -8.86 2.34 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.155 1.382 . . . . 0.0 113.809 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -130.06 -2.67 4.56 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.586 1.554 . . . . 0.0 113.766 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -149.83 163.03 39.12 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.419 1.487 . . . . 0.0 111.318 177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -144.56 144.28 31.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.613 1.565 . . . . 0.0 111.841 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.02 10.11 0.08 OUTLIER Glycine 0 CA--C 1.539 1.544 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -137.29 15.06 3.0 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.43 1.492 . . . . 0.0 112.302 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.585 ' H ' ' CD ' ' A' ' 15' ' ' PRO . 77.5 p -146.75 -23.48 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.606 1.962 . . . . 0.0 116.214 -174.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.585 ' CD ' ' H ' ' A' ' 14' ' ' SER . 87.7 Cg_exo -53.79 143.86 57.15 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 122.579 2.186 . . . . 0.0 113.836 169.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.59 15.52 1.61 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 t -146.75 147.46 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.427 1.891 . . . . 0.0 110.156 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.1 t -143.19 11.33 1.75 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.605 1.562 . . . . 0.0 113.303 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.7 mt 58.35 170.58 0.06 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.245 2.218 . . . . 0.0 113.917 -173.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.0 m -161.56 162.05 30.05 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.704 2.002 . . . . 0.0 109.222 177.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.15 137.11 58.13 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.544 -0.722 . . . . 0.0 111.923 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.79 -160.11 32.89 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 123.901 0.762 . . . . 0.0 114.937 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -98.48 122.62 41.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.919 1.288 . . . . 0.0 110.616 173.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -134.65 172.71 12.56 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.773 1.229 . . . . 0.0 112.698 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.44 154.25 38.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 126.458 1.903 . . . . 0.0 108.57 170.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.3 mt -124.97 126.91 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -141.26 150.38 42.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.05 0.54 . . . . 0.0 112.156 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -77.07 134.98 38.61 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.589 -0.694 . . . . 0.0 111.298 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -61.48 -28.32 69.21 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.41 -32.19 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.379 0.672 . . . . 0.0 112.042 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.5 mt 55.3 171.39 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.453 1.901 . . . . 0.0 114.208 -169.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.6 t -65.18 147.31 98.65 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 121.133 -0.979 . . . . 0.0 111.18 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.13 -22.05 18.32 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.319 2.679 . . . . 0.0 114.14 169.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -84.04 -14.32 50.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.846 1.258 . . . . 0.0 113.733 175.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.2 2.18 62.34 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.98 1.752 . . . . 0.0 114.289 -174.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -75.03 159.74 31.37 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.597 1.159 . . . . 0.0 112.203 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -61.97 156.03 22.16 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.805 0.842 . . . . 0.0 112.191 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.5 mt -130.65 66.84 1.51 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.48 1.512 . . . . 0.0 111.134 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.76 141.66 36.1 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.601 1.16 . . . . 0.0 112.857 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.57 128.21 36.02 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.039 0.936 . . . . 0.0 108.789 169.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.0 m -128.37 115.0 17.56 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.055 0.942 . . . . 0.0 110.801 -170.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -59.89 135.19 90.03 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 126.934 2.094 . . . . 0.0 112.086 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.89 -11.45 19.89 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.289 2.659 . . . . 0.0 114.602 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.63 8.83 82.37 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-O 119.079 -0.845 . . . . 0.0 115.119 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -156.72 165.34 36.51 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.303 1.441 . . . . 0.0 112.134 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -87.74 166.6 14.52 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.436 1.095 . . . . 0.0 111.768 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 49.85 36.91 12.26 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.83 1.652 . . . . 0.0 113.839 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.8 m -135.97 138.55 27.97 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 126.228 1.811 . . . . 0.0 110.206 -169.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.3 160.57 4.63 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.94 3.76 . . . . 0.0 115.81 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.5 t -111.56 148.71 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.904 1.281 . . . . 0.0 110.724 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 m -123.36 167.24 14.06 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.256 1.422 . . . . 0.0 110.774 -169.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 p -121.48 138.25 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.167 0.987 . . . . 0.0 111.212 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.5 m -156.51 168.17 12.94 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 124.355 1.062 . . . . 0.0 112.882 -169.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.14 152.59 10.59 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.648 2.899 . . . . 0.0 114.286 169.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.4 tp -105.6 137.2 43.83 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.459 1.504 . . . . 0.0 110.45 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -135.23 -24.24 1.43 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.075 1.35 . . . . 0.0 112.751 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.18 5.83 9.35 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.199 1.381 . . . . 0.0 113.759 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 m -61.85 150.48 37.2 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.485 1.142 . . . . 0.0 111.532 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.2 p -61.8 -15.05 38.4 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -72.86 -24.01 60.82 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.355 1.062 . . . . 0.0 112.412 171.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -104.88 -9.33 18.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.519 1.927 . . . . 0.0 112.621 -174.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.62 142.0 34.5 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.596 1.158 . . . . 0.0 111.328 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -135.73 171.34 14.6 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.944 1.355 . . . . 0.0 112.111 -169.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.1 mt -126.17 136.45 60.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.024 2.13 . . . . 0.0 106.747 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.7 tp -136.84 126.53 25.46 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.948 1.299 . . . . 0.0 109.446 -169.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.2 mtp-105 -141.46 140.84 33.65 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.753 0.821 . . . . 0.0 111.121 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.0 t -65.24 141.56 58.59 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.908 0.483 . . . . 0.0 110.929 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -115.12 -51.27 2.72 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.434 1.094 . . . . 0.0 111.093 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.23 109.25 4.45 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.379 1.071 . . . . 0.0 110.996 169.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.2 m -59.18 -26.47 64.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.801 0.84 . . . . 0.0 111.166 168.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -60.99 -20.94 63.05 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.012 2.125 . . . . 0.0 113.398 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -130.26 6.32 4.91 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.308 1.843 . . . . 0.0 113.237 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 47.37 30.44 1.55 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.142 2.177 . . . . 0.0 114.281 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.0 p -90.6 143.58 26.6 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.25 -0.907 . . . . 0.0 112.367 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -139.31 141.64 37.71 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.683 1.593 . . . . 0.0 111.104 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.5 p -77.87 147.71 34.98 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.711 -0.618 . . . . 0.0 111.06 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.0 mm -129.26 127.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.421 1.488 . . . . 0.0 109.71 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.0 m -142.84 142.38 22.25 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.197 1.399 . . . . 0.0 110.355 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.1 145.39 31.05 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.217 2.611 . . . . 0.0 111.314 176.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.53 -28.22 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.311 -0.868 . . . . 0.0 111.769 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.55 -24.96 76.17 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 114.868 0.707 . . . . 0.0 114.868 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.9 m -148.17 65.51 8.83 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 125.429 1.492 . . . . 0.0 111.614 -176.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -64.13 -17.9 61.47 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.843 3.028 . . . . 0.0 113.669 -173.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -69.96 -2.62 13.04 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 127.688 2.395 . . . . 0.0 114.636 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.2 m -132.8 174.72 10.02 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.372 1.869 . . . . 0.0 111.686 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -141.27 172.66 12.37 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.371 1.469 . . . . 0.0 113.164 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -115.99 127.25 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.903 1.281 . . . . 0.0 110.413 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.56 -157.48 7.18 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.489 1.519 . . . . 0.0 111.35 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -141.99 142.24 32.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.135 0.974 . . . . 0.0 111.665 -171.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.94 -165.25 12.1 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.361 1.458 . . . . 0.0 113.466 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.59 135.15 23.44 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.265 1.426 . . . . 0.0 113.049 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.23 -8.64 59.08 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.969 1.271 . . . . 0.0 114.012 -172.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 49.29 56.16 8.23 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.485 1.914 . . . . 0.0 113.949 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.9 m -133.89 150.43 74.5 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 126.266 1.826 . . . . 0.0 108.065 169.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.01 142.71 52.02 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.225 1.283 . . . . 0.0 109.721 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.05 151.5 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.815 1.646 . . . . 0.0 111.536 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.14 132.18 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.074 0.95 . . . . 0.0 111.044 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.34 161.45 57.2 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.833 1.653 . . . . 0.0 112.193 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -65.04 174.06 5.26 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 123.277 2.652 . . . . 0.0 113.31 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.67 104.15 1.68 Allowed 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.779 2.319 . . . . 0.0 111.01 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.405 ' HB3' ' CE2' ' A' ' 103' ' ' TYR . 65.2 t30 -143.46 13.51 1.77 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.657 1.183 . . . . 0.0 113.356 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 70.37 40.88 1.07 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.913 2.485 . . . . 0.0 113.773 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.405 ' CE2' ' HB3' ' A' ' 101' ' ' ASN . 90.7 m-85 -61.97 143.46 56.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.089 0.556 . . . . 0.0 110.887 169.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.92 156.55 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.206 1.002 . . . . 0.0 112.253 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -129.8 137.06 50.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.496 1.518 . . . . 0.0 110.448 172.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.9 m -71.0 134.23 46.98 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.698 1.199 . . . . 0.0 108.895 169.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.7 mt -126.24 73.93 1.41 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.878 0.871 . . . . 0.0 109.966 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.3 m -78.93 129.12 34.16 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.269 1.028 . . . . 0.0 111.116 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.7 tp -71.2 145.83 49.44 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.455 0.702 . . . . 0.0 111.226 171.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 p -124.55 -177.17 3.72 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.741 1.616 . . . . 0.0 111.719 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.2 p -59.04 -13.44 6.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.22 25.96 0.18 Allowed Glycine 0 CA--C 1.533 1.197 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 178.55 -149.25 8.87 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.023 1.296 . . . . 0.0 112.127 -173.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -131.77 168.44 17.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.286 1.834 . . . . 0.0 112.024 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -134.15 142.43 47.46 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.393 2.277 . . . . 0.0 109.515 174.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.1 mt -124.37 121.78 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.419 1.088 . . . . 0.0 109.231 -171.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -138.17 158.04 45.09 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.194 1.398 . . . . 0.0 112.68 -171.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -59.8 -18.18 41.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 125.23 -35.71 3.01 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.916 1.722 . . . . 0.0 112.623 -169.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -110.17 4.18 20.82 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.503 1.921 . . . . 0.0 113.557 -170.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? 57.39 21.6 7.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.858 2.063 . . . . 0.0 113.781 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.1 p -77.62 -30.58 52.35 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.391 -0.818 . . . . 0.0 112.02 175.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.1 m -148.07 155.81 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.667 1.587 . . . . 0.0 111.959 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.1 t -130.5 153.37 48.89 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.577 1.951 . . . . 0.0 111.248 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.3 m0 -69.88 139.57 53.05 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.289 0.635 . . . . 0.0 111.812 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 88.1 p -147.76 175.06 11.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.929 1.292 . . . . 0.0 111.909 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.43 151.33 46.35 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.53 1.532 . . . . 0.0 109.898 173.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -82.59 -33.56 27.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.179 0.992 . . . . 0.0 111.704 -169.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -138.93 -6.21 1.45 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.674 1.99 . . . . 0.0 112.634 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.79 32.36 14.78 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.852 1.661 . . . . 0.0 114.243 -170.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.3 p -81.58 156.63 25.1 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.26 1.024 . . . . 0.0 111.509 170.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.84 139.59 57.77 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.252 -0.905 . . . . 0.0 111.674 172.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.67 86.0 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.125 1.345 . . . . 0.0 114.718 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -79.64 144.65 33.57 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.929 1.292 . . . . 0.0 113.25 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -75.7 128.44 35.21 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.854 -1.154 . . . . 0.0 110.655 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.95 148.53 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.182 0.593 . . . . 0.0 110.799 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.7 t -126.07 160.83 29.04 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.812 1.245 . . . . 0.0 111.779 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.8 mt -134.22 140.86 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.823 1.649 . . . . 0.0 109.292 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 169.43 -159.73 32.69 Favored Glycine 0 N--CA 1.468 0.815 0 C-N-CA 123.776 0.703 . . . . 0.0 112.61 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.96 149.68 18.32 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 117.62 0.71 . . . . 0.0 111.764 169.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -52.63 119.09 4.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.482 1.513 . . . . 0.0 113.428 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.23 164.12 26.3 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.848 1.259 . . . . 0.0 114.174 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 t -93.65 -9.44 37.9 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.785 1.234 . . . . 0.0 114.229 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -142.11 -44.93 0.34 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.483 1.113 . . . . 0.0 113.028 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.8 p -91.61 1.93 56.81 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.6 5.09 6.07 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 126.414 1.959 . . . . 0.0 116.281 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -126.48 150.84 48.48 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.408 1.483 . . . . 0.0 112.252 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -142.16 175.98 9.33 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 127.389 2.276 . . . . 0.0 110.104 -169.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.65 139.7 28.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 124.354 1.062 . . . . 0.0 109.529 169.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -118.22 124.82 73.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 125.694 1.598 . . . . 0.0 107.15 174.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -147.74 153.44 39.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.644 1.178 . . . . 0.0 109.433 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.97 155.91 39.51 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.998 -1.064 . . . . 0.0 112.945 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 C--O 1.251 1.175 0 C-N-CA 126.221 1.808 . . . . 0.0 111.284 171.877 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.423 0.154 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.16 22.14 0.3 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.301 0.953 . . . . 0.0 114.527 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -154.91 171.66 19.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.262 1.825 . . . . 0.0 111.306 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -139.14 0.53 1.94 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.876 1.27 . . . . 0.0 113.272 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -152.52 167.67 28.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.905 1.682 . . . . 0.0 111.43 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -149.24 154.61 39.33 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.121 1.368 . . . . 0.0 110.882 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -148.79 151.37 34.67 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.906 1.283 . . . . 0.0 111.168 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -154.45 164.63 38.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.709 1.603 . . . . 0.0 111.142 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -150.01 148.15 28.7 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.31 1.044 . . . . 0.0 111.51 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -156.3 -33.6 0.09 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.461 1.504 . . . . 0.0 112.128 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.9 p -150.17 173.9 13.4 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.337 1.855 . . . . 0.0 111.578 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.87 -21.82 0.03 OUTLIER Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.048 0.832 . . . . 0.0 114.773 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -139.34 162.43 35.03 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.066 1.747 . . . . 0.0 110.905 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.0 p -152.43 160.62 31.01 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 125.409 1.484 . . . . 0.0 111.544 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.43 148.27 34.49 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.52 2.813 . . . . 0.0 114.164 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.01 31.64 1.13 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.884 1.273 . . . . 0.0 112.651 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.19 143.21 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.547 1.539 . . . . 0.0 110.622 -172.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.7 p -129.26 1.87 5.15 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.064 1.746 . . . . 0.0 112.969 -171.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt 68.24 160.62 0.18 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 129.294 3.037 . . . . 0.0 113.165 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.1 m -151.45 159.53 44.15 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.668 1.987 . . . . 0.0 108.955 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.84 131.14 48.83 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.489 -0.757 . . . . 0.0 111.858 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.1 -163.11 36.86 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -100.56 126.93 47.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.128 0.971 . . . . 0.0 110.345 174.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.05 172.3 13.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.238 1.415 . . . . 0.0 112.292 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 pt -126.96 152.14 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.111 1.764 . . . . 0.0 108.518 172.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.1 mt -131.04 115.89 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -140.49 151.48 44.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.702 0.763 . . . . 0.0 112.408 -177.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -81.45 136.72 35.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.436 -173.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.8 mtp-105 -65.13 -18.22 65.12 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.9 t -66.23 -22.64 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.135 0.974 . . . . 0.0 112.375 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.4 mt 59.82 172.95 0.08 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.656 1.982 . . . . 0.0 113.718 -172.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.6 p -67.19 162.86 51.0 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.506 1.122 . . . . 0.0 112.024 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -68.23 -4.55 12.93 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 122.827 2.351 . . . . 0.0 112.961 170.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -100.76 -8.72 22.46 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.858 2.063 . . . . 0.0 113.32 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.4 24.42 28.81 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.489 1.042 . . . . 0.0 113.987 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.52 170.37 12.09 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.816 1.247 . . . . 0.0 111.836 -176.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -56.77 144.16 33.92 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.015 -1.053 . . . . 0.0 111.557 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.7 tp -125.11 72.98 1.26 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.328 1.451 . . . . 0.0 109.887 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.31 151.42 24.77 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.676 -1.147 . . . . 0.0 113.718 -170.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.59 134.05 55.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.852 0.861 . . . . 0.0 108.897 168.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 85.6 m -134.54 126.05 28.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.864 0.865 . . . . 0.0 111.123 -170.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -60.49 130.3 89.93 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.518 1.927 . . . . 0.0 111.948 -176.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.32 -10.41 19.1 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.442 2.761 . . . . 0.0 114.465 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.53 -2.32 58.91 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.318 0.961 . . . . 0.0 115.152 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -160.28 171.22 19.54 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.082 1.353 . . . . 0.0 112.94 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -96.51 169.14 10.1 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.403 1.881 . . . . 0.0 111.121 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 mmt-85 52.13 32.51 10.61 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.113 1.765 . . . . 0.0 114.022 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.1 m -137.11 138.13 24.69 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.301 1.441 . . . . 0.0 110.731 -169.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.7 155.38 10.59 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.567 3.512 . . . . 0.0 114.847 172.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 t -105.03 153.81 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.867 1.267 . . . . 0.0 110.542 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 m -125.42 171.06 10.77 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.197 1.399 . . . . 0.0 110.186 -170.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.64 141.66 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.911 -1.118 . . . . 0.0 112.047 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.1 m -153.12 166.16 16.1 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.052 0.941 . . . . 0.0 112.327 -171.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.86 164.79 2.2 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.648 2.898 . . . . 0.0 113.564 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tt -127.59 141.8 51.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.729 1.211 . . . . 0.0 111.785 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -143.36 -13.6 0.69 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.43 -8.35 8.94 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.096 1.332 . . . . 0.0 114.347 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -63.44 157.86 22.21 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.895 1.348 . . . . 0.0 113.302 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 p -64.22 -11.91 35.64 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -66.53 -36.32 82.4 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.207 1.003 . . . . 0.0 112.161 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.81 6.4 11.49 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.58 147.27 24.04 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.793 0.806 . . . . 0.0 111.652 172.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -138.61 172.09 13.4 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.661 1.22 . . . . 0.0 112.306 -169.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.2 mt -120.77 135.47 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.498 2.319 . . . . 0.0 107.066 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.28 122.3 19.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.123 1.369 . . . . 0.0 109.544 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -140.92 137.98 33.52 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.309 0.644 . . . . 0.0 111.633 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.5 t -64.46 138.94 58.69 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.124 0.569 . . . . 0.0 111.151 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -115.17 -51.29 2.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.557 1.143 . . . . 0.0 111.339 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.52 109.96 4.81 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.583 1.153 . . . . 0.0 111.625 170.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.1 m -58.98 -23.72 62.02 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.025 0.93 . . . . 0.0 111.468 168.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.07 -21.69 66.62 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.075 2.15 . . . . 0.0 113.341 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -130.4 7.8 4.97 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.956 1.703 . . . . 0.0 113.002 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 46.56 34.87 2.6 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.667 1.987 . . . . 0.0 113.47 -168.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.6 p -92.34 142.76 27.1 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.531 -0.731 . . . . 0.0 112.275 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -138.73 144.15 39.37 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.86 1.664 . . . . 0.0 110.478 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.0 p -77.96 150.1 34.03 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.56 0.744 . . . . 0.0 111.018 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.8 mm -128.73 126.87 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 0.0 109.479 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 m -144.92 145.93 29.35 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.701 1.601 . . . . 0.0 110.51 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.27 145.41 34.49 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.832 2.354 . . . . 0.0 110.831 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.5 m -65.22 -24.69 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.004 -1.06 . . . . 0.0 113.119 177.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.65 -17.96 60.94 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.062 0.839 . . . . 0.0 114.61 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 42.5 m -144.1 62.14 9.99 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.434 1.494 . . . . 0.0 110.962 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -61.8 -18.59 61.59 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.013 3.142 . . . . 0.0 113.423 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -71.35 9.33 0.81 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 128.314 2.645 . . . . 0.0 114.148 169.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.1 p -138.44 172.53 12.75 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.886 1.675 . . . . 0.0 111.966 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -141.44 169.75 17.02 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.167 1.387 . . . . 0.0 112.837 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 mm -115.97 128.48 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.932 1.293 . . . . 0.0 110.567 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.37 -160.77 8.55 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.778 1.656 . . . . 0.0 111.926 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -140.27 139.63 35.56 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.443 1.097 . . . . 0.0 111.468 -172.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.18 -164.85 11.39 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.383 1.468 . . . . 0.0 113.208 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.3 139.38 19.16 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.928 1.291 . . . . 0.0 113.084 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.3 -7.72 66.63 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.825 1.202 . . . . 0.0 114.13 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 47.97 56.42 7.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.516 1.926 . . . . 0.0 113.974 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.71 150.96 76.17 Favored Pre-proline 0 C--O 1.24 0.571 0 C-N-CA 126.112 1.765 . . . . 0.0 108.386 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.87 142.67 58.11 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.23 1.286 . . . . 0.0 109.762 173.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.8 m -132.84 150.46 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.681 1.592 . . . . 0.0 111.354 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 t -83.26 132.92 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.764 0.826 . . . . 0.0 110.816 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.6 mt -138.39 162.33 54.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.982 1.713 . . . . 0.0 112.384 -169.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -61.1 167.19 9.48 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.824 2.349 . . . . 0.0 113.302 174.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.66 125.98 10.46 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.735 2.29 . . . . 0.0 110.216 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -146.95 -106.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.806 1.242 . . . . 0.0 109.304 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -145.22 21.55 1.55 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.518 1.927 . . . . 0.0 110.471 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -66.53 133.75 51.0 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.386 -0.821 . . . . 0.0 111.385 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.4 m -144.78 160.27 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.964 1.306 . . . . 0.0 111.812 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -130.84 148.77 52.66 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.406 1.482 . . . . 0.0 110.406 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.9 m -74.98 139.11 42.73 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.168 0.987 . . . . 0.0 109.262 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.59 73.92 1.22 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.143 0.977 . . . . 0.0 109.31 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 93.2 m -76.96 118.9 19.99 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.289 1.036 . . . . 0.0 110.594 -176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 tp -66.98 146.48 54.33 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.285 0.634 . . . . 0.0 111.156 170.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.2 p -125.42 -178.42 4.22 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.685 1.594 . . . . 0.0 111.233 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.0 t -60.26 -18.48 49.3 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -158.7 28.2 0.42 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.445 1.021 . . . . 0.0 114.465 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.63 -153.07 16.61 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.459 1.028 . . . . 0.0 113.018 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -133.1 168.71 18.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.87 2.068 . . . . 0.0 111.981 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -135.88 151.23 49.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.685 1.994 . . . . 0.0 110.412 171.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.7 mt -132.17 114.55 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.033 0.933 . . . . 0.0 109.949 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -135.47 156.43 48.91 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.199 1.0 . . . . 0.0 111.973 -169.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -60.35 -31.23 70.12 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.457 1.503 . . . . 0.0 114.829 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 133.09 -40.76 1.56 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.658 2.075 . . . . 0.0 112.797 -174.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -81.37 -6.45 58.93 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.676 1.19 . . . . 0.0 114.05 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 59.18 16.08 4.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.962 2.105 . . . . 0.0 113.999 -170.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.5 p -69.73 -23.39 63.39 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.871 1.268 . . . . 0.0 112.265 178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.7 m -144.27 170.01 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.101 1.76 . . . . 0.0 111.701 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 t -142.38 156.83 45.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.729 2.012 . . . . 0.0 110.676 173.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -70.9 138.72 50.38 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.234 0.614 . . . . 0.0 111.354 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.9 p -149.29 173.0 13.97 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.549 1.14 . . . . 0.0 112.504 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.1 mt -123.97 173.59 8.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.911 1.684 . . . . 0.0 109.879 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -111.41 -33.73 6.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.079 0.952 . . . . 0.0 111.459 -171.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -140.98 -9.49 1.01 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.646 1.978 . . . . 0.0 112.683 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.71 24.28 8.81 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.055 1.742 . . . . 0.0 114.784 -169.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 p -71.88 154.75 41.04 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.19 -0.944 . . . . 0.0 111.181 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.2 143.43 54.0 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.887 -1.133 . . . . 0.0 111.764 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.07 4.2 89.65 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.481 1.038 . . . . 0.0 114.153 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -73.56 142.58 46.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.825 1.313 . . . . 0.0 112.46 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -77.62 111.37 13.31 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.777 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 p -54.7 149.09 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.895 0.878 . . . . 0.0 111.434 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.7 t -130.55 168.63 16.76 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.561 1.544 . . . . 0.0 112.008 -169.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.8 mt -134.74 141.73 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.041 1.736 . . . . 0.0 108.866 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.91 -162.97 36.77 Favored Glycine 0 CA--C 1.526 0.722 0 O-C-N 121.52 -0.737 . . . . 0.0 112.283 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.61 153.56 10.15 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 117.631 0.715 . . . . 0.0 111.803 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -53.51 122.3 9.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.664 1.186 . . . . 0.0 113.039 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.69 173.68 7.81 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.228 1.411 . . . . 0.0 113.703 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 t -105.15 -5.06 21.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.821 1.248 . . . . 0.0 114.355 -172.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -148.44 -41.04 0.16 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.353 1.061 . . . . 0.0 112.821 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.2 p -96.91 4.98 51.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.376 1.47 . . . . 0.0 114.487 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.87 2.66 16.09 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.908 1.242 . . . . 0.0 115.575 -174.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -130.32 146.31 51.9 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.897 1.848 . . . . 0.0 111.134 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -136.97 174.36 10.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.875 1.27 . . . . 0.0 111.835 -168.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.5 p -138.53 139.14 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.757 1.223 . . . . 0.0 109.461 172.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.81 124.49 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 125.627 1.571 . . . . 0.0 107.067 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.98 153.78 38.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.856 -170.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -67.9 155.57 39.12 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.074 -1.016 . . . . 0.0 112.429 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.5 t . . . . . 0 C--O 1.252 1.205 0 C-N-CA 125.996 1.719 . . . . 0.0 111.228 172.429 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.17 10.5 0.22 Allowed Glycine 0 CA--C 1.538 1.508 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 177.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -154.26 169.76 22.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.253 1.821 . . . . 0.0 110.258 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 55.52 16.41 1.84 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.85 2.06 . . . . 0.0 115.307 -175.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -140.03 -4.63 1.34 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.973 1.709 . . . . 0.0 113.214 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -153.76 156.55 37.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.827 1.651 . . . . 0.0 110.845 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -148.22 19.85 1.09 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -171.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -134.22 169.95 16.43 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 120.99 -1.069 . . . . 0.0 112.772 -171.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -67.71 164.25 19.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.823 0.849 . . . . 0.0 112.314 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -148.76 155.7 41.34 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.257 1.423 . . . . 0.0 111.524 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.7 p -151.13 158.67 44.3 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.804 1.242 . . . . 0.0 112.958 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.94 25.85 0.06 OUTLIER Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.325 0.964 . . . . 0.0 114.651 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -143.69 21.4 1.82 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.034 1.334 . . . . 0.0 112.73 -171.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.2 m -141.21 148.85 53.07 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 125.536 1.534 . . . . 0.0 111.372 -175.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -73.51 158.72 47.42 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.116 2.544 . . . . 0.0 112.589 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.99 29.35 1.49 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.31 1.444 . . . . 0.0 112.263 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.57 147.02 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.581 1.552 . . . . 0.0 110.374 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.7 t -133.83 8.73 3.85 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.5 mt 58.42 175.44 0.06 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.978 2.111 . . . . 0.0 113.967 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 t -159.94 170.1 22.07 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.29 1.436 . . . . 0.0 109.825 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 140.46 58.55 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 121.701 -0.625 . . . . 0.0 112.271 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.14 -162.37 33.15 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.203 0.906 . . . . 0.0 114.391 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -95.19 125.33 39.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.017 0.927 . . . . 0.0 110.174 170.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -134.19 170.87 15.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.367 1.467 . . . . 0.0 112.312 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.8 pt -123.9 151.55 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 126.119 1.768 . . . . 0.0 108.361 170.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.1 mt -128.18 120.12 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -139.94 149.83 43.79 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.743 0.817 . . . . 0.0 112.061 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -75.9 136.39 40.11 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.655 -0.653 . . . . 0.0 111.79 -174.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.4 tpt85 -65.76 -15.47 62.88 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.5 t -70.35 -20.66 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.633 1.173 . . . . 0.0 112.489 172.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 61.13 167.87 0.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.108 2.163 . . . . 0.0 112.569 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.0 t -65.8 150.02 96.82 Favored Pre-proline 0 CA--C 1.539 0.556 0 O-C-N 121.191 -0.943 . . . . 0.0 111.072 171.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.61 -14.89 42.64 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.87 2.38 . . . . 0.0 112.97 169.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -71.39 -15.32 62.36 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.403 1.481 . . . . 0.0 113.104 169.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.07 27.74 36.36 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.744 1.64 . . . . 0.0 113.792 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.83 166.1 19.7 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.25 1.42 . . . . 0.0 111.514 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.04 141.22 54.57 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.437 0.695 . . . . 0.0 111.572 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.1 tp -122.39 74.4 1.17 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.094 1.758 . . . . 0.0 109.2 -169.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.29 147.13 29.07 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.352 1.461 . . . . 0.0 114.547 -169.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.1 tp -58.16 136.18 57.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.232 1.013 . . . . 0.0 109.148 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.1 m -132.94 121.94 23.57 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.982 0.913 . . . . 0.0 111.373 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -60.01 130.96 89.27 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.526 2.331 . . . . 0.0 111.498 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.63 -8.58 19.44 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.6 2.866 . . . . 0.0 114.432 -177.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.02 -2.27 65.92 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.227 0.917 . . . . 0.0 114.958 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -156.46 169.85 23.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.084 1.354 . . . . 0.0 113.001 -173.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -99.46 159.28 15.13 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.345 1.858 . . . . 0.0 110.527 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 57.49 39.9 27.57 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.788 1.635 . . . . 0.0 113.402 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.1 m -142.22 139.2 17.49 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 125.963 1.705 . . . . 0.0 110.733 -172.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -52.96 156.95 8.79 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.869 3.713 . . . . 0.0 115.389 172.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 t -105.29 156.81 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.947 1.299 . . . . 0.0 110.711 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.6 m -127.94 170.16 13.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.715 1.606 . . . . 0.0 110.644 -171.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.1 140.16 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.843 1.257 . . . . 0.0 111.425 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.4 m -152.82 164.21 21.04 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 124.513 1.125 . . . . 0.0 112.758 -172.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -53.6 159.35 6.67 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.735 2.957 . . . . 0.0 113.604 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.2 tp -116.46 140.41 49.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.654 1.182 . . . . 0.0 111.725 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -140.68 -37.55 0.45 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.633 1.973 . . . . 0.0 112.517 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.11 3.58 1.21 Allowed Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.82 1.2 . . . . 0.0 115.374 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -62.39 154.68 27.4 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.535 1.667 . . . . 0.0 112.388 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.4 p -68.95 -14.79 63.25 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 173.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.57 -22.72 60.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.202 0.91 . . . . 0.0 112.343 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.73 6.4 11.56 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.111 2.564 . . . . 0.0 112.687 -169.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.17 149.51 37.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.966 1.306 . . . . 0.0 110.896 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -136.83 171.87 13.85 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 123.008 1.385 . . . . 0.0 112.856 -168.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.6 mt -120.2 135.33 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.948 2.499 . . . . 0.0 106.472 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.0 tp -135.73 126.21 26.84 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.116 1.366 . . . . 0.0 109.101 -172.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -142.82 139.59 30.99 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.634 0.773 . . . . 0.0 110.899 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.4 t -65.31 140.19 58.67 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.934 0.494 . . . . 0.0 110.874 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -109.84 -52.74 2.74 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.608 1.163 . . . . 0.0 110.62 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -145.18 106.86 4.25 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.721 1.208 . . . . 0.0 110.841 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 m -51.81 -31.81 28.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.204 1.802 . . . . 0.0 114.604 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 71' ' ' ASN . 3.2 p30 -73.71 -18.04 61.05 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.504 2.322 . . . . 0.0 114.151 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -117.51 6.37 12.54 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.923 1.689 . . . . 0.0 113.073 171.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 43.97 33.44 0.77 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.018 2.127 . . . . 0.0 114.267 -169.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -87.44 145.42 26.29 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.722 -1.236 . . . . 0.0 112.04 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -141.24 141.72 33.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.999 1.319 . . . . 0.0 111.422 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 p -80.46 146.58 31.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.76 0.824 . . . . 0.0 111.225 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.0 mm -130.16 122.26 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.45 1.5 . . . . 0.0 111.037 -171.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 m -142.04 147.66 45.37 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 125.256 1.423 . . . . 0.0 110.894 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.74 146.94 34.45 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.82 2.347 . . . . 0.0 110.977 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.0 m -65.6 -23.96 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.864 -1.148 . . . . 0.0 112.793 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.87 -6.58 72.12 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.6 1.095 . . . . 0.0 114.889 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.3 t -152.81 67.39 6.52 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 118.565 1.182 . . . . 0.0 111.867 176.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.16 -13.35 31.43 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.686 2.257 . . . . 0.0 113.103 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -78.16 11.26 2.41 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.473 1.909 . . . . 0.0 113.447 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.5 m -136.89 169.29 18.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.5 1.92 . . . . 0.0 111.783 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -141.61 167.18 22.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.353 1.461 . . . . 0.0 111.842 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.8 mm -119.18 130.98 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.665 1.186 . . . . 0.0 110.89 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.0 -158.86 8.26 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.722 1.629 . . . . 0.0 111.676 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -140.54 143.54 35.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.457 1.103 . . . . 0.0 111.792 -172.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.9 -165.34 12.16 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.394 1.474 . . . . 0.0 113.018 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.92 139.71 21.66 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.914 1.286 . . . . 0.0 113.185 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.12 -5.71 65.97 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.762 1.173 . . . . 0.0 114.18 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 48.38 55.85 8.31 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.6 1.96 . . . . 0.0 114.401 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.68 149.07 69.78 Favored Pre-proline 0 C--O 1.24 0.567 0 C-N-CA 126.291 1.837 . . . . 0.0 107.573 169.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.4 147.64 59.2 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.022 1.148 . . . . 0.0 109.802 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.32 149.93 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.743 1.617 . . . . 0.0 110.973 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.2 t -77.7 137.34 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.504 0.721 . . . . 0.0 110.368 173.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.9 mt -138.89 164.63 38.12 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.069 2.148 . . . . 0.0 110.677 -170.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.92 159.74 52.18 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 122.109 1.872 . . . . 0.0 111.178 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.23 119.84 6.57 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.031 2.487 . . . . 0.0 110.328 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -144.11 -88.46 0.12 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 110.752 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -156.09 14.59 0.33 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.102 1.361 . . . . 0.0 113.414 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -70.15 134.34 48.03 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.408 -0.808 . . . . 0.0 111.477 -174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.64 160.02 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.484 1.113 . . . . 0.0 112.344 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -128.07 135.07 49.32 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.989 1.316 . . . . 0.0 110.769 171.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.0 m -76.45 129.18 36.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.753 1.221 . . . . 0.0 109.391 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 42.4 mt -117.05 129.34 55.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.097 0.959 . . . . 0.0 109.793 -178.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 m -133.27 118.03 18.07 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.649 1.18 . . . . 0.0 110.212 -169.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp -65.07 147.27 53.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.246 0.618 . . . . 0.0 111.335 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.3 p -129.06 -178.84 4.8 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.509 1.524 . . . . 0.0 111.686 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 64.3 p -59.05 -15.0 11.31 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.92 27.51 0.24 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.215 0.912 . . . . 0.0 114.64 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 174.42 -148.35 9.8 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.954 1.264 . . . . 0.0 112.155 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -131.8 172.12 12.69 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.936 2.095 . . . . 0.0 111.547 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -137.82 152.98 49.67 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.774 2.43 . . . . 0.0 109.526 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.7 mt -133.71 126.47 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.309 1.444 . . . . 0.0 108.824 -170.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -140.3 159.43 42.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.643 1.177 . . . . 0.0 113.14 -172.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.71 -24.17 67.54 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -169.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.9 -37.13 2.1 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.613 1.102 . . . . 0.0 113.032 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -117.38 12.17 14.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.478 1.911 . . . . 0.0 113.709 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 62.42 16.63 8.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.757 2.023 . . . . 0.0 114.185 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.9 p -72.16 -29.17 63.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.72 0.808 . . . . 0.0 112.534 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.0 m -145.85 177.45 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.494 1.517 . . . . 0.0 111.837 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t -148.97 153.05 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.648 2.379 . . . . 0.0 110.093 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -69.85 144.92 52.41 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.534 -0.729 . . . . 0.0 111.712 171.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 87.7 p -151.94 171.6 17.55 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.673 1.189 . . . . 0.0 112.734 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.4 mt -125.6 165.78 17.91 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.356 1.862 . . . . 0.0 110.015 174.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -104.8 -32.8 8.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.871 0.869 . . . . 0.0 112.144 -169.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -138.81 -8.33 1.4 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.661 1.984 . . . . 0.0 112.436 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.51 21.68 5.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.009 1.724 . . . . 0.0 114.621 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.2 p -73.08 154.13 40.53 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.961 -1.087 . . . . 0.0 111.683 171.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.65 142.82 58.26 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.299 -0.876 . . . . 0.0 112.263 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.05 1.68 90.08 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.904 1.24 . . . . 0.0 114.479 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.93 141.76 45.96 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.741 1.27 . . . . 0.0 112.776 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -76.22 117.86 18.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.23 -0.919 . . . . 0.0 110.312 173.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.88 148.29 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.804 0.842 . . . . 0.0 111.57 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 t -128.68 167.73 16.8 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.586 1.555 . . . . 0.0 111.781 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.7 mt -135.6 141.22 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.603 1.561 . . . . 0.0 109.582 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -179.41 179.86 48.82 Favored Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.944 1.259 . . . . 0.0 111.605 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.07 -40.41 58.29 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.221 1.51 . . . . 0.0 114.334 -173.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -171.63 173.14 4.75 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 128.844 2.858 . . . . 0.0 109.331 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.74 139.87 36.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.201 1.0 . . . . 0.0 112.629 169.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.6 t -60.98 -20.79 62.83 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -169.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -137.71 -38.88 0.58 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.465 1.106 . . . . 0.0 113.222 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 86.8 p -93.35 3.67 55.24 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.294 1.437 . . . . 0.0 114.606 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.23 15.66 1.37 Allowed Glycine 0 CA--C 1.543 1.799 0 C-N-CA 125.856 1.693 . . . . 0.0 115.763 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -134.73 152.46 51.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.916 1.686 . . . . 0.0 111.451 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -141.77 175.9 9.34 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.884 2.074 . . . . 0.0 110.594 -169.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.82 138.37 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 125.123 1.369 . . . . 0.0 108.588 170.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.77 123.29 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -149.0 154.01 38.73 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.922 1.289 . . . . 0.0 109.239 -171.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.58 155.85 39.2 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.907 -1.12 . . . . 0.0 112.701 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 C--O 1.252 1.211 0 C-N-CA 126.146 1.778 . . . . 0.0 111.276 171.415 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.01 174.87 42.92 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.526 1.06 . . . . 0.0 113.095 176.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -140.04 3.51 2.0 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.622 1.169 . . . . 0.0 113.548 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -61.3 -12.59 14.21 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.476 1.91 . . . . 0.0 115.077 -176.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -125.21 11.11 8.13 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.458 1.903 . . . . 0.0 112.608 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.4 m80 53.66 -167.76 0.07 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.854 2.062 . . . . 0.0 113.936 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -133.95 8.84 3.82 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.741 1.616 . . . . 0.0 112.943 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -152.52 170.61 19.74 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.373 1.869 . . . . 0.0 111.666 -173.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.0 p-80 -152.54 172.5 16.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.658 1.583 . . . . 0.0 111.749 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -147.58 162.65 38.67 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.948 1.299 . . . . 0.0 111.356 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.3 t -138.78 13.04 2.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.944 1.697 . . . . 0.0 112.677 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.99 25.54 2.23 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.709 1.623 . . . . 0.0 113.865 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.92 -13.36 61.66 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.997 1.319 . . . . 0.0 113.815 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.9 m 46.88 54.72 15.61 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 126.778 2.031 . . . . 0.0 115.134 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.41 179.61 4.92 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.567 2.844 . . . . 0.0 113.459 177.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 51.6 39.59 25.3 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.89 1.676 . . . . 0.0 113.593 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.8 t -59.1 138.75 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.05 1.34 . . . . 0.0 110.15 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 t -129.86 10.49 5.52 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -172.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt 60.16 170.85 0.08 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.429 2.292 . . . . 0.0 114.343 -177.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.7 m -149.69 163.16 38.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.315 1.846 . . . . 0.0 109.61 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.17 54.76 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.458 -0.776 . . . . 0.0 111.417 170.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.84 -164.3 36.9 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.914 0.768 . . . . 0.0 114.604 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -94.52 125.65 39.3 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.017 0.927 . . . . 0.0 110.232 170.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -134.64 171.12 14.79 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.428 1.491 . . . . 0.0 112.409 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.7 pt -125.38 152.42 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.173 1.789 . . . . 0.0 108.445 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.9 mt -128.72 119.85 50.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -140.25 148.96 42.25 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.696 0.798 . . . . 0.0 112.555 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -78.7 135.06 37.07 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.903 -0.498 . . . . 0.0 111.544 -174.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -59.59 -22.84 62.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.089 1.356 . . . . 0.0 114.139 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.56 -24.33 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.172 0.989 . . . . 0.0 112.866 175.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.6 mt 60.85 169.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.856 2.062 . . . . 0.0 113.867 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.9 p -75.37 160.6 79.44 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.331 1.052 . . . . 0.0 112.762 -175.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.2 -16.72 44.71 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.596 2.197 . . . . 0.0 112.694 170.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -76.19 -16.76 59.78 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.53 1.532 . . . . 0.0 113.094 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.72 22.2 19.13 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.249 1.404 . . . . 0.0 114.113 177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.38 172.08 12.61 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.895 1.278 . . . . 0.0 112.708 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -57.08 127.55 32.52 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.419 1.088 . . . . 0.0 111.447 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.8 tp -105.41 79.24 1.45 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.675 1.59 . . . . 0.0 110.016 -173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.29 147.64 27.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.788 1.635 . . . . 0.0 114.203 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.4 tp -59.64 138.36 57.76 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.163 1.385 . . . . 0.0 110.863 170.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 m -130.42 126.52 37.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.102 0.961 . . . . 0.0 111.93 -171.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -61.25 130.51 91.66 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 126.319 1.848 . . . . 0.0 111.657 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.41 -6.49 16.39 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.707 2.938 . . . . 0.0 114.878 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.76 -2.29 62.07 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.832 -0.982 . . . . 0.0 115.082 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -160.22 169.75 22.59 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.919 1.359 . . . . 0.0 112.863 -172.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -95.17 167.55 11.3 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.894 1.677 . . . . 0.0 111.405 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.8 tpt85 47.49 40.71 11.77 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.11 2.164 . . . . 0.0 113.694 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.6 m -139.76 140.61 25.21 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 125.159 1.384 . . . . 0.0 111.83 -169.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -44.53 150.18 0.84 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 126.338 4.692 . . . . 0.0 115.424 169.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.57 155.84 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.145 1.378 . . . . 0.0 110.699 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 52' ' ' VAL . 2.9 m -126.74 176.06 7.53 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.753 1.621 . . . . 0.0 111.082 -169.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -130.62 145.74 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.049 1.34 . . . . 0.0 111.452 176.162 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.6 m -151.22 159.67 33.19 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.938 1.295 . . . . 0.0 111.945 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.66 132.38 35.06 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.84 1.693 . . . . 0.0 110.758 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.69 138.73 57.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.161 1.384 . . . . 0.0 111.436 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -132.45 -22.34 2.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.946 1.298 . . . . 0.0 112.594 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.73 -1.82 32.12 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.944 1.735 . . . . 0.0 113.478 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.6 p -80.04 159.42 26.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.792 1.237 . . . . 0.0 113.076 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.3 m -60.19 -18.16 46.24 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.76 -35.26 80.0 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.04 0.936 . . . . 0.0 112.458 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.31 0.0 OUTLIER -120.47 14.06 11.89 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.16 149.69 23.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.267 1.027 . . . . 0.0 111.707 170.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -139.47 171.53 14.13 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.635 1.207 . . . . 0.0 113.131 -169.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.8 mt -120.8 137.04 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 127.721 2.408 . . . . 0.0 107.351 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.5 tp -137.0 125.61 23.73 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.487 1.515 . . . . 0.0 109.491 -171.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -142.88 135.69 27.92 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.08 0.952 . . . . 0.0 110.999 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -63.87 140.23 58.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.321 0.649 . . . . 0.0 111.37 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -112.06 -52.89 2.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.421 1.088 . . . . 0.0 111.25 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -147.89 117.34 6.98 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.13 . . . . 0.0 111.087 169.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -36.18 80.82 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 112.936 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -61.26 -17.35 53.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.927 2.091 . . . . 0.0 114.883 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 m -123.99 8.32 8.67 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.143 1.777 . . . . 0.0 113.624 172.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 43.36 33.56 0.62 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.31 1.844 . . . . 0.0 114.545 -169.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 p -89.25 144.81 25.82 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.386 -1.446 . . . . 0.0 112.316 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -139.71 140.82 36.91 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.357 1.463 . . . . 0.0 111.297 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.4 p -79.02 148.3 32.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.015 0.526 . . . . 0.0 110.858 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.13 129.9 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.524 1.53 . . . . 0.0 109.362 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.0 m -145.63 145.98 27.74 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.641 1.576 . . . . 0.0 110.622 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.19 145.91 35.52 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.999 2.466 . . . . 0.0 111.043 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.71 -25.78 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.925 -1.109 . . . . 0.0 113.057 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.87 -23.44 61.86 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 123.858 0.742 . . . . 0.0 114.388 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m -142.09 64.13 16.75 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.701 1.6 . . . . 0.0 111.112 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -61.3 -19.38 63.7 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.917 3.078 . . . . 0.0 113.244 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -71.19 9.0 0.82 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 128.234 2.614 . . . . 0.0 114.415 169.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.8 p -138.03 172.73 12.49 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.717 1.607 . . . . 0.0 112.345 173.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -137.98 171.6 14.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.917 1.687 . . . . 0.0 112.567 -171.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -120.39 126.7 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.15 1.38 . . . . 0.0 110.728 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.75 -158.59 7.6 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.874 1.702 . . . . 0.0 111.385 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -141.3 144.09 34.43 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.343 1.071 . . . . 0.0 111.763 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.84 -165.2 12.29 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.494 1.521 . . . . 0.0 113.059 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.24 138.92 25.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.003 1.321 . . . . 0.0 113.257 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.18 -1.63 67.62 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.607 1.099 . . . . 0.0 114.354 -173.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 48.52 55.67 8.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.236 1.815 . . . . 0.0 113.669 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.8 p -132.68 137.2 29.25 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 127.695 2.398 . . . . 0.0 107.479 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.31 143.29 47.76 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.112 -1.149 . . . . 0.0 109.112 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.13 147.13 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.178 1.391 . . . . 0.0 110.932 -172.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.64 138.87 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.423 0.689 . . . . 0.0 109.964 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.3 mt -142.31 163.55 38.8 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 125.826 1.65 . . . . 0.0 111.728 -169.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.92 165.77 30.02 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.05 2.5 . . . . 0.0 111.751 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.43 123.7 9.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.555 2.17 . . . . 0.0 110.924 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -147.07 -92.11 0.09 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.164 0.985 . . . . 0.0 110.511 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -154.53 17.47 0.46 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.563 1.545 . . . . 0.0 112.794 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -67.48 134.69 51.81 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.605 0.762 . . . . 0.0 111.92 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.5 m -145.73 161.45 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.059 1.344 . . . . 0.0 112.391 -175.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -129.75 138.19 50.96 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.466 1.506 . . . . 0.0 110.875 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.5 m -74.95 125.52 29.06 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.242 1.417 . . . . 0.0 109.228 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.1 mt -116.46 128.41 55.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 109.876 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.0 m -134.89 121.77 21.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.911 0.884 . . . . 0.0 110.858 -169.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 tp -67.92 148.24 51.38 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.262 0.625 . . . . 0.0 111.448 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 p -129.39 -176.67 3.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.93 1.692 . . . . 0.0 111.452 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.1 p -58.56 -17.71 23.86 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.68 29.37 0.24 Allowed Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.506 1.05 . . . . 0.0 114.017 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.48 -150.99 10.47 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.977 1.275 . . . . 0.0 112.172 -173.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -134.86 171.93 13.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.077 2.151 . . . . 0.0 111.536 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -137.83 154.49 49.51 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.52 1.928 . . . . 0.0 110.91 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 31.5 mt -135.32 118.53 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.084 1.354 . . . . 0.0 110.057 -169.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -134.9 157.96 45.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.218 1.007 . . . . 0.0 112.831 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -62.53 -26.76 68.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -169.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.48 -40.35 1.67 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.145 1.355 . . . . 0.0 113.143 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -98.54 1.5 46.6 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.643 1.577 . . . . 0.0 113.641 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 65.22 12.84 8.34 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.942 2.097 . . . . 0.0 113.738 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.2 p -73.49 -23.84 60.1 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.46 1.104 . . . . 0.0 112.812 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.6 m -143.3 173.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.552 1.541 . . . . 0.0 112.017 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 t -145.17 154.0 41.97 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.582 2.753 . . . . 0.0 109.767 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -72.32 145.24 47.94 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.401 -0.812 . . . . 0.0 111.491 170.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.0 p -154.84 162.14 41.21 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.362 1.065 . . . . 0.0 112.868 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.5 mt -109.91 170.55 8.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.797 1.639 . . . . 0.0 109.375 169.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -109.77 -31.74 7.33 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.224 1.01 . . . . 0.0 112.059 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -135.83 -10.11 2.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.756 2.022 . . . . 0.0 112.081 169.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.65 27.98 11.36 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.98 1.712 . . . . 0.0 113.939 -170.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.1 p -75.47 155.6 36.07 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.222 1.009 . . . . 0.0 111.657 170.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.26 136.54 55.99 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.244 -0.91 . . . . 0.0 111.427 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.03 0.75 88.93 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.466 1.031 . . . . 0.0 114.536 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -71.17 142.72 50.68 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.807 1.303 . . . . 0.0 112.73 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.1 119.87 19.85 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.302 -0.874 . . . . 0.0 110.06 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 p -62.47 150.34 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.521 0.729 . . . . 0.0 111.357 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.1 m -131.95 168.98 16.95 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.309 1.844 . . . . 0.0 111.293 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.6 mt -134.63 143.71 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.05 1.34 . . . . 0.0 109.379 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.28 179.33 47.53 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 124.819 1.2 . . . . 0.0 111.743 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.31 -42.65 61.33 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.963 1.382 . . . . 0.0 114.291 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -169.71 172.93 6.53 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.166 2.586 . . . . 0.0 109.559 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.51 135.02 33.05 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.168 0.987 . . . . 0.0 112.254 170.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.6 t -56.98 -24.56 54.32 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.273 1.829 . . . . 0.0 115.809 -169.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -130.83 -36.41 1.38 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.962 1.305 . . . . 0.0 112.826 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 t -96.3 1.14 51.71 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -171.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.83 26.37 0.77 Allowed Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.105 1.336 . . . . 0.0 115.948 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -145.92 149.7 34.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.17 1.788 . . . . 0.0 111.594 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -141.62 176.76 8.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.956 1.702 . . . . 0.0 111.826 -169.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.22 140.16 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.629 1.572 . . . . 0.0 108.807 169.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.18 123.59 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.98 153.32 37.77 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.599 1.16 . . . . 0.0 109.474 -170.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.09 155.01 40.47 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.945 -1.097 . . . . 0.0 112.736 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.3 t . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.317 1.847 . . . . 0.0 111.31 171.199 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.98 -15.6 0.06 OUTLIER Glycine 0 CA--C 1.538 1.504 0 N-CA-C 115.656 1.022 . . . . 0.0 115.656 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -145.77 161.92 38.83 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.737 1.615 . . . . 0.0 111.221 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -142.15 161.96 36.67 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.701 1.6 . . . . 0.0 111.963 -174.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -147.99 161.64 40.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.011 1.324 . . . . 0.0 111.806 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -146.22 158.23 43.87 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.377 1.471 . . . . 0.0 112.106 -173.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -120.64 -7.2 9.65 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.41 1.484 . . . . 0.0 113.462 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -131.48 7.17 4.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.902 2.081 . . . . 0.0 113.353 -173.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -141.85 -9.88 0.91 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.489 1.516 . . . . 0.0 114.03 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -134.8 -21.04 1.72 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.255 1.422 . . . . 0.0 114.009 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.1 m -132.96 13.57 4.31 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.712 1.605 . . . . 0.0 112.72 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.51 -172.47 44.57 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.803 1.668 . . . . 0.0 112.307 -174.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -141.52 9.0 2.0 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.818 1.647 . . . . 0.0 113.441 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.0 m -149.72 165.66 17.06 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.278 1.831 . . . . 0.0 111.298 -169.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.92 147.83 24.73 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.606 2.87 . . . . 0.0 114.119 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.07 41.69 1.4 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.836 1.254 . . . . 0.0 112.276 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -140.68 161.18 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.191 1.796 . . . . 0.0 111.38 -170.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.0 p -109.71 9.31 24.93 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.478 1.511 . . . . 0.0 113.518 -170.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.2 mt 66.73 167.88 0.23 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.044 2.938 . . . . 0.0 113.523 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.5 m -148.53 162.9 38.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.696 1.998 . . . . 0.0 109.3 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.8 137.24 56.48 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.399 -0.813 . . . . 0.0 111.495 172.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.14 -162.94 36.15 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.312 0.885 . . . . 0.0 115.312 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -94.02 121.85 35.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.01 1.324 . . . . 0.0 110.282 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -133.5 170.49 15.42 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.483 1.113 . . . . 0.0 112.801 -173.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.26 154.74 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 126.353 1.861 . . . . 0.0 108.855 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.0 mt -130.24 120.15 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -145.49 160.53 41.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.777 0.831 . . . . 0.0 112.458 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -99.6 121.44 41.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.486 0.714 . . . . 0.0 110.871 -174.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -63.42 -14.73 53.54 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.8 t -60.57 -26.49 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.324 1.049 . . . . 0.0 112.358 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.4 mt 58.32 175.94 0.06 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.088 1.755 . . . . 0.0 112.666 -170.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.6 p -108.28 164.08 15.54 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 124.663 1.185 . . . . 0.0 113.514 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -55.68 -16.63 15.48 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 124.303 3.336 . . . . 0.0 115.18 169.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -63.75 -22.82 67.1 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.718 1.607 . . . . 0.0 112.604 171.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.7 24.79 37.45 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.528 1.537 . . . . 0.0 113.707 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -138.37 167.75 21.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.761 1.225 . . . . 0.0 112.179 -172.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.84 141.34 39.21 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.621 1.168 . . . . 0.0 111.519 173.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.1 tp -116.66 78.03 1.17 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.882 1.273 . . . . 0.0 110.414 -169.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.96 153.07 21.86 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.621 1.169 . . . . 0.0 113.368 -171.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -62.1 136.15 57.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.608 1.163 . . . . 0.0 109.901 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.8 m -128.05 124.72 37.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.667 1.187 . . . . 0.0 111.644 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -68.27 136.18 91.28 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.149 0.98 . . . . 0.0 112.315 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.04 -13.16 19.41 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.547 2.831 . . . . 0.0 115.015 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.93 5.79 73.15 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.324 0.964 . . . . 0.0 115.191 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -157.0 167.57 30.07 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.051 1.741 . . . . 0.0 111.78 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -98.65 167.09 11.0 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.005 1.322 . . . . 0.0 111.453 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 47.78 43.36 16.95 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.642 1.977 . . . . 0.0 113.079 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.0 m -141.07 138.96 18.46 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 125.407 1.483 . . . . 0.0 111.272 -169.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -46.5 157.06 0.5 Allowed 'Trans proline' 0 C--N 1.354 0.852 1 C-N-CA 126.121 4.547 . . . . 0.0 115.306 169.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 t -117.43 149.68 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.384 1.474 . . . . 0.0 109.774 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 m -124.89 174.97 7.6 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.097 1.359 . . . . 0.0 110.429 -169.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 m -127.02 144.33 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 120.902 -1.124 . . . . 0.0 111.602 172.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.4 m -148.38 166.02 16.67 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.803 1.241 . . . . 0.0 112.462 -176.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.58 163.26 2.82 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.79 2.993 . . . . 0.0 113.469 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.2 tp -126.26 143.73 51.04 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.794 1.238 . . . . 0.0 111.552 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -147.98 -32.33 0.27 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.328 1.451 . . . . 0.0 113.434 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.26 -9.65 0.83 Allowed Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.358 1.456 . . . . 0.0 114.365 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -63.08 139.65 58.79 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.979 1.39 . . . . 0.0 111.916 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.7 p -63.99 -11.05 25.22 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.387 1.475 . . . . 0.0 114.353 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.99 -20.08 64.99 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.487 1.04 . . . . 0.0 112.095 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -109.07 3.94 22.56 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.482 1.913 . . . . 0.0 113.282 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.29 144.58 29.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.125 0.964 . . . . 0.0 111.687 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -139.54 173.66 11.31 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.899 1.333 . . . . 0.0 112.123 -169.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.0 mt -122.75 135.44 62.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 127.746 2.418 . . . . 0.0 106.745 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.0 tp -137.04 124.53 22.12 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.978 1.311 . . . . 0.0 109.379 -172.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -142.77 138.57 30.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.403 0.681 . . . . 0.0 111.196 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.8 t -64.53 139.41 58.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.967 0.507 . . . . 0.0 110.984 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -114.21 -51.01 2.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.528 1.131 . . . . 0.0 110.762 174.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.23 107.71 4.1 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.172 0.989 . . . . 0.0 111.208 169.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.6 m -58.27 -25.94 62.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.987 0.915 . . . . 0.0 111.311 168.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -62.24 -21.6 65.3 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.095 2.158 . . . . 0.0 113.399 173.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.4 m -130.37 9.1 5.11 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.913 1.685 . . . . 0.0 113.026 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 47.0 32.1 1.76 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.014 2.126 . . . . 0.0 114.23 -169.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 p -92.55 142.49 27.34 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.158 -0.964 . . . . 0.0 112.319 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -139.06 144.54 38.82 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.072 1.749 . . . . 0.0 110.653 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.0 p -77.85 148.5 34.64 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.182 0.593 . . . . 0.0 110.82 172.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 mm -128.17 126.86 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.572 1.549 . . . . 0.0 109.417 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.9 m -143.9 148.91 44.21 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 125.541 1.536 . . . . 0.0 109.785 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.51 150.76 28.47 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.031 2.487 . . . . 0.0 111.055 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.03 -26.38 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.023 -1.048 . . . . 0.0 113.552 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.84 -20.79 55.1 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.738 0.685 . . . . 0.0 114.485 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.6 m -142.39 61.13 11.23 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 125.635 1.574 . . . . 0.0 111.526 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -61.31 -17.16 51.39 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.69 2.926 . . . . 0.0 113.178 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -72.87 13.55 0.37 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 128.591 2.756 . . . . 0.0 113.481 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.8 p -144.0 170.13 16.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.428 2.291 . . . . 0.0 111.119 173.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -139.65 170.71 15.4 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.217 1.807 . . . . 0.0 111.979 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -117.1 126.79 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.732 1.213 . . . . 0.0 110.77 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.79 -158.67 7.63 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 126.072 1.796 . . . . 0.0 111.328 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -144.96 144.77 31.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.178 0.989 . . . . 0.0 111.897 -174.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.03 -161.13 9.83 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.573 1.558 . . . . 0.0 113.116 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.18 137.7 21.8 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.921 1.288 . . . . 0.0 113.018 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.56 -5.83 64.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.724 1.154 . . . . 0.0 114.248 -172.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 47.49 52.65 12.12 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.402 1.881 . . . . 0.0 113.719 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.84 141.39 41.51 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 127.213 2.205 . . . . 0.0 107.478 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.54 140.12 55.98 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 N-CA-C 108.944 -1.214 . . . . 0.0 108.944 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.53 148.02 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.327 1.451 . . . . 0.0 111.275 -175.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.0 t -77.26 137.42 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.577 0.751 . . . . 0.0 110.426 173.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -141.0 161.76 51.93 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.209 1.803 . . . . 0.0 110.799 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.32 162.5 38.33 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.555 2.17 . . . . 0.0 111.291 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.96 127.77 27.48 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.15 2.566 . . . . 0.0 113.02 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -149.3 -107.82 0.07 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.203 1.401 . . . . 0.0 108.994 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -143.83 21.22 1.8 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.535 1.934 . . . . 0.0 110.581 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -65.82 131.99 47.63 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.339 -0.85 . . . . 0.0 111.677 -173.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.5 m -143.56 161.24 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.437 1.495 . . . . 0.0 111.335 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -130.83 152.27 50.35 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.214 1.406 . . . . 0.0 110.135 169.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.4 m -77.03 135.58 38.66 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.158 1.383 . . . . 0.0 109.294 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -126.09 73.78 1.39 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.246 1.018 . . . . 0.0 109.137 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.8 m -83.92 127.16 33.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.3 1.04 . . . . 0.0 111.015 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 tp -69.58 147.36 50.83 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.727 0.811 . . . . 0.0 111.405 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.1 p -129.91 175.53 8.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.381 1.473 . . . . 0.0 111.791 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 75.9 p -62.88 -11.5 18.69 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.65 17.22 1.63 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.76 1.171 . . . . 0.0 115.291 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.63 -137.22 4.99 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 118.645 1.222 . . . . 0.0 112.498 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -133.6 169.07 17.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.421 2.288 . . . . 0.0 111.336 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -131.39 147.39 52.56 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.304 1.842 . . . . 0.0 110.43 172.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.8 mt -130.53 114.01 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.055 0.942 . . . . 0.0 110.022 -170.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -136.89 151.99 49.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.86 1.264 . . . . 0.0 111.433 -169.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.0 -31.37 62.99 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.55 -40.11 1.59 Allowed Glycine 0 N--CA 1.471 1.019 0 C-N-CA 125.221 1.391 . . . . 0.0 112.649 -171.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -79.77 -5.76 55.96 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.913 1.285 . . . . 0.0 114.214 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? 57.1 14.14 1.87 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 126.998 2.119 . . . . 0.0 114.26 -169.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.8 p -69.46 -26.54 64.63 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.625 1.97 . . . . 0.0 113.501 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.5 m -143.88 168.71 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.005 1.722 . . . . 0.0 111.322 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.6 t -140.93 156.88 46.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.157 1.783 . . . . 0.0 110.863 172.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -71.52 138.74 49.13 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.18 0.592 . . . . 0.0 111.148 170.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 98.3 p -147.94 172.97 13.35 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.344 1.058 . . . . 0.0 112.552 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.92 149.18 46.18 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.077 1.351 . . . . 0.0 110.001 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -82.55 -34.41 27.8 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.433 0.693 . . . . 0.0 111.285 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -141.0 -7.83 1.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.33 1.852 . . . . 0.0 112.785 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.45 28.16 13.25 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.816 1.646 . . . . 0.0 114.319 -170.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.0 p -76.81 157.84 31.26 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.987 -1.071 . . . . 0.0 111.39 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -71.24 144.51 50.05 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.074 -1.016 . . . . 0.0 112.036 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.11 0.83 84.1 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.423 1.011 . . . . 0.0 114.395 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -70.01 149.4 47.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.964 1.306 . . . . 0.0 112.579 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.91 114.22 21.52 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.991 -1.068 . . . . 0.0 109.774 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.7 p -56.96 146.09 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 111.353 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.3 t -124.94 165.8 17.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.99 1.316 . . . . 0.0 111.957 -169.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.8 mt -134.98 143.06 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.725 1.61 . . . . 0.0 108.81 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.66 -157.81 30.33 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.076 0.846 . . . . 0.0 111.85 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.54 157.51 5.15 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.664 0.732 . . . . 0.0 111.91 169.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -57.84 153.08 14.59 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.33 1.052 . . . . 0.0 112.691 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.24 171.24 7.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.911 1.685 . . . . 0.0 112.738 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.3 t -107.2 -3.45 19.81 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -170.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -145.82 -43.93 0.21 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.384 1.073 . . . . 0.0 112.536 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 86.2 p -95.48 -0.3 52.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.52 -3.71 27.76 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.5 1.524 . . . . 0.0 115.924 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -125.66 152.58 45.03 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.524 1.662 . . . . 0.0 111.541 -174.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -137.59 175.48 9.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.656 1.583 . . . . 0.0 111.947 -168.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.0 p -138.41 139.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.7 1.2 . . . . 0.0 109.857 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 mp -122.45 124.51 70.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.968 1.707 . . . . 0.0 106.95 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -149.07 154.03 38.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.104 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.24 155.16 40.28 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.102 -0.999 . . . . 0.0 112.62 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.6 t . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.077 1.751 . . . . 0.0 111.313 171.989 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 tpp . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.9 173.89 45.44 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.907 1.241 . . . . 0.0 112.699 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.2 m80 57.57 6.22 0.4 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 127.019 2.127 . . . . 0.0 116.182 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -147.4 159.92 43.14 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.169 2.188 . . . . 0.0 110.802 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -133.61 -2.68 3.01 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.863 1.265 . . . . 0.0 113.771 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -155.54 152.67 29.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.327 1.851 . . . . 0.0 110.626 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -145.33 154.81 42.72 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.397 1.479 . . . . 0.0 111.743 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -141.17 2.1 1.67 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.938 1.295 . . . . 0.0 114.317 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -64.07 160.74 17.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.932 1.293 . . . . 0.0 113.15 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -65.79 -12.09 51.33 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.697 1.599 . . . . 0.0 114.989 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.8 t -55.16 153.35 6.88 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.314 1.446 . . . . 0.0 113.323 173.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.41 -175.7 43.98 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.978 1.275 . . . . 0.0 113.366 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -147.52 170.65 16.99 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.85 1.66 . . . . 0.0 111.905 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.2 m -138.87 151.68 68.84 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.228 1.411 . . . . 0.0 111.924 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.11 173.58 13.43 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.727 2.951 . . . . 0.0 112.471 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.34 27.31 9.75 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.872 1.269 . . . . 0.0 113.43 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -162.71 156.52 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 127.916 2.486 . . . . 0.0 110.707 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 t -149.97 29.8 0.73 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 123.58 1.657 . . . . 0.0 114.81 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -69.09 172.39 6.85 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.295 2.238 . . . . 0.0 111.826 169.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 t -154.18 169.53 23.38 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.945 1.298 . . . . 0.0 109.841 171.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.88 139.43 58.76 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 173.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.89 -161.34 32.29 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.267 0.937 . . . . 0.0 114.374 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -98.93 125.61 44.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.077 0.951 . . . . 0.0 110.111 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -134.28 172.47 12.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.572 1.549 . . . . 0.0 112.239 -171.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.4 pt -127.04 154.58 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 126.477 1.911 . . . . 0.0 108.62 171.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.66 123.77 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -141.36 150.22 42.15 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.362 0.665 . . . . 0.0 112.485 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -84.82 134.56 34.3 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.192 0.597 . . . . 0.0 111.635 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -64.83 -13.59 56.49 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.6 t -67.73 -24.68 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.447 1.022 . . . . 0.0 112.399 171.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mp 58.38 166.89 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.898 2.079 . . . . 0.0 113.97 -170.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.0 p -69.64 161.45 74.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 124.626 1.17 . . . . 0.0 112.362 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.96 -16.21 49.03 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.491 2.127 . . . . 0.0 113.004 170.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -74.29 -20.15 60.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.28 1.432 . . . . 0.0 112.894 169.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.5 24.42 14.03 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.004 1.287 . . . . 0.0 113.923 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -128.94 171.22 12.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.048 1.339 . . . . 0.0 112.259 -174.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -54.86 137.32 45.49 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.377 1.071 . . . . 0.0 111.367 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.3 tp -116.6 79.63 1.35 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.355 1.462 . . . . 0.0 110.27 -169.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.72 145.17 29.73 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -169.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -59.39 130.95 49.42 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.803 1.241 . . . . 0.0 109.201 168.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.1 m -128.52 117.37 21.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.436 1.094 . . . . 0.0 110.909 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.87 134.3 89.77 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.512 1.925 . . . . 0.0 112.141 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.59 -10.46 18.68 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.497 2.798 . . . . 0.0 114.795 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.21 6.19 81.85 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 119.01 -0.883 . . . . 0.0 115.254 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -157.7 163.24 38.37 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.94 1.37 . . . . 0.0 112.241 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -90.8 165.62 13.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.318 1.047 . . . . 0.0 111.631 -175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 50.67 35.77 12.53 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.308 1.843 . . . . 0.0 113.707 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.0 m -134.06 138.96 31.78 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 125.385 1.474 . . . . 0.0 111.319 -169.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -46.62 153.15 1.32 Allowed 'Trans proline' 0 C--N 1.354 0.817 1 C-N-CA 125.973 4.449 . . . . 0.0 115.238 169.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.05 147.75 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.687 1.195 . . . . 0.0 110.388 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 m -120.95 173.02 7.5 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.377 1.471 . . . . 0.0 111.347 -168.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.47 143.91 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.875 1.27 . . . . 0.0 111.446 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.1 m -151.41 159.84 32.79 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.136 1.374 . . . . 0.0 111.478 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -62.55 132.95 40.22 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.241 1.961 . . . . 0.0 110.779 173.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.1 tp -63.79 137.28 57.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.284 1.034 . . . . 0.0 111.308 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -135.93 -24.03 1.32 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.298 1.439 . . . . 0.0 112.811 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.14 5.96 22.81 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.147 1.356 . . . . 0.0 114.037 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.3 t -62.48 147.93 47.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.425 1.113 . . . . 0.0 111.788 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.8 m -58.24 -20.29 40.81 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.097 0.959 . . . . 0.0 113.53 172.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.87 -20.98 65.18 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.927 0.891 . . . . 0.0 112.853 173.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -104.29 -1.54 26.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.145 1.778 . . . . 0.0 112.617 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.95 138.81 41.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.807 1.243 . . . . 0.0 111.517 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -136.0 170.43 16.02 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.745 1.218 . . . . 0.0 111.873 -169.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.0 mt -124.69 136.87 59.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 126.514 1.926 . . . . 0.0 107.358 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.6 tp -136.51 126.51 26.02 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.383 1.473 . . . . 0.0 109.506 -169.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -144.25 138.05 27.72 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.15 0.98 . . . . 0.0 110.788 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 t -63.84 141.87 58.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.933 0.493 . . . . 0.0 111.529 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -113.4 -52.27 2.77 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.505 1.122 . . . . 0.0 110.76 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.43 107.49 4.02 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.276 1.03 . . . . 0.0 110.971 169.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.1 m -57.96 -26.56 62.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.939 0.896 . . . . 0.0 111.369 168.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -61.7 -20.81 63.89 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.091 2.156 . . . . 0.0 113.664 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.8 m -130.36 9.39 5.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.242 1.817 . . . . 0.0 112.949 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 47.23 28.55 1.02 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.291 2.236 . . . . 0.0 114.734 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -88.53 142.33 27.79 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.592 -1.318 . . . . 0.0 112.443 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -138.45 141.7 39.47 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.932 1.693 . . . . 0.0 110.891 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.2 p -77.88 147.57 35.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.148 0.579 . . . . 0.0 110.758 172.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.6 mm -128.49 131.41 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.42 1.488 . . . . 0.0 109.507 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.1 m -144.54 148.33 39.75 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 125.918 1.687 . . . . 0.0 110.549 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.9 145.89 28.95 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.121 2.547 . . . . 0.0 111.322 173.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.34 -28.76 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 O-C-N 121.189 -0.945 . . . . 0.0 112.003 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.43 -25.3 74.63 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 123.738 0.685 . . . . 0.0 114.753 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.1 m -144.59 67.37 14.23 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.451 1.5 . . . . 0.0 111.554 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.82 -13.46 37.2 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.416 2.744 . . . . 0.0 113.658 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -73.99 1.99 9.68 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.976 1.71 . . . . 0.0 114.002 170.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m -132.74 173.56 11.23 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.7 1.6 . . . . 0.0 111.782 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -137.4 172.43 12.99 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.453 1.501 . . . . 0.0 112.775 -174.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.9 mm -119.28 123.02 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.098 1.359 . . . . 0.0 110.14 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.45 -161.43 9.75 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.981 1.753 . . . . 0.0 111.144 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -142.07 143.2 32.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.383 1.092 . . . . 0.0 111.703 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.68 -162.32 10.36 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.092 1.33 . . . . 0.0 113.35 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.08 137.71 21.2 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.17 1.388 . . . . 0.0 113.058 -177.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.48 -5.71 65.03 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.771 1.177 . . . . 0.0 114.167 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 47.99 55.91 7.99 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.256 1.822 . . . . 0.0 113.563 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.89 141.12 33.76 Favored Pre-proline 0 N--CA 1.468 0.457 0 C-N-CA 127.262 2.225 . . . . 0.0 107.658 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -66.43 144.18 72.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.142 1.228 . . . . 0.0 109.836 174.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.24 145.13 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.521 1.528 . . . . 0.0 111.992 -172.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.2 t -74.19 119.2 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.194 0.997 . . . . 0.0 110.361 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -129.95 164.64 39.07 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.842 2.057 . . . . 0.0 111.457 -169.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.04 166.34 27.03 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.154 2.569 . . . . 0.0 112.339 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.85 121.05 7.02 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.335 2.023 . . . . 0.0 110.374 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -148.11 -90.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.762 0.825 . . . . 0.0 110.827 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -155.81 17.75 0.38 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.648 1.579 . . . . 0.0 112.727 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -66.47 137.2 56.66 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.583 -0.698 . . . . 0.0 111.802 -174.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.0 m -144.53 160.46 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.788 1.235 . . . . 0.0 112.231 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -129.6 138.0 51.02 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.644 1.578 . . . . 0.0 110.145 169.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -71.4 127.51 32.8 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.67 1.188 . . . . 0.0 108.793 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.8 mt -125.92 115.76 20.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.192 0.997 . . . . 0.0 108.739 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.8 m -136.52 134.49 37.61 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.733 0.813 . . . . 0.0 111.261 -169.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.66 152.11 45.09 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.008 1.323 . . . . 0.0 112.14 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 p -131.61 -178.75 5.0 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.096 1.758 . . . . 0.0 111.373 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.6 p -60.54 -13.0 11.46 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.82 24.45 0.26 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.274 0.94 . . . . 0.0 114.885 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 176.02 -147.6 8.76 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.147 0.974 . . . . 0.0 113.112 -173.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -132.02 167.26 20.0 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.082 2.153 . . . . 0.0 111.233 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -122.27 155.12 36.57 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.923 2.089 . . . . 0.0 109.964 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mt -134.84 117.15 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.01 1.724 . . . . 0.0 108.276 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -134.91 157.21 47.44 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.732 1.213 . . . . 0.0 111.633 -173.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -60.96 -25.69 67.01 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.93 -40.36 1.66 Allowed Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.003 1.763 . . . . 0.0 112.425 -169.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -98.82 4.4 47.59 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 114.06 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 58.08 14.56 2.76 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.282 2.233 . . . . 0.0 114.352 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.4 p -71.13 -24.74 62.34 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.164 0.985 . . . . 0.0 112.597 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.78 172.9 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.867 1.667 . . . . 0.0 111.988 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.0 t -143.74 150.99 39.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.462 3.105 . . . . 0.0 108.816 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -73.51 144.84 45.99 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.41 -0.806 . . . . 0.0 111.507 170.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 93.1 p -154.07 173.98 15.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.447 1.099 . . . . 0.0 112.322 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.7 mt -121.11 170.51 9.48 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.841 2.056 . . . . 0.0 109.503 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -105.06 -33.87 8.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.025 0.93 . . . . 0.0 111.9 -169.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -139.33 -8.51 1.3 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.015 2.126 . . . . 0.0 112.456 170.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.8 24.53 10.87 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 126.211 1.805 . . . . 0.0 114.521 -171.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.5 p -73.26 158.76 34.55 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 111.736 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.72 142.91 54.86 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.21 -0.931 . . . . 0.0 112.009 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.02 6.23 85.74 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.659 1.123 . . . . 0.0 114.444 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.74 137.16 38.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.826 1.313 . . . . 0.0 112.498 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -71.95 134.35 45.91 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.369 -0.832 . . . . 0.0 110.834 174.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.48 155.59 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.462 0.649 . . . . 0.0 110.962 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.6 t -127.11 159.21 34.89 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.359 1.464 . . . . 0.0 110.91 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.97 137.07 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.468 1.507 . . . . 0.0 108.736 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 178.48 178.46 47.87 Favored Glycine 0 N--CA 1.471 0.976 0 C-N-CA 124.674 1.13 . . . . 0.0 111.44 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.87 -41.34 57.98 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.265 1.532 . . . . 0.0 114.19 -173.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -167.62 176.0 6.7 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.944 2.498 . . . . 0.0 111.382 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.12 140.08 35.95 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.332 1.053 . . . . 0.0 111.88 169.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.6 t -62.85 -22.59 66.79 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -171.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -134.01 -35.42 0.95 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.959 1.304 . . . . 0.0 113.076 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.0 t -97.8 2.8 49.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.812 1.245 . . . . 0.0 114.323 -171.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.91 17.6 1.26 Allowed Glycine 0 CA--C 1.544 1.865 0 C-N-CA 125.4 1.476 . . . . 0.0 116.27 -174.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -140.45 149.23 42.3 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.135 1.774 . . . . 0.0 112.142 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -140.89 178.17 7.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.717 2.007 . . . . 0.0 111.18 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.2 141.22 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.77 1.228 . . . . 0.0 109.286 169.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.33 123.62 71.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.575 1.55 . . . . 0.0 106.939 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -145.94 153.19 40.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.665 1.186 . . . . 0.0 109.482 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -67.45 155.28 39.41 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.04 -1.038 . . . . 0.0 112.774 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 77.1 t . . . . . 0 C--O 1.251 1.177 0 C-N-CA 126.171 1.789 . . . . 0.0 111.309 172.228 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.44 174.95 43.38 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.331 0.967 . . . . 0.0 113.664 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -139.25 5.05 2.26 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.369 1.467 . . . . 0.0 113.909 -176.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -63.85 157.04 25.67 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.624 1.17 . . . . 0.0 112.761 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -149.65 159.78 44.05 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.252 1.421 . . . . 0.0 110.947 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -133.96 -3.89 2.82 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.159 1.384 . . . . 0.0 113.887 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -132.29 -9.4 3.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.679 1.192 . . . . 0.0 114.096 -175.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -149.68 134.2 17.54 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.28 1.432 . . . . 0.0 110.574 173.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -137.61 -8.33 1.67 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -62.45 -11.82 18.21 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.204 1.802 . . . . 0.0 114.761 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.3 m -130.57 18.38 5.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.213 1.805 . . . . 0.0 112.526 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.09 14.35 0.76 Allowed Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.671 1.129 . . . . 0.0 115.431 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -149.46 158.32 44.07 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.055 1.742 . . . . 0.0 110.98 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.7 p -151.76 161.53 29.28 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.195 1.398 . . . . 0.0 112.244 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.39 151.07 24.39 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.679 2.919 . . . . 0.0 114.596 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.77 23.44 4.28 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.431 1.492 . . . . 0.0 112.869 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 p -68.64 161.56 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.804 2.042 . . . . 0.0 111.097 171.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.2 t -144.66 12.17 1.47 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.7 mt 55.73 176.93 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.537 1.935 . . . . 0.0 113.828 -172.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -160.76 169.28 23.07 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.095 1.358 . . . . 0.0 109.928 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.16 133.07 50.75 Favored 'General case' 0 CA--C 1.548 0.865 0 O-C-N 121.855 -0.528 . . . . 0.0 111.703 170.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.24 -164.99 37.95 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.841 0.734 . . . . 0.0 114.5 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -97.07 126.48 42.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.982 0.913 . . . . 0.0 110.318 171.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.15 172.05 13.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.56 1.544 . . . . 0.0 112.442 -170.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.6 pt -127.17 156.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.472 1.909 . . . . 0.0 108.763 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.8 mt -128.38 126.75 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.91 151.82 39.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.316 0.646 . . . . 0.0 111.735 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -86.2 138.36 31.93 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.75 -0.594 . . . . 0.0 112.038 -173.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.8 mmm180 -62.05 -19.08 62.52 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.4 -24.41 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 119.269 0.941 . . . . 0.0 112.936 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 mp 58.59 166.35 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.684 1.994 . . . . 0.0 114.178 -170.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.7 t -73.28 145.99 86.21 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 124.392 1.077 . . . . 0.0 111.936 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.27 -19.49 28.06 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.611 2.874 . . . . 0.0 113.754 168.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -67.8 -18.7 64.94 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.848 1.659 . . . . 0.0 113.348 172.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.23 26.62 13.63 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.853 1.692 . . . . 0.0 113.983 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -134.32 160.58 37.49 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.727 1.211 . . . . 0.0 111.918 -171.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -54.67 129.37 36.42 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.086 1.355 . . . . 0.0 111.323 176.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 24.3 tp -98.73 79.89 2.48 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.731 1.213 . . . . 0.0 110.552 -172.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.78 141.23 36.48 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.574 1.149 . . . . 0.0 113.987 -169.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.561 HD12 ' CZ2' ' A' ' 63' ' ' TRP . 0.6 OUTLIER -60.99 125.04 22.28 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.326 1.45 . . . . 0.0 107.957 169.001 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.406 ' N ' HD13 ' A' ' 40' ' ' LEU . 87.7 m -126.33 124.64 40.74 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.344 1.058 . . . . 0.0 112.054 -169.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.59 134.37 95.99 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.905 2.082 . . . . 0.0 111.885 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.83 -10.8 19.99 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.366 2.71 . . . . 0.0 114.462 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.89 6.16 76.38 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.962 -0.91 . . . . 0.0 115.262 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -157.17 166.66 32.59 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.005 1.402 . . . . 0.0 112.278 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -89.36 165.42 14.38 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.388 1.075 . . . . 0.0 111.828 -174.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 45.95 43.64 10.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.582 1.953 . . . . 0.0 113.497 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 m -138.31 139.01 23.91 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 125.507 1.523 . . . . 0.0 110.813 -169.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -45.84 157.81 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.881 1 C-N-CA 126.279 4.653 . . . . 0.0 115.483 169.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.15 151.02 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.316 1.446 . . . . 0.0 110.42 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 m -130.92 170.28 14.65 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.174 1.39 . . . . 0.0 110.339 -169.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.12 146.54 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.993 -1.067 . . . . 0.0 112.075 175.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -150.6 160.41 32.72 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.642 1.177 . . . . 0.0 112.223 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.06 128.03 27.39 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.46 2.774 . . . . 0.0 111.75 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 tp -64.11 136.22 57.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.481 0.713 . . . . 0.0 111.042 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -134.47 -26.89 1.39 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.206 1.403 . . . . 0.0 112.606 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.8 8.76 13.32 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.293 1.425 . . . . 0.0 113.938 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.5 t -66.98 160.13 27.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.596 1.198 . . . . 0.0 111.941 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.5 m -73.6 -16.28 61.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.088 0.955 . . . . 0.0 111.665 -176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.26 -16.73 58.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.064 1.745 . . . . 0.0 112.829 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -101.5 -5.45 25.19 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.02 1.728 . . . . 0.0 112.343 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.97 143.23 36.93 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.991 1.316 . . . . 0.0 111.735 -174.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.561 ' CZ2' HD12 ' A' ' 40' ' ' LEU . 90.3 m95 -136.4 168.12 20.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.542 1.163 . . . . 0.0 112.333 -169.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.2 mt -121.56 134.82 63.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.92 2.088 . . . . 0.0 106.654 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.1 tp -134.79 126.82 29.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.49 1.516 . . . . 0.0 109.655 -169.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -143.0 140.25 30.94 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.146 0.978 . . . . 0.0 110.894 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.7 t -65.92 140.23 58.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.707 0.403 . . . . 0.0 111.132 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -112.87 -51.2 2.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.414 1.086 . . . . 0.0 111.026 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.62 108.7 4.41 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.469 1.107 . . . . 0.0 110.93 169.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.1 m -58.08 -26.59 62.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.83 0.852 . . . . 0.0 111.188 168.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -61.36 -20.6 63.18 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.136 2.174 . . . . 0.0 113.51 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t -130.48 6.92 4.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.851 1.66 . . . . 0.0 113.401 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 48.1 31.29 2.44 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.26 1.824 . . . . 0.0 114.035 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -89.03 143.46 26.84 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.266 -0.896 . . . . 0.0 111.848 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -138.53 141.61 39.32 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.443 1.497 . . . . 0.0 110.795 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.9 p -78.02 147.44 34.82 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.092 0.557 . . . . 0.0 110.678 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.2 mm -127.63 128.09 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.48 1.512 . . . . 0.0 109.302 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.1 m -142.16 141.01 20.23 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.674 1.59 . . . . 0.0 110.5 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.09 143.41 32.33 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.853 2.369 . . . . 0.0 111.224 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.86 -28.8 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 121.297 -0.877 . . . . 0.0 111.631 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.17 -10.51 86.01 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.4 m -156.4 68.05 4.6 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.846 1.658 . . . . 0.0 110.469 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -63.55 -17.84 61.76 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.789 2.992 . . . . 0.0 113.5 -173.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -76.24 6.15 5.91 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 127.848 2.459 . . . . 0.0 114.657 171.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.7 m -131.23 175.31 9.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.977 1.711 . . . . 0.0 112.088 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -139.06 171.99 13.5 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.546 1.538 . . . . 0.0 113.28 -172.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.7 mm -120.17 130.79 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.272 1.429 . . . . 0.0 110.601 174.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.47 -157.63 7.34 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.645 1.593 . . . . 0.0 111.422 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -141.7 142.61 33.33 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.24 1.016 . . . . 0.0 111.848 -172.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.94 -163.21 10.57 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.247 1.403 . . . . 0.0 113.381 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.2 139.96 22.43 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.011 1.324 . . . . 0.0 113.136 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.46 -2.29 73.83 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.512 1.053 . . . . 0.0 114.292 -173.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 48.7 56.34 7.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.18 1.792 . . . . 0.0 113.41 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.7 p -133.83 136.88 27.34 Favored Pre-proline 0 C--O 1.238 0.49 0 C-N-CA 127.548 2.339 . . . . 0.0 107.751 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.75 142.77 59.13 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.202 1.268 . . . . 0.0 109.462 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.03 149.29 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.023 1.329 . . . . 0.0 111.472 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 t -76.22 134.93 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.851 0.861 . . . . 0.0 110.402 174.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.5 mt -141.17 161.62 52.27 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.649 1.58 . . . . 0.0 112.039 -169.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.9 165.65 29.18 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.062 2.508 . . . . 0.0 111.765 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.62 124.07 9.97 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.5 2.133 . . . . 0.0 110.702 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -148.01 -89.61 0.08 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.076 0.95 . . . . 0.0 110.592 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -154.82 15.95 0.43 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.431 1.493 . . . . 0.0 112.901 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -67.01 134.36 51.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.425 0.69 . . . . 0.0 111.906 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -144.92 161.03 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.949 1.3 . . . . 0.0 112.069 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -130.99 137.61 49.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.252 1.421 . . . . 0.0 110.762 169.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.9 m -72.19 131.74 43.17 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.899 1.28 . . . . 0.0 108.705 169.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.7 mt -121.94 73.49 1.09 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.071 0.938 . . . . 0.0 109.324 -176.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 93.3 m -73.42 119.47 17.7 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.755 1.222 . . . . 0.0 110.656 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.7 tp -68.41 147.63 51.8 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.077 0.551 . . . . 0.0 111.271 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.0 p -133.82 177.05 8.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.987 1.715 . . . . 0.0 110.515 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.9 m -59.88 -12.69 8.18 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.93 31.25 0.28 Allowed Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.761 1.172 . . . . 0.0 114.096 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.29 -160.62 34.22 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.976 1.274 . . . . 0.0 112.072 -174.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -127.92 172.11 11.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.255 1.822 . . . . 0.0 112.075 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -136.69 150.18 48.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.21 1.804 . . . . 0.0 110.099 170.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.1 mt -129.1 114.84 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.103 0.961 . . . . 0.0 109.516 -169.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -134.8 155.74 50.08 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.124 0.969 . . . . 0.0 112.248 -169.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.86 -28.99 69.88 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.68 -40.6 1.61 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.063 1.792 . . . . 0.0 112.756 -172.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.08 -5.2 59.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.974 1.309 . . . . 0.0 113.983 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? 57.11 17.86 3.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.623 1.969 . . . . 0.0 113.374 -169.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 49.0 p -71.02 -24.46 62.37 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.195 0.998 . . . . 0.0 112.168 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.9 m -144.26 173.68 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.006 1.723 . . . . 0.0 112.162 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.4 t -146.14 154.81 42.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.481 2.712 . . . . 0.0 110.044 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -73.19 142.04 47.37 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.464 -0.773 . . . . 0.0 111.777 170.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 91.7 p -152.92 170.47 20.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.025 1.33 . . . . 0.0 112.63 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.81 156.06 31.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.954 1.302 . . . . 0.0 110.386 173.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -89.93 -31.47 17.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.281 0.632 . . . . 0.0 111.501 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -138.07 -4.12 1.74 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.556 1.542 . . . . 0.0 113.639 172.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.85 27.26 2.26 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.303 1.841 . . . . 0.0 114.452 -169.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.6 p -76.33 161.0 29.09 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.899 0.88 . . . . 0.0 111.471 174.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.72 142.39 51.47 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.911 -1.118 . . . . 0.0 111.359 169.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.41 5.79 82.79 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.322 0.963 . . . . 0.0 114.019 -173.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.53 140.57 49.95 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.906 1.283 . . . . 0.0 111.858 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.56 111.19 14.36 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 170.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.32 147.39 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.634 0.73 . . . . 0.0 111.175 172.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.3 m -134.22 171.54 14.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.76 1.624 . . . . 0.0 111.399 -169.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 70.0 mt -134.34 143.69 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.983 1.313 . . . . 0.0 109.231 -173.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.03 179.04 47.22 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.895 1.236 . . . . 0.0 111.65 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.47 -42.47 61.62 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.091 1.445 . . . . 0.0 114.266 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -169.3 174.28 6.18 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.266 2.626 . . . . 0.0 111.027 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -142.46 141.83 32.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.185 0.994 . . . . 0.0 111.866 169.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 t -66.26 -18.61 65.46 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -138.62 -43.66 0.49 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.194 0.998 . . . . 0.0 113.293 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.8 p -86.07 0.49 53.31 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.081 1.352 . . . . 0.0 114.381 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.95 19.68 0.96 Allowed Glycine 0 CA--C 1.541 1.666 0 C-N-CA 126.505 2.002 . . . . 0.0 116.622 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -144.94 149.78 35.83 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.069 1.935 . . . . 0.0 112.057 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -139.4 177.71 7.73 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.988 1.715 . . . . 0.0 112.368 -169.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.3 p -140.78 139.93 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.831 1.252 . . . . 0.0 109.607 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.17 125.87 74.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 125.821 1.648 . . . . 0.0 107.192 172.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -148.58 153.76 38.81 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.646 1.178 . . . . 0.0 109.46 -170.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -67.71 155.11 39.99 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.921 -1.112 . . . . 0.0 112.775 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.145 1.778 . . . . 0.0 111.323 171.908 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 tpp . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -169.48 16.18 0.06 OUTLIER Glycine 0 CA--C 1.539 1.575 0 N-CA-C 116.154 1.222 . . . . 0.0 116.154 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -141.95 0.76 1.42 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 118.702 1.251 . . . . 0.0 113.996 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -142.42 162.01 36.56 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.22 1.408 . . . . 0.0 111.56 -177.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -138.26 16.19 2.79 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.94 1.296 . . . . 0.0 112.722 -173.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 62.52 2.54 0.93 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.194 2.197 . . . . 0.0 114.627 -169.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -149.33 172.34 15.05 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.917 2.087 . . . . 0.0 110.72 171.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -136.87 -4.62 1.96 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.197 1.399 . . . . 0.0 113.516 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -63.96 -19.31 65.05 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.297 1.439 . . . . 0.0 114.333 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -127.69 16.98 6.92 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.819 1.648 . . . . 0.0 112.221 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.8 m 55.24 -10.92 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 129.484 3.114 . . . . 0.0 119.088 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.84 14.23 0.03 OUTLIER Glycine 0 CA--C 1.537 1.45 0 N-CA-C 116.7 1.44 . . . . 0.0 116.7 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -140.58 168.07 20.67 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.058 1.429 . . . . 0.0 111.66 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.9 m -60.7 155.1 53.32 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 124.432 1.093 . . . . 0.0 112.542 174.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.0 134.78 43.37 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.639 2.893 . . . . 0.0 114.402 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.4 27.13 0.93 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.137 1.375 . . . . 0.0 112.69 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.19 151.41 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.738 1.215 . . . . 0.0 110.648 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 t -143.92 13.66 1.68 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.6 mt 59.62 166.9 0.06 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.286 2.235 . . . . 0.0 113.973 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.2 m -150.73 160.17 44.03 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.073 1.749 . . . . 0.0 109.382 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.52 131.14 45.66 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.652 -0.655 . . . . 0.0 111.362 171.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.93 -166.11 39.43 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -95.52 124.1 39.39 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.231 1.012 . . . . 0.0 110.037 172.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -133.17 171.83 13.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.098 1.359 . . . . 0.0 112.259 -173.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 pt -124.57 153.05 31.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.888 1.675 . . . . 0.0 108.431 170.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.7 mt -128.49 118.97 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -138.56 149.6 45.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.504 0.669 . . . . 0.0 112.212 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -77.6 136.58 38.27 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.04 -0.413 . . . . 0.0 111.463 -173.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -64.94 -24.28 67.47 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.3 t -65.98 -38.25 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.819 0.847 . . . . 0.0 112.489 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 37' ' ' LYS . 73.3 mt 54.48 173.25 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.104 1.761 . . . . 0.0 114.66 -169.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.0 p -100.72 163.91 17.19 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.685 1.194 . . . . 0.0 112.068 176.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.2 -2.61 6.04 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.335 2.69 . . . . 0.0 114.363 170.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -73.41 -13.4 61.07 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.979 1.312 . . . . 0.0 113.967 172.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.25 14.1 75.17 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.431 172.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -133.05 167.31 20.54 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.974 1.309 . . . . 0.0 113.014 -175.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HA ' HD22 ' A' ' 31' ' ' LEU . 97.9 mttt -60.78 156.3 17.41 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.802 1.241 . . . . 0.0 113.136 -175.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.3 mt -124.37 72.84 1.21 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.125 1.77 . . . . 0.0 109.8 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.46 142.86 33.86 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.445 1.098 . . . . 0.0 113.292 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.8 tp -56.74 135.76 55.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.857 0.863 . . . . 0.0 109.218 169.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 90.5 m -132.26 122.55 25.35 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.266 1.026 . . . . 0.0 110.827 -173.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -64.07 138.13 97.32 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 127.128 2.171 . . . . 0.0 111.907 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -74.06 -12.1 23.51 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.299 2.666 . . . . 0.0 114.933 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.29 7.26 86.94 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.006 0.812 . . . . 0.0 114.76 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -154.09 166.42 33.11 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.947 1.699 . . . . 0.0 111.764 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -93.83 164.69 13.02 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.936 0.894 . . . . 0.0 111.812 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.6 tpt85 46.68 40.12 8.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.816 2.046 . . . . 0.0 114.032 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.7 m -133.98 142.1 42.15 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.563 1.545 . . . . 0.0 111.057 -169.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -44.67 156.28 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.828 1 C-N-CA 126.003 4.469 . . . . 0.0 115.589 169.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.88 158.43 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.798 1.239 . . . . 0.0 110.207 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -128.71 170.28 13.48 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.698 1.599 . . . . 0.0 110.971 -169.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.8 p -125.49 142.29 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.833 1.253 . . . . 0.0 111.257 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 m -159.04 168.49 12.3 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.711 1.204 . . . . 0.0 113.004 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -49.97 161.56 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.677 3.585 . . . . 0.0 114.857 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.3 tp -123.01 132.26 54.05 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.739 1.216 . . . . 0.0 111.343 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -134.19 -29.27 1.27 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.922 2.089 . . . . 0.0 112.27 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.53 4.09 1.98 Allowed Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.642 1.417 . . . . 0.0 116.642 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -71.0 165.1 24.19 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.056 1.928 . . . . 0.0 113.391 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.2 m -69.02 -16.98 63.85 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.29 -24.84 62.23 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.022 0.828 . . . . 0.0 112.28 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.62 6.28 11.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.084 2.554 . . . . 0.0 112.409 -169.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.99 148.07 39.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.979 1.312 . . . . 0.0 110.745 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -137.51 174.02 11.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 122.69 1.233 . . . . 0.0 112.901 -168.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.8 mt -122.96 139.15 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.194 2.198 . . . . 0.0 107.09 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.7 tp -137.31 123.22 20.14 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.409 1.483 . . . . 0.0 109.044 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -144.13 138.34 28.12 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.507 0.723 . . . . 0.0 111.117 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.2 t -65.96 139.33 58.23 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.734 0.414 . . . . 0.0 111.002 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -111.93 -50.61 2.9 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.809 1.244 . . . . 0.0 110.282 174.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.01 106.9 3.97 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.432 1.093 . . . . 0.0 110.84 169.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.4 m -58.05 -25.5 61.3 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.959 0.903 . . . . 0.0 111.506 168.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -63.73 -20.99 66.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.022 2.129 . . . . 0.0 113.495 174.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -130.1 9.02 5.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.126 1.77 . . . . 0.0 112.644 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 45.87 32.69 1.36 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.422 2.289 . . . . 0.0 114.217 -169.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.5 p -91.62 140.95 29.23 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.919 -1.113 . . . . 0.0 112.091 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -136.84 144.89 43.86 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.878 1.671 . . . . 0.0 110.733 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.1 p -77.78 150.64 34.29 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.192 0.597 . . . . 0.0 110.965 170.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.9 mm -130.44 129.73 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.976 1.71 . . . . 0.0 108.519 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.1 p -151.98 155.09 33.4 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.171 0.988 . . . . 0.0 111.866 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.88 146.05 29.19 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.994 2.462 . . . . 0.0 110.841 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.49 -24.26 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.851 -1.156 . . . . 0.0 113.072 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.71 -19.54 57.89 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.033 0.825 . . . . 0.0 114.728 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.0 m -142.22 62.58 13.9 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 125.66 1.584 . . . . 0.0 111.266 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.36 -13.98 39.37 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.268 2.645 . . . . 0.0 113.491 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -74.08 6.84 3.1 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.293 1.837 . . . . 0.0 114.001 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -129.75 175.54 8.75 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.637 1.575 . . . . 0.0 111.331 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -141.0 167.96 20.94 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.618 1.567 . . . . 0.0 111.07 -172.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.7 mm -122.23 128.04 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.296 1.038 . . . . 0.0 110.552 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.77 -159.18 7.88 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.985 1.755 . . . . 0.0 111.243 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -143.83 148.32 35.36 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.595 1.197 . . . . 0.0 111.996 -174.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.51 -160.36 9.56 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.397 1.475 . . . . 0.0 112.968 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.46 138.35 27.68 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.832 1.253 . . . . 0.0 112.959 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.6 -3.59 63.32 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.612 1.101 . . . . 0.0 114.284 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 47.67 54.21 10.14 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.106 1.762 . . . . 0.0 113.602 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.98 138.44 30.68 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 127.53 2.332 . . . . 0.0 107.473 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.78 144.45 59.41 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.292 1.328 . . . . 0.0 109.284 174.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.01 149.87 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.253 1.421 . . . . 0.0 111.343 -174.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.96 134.26 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.01 0.924 . . . . 0.0 110.677 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.0 mt -139.23 162.1 53.86 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.586 1.555 . . . . 0.0 110.784 -172.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.69 161.14 45.02 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.34 2.027 . . . . 0.0 111.574 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.33 119.75 6.34 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.564 2.176 . . . . 0.0 110.307 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -146.49 -82.64 0.13 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.309 1.044 . . . . 0.0 110.793 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -154.72 10.48 0.35 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.005 1.322 . . . . 0.0 113.945 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -67.39 128.65 37.21 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.391 -0.818 . . . . 0.0 111.776 -175.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.4 m -143.6 163.76 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.757 1.623 . . . . 0.0 111.234 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -130.47 145.78 51.9 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.034 1.333 . . . . 0.0 110.332 171.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.2 m -74.94 134.96 41.43 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.848 1.259 . . . . 0.0 109.222 169.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.85 123.85 44.66 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.389 1.075 . . . . 0.0 109.49 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.3 m -135.09 127.17 29.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.952 0.901 . . . . 0.0 110.491 -169.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.1 153.24 41.41 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.795 0.807 . . . . 0.0 113.049 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.7 p -127.99 -177.45 4.13 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.422 1.889 . . . . 0.0 110.15 171.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.1 p -60.9 -14.59 23.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.61 30.71 0.26 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.51 1.052 . . . . 0.0 114.142 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.49 -149.78 9.61 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.795 1.188 . . . . 0.0 112.537 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -132.64 170.19 15.57 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.972 2.109 . . . . 0.0 112.358 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -134.73 152.12 51.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.306 2.643 . . . . 0.0 108.805 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.2 mt -132.46 125.13 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.826 1.251 . . . . 0.0 108.242 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -137.25 160.09 40.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.246 1.018 . . . . 0.0 112.342 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -63.67 -22.19 66.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 -170.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.87 -40.5 1.77 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.614 1.578 . . . . 0.0 112.725 -171.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -98.38 5.67 47.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.94 1.696 . . . . 0.0 113.401 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 57.11 18.04 3.86 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.156 2.182 . . . . 0.0 114.227 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p -74.37 -24.6 59.18 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.251 -0.905 . . . . 0.0 112.384 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.1 m -143.73 174.61 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.661 1.584 . . . . 0.0 112.104 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t -148.45 154.36 39.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.96 2.504 . . . . 0.0 110.111 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -70.29 143.59 52.02 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.386 -0.821 . . . . 0.0 111.802 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.1 p -151.54 172.46 15.97 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.154 1.382 . . . . 0.0 112.621 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.0 mt -128.81 177.59 6.96 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.338 1.855 . . . . 0.0 110.095 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -123.93 -31.93 3.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.258 1.423 . . . . 0.0 111.332 -169.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -143.41 -5.54 0.84 Allowed 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 173.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.17 34.61 17.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.692 1.597 . . . . 0.0 114.786 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.4 p -90.98 160.78 15.45 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.323 -0.861 . . . . 0.0 111.946 171.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.06 142.98 52.61 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.756 -1.215 . . . . 0.0 112.139 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.49 -0.5 87.83 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.535 1.064 . . . . 0.0 114.24 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -63.76 142.99 58.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.102 1.761 . . . . 0.0 112.443 174.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.54 116.78 24.05 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.144 -0.972 . . . . 0.0 109.759 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.3 p -58.82 152.92 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.24 1.016 . . . . 0.0 112.214 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.6 m -130.26 168.88 16.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.536 1.534 . . . . 0.0 111.767 -170.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.2 mt -136.65 143.38 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.217 1.407 . . . . 0.0 109.535 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 178.93 178.2 48.03 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.03 1.3 . . . . 0.0 111.905 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.59 -42.5 44.75 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 119.258 1.529 . . . . 0.0 114.562 -172.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -167.28 176.31 6.8 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 129.091 2.956 . . . . 0.0 108.374 172.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.53 137.93 35.87 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.228 -0.92 . . . . 0.0 112.364 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.2 t -59.93 -21.53 61.25 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.958 1.703 . . . . 0.0 115.218 -169.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -134.34 -36.51 0.89 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.399 1.08 . . . . 0.0 113.613 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -103.41 2.44 33.87 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.86 10.81 1.44 Allowed Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.294 1.426 . . . . 0.0 115.377 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -131.51 142.67 50.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.849 1.66 . . . . 0.0 109.921 -169.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -139.41 175.89 9.18 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.692 1.597 . . . . 0.0 111.85 -168.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.71 139.56 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.848 1.259 . . . . 0.0 109.403 169.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.42 125.49 73.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.731 1.613 . . . . 0.0 107.088 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.07 153.91 38.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.733 1.213 . . . . 0.0 108.974 -170.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -68.63 155.6 39.71 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.923 -1.111 . . . . 0.0 112.497 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.6 t . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.107 1.763 . . . . 0.0 111.279 171.807 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -151.25 159.37 44.4 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.356 1.862 . . . . 0.0 109.424 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.44 140.65 58.89 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 121.562 -0.711 . . . . 0.0 112.243 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.45 -161.7 33.81 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.24 0.924 . . . . 0.0 114.426 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -98.44 126.75 44.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.187 0.995 . . . . 0.0 110.338 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -135.59 171.52 14.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.13 1.372 . . . . 0.0 112.701 -171.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.4 pt -124.82 153.62 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 126.329 1.852 . . . . 0.0 108.393 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.63 122.56 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -140.09 147.45 40.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.537 0.735 . . . . 0.0 111.393 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -75.62 136.7 40.46 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.918 -0.489 . . . . 0.0 111.117 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.7 tpt85 -66.28 -20.17 66.03 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -171.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.4 t . . . . . 0 N--CA 1.481 1.104 0 C-N-CA 124.809 1.244 . . . . 0.0 112.546 173.019 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.8 tp . . . . . 0 N--CA 1.473 0.709 0 CA-C-O 121.325 0.583 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.7 144.12 30.45 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -169.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.79 132.38 53.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.653 1.181 . . . . 0.0 109.246 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.8 m -130.7 118.85 21.52 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.292 1.037 . . . . 0.0 111.139 -169.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -61.54 137.38 94.8 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 126.305 1.842 . . . . 0.0 112.513 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.57 -13.78 20.15 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.441 2.761 . . . . 0.0 114.926 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.25 8.15 84.03 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -153.58 161.95 41.72 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.811 1.644 . . . . 0.0 111.732 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -89.77 165.73 13.98 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.007 0.923 . . . . 0.0 111.586 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 49.57 38.54 15.02 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.773 1.629 . . . . 0.0 113.813 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.4 m -136.2 141.17 35.14 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 125.562 1.545 . . . . 0.0 111.322 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -45.55 154.98 0.51 Allowed 'Trans proline' 0 C--N 1.353 0.804 1 C-N-CA 126.167 4.578 . . . . 0.0 115.49 169.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.3 t -110.89 153.96 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.065 1.346 . . . . 0.0 110.118 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 m -128.13 172.51 10.92 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.695 1.598 . . . . 0.0 110.938 -169.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.97 144.71 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.692 1.197 . . . . 0.0 111.42 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -149.54 158.98 37.31 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 124.921 1.288 . . . . 0.0 111.872 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -63.24 130.35 28.41 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.279 1.986 . . . . 0.0 110.527 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.6 tp -63.28 136.3 57.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.373 1.069 . . . . 0.0 111.428 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -130.36 -26.87 2.26 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.192 1.797 . . . . 0.0 112.021 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.64 4.68 19.32 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.451 1.5 . . . . 0.0 114.175 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.4 p -65.74 159.45 25.09 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.783 1.291 . . . . 0.0 113.209 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -62.66 -19.1 63.5 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -68.55 -27.21 65.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.907 0.883 . . . . 0.0 112.324 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -102.38 -7.46 21.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.9 1.68 . . . . 0.0 113.197 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.64 146.37 28.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.452 1.101 . . . . 0.0 111.456 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -138.31 170.48 15.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.471 1.129 . . . . 0.0 111.858 -169.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.4 mt -121.2 136.0 59.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 127.294 2.238 . . . . 0.0 107.126 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.3 tp -137.18 124.44 21.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.274 1.43 . . . . 0.0 109.727 -170.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -141.84 140.21 32.88 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.605 0.762 . . . . 0.0 111.134 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.7 t -65.74 139.37 58.35 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.833 0.453 . . . . 0.0 110.988 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -115.19 -47.27 2.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.289 1.036 . . . . 0.0 111.595 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.37 109.48 3.73 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.308 1.043 . . . . 0.0 111.059 170.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -57.94 -27.58 63.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.828 0.851 . . . . 0.0 111.101 168.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -60.62 -21.28 62.54 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.127 2.171 . . . . 0.0 113.574 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -130.21 10.84 5.4 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.869 1.668 . . . . 0.0 112.737 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 46.36 28.51 0.72 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.967 2.107 . . . . 0.0 113.858 -168.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 p -89.71 140.03 29.98 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.85 -1.156 . . . . 0.0 112.424 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -135.26 142.93 46.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.137 1.775 . . . . 0.0 111.322 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.0 p -78.33 148.5 33.75 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.032 0.533 . . . . 0.0 110.767 172.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.2 mm -128.67 130.16 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.547 1.539 . . . . 0.0 109.807 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 m -144.8 149.65 43.72 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 126.208 1.803 . . . . 0.0 110.232 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.91 148.1 31.45 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.007 2.471 . . . . 0.0 111.143 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 m -66.18 -25.48 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 120.757 -1.215 . . . . 0.0 113.199 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.67 -21.82 65.61 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.762 0.696 . . . . 0.0 114.389 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.3 m -143.7 66.75 15.54 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 125.73 1.612 . . . . 0.0 111.047 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.23 -13.19 30.72 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.894 2.396 . . . . 0.0 113.678 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -76.55 4.69 8.73 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.046 1.738 . . . . 0.0 114.297 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.6 p -139.19 175.29 9.68 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.595 1.543 . . . . 0.0 112.579 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -138.53 171.49 14.28 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.357 1.463 . . . . 0.0 113.195 -169.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.8 mm -120.71 127.91 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.16 1.384 . . . . 0.0 110.364 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.84 -155.74 6.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.759 1.647 . . . . 0.0 110.968 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -143.25 145.06 32.41 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.492 1.146 . . . . 0.0 112.053 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.66 -162.99 10.97 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.428 1.49 . . . . 0.0 113.26 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.16 136.51 23.87 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.174 1.39 . . . . 0.0 113.054 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.77 -4.48 63.49 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.738 1.161 . . . . 0.0 114.268 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 48.54 54.71 10.09 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.425 1.89 . . . . 0.0 113.567 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.86 140.24 37.6 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 127.454 2.301 . . . . 0.0 107.674 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.28 141.21 46.51 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.076 1.184 . . . . 0.0 109.278 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.5 151.6 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.348 1.459 . . . . 0.0 111.681 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.3 t -76.91 134.6 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.115 0.966 . . . . 0.0 110.858 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -139.74 160.52 60.75 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.032 1.733 . . . . 0.0 111.825 -169.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.68 164.19 32.23 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.965 2.443 . . . . 0.0 111.983 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.71 120.51 6.73 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.43 2.087 . . . . 0.0 110.516 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -147.0 -90.91 0.09 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.0 0.92 . . . . 0.0 110.793 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -155.52 17.94 0.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.315 1.446 . . . . 0.0 113.096 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -67.36 136.33 54.62 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.486 -0.759 . . . . 0.0 111.99 -173.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.9 m -145.09 161.11 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.907 1.283 . . . . 0.0 112.545 -175.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -131.36 137.24 48.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.671 1.588 . . . . 0.0 110.737 169.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.1 m -68.49 129.67 40.6 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 169.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 44.3 mt -127.08 116.59 20.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.22 1.008 . . . . 0.0 108.693 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 m -131.6 128.29 38.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.813 0.845 . . . . 0.0 111.295 -169.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp -69.06 151.43 46.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.266 1.027 . . . . 0.0 112.147 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.6 p -129.02 -176.62 3.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.128 1.771 . . . . 0.0 111.465 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.2 p -60.34 -15.89 29.8 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.66 18.17 0.24 Allowed Glycine 0 CA--C 1.534 1.253 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.07 -150.39 8.33 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.15 1.357 . . . . 0.0 112.061 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -133.66 168.22 19.08 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.694 1.998 . . . . 0.0 111.693 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -130.0 148.71 51.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.257 2.223 . . . . 0.0 109.968 174.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.85 122.94 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.779 1.231 . . . . 0.0 109.563 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -137.96 160.4 39.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.73 1.212 . . . . 0.0 112.675 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.35 -24.38 66.42 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -172.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 124.93 -40.22 1.93 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.519 1.533 . . . . 0.0 113.077 -173.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -93.47 -3.05 53.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.298 1.439 . . . . 0.0 113.511 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 70.16 14.51 7.67 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.609 2.364 . . . . 0.0 113.413 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.2 p -72.75 -23.79 60.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.747 1.219 . . . . 0.0 112.703 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.3 m -146.02 172.66 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.91 1.684 . . . . 0.0 111.833 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.0 m -143.82 155.18 44.05 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.076 2.151 . . . . 0.0 111.214 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 38.0 m0 -73.1 140.58 47.23 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.938 -0.477 . . . . 0.0 111.848 169.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.3 p -153.56 170.71 20.14 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.225 1.41 . . . . 0.0 112.547 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.88 164.88 14.39 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.821 1.648 . . . . 0.0 110.068 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -99.62 -32.84 10.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.669 0.787 . . . . 0.0 111.623 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -143.83 -0.8 1.02 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.482 1.913 . . . . 0.0 114.196 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 50.31 27.49 2.72 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.125 2.17 . . . . 0.0 115.9 -172.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.2 p -79.4 160.0 26.85 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.901 -1.124 . . . . 0.0 112.663 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.71 138.55 58.46 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.606 0.762 . . . . 0.0 112.152 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.03 -0.3 89.86 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.658 1.123 . . . . 0.0 114.757 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -76.28 154.17 35.36 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.798 1.299 . . . . 0.0 113.169 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -81.77 122.73 28.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.058 -1.026 . . . . 0.0 110.71 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.12 151.43 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.094 0.958 . . . . 0.0 111.011 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.3 m -134.83 168.42 19.09 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.7 1.6 . . . . 0.0 111.283 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.2 mt -132.77 145.12 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.007 1.323 . . . . 0.0 109.268 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.6 -161.28 34.99 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 123.813 0.721 . . . . 0.0 112.529 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 149.16 17.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 117.828 0.814 . . . . 0.0 111.956 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.68 116.38 2.47 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.39 1.476 . . . . 0.0 113.934 -172.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.84 157.23 37.86 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.4 t -87.66 -12.98 43.84 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -133.64 -37.86 0.92 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.48 1.112 . . . . 0.0 113.44 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.4 p -104.81 2.18 29.85 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.857 1.263 . . . . 0.0 114.26 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.47 10.94 1.77 Allowed Glycine 0 CA--C 1.542 1.749 0 C-N-CA 125.888 1.708 . . . . 0.0 115.819 -176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -135.46 145.98 47.72 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.435 1.894 . . . . 0.0 111.225 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -138.06 178.51 7.07 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 126.949 2.1 . . . . 0.0 111.237 -168.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.31 138.09 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 124.169 0.987 . . . . 0.0 109.36 168.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.04 124.2 72.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 125.947 1.699 . . . . 0.0 107.215 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -147.93 152.5 37.65 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.535 1.134 . . . . 0.0 109.432 -170.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.74 155.58 38.94 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.046 -1.034 . . . . 0.0 112.909 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.133 1.773 . . . . 0.0 111.216 171.815 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 CA--C 1.543 0.683 0 CA-C-O 121.387 0.613 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 t -154.26 167.4 30.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.31 1.044 . . . . 0.0 110.087 173.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 125.06 22.7 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 122.091 -0.38 . . . . 0.0 111.506 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.2 -165.87 38.17 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -99.71 124.8 45.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.236 1.014 . . . . 0.0 110.087 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -134.2 170.02 16.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.28 1.432 . . . . 0.0 112.508 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 pt -125.07 152.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.242 1.817 . . . . 0.0 108.328 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.1 mt -128.94 119.33 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -137.85 147.8 44.83 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.279 0.631 . . . . 0.0 112.477 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -79.36 133.78 36.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.75 0.42 . . . . 0.0 111.234 -173.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -61.63 -21.78 64.68 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.187 1.395 . . . . 0.0 114.343 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.2 t . . . . . 0 N--CA 1.479 1.024 0 C-N-CA 123.976 0.91 . . . . 0.0 112.497 174.78 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 CA--C 1.54 0.585 0 CA-C-O 121.104 0.478 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.51 147.46 30.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.048 1.739 . . . . 0.0 114.287 -171.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.1 tp -60.25 136.73 58.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.207 1.403 . . . . 0.0 110.784 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 m -124.26 120.27 31.74 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.403 1.481 . . . . 0.0 111.473 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -63.62 133.3 95.48 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.764 1.626 . . . . 0.0 111.39 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.83 -11.48 21.82 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.077 2.518 . . . . 0.0 114.587 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.93 84.8 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 119.14 -0.811 . . . . 0.0 114.92 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -156.1 161.56 40.37 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.196 1.398 . . . . 0.0 112.036 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -88.96 164.51 15.08 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.131 0.972 . . . . 0.0 111.863 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 47.3 mmt-85 50.57 34.57 9.79 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.874 1.67 . . . . 0.0 113.986 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.8 m -132.29 138.9 33.29 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.848 1.659 . . . . 0.0 110.653 -169.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.99 154.74 12.58 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.685 3.59 . . . . 0.0 115.229 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -100.92 156.66 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.839 1.256 . . . . 0.0 110.642 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 52' ' ' VAL . 2.9 m -126.98 178.24 6.11 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.675 1.59 . . . . 0.0 110.694 -170.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -134.98 148.96 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.911 1.284 . . . . 0.0 111.406 176.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.5 m -158.84 162.79 25.87 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 125.08 1.352 . . . . 0.0 112.76 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.67 127.62 16.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.53 2.153 . . . . 0.0 111.034 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.5 tp -65.2 140.22 58.73 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -137.26 10.64 3.01 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.986 1.315 . . . . 0.0 113.101 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.25 0.15 89.45 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.772 1.177 . . . . 0.0 114.948 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -64.66 142.51 58.4 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 118.678 1.239 . . . . 0.0 112.08 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.0 p -60.9 -14.13 20.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.037 1.335 . . . . 0.0 114.07 172.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.49 -21.55 64.6 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.201 -0.937 . . . . 0.0 112.626 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -118.28 9.5 12.54 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.975 1.31 . . . . 0.0 113.604 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -106.79 146.54 30.76 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.771 1.228 . . . . 0.0 110.894 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -138.94 173.96 11.01 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 122.478 1.133 . . . . 0.0 112.096 -168.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.7 mt -124.55 134.95 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 127.54 2.336 . . . . 0.0 106.948 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.02 124.88 22.6 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.376 1.47 . . . . 0.0 109.26 -170.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -146.39 139.32 25.52 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.069 0.548 . . . . 0.0 111.754 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 t -66.53 140.8 58.0 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.991 0.516 . . . . 0.0 111.592 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -114.85 -52.59 2.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.82 1.248 . . . . 0.0 111.223 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.86 110.32 5.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.77 1.228 . . . . 0.0 111.405 169.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.9 m -57.71 -24.7 58.19 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.956 0.903 . . . . 0.0 111.663 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -64.64 -21.97 66.86 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.009 2.124 . . . . 0.0 113.626 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.5 m -130.31 12.51 5.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.997 1.719 . . . . 0.0 112.686 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 42.95 35.33 0.73 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.623 1.969 . . . . 0.0 113.582 -169.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 p -87.58 139.28 30.7 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.76 -1.212 . . . . 0.0 111.709 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -135.94 143.57 44.99 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.57 1.548 . . . . 0.0 110.074 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.9 p -77.73 150.54 34.4 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.716 0.806 . . . . 0.0 110.793 173.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.9 mm -128.6 127.12 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.613 1.565 . . . . 0.0 109.44 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.6 m -143.79 148.11 41.39 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 125.835 1.654 . . . . 0.0 110.316 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.38 148.56 34.03 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.203 2.602 . . . . 0.0 111.172 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.5 m -66.79 -24.76 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.732 -1.23 . . . . 0.0 113.015 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.44 -23.9 74.34 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 123.938 0.78 . . . . 0.0 114.107 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.8 m -143.43 74.36 17.19 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 125.972 1.709 . . . . 0.0 110.368 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -61.81 -13.31 29.83 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.236 2.624 . . . . 0.0 113.192 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -89.38 9.58 25.68 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 128.52 2.728 . . . . 0.0 114.614 174.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.8 p -133.28 174.7 10.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.943 1.297 . . . . 0.0 112.009 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -141.36 170.07 16.42 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.882 1.273 . . . . 0.0 113.286 -170.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -120.48 128.95 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.164 1.386 . . . . 0.0 110.532 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.54 -159.61 8.22 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.652 1.596 . . . . 0.0 111.621 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -138.74 141.09 38.87 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.347 1.073 . . . . 0.0 111.956 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.78 -163.73 10.85 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.447 1.499 . . . . 0.0 113.425 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.77 140.14 19.9 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.045 1.338 . . . . 0.0 113.314 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.46 -4.74 73.62 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.686 1.136 . . . . 0.0 114.254 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 49.19 55.02 9.95 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.466 1.906 . . . . 0.0 114.333 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.8 149.05 70.8 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 126.103 1.761 . . . . 0.0 107.843 169.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.63 147.59 51.59 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.147 1.231 . . . . 0.0 109.877 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.26 153.02 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.74 1.616 . . . . 0.0 111.664 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.85 132.01 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.098 0.959 . . . . 0.0 111.158 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.3 mt -137.91 161.8 57.83 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 126.312 1.845 . . . . 0.0 112.053 -169.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.43 165.76 29.48 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.093 2.528 . . . . 0.0 111.944 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.6 123.02 9.1 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.446 2.097 . . . . 0.0 110.45 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -147.66 -88.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.719 0.808 . . . . 0.0 110.609 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -155.48 16.11 0.39 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.481 1.512 . . . . 0.0 112.954 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -65.9 132.7 49.28 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.502 -0.749 . . . . 0.0 111.936 -172.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.79 159.45 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.328 1.451 . . . . 0.0 111.522 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -129.3 145.98 51.27 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.157 1.383 . . . . 0.0 110.003 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.9 m -81.79 133.96 35.39 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.086 0.954 . . . . 0.0 109.735 173.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.45 132.7 54.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.041 1.336 . . . . 0.0 109.516 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 61.1 m -142.14 122.76 14.19 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.007 -1.058 . . . . 0.0 110.617 -173.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.5 mt -62.65 152.98 33.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.66 0.743 . . . . 0.0 112.65 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.9 p -126.17 -179.92 4.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.61 1.964 . . . . 0.0 109.808 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.5 m -61.38 -8.7 4.23 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.18 26.98 0.2 Allowed Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.229 0.919 . . . . 0.0 114.66 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.92 -151.72 11.02 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.946 1.26 . . . . 0.0 112.814 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -131.73 170.21 15.13 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.011 2.124 . . . . 0.0 112.113 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -137.31 152.8 50.15 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.292 2.637 . . . . 0.0 109.127 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.88 118.46 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.638 1.175 . . . . 0.0 109.176 -169.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -134.85 160.18 39.04 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -169.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -62.72 -25.98 68.45 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.626 1.97 . . . . 0.0 116.14 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 128.9 -32.99 3.17 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.054 1.312 . . . . 0.0 113.515 -173.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -113.72 9.86 17.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.298 1.839 . . . . 0.0 113.542 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 62.57 16.55 8.88 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.9 2.08 . . . . 0.0 113.98 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.8 p -70.2 -27.49 64.54 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.716 0.806 . . . . 0.0 112.437 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.0 m -146.0 173.13 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.466 1.506 . . . . 0.0 112.061 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 t -141.77 154.19 45.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.292 2.237 . . . . 0.0 109.596 172.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -69.66 144.31 52.93 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.696 -0.627 . . . . 0.0 110.688 169.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.0 p -155.03 168.59 26.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.498 1.119 . . . . 0.0 112.171 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.4 mt -113.94 163.76 14.69 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.119 1.767 . . . . 0.0 109.564 171.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -97.13 -33.69 11.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.925 0.89 . . . . 0.0 111.793 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -136.57 -6.49 1.97 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.969 2.108 . . . . 0.0 112.123 171.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.1 27.74 11.91 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.17 1.788 . . . . 0.0 114.268 -171.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.8 p -78.03 157.21 29.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.22 1.008 . . . . 0.0 111.995 172.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.48 139.39 58.5 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.235 -0.916 . . . . 0.0 111.736 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.26 0.74 90.05 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.712 1.148 . . . . 0.0 114.703 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.48 144.94 46.02 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.666 1.233 . . . . 0.0 112.834 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.49 120.49 21.79 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 173.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.82 149.8 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.571 0.7 . . . . 0.0 111.382 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 t -130.2 166.66 19.81 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.999 1.72 . . . . 0.0 111.677 -169.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.75 140.26 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.645 1.578 . . . . 0.0 109.184 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 171.32 -161.61 34.12 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 121.528 -0.733 . . . . 0.0 112.663 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.17 152.86 12.83 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 117.667 0.734 . . . . 0.0 111.715 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -51.88 109.28 0.35 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.418 1.487 . . . . 0.0 113.121 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.99 142.92 55.79 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.787 0.835 . . . . 0.0 113.163 -173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.0 t -60.07 -20.57 58.73 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -135.74 -40.26 0.7 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.947 1.299 . . . . 0.0 113.006 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.6 t -91.0 1.26 57.21 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -172.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.77 14.69 1.93 Allowed Glycine 0 CA--C 1.542 1.75 0 C-N-CA 125.115 1.34 . . . . 0.0 116.003 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.69 145.36 49.84 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.395 1.478 . . . . 0.0 111.476 -174.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -140.78 175.09 9.89 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.374 1.87 . . . . 0.0 110.613 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.48 141.03 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.123 1.369 . . . . 0.0 108.977 169.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 mp -121.31 124.37 71.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.649 1.58 . . . . 0.0 107.167 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -149.0 154.24 39.07 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.687 1.195 . . . . 0.0 109.181 -169.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -68.68 154.46 41.9 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.928 -1.107 . . . . 0.0 112.577 -177.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.324 1.85 . . . . 0.0 111.374 171.226 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.55 0.971 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 t -159.66 168.91 24.88 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.92 1.288 . . . . 0.0 110.269 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.27 139.67 57.32 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.811 -0.555 . . . . 0.0 111.995 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.76 -163.45 35.25 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.916 0.769 . . . . 0.0 114.51 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -95.1 124.0 38.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.959 0.903 . . . . 0.0 109.77 170.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -133.45 173.25 11.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.552 1.541 . . . . 0.0 112.026 -172.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.4 pt -126.37 152.26 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.95 1.7 . . . . 0.0 108.542 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 mt -123.54 122.95 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -137.74 146.7 44.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.512 0.725 . . . . 0.0 110.836 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -67.01 143.32 56.84 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -63.5 -23.54 67.44 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.882 -0.511 . . . . 0.0 112.212 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.469 0.487 0 C-N-CA 125.453 1.501 . . . . 0.0 108.391 168.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.2 tp . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 121.553 0.692 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.39 149.81 28.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.981 1.712 . . . . 0.0 115.041 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 tp -62.38 137.02 58.18 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.261 1.424 . . . . 0.0 110.384 169.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 m -127.61 120.39 28.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.799 1.24 . . . . 0.0 111.287 -174.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -66.18 135.52 95.05 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.095 1.358 . . . . 0.0 112.218 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.1 -13.41 21.22 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.339 2.693 . . . . 0.0 114.666 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.41 7.87 81.82 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.1 0.857 . . . . 0.0 115.035 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -154.77 164.65 38.48 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.239 1.816 . . . . 0.0 111.382 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -98.89 165.78 11.6 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.894 1.278 . . . . 0.0 111.435 -173.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 47.38 43.46 15.38 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.938 1.695 . . . . 0.0 113.494 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.6 m -139.33 137.99 19.9 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 126.381 1.872 . . . . 0.0 109.852 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.79 161.65 3.01 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.766 3.644 . . . . 0.0 115.597 173.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.46 148.55 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.875 1.27 . . . . 0.0 110.599 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 m -123.47 173.84 7.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.055 1.342 . . . . 0.0 111.039 -169.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.19 148.48 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.983 1.313 . . . . 0.0 111.533 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 m -154.34 160.21 31.16 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.153 0.981 . . . . 0.0 113.039 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.27 122.34 9.59 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.896 2.398 . . . . 0.0 110.575 170.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.58 136.54 57.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.379 1.471 . . . . 0.0 112.619 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -133.48 9.52 4.0 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.262 1.425 . . . . 0.0 112.41 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.82 8.09 60.1 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.147 1.356 . . . . 0.0 114.882 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.8 p -69.61 153.48 43.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 112.914 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -62.07 -17.7 58.36 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.93 -23.4 63.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.878 1.271 . . . . 0.0 112.544 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -118.27 4.82 11.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.063 1.745 . . . . 0.0 113.162 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.63 139.92 35.63 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.703 1.201 . . . . 0.0 110.774 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -133.74 171.08 14.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.756 1.265 . . . . 0.0 112.149 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.1 mt -125.88 135.53 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 127.571 2.349 . . . . 0.0 106.657 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.0 tp -136.2 126.3 26.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.113 1.365 . . . . 0.0 109.064 -170.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -142.22 140.63 32.36 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.795 0.838 . . . . 0.0 110.833 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.8 t -65.64 141.04 58.53 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.853 0.461 . . . . 0.0 111.006 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -112.11 -52.87 2.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.437 1.095 . . . . 0.0 110.743 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.97 109.28 4.68 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.591 1.156 . . . . 0.0 110.479 169.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.7 m -58.15 -25.25 61.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.948 0.899 . . . . 0.0 111.399 168.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -63.39 -21.52 66.33 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.0 2.12 . . . . 0.0 113.451 174.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.1 m -130.26 9.7 5.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.043 1.737 . . . . 0.0 113.105 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 45.52 33.32 1.32 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.765 2.026 . . . . 0.0 114.217 -169.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.8 p -87.72 143.15 27.31 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.79 -1.193 . . . . 0.0 112.073 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -140.43 140.23 35.39 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.287 1.435 . . . . 0.0 111.052 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.6 p -77.94 142.24 38.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.498 0.719 . . . . 0.0 111.079 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.1 mm -123.91 124.81 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.172 1.389 . . . . 0.0 109.836 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 m -142.31 145.7 36.31 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 125.437 1.495 . . . . 0.0 109.661 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.76 150.08 27.03 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.73 2.287 . . . . 0.0 111.274 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.5 t -65.05 -30.55 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 121.216 -0.927 . . . . 0.0 111.764 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.18 -11.11 82.82 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.3 m -155.49 63.67 3.74 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 125.525 1.53 . . . . 0.0 111.485 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -63.88 -19.24 66.5 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.994 3.129 . . . . 0.0 113.689 -173.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -68.11 -2.18 7.41 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 128.026 2.53 . . . . 0.0 114.553 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.4 m -132.24 166.58 21.54 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.602 1.961 . . . . 0.0 110.86 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -142.39 171.21 14.36 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.331 1.452 . . . . 0.0 112.946 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.27 126.26 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.837 1.255 . . . . 0.0 110.721 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.43 -158.98 7.91 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.475 1.512 . . . . 0.0 111.676 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -139.59 140.41 37.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.355 1.062 . . . . 0.0 111.555 -170.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.01 -166.06 12.75 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.284 1.421 . . . . 0.0 113.193 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.7 137.19 20.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.258 1.423 . . . . 0.0 113.159 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.9 -6.95 64.7 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.779 1.181 . . . . 0.0 114.183 -172.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 48.88 56.76 7.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.552 1.941 . . . . 0.0 114.216 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.95 151.57 78.22 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 126.292 1.837 . . . . 0.0 108.047 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.02 141.91 54.7 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 120.939 1.092 . . . . 0.0 109.626 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.27 152.71 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.372 1.469 . . . . 0.0 111.032 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 49.9 t -79.63 136.28 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.917 0.887 . . . . 0.0 111.07 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -140.84 165.19 31.32 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.674 1.99 . . . . 0.0 111.861 -170.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.64 176.43 2.27 Favored 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 123.558 2.838 . . . . 0.0 113.501 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.29 43.44 1.49 Allowed 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.78 2.987 . . . . 0.0 113.527 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -80.7 13.71 2.45 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.746 1.618 . . . . 0.0 114.407 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 70.74 44.69 0.62 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.714 2.405 . . . . 0.0 113.588 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -64.25 143.8 57.62 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.741 0.817 . . . . 0.0 111.273 169.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.6 m -141.86 156.21 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.403 1.081 . . . . 0.0 112.399 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -127.2 140.95 51.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.075 1.35 . . . . 0.0 111.176 170.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.8 m -78.88 127.04 31.5 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.741 1.216 . . . . 0.0 109.149 172.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.3 mt -115.39 128.64 56.2 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.809 0.843 . . . . 0.0 109.575 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.1 m -131.34 118.27 20.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.243 1.017 . . . . 0.0 110.189 -169.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.7 tp -66.03 145.73 55.52 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.761 -0.587 . . . . 0.0 111.17 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.0 p -127.55 175.35 8.32 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.963 1.705 . . . . 0.0 110.527 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.5 p -57.83 -16.51 11.85 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -155.06 23.74 0.6 Allowed Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.629 1.109 . . . . 0.0 114.565 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.95 -149.83 9.48 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.877 1.227 . . . . 0.0 112.607 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -134.0 171.11 14.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.186 2.194 . . . . 0.0 111.574 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -136.78 154.46 50.55 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.364 2.266 . . . . 0.0 109.95 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.5 mt -134.45 121.04 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.133 1.373 . . . . 0.0 109.355 -169.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -137.0 158.3 44.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.567 1.147 . . . . 0.0 112.614 -170.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.3 -33.38 75.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -171.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.21 -31.36 2.7 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.283 1.42 . . . . 0.0 113.772 -169.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -104.19 -2.21 26.07 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.539 1.536 . . . . 0.0 113.887 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 64.82 13.04 8.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.295 2.238 . . . . 0.0 114.128 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.4 p -69.98 -21.26 63.25 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.588 1.155 . . . . 0.0 112.824 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.89 169.6 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.486 1.515 . . . . 0.0 112.661 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.9 t -140.67 153.71 46.1 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.919 2.487 . . . . 0.0 109.66 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -69.9 144.8 52.35 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.455 -0.778 . . . . 0.0 110.137 168.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.7 p -149.34 171.6 16.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.378 1.071 . . . . 0.0 112.993 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.5 mt -125.15 165.7 17.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.108 1.763 . . . . 0.0 109.625 172.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -105.19 -32.71 8.53 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.904 0.882 . . . . 0.0 111.94 -169.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -140.24 -10.08 1.12 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.757 2.023 . . . . 0.0 112.662 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.68 27.13 12.15 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.569 1.548 . . . . 0.0 114.24 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.9 p -78.31 157.62 29.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.415 1.086 . . . . 0.0 111.807 170.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.87 141.57 58.73 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.259 -0.901 . . . . 0.0 112.161 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.27 4.96 89.22 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.5 1.048 . . . . 0.0 114.458 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -75.13 137.45 41.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.769 1.228 . . . . 0.0 112.402 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.41 128.28 35.15 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.508 -0.745 . . . . 0.0 110.569 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.5 t -64.23 150.71 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.229 0.612 . . . . 0.0 110.557 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.4 t -126.95 161.96 27.08 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.823 1.249 . . . . 0.0 111.796 -175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.7 mt -134.21 142.04 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.98 1.712 . . . . 0.0 108.78 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.84 -156.71 28.81 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 124.631 1.11 . . . . 0.0 110.716 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.77 166.43 1.91 Allowed 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.717 1.259 . . . . 0.0 111.685 169.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -56.35 157.01 5.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.06 0.944 . . . . 0.0 112.82 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.53 136.16 51.34 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.607 1.163 . . . . 0.0 112.312 -172.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.1 t -55.59 -26.84 45.98 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.254 1.822 . . . . 0.0 115.834 -169.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -130.16 -32.82 1.78 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.094 0.958 . . . . 0.0 113.385 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 96.6 p -103.87 -2.25 26.52 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.8 27.76 1.1 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 125.955 1.74 . . . . 0.0 114.859 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -147.64 142.1 26.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.765 2.026 . . . . 0.0 110.943 -169.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -140.74 175.75 9.36 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.956 1.702 . . . . 0.0 111.21 -168.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.55 140.16 26.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.735 1.214 . . . . 0.0 109.299 169.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.62 125.05 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 125.677 1.591 . . . . 0.0 107.354 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -148.98 153.62 38.2 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.8 1.24 . . . . 0.0 109.673 -171.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -67.9 155.22 39.9 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.998 -1.064 . . . . 0.0 112.882 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.328 1.851 . . . . 0.0 111.217 171.154 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.3 mt . . . . . 0 CA--C 1.549 0.94 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 t -159.92 168.21 26.24 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.215 1.406 . . . . 0.0 109.861 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.85 137.2 57.62 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.653 -0.654 . . . . 0.0 112.176 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.73 -162.88 35.41 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.968 0.794 . . . . 0.0 114.604 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -97.14 124.91 41.32 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.215 1.006 . . . . 0.0 109.978 172.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -133.88 173.11 11.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.637 1.575 . . . . 0.0 112.235 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.8 pt -125.88 151.66 32.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 126.051 1.74 . . . . 0.0 108.452 170.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 mt -124.64 119.17 55.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -137.63 148.11 45.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.776 0.83 . . . . 0.0 110.581 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -72.79 149.11 43.92 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.176 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -61.81 -24.94 67.19 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.686 -0.633 . . . . 0.0 112.569 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.0 t . . . . . 0 N--CA 1.473 0.725 0 C-N-CA 125.545 1.538 . . . . 0.0 109.671 169.604 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 121.78 0.8 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.38 150.83 19.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -168.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.3 tp -60.45 135.63 57.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.806 1.242 . . . . 0.0 110.032 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -129.97 121.06 25.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.803 1.241 . . . . 0.0 111.247 -173.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -65.03 136.29 96.69 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.956 1.302 . . . . 0.0 112.458 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.07 -13.31 21.3 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.51 2.807 . . . . 0.0 114.688 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.01 7.42 80.68 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 124.223 0.916 . . . . 0.0 115.071 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -153.92 166.59 32.48 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.351 1.86 . . . . 0.0 111.299 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -102.57 166.64 10.41 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.743 1.217 . . . . 0.0 111.545 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 51.15 40.93 27.04 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.773 1.629 . . . . 0.0 112.425 -174.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.9 m -141.16 137.89 17.26 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 126.139 1.776 . . . . 0.0 110.47 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -52.71 158.17 6.49 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.736 3.624 . . . . 0.0 115.43 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 t -110.26 148.99 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.861 1.264 . . . . 0.0 110.74 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 52' ' ' VAL . 1.3 m -121.66 176.5 5.68 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.216 1.407 . . . . 0.0 111.494 -169.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.461 ' H ' HG22 ' A' ' 51' ' ' THR . 0.3 OUTLIER -131.34 146.04 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.109 1.364 . . . . 0.0 111.647 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.1 m -153.79 163.06 25.13 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.469 1.108 . . . . 0.0 113.303 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -60.49 124.38 14.98 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.394 2.73 . . . . 0.0 110.418 168.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.46 136.21 57.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.33 1.052 . . . . 0.0 111.786 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -132.81 7.72 4.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.023 1.329 . . . . 0.0 112.449 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.53 9.61 58.78 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.92 1.247 . . . . 0.0 114.592 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.0 p -68.77 154.3 42.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.26 1.424 . . . . 0.0 112.729 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.4 p -62.54 -17.12 59.2 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -70.48 -24.41 62.86 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.858 1.263 . . . . 0.0 112.402 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.23 3.14 12.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.04 1.736 . . . . 0.0 113.235 -176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.89 140.26 32.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 110.558 171.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -134.15 171.31 14.41 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.763 1.268 . . . . 0.0 111.7 -169.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.4 mt -125.92 136.28 61.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 127.052 2.141 . . . . 0.0 106.566 -175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.6 tp -137.41 124.47 21.53 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.1 1.36 . . . . 0.0 108.901 -169.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -142.62 134.26 26.67 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.768 0.827 . . . . 0.0 110.946 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.3 t -63.78 137.03 57.88 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.998 0.519 . . . . 0.0 110.853 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -112.79 -47.38 3.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.324 1.05 . . . . 0.0 111.691 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.46 111.46 4.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.302 1.441 . . . . 0.0 110.708 170.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.2 m -58.99 -24.32 62.61 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.987 0.915 . . . . 0.0 111.533 168.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -64.18 -21.82 66.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.872 2.069 . . . . 0.0 113.522 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 m -130.33 11.75 5.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.684 1.594 . . . . 0.0 112.853 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 44.09 32.26 0.63 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.592 1.957 . . . . 0.0 113.509 -169.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 p -87.11 139.82 30.18 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.163 -0.96 . . . . 0.0 111.876 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -135.44 141.92 45.5 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.636 1.574 . . . . 0.0 110.978 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -77.5 145.72 36.82 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.808 0.443 . . . . 0.0 110.849 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.8 mm -127.14 126.73 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.32 1.448 . . . . 0.0 109.673 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 57.1 m -144.01 147.94 40.0 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 126.103 1.761 . . . . 0.0 109.578 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.63 149.93 24.11 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.887 2.392 . . . . 0.0 111.445 175.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.91 -29.72 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.058 -1.026 . . . . 0.0 111.811 173.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.21 -13.97 81.12 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 115.424 0.929 . . . . 0.0 115.424 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.0 m -151.98 62.48 4.72 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 125.682 1.593 . . . . 0.0 111.536 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.13 -13.65 39.04 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.414 2.742 . . . . 0.0 114.034 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -73.18 6.33 2.86 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.425 1.89 . . . . 0.0 114.063 170.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -138.89 166.31 24.79 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.295 1.838 . . . . 0.0 111.088 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -136.56 171.23 14.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.348 1.459 . . . . 0.0 113.089 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.6 mm -120.9 130.62 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.143 1.377 . . . . 0.0 110.929 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.75 -156.15 6.9 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.917 1.722 . . . . 0.0 111.834 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -142.6 142.37 32.12 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.402 1.081 . . . . 0.0 111.518 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.22 -166.44 13.13 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.31 1.433 . . . . 0.0 113.401 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.2 138.65 20.13 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.085 1.354 . . . . 0.0 113.221 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.7 -6.57 67.58 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.724 1.154 . . . . 0.0 114.089 -172.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 49.67 56.54 7.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.578 1.951 . . . . 0.0 114.21 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.08 150.23 75.48 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 126.153 1.781 . . . . 0.0 108.127 169.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.94 142.38 56.73 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.192 1.261 . . . . 0.0 109.693 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.28 148.16 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.724 1.61 . . . . 0.0 111.096 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.73 138.8 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.938 0.895 . . . . 0.0 110.575 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.7 mt -140.53 161.74 53.05 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.31 1.844 . . . . 0.0 111.013 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.12 164.83 30.56 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.94 2.427 . . . . 0.0 111.879 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.23 119.55 6.07 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.528 2.152 . . . . 0.0 110.47 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -147.5 -89.6 0.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.821 0.848 . . . . 0.0 110.977 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -155.91 17.25 0.37 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.117 1.367 . . . . 0.0 113.235 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -67.56 135.86 53.61 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.525 -0.735 . . . . 0.0 112.075 -173.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.7 m -145.03 159.83 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.034 1.334 . . . . 0.0 112.646 -175.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -129.55 136.28 49.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.538 1.535 . . . . 0.0 110.925 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.3 m -74.35 128.98 36.91 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 109.437 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -118.01 125.81 51.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.175 0.99 . . . . 0.0 109.335 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.0 m -130.52 118.32 20.91 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.272 1.029 . . . . 0.0 111.155 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.99 148.39 51.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.641 0.776 . . . . 0.0 111.34 173.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.8 p -132.26 174.42 10.24 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.035 1.734 . . . . 0.0 110.35 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.8 m -61.67 -10.39 8.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.54 36.71 0.39 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.396 0.998 . . . . 0.0 113.944 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.24 -166.57 34.72 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.793 1.187 . . . . 0.0 112.708 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -121.23 166.83 13.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.484 1.914 . . . . 0.0 111.293 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -135.09 152.31 51.54 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.592 1.557 . . . . 0.0 110.454 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.58 117.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.136 1.374 . . . . 0.0 109.263 -169.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -136.48 157.73 46.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.66 1.184 . . . . 0.0 112.373 -169.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -63.72 -31.06 72.12 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -171.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.14 -26.14 3.27 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.313 1.435 . . . . 0.0 114.175 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -113.62 1.21 14.86 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.112 1.765 . . . . 0.0 114.0 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 64.32 12.87 7.57 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.453 2.301 . . . . 0.0 114.239 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.3 p -73.22 -22.37 60.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.163 0.985 . . . . 0.0 112.9 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 m -144.69 170.85 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.66 1.584 . . . . 0.0 112.437 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.5 t -144.27 150.43 37.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 129.215 3.006 . . . . 0.0 108.885 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.5 m0 -69.94 145.87 51.57 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.16 -0.962 . . . . 0.0 110.52 169.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.0 p -156.41 174.22 15.74 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.805 1.242 . . . . 0.0 112.575 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -120.35 171.87 8.21 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.144 1.777 . . . . 0.0 110.059 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -108.27 -31.83 7.72 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.968 1.307 . . . . 0.0 110.811 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -142.83 -13.34 0.75 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 127.425 2.29 . . . . 0.0 112.96 169.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.93 22.04 8.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.615 1.966 . . . . 0.0 114.729 -170.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.7 p -70.7 158.28 36.53 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.64 1.176 . . . . 0.0 111.944 170.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.56 136.84 57.44 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.244 -0.91 . . . . 0.0 111.886 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.09 0.74 89.67 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.644 1.116 . . . . 0.0 114.367 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -72.32 138.86 47.62 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.806 1.303 . . . . 0.0 112.584 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.9 125.41 28.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.463 0.705 . . . . 0.0 110.26 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.0 153.56 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.596 0.713 . . . . 0.0 110.315 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.1 m -135.34 165.19 26.03 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.193 1.397 . . . . 0.0 111.572 -172.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.8 mt -134.07 142.2 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.262 1.425 . . . . 0.0 108.96 -175.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.91 179.54 48.02 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 124.602 1.096 . . . . 0.0 111.496 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.48 -40.83 62.8 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.005 1.402 . . . . 0.0 114.274 -173.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -169.6 174.11 6.02 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.857 2.463 . . . . 0.0 111.61 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.27 150.63 39.52 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.574 1.149 . . . . 0.0 111.908 169.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -83.06 -7.02 59.7 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -169.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -142.38 -40.93 0.34 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.205 1.002 . . . . 0.0 112.524 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.9 p -95.3 3.54 54.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.432 1.493 . . . . 0.0 114.212 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.29 22.91 0.61 Allowed Glycine 0 CA--C 1.544 1.87 0 C-N-CA 125.818 1.675 . . . . 0.0 115.802 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -147.58 143.98 28.14 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.836 1.655 . . . . 0.0 111.066 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -136.45 175.54 9.52 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.398 1.879 . . . . 0.0 111.338 -169.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.45 137.76 25.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.653 1.181 . . . . 0.0 109.373 169.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -116.01 124.24 72.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 125.916 1.686 . . . . 0.0 107.14 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.6 153.09 38.98 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.845 1.258 . . . . 0.0 109.497 -171.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.08 155.4 39.63 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.008 -1.057 . . . . 0.0 112.803 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.3 t . . . . . 0 C--O 1.252 1.21 0 C-N-CA 126.121 1.769 . . . . 0.0 111.292 171.879 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 CA--C 1.543 0.699 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.6 t -161.58 170.46 19.78 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.302 1.841 . . . . 0.0 109.232 174.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.03 134.12 54.39 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.564 -0.71 . . . . 0.0 112.308 173.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.08 -161.24 34.2 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.114 0.864 . . . . 0.0 114.311 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -100.49 125.8 46.85 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.125 0.97 . . . . 0.0 110.213 173.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -134.86 172.76 12.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.537 1.535 . . . . 0.0 112.514 -170.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.97 154.69 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 126.461 1.904 . . . . 0.0 108.657 170.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 mt -129.92 118.92 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -141.61 153.37 44.73 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.68 0.792 . . . . 0.0 112.237 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -84.11 138.35 33.08 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.793 -0.567 . . . . 0.0 112.031 -172.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -63.36 -19.83 64.99 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.3 t . . . . . 0 N--CA 1.479 0.99 0 C-N-CA 123.908 0.883 . . . . 0.0 112.319 173.174 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.9 tp . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 121.6 0.714 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.89 150.85 30.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.876 1.27 . . . . 0.0 113.12 -170.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.2 tp -61.44 139.56 58.19 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.256 1.022 . . . . 0.0 110.016 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.2 m -130.7 122.12 26.74 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.564 1.145 . . . . 0.0 111.584 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -64.24 135.52 96.37 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.637 1.175 . . . . 0.0 112.061 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.07 -13.68 21.2 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.428 2.752 . . . . 0.0 114.852 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.35 7.28 76.63 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.083 0.849 . . . . 0.0 114.957 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -156.01 164.46 38.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.583 1.553 . . . . 0.0 112.085 -174.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -90.77 164.47 14.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.442 1.097 . . . . 0.0 111.761 -174.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 49.48 39.38 16.59 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.843 1.657 . . . . 0.0 113.586 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.9 m -136.5 140.73 33.23 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.674 1.59 . . . . 0.0 111.198 -169.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -45.55 156.58 0.37 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 126.093 4.528 . . . . 0.0 115.277 169.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.92 150.74 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.719 1.207 . . . . 0.0 110.065 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.9 m -124.44 176.05 6.74 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.744 1.618 . . . . 0.0 110.265 -169.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.09 147.53 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.679 1.127 . . . . 0.0 112.1 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 m -150.84 160.83 31.63 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.94 1.296 . . . . 0.0 111.795 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -64.22 134.21 41.35 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.009 1.806 . . . . 0.0 111.613 170.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.6 tp -67.53 137.73 55.97 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.645 0.778 . . . . 0.0 111.515 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -138.29 8.81 2.7 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.864 1.265 . . . . 0.0 112.98 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.46 -7.07 58.89 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 125.058 1.313 . . . . 0.0 115.095 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -67.05 145.81 54.98 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.549 1.174 . . . . 0.0 111.827 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.4 p -60.33 -12.3 8.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.756 1.622 . . . . 0.0 114.96 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -68.66 -23.7 64.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.216 1.006 . . . . 0.0 112.36 174.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -114.76 4.5 14.98 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.573 1.549 . . . . 0.0 113.231 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.1 140.9 36.72 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.045 0.938 . . . . 0.0 111.126 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -134.14 170.56 15.49 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 122.83 1.3 . . . . 0.0 111.94 -169.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.58 135.34 62.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 127.485 2.314 . . . . 0.0 106.208 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.3 tp -136.62 124.17 22.24 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.044 1.338 . . . . 0.0 108.561 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -142.33 139.31 31.77 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.347 0.659 . . . . 0.0 111.048 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 t -64.59 138.55 58.47 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.966 0.506 . . . . 0.0 110.735 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -110.23 -53.03 2.72 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.453 1.101 . . . . 0.0 111.047 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.14 109.97 5.08 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.024 1.329 . . . . 0.0 110.648 169.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.4 m -57.73 -23.51 52.27 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.997 0.919 . . . . 0.0 111.748 168.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -65.21 -22.18 66.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.061 2.144 . . . . 0.0 113.439 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 m -130.32 12.03 5.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.145 1.778 . . . . 0.0 112.784 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 42.74 34.96 0.64 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.938 2.095 . . . . 0.0 113.412 -169.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -86.03 143.96 27.83 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 120.966 -1.084 . . . . 0.0 112.391 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -138.54 140.49 39.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.25 1.42 . . . . 0.0 111.068 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.8 p -77.84 146.36 35.75 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.206 0.603 . . . . 0.0 110.75 171.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.3 mm -130.79 120.46 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.284 1.433 . . . . 0.0 110.426 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.9 m -141.71 148.77 51.04 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.367 1.467 . . . . 0.0 110.343 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.08 148.34 24.49 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.841 2.361 . . . . 0.0 111.674 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.28 -31.12 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 121.198 -0.939 . . . . 0.0 111.881 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.74 -23.56 72.23 Favored Glycine 0 CA--C 1.539 1.543 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.1 m -144.43 60.66 7.92 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.315 1.446 . . . . 0.0 112.352 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.69 -12.1 26.96 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.502 2.801 . . . . 0.0 114.143 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -75.63 14.46 0.63 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.812 2.045 . . . . 0.0 113.336 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -142.32 171.61 13.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.995 2.118 . . . . 0.0 111.289 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -144.08 167.03 23.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.946 1.299 . . . . 0.0 112.027 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -118.38 131.74 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.517 1.127 . . . . 0.0 111.185 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -148.63 -157.72 7.69 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.952 1.739 . . . . 0.0 111.284 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -141.59 145.19 34.76 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.265 1.032 . . . . 0.0 111.802 -174.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.4 -164.22 11.75 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.491 1.52 . . . . 0.0 112.955 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.62 138.3 23.11 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.957 1.303 . . . . 0.0 113.045 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.63 -3.51 63.18 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.684 1.135 . . . . 0.0 114.322 -173.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 47.56 55.19 8.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.295 1.838 . . . . 0.0 113.713 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.91 138.76 31.49 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 127.693 2.397 . . . . 0.0 107.45 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.27 142.48 55.34 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 N-CA-C 109.206 -1.113 . . . . 0.0 109.206 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 m -133.27 151.08 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.139 1.376 . . . . 0.0 111.627 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.19 136.53 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.753 0.821 . . . . 0.0 110.783 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.9 mt -139.41 163.76 43.29 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 127.154 2.182 . . . . 0.0 110.286 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.16 159.31 53.67 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.153 1.902 . . . . 0.0 111.464 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -71.4 118.18 5.53 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.744 2.296 . . . . 0.0 110.294 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -145.47 -88.76 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.763 0.825 . . . . 0.0 111.018 -175.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -155.21 15.89 0.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.932 1.293 . . . . 0.0 113.387 -173.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -69.93 133.81 47.71 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.437 -0.789 . . . . 0.0 111.581 -175.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.0 m -141.8 160.99 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.422 1.089 . . . . 0.0 112.441 -174.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -129.06 134.85 48.27 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.339 1.456 . . . . 0.0 110.441 170.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.3 m -75.66 129.8 37.71 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.388 1.075 . . . . 0.0 109.406 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.1 mt -120.46 132.23 55.12 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.207 1.003 . . . . 0.0 109.786 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.1 m -133.2 118.26 18.42 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.194 0.998 . . . . 0.0 110.357 -170.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.28 137.27 58.23 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.862 1.265 . . . . 0.0 110.449 171.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 p -126.46 173.17 9.59 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.239 1.415 . . . . 0.0 111.798 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.4 m -58.13 -10.18 1.79 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.0 36.82 0.33 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.128 1.347 . . . . 0.0 113.251 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.78 -150.2 17.42 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.398 1.099 . . . . 0.0 114.148 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -132.83 169.59 16.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.949 2.499 . . . . 0.0 110.564 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -135.22 150.81 50.16 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.901 2.081 . . . . 0.0 109.451 171.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.1 mt -133.32 119.94 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.207 1.403 . . . . 0.0 109.515 -169.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -137.07 157.06 47.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.201 1.0 . . . . 0.0 112.552 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.09 -31.68 71.36 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.6 -40.28 1.63 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.798 1.666 . . . . 0.0 113.175 -172.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.3 -10.08 59.75 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.6 1.16 . . . . 0.0 113.946 173.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 67.39 12.95 9.18 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.798 2.039 . . . . 0.0 112.758 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.5 p -73.24 -23.97 60.42 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.281 1.432 . . . . 0.0 112.692 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.3 m -142.83 170.39 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.863 1.665 . . . . 0.0 112.025 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.4 t -142.15 151.81 42.6 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 128.903 2.881 . . . . 0.0 109.359 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -70.02 143.55 52.51 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 119.153 0.888 . . . . 0.0 111.29 169.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.6 p -152.08 170.81 19.03 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.822 1.249 . . . . 0.0 112.969 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.89 166.23 18.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.185 1.794 . . . . 0.0 110.111 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -109.02 -32.35 7.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.969 0.908 . . . . 0.0 111.689 -169.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -139.5 -10.89 1.21 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.436 1.894 . . . . 0.0 112.729 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.3 23.97 7.77 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.993 1.717 . . . . 0.0 114.685 -170.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.7 p -70.52 153.12 43.25 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.028 -1.045 . . . . 0.0 111.457 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.18 137.91 57.92 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.116 -0.99 . . . . 0.0 111.444 172.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.19 0.3 88.7 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.472 1.034 . . . . 0.0 114.251 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -69.56 142.38 53.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.873 1.337 . . . . 0.0 112.609 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.14 116.48 16.87 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.385 -0.822 . . . . 0.0 109.693 170.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.36 150.1 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.573 0.749 . . . . 0.0 111.59 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 57.5 m -129.81 169.54 15.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.591 1.556 . . . . 0.0 111.468 -169.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.6 mt -135.26 143.63 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.338 1.455 . . . . 0.0 108.862 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.35 179.12 47.49 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.672 1.13 . . . . 0.0 111.666 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.69 -41.98 61.84 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.092 1.446 . . . . 0.0 114.271 -172.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -168.81 172.28 7.93 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.915 2.486 . . . . 0.0 109.818 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.07 138.62 33.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.144 0.978 . . . . 0.0 112.436 169.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.0 t -62.97 -14.75 51.38 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -169.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.43 -36.89 0.43 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.38 1.072 . . . . 0.0 112.958 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.8 p -98.33 2.27 47.89 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.362 1.465 . . . . 0.0 114.529 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.33 12.64 1.76 Allowed Glycine 0 CA--C 1.544 1.86 0 C-N-CA 125.547 1.546 . . . . 0.0 116.202 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -135.48 145.34 47.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.22 1.808 . . . . 0.0 111.364 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -139.35 175.87 9.19 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.335 1.454 . . . . 0.0 111.98 -169.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.65 138.99 38.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.764 1.225 . . . . 0.0 109.421 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.5 125.74 74.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 125.404 1.481 . . . . 0.0 107.276 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -148.93 153.99 38.78 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.798 1.239 . . . . 0.0 109.304 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -67.49 155.86 38.05 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.094 -1.004 . . . . 0.0 112.827 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.073 1.749 . . . . 0.0 111.278 172.223 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 CA--C 1.542 0.645 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 t -160.78 170.95 19.69 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.141 1.776 . . . . 0.0 109.414 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.22 133.1 49.92 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.631 -0.668 . . . . 0.0 111.656 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.25 -163.01 35.78 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.975 0.798 . . . . 0.0 114.183 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -98.63 125.64 43.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.826 0.851 . . . . 0.0 109.98 171.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -134.3 172.75 12.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.332 1.453 . . . . 0.0 112.284 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.0 pt -125.46 156.64 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 126.352 1.861 . . . . 0.0 109.058 171.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.8 mt -130.08 119.76 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -142.28 152.24 42.81 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.712 0.805 . . . . 0.0 112.346 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -84.3 137.81 33.25 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.871 -0.518 . . . . 0.0 111.736 -174.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -59.34 -19.54 47.41 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.3 t . . . . . 0 N--CA 1.478 0.929 0 C-N-CA 124.448 1.099 . . . . 0.0 112.834 175.923 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.6 tp . . . . . 0 N--CA 1.468 0.464 0 CA-C-O 121.171 0.51 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.98 148.2 26.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -59.3 135.25 57.59 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.006 1.323 . . . . 0.0 110.058 169.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 m -126.82 121.09 30.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.974 1.31 . . . . 0.0 110.877 -174.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -63.94 138.02 97.27 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.224 1.409 . . . . 0.0 111.913 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.03 -13.56 21.32 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.418 2.745 . . . . 0.0 114.845 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.87 4.43 72.42 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.481 1.039 . . . . 0.0 114.955 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.4 ptt-85 -156.14 172.95 17.55 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.294 1.838 . . . . 0.0 111.565 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -101.04 168.79 9.37 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.837 1.255 . . . . 0.0 111.396 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 50.04 35.08 9.15 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.002 2.121 . . . . 0.0 113.849 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.9 m -133.67 141.73 41.18 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.693 1.597 . . . . 0.0 111.274 -169.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -45.72 160.27 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.859 1 C-N-CA 126.174 4.582 . . . . 0.0 115.259 169.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.4 t -116.11 154.73 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.606 1.162 . . . . 0.0 109.964 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -128.5 172.04 11.52 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.429 1.492 . . . . 0.0 110.857 -169.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.61 149.23 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.902 1.281 . . . . 0.0 111.478 176.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 m -157.14 161.36 29.57 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.402 1.081 . . . . 0.0 113.122 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.04 122.28 11.42 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.779 2.986 . . . . 0.0 111.449 169.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.9 tp -59.01 138.45 57.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.2 1.0 . . . . 0.0 111.81 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -132.71 5.15 3.94 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.944 1.298 . . . . 0.0 112.756 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.6 7.33 60.96 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.784 1.183 . . . . 0.0 114.742 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.9 p -67.27 153.9 42.59 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.032 1.333 . . . . 0.0 112.541 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.7 p -62.49 -17.3 59.32 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -70.84 -22.3 62.34 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.552 1.141 . . . . 0.0 112.338 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.23 1.42 11.88 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.483 1.513 . . . . 0.0 113.638 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.34 146.08 27.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.522 1.129 . . . . 0.0 111.018 171.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -138.15 172.44 12.92 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.582 1.182 . . . . 0.0 111.901 -169.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.8 mt -119.6 136.79 55.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.847 2.459 . . . . 0.0 106.792 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.2 tp -135.99 128.21 29.98 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.132 1.373 . . . . 0.0 109.311 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.09 140.67 29.61 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.875 0.87 . . . . 0.0 110.785 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.9 t -66.01 140.31 58.28 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.726 0.41 . . . . 0.0 110.758 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -109.68 -52.73 2.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.544 1.138 . . . . 0.0 110.47 173.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.17 108.48 4.27 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.48 1.112 . . . . 0.0 110.691 169.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -57.44 -25.5 59.74 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.964 0.906 . . . . 0.0 111.56 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -62.85 -20.51 65.17 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.052 2.141 . . . . 0.0 113.535 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -130.23 9.01 5.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.132 1.773 . . . . 0.0 112.671 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 47.5 29.28 1.34 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.372 1.869 . . . . 0.0 114.325 -169.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.9 p -87.48 144.73 26.58 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.686 -1.259 . . . . 0.0 112.193 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -139.43 142.62 37.42 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.576 1.55 . . . . 0.0 111.288 -176.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.2 p -81.28 149.64 28.89 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.414 0.685 . . . . 0.0 110.882 171.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.5 mm -133.59 124.97 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.509 1.524 . . . . 0.0 110.481 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 m -142.83 153.27 60.86 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.889 1.676 . . . . 0.0 110.362 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.73 151.82 28.6 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.044 2.496 . . . . 0.0 111.199 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.9 -25.74 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.987 -1.071 . . . . 0.0 113.303 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.11 -18.19 54.25 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 123.927 0.775 . . . . 0.0 114.727 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.9 m -141.31 60.3 11.84 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 125.514 1.526 . . . . 0.0 111.536 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -62.22 -17.1 55.07 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.796 2.997 . . . . 0.0 113.286 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -72.15 9.47 0.97 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 128.191 2.596 . . . . 0.0 113.384 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 p -137.79 169.24 18.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.165 2.186 . . . . 0.0 111.095 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -143.73 164.6 29.99 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.001 1.32 . . . . 0.0 111.566 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -115.53 127.43 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.374 1.07 . . . . 0.0 111.154 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.49 -160.55 8.46 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.004 1.764 . . . . 0.0 111.367 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -142.93 147.88 35.98 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.251 1.026 . . . . 0.0 111.917 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -153.06 -159.12 8.88 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.531 1.539 . . . . 0.0 112.92 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.3 141.14 19.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.736 1.214 . . . . 0.0 113.077 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.7 -4.24 72.17 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.613 1.102 . . . . 0.0 114.359 -173.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 46.99 53.87 9.97 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.139 1.775 . . . . 0.0 113.625 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.32 138.53 32.44 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 127.6 2.36 . . . . 0.0 107.266 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.54 143.17 56.14 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 108.844 -1.252 . . . . 0.0 108.844 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.3 m -132.62 148.41 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.951 1.301 . . . . 0.0 110.818 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.2 t -75.54 137.16 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.547 0.739 . . . . 0.0 110.159 173.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.3 mt -142.92 164.68 30.65 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.702 2.001 . . . . 0.0 110.399 -171.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.87 155.59 43.58 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.216 1.944 . . . . 0.0 110.982 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.95 125.09 17.16 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.431 2.754 . . . . 0.0 112.684 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -145.12 -107.47 0.11 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.96 1.304 . . . . 0.0 109.107 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -143.56 20.06 1.85 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.174 1.789 . . . . 0.0 110.928 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -68.14 134.62 50.83 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.231 -0.918 . . . . 0.0 111.511 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.0 m -143.0 161.88 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.015 0.926 . . . . 0.0 112.065 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -129.96 134.36 47.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.017 1.327 . . . . 0.0 109.979 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.0 m -70.85 127.39 32.46 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.988 1.315 . . . . 0.0 108.743 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.1 mt -125.0 115.34 20.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.113 0.965 . . . . 0.0 109.027 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.7 m -136.62 133.68 36.55 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.49 0.716 . . . . 0.0 112.564 -169.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.9 tp -66.12 150.21 49.09 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.878 1.271 . . . . 0.0 112.602 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 p -136.89 175.81 9.28 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.663 1.585 . . . . 0.0 112.01 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.8 m -62.89 -4.97 2.44 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.75 19.64 0.21 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.455 1.026 . . . . 0.0 115.044 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.38 -156.87 28.32 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.682 1.135 . . . . 0.0 112.189 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.6 170.55 9.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.943 2.097 . . . . 0.0 110.91 174.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -132.21 149.52 52.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.828 1.651 . . . . 0.0 110.952 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.4 mt -135.11 117.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.164 1.386 . . . . 0.0 109.203 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -134.72 158.75 43.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.218 1.007 . . . . 0.0 111.942 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.03 -21.98 66.53 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -171.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.51 -40.28 1.83 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.375 1.464 . . . . 0.0 112.716 -170.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -98.26 5.22 48.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.329 1.451 . . . . 0.0 113.836 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 58.14 14.49 2.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.256 2.222 . . . . 0.0 114.221 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.3 p -72.97 -23.2 60.63 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.012 0.925 . . . . 0.0 112.547 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.0 m -143.79 173.01 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.768 1.627 . . . . 0.0 112.284 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.3 t -144.23 150.82 38.55 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.78 2.832 . . . . 0.0 109.106 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -70.24 145.03 51.65 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.115 -0.99 . . . . 0.0 111.372 169.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 99.3 p -153.63 173.28 16.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.715 1.206 . . . . 0.0 112.418 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.8 mt -126.39 174.1 8.85 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.128 1.771 . . . . 0.0 109.687 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -115.66 -33.5 5.17 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.996 0.918 . . . . 0.0 111.111 -170.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -141.52 -10.66 0.93 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.46 1.904 . . . . 0.0 112.946 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.84 22.37 6.98 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.96 1.704 . . . . 0.0 114.824 -170.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.5 p -70.94 158.02 37.18 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.115 0.966 . . . . 0.0 111.826 170.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.0 139.98 57.7 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.132 -0.98 . . . . 0.0 112.01 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.87 2.75 88.85 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.345 0.974 . . . . 0.0 114.064 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -69.93 139.09 52.86 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.651 1.225 . . . . 0.0 112.148 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.75 120.09 19.82 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.746 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.18 150.73 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.436 0.694 . . . . 0.0 111.202 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.2 m -130.33 167.71 18.08 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.058 1.343 . . . . 0.0 111.561 -171.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.3 mt -134.94 145.14 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.291 1.436 . . . . 0.0 108.753 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.4 -179.86 47.95 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 124.89 1.234 . . . . 0.0 111.231 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.39 -39.48 60.92 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.217 1.508 . . . . 0.0 113.849 -175.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -169.96 175.4 5.14 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.889 2.476 . . . . 0.0 111.826 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.87 162.12 36.27 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.306 1.442 . . . . 0.0 111.687 169.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.4 t -92.7 -13.28 29.61 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -169.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -140.78 -32.49 0.57 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.541 1.137 . . . . 0.0 113.331 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.6 p -107.31 4.55 26.61 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.678 1.591 . . . . 0.0 114.045 -173.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.51 15.35 1.16 Allowed Glycine 0 CA--C 1.541 1.709 0 C-N-CA 126.348 1.928 . . . . 0.0 115.513 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -141.26 147.34 38.07 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.563 1.945 . . . . 0.0 110.353 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -141.1 177.48 8.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.21 1.804 . . . . 0.0 110.726 -169.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.23 142.61 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.025 0.93 . . . . 0.0 109.834 169.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.44 126.98 75.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.544 1.538 . . . . 0.0 107.053 173.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.91 153.84 38.58 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.908 1.283 . . . . 0.0 109.088 -170.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -66.78 155.06 39.22 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.049 -1.032 . . . . 0.0 112.53 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.2 t . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.991 1.716 . . . . 0.0 111.239 172.635 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 t -157.8 167.57 29.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.046 1.338 . . . . 0.0 110.207 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.14 135.6 53.79 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.928 -0.483 . . . . 0.0 111.275 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.6 -162.55 35.94 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 115.161 0.824 . . . . 0.0 115.161 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.96 119.7 35.93 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.946 1.298 . . . . 0.0 109.909 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -133.85 170.58 15.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.708 1.203 . . . . 0.0 112.468 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.8 pt -129.65 153.95 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 126.385 1.874 . . . . 0.0 108.763 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.7 mt -130.61 119.61 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -140.03 148.02 41.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.579 0.752 . . . . 0.0 111.639 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -75.72 137.46 40.64 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.592 -0.692 . . . . 0.0 111.213 -172.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -60.58 -29.23 69.05 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.39 1.076 . . . . 0.0 113.714 -175.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 123.706 0.802 . . . . 0.0 111.669 178.766 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.8 mt . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 121.385 0.612 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.34 145.61 26.26 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.162 0.985 . . . . 0.0 112.44 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.51 132.18 50.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.922 0.889 . . . . 0.0 109.242 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.3 m -130.91 127.29 38.18 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.098 0.959 . . . . 0.0 110.826 -170.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.16 129.3 94.41 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.24 1.416 . . . . 0.0 111.142 -175.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.01 -11.08 19.72 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.078 2.519 . . . . 0.0 114.164 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.12 -4.28 52.08 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.5 1.047 . . . . 0.0 115.196 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -160.72 166.88 27.99 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.067 1.433 . . . . 0.0 113.035 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -89.17 161.97 16.17 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.109 1.764 . . . . 0.0 111.039 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 56.07 38.32 29.78 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.067 1.747 . . . . 0.0 113.783 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.7 m -141.86 140.91 20.63 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.401 1.88 . . . . 0.0 109.685 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.91 148.66 71.03 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.043 2.495 . . . . 0.0 113.717 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.65 157.61 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.061 1.344 . . . . 0.0 110.653 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -126.0 171.49 10.74 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.416 1.486 . . . . 0.0 111.115 -171.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -127.59 139.08 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 121.01 -1.056 . . . . 0.0 111.3 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -161.18 168.93 10.66 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.536 1.134 . . . . 0.0 113.161 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.83 152.8 12.76 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.604 3.536 . . . . 0.0 114.304 169.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.02 134.95 51.29 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.083 1.753 . . . . 0.0 110.094 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -130.88 -10.93 3.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.817 1.647 . . . . 0.0 113.68 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.99 -4.28 16.43 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.655 1.598 . . . . 0.0 114.395 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.0 t -63.07 165.13 7.41 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.036 1.418 . . . . 0.0 113.035 175.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.0 p -71.6 -15.18 62.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.66 1.184 . . . . 0.0 113.972 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.14 -31.33 72.49 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.417 1.008 . . . . 0.0 112.823 -178.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -113.22 4.84 16.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.356 1.462 . . . . 0.0 112.843 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.66 145.52 27.51 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.718 1.207 . . . . 0.0 111.614 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -141.48 174.12 10.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.646 1.212 . . . . 0.0 111.743 -169.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.7 mt -125.7 136.72 59.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.921 2.089 . . . . 0.0 107.357 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.3 tp -134.63 129.65 35.22 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.648 1.579 . . . . 0.0 108.816 -171.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.9 mtt85 -146.29 131.4 18.33 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.308 0.643 . . . . 0.0 110.64 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -64.33 138.0 58.2 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.401 0.546 . . . . 0.0 111.068 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -115.1 -47.78 2.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.332 1.053 . . . . 0.0 111.605 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.68 110.46 4.3 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.487 1.115 . . . . 0.0 111.476 170.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.9 m -59.51 -24.69 63.86 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.957 0.903 . . . . 0.0 111.412 168.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -63.96 -21.4 66.47 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.915 2.086 . . . . 0.0 113.495 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -130.18 9.28 5.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.674 1.59 . . . . 0.0 112.852 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 46.02 33.7 1.76 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.533 1.933 . . . . 0.0 113.55 -169.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.0 p -93.37 138.62 31.53 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.001 -1.062 . . . . 0.0 112.031 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -134.69 145.13 48.24 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.204 1.802 . . . . 0.0 110.789 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.7 p -77.98 152.75 32.95 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.854 -0.529 . . . . 0.0 110.958 171.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.1 mm -129.11 130.11 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.568 1.547 . . . . 0.0 109.045 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.8 m -142.99 145.98 35.34 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.628 1.571 . . . . 0.0 110.612 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.06 146.77 32.83 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.185 2.59 . . . . 0.0 111.102 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.84 -24.98 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.943 -1.098 . . . . 0.0 113.427 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.4 -22.15 63.17 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.743 0.687 . . . . 0.0 114.197 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.2 m -143.04 64.91 15.02 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 126.144 1.777 . . . . 0.0 110.473 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -63.76 -15.37 48.49 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.197 2.598 . . . . 0.0 113.364 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -71.94 0.3 9.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.229 1.811 . . . . 0.0 113.918 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m -131.01 173.63 10.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.916 1.686 . . . . 0.0 111.545 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -140.6 171.83 13.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.556 1.142 . . . . 0.0 113.474 -170.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.07 130.64 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.234 1.414 . . . . 0.0 110.587 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.14 -158.26 7.66 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.8 1.667 . . . . 0.0 111.513 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -142.42 145.35 33.71 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.351 1.075 . . . . 0.0 111.956 -173.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.62 -163.46 11.28 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.481 1.515 . . . . 0.0 112.942 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.83 138.17 24.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.904 1.281 . . . . 0.0 113.081 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.36 -6.78 61.52 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.821 1.2 . . . . 0.0 114.173 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 48.17 56.22 7.67 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.417 1.887 . . . . 0.0 114.177 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.02 149.2 67.7 Favored Pre-proline 0 C--O 1.239 0.512 0 C-N-CA 126.511 1.924 . . . . 0.0 107.896 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -69.76 146.01 58.89 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.338 1.358 . . . . 0.0 110.073 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.27 150.01 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.966 1.706 . . . . 0.0 111.274 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.81 134.66 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.085 0.954 . . . . 0.0 110.179 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.7 mt -137.74 162.46 54.39 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.79 1.636 . . . . 0.0 112.243 -169.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.75 167.85 21.83 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.267 2.645 . . . . 0.0 111.828 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.86 127.03 12.5 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.318 2.012 . . . . 0.0 110.676 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -149.78 -93.32 0.07 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.789 0.836 . . . . 0.0 110.541 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -155.4 18.14 0.41 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.908 1.683 . . . . 0.0 112.343 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -66.04 135.4 54.59 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.73 -0.606 . . . . 0.0 111.64 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -144.99 160.8 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.968 1.307 . . . . 0.0 111.756 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -130.32 144.24 51.26 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.53 1.532 . . . . 0.0 110.537 170.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.1 m -76.31 134.83 39.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.163 1.385 . . . . 0.0 109.409 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.21 125.62 50.54 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.413 1.085 . . . . 0.0 109.478 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.8 m -132.3 117.0 17.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.672 0.789 . . . . 0.0 110.246 -170.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 tp -66.16 146.72 54.31 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.181 0.592 . . . . 0.0 111.109 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.1 p -127.59 -177.97 4.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.593 1.557 . . . . 0.0 111.627 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.0 p -59.48 -13.57 9.37 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.13 25.85 0.19 Allowed Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.202 0.841 . . . . 0.0 115.202 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.55 -149.57 9.44 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.878 1.228 . . . . 0.0 112.273 -173.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -128.46 170.11 13.53 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.609 1.964 . . . . 0.0 111.781 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -137.05 153.59 50.57 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.976 2.511 . . . . 0.0 109.037 170.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.0 mt -133.56 127.88 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.807 1.243 . . . . 0.0 108.717 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -138.29 159.9 40.87 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.457 1.103 . . . . 0.0 112.734 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.45 -23.01 67.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 125.86 -39.51 2.02 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.97 1.272 . . . . 0.0 113.102 -171.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -98.66 1.58 46.38 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.889 1.675 . . . . 0.0 113.732 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.6 mmm-85 66.39 13.17 9.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.1 2.16 . . . . 0.0 113.655 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 72.8 p -74.84 -24.82 58.66 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.46 1.104 . . . . 0.0 112.683 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.2 m -143.46 174.25 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.738 1.615 . . . . 0.0 111.693 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 t -147.23 152.89 39.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.609 2.364 . . . . 0.0 110.176 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -70.01 143.43 52.57 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.543 -0.723 . . . . 0.0 111.413 171.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 81.3 p -153.26 172.14 17.45 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.807 1.243 . . . . 0.0 112.527 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -123.92 172.97 8.51 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.332 1.853 . . . . 0.0 110.207 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -119.44 -29.76 5.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.777 1.631 . . . . 0.0 112.065 -169.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -142.41 -8.7 0.86 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.995 1.718 . . . . 0.0 114.294 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.22 51.84 13.69 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.359 1.064 . . . . 0.0 113.649 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.5 p -126.99 167.1 16.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.887 0.875 . . . . 0.0 112.306 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -73.0 146.21 46.14 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.742 -1.224 . . . . 0.0 112.568 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.79 -8.49 69.21 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.44 1.019 . . . . 0.0 114.016 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -61.28 157.34 16.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.621 1.968 . . . . 0.0 112.602 169.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -109.11 124.87 51.48 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.424 1.089 . . . . 0.0 109.231 171.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -60.0 148.19 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.731 0.813 . . . . 0.0 111.886 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.2 m -130.91 168.22 17.68 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.734 1.614 . . . . 0.0 112.087 -170.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 80.8 mt -133.91 143.87 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.401 1.48 . . . . 0.0 109.712 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.49 179.79 48.79 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.036 1.303 . . . . 0.0 111.655 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.75 -40.54 54.95 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.248 1.524 . . . . 0.0 114.542 -172.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -171.92 173.41 4.46 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.057 2.943 . . . . 0.0 108.942 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.64 137.94 33.98 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.242 -0.911 . . . . 0.0 112.785 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.6 t -61.84 -21.02 64.29 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.73 1.612 . . . . 0.0 115.303 -170.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -134.18 -38.01 0.87 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.509 1.124 . . . . 0.0 113.312 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.3 p -98.19 4.06 48.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.152 1.381 . . . . 0.0 114.626 -171.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.53 14.25 1.03 Allowed Glycine 0 CA--C 1.544 1.892 0 C-N-CA 126.017 1.77 . . . . 0.0 115.9 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -134.53 150.66 50.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.88 1.672 . . . . 0.0 111.915 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -141.41 175.6 9.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.996 2.118 . . . . 0.0 110.795 -169.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.86 138.46 34.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 125.03 1.332 . . . . 0.0 108.814 169.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.8 123.5 71.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.716 1.606 . . . . 0.0 106.768 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -146.9 153.83 40.58 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.597 1.159 . . . . 0.0 109.168 -169.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -68.62 154.57 41.66 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.967 -1.083 . . . . 0.0 112.518 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.256 1.822 . . . . 0.0 111.405 171.902 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 t -159.7 168.43 25.98 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.084 1.354 . . . . 0.0 109.879 173.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.53 131.83 48.18 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.854 -0.529 . . . . 0.0 111.632 171.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.55 -168.49 41.34 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 114.643 0.617 . . . . 0.0 114.643 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -94.49 125.75 39.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.043 0.937 . . . . 0.0 109.793 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -132.73 166.15 22.87 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.709 1.604 . . . . 0.0 111.887 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.1 pt -117.69 151.1 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 125.489 1.516 . . . . 0.0 108.45 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.0 mt -130.33 113.43 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -136.47 143.39 43.82 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.439 1.095 . . . . 0.0 110.089 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -71.01 150.08 45.98 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.797 -0.564 . . . . 0.0 111.329 -172.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -63.83 -13.88 48.31 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.8 t . . . . . 0 N--CA 1.474 0.741 0 C-N-CA 126.611 1.964 . . . . 0.0 108.889 169.729 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 tm? . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 121.657 0.742 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.53 150.12 21.44 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.827 1.651 . . . . 0.0 115.045 -168.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.77 134.99 57.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.18 0.992 . . . . 0.0 109.14 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.2 m -135.4 125.38 25.84 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.216 1.007 . . . . 0.0 111.301 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -67.0 140.42 96.04 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.551 1.94 . . . . 0.0 112.878 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.29 -15.64 17.89 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.705 2.937 . . . . 0.0 114.943 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.98 7.21 66.2 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.306 0.955 . . . . 0.0 115.076 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -156.97 167.04 31.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.515 1.926 . . . . 0.0 111.322 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -100.13 167.83 10.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.809 1.243 . . . . 0.0 111.267 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 50.85 38.91 21.12 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.672 1.589 . . . . 0.0 113.256 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.1 m -139.87 138.41 19.72 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 126.129 1.772 . . . . 0.0 110.557 -169.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.21 159.83 3.85 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.861 3.707 . . . . 0.0 115.542 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 t -114.0 149.64 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.107 1.363 . . . . 0.0 110.643 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 52' ' ' VAL . 2.8 m -125.2 174.42 8.11 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.268 1.427 . . . . 0.0 110.909 -169.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 51' ' ' THR . 0.3 OUTLIER -127.06 143.02 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.951 1.301 . . . . 0.0 111.365 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.3 m -152.99 162.51 26.21 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 124.302 1.041 . . . . 0.0 113.047 -173.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.34 150.57 40.62 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.446 2.764 . . . . 0.0 112.754 169.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.8 tp -108.14 134.19 51.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.864 1.266 . . . . 0.0 111.585 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -133.82 -26.88 1.52 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.823 2.049 . . . . 0.0 112.405 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.8 5.47 2.2 Favored Glycine 0 CA--C 1.537 1.464 0 N-CA-C 116.811 1.484 . . . . 0.0 116.811 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.3 p -72.83 165.28 25.19 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.899 1.849 . . . . 0.0 113.798 -175.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.3 m -70.04 -14.48 62.7 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -73.14 -25.34 60.79 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.974 0.91 . . . . 0.0 112.458 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.61 5.82 11.64 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.343 2.657 . . . . 0.0 112.23 -172.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.8 147.89 33.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.506 1.522 . . . . 0.0 110.257 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -134.96 171.66 14.1 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.886 1.326 . . . . 0.0 112.291 -168.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.3 mt -125.66 134.46 66.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 127.505 2.322 . . . . 0.0 106.249 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.4 tp -137.13 123.38 20.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.067 1.347 . . . . 0.0 109.624 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -142.81 140.03 31.17 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.495 0.718 . . . . 0.0 111.388 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.3 t -65.5 142.43 58.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.355 0.662 . . . . 0.0 111.451 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -117.19 -52.74 2.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.749 1.219 . . . . 0.0 111.823 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.2 111.24 5.32 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.3 1.04 . . . . 0.0 111.006 170.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.3 m -57.28 -24.35 54.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.887 0.875 . . . . 0.0 111.26 168.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -65.37 -21.6 66.7 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.924 2.089 . . . . 0.0 113.633 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.6 t -130.5 14.69 5.49 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.193 1.397 . . . . 0.0 112.898 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 43.89 34.56 0.92 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.24 1.816 . . . . 0.0 113.475 -169.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.1 p -88.0 143.23 27.21 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.995 -1.065 . . . . 0.0 112.106 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -139.17 143.22 38.04 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.328 1.451 . . . . 0.0 110.993 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.4 p -77.7 147.99 35.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.288 0.635 . . . . 0.0 110.723 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.0 mm -128.28 126.08 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.462 1.505 . . . . 0.0 109.397 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.0 m -143.34 146.46 36.24 Favored Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 125.791 1.637 . . . . 0.0 109.539 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.57 150.84 28.34 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.765 2.31 . . . . 0.0 111.53 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.49 -30.53 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 121.297 -0.877 . . . . 0.0 111.836 172.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.73 -14.89 78.99 Favored Glycine 0 CA--C 1.539 1.564 0 N-CA-C 115.595 0.998 . . . . 0.0 115.595 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.6 m -151.6 61.75 4.47 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 125.819 1.648 . . . . 0.0 111.56 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -62.8 -17.21 58.19 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 124.065 3.176 . . . . 0.0 113.669 -173.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -72.77 13.11 0.41 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 128.484 2.713 . . . . 0.0 114.238 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.8 p -141.46 171.34 14.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.731 2.012 . . . . 0.0 111.596 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -138.83 170.09 16.63 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.634 1.574 . . . . 0.0 112.469 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.71 129.88 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.865 1.266 . . . . 0.0 110.897 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.75 -156.15 6.82 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.83 1.681 . . . . 0.0 111.693 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -143.01 141.11 31.27 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.387 1.075 . . . . 0.0 111.526 -171.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.14 -166.78 13.0 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.36 1.457 . . . . 0.0 113.035 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.72 137.47 20.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.979 1.311 . . . . 0.0 113.164 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.32 -7.28 61.88 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.85 1.214 . . . . 0.0 114.094 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 48.69 56.32 7.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.575 1.95 . . . . 0.0 114.298 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.64 151.02 77.4 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 126.2 1.8 . . . . 0.0 108.201 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.57 142.16 57.91 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.269 1.313 . . . . 0.0 109.84 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.34 148.92 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.615 1.566 . . . . 0.0 111.123 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.87 139.47 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.838 0.855 . . . . 0.0 110.602 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.67 161.67 57.28 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.666 1.986 . . . . 0.0 110.944 -172.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -69.65 164.88 32.79 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.703 2.269 . . . . 0.0 111.482 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.0 123.44 10.02 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.455 2.103 . . . . 0.0 110.851 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -147.72 -91.34 0.08 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.245 1.018 . . . . 0.0 110.482 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -156.01 18.34 0.37 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.524 1.53 . . . . 0.0 112.955 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -68.2 136.13 53.11 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.544 -0.722 . . . . 0.0 112.125 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.7 m -145.19 161.55 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.06 1.344 . . . . 0.0 112.537 -174.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -131.49 136.79 48.2 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.964 1.706 . . . . 0.0 110.571 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.6 m -71.92 131.58 43.17 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.098 0.959 . . . . 0.0 108.717 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.1 mt -123.52 128.19 49.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.096 0.958 . . . . 0.0 109.424 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.1 m -133.63 120.35 20.56 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.772 0.829 . . . . 0.0 110.586 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.83 146.82 54.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.065 0.546 . . . . 0.0 111.246 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -126.43 178.85 5.6 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.585 1.554 . . . . 0.0 110.818 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.0 p -60.23 -14.98 20.54 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.75 33.66 0.36 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.659 1.124 . . . . 0.0 114.088 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.61 -154.46 24.23 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.927 1.251 . . . . 0.0 112.909 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -126.71 170.93 11.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.272 2.229 . . . . 0.0 111.119 174.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -135.44 151.05 50.04 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.361 2.264 . . . . 0.0 109.255 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.9 mt -132.94 125.3 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.921 1.289 . . . . 0.0 108.778 -170.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -138.12 157.67 45.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.598 1.159 . . . . 0.0 112.648 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -60.72 -32.98 72.21 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -174.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.38 -40.28 1.64 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.9 1.714 . . . . 0.0 113.298 -172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.65 -13.1 59.73 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.598 1.159 . . . . 0.0 113.585 171.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 69.99 13.85 7.86 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.221 2.208 . . . . 0.0 112.796 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.2 p -71.99 -21.53 61.55 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.84 1.656 . . . . 0.0 112.856 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.0 m -144.97 170.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.071 1.749 . . . . 0.0 111.754 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.3 t -141.23 156.47 45.9 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.255 1.822 . . . . 0.0 110.838 171.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -70.05 140.17 52.76 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.595 -0.691 . . . . 0.0 111.345 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.8 p -151.64 172.15 16.52 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.438 1.095 . . . . 0.0 112.498 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -117.34 174.73 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.137 1.775 . . . . 0.0 109.794 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -112.16 -31.88 6.73 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.977 1.311 . . . . 0.0 110.648 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -142.7 -13.3 0.76 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.546 2.338 . . . . 0.0 112.734 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.96 20.53 6.83 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.75 2.02 . . . . 0.0 114.78 -171.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.7 p -70.86 155.78 40.37 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.571 1.148 . . . . 0.0 111.921 171.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.12 137.22 58.04 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.408 -0.807 . . . . 0.0 112.457 172.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.14 -1.83 87.63 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.98 1.276 . . . . 0.0 114.455 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 139.01 45.81 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.75 1.275 . . . . 0.0 112.823 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.36 127.0 32.16 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.528 -0.732 . . . . 0.0 110.266 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.36 152.07 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.117 0.567 . . . . 0.0 110.426 175.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.7 m -130.34 161.98 30.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.574 1.549 . . . . 0.0 111.563 -173.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.0 mt -131.87 143.73 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.377 1.471 . . . . 0.0 108.84 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.44 -157.64 30.19 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 123.73 0.681 . . . . 0.0 112.236 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.16 159.99 4.07 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 117.832 0.816 . . . . 0.0 112.063 169.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.43 148.77 11.35 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.784 1.234 . . . . 0.0 112.229 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.8 138.93 53.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.988 1.315 . . . . 0.0 112.939 -170.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -60.07 -21.75 61.85 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -131.45 -39.93 1.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 85.9 p -98.59 3.78 48.01 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -173.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.43 -3.18 31.09 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.492 1.044 . . . . 0.0 115.02 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -121.45 154.88 35.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.941 1.696 . . . . 0.0 111.21 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -137.83 175.09 9.9 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.258 1.823 . . . . 0.0 111.155 -170.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.8 t -133.58 135.05 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.621 1.568 . . . . 0.0 107.956 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 47.6 mt -130.59 119.05 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -149.31 152.46 35.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.997 -168.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -68.93 154.4 42.11 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.167 -0.958 . . . . 0.0 112.587 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 C--O 1.254 1.311 0 C-N-CA 126.338 1.855 . . . . 0.0 111.422 172.324 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.9 mt . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.714 0.769 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -157.49 167.49 30.05 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.494 1.118 . . . . 0.0 110.034 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.39 124.0 20.17 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.994 -0.441 . . . . 0.0 111.259 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.36 -166.05 37.83 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -101.53 123.91 46.33 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.198 0.999 . . . . 0.0 109.908 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.86 169.7 15.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.073 1.349 . . . . 0.0 112.454 -171.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.4 pt -123.52 152.01 28.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.992 1.717 . . . . 0.0 108.302 171.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.83 121.2 57.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -136.66 147.07 46.64 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.118 0.967 . . . . 0.0 111.022 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -73.62 148.11 43.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.828 -0.545 . . . . 0.0 110.832 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.7 tpt85 -64.61 -16.64 63.04 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.476 0.869 0 C-N-CA 126.084 1.754 . . . . 0.0 109.117 169.619 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.47 0.548 0 CA-C-O 121.13 0.49 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.24 151.15 24.46 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -167.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 tp -57.37 132.33 52.76 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.111 1.365 . . . . 0.0 109.778 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.0 m -130.47 124.82 32.88 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.929 0.892 . . . . 0.0 111.479 -170.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -61.11 128.87 90.05 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.14 1.376 . . . . 0.0 111.404 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.67 -11.36 20.3 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.326 2.684 . . . . 0.0 114.208 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.87 -5.15 50.25 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.456 1.027 . . . . 0.0 115.104 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -160.02 168.28 25.97 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.903 1.351 . . . . 0.0 113.067 -173.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -88.7 167.7 13.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.085 1.754 . . . . 0.0 111.394 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 48.92 40.42 16.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.678 1.991 . . . . 0.0 113.466 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.6 m -141.04 137.16 16.64 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 126.062 1.745 . . . . 0.0 110.03 -172.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.73 141.86 42.92 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.309 3.34 . . . . 0.0 114.547 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 t -84.74 149.15 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.398 1.079 . . . . 0.0 110.509 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 52' ' ' VAL . 1.4 m -122.7 178.08 5.17 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.172 1.389 . . . . 0.0 110.595 -170.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.473 ' H ' HG22 ' A' ' 51' ' ' THR . 0.3 OUTLIER -130.27 148.61 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.695 1.198 . . . . 0.0 111.253 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.4 p -155.11 159.01 32.15 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 123.539 0.736 . . . . 0.0 112.792 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.71 128.41 30.21 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.569 2.179 . . . . 0.0 111.213 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.92 131.51 49.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.391 1.076 . . . . 0.0 111.079 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -123.04 -19.36 6.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.587 1.155 . . . . 0.0 112.221 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.35 60.67 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.698 1.142 . . . . 0.0 113.261 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.5 t -67.74 162.26 24.21 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.066 1.346 . . . . 0.0 111.766 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.4 p -57.09 -18.74 15.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.62 1.168 . . . . 0.0 113.944 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.21 -32.88 74.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.685 1.194 . . . . 0.0 113.04 173.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -111.4 -0.65 16.23 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.42 146.48 24.73 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 122.33 1.062 . . . . 0.0 111.868 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -140.5 172.81 12.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.963 1.305 . . . . 0.0 111.427 -169.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.8 mt -123.03 135.19 63.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.072 2.149 . . . . 0.0 107.025 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.04 123.85 21.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.194 1.398 . . . . 0.0 109.17 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -144.03 139.96 29.28 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.461 0.705 . . . . 0.0 111.922 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 t -66.32 139.2 58.03 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.014 0.526 . . . . 0.0 111.651 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -114.58 -52.79 2.69 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.649 1.18 . . . . 0.0 111.303 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.85 109.95 4.93 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.614 1.165 . . . . 0.0 111.34 171.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.4 m -57.92 -24.58 58.43 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.877 0.871 . . . . 0.0 111.65 168.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -64.11 -22.57 66.99 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.129 2.171 . . . . 0.0 113.641 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.7 m -130.31 12.25 5.5 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.772 1.629 . . . . 0.0 112.671 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 43.99 35.35 1.13 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.595 1.958 . . . . 0.0 113.487 -168.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 p -89.45 140.43 29.52 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.836 -1.165 . . . . 0.0 112.028 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -136.55 144.73 44.37 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.03 1.732 . . . . 0.0 110.14 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.2 p -77.68 149.81 34.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.404 0.682 . . . . 0.0 110.667 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.0 mm -128.55 126.81 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.563 1.545 . . . . 0.0 109.184 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.1 m -144.77 142.9 19.53 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.348 1.459 . . . . 0.0 110.105 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.04 145.38 35.4 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.983 2.455 . . . . 0.0 111.114 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.6 m -66.01 -23.1 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.708 -1.245 . . . . 0.0 112.733 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.09 -9.69 81.87 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.675 1.131 . . . . 0.0 114.625 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.8 t -152.35 66.03 6.28 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.048 1.339 . . . . 0.0 110.883 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.99 -18.18 61.45 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.265 2.643 . . . . 0.0 112.949 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -78.61 5.22 11.5 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.406 2.282 . . . . 0.0 114.096 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 m -130.87 171.91 12.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.372 1.869 . . . . 0.0 111.182 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -138.7 173.59 11.42 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.39 1.476 . . . . 0.0 112.915 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.0 mm -121.67 129.79 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.232 1.413 . . . . 0.0 110.81 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.12 -156.85 7.13 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.76 1.648 . . . . 0.0 111.958 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -142.66 142.37 32.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.437 1.095 . . . . 0.0 111.646 -171.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.93 -165.13 12.0 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.303 1.43 . . . . 0.0 113.405 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.57 138.84 21.75 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.063 1.345 . . . . 0.0 113.217 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.69 -6.42 67.51 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.746 1.165 . . . . 0.0 114.097 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 49.04 57.78 6.08 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.373 1.869 . . . . 0.0 113.932 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.65 149.7 72.77 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 126.101 1.761 . . . . 0.0 108.13 169.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.75 144.4 53.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.242 1.294 . . . . 0.0 109.643 174.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.88 146.96 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.577 1.551 . . . . 0.0 110.945 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.9 t -76.22 137.99 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.567 0.747 . . . . 0.0 109.887 171.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.9 mt -140.21 162.97 47.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.946 1.699 . . . . 0.0 112.194 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.34 166.66 24.64 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.252 2.635 . . . . 0.0 111.71 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.44 126.81 11.92 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.311 2.007 . . . . 0.0 110.909 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -148.62 -106.18 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.604 1.161 . . . . 0.0 109.413 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -145.25 21.58 1.54 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.422 1.889 . . . . 0.0 110.59 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -66.73 133.5 50.31 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.226 -0.921 . . . . 0.0 111.774 -173.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.7 m -144.71 160.33 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.336 1.455 . . . . 0.0 111.994 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -130.06 145.66 51.69 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.611 1.564 . . . . 0.0 109.973 169.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -77.03 134.86 38.68 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.801 1.241 . . . . 0.0 109.583 171.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.66 126.06 51.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.644 1.177 . . . . 0.0 109.722 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.2 m -132.77 120.13 21.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.247 1.019 . . . . 0.0 110.284 -175.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 tp -65.33 146.6 54.72 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.203 0.601 . . . . 0.0 111.334 172.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 p -127.76 176.53 7.47 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.564 1.545 . . . . 0.0 111.497 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -60.51 -10.31 4.86 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.88 31.89 0.29 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.496 1.046 . . . . 0.0 114.064 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.38 -151.82 19.12 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.721 1.153 . . . . 0.0 113.02 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -131.64 170.22 15.07 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 128.007 2.523 . . . . 0.0 110.591 175.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -134.59 155.36 50.59 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.683 1.593 . . . . 0.0 111.076 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.1 mt -135.09 115.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.774 1.629 . . . . 0.0 108.98 -170.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -134.36 158.15 44.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.227 1.011 . . . . 0.0 112.866 -170.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -61.25 -18.1 56.72 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 120.27 -33.83 4.37 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.885 1.231 . . . . 0.0 113.279 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -107.94 5.73 26.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.477 1.911 . . . . 0.0 113.18 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.8 mmm-85 63.19 16.98 9.84 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.148 2.179 . . . . 0.0 113.998 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.8 p -74.71 -27.91 60.59 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.235 1.014 . . . . 0.0 112.799 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.7 m -143.19 175.27 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.314 1.446 . . . . 0.0 111.735 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -144.41 150.98 38.6 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 128.449 2.7 . . . . 0.0 109.675 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -71.0 145.01 50.26 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.583 -0.698 . . . . 0.0 111.517 169.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.5 p -152.32 176.42 11.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.552 1.141 . . . . 0.0 112.557 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -132.08 171.29 13.81 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.067 2.147 . . . . 0.0 109.861 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -111.68 -35.89 5.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.305 1.042 . . . . 0.0 111.159 -170.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -141.38 -10.95 0.94 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.079 2.152 . . . . 0.0 112.63 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.77 19.14 5.37 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.455 1.902 . . . . 0.0 115.134 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.6 p -70.69 157.81 37.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.319 1.047 . . . . 0.0 112.148 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.52 137.54 58.15 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.372 -0.83 . . . . 0.0 112.612 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.14 -1.22 89.06 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.536 1.065 . . . . 0.0 114.564 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -69.21 141.47 54.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.66 1.184 . . . . 0.0 112.501 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.91 128.88 34.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.579 0.752 . . . . 0.0 110.424 174.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.08 151.62 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.429 0.692 . . . . 0.0 110.714 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.6 t -126.27 165.24 19.33 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.256 1.422 . . . . 0.0 111.539 -174.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.0 mt -135.68 140.48 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.608 1.563 . . . . 0.0 109.672 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.0 -179.49 48.9 Favored Glycine 0 N--CA 1.469 0.889 0 C-N-CA 124.9 1.238 . . . . 0.0 111.768 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.22 -41.05 62.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 119.034 1.417 . . . . 0.0 114.035 -173.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -168.62 172.17 8.25 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.809 2.444 . . . . 0.0 109.96 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.69 141.23 35.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.356 1.062 . . . . 0.0 112.547 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.5 t -60.43 -21.06 61.84 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -134.3 -38.4 0.85 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.3 p -96.65 5.36 50.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.347 1.459 . . . . 0.0 114.354 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.62 10.75 3.68 Favored Glycine 0 CA--C 1.542 1.764 0 C-N-CA 125.107 1.336 . . . . 0.0 115.658 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -136.22 149.1 48.4 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.85 2.06 . . . . 0.0 110.412 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -137.75 176.25 8.87 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.525 1.93 . . . . 0.0 112.022 -169.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.1 t -134.77 137.07 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.924 1.69 . . . . 0.0 108.509 171.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.94 123.75 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.06 154.19 38.92 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.651 1.18 . . . . 0.0 108.989 -170.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -68.75 154.75 41.4 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.682 -1.261 . . . . 0.0 112.594 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.394 1.878 . . . . 0.0 111.462 171.328 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 CA--C 1.542 0.657 0 CA-C-O 122.513 1.149 . . . . 0.0 114.031 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 t -160.08 170.07 22.03 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.662 1.585 . . . . 0.0 109.575 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 130.84 44.54 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.58 -0.7 . . . . 0.0 111.512 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.11 -163.02 36.52 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 121.623 -0.673 . . . . 0.0 114.627 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -98.41 124.33 43.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.049 0.939 . . . . 0.0 110.094 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -133.1 171.75 13.57 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.084 1.354 . . . . 0.0 112.679 -171.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.0 pt -125.72 153.32 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 126.368 1.867 . . . . 0.0 108.643 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mt -129.13 120.04 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -138.69 149.32 44.99 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.876 0.871 . . . . 0.0 111.326 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -75.65 144.51 41.65 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.98 -0.45 . . . . 0.0 110.648 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -62.13 -15.04 42.92 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.471 0.586 0 C-N-CA 125.37 1.468 . . . . 0.0 109.419 172.653 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.4 tp . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 121.366 0.603 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.96 149.52 22.54 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.934 1.294 . . . . 0.0 113.665 -171.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 tp -58.17 135.2 57.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.001 1.32 . . . . 0.0 110.081 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.6 m -127.38 127.11 43.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.793 1.237 . . . . 0.0 111.276 -174.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -66.9 132.23 93.89 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.762 0.825 . . . . 0.0 111.654 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.27 -10.34 22.38 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.1 2.534 . . . . 0.0 114.348 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.81 85.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 123.994 0.807 . . . . 0.0 114.64 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -148.53 150.89 34.16 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.94 1.696 . . . . 0.0 111.046 -171.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -90.67 159.55 16.33 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.588 1.155 . . . . 0.0 111.005 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 49.87 39.27 17.96 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.163 1.385 . . . . 0.0 112.969 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.3 m -135.03 137.52 27.27 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.907 1.683 . . . . 0.0 110.401 -169.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -53.41 152.92 18.97 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.514 3.476 . . . . 0.0 114.752 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.3 t -102.68 150.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.777 1.231 . . . . 0.0 110.801 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -122.76 172.85 8.13 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.159 1.383 . . . . 0.0 111.215 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.36 139.92 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.938 1.295 . . . . 0.0 111.352 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.9 m -151.76 166.06 16.06 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.401 1.081 . . . . 0.0 112.962 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.14 162.73 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 124.03 3.154 . . . . 0.0 114.113 169.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.5 tp -126.97 143.24 51.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.137 1.375 . . . . 0.0 111.485 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -145.68 -30.38 0.41 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.037 1.335 . . . . 0.0 113.579 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.94 -9.63 1.8 Allowed Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.259 1.409 . . . . 0.0 114.156 -174.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.4 t -64.21 140.35 58.86 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.825 1.313 . . . . 0.0 112.108 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -61.56 -12.63 16.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.584 1.554 . . . . 0.0 114.286 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.19 -22.49 65.73 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.162 -0.961 . . . . 0.0 112.027 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -106.69 1.78 25.32 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.998 1.719 . . . . 0.0 113.296 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.67 147.75 25.64 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.143 0.973 . . . . 0.0 111.489 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -141.31 169.77 16.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.54 1.136 . . . . 0.0 111.776 -169.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.18 138.79 42.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 126.729 2.012 . . . . 0.0 108.011 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.7 tp -136.84 127.94 27.83 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.847 1.659 . . . . 0.0 109.459 -173.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -143.5 142.28 31.09 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.895 0.878 . . . . 0.0 111.374 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.6 t -66.65 142.15 57.55 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.099 0.56 . . . . 0.0 111.176 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -115.18 -52.6 2.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.291 1.036 . . . . 0.0 111.522 174.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.73 110.64 4.99 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.648 1.179 . . . . 0.0 111.306 171.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.7 m -58.43 -24.43 60.18 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.938 0.895 . . . . 0.0 111.447 168.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -64.1 -21.62 66.6 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.998 2.119 . . . . 0.0 113.421 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 m -130.29 10.89 5.37 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.9 1.68 . . . . 0.0 113.021 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 44.5 33.93 1.0 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.491 1.916 . . . . 0.0 113.794 -169.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.1 p -89.63 144.61 25.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.859 0.864 . . . . 0.0 112.055 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -140.2 142.18 35.89 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.539 1.535 . . . . 0.0 110.838 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.0 p -77.83 146.61 35.62 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.012 0.525 . . . . 0.0 110.506 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.6 mm -128.02 125.93 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.402 1.481 . . . . 0.0 109.094 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.2 m -142.46 143.41 26.64 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 124.556 1.142 . . . . 0.0 110.391 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.93 140.7 42.66 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.061 2.507 . . . . 0.0 110.682 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.35 -25.65 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.27 -13.93 59.53 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.45 1.024 . . . . 0.0 114.752 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.5 m -140.45 61.44 16.41 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.421 1.488 . . . . 0.0 111.517 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -61.58 -17.43 54.12 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.659 2.906 . . . . 0.0 113.295 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -71.68 8.66 1.07 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 128.105 2.562 . . . . 0.0 114.079 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.9 m -141.1 172.19 13.02 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.504 2.321 . . . . 0.0 111.32 172.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -137.27 171.65 14.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.081 2.152 . . . . 0.0 112.045 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.97 124.28 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.805 1.242 . . . . 0.0 110.36 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.48 -160.89 8.51 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.806 1.67 . . . . 0.0 111.891 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -139.92 140.01 36.31 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.65 1.18 . . . . 0.0 111.449 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.46 -166.82 12.4 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.2 1.381 . . . . 0.0 113.384 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.0 137.95 20.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.073 1.349 . . . . 0.0 113.143 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.79 -7.08 62.86 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.735 1.159 . . . . 0.0 114.06 -172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 48.49 57.66 6.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.384 1.874 . . . . 0.0 113.829 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.87 149.74 71.39 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 126.176 1.79 . . . . 0.0 108.461 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.07 144.4 57.55 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.595 1.53 . . . . 0.0 110.042 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.38 145.6 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.73 1.612 . . . . 0.0 111.859 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.0 t -74.22 122.83 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.149 0.979 . . . . 0.0 110.346 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 mp -132.4 163.09 52.97 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.802 2.041 . . . . 0.0 110.481 -169.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.31 165.41 32.65 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.75 2.3 . . . . 0.0 111.97 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.3 126.12 20.52 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.04 2.494 . . . . 0.0 112.026 170.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -149.63 -90.75 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.087 0.955 . . . . 0.0 110.184 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -156.27 16.82 0.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.832 1.653 . . . . 0.0 112.513 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -66.27 132.6 48.77 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.324 0.65 . . . . 0.0 111.839 -171.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.0 m -144.21 160.69 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.093 1.357 . . . . 0.0 111.827 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -131.5 136.5 47.94 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.29 1.436 . . . . 0.0 110.411 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 61.7 m -72.73 132.87 44.2 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.542 1.137 . . . . 0.0 109.195 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.5 mt -124.17 73.68 1.25 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.844 0.857 . . . . 0.0 109.419 -174.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.0 m -74.59 125.27 28.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.369 1.067 . . . . 0.0 110.698 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 tp -69.05 146.4 52.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.267 0.627 . . . . 0.0 111.168 171.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 p -126.92 175.72 7.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.609 1.564 . . . . 0.0 111.009 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.1 m -59.72 -11.62 5.48 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.0 24.3 0.33 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.898 1.237 . . . . 0.0 114.42 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.19 -149.03 11.25 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 118.298 1.049 . . . . 0.0 112.895 -173.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -133.81 169.73 16.64 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.22 2.208 . . . . 0.0 111.894 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -136.14 145.89 46.31 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.082 2.153 . . . . 0.0 109.451 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -125.7 122.87 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.401 1.08 . . . . 0.0 108.914 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -139.27 157.68 45.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.344 1.058 . . . . 0.0 112.737 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -60.33 -29.74 69.08 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.914 1.686 . . . . 0.0 115.284 -173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 128.91 -40.07 1.76 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.892 1.711 . . . . 0.0 113.237 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -79.9 -10.25 59.76 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.653 1.181 . . . . 0.0 113.927 173.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 68.52 12.8 8.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.848 2.059 . . . . 0.0 112.837 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.8 p -74.12 -25.06 59.56 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.159 1.384 . . . . 0.0 112.512 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.2 m -144.31 171.35 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.908 1.683 . . . . 0.0 111.915 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.6 t -144.85 154.15 42.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.864 2.466 . . . . 0.0 109.938 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -69.95 145.45 51.88 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.62 -0.675 . . . . 0.0 111.603 170.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.9 p -150.32 177.04 10.33 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.112 0.965 . . . . 0.0 112.329 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.15 166.86 18.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.493 1.917 . . . . 0.0 109.354 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -110.01 -32.17 7.12 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.875 0.87 . . . . 0.0 112.023 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -139.94 -10.13 1.16 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.677 1.991 . . . . 0.0 112.644 170.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.18 24.29 7.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.82 1.648 . . . . 0.0 114.302 -169.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.3 p -73.45 154.85 39.79 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.783 -1.198 . . . . 0.0 111.0 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.45 142.83 58.03 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.154 -0.967 . . . . 0.0 112.001 173.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.43 5.8 89.12 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.667 1.127 . . . . 0.0 114.297 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -75.4 137.69 41.19 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.783 1.291 . . . . 0.0 112.61 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -72.94 123.91 24.41 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.5 -0.75 . . . . 0.0 110.167 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.0 t -60.92 149.39 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.564 0.746 . . . . 0.0 110.623 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.4 p -125.06 166.44 16.37 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.817 1.247 . . . . 0.0 112.384 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 84.8 mt -135.03 142.04 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.151 1.381 . . . . 0.0 109.185 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.37 177.96 46.65 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.728 1.156 . . . . 0.0 111.73 174.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.38 -40.15 48.86 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 119.087 1.443 . . . . 0.0 114.212 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -168.97 174.45 6.36 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.661 2.784 . . . . 0.0 110.734 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.92 141.23 38.49 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.183 0.993 . . . . 0.0 111.627 169.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.0 t -62.86 -21.09 65.71 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -169.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -137.94 -35.21 0.64 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p -97.52 3.46 50.66 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 114.19 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.95 17.83 1.23 Allowed Glycine 0 CA--C 1.542 1.767 0 C-N-CA 125.805 1.669 . . . . 0.0 115.805 -176.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -140.07 146.37 38.85 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.238 1.815 . . . . 0.0 110.766 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -140.4 175.85 9.26 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.812 1.245 . . . . 0.0 112.184 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.1 p -140.85 138.87 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.856 1.262 . . . . 0.0 109.409 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.18 125.92 74.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 125.785 1.634 . . . . 0.0 107.144 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -149.13 154.2 38.86 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.866 1.266 . . . . 0.0 109.101 -171.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -67.86 155.43 39.39 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.86 -1.15 . . . . 0.0 112.663 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.7 t . . . . . 0 C--O 1.252 1.227 0 C-N-CA 126.127 1.771 . . . . 0.0 111.28 171.853 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 m -151.44 159.41 44.22 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.296 1.839 . . . . 0.0 109.231 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.41 136.27 56.94 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.307 -0.871 . . . . 0.0 111.505 174.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.62 -164.77 37.55 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 114.788 0.675 . . . . 0.0 114.788 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -95.06 125.58 39.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.217 1.007 . . . . 0.0 110.213 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -134.62 172.26 13.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.694 1.598 . . . . 0.0 111.973 -172.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.2 pt -126.17 154.22 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.919 1.687 . . . . 0.0 108.535 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.9 mt -128.9 119.41 49.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -141.24 152.88 44.91 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.359 0.663 . . . . 0.0 111.655 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -88.43 133.32 34.15 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.029 -0.419 . . . . 0.0 111.289 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -62.52 -18.69 62.49 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 N--CA 1.478 0.959 0 C-N-CA 124.298 1.039 . . . . 0.0 112.509 173.848 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.3 tp . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.389 0.614 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.25 149.62 28.93 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.503 1.521 . . . . 0.0 114.014 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.35 139.92 57.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.332 1.053 . . . . 0.0 109.598 169.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 m -132.34 123.41 26.76 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.216 1.006 . . . . 0.0 111.611 -174.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -60.18 129.65 88.74 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 126.4 1.88 . . . . 0.0 111.507 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.14 -3.86 14.19 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.736 2.957 . . . . 0.0 115.12 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.78 9.03 87.43 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 119.046 0.839 . . . . 0.0 114.702 -176.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -144.75 164.59 30.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.156 1.382 . . . . 0.0 112.476 -170.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -101.97 157.85 16.56 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.729 1.212 . . . . 0.0 109.841 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 49.27 33.72 5.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.022 1.329 . . . . 0.0 113.607 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.0 m -129.0 136.27 28.92 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 126.111 1.764 . . . . 0.0 110.083 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.6 149.18 19.11 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.771 3.647 . . . . 0.0 115.237 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.51 151.46 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.101 1.361 . . . . 0.0 110.819 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 m -122.14 175.78 6.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.22 1.408 . . . . 0.0 111.394 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.68 139.94 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.801 1.24 . . . . 0.0 111.516 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.0 m -152.68 166.43 15.4 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 124.249 1.02 . . . . 0.0 113.326 -171.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.7 161.32 6.15 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.652 2.901 . . . . 0.0 113.127 168.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.3 tp -121.84 138.44 54.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.461 1.104 . . . . 0.0 111.74 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -139.53 -37.18 0.5 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.744 2.018 . . . . 0.0 112.363 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.82 3.77 1.07 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.908 1.242 . . . . 0.0 115.334 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.7 t -63.44 153.84 34.04 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.476 1.638 . . . . 0.0 112.381 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.7 p -70.52 -11.16 60.75 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -75.16 -23.62 57.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.29 0.95 . . . . 0.0 112.209 175.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.72 3.55 11.66 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.33 2.652 . . . . 0.0 112.259 -170.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.46 148.88 32.18 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.337 1.455 . . . . 0.0 110.315 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -136.24 172.98 12.22 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.699 1.238 . . . . 0.0 112.537 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.1 mt -129.83 135.18 61.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 126.735 2.014 . . . . 0.0 106.709 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.5 tp -134.65 128.8 33.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.349 1.459 . . . . 0.0 109.472 -169.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -143.06 130.6 21.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.782 0.833 . . . . 0.0 110.383 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 t -64.02 138.49 58.48 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.485 0.584 . . . . 0.0 111.287 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -115.27 -51.86 2.69 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.32 1.048 . . . . 0.0 111.471 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.43 109.35 4.45 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.255 1.022 . . . . 0.0 111.127 170.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.9 m -58.03 -25.99 61.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.841 0.857 . . . . 0.0 111.141 168.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -62.79 -20.62 65.18 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.151 2.18 . . . . 0.0 113.598 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 t -130.42 9.98 5.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.684 1.593 . . . . 0.0 112.996 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 47.46 32.59 2.4 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.986 1.714 . . . . 0.0 114.087 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -90.24 140.72 29.41 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.857 -1.152 . . . . 0.0 112.362 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -138.32 145.09 40.78 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.865 1.666 . . . . 0.0 110.791 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.2 p -77.89 150.14 34.15 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.974 173.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 mm -124.54 127.75 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.374 1.47 . . . . 0.0 109.274 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.3 m -140.33 143.76 34.57 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.85 1.66 . . . . 0.0 110.22 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.87 147.24 30.57 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.121 2.548 . . . . 0.0 111.637 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.47 -29.89 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 121.122 -0.986 . . . . 0.0 111.882 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.75 -26.1 73.58 Favored Glycine 0 CA--C 1.538 1.506 0 O-C-N 121.705 -0.622 . . . . 0.0 114.448 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -145.64 64.95 10.91 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.508 1.523 . . . . 0.0 111.587 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.95 -13.65 36.35 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.505 2.803 . . . . 0.0 113.938 -174.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -73.7 10.04 1.24 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.926 2.09 . . . . 0.0 113.979 169.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.9 p -138.53 174.64 10.32 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.417 1.487 . . . . 0.0 112.389 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -142.11 168.25 20.2 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.942 1.297 . . . . 0.0 113.024 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -117.4 130.34 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.69 1.196 . . . . 0.0 110.849 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.35 -158.62 7.63 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.86 1.695 . . . . 0.0 111.69 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -142.25 141.95 32.55 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.452 1.101 . . . . 0.0 111.474 -173.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.39 -166.48 12.53 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.409 1.48 . . . . 0.0 113.184 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.45 138.15 22.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.016 1.326 . . . . 0.0 113.128 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.55 -6.56 63.06 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.731 1.158 . . . . 0.0 114.196 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 49.45 57.33 6.61 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.323 1.849 . . . . 0.0 113.976 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.7 149.34 71.73 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.327 1.851 . . . . 0.0 108.19 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.09 144.73 58.62 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.435 1.423 . . . . 0.0 109.712 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.35 150.01 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.782 1.633 . . . . 0.0 111.257 -176.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.83 136.28 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.262 0.625 . . . . 0.0 110.854 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.4 mt -134.63 158.3 75.39 Favored Pre-proline 0 C--O 1.239 0.549 0 C-N-CA 126.331 1.852 . . . . 0.0 111.65 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -60.59 164.89 12.42 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 122.649 2.233 . . . . 0.0 112.927 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.64 124.95 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.662 2.242 . . . . 0.0 110.665 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -147.99 -95.54 0.08 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.038 0.935 . . . . 0.0 110.354 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -155.24 21.06 0.42 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.163 1.785 . . . . 0.0 112.146 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -67.34 139.13 57.2 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.69 -0.631 . . . . 0.0 111.565 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.5 m -144.89 159.34 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.689 1.196 . . . . 0.0 112.047 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -128.76 148.67 50.87 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.528 1.531 . . . . 0.0 110.251 169.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 79.2 m -76.51 132.88 39.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.963 1.305 . . . . 0.0 109.209 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.41 115.98 22.51 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.391 1.077 . . . . 0.0 108.954 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 55.4 m -134.09 128.78 34.89 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.67 0.788 . . . . 0.0 110.968 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.8 mt -63.0 153.37 34.05 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 p -127.89 178.63 6.04 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.496 1.918 . . . . 0.0 110.057 170.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -61.56 -8.25 4.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.17 37.85 0.26 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.799 1.19 . . . . 0.0 113.578 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.57 -153.02 22.79 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.133 0.873 . . . . 0.0 113.231 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -132.26 169.25 16.73 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.718 2.407 . . . . 0.0 111.731 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -130.81 154.3 48.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.026 2.131 . . . . 0.0 110.295 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.4 mt -135.04 114.72 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.624 1.17 . . . . 0.0 109.176 -172.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -134.29 156.07 49.1 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.062 0.945 . . . . 0.0 112.312 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -61.63 -30.16 70.52 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -170.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.83 -40.5 1.6 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.855 1.693 . . . . 0.0 112.785 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -84.39 -5.64 59.3 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.966 1.307 . . . . 0.0 113.888 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 57.17 18.13 3.97 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.752 2.021 . . . . 0.0 113.415 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.5 p -72.07 -24.54 61.53 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.394 1.077 . . . . 0.0 112.259 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.3 m -143.75 173.92 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.943 1.697 . . . . 0.0 111.982 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 t -146.39 152.48 39.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.409 2.683 . . . . 0.0 109.979 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -70.57 144.78 51.13 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.385 -0.822 . . . . 0.0 111.8 170.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.6 p -152.88 174.76 13.69 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.067 1.347 . . . . 0.0 112.273 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -128.68 170.18 13.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.161 1.784 . . . . 0.0 110.199 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -109.03 -36.58 6.04 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.431 0.693 . . . . 0.0 111.864 -169.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -144.91 -0.15 0.92 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.091 1.756 . . . . 0.0 114.495 173.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.26 23.27 1.61 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.878 2.071 . . . . 0.0 116.122 -171.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.4 p -75.22 156.35 35.88 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.779 -1.201 . . . . 0.0 112.06 172.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.26 138.18 57.48 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.472 -0.767 . . . . 0.0 111.836 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.19 4.68 89.59 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.885 1.231 . . . . 0.0 114.422 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.6 146.96 30.95 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.198 1.499 . . . . 0.0 112.783 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -76.14 130.88 38.94 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.265 -0.897 . . . . 0.0 110.781 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.22 151.21 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.906 0.482 . . . . 0.0 110.453 173.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.8 m -129.9 164.45 24.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.464 1.506 . . . . 0.0 111.783 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.4 mt -133.56 143.27 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.305 1.442 . . . . 0.0 109.556 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.61 179.98 48.01 Favored Glycine 0 N--CA 1.471 0.976 0 C-N-CA 124.832 1.206 . . . . 0.0 111.745 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.79 -41.16 61.48 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 119.155 1.477 . . . . 0.0 114.27 -173.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -169.11 170.33 8.84 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.004 2.522 . . . . 0.0 109.906 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.42 130.61 23.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.155 0.982 . . . . 0.0 112.446 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.1 t -56.59 -28.75 61.04 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -122.36 -26.72 4.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.437 1.095 . . . . 0.0 113.856 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 72.9 p -116.48 0.02 12.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.757 1.223 . . . . 0.0 114.1 -171.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.14 33.88 0.65 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.619 2.057 . . . . 0.0 114.827 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 145.99 22.51 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.279 2.232 . . . . 0.0 110.597 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -143.3 175.72 9.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.422 1.489 . . . . 0.0 111.556 -168.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.4 p -139.44 138.9 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.488 1.115 . . . . 0.0 109.643 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.76 125.02 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 C-N-CA 125.984 1.714 . . . . 0.0 107.11 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -149.13 155.07 40.13 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.644 1.178 . . . . 0.0 109.08 -170.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -68.65 155.79 39.39 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.022 -1.049 . . . . 0.0 112.549 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.9 t . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.086 1.754 . . . . 0.0 111.301 171.856 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 122.41 1.1 . . . . 0.0 113.918 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.2 m -152.5 165.33 35.44 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.366 1.867 . . . . 0.0 109.228 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.78 130.59 44.08 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 121.5 -0.75 . . . . 0.0 110.958 169.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.06 -165.31 38.66 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 114.721 0.648 . . . . 0.0 114.721 -175.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -95.64 122.99 38.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.168 0.987 . . . . 0.0 110.304 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -133.98 174.74 10.15 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.246 1.418 . . . . 0.0 112.424 -172.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.0 pt -131.08 155.98 42.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 126.246 1.818 . . . . 0.0 108.936 171.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 mt -127.49 127.72 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -142.47 147.88 36.81 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.762 0.825 . . . . 0.0 111.564 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -78.06 133.44 37.91 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.92 -0.487 . . . . 0.0 111.043 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -60.91 -25.51 66.8 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.4 t . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 123.827 0.851 . . . . 0.0 112.36 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.1 mt . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 121.449 0.642 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.81 150.25 29.25 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.4 tp -58.6 134.39 56.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.304 1.442 . . . . 0.0 109.529 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 m -127.07 125.28 41.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.741 1.216 . . . . 0.0 111.192 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 79' ' ' PRO . 38.3 t80 -66.19 138.63 96.12 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.842 1.257 . . . . 0.0 112.094 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -76.56 -15.16 17.57 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.132 2.555 . . . . 0.0 114.911 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.31 3.72 69.23 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.535 1.064 . . . . 0.0 115.012 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -155.31 179.91 8.71 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.681 1.993 . . . . 0.0 110.756 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -110.42 170.64 7.95 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.939 1.295 . . . . 0.0 111.158 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 50.63 40.75 24.6 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.411 1.884 . . . . 0.0 112.83 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 m -140.87 141.59 24.95 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 126.14 1.776 . . . . 0.0 110.344 -169.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -52.95 163.31 2.13 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 125.293 3.995 . . . . 0.0 115.981 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.9 t -115.01 149.68 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.127 1.371 . . . . 0.0 110.857 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 m -127.8 176.0 7.9 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.301 1.441 . . . . 0.0 111.261 -168.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.7 m -123.43 156.29 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.965 -1.084 . . . . 0.0 112.045 170.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.3 m -153.0 167.05 14.15 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 124.946 1.298 . . . . 0.0 112.375 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.05 118.53 5.44 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.682 2.921 . . . . 0.0 111.671 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.63 134.76 52.96 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.789 -0.569 . . . . 0.0 111.842 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -138.61 3.42 2.29 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.566 1.546 . . . . 0.0 113.712 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.5 0.67 86.28 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.943 1.258 . . . . 0.0 115.033 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.7 t -63.29 147.41 51.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.402 1.601 . . . . 0.0 112.401 175.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.7 m -59.53 -13.51 9.35 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.325 1.45 . . . . 0.0 114.405 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.03 -26.16 63.91 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.162 0.892 . . . . 0.0 112.371 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -118.63 0.89 11.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.906 1.682 . . . . 0.0 114.45 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.16 145.48 27.96 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.617 1.167 . . . . 0.0 110.55 171.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -136.05 169.96 16.78 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 123.015 1.388 . . . . 0.0 112.546 -168.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.1 mt -117.54 137.15 52.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 128.578 2.751 . . . . 0.0 107.3 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.2 tp -134.65 128.99 34.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.573 1.549 . . . . 0.0 109.211 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -142.65 138.17 30.47 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.469 1.108 . . . . 0.0 110.732 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.8 t -67.81 141.26 56.55 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.947 0.499 . . . . 0.0 110.552 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -108.8 -51.25 2.91 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.623 1.169 . . . . 0.0 110.715 174.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.21 109.87 4.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.142 1.377 . . . . 0.0 110.595 169.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.9 m -56.96 -24.38 52.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.945 0.898 . . . . 0.0 111.745 168.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -65.21 -20.93 66.67 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.096 2.158 . . . . 0.0 113.589 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -130.8 14.59 5.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.838 1.655 . . . . 0.0 112.844 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 43.36 33.77 0.65 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.571 1.948 . . . . 0.0 114.113 -169.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -85.9 145.56 27.11 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.893 -1.129 . . . . 0.0 112.037 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -141.52 148.97 40.25 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.149 1.38 . . . . 0.0 111.58 -177.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.3 p -91.34 145.78 24.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.25 1.02 . . . . 0.0 110.641 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.8 mm -127.91 115.76 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.768 2.027 . . . . 0.0 110.257 -172.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.4 m -134.62 146.15 57.89 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 123.882 0.873 . . . . 0.0 110.712 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HG3' ' CE1' ' A' ' 42' ' ' TYR . 62.2 Cg_endo -70.8 146.59 54.17 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.729 2.286 . . . . 0.0 109.92 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.31 -22.06 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.82 -11.13 54.27 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.554 1.073 . . . . 0.0 115.241 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.5 m -144.22 62.0 9.68 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.954 1.302 . . . . 0.0 111.795 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.49 -17.1 46.15 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.109 3.206 . . . . 0.0 113.846 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -71.65 19.02 0.07 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 128.653 2.781 . . . . 0.0 114.497 169.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.6 p -142.31 164.96 28.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.044 1.738 . . . . 0.0 112.226 171.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -143.83 140.37 29.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.568 1.547 . . . . 0.0 111.09 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.4 mm -85.04 132.25 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.79 -0.569 . . . . 0.0 111.086 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.1 -165.11 10.77 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.889 2.185 . . . . 0.0 112.021 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -144.04 141.62 30.2 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.387 1.075 . . . . 0.0 111.674 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.26 -163.55 11.05 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.319 1.438 . . . . 0.0 113.31 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.64 140.41 18.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.987 1.315 . . . . 0.0 113.207 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.93 -7.85 70.21 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.572 1.082 . . . . 0.0 114.012 -172.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 48.22 58.05 5.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.334 1.854 . . . . 0.0 113.853 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.2 m -133.25 149.25 72.03 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 126.272 1.829 . . . . 0.0 107.458 169.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.47 145.29 58.37 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.298 1.142 . . . . 0.0 109.395 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.06 172.06 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.581 1.952 . . . . 0.0 109.797 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -119.51 136.25 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.323 -0.861 . . . . 0.0 111.215 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -140.87 165.15 31.52 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 127.27 2.228 . . . . 0.0 110.474 -169.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -77.3 155.41 32.67 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.497 2.131 . . . . 0.0 111.643 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.39 124.85 12.61 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.194 3.263 . . . . 0.0 113.537 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -149.49 -88.85 0.08 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.616 1.166 . . . . 0.0 110.428 -176.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -154.89 8.84 0.31 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.23 1.412 . . . . 0.0 114.218 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.02 139.82 54.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.384 -0.822 . . . . 0.0 110.845 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.3 m -148.93 164.26 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.112 1.365 . . . . 0.0 111.417 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -129.47 131.36 46.67 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.121 1.369 . . . . 0.0 110.536 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.8 m -75.93 130.57 38.68 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.275 1.03 . . . . 0.0 109.559 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.7 mt -117.38 129.58 55.95 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.569 1.147 . . . . 0.0 109.447 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 m -137.02 129.29 29.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.093 0.957 . . . . 0.0 110.228 -170.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.2 mt -65.68 153.62 41.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.697 0.76 . . . . 0.0 113.025 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.1 p -127.78 -179.22 4.83 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.024 1.73 . . . . 0.0 110.274 170.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 75.7 p -60.89 -12.81 12.26 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.0 29.45 0.29 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.422 1.011 . . . . 0.0 114.658 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 176.95 -153.06 13.01 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 118.386 1.093 . . . . 0.0 113.25 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -131.58 169.74 15.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.108 2.163 . . . . 0.0 112.266 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -136.49 149.72 48.31 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.424 2.289 . . . . 0.0 109.462 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.9 mt -132.58 115.61 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.678 1.191 . . . . 0.0 109.106 -170.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -135.91 149.89 49.12 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.513 1.125 . . . . 0.0 111.649 -169.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -55.11 -34.12 63.43 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.082 0.953 . . . . 0.0 113.129 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.49 -29.83 2.85 Favored Glycine 0 N--CA 1.47 0.965 0 C-N-CA 125.856 1.693 . . . . 0.0 113.916 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -79.61 -6.02 56.23 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 60.59 12.92 3.88 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.474 2.31 . . . . 0.0 114.048 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.3 p -65.75 -28.19 68.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.837 2.055 . . . . 0.0 112.761 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.0 m -144.89 171.06 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.014 1.725 . . . . 0.0 112.135 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.2 t -146.15 156.02 43.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.413 2.685 . . . . 0.0 110.032 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -72.23 145.25 48.09 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.49 -0.756 . . . . 0.0 111.866 171.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.7 p -154.41 177.18 11.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.056 1.342 . . . . 0.0 112.232 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -118.96 169.52 9.82 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.644 1.578 . . . . 0.0 110.211 173.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -95.26 -33.32 12.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.354 0.662 . . . . 0.0 111.979 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -144.8 0.52 0.97 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.479 1.912 . . . . 0.0 114.42 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.08 26.54 3.88 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.864 2.066 . . . . 0.0 116.038 -172.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.5 p -82.6 160.16 22.57 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 120.965 -1.084 . . . . 0.0 112.246 172.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.14 141.46 58.76 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.303 -0.873 . . . . 0.0 111.93 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.28 1.19 89.52 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.178 0.894 . . . . 0.0 114.817 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -83.35 149.69 26.57 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.99 1.395 . . . . 0.0 113.45 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -74.87 136.76 41.5 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.312 -0.867 . . . . 0.0 111.056 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.0 t -70.34 154.54 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.106 0.479 . . . . 0.0 110.568 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -131.58 164.92 24.79 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.342 1.857 . . . . 0.0 111.343 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.6 mt -136.8 140.27 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.572 1.549 . . . . 0.0 109.638 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.99 177.96 47.14 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 125.056 1.312 . . . . 0.0 111.44 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.09 36.48 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.315 1.557 . . . . 0.0 114.553 -171.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -170.28 171.25 6.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.561 2.744 . . . . 0.0 108.968 176.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.0 127.21 21.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.766 0.826 . . . . 0.0 111.176 170.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.9 t -60.67 -14.17 19.15 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.258 1.823 . . . . 0.0 115.682 -170.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -128.65 -38.85 1.68 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.356 1.063 . . . . 0.0 113.185 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.3 p -111.96 2.99 17.19 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -171.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.37 13.83 0.53 Allowed Glycine 0 CA--C 1.539 1.537 0 N-CA-C 116.327 1.291 . . . . 0.0 116.327 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -134.68 147.84 50.2 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.255 2.027 . . . . 0.0 111.074 -172.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -139.8 176.01 9.1 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.491 1.516 . . . . 0.0 112.371 -168.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.3 t -135.82 139.14 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.101 1.36 . . . . 0.0 109.099 170.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.7 125.7 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 169.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.19 154.67 39.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.477 1.111 . . . . 0.0 109.56 -171.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -68.11 155.79 38.82 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.043 -1.036 . . . . 0.0 112.606 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.6 t . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.131 1.772 . . . . 0.0 111.31 171.584 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 CA--C 1.547 0.846 0 CA-C-O 122.377 1.084 . . . . 0.0 113.917 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.0 m -161.56 162.05 30.05 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.704 2.002 . . . . 0.0 109.222 177.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.15 137.11 58.13 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.544 -0.722 . . . . 0.0 111.923 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.79 -160.11 32.89 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 123.901 0.762 . . . . 0.0 114.937 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -98.48 122.62 41.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.919 1.288 . . . . 0.0 110.616 173.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -134.65 172.71 12.56 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.773 1.229 . . . . 0.0 112.698 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.44 154.25 38.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 126.458 1.903 . . . . 0.0 108.57 170.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.3 mt -124.97 126.91 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -141.26 150.38 42.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.05 0.54 . . . . 0.0 112.156 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -77.07 134.98 38.61 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.589 -0.694 . . . . 0.0 111.298 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -61.48 -28.32 69.21 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 N--CA 1.48 1.07 0 C-N-CA 123.379 0.672 . . . . 0.0 112.042 -178.708 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.5 mt . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.964 0.411 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.76 141.66 36.1 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.601 1.16 . . . . 0.0 112.857 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.57 128.21 36.02 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.039 0.936 . . . . 0.0 108.789 169.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.0 m -128.37 115.0 17.56 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.055 0.942 . . . . 0.0 110.801 -170.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -59.89 135.19 90.03 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 126.934 2.094 . . . . 0.0 112.086 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.89 -11.45 19.89 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.289 2.659 . . . . 0.0 114.602 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.63 8.83 82.37 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-O 119.079 -0.845 . . . . 0.0 115.119 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -156.72 165.34 36.51 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.303 1.441 . . . . 0.0 112.134 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -87.74 166.6 14.52 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.436 1.095 . . . . 0.0 111.768 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 49.85 36.91 12.26 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.83 1.652 . . . . 0.0 113.839 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.8 m -135.97 138.55 27.97 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 126.228 1.811 . . . . 0.0 110.206 -169.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.3 160.57 4.63 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.94 3.76 . . . . 0.0 115.81 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.5 t -111.56 148.71 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.904 1.281 . . . . 0.0 110.724 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 m -123.36 167.24 14.06 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.256 1.422 . . . . 0.0 110.774 -169.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 p -121.48 138.25 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.167 0.987 . . . . 0.0 111.212 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.5 m -156.51 168.17 12.94 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 124.355 1.062 . . . . 0.0 112.882 -169.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.14 152.59 10.59 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.648 2.899 . . . . 0.0 114.286 169.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.4 tp -105.6 137.2 43.83 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.459 1.504 . . . . 0.0 110.45 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -135.23 -24.24 1.43 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.075 1.35 . . . . 0.0 112.751 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.18 5.83 9.35 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.199 1.381 . . . . 0.0 113.759 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 m -61.85 150.48 37.2 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.485 1.142 . . . . 0.0 111.532 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.2 p -61.8 -15.05 38.4 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -72.86 -24.01 60.82 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.355 1.062 . . . . 0.0 112.412 171.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -104.88 -9.33 18.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.519 1.927 . . . . 0.0 112.621 -174.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.62 142.0 34.5 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.596 1.158 . . . . 0.0 111.328 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -135.73 171.34 14.6 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.944 1.355 . . . . 0.0 112.111 -169.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.1 mt -126.17 136.45 60.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.024 2.13 . . . . 0.0 106.747 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.7 tp -136.84 126.53 25.46 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.948 1.299 . . . . 0.0 109.446 -169.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.2 mtp-105 -141.46 140.84 33.65 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.753 0.821 . . . . 0.0 111.121 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.0 t -65.24 141.56 58.59 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.908 0.483 . . . . 0.0 110.929 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -115.12 -51.27 2.72 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.434 1.094 . . . . 0.0 111.093 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.23 109.25 4.45 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.379 1.071 . . . . 0.0 110.996 169.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.2 m -59.18 -26.47 64.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.801 0.84 . . . . 0.0 111.166 168.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -60.99 -20.94 63.05 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.012 2.125 . . . . 0.0 113.398 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -130.26 6.32 4.91 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.308 1.843 . . . . 0.0 113.237 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 47.37 30.44 1.55 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.142 2.177 . . . . 0.0 114.281 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.0 p -90.6 143.58 26.6 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.25 -0.907 . . . . 0.0 112.367 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -139.31 141.64 37.71 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.683 1.593 . . . . 0.0 111.104 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.5 p -77.87 147.71 34.98 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.711 -0.618 . . . . 0.0 111.06 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.0 mm -129.26 127.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.421 1.488 . . . . 0.0 109.71 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.0 m -142.84 142.38 22.25 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.197 1.399 . . . . 0.0 110.355 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.1 145.39 31.05 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.217 2.611 . . . . 0.0 111.314 176.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.53 -28.22 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.311 -0.868 . . . . 0.0 111.769 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.55 -24.96 76.17 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 114.868 0.707 . . . . 0.0 114.868 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.9 m -148.17 65.51 8.83 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 125.429 1.492 . . . . 0.0 111.614 -176.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -64.13 -17.9 61.47 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.843 3.028 . . . . 0.0 113.669 -173.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -69.96 -2.62 13.04 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 127.688 2.395 . . . . 0.0 114.636 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.2 m -132.8 174.72 10.02 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.372 1.869 . . . . 0.0 111.686 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -141.27 172.66 12.37 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.371 1.469 . . . . 0.0 113.164 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -115.99 127.25 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.903 1.281 . . . . 0.0 110.413 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.56 -157.48 7.18 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.489 1.519 . . . . 0.0 111.35 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -141.99 142.24 32.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.135 0.974 . . . . 0.0 111.665 -171.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.94 -165.25 12.1 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.361 1.458 . . . . 0.0 113.466 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.59 135.15 23.44 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.265 1.426 . . . . 0.0 113.049 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.23 -8.64 59.08 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.969 1.271 . . . . 0.0 114.012 -172.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 49.29 56.16 8.23 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.485 1.914 . . . . 0.0 113.949 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.9 m -133.89 150.43 74.5 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 126.266 1.826 . . . . 0.0 108.065 169.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.01 142.71 52.02 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.225 1.283 . . . . 0.0 109.721 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.05 151.5 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.815 1.646 . . . . 0.0 111.536 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.14 132.18 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.074 0.95 . . . . 0.0 111.044 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.34 161.45 57.2 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.833 1.653 . . . . 0.0 112.193 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -65.04 174.06 5.26 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 123.277 2.652 . . . . 0.0 113.31 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.67 104.15 1.68 Allowed 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.779 2.319 . . . . 0.0 111.01 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.405 ' HB3' ' CE2' ' A' ' 103' ' ' TYR . 65.2 t30 -143.46 13.51 1.77 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.657 1.183 . . . . 0.0 113.356 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 70.37 40.88 1.07 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.913 2.485 . . . . 0.0 113.773 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.405 ' CE2' ' HB3' ' A' ' 101' ' ' ASN . 90.7 m-85 -61.97 143.46 56.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.089 0.556 . . . . 0.0 110.887 169.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.92 156.55 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.206 1.002 . . . . 0.0 112.253 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -129.8 137.06 50.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.496 1.518 . . . . 0.0 110.448 172.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.9 m -71.0 134.23 46.98 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.698 1.199 . . . . 0.0 108.895 169.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.7 mt -126.24 73.93 1.41 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.878 0.871 . . . . 0.0 109.966 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.3 m -78.93 129.12 34.16 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.269 1.028 . . . . 0.0 111.116 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.7 tp -71.2 145.83 49.44 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.455 0.702 . . . . 0.0 111.226 171.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 p -124.55 -177.17 3.72 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.741 1.616 . . . . 0.0 111.719 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.2 p -59.04 -13.44 6.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.22 25.96 0.18 Allowed Glycine 0 CA--C 1.533 1.197 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 178.55 -149.25 8.87 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.023 1.296 . . . . 0.0 112.127 -173.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -131.77 168.44 17.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.286 1.834 . . . . 0.0 112.024 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -134.15 142.43 47.46 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.393 2.277 . . . . 0.0 109.515 174.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.1 mt -124.37 121.78 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.419 1.088 . . . . 0.0 109.231 -171.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -138.17 158.04 45.09 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.194 1.398 . . . . 0.0 112.68 -171.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -59.8 -18.18 41.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 125.23 -35.71 3.01 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.916 1.722 . . . . 0.0 112.623 -169.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -110.17 4.18 20.82 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.503 1.921 . . . . 0.0 113.557 -170.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? 57.39 21.6 7.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.858 2.063 . . . . 0.0 113.781 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.1 p -77.62 -30.58 52.35 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.391 -0.818 . . . . 0.0 112.02 175.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.1 m -148.07 155.81 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.667 1.587 . . . . 0.0 111.959 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.1 t -130.5 153.37 48.89 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.577 1.951 . . . . 0.0 111.248 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.3 m0 -69.88 139.57 53.05 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.289 0.635 . . . . 0.0 111.812 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 88.1 p -147.76 175.06 11.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.929 1.292 . . . . 0.0 111.909 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.43 151.33 46.35 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.53 1.532 . . . . 0.0 109.898 173.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -82.59 -33.56 27.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.179 0.992 . . . . 0.0 111.704 -169.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -138.93 -6.21 1.45 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.674 1.99 . . . . 0.0 112.634 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.79 32.36 14.78 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.852 1.661 . . . . 0.0 114.243 -170.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.3 p -81.58 156.63 25.1 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.26 1.024 . . . . 0.0 111.509 170.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.84 139.59 57.77 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.252 -0.905 . . . . 0.0 111.674 172.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.67 86.0 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.125 1.345 . . . . 0.0 114.718 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -79.64 144.65 33.57 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.929 1.292 . . . . 0.0 113.25 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -75.7 128.44 35.21 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.854 -1.154 . . . . 0.0 110.655 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.95 148.53 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.182 0.593 . . . . 0.0 110.799 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.7 t -126.07 160.83 29.04 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.812 1.245 . . . . 0.0 111.779 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.8 mt -134.22 140.86 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.823 1.649 . . . . 0.0 109.292 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 169.43 -159.73 32.69 Favored Glycine 0 N--CA 1.468 0.815 0 C-N-CA 123.776 0.703 . . . . 0.0 112.61 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.96 149.68 18.32 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 117.62 0.71 . . . . 0.0 111.764 169.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -52.63 119.09 4.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.482 1.513 . . . . 0.0 113.428 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.23 164.12 26.3 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.848 1.259 . . . . 0.0 114.174 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 t -93.65 -9.44 37.9 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.785 1.234 . . . . 0.0 114.229 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -142.11 -44.93 0.34 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.483 1.113 . . . . 0.0 113.028 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.8 p -91.61 1.93 56.81 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.6 5.09 6.07 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 126.414 1.959 . . . . 0.0 116.281 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -126.48 150.84 48.48 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.408 1.483 . . . . 0.0 112.252 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -142.16 175.98 9.33 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 127.389 2.276 . . . . 0.0 110.104 -169.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.65 139.7 28.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 124.354 1.062 . . . . 0.0 109.529 169.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -118.22 124.82 73.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 125.694 1.598 . . . . 0.0 107.15 174.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -147.74 153.44 39.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.644 1.178 . . . . 0.0 109.433 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.97 155.91 39.51 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.998 -1.064 . . . . 0.0 112.945 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 C--O 1.251 1.175 0 C-N-CA 126.221 1.808 . . . . 0.0 111.284 171.877 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt . . . . . 0 CA--C 1.544 0.719 0 CA-C-O 122.0 0.905 . . . . 0.0 113.165 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.1 m -151.45 159.53 44.15 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.668 1.987 . . . . 0.0 108.955 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.84 131.14 48.83 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.489 -0.757 . . . . 0.0 111.858 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.1 -163.11 36.86 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -100.56 126.93 47.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.128 0.971 . . . . 0.0 110.345 174.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.05 172.3 13.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.238 1.415 . . . . 0.0 112.292 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 pt -126.96 152.14 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.111 1.764 . . . . 0.0 108.518 172.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.1 mt -131.04 115.89 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -140.49 151.48 44.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.702 0.763 . . . . 0.0 112.408 -177.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -81.45 136.72 35.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.436 -173.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.8 mtp-105 -65.13 -18.22 65.12 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.9 t . . . . . 0 N--CA 1.478 0.929 0 C-N-CA 124.135 0.974 . . . . 0.0 112.375 173.114 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 121.771 0.796 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.31 151.42 24.77 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.676 -1.147 . . . . 0.0 113.718 -170.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.59 134.05 55.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.852 0.861 . . . . 0.0 108.897 168.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 85.6 m -134.54 126.05 28.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.864 0.865 . . . . 0.0 111.123 -170.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -60.49 130.3 89.93 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.518 1.927 . . . . 0.0 111.948 -176.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.32 -10.41 19.1 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.442 2.761 . . . . 0.0 114.465 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.53 -2.32 58.91 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.318 0.961 . . . . 0.0 115.152 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -160.28 171.22 19.54 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.082 1.353 . . . . 0.0 112.94 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -96.51 169.14 10.1 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.403 1.881 . . . . 0.0 111.121 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 mmt-85 52.13 32.51 10.61 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.113 1.765 . . . . 0.0 114.022 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.1 m -137.11 138.13 24.69 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.301 1.441 . . . . 0.0 110.731 -169.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.7 155.38 10.59 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.567 3.512 . . . . 0.0 114.847 172.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 t -105.03 153.81 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.867 1.267 . . . . 0.0 110.542 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 m -125.42 171.06 10.77 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.197 1.399 . . . . 0.0 110.186 -170.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.64 141.66 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.911 -1.118 . . . . 0.0 112.047 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.1 m -153.12 166.16 16.1 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.052 0.941 . . . . 0.0 112.327 -171.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.86 164.79 2.2 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.648 2.898 . . . . 0.0 113.564 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tt -127.59 141.8 51.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.729 1.211 . . . . 0.0 111.785 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -143.36 -13.6 0.69 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.43 -8.35 8.94 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.096 1.332 . . . . 0.0 114.347 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -63.44 157.86 22.21 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.895 1.348 . . . . 0.0 113.302 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 p -64.22 -11.91 35.64 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -66.53 -36.32 82.4 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.207 1.003 . . . . 0.0 112.161 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.81 6.4 11.49 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.58 147.27 24.04 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.793 0.806 . . . . 0.0 111.652 172.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -138.61 172.09 13.4 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.661 1.22 . . . . 0.0 112.306 -169.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.2 mt -120.77 135.47 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.498 2.319 . . . . 0.0 107.066 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.28 122.3 19.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.123 1.369 . . . . 0.0 109.544 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -140.92 137.98 33.52 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.309 0.644 . . . . 0.0 111.633 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.5 t -64.46 138.94 58.69 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.124 0.569 . . . . 0.0 111.151 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -115.17 -51.29 2.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.557 1.143 . . . . 0.0 111.339 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.52 109.96 4.81 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.583 1.153 . . . . 0.0 111.625 170.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.1 m -58.98 -23.72 62.02 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.025 0.93 . . . . 0.0 111.468 168.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.07 -21.69 66.62 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.075 2.15 . . . . 0.0 113.341 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -130.4 7.8 4.97 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.956 1.703 . . . . 0.0 113.002 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 46.56 34.87 2.6 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.667 1.987 . . . . 0.0 113.47 -168.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.6 p -92.34 142.76 27.1 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.531 -0.731 . . . . 0.0 112.275 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -138.73 144.15 39.37 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.86 1.664 . . . . 0.0 110.478 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.0 p -77.96 150.1 34.03 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.56 0.744 . . . . 0.0 111.018 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.8 mm -128.73 126.87 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 0.0 109.479 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 m -144.92 145.93 29.35 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.701 1.601 . . . . 0.0 110.51 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.27 145.41 34.49 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.832 2.354 . . . . 0.0 110.831 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.5 m -65.22 -24.69 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.004 -1.06 . . . . 0.0 113.119 177.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.65 -17.96 60.94 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.062 0.839 . . . . 0.0 114.61 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 42.5 m -144.1 62.14 9.99 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.434 1.494 . . . . 0.0 110.962 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -61.8 -18.59 61.59 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.013 3.142 . . . . 0.0 113.423 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -71.35 9.33 0.81 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 128.314 2.645 . . . . 0.0 114.148 169.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.1 p -138.44 172.53 12.75 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.886 1.675 . . . . 0.0 111.966 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -141.44 169.75 17.02 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.167 1.387 . . . . 0.0 112.837 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 mm -115.97 128.48 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.932 1.293 . . . . 0.0 110.567 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.37 -160.77 8.55 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.778 1.656 . . . . 0.0 111.926 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -140.27 139.63 35.56 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.443 1.097 . . . . 0.0 111.468 -172.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.18 -164.85 11.39 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.383 1.468 . . . . 0.0 113.208 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.3 139.38 19.16 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.928 1.291 . . . . 0.0 113.084 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.3 -7.72 66.63 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.825 1.202 . . . . 0.0 114.13 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 47.97 56.42 7.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.516 1.926 . . . . 0.0 113.974 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.71 150.96 76.17 Favored Pre-proline 0 C--O 1.24 0.571 0 C-N-CA 126.112 1.765 . . . . 0.0 108.386 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.87 142.67 58.11 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.23 1.286 . . . . 0.0 109.762 173.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.8 m -132.84 150.46 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.681 1.592 . . . . 0.0 111.354 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 t -83.26 132.92 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.764 0.826 . . . . 0.0 110.816 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.6 mt -138.39 162.33 54.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.982 1.713 . . . . 0.0 112.384 -169.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -61.1 167.19 9.48 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.824 2.349 . . . . 0.0 113.302 174.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.66 125.98 10.46 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.735 2.29 . . . . 0.0 110.216 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -146.95 -106.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.806 1.242 . . . . 0.0 109.304 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -145.22 21.55 1.55 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.518 1.927 . . . . 0.0 110.471 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -66.53 133.75 51.0 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.386 -0.821 . . . . 0.0 111.385 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.4 m -144.78 160.27 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.964 1.306 . . . . 0.0 111.812 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -130.84 148.77 52.66 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.406 1.482 . . . . 0.0 110.406 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.9 m -74.98 139.11 42.73 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.168 0.987 . . . . 0.0 109.262 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.59 73.92 1.22 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.143 0.977 . . . . 0.0 109.31 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 93.2 m -76.96 118.9 19.99 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.289 1.036 . . . . 0.0 110.594 -176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 tp -66.98 146.48 54.33 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.285 0.634 . . . . 0.0 111.156 170.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.2 p -125.42 -178.42 4.22 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.685 1.594 . . . . 0.0 111.233 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.0 t -60.26 -18.48 49.3 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -158.7 28.2 0.42 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.445 1.021 . . . . 0.0 114.465 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.63 -153.07 16.61 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.459 1.028 . . . . 0.0 113.018 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -133.1 168.71 18.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.87 2.068 . . . . 0.0 111.981 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -135.88 151.23 49.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.685 1.994 . . . . 0.0 110.412 171.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.7 mt -132.17 114.55 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.033 0.933 . . . . 0.0 109.949 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -135.47 156.43 48.91 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.199 1.0 . . . . 0.0 111.973 -169.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -60.35 -31.23 70.12 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.457 1.503 . . . . 0.0 114.829 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 133.09 -40.76 1.56 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.658 2.075 . . . . 0.0 112.797 -174.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -81.37 -6.45 58.93 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.676 1.19 . . . . 0.0 114.05 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 59.18 16.08 4.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.962 2.105 . . . . 0.0 113.999 -170.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.5 p -69.73 -23.39 63.39 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.871 1.268 . . . . 0.0 112.265 178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.7 m -144.27 170.01 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.101 1.76 . . . . 0.0 111.701 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 t -142.38 156.83 45.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.729 2.012 . . . . 0.0 110.676 173.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -70.9 138.72 50.38 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.234 0.614 . . . . 0.0 111.354 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.9 p -149.29 173.0 13.97 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.549 1.14 . . . . 0.0 112.504 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.1 mt -123.97 173.59 8.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.911 1.684 . . . . 0.0 109.879 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -111.41 -33.73 6.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.079 0.952 . . . . 0.0 111.459 -171.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -140.98 -9.49 1.01 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.646 1.978 . . . . 0.0 112.683 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.71 24.28 8.81 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.055 1.742 . . . . 0.0 114.784 -169.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 p -71.88 154.75 41.04 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.19 -0.944 . . . . 0.0 111.181 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.2 143.43 54.0 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.887 -1.133 . . . . 0.0 111.764 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.07 4.2 89.65 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.481 1.038 . . . . 0.0 114.153 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -73.56 142.58 46.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.825 1.313 . . . . 0.0 112.46 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -77.62 111.37 13.31 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.777 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 p -54.7 149.09 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.895 0.878 . . . . 0.0 111.434 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.7 t -130.55 168.63 16.76 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.561 1.544 . . . . 0.0 112.008 -169.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.8 mt -134.74 141.73 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.041 1.736 . . . . 0.0 108.866 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.91 -162.97 36.77 Favored Glycine 0 CA--C 1.526 0.722 0 O-C-N 121.52 -0.737 . . . . 0.0 112.283 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.61 153.56 10.15 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 117.631 0.715 . . . . 0.0 111.803 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -53.51 122.3 9.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.664 1.186 . . . . 0.0 113.039 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.69 173.68 7.81 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.228 1.411 . . . . 0.0 113.703 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 t -105.15 -5.06 21.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.821 1.248 . . . . 0.0 114.355 -172.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -148.44 -41.04 0.16 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.353 1.061 . . . . 0.0 112.821 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.2 p -96.91 4.98 51.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.376 1.47 . . . . 0.0 114.487 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.87 2.66 16.09 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.908 1.242 . . . . 0.0 115.575 -174.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -130.32 146.31 51.9 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.897 1.848 . . . . 0.0 111.134 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -136.97 174.36 10.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.875 1.27 . . . . 0.0 111.835 -168.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.5 p -138.53 139.14 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.757 1.223 . . . . 0.0 109.461 172.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.81 124.49 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 125.627 1.571 . . . . 0.0 107.067 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.98 153.78 38.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.856 -170.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -67.9 155.57 39.12 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.074 -1.016 . . . . 0.0 112.429 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.5 t . . . . . 0 C--O 1.252 1.205 0 C-N-CA 125.996 1.719 . . . . 0.0 111.228 172.429 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 t -159.94 170.1 22.07 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.29 1.436 . . . . 0.0 109.825 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 140.46 58.55 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 121.701 -0.625 . . . . 0.0 112.271 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.14 -162.37 33.15 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.203 0.906 . . . . 0.0 114.391 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -95.19 125.33 39.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.017 0.927 . . . . 0.0 110.174 170.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -134.19 170.87 15.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.367 1.467 . . . . 0.0 112.312 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.8 pt -123.9 151.55 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 126.119 1.768 . . . . 0.0 108.361 170.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.1 mt -128.18 120.12 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -139.94 149.83 43.79 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.743 0.817 . . . . 0.0 112.061 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -75.9 136.39 40.11 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.655 -0.653 . . . . 0.0 111.79 -174.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.4 tpt85 -65.76 -15.47 62.88 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 N--CA 1.478 0.95 0 C-N-CA 124.633 1.173 . . . . 0.0 112.489 172.721 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.1 tp . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.29 147.13 29.07 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.352 1.461 . . . . 0.0 114.547 -169.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.1 tp -58.16 136.18 57.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.232 1.013 . . . . 0.0 109.148 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.1 m -132.94 121.94 23.57 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.982 0.913 . . . . 0.0 111.373 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -60.01 130.96 89.27 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.526 2.331 . . . . 0.0 111.498 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.63 -8.58 19.44 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.6 2.866 . . . . 0.0 114.432 -177.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.02 -2.27 65.92 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.227 0.917 . . . . 0.0 114.958 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -156.46 169.85 23.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.084 1.354 . . . . 0.0 113.001 -173.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -99.46 159.28 15.13 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.345 1.858 . . . . 0.0 110.527 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 57.49 39.9 27.57 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.788 1.635 . . . . 0.0 113.402 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.1 m -142.22 139.2 17.49 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 125.963 1.705 . . . . 0.0 110.733 -172.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -52.96 156.95 8.79 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.869 3.713 . . . . 0.0 115.389 172.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 t -105.29 156.81 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.947 1.299 . . . . 0.0 110.711 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.6 m -127.94 170.16 13.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.715 1.606 . . . . 0.0 110.644 -171.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.1 140.16 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.843 1.257 . . . . 0.0 111.425 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.4 m -152.82 164.21 21.04 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 124.513 1.125 . . . . 0.0 112.758 -172.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -53.6 159.35 6.67 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.735 2.957 . . . . 0.0 113.604 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.2 tp -116.46 140.41 49.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.654 1.182 . . . . 0.0 111.725 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -140.68 -37.55 0.45 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.633 1.973 . . . . 0.0 112.517 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.11 3.58 1.21 Allowed Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.82 1.2 . . . . 0.0 115.374 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -62.39 154.68 27.4 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.535 1.667 . . . . 0.0 112.388 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.4 p -68.95 -14.79 63.25 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 173.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.57 -22.72 60.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.202 0.91 . . . . 0.0 112.343 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.73 6.4 11.56 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.111 2.564 . . . . 0.0 112.687 -169.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.17 149.51 37.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.966 1.306 . . . . 0.0 110.896 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -136.83 171.87 13.85 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 123.008 1.385 . . . . 0.0 112.856 -168.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.6 mt -120.2 135.33 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.948 2.499 . . . . 0.0 106.472 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.0 tp -135.73 126.21 26.84 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.116 1.366 . . . . 0.0 109.101 -172.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -142.82 139.59 30.99 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.634 0.773 . . . . 0.0 110.899 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.4 t -65.31 140.19 58.67 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.934 0.494 . . . . 0.0 110.874 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -109.84 -52.74 2.74 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.608 1.163 . . . . 0.0 110.62 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -145.18 106.86 4.25 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.721 1.208 . . . . 0.0 110.841 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 m -51.81 -31.81 28.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.204 1.802 . . . . 0.0 114.604 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 71' ' ' ASN . 3.2 p30 -73.71 -18.04 61.05 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.504 2.322 . . . . 0.0 114.151 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -117.51 6.37 12.54 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.923 1.689 . . . . 0.0 113.073 171.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 43.97 33.44 0.77 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.018 2.127 . . . . 0.0 114.267 -169.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -87.44 145.42 26.29 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.722 -1.236 . . . . 0.0 112.04 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -141.24 141.72 33.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.999 1.319 . . . . 0.0 111.422 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 p -80.46 146.58 31.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.76 0.824 . . . . 0.0 111.225 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.0 mm -130.16 122.26 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.45 1.5 . . . . 0.0 111.037 -171.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 m -142.04 147.66 45.37 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 125.256 1.423 . . . . 0.0 110.894 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.74 146.94 34.45 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.82 2.347 . . . . 0.0 110.977 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.0 m -65.6 -23.96 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.864 -1.148 . . . . 0.0 112.793 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.87 -6.58 72.12 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.6 1.095 . . . . 0.0 114.889 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.3 t -152.81 67.39 6.52 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 118.565 1.182 . . . . 0.0 111.867 176.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.16 -13.35 31.43 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.686 2.257 . . . . 0.0 113.103 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -78.16 11.26 2.41 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.473 1.909 . . . . 0.0 113.447 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.5 m -136.89 169.29 18.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.5 1.92 . . . . 0.0 111.783 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -141.61 167.18 22.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.353 1.461 . . . . 0.0 111.842 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.8 mm -119.18 130.98 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.665 1.186 . . . . 0.0 110.89 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.0 -158.86 8.26 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.722 1.629 . . . . 0.0 111.676 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -140.54 143.54 35.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.457 1.103 . . . . 0.0 111.792 -172.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.9 -165.34 12.16 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.394 1.474 . . . . 0.0 113.018 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.92 139.71 21.66 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.914 1.286 . . . . 0.0 113.185 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.12 -5.71 65.97 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.762 1.173 . . . . 0.0 114.18 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 48.38 55.85 8.31 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.6 1.96 . . . . 0.0 114.401 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.68 149.07 69.78 Favored Pre-proline 0 C--O 1.24 0.567 0 C-N-CA 126.291 1.837 . . . . 0.0 107.573 169.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.4 147.64 59.2 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.022 1.148 . . . . 0.0 109.802 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.32 149.93 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.743 1.617 . . . . 0.0 110.973 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.2 t -77.7 137.34 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.504 0.721 . . . . 0.0 110.368 173.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.9 mt -138.89 164.63 38.12 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.069 2.148 . . . . 0.0 110.677 -170.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.92 159.74 52.18 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 122.109 1.872 . . . . 0.0 111.178 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.23 119.84 6.57 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.031 2.487 . . . . 0.0 110.328 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -144.11 -88.46 0.12 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 110.752 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -156.09 14.59 0.33 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.102 1.361 . . . . 0.0 113.414 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -70.15 134.34 48.03 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.408 -0.808 . . . . 0.0 111.477 -174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.64 160.02 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.484 1.113 . . . . 0.0 112.344 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -128.07 135.07 49.32 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.989 1.316 . . . . 0.0 110.769 171.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.0 m -76.45 129.18 36.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.753 1.221 . . . . 0.0 109.391 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 42.4 mt -117.05 129.34 55.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.097 0.959 . . . . 0.0 109.793 -178.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 m -133.27 118.03 18.07 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.649 1.18 . . . . 0.0 110.212 -169.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp -65.07 147.27 53.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.246 0.618 . . . . 0.0 111.335 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.3 p -129.06 -178.84 4.8 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.509 1.524 . . . . 0.0 111.686 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 64.3 p -59.05 -15.0 11.31 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.92 27.51 0.24 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.215 0.912 . . . . 0.0 114.64 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 174.42 -148.35 9.8 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.954 1.264 . . . . 0.0 112.155 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -131.8 172.12 12.69 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.936 2.095 . . . . 0.0 111.547 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -137.82 152.98 49.67 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.774 2.43 . . . . 0.0 109.526 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.7 mt -133.71 126.47 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.309 1.444 . . . . 0.0 108.824 -170.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -140.3 159.43 42.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.643 1.177 . . . . 0.0 113.14 -172.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.71 -24.17 67.54 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -169.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.9 -37.13 2.1 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.613 1.102 . . . . 0.0 113.032 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -117.38 12.17 14.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.478 1.911 . . . . 0.0 113.709 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 62.42 16.63 8.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.757 2.023 . . . . 0.0 114.185 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.9 p -72.16 -29.17 63.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.72 0.808 . . . . 0.0 112.534 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.0 m -145.85 177.45 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.494 1.517 . . . . 0.0 111.837 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t -148.97 153.05 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.648 2.379 . . . . 0.0 110.093 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -69.85 144.92 52.41 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.534 -0.729 . . . . 0.0 111.712 171.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 87.7 p -151.94 171.6 17.55 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.673 1.189 . . . . 0.0 112.734 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.4 mt -125.6 165.78 17.91 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.356 1.862 . . . . 0.0 110.015 174.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -104.8 -32.8 8.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.871 0.869 . . . . 0.0 112.144 -169.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -138.81 -8.33 1.4 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.661 1.984 . . . . 0.0 112.436 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.51 21.68 5.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.009 1.724 . . . . 0.0 114.621 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.2 p -73.08 154.13 40.53 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.961 -1.087 . . . . 0.0 111.683 171.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.65 142.82 58.26 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.299 -0.876 . . . . 0.0 112.263 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.05 1.68 90.08 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.904 1.24 . . . . 0.0 114.479 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.93 141.76 45.96 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.741 1.27 . . . . 0.0 112.776 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -76.22 117.86 18.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.23 -0.919 . . . . 0.0 110.312 173.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.88 148.29 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.804 0.842 . . . . 0.0 111.57 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 t -128.68 167.73 16.8 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.586 1.555 . . . . 0.0 111.781 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.7 mt -135.6 141.22 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.603 1.561 . . . . 0.0 109.582 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -179.41 179.86 48.82 Favored Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.944 1.259 . . . . 0.0 111.605 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.07 -40.41 58.29 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.221 1.51 . . . . 0.0 114.334 -173.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -171.63 173.14 4.75 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 128.844 2.858 . . . . 0.0 109.331 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.74 139.87 36.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.201 1.0 . . . . 0.0 112.629 169.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.6 t -60.98 -20.79 62.83 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -169.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -137.71 -38.88 0.58 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.465 1.106 . . . . 0.0 113.222 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 86.8 p -93.35 3.67 55.24 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.294 1.437 . . . . 0.0 114.606 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.23 15.66 1.37 Allowed Glycine 0 CA--C 1.543 1.799 0 C-N-CA 125.856 1.693 . . . . 0.0 115.763 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -134.73 152.46 51.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.916 1.686 . . . . 0.0 111.451 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -141.77 175.9 9.34 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.884 2.074 . . . . 0.0 110.594 -169.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.82 138.37 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 125.123 1.369 . . . . 0.0 108.588 170.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.77 123.29 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -149.0 154.01 38.73 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.922 1.289 . . . . 0.0 109.239 -171.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.58 155.85 39.2 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.907 -1.12 . . . . 0.0 112.701 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 C--O 1.252 1.211 0 C-N-CA 126.146 1.778 . . . . 0.0 111.276 171.415 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.7 m -149.69 163.16 38.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.315 1.846 . . . . 0.0 109.61 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.17 54.76 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.458 -0.776 . . . . 0.0 111.417 170.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.84 -164.3 36.9 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.914 0.768 . . . . 0.0 114.604 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -94.52 125.65 39.3 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.017 0.927 . . . . 0.0 110.232 170.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -134.64 171.12 14.79 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.428 1.491 . . . . 0.0 112.409 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.7 pt -125.38 152.42 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.173 1.789 . . . . 0.0 108.445 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.9 mt -128.72 119.85 50.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -140.25 148.96 42.25 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.696 0.798 . . . . 0.0 112.555 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -78.7 135.06 37.07 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.903 -0.498 . . . . 0.0 111.544 -174.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -59.59 -22.84 62.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.089 1.356 . . . . 0.0 114.139 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.6 t . . . . . 0 N--CA 1.481 1.094 0 C-N-CA 124.172 0.989 . . . . 0.0 112.866 175.204 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.8 tp . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 121.028 0.442 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.29 147.64 27.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.788 1.635 . . . . 0.0 114.203 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.4 tp -59.64 138.36 57.76 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.163 1.385 . . . . 0.0 110.863 170.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 m -130.42 126.52 37.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.102 0.961 . . . . 0.0 111.93 -171.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -61.25 130.51 91.66 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 126.319 1.848 . . . . 0.0 111.657 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.41 -6.49 16.39 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.707 2.938 . . . . 0.0 114.878 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.76 -2.29 62.07 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.832 -0.982 . . . . 0.0 115.082 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -160.22 169.75 22.59 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.919 1.359 . . . . 0.0 112.863 -172.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -95.17 167.55 11.3 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.894 1.677 . . . . 0.0 111.405 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.8 tpt85 47.49 40.71 11.77 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.11 2.164 . . . . 0.0 113.694 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.6 m -139.76 140.61 25.21 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 125.159 1.384 . . . . 0.0 111.83 -169.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -44.53 150.18 0.84 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 126.338 4.692 . . . . 0.0 115.424 169.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.57 155.84 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.145 1.378 . . . . 0.0 110.699 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 52' ' ' VAL . 2.9 m -126.74 176.06 7.53 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.753 1.621 . . . . 0.0 111.082 -169.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -130.62 145.74 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.049 1.34 . . . . 0.0 111.452 176.162 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.6 m -151.22 159.67 33.19 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.938 1.295 . . . . 0.0 111.945 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.66 132.38 35.06 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.84 1.693 . . . . 0.0 110.758 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.69 138.73 57.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.161 1.384 . . . . 0.0 111.436 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -132.45 -22.34 2.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.946 1.298 . . . . 0.0 112.594 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.73 -1.82 32.12 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.944 1.735 . . . . 0.0 113.478 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.6 p -80.04 159.42 26.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.792 1.237 . . . . 0.0 113.076 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.3 m -60.19 -18.16 46.24 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.76 -35.26 80.0 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.04 0.936 . . . . 0.0 112.458 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.31 0.0 OUTLIER -120.47 14.06 11.89 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.16 149.69 23.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.267 1.027 . . . . 0.0 111.707 170.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -139.47 171.53 14.13 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.635 1.207 . . . . 0.0 113.131 -169.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.8 mt -120.8 137.04 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 127.721 2.408 . . . . 0.0 107.351 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.5 tp -137.0 125.61 23.73 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.487 1.515 . . . . 0.0 109.491 -171.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -142.88 135.69 27.92 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.08 0.952 . . . . 0.0 110.999 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -63.87 140.23 58.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.321 0.649 . . . . 0.0 111.37 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -112.06 -52.89 2.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.421 1.088 . . . . 0.0 111.25 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -147.89 117.34 6.98 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.13 . . . . 0.0 111.087 169.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -36.18 80.82 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 112.936 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -61.26 -17.35 53.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.927 2.091 . . . . 0.0 114.883 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 m -123.99 8.32 8.67 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.143 1.777 . . . . 0.0 113.624 172.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 43.36 33.56 0.62 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.31 1.844 . . . . 0.0 114.545 -169.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 p -89.25 144.81 25.82 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.386 -1.446 . . . . 0.0 112.316 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -139.71 140.82 36.91 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.357 1.463 . . . . 0.0 111.297 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.4 p -79.02 148.3 32.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.015 0.526 . . . . 0.0 110.858 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.13 129.9 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.524 1.53 . . . . 0.0 109.362 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.0 m -145.63 145.98 27.74 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.641 1.576 . . . . 0.0 110.622 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.19 145.91 35.52 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.999 2.466 . . . . 0.0 111.043 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.71 -25.78 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.925 -1.109 . . . . 0.0 113.057 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.87 -23.44 61.86 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 123.858 0.742 . . . . 0.0 114.388 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m -142.09 64.13 16.75 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.701 1.6 . . . . 0.0 111.112 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -61.3 -19.38 63.7 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.917 3.078 . . . . 0.0 113.244 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -71.19 9.0 0.82 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 128.234 2.614 . . . . 0.0 114.415 169.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.8 p -138.03 172.73 12.49 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.717 1.607 . . . . 0.0 112.345 173.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -137.98 171.6 14.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.917 1.687 . . . . 0.0 112.567 -171.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -120.39 126.7 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.15 1.38 . . . . 0.0 110.728 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.75 -158.59 7.6 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.874 1.702 . . . . 0.0 111.385 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -141.3 144.09 34.43 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.343 1.071 . . . . 0.0 111.763 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.84 -165.2 12.29 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.494 1.521 . . . . 0.0 113.059 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.24 138.92 25.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.003 1.321 . . . . 0.0 113.257 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.18 -1.63 67.62 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.607 1.099 . . . . 0.0 114.354 -173.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 48.52 55.67 8.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.236 1.815 . . . . 0.0 113.669 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.8 p -132.68 137.2 29.25 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 127.695 2.398 . . . . 0.0 107.479 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.31 143.29 47.76 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.112 -1.149 . . . . 0.0 109.112 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.13 147.13 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.178 1.391 . . . . 0.0 110.932 -172.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.64 138.87 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.423 0.689 . . . . 0.0 109.964 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.3 mt -142.31 163.55 38.8 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 125.826 1.65 . . . . 0.0 111.728 -169.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.92 165.77 30.02 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.05 2.5 . . . . 0.0 111.751 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.43 123.7 9.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.555 2.17 . . . . 0.0 110.924 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -147.07 -92.11 0.09 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.164 0.985 . . . . 0.0 110.511 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -154.53 17.47 0.46 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.563 1.545 . . . . 0.0 112.794 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -67.48 134.69 51.81 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.605 0.762 . . . . 0.0 111.92 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.5 m -145.73 161.45 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.059 1.344 . . . . 0.0 112.391 -175.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -129.75 138.19 50.96 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.466 1.506 . . . . 0.0 110.875 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.5 m -74.95 125.52 29.06 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.242 1.417 . . . . 0.0 109.228 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.1 mt -116.46 128.41 55.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 109.876 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.0 m -134.89 121.77 21.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.911 0.884 . . . . 0.0 110.858 -169.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 tp -67.92 148.24 51.38 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.262 0.625 . . . . 0.0 111.448 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 p -129.39 -176.67 3.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.93 1.692 . . . . 0.0 111.452 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.1 p -58.56 -17.71 23.86 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.68 29.37 0.24 Allowed Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.506 1.05 . . . . 0.0 114.017 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.48 -150.99 10.47 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.977 1.275 . . . . 0.0 112.172 -173.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -134.86 171.93 13.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.077 2.151 . . . . 0.0 111.536 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -137.83 154.49 49.51 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.52 1.928 . . . . 0.0 110.91 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 31.5 mt -135.32 118.53 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.084 1.354 . . . . 0.0 110.057 -169.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -134.9 157.96 45.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.218 1.007 . . . . 0.0 112.831 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -62.53 -26.76 68.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -169.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.48 -40.35 1.67 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.145 1.355 . . . . 0.0 113.143 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -98.54 1.5 46.6 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.643 1.577 . . . . 0.0 113.641 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 65.22 12.84 8.34 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.942 2.097 . . . . 0.0 113.738 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.2 p -73.49 -23.84 60.1 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.46 1.104 . . . . 0.0 112.812 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.6 m -143.3 173.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.552 1.541 . . . . 0.0 112.017 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 t -145.17 154.0 41.97 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.582 2.753 . . . . 0.0 109.767 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -72.32 145.24 47.94 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.401 -0.812 . . . . 0.0 111.491 170.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.0 p -154.84 162.14 41.21 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.362 1.065 . . . . 0.0 112.868 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.5 mt -109.91 170.55 8.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.797 1.639 . . . . 0.0 109.375 169.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -109.77 -31.74 7.33 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.224 1.01 . . . . 0.0 112.059 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -135.83 -10.11 2.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.756 2.022 . . . . 0.0 112.081 169.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.65 27.98 11.36 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.98 1.712 . . . . 0.0 113.939 -170.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.1 p -75.47 155.6 36.07 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.222 1.009 . . . . 0.0 111.657 170.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.26 136.54 55.99 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.244 -0.91 . . . . 0.0 111.427 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.03 0.75 88.93 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.466 1.031 . . . . 0.0 114.536 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -71.17 142.72 50.68 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.807 1.303 . . . . 0.0 112.73 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.1 119.87 19.85 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.302 -0.874 . . . . 0.0 110.06 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 p -62.47 150.34 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.521 0.729 . . . . 0.0 111.357 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.1 m -131.95 168.98 16.95 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.309 1.844 . . . . 0.0 111.293 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.6 mt -134.63 143.71 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.05 1.34 . . . . 0.0 109.379 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.28 179.33 47.53 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 124.819 1.2 . . . . 0.0 111.743 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.31 -42.65 61.33 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.963 1.382 . . . . 0.0 114.291 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -169.71 172.93 6.53 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.166 2.586 . . . . 0.0 109.559 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.51 135.02 33.05 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.168 0.987 . . . . 0.0 112.254 170.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.6 t -56.98 -24.56 54.32 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.273 1.829 . . . . 0.0 115.809 -169.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -130.83 -36.41 1.38 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.962 1.305 . . . . 0.0 112.826 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 t -96.3 1.14 51.71 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -171.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.83 26.37 0.77 Allowed Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.105 1.336 . . . . 0.0 115.948 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -145.92 149.7 34.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.17 1.788 . . . . 0.0 111.594 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -141.62 176.76 8.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.956 1.702 . . . . 0.0 111.826 -169.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.22 140.16 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.629 1.572 . . . . 0.0 108.807 169.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.18 123.59 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.98 153.32 37.77 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.599 1.16 . . . . 0.0 109.474 -170.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.09 155.01 40.47 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.945 -1.097 . . . . 0.0 112.736 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.3 t . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.317 1.847 . . . . 0.0 111.31 171.199 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.2 mt . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 113.523 0.934 . . . . 0.0 113.523 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.5 m -148.53 162.9 38.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.696 1.998 . . . . 0.0 109.3 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.8 137.24 56.48 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.399 -0.813 . . . . 0.0 111.495 172.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.14 -162.94 36.15 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.312 0.885 . . . . 0.0 115.312 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -94.02 121.85 35.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.01 1.324 . . . . 0.0 110.282 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -133.5 170.49 15.42 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.483 1.113 . . . . 0.0 112.801 -173.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.26 154.74 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 126.353 1.861 . . . . 0.0 108.855 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.0 mt -130.24 120.15 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -145.49 160.53 41.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.777 0.831 . . . . 0.0 112.458 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -99.6 121.44 41.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.486 0.714 . . . . 0.0 110.871 -174.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -63.42 -14.73 53.54 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.8 t . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 124.324 1.049 . . . . 0.0 112.358 171.82 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.1 tp . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 121.343 0.592 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.96 153.07 21.86 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.621 1.169 . . . . 0.0 113.368 -171.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -62.1 136.15 57.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.608 1.163 . . . . 0.0 109.901 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.8 m -128.05 124.72 37.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.667 1.187 . . . . 0.0 111.644 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -68.27 136.18 91.28 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.149 0.98 . . . . 0.0 112.315 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.04 -13.16 19.41 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.547 2.831 . . . . 0.0 115.015 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.93 5.79 73.15 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.324 0.964 . . . . 0.0 115.191 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -157.0 167.57 30.07 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.051 1.741 . . . . 0.0 111.78 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -98.65 167.09 11.0 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.005 1.322 . . . . 0.0 111.453 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 47.78 43.36 16.95 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.642 1.977 . . . . 0.0 113.079 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.0 m -141.07 138.96 18.46 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 125.407 1.483 . . . . 0.0 111.272 -169.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -46.5 157.06 0.5 Allowed 'Trans proline' 0 C--N 1.354 0.852 1 C-N-CA 126.121 4.547 . . . . 0.0 115.306 169.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 t -117.43 149.68 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.384 1.474 . . . . 0.0 109.774 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 m -124.89 174.97 7.6 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.097 1.359 . . . . 0.0 110.429 -169.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 m -127.02 144.33 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 120.902 -1.124 . . . . 0.0 111.602 172.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.4 m -148.38 166.02 16.67 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.803 1.241 . . . . 0.0 112.462 -176.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.58 163.26 2.82 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.79 2.993 . . . . 0.0 113.469 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.2 tp -126.26 143.73 51.04 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.794 1.238 . . . . 0.0 111.552 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -147.98 -32.33 0.27 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.328 1.451 . . . . 0.0 113.434 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.26 -9.65 0.83 Allowed Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.358 1.456 . . . . 0.0 114.365 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -63.08 139.65 58.79 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.979 1.39 . . . . 0.0 111.916 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.7 p -63.99 -11.05 25.22 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.387 1.475 . . . . 0.0 114.353 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.99 -20.08 64.99 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.487 1.04 . . . . 0.0 112.095 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -109.07 3.94 22.56 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.482 1.913 . . . . 0.0 113.282 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.29 144.58 29.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.125 0.964 . . . . 0.0 111.687 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -139.54 173.66 11.31 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.899 1.333 . . . . 0.0 112.123 -169.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.0 mt -122.75 135.44 62.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 127.746 2.418 . . . . 0.0 106.745 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.0 tp -137.04 124.53 22.12 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.978 1.311 . . . . 0.0 109.379 -172.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -142.77 138.57 30.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.403 0.681 . . . . 0.0 111.196 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.8 t -64.53 139.41 58.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.967 0.507 . . . . 0.0 110.984 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -114.21 -51.01 2.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.528 1.131 . . . . 0.0 110.762 174.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.23 107.71 4.1 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.172 0.989 . . . . 0.0 111.208 169.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.6 m -58.27 -25.94 62.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.987 0.915 . . . . 0.0 111.311 168.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -62.24 -21.6 65.3 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.095 2.158 . . . . 0.0 113.399 173.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.4 m -130.37 9.1 5.11 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.913 1.685 . . . . 0.0 113.026 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 47.0 32.1 1.76 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.014 2.126 . . . . 0.0 114.23 -169.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 p -92.55 142.49 27.34 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.158 -0.964 . . . . 0.0 112.319 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -139.06 144.54 38.82 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.072 1.749 . . . . 0.0 110.653 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.0 p -77.85 148.5 34.64 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.182 0.593 . . . . 0.0 110.82 172.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 mm -128.17 126.86 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.572 1.549 . . . . 0.0 109.417 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.9 m -143.9 148.91 44.21 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 125.541 1.536 . . . . 0.0 109.785 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.51 150.76 28.47 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.031 2.487 . . . . 0.0 111.055 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.03 -26.38 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.023 -1.048 . . . . 0.0 113.552 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.84 -20.79 55.1 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.738 0.685 . . . . 0.0 114.485 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.6 m -142.39 61.13 11.23 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 125.635 1.574 . . . . 0.0 111.526 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -61.31 -17.16 51.39 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.69 2.926 . . . . 0.0 113.178 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -72.87 13.55 0.37 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 128.591 2.756 . . . . 0.0 113.481 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.8 p -144.0 170.13 16.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.428 2.291 . . . . 0.0 111.119 173.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -139.65 170.71 15.4 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.217 1.807 . . . . 0.0 111.979 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -117.1 126.79 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.732 1.213 . . . . 0.0 110.77 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.79 -158.67 7.63 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 126.072 1.796 . . . . 0.0 111.328 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -144.96 144.77 31.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.178 0.989 . . . . 0.0 111.897 -174.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.03 -161.13 9.83 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.573 1.558 . . . . 0.0 113.116 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.18 137.7 21.8 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.921 1.288 . . . . 0.0 113.018 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.56 -5.83 64.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.724 1.154 . . . . 0.0 114.248 -172.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 47.49 52.65 12.12 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.402 1.881 . . . . 0.0 113.719 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.84 141.39 41.51 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 127.213 2.205 . . . . 0.0 107.478 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.54 140.12 55.98 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 N-CA-C 108.944 -1.214 . . . . 0.0 108.944 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.53 148.02 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.327 1.451 . . . . 0.0 111.275 -175.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.0 t -77.26 137.42 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.577 0.751 . . . . 0.0 110.426 173.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -141.0 161.76 51.93 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.209 1.803 . . . . 0.0 110.799 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.32 162.5 38.33 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.555 2.17 . . . . 0.0 111.291 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.96 127.77 27.48 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.15 2.566 . . . . 0.0 113.02 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -149.3 -107.82 0.07 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.203 1.401 . . . . 0.0 108.994 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -143.83 21.22 1.8 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.535 1.934 . . . . 0.0 110.581 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -65.82 131.99 47.63 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.339 -0.85 . . . . 0.0 111.677 -173.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.5 m -143.56 161.24 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.437 1.495 . . . . 0.0 111.335 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -130.83 152.27 50.35 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.214 1.406 . . . . 0.0 110.135 169.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.4 m -77.03 135.58 38.66 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.158 1.383 . . . . 0.0 109.294 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -126.09 73.78 1.39 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.246 1.018 . . . . 0.0 109.137 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.8 m -83.92 127.16 33.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.3 1.04 . . . . 0.0 111.015 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 tp -69.58 147.36 50.83 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.727 0.811 . . . . 0.0 111.405 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.1 p -129.91 175.53 8.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.381 1.473 . . . . 0.0 111.791 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 75.9 p -62.88 -11.5 18.69 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.65 17.22 1.63 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.76 1.171 . . . . 0.0 115.291 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.63 -137.22 4.99 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 118.645 1.222 . . . . 0.0 112.498 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -133.6 169.07 17.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.421 2.288 . . . . 0.0 111.336 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -131.39 147.39 52.56 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.304 1.842 . . . . 0.0 110.43 172.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.8 mt -130.53 114.01 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.055 0.942 . . . . 0.0 110.022 -170.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -136.89 151.99 49.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.86 1.264 . . . . 0.0 111.433 -169.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.0 -31.37 62.99 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.55 -40.11 1.59 Allowed Glycine 0 N--CA 1.471 1.019 0 C-N-CA 125.221 1.391 . . . . 0.0 112.649 -171.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -79.77 -5.76 55.96 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.913 1.285 . . . . 0.0 114.214 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? 57.1 14.14 1.87 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 126.998 2.119 . . . . 0.0 114.26 -169.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.8 p -69.46 -26.54 64.63 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.625 1.97 . . . . 0.0 113.501 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.5 m -143.88 168.71 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.005 1.722 . . . . 0.0 111.322 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.6 t -140.93 156.88 46.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.157 1.783 . . . . 0.0 110.863 172.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -71.52 138.74 49.13 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.18 0.592 . . . . 0.0 111.148 170.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 98.3 p -147.94 172.97 13.35 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.344 1.058 . . . . 0.0 112.552 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.92 149.18 46.18 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.077 1.351 . . . . 0.0 110.001 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -82.55 -34.41 27.8 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.433 0.693 . . . . 0.0 111.285 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -141.0 -7.83 1.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.33 1.852 . . . . 0.0 112.785 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.45 28.16 13.25 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.816 1.646 . . . . 0.0 114.319 -170.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.0 p -76.81 157.84 31.26 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.987 -1.071 . . . . 0.0 111.39 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -71.24 144.51 50.05 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.074 -1.016 . . . . 0.0 112.036 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.11 0.83 84.1 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.423 1.011 . . . . 0.0 114.395 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -70.01 149.4 47.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.964 1.306 . . . . 0.0 112.579 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.91 114.22 21.52 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.991 -1.068 . . . . 0.0 109.774 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.7 p -56.96 146.09 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 111.353 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.3 t -124.94 165.8 17.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.99 1.316 . . . . 0.0 111.957 -169.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.8 mt -134.98 143.06 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.725 1.61 . . . . 0.0 108.81 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.66 -157.81 30.33 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.076 0.846 . . . . 0.0 111.85 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.54 157.51 5.15 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.664 0.732 . . . . 0.0 111.91 169.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -57.84 153.08 14.59 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.33 1.052 . . . . 0.0 112.691 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.24 171.24 7.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.911 1.685 . . . . 0.0 112.738 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.3 t -107.2 -3.45 19.81 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -170.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -145.82 -43.93 0.21 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.384 1.073 . . . . 0.0 112.536 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 86.2 p -95.48 -0.3 52.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.52 -3.71 27.76 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.5 1.524 . . . . 0.0 115.924 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -125.66 152.58 45.03 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.524 1.662 . . . . 0.0 111.541 -174.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -137.59 175.48 9.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.656 1.583 . . . . 0.0 111.947 -168.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.0 p -138.41 139.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.7 1.2 . . . . 0.0 109.857 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 mp -122.45 124.51 70.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.968 1.707 . . . . 0.0 106.95 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -149.07 154.03 38.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.104 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.24 155.16 40.28 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.102 -0.999 . . . . 0.0 112.62 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.6 t . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.077 1.751 . . . . 0.0 111.313 171.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.542 0.655 0 CA-C-O 121.572 0.701 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 t -154.18 169.53 23.38 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.945 1.298 . . . . 0.0 109.841 171.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.88 139.43 58.76 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 173.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.89 -161.34 32.29 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.267 0.937 . . . . 0.0 114.374 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -98.93 125.61 44.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.077 0.951 . . . . 0.0 110.111 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -134.28 172.47 12.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.572 1.549 . . . . 0.0 112.239 -171.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.4 pt -127.04 154.58 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 126.477 1.911 . . . . 0.0 108.62 171.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.66 123.77 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -141.36 150.22 42.15 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.362 0.665 . . . . 0.0 112.485 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -84.82 134.56 34.3 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.192 0.597 . . . . 0.0 111.635 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -64.83 -13.59 56.49 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.6 t . . . . . 0 N--CA 1.478 0.94 0 CA-C-N 119.447 1.022 . . . . 0.0 112.399 171.84 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.3 tp . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 121.213 0.53 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.72 145.17 29.73 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -169.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -59.39 130.95 49.42 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.803 1.241 . . . . 0.0 109.201 168.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.1 m -128.52 117.37 21.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.436 1.094 . . . . 0.0 110.909 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.87 134.3 89.77 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.512 1.925 . . . . 0.0 112.141 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.59 -10.46 18.68 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.497 2.798 . . . . 0.0 114.795 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.21 6.19 81.85 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 119.01 -0.883 . . . . 0.0 115.254 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -157.7 163.24 38.37 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.94 1.37 . . . . 0.0 112.241 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -90.8 165.62 13.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.318 1.047 . . . . 0.0 111.631 -175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 50.67 35.77 12.53 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.308 1.843 . . . . 0.0 113.707 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.0 m -134.06 138.96 31.78 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 125.385 1.474 . . . . 0.0 111.319 -169.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -46.62 153.15 1.32 Allowed 'Trans proline' 0 C--N 1.354 0.817 1 C-N-CA 125.973 4.449 . . . . 0.0 115.238 169.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.05 147.75 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.687 1.195 . . . . 0.0 110.388 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 m -120.95 173.02 7.5 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.377 1.471 . . . . 0.0 111.347 -168.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.47 143.91 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.875 1.27 . . . . 0.0 111.446 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.1 m -151.41 159.84 32.79 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.136 1.374 . . . . 0.0 111.478 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -62.55 132.95 40.22 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.241 1.961 . . . . 0.0 110.779 173.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.1 tp -63.79 137.28 57.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.284 1.034 . . . . 0.0 111.308 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -135.93 -24.03 1.32 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.298 1.439 . . . . 0.0 112.811 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.14 5.96 22.81 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.147 1.356 . . . . 0.0 114.037 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.3 t -62.48 147.93 47.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.425 1.113 . . . . 0.0 111.788 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.8 m -58.24 -20.29 40.81 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.097 0.959 . . . . 0.0 113.53 172.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.87 -20.98 65.18 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.927 0.891 . . . . 0.0 112.853 173.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -104.29 -1.54 26.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.145 1.778 . . . . 0.0 112.617 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.95 138.81 41.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.807 1.243 . . . . 0.0 111.517 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -136.0 170.43 16.02 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.745 1.218 . . . . 0.0 111.873 -169.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.0 mt -124.69 136.87 59.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 126.514 1.926 . . . . 0.0 107.358 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.6 tp -136.51 126.51 26.02 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.383 1.473 . . . . 0.0 109.506 -169.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -144.25 138.05 27.72 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.15 0.98 . . . . 0.0 110.788 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 t -63.84 141.87 58.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.933 0.493 . . . . 0.0 111.529 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -113.4 -52.27 2.77 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.505 1.122 . . . . 0.0 110.76 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.43 107.49 4.02 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.276 1.03 . . . . 0.0 110.971 169.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.1 m -57.96 -26.56 62.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.939 0.896 . . . . 0.0 111.369 168.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -61.7 -20.81 63.89 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.091 2.156 . . . . 0.0 113.664 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.8 m -130.36 9.39 5.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.242 1.817 . . . . 0.0 112.949 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 47.23 28.55 1.02 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.291 2.236 . . . . 0.0 114.734 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -88.53 142.33 27.79 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.592 -1.318 . . . . 0.0 112.443 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -138.45 141.7 39.47 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.932 1.693 . . . . 0.0 110.891 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.2 p -77.88 147.57 35.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.148 0.579 . . . . 0.0 110.758 172.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.6 mm -128.49 131.41 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.42 1.488 . . . . 0.0 109.507 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.1 m -144.54 148.33 39.75 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 125.918 1.687 . . . . 0.0 110.549 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.9 145.89 28.95 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.121 2.547 . . . . 0.0 111.322 173.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.34 -28.76 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 O-C-N 121.189 -0.945 . . . . 0.0 112.003 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.43 -25.3 74.63 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 123.738 0.685 . . . . 0.0 114.753 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.1 m -144.59 67.37 14.23 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.451 1.5 . . . . 0.0 111.554 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.82 -13.46 37.2 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.416 2.744 . . . . 0.0 113.658 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -73.99 1.99 9.68 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.976 1.71 . . . . 0.0 114.002 170.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m -132.74 173.56 11.23 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.7 1.6 . . . . 0.0 111.782 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -137.4 172.43 12.99 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.453 1.501 . . . . 0.0 112.775 -174.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.9 mm -119.28 123.02 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.098 1.359 . . . . 0.0 110.14 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.45 -161.43 9.75 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.981 1.753 . . . . 0.0 111.144 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -142.07 143.2 32.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.383 1.092 . . . . 0.0 111.703 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.68 -162.32 10.36 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.092 1.33 . . . . 0.0 113.35 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.08 137.71 21.2 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.17 1.388 . . . . 0.0 113.058 -177.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.48 -5.71 65.03 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.771 1.177 . . . . 0.0 114.167 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 47.99 55.91 7.99 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.256 1.822 . . . . 0.0 113.563 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.89 141.12 33.76 Favored Pre-proline 0 N--CA 1.468 0.457 0 C-N-CA 127.262 2.225 . . . . 0.0 107.658 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -66.43 144.18 72.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.142 1.228 . . . . 0.0 109.836 174.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.24 145.13 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.521 1.528 . . . . 0.0 111.992 -172.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.2 t -74.19 119.2 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.194 0.997 . . . . 0.0 110.361 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -129.95 164.64 39.07 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.842 2.057 . . . . 0.0 111.457 -169.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.04 166.34 27.03 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.154 2.569 . . . . 0.0 112.339 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.85 121.05 7.02 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.335 2.023 . . . . 0.0 110.374 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -148.11 -90.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.762 0.825 . . . . 0.0 110.827 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -155.81 17.75 0.38 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.648 1.579 . . . . 0.0 112.727 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -66.47 137.2 56.66 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.583 -0.698 . . . . 0.0 111.802 -174.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.0 m -144.53 160.46 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.788 1.235 . . . . 0.0 112.231 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -129.6 138.0 51.02 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.644 1.578 . . . . 0.0 110.145 169.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -71.4 127.51 32.8 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.67 1.188 . . . . 0.0 108.793 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.8 mt -125.92 115.76 20.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.192 0.997 . . . . 0.0 108.739 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.8 m -136.52 134.49 37.61 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.733 0.813 . . . . 0.0 111.261 -169.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.66 152.11 45.09 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.008 1.323 . . . . 0.0 112.14 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 p -131.61 -178.75 5.0 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.096 1.758 . . . . 0.0 111.373 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.6 p -60.54 -13.0 11.46 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.82 24.45 0.26 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.274 0.94 . . . . 0.0 114.885 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 176.02 -147.6 8.76 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.147 0.974 . . . . 0.0 113.112 -173.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -132.02 167.26 20.0 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.082 2.153 . . . . 0.0 111.233 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -122.27 155.12 36.57 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.923 2.089 . . . . 0.0 109.964 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mt -134.84 117.15 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.01 1.724 . . . . 0.0 108.276 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -134.91 157.21 47.44 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.732 1.213 . . . . 0.0 111.633 -173.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -60.96 -25.69 67.01 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.93 -40.36 1.66 Allowed Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.003 1.763 . . . . 0.0 112.425 -169.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -98.82 4.4 47.59 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 114.06 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 58.08 14.56 2.76 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.282 2.233 . . . . 0.0 114.352 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.4 p -71.13 -24.74 62.34 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.164 0.985 . . . . 0.0 112.597 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.78 172.9 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.867 1.667 . . . . 0.0 111.988 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.0 t -143.74 150.99 39.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.462 3.105 . . . . 0.0 108.816 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -73.51 144.84 45.99 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.41 -0.806 . . . . 0.0 111.507 170.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 93.1 p -154.07 173.98 15.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.447 1.099 . . . . 0.0 112.322 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.7 mt -121.11 170.51 9.48 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.841 2.056 . . . . 0.0 109.503 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -105.06 -33.87 8.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.025 0.93 . . . . 0.0 111.9 -169.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -139.33 -8.51 1.3 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.015 2.126 . . . . 0.0 112.456 170.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.8 24.53 10.87 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 126.211 1.805 . . . . 0.0 114.521 -171.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.5 p -73.26 158.76 34.55 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 111.736 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.72 142.91 54.86 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.21 -0.931 . . . . 0.0 112.009 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.02 6.23 85.74 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.659 1.123 . . . . 0.0 114.444 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.74 137.16 38.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.826 1.313 . . . . 0.0 112.498 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -71.95 134.35 45.91 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.369 -0.832 . . . . 0.0 110.834 174.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.48 155.59 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.462 0.649 . . . . 0.0 110.962 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.6 t -127.11 159.21 34.89 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.359 1.464 . . . . 0.0 110.91 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.97 137.07 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.468 1.507 . . . . 0.0 108.736 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 178.48 178.46 47.87 Favored Glycine 0 N--CA 1.471 0.976 0 C-N-CA 124.674 1.13 . . . . 0.0 111.44 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.87 -41.34 57.98 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.265 1.532 . . . . 0.0 114.19 -173.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -167.62 176.0 6.7 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.944 2.498 . . . . 0.0 111.382 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.12 140.08 35.95 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.332 1.053 . . . . 0.0 111.88 169.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.6 t -62.85 -22.59 66.79 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -171.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -134.01 -35.42 0.95 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.959 1.304 . . . . 0.0 113.076 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.0 t -97.8 2.8 49.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.812 1.245 . . . . 0.0 114.323 -171.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.91 17.6 1.26 Allowed Glycine 0 CA--C 1.544 1.865 0 C-N-CA 125.4 1.476 . . . . 0.0 116.27 -174.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -140.45 149.23 42.3 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.135 1.774 . . . . 0.0 112.142 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -140.89 178.17 7.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.717 2.007 . . . . 0.0 111.18 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.2 141.22 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.77 1.228 . . . . 0.0 109.286 169.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.33 123.62 71.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.575 1.55 . . . . 0.0 106.939 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -145.94 153.19 40.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.665 1.186 . . . . 0.0 109.482 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -67.45 155.28 39.41 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.04 -1.038 . . . . 0.0 112.774 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 77.1 t . . . . . 0 C--O 1.251 1.177 0 C-N-CA 126.171 1.789 . . . . 0.0 111.309 172.228 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 CA--C 1.547 0.853 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -160.76 169.28 23.07 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.095 1.358 . . . . 0.0 109.928 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.16 133.07 50.75 Favored 'General case' 0 CA--C 1.548 0.865 0 O-C-N 121.855 -0.528 . . . . 0.0 111.703 170.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.24 -164.99 37.95 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.841 0.734 . . . . 0.0 114.5 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -97.07 126.48 42.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.982 0.913 . . . . 0.0 110.318 171.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.15 172.05 13.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.56 1.544 . . . . 0.0 112.442 -170.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.6 pt -127.17 156.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.472 1.909 . . . . 0.0 108.763 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.8 mt -128.38 126.75 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.91 151.82 39.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.316 0.646 . . . . 0.0 111.735 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -86.2 138.36 31.93 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.75 -0.594 . . . . 0.0 112.038 -173.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.8 mmm180 -62.05 -19.08 62.52 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t . . . . . 0 N--CA 1.48 1.061 0 CA-C-N 119.269 0.941 . . . . 0.0 112.936 176.439 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 24.3 tp . . . . . 0 N--CA 1.467 0.383 0 CA-C-O 121.15 0.5 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.78 141.23 36.48 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.574 1.149 . . . . 0.0 113.987 -169.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.561 HD12 ' CZ2' ' A' ' 63' ' ' TRP . 0.6 OUTLIER -60.99 125.04 22.28 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.326 1.45 . . . . 0.0 107.957 169.001 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.406 ' N ' HD13 ' A' ' 40' ' ' LEU . 87.7 m -126.33 124.64 40.74 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.344 1.058 . . . . 0.0 112.054 -169.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.59 134.37 95.99 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.905 2.082 . . . . 0.0 111.885 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.83 -10.8 19.99 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.366 2.71 . . . . 0.0 114.462 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.89 6.16 76.38 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.962 -0.91 . . . . 0.0 115.262 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -157.17 166.66 32.59 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.005 1.402 . . . . 0.0 112.278 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -89.36 165.42 14.38 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.388 1.075 . . . . 0.0 111.828 -174.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 45.95 43.64 10.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.582 1.953 . . . . 0.0 113.497 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 m -138.31 139.01 23.91 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 125.507 1.523 . . . . 0.0 110.813 -169.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -45.84 157.81 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.881 1 C-N-CA 126.279 4.653 . . . . 0.0 115.483 169.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.15 151.02 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.316 1.446 . . . . 0.0 110.42 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 m -130.92 170.28 14.65 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.174 1.39 . . . . 0.0 110.339 -169.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.12 146.54 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.993 -1.067 . . . . 0.0 112.075 175.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -150.6 160.41 32.72 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.642 1.177 . . . . 0.0 112.223 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.06 128.03 27.39 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.46 2.774 . . . . 0.0 111.75 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 tp -64.11 136.22 57.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.481 0.713 . . . . 0.0 111.042 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -134.47 -26.89 1.39 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.206 1.403 . . . . 0.0 112.606 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.8 8.76 13.32 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.293 1.425 . . . . 0.0 113.938 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.5 t -66.98 160.13 27.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.596 1.198 . . . . 0.0 111.941 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.5 m -73.6 -16.28 61.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.088 0.955 . . . . 0.0 111.665 -176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.26 -16.73 58.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.064 1.745 . . . . 0.0 112.829 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -101.5 -5.45 25.19 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.02 1.728 . . . . 0.0 112.343 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.97 143.23 36.93 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.991 1.316 . . . . 0.0 111.735 -174.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.561 ' CZ2' HD12 ' A' ' 40' ' ' LEU . 90.3 m95 -136.4 168.12 20.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.542 1.163 . . . . 0.0 112.333 -169.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.2 mt -121.56 134.82 63.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.92 2.088 . . . . 0.0 106.654 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.1 tp -134.79 126.82 29.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.49 1.516 . . . . 0.0 109.655 -169.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -143.0 140.25 30.94 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.146 0.978 . . . . 0.0 110.894 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.7 t -65.92 140.23 58.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.707 0.403 . . . . 0.0 111.132 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -112.87 -51.2 2.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.414 1.086 . . . . 0.0 111.026 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.62 108.7 4.41 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.469 1.107 . . . . 0.0 110.93 169.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.1 m -58.08 -26.59 62.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.83 0.852 . . . . 0.0 111.188 168.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -61.36 -20.6 63.18 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.136 2.174 . . . . 0.0 113.51 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t -130.48 6.92 4.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.851 1.66 . . . . 0.0 113.401 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 48.1 31.29 2.44 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.26 1.824 . . . . 0.0 114.035 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -89.03 143.46 26.84 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.266 -0.896 . . . . 0.0 111.848 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -138.53 141.61 39.32 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.443 1.497 . . . . 0.0 110.795 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.9 p -78.02 147.44 34.82 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.092 0.557 . . . . 0.0 110.678 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.2 mm -127.63 128.09 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.48 1.512 . . . . 0.0 109.302 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.1 m -142.16 141.01 20.23 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.674 1.59 . . . . 0.0 110.5 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.09 143.41 32.33 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.853 2.369 . . . . 0.0 111.224 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.86 -28.8 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 121.297 -0.877 . . . . 0.0 111.631 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.17 -10.51 86.01 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.4 m -156.4 68.05 4.6 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.846 1.658 . . . . 0.0 110.469 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -63.55 -17.84 61.76 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.789 2.992 . . . . 0.0 113.5 -173.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -76.24 6.15 5.91 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 127.848 2.459 . . . . 0.0 114.657 171.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.7 m -131.23 175.31 9.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.977 1.711 . . . . 0.0 112.088 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -139.06 171.99 13.5 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.546 1.538 . . . . 0.0 113.28 -172.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.7 mm -120.17 130.79 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.272 1.429 . . . . 0.0 110.601 174.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.47 -157.63 7.34 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.645 1.593 . . . . 0.0 111.422 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -141.7 142.61 33.33 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.24 1.016 . . . . 0.0 111.848 -172.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.94 -163.21 10.57 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.247 1.403 . . . . 0.0 113.381 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.2 139.96 22.43 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.011 1.324 . . . . 0.0 113.136 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.46 -2.29 73.83 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.512 1.053 . . . . 0.0 114.292 -173.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 48.7 56.34 7.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.18 1.792 . . . . 0.0 113.41 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.7 p -133.83 136.88 27.34 Favored Pre-proline 0 C--O 1.238 0.49 0 C-N-CA 127.548 2.339 . . . . 0.0 107.751 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.75 142.77 59.13 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.202 1.268 . . . . 0.0 109.462 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.03 149.29 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.023 1.329 . . . . 0.0 111.472 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 t -76.22 134.93 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.851 0.861 . . . . 0.0 110.402 174.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.5 mt -141.17 161.62 52.27 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.649 1.58 . . . . 0.0 112.039 -169.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.9 165.65 29.18 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.062 2.508 . . . . 0.0 111.765 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.62 124.07 9.97 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.5 2.133 . . . . 0.0 110.702 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -148.01 -89.61 0.08 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.076 0.95 . . . . 0.0 110.592 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -154.82 15.95 0.43 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.431 1.493 . . . . 0.0 112.901 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -67.01 134.36 51.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.425 0.69 . . . . 0.0 111.906 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -144.92 161.03 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.949 1.3 . . . . 0.0 112.069 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -130.99 137.61 49.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.252 1.421 . . . . 0.0 110.762 169.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.9 m -72.19 131.74 43.17 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.899 1.28 . . . . 0.0 108.705 169.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.7 mt -121.94 73.49 1.09 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.071 0.938 . . . . 0.0 109.324 -176.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 93.3 m -73.42 119.47 17.7 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.755 1.222 . . . . 0.0 110.656 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.7 tp -68.41 147.63 51.8 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.077 0.551 . . . . 0.0 111.271 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.0 p -133.82 177.05 8.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.987 1.715 . . . . 0.0 110.515 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.9 m -59.88 -12.69 8.18 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.93 31.25 0.28 Allowed Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.761 1.172 . . . . 0.0 114.096 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.29 -160.62 34.22 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.976 1.274 . . . . 0.0 112.072 -174.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -127.92 172.11 11.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.255 1.822 . . . . 0.0 112.075 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -136.69 150.18 48.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.21 1.804 . . . . 0.0 110.099 170.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.1 mt -129.1 114.84 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.103 0.961 . . . . 0.0 109.516 -169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -134.8 155.74 50.08 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.124 0.969 . . . . 0.0 112.248 -169.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.86 -28.99 69.88 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.68 -40.6 1.61 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.063 1.792 . . . . 0.0 112.756 -172.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.08 -5.2 59.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.974 1.309 . . . . 0.0 113.983 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? 57.11 17.86 3.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.623 1.969 . . . . 0.0 113.374 -169.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 49.0 p -71.02 -24.46 62.37 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.195 0.998 . . . . 0.0 112.168 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.9 m -144.26 173.68 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.006 1.723 . . . . 0.0 112.162 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.4 t -146.14 154.81 42.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.481 2.712 . . . . 0.0 110.044 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -73.19 142.04 47.37 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.464 -0.773 . . . . 0.0 111.777 170.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 91.7 p -152.92 170.47 20.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.025 1.33 . . . . 0.0 112.63 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.81 156.06 31.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.954 1.302 . . . . 0.0 110.386 173.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -89.93 -31.47 17.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.281 0.632 . . . . 0.0 111.501 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -138.07 -4.12 1.74 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.556 1.542 . . . . 0.0 113.639 172.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.85 27.26 2.26 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.303 1.841 . . . . 0.0 114.452 -169.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.6 p -76.33 161.0 29.09 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.899 0.88 . . . . 0.0 111.471 174.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.72 142.39 51.47 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.911 -1.118 . . . . 0.0 111.359 169.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.41 5.79 82.79 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.322 0.963 . . . . 0.0 114.019 -173.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.53 140.57 49.95 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.906 1.283 . . . . 0.0 111.858 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.56 111.19 14.36 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 170.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.32 147.39 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.634 0.73 . . . . 0.0 111.175 172.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.3 m -134.22 171.54 14.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.76 1.624 . . . . 0.0 111.399 -169.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 70.0 mt -134.34 143.69 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.983 1.313 . . . . 0.0 109.231 -173.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.03 179.04 47.22 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.895 1.236 . . . . 0.0 111.65 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.47 -42.47 61.62 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.091 1.445 . . . . 0.0 114.266 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -169.3 174.28 6.18 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.266 2.626 . . . . 0.0 111.027 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -142.46 141.83 32.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.185 0.994 . . . . 0.0 111.866 169.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 t -66.26 -18.61 65.46 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -138.62 -43.66 0.49 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.194 0.998 . . . . 0.0 113.293 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.8 p -86.07 0.49 53.31 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.081 1.352 . . . . 0.0 114.381 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.95 19.68 0.96 Allowed Glycine 0 CA--C 1.541 1.666 0 C-N-CA 126.505 2.002 . . . . 0.0 116.622 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -144.94 149.78 35.83 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.069 1.935 . . . . 0.0 112.057 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -139.4 177.71 7.73 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.988 1.715 . . . . 0.0 112.368 -169.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.3 p -140.78 139.93 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.831 1.252 . . . . 0.0 109.607 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.17 125.87 74.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 125.821 1.648 . . . . 0.0 107.192 172.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -148.58 153.76 38.81 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.646 1.178 . . . . 0.0 109.46 -170.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -67.71 155.11 39.99 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.921 -1.112 . . . . 0.0 112.775 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.145 1.778 . . . . 0.0 111.323 171.908 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 CA--C 1.549 0.91 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.2 m -150.73 160.17 44.03 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.073 1.749 . . . . 0.0 109.382 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.52 131.14 45.66 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.652 -0.655 . . . . 0.0 111.362 171.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.93 -166.11 39.43 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -95.52 124.1 39.39 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.231 1.012 . . . . 0.0 110.037 172.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -133.17 171.83 13.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.098 1.359 . . . . 0.0 112.259 -173.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 pt -124.57 153.05 31.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.888 1.675 . . . . 0.0 108.431 170.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.7 mt -128.49 118.97 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -138.56 149.6 45.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.504 0.669 . . . . 0.0 112.212 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -77.6 136.58 38.27 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.04 -0.413 . . . . 0.0 111.463 -173.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -64.94 -24.28 67.47 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.3 t . . . . . 0 N--CA 1.481 1.104 0 C-N-CA 123.819 0.847 . . . . 0.0 112.489 -178.312 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.471 0.581 0 CA-C-O 121.095 0.474 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.46 142.86 33.86 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.445 1.098 . . . . 0.0 113.292 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.8 tp -56.74 135.76 55.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.857 0.863 . . . . 0.0 109.218 169.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 90.5 m -132.26 122.55 25.35 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.266 1.026 . . . . 0.0 110.827 -173.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -64.07 138.13 97.32 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 127.128 2.171 . . . . 0.0 111.907 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -74.06 -12.1 23.51 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.299 2.666 . . . . 0.0 114.933 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.29 7.26 86.94 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.006 0.812 . . . . 0.0 114.76 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -154.09 166.42 33.11 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.947 1.699 . . . . 0.0 111.764 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -93.83 164.69 13.02 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.936 0.894 . . . . 0.0 111.812 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.6 tpt85 46.68 40.12 8.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.816 2.046 . . . . 0.0 114.032 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.7 m -133.98 142.1 42.15 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.563 1.545 . . . . 0.0 111.057 -169.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -44.67 156.28 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.828 1 C-N-CA 126.003 4.469 . . . . 0.0 115.589 169.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.88 158.43 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.798 1.239 . . . . 0.0 110.207 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -128.71 170.28 13.48 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.698 1.599 . . . . 0.0 110.971 -169.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.8 p -125.49 142.29 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.833 1.253 . . . . 0.0 111.257 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 m -159.04 168.49 12.3 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.711 1.204 . . . . 0.0 113.004 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -49.97 161.56 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.677 3.585 . . . . 0.0 114.857 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.3 tp -123.01 132.26 54.05 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.739 1.216 . . . . 0.0 111.343 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -134.19 -29.27 1.27 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.922 2.089 . . . . 0.0 112.27 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.53 4.09 1.98 Allowed Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.642 1.417 . . . . 0.0 116.642 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -71.0 165.1 24.19 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.056 1.928 . . . . 0.0 113.391 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.2 m -69.02 -16.98 63.85 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.29 -24.84 62.23 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.022 0.828 . . . . 0.0 112.28 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.62 6.28 11.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.084 2.554 . . . . 0.0 112.409 -169.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.99 148.07 39.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.979 1.312 . . . . 0.0 110.745 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -137.51 174.02 11.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 122.69 1.233 . . . . 0.0 112.901 -168.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.8 mt -122.96 139.15 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.194 2.198 . . . . 0.0 107.09 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.7 tp -137.31 123.22 20.14 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.409 1.483 . . . . 0.0 109.044 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -144.13 138.34 28.12 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.507 0.723 . . . . 0.0 111.117 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.2 t -65.96 139.33 58.23 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.734 0.414 . . . . 0.0 111.002 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -111.93 -50.61 2.9 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.809 1.244 . . . . 0.0 110.282 174.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.01 106.9 3.97 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.432 1.093 . . . . 0.0 110.84 169.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.4 m -58.05 -25.5 61.3 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.959 0.903 . . . . 0.0 111.506 168.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -63.73 -20.99 66.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.022 2.129 . . . . 0.0 113.495 174.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -130.1 9.02 5.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.126 1.77 . . . . 0.0 112.644 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 45.87 32.69 1.36 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.422 2.289 . . . . 0.0 114.217 -169.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.5 p -91.62 140.95 29.23 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.919 -1.113 . . . . 0.0 112.091 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -136.84 144.89 43.86 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.878 1.671 . . . . 0.0 110.733 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.1 p -77.78 150.64 34.29 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.192 0.597 . . . . 0.0 110.965 170.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.9 mm -130.44 129.73 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.976 1.71 . . . . 0.0 108.519 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.1 p -151.98 155.09 33.4 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.171 0.988 . . . . 0.0 111.866 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.88 146.05 29.19 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.994 2.462 . . . . 0.0 110.841 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.49 -24.26 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.851 -1.156 . . . . 0.0 113.072 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.71 -19.54 57.89 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.033 0.825 . . . . 0.0 114.728 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.0 m -142.22 62.58 13.9 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 125.66 1.584 . . . . 0.0 111.266 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.36 -13.98 39.37 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.268 2.645 . . . . 0.0 113.491 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -74.08 6.84 3.1 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.293 1.837 . . . . 0.0 114.001 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -129.75 175.54 8.75 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.637 1.575 . . . . 0.0 111.331 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -141.0 167.96 20.94 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.618 1.567 . . . . 0.0 111.07 -172.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.7 mm -122.23 128.04 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.296 1.038 . . . . 0.0 110.552 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.77 -159.18 7.88 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.985 1.755 . . . . 0.0 111.243 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -143.83 148.32 35.36 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.595 1.197 . . . . 0.0 111.996 -174.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.51 -160.36 9.56 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.397 1.475 . . . . 0.0 112.968 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.46 138.35 27.68 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.832 1.253 . . . . 0.0 112.959 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.6 -3.59 63.32 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.612 1.101 . . . . 0.0 114.284 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 47.67 54.21 10.14 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.106 1.762 . . . . 0.0 113.602 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.98 138.44 30.68 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 127.53 2.332 . . . . 0.0 107.473 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.78 144.45 59.41 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.292 1.328 . . . . 0.0 109.284 174.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.01 149.87 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.253 1.421 . . . . 0.0 111.343 -174.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.96 134.26 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.01 0.924 . . . . 0.0 110.677 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.0 mt -139.23 162.1 53.86 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.586 1.555 . . . . 0.0 110.784 -172.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.69 161.14 45.02 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.34 2.027 . . . . 0.0 111.574 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.33 119.75 6.34 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.564 2.176 . . . . 0.0 110.307 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -146.49 -82.64 0.13 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.309 1.044 . . . . 0.0 110.793 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -154.72 10.48 0.35 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.005 1.322 . . . . 0.0 113.945 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -67.39 128.65 37.21 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.391 -0.818 . . . . 0.0 111.776 -175.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.4 m -143.6 163.76 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.757 1.623 . . . . 0.0 111.234 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -130.47 145.78 51.9 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.034 1.333 . . . . 0.0 110.332 171.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.2 m -74.94 134.96 41.43 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.848 1.259 . . . . 0.0 109.222 169.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.85 123.85 44.66 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.389 1.075 . . . . 0.0 109.49 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.3 m -135.09 127.17 29.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.952 0.901 . . . . 0.0 110.491 -169.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.1 153.24 41.41 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.795 0.807 . . . . 0.0 113.049 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.7 p -127.99 -177.45 4.13 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.422 1.889 . . . . 0.0 110.15 171.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.1 p -60.9 -14.59 23.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.61 30.71 0.26 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.51 1.052 . . . . 0.0 114.142 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.49 -149.78 9.61 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.795 1.188 . . . . 0.0 112.537 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -132.64 170.19 15.57 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.972 2.109 . . . . 0.0 112.358 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -134.73 152.12 51.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.306 2.643 . . . . 0.0 108.805 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.2 mt -132.46 125.13 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.826 1.251 . . . . 0.0 108.242 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -137.25 160.09 40.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.246 1.018 . . . . 0.0 112.342 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -63.67 -22.19 66.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 -170.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.87 -40.5 1.77 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.614 1.578 . . . . 0.0 112.725 -171.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -98.38 5.67 47.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.94 1.696 . . . . 0.0 113.401 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 57.11 18.04 3.86 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.156 2.182 . . . . 0.0 114.227 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p -74.37 -24.6 59.18 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.251 -0.905 . . . . 0.0 112.384 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.1 m -143.73 174.61 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.661 1.584 . . . . 0.0 112.104 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t -148.45 154.36 39.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.96 2.504 . . . . 0.0 110.111 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -70.29 143.59 52.02 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.386 -0.821 . . . . 0.0 111.802 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.1 p -151.54 172.46 15.97 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.154 1.382 . . . . 0.0 112.621 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.0 mt -128.81 177.59 6.96 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.338 1.855 . . . . 0.0 110.095 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -123.93 -31.93 3.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.258 1.423 . . . . 0.0 111.332 -169.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -143.41 -5.54 0.84 Allowed 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 173.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.17 34.61 17.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.692 1.597 . . . . 0.0 114.786 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.4 p -90.98 160.78 15.45 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.323 -0.861 . . . . 0.0 111.946 171.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.06 142.98 52.61 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.756 -1.215 . . . . 0.0 112.139 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.49 -0.5 87.83 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.535 1.064 . . . . 0.0 114.24 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -63.76 142.99 58.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.102 1.761 . . . . 0.0 112.443 174.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.54 116.78 24.05 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.144 -0.972 . . . . 0.0 109.759 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.3 p -58.82 152.92 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.24 1.016 . . . . 0.0 112.214 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.6 m -130.26 168.88 16.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.536 1.534 . . . . 0.0 111.767 -170.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.2 mt -136.65 143.38 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.217 1.407 . . . . 0.0 109.535 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 178.93 178.2 48.03 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.03 1.3 . . . . 0.0 111.905 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.59 -42.5 44.75 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 119.258 1.529 . . . . 0.0 114.562 -172.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -167.28 176.31 6.8 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 129.091 2.956 . . . . 0.0 108.374 172.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.53 137.93 35.87 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.228 -0.92 . . . . 0.0 112.364 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.2 t -59.93 -21.53 61.25 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.958 1.703 . . . . 0.0 115.218 -169.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -134.34 -36.51 0.89 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.399 1.08 . . . . 0.0 113.613 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -103.41 2.44 33.87 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.86 10.81 1.44 Allowed Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.294 1.426 . . . . 0.0 115.377 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -131.51 142.67 50.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.849 1.66 . . . . 0.0 109.921 -169.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -139.41 175.89 9.18 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.692 1.597 . . . . 0.0 111.85 -168.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.71 139.56 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.848 1.259 . . . . 0.0 109.403 169.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.42 125.49 73.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.731 1.613 . . . . 0.0 107.088 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.07 153.91 38.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.733 1.213 . . . . 0.0 108.974 -170.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -68.63 155.6 39.71 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.923 -1.111 . . . . 0.0 112.497 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.6 t . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.107 1.763 . . . . 0.0 111.279 171.807 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.488 1.461 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.72 -14.59 0.06 OUTLIER Glycine 0 CA--C 1.538 1.503 0 N-CA-C 115.795 1.078 . . . . 0.0 115.795 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -144.95 167.57 22.33 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.792 1.637 . . . . 0.0 111.567 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -154.6 145.45 22.52 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.915 1.286 . . . . 0.0 111.057 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -152.14 7.97 0.47 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.188 1.395 . . . . 0.0 113.641 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -74.99 -14.9 60.67 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -169.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -133.37 4.4 3.69 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.146 1.378 . . . . 0.0 114.008 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -156.84 157.34 34.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.075 1.35 . . . . 0.0 112.182 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.453 ' CG ' ' H ' ' A' ' 10' ' ' HIS . 8.3 t60 -147.45 -177.76 5.87 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.579 1.551 . . . . 0.0 111.144 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.453 ' H ' ' CG ' ' A' ' 9' ' ' HIS . 95.9 m-70 -131.12 171.03 13.74 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.098 1.759 . . . . 0.0 111.832 -176.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.8 p 44.63 34.09 1.07 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.698 1.999 . . . . 0.0 115.284 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.98 -19.6 0.06 OUTLIER Glycine 0 CA--C 1.539 1.546 0 C-N-CA 125.435 1.493 . . . . 0.0 114.545 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -129.05 16.64 6.2 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.966 1.706 . . . . 0.0 112.283 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 p -134.68 41.1 0.61 Allowed Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 126.075 1.75 . . . . 0.0 114.617 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -67.39 163.68 33.67 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.977 2.451 . . . . 0.0 113.011 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.03 24.41 2.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.726 1.21 . . . . 0.0 113.681 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.4 t -140.72 145.0 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.813 1.645 . . . . 0.0 110.484 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -148.88 11.36 0.84 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.4 1.48 . . . . 0.0 113.315 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.9 mt 59.13 169.09 0.06 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 127.102 2.161 . . . . 0.0 113.904 -172.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -151.25 159.37 44.4 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.356 1.862 . . . . 0.0 109.424 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.44 140.65 58.89 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 121.562 -0.711 . . . . 0.0 112.243 173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.45 -161.7 33.81 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.24 0.924 . . . . 0.0 114.426 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -98.44 126.75 44.09 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.187 0.995 . . . . 0.0 110.338 172.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -135.59 171.52 14.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.13 1.372 . . . . 0.0 112.701 -171.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.4 pt -124.82 153.62 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 C-N-CA 126.329 1.852 . . . . 0.0 108.393 169.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.7 mt -127.63 122.56 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -140.09 147.45 40.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.537 0.735 . . . . 0.0 111.393 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -75.62 136.7 40.46 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.918 -0.489 . . . . 0.0 111.117 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.7 tpt85 -66.28 -20.17 66.03 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -171.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.4 t -64.12 -24.26 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.809 1.244 . . . . 0.0 112.546 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 40.0 mt 60.88 170.63 0.1 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.906 2.082 . . . . 0.0 113.73 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.6 t -73.52 147.68 87.38 Favored Pre-proline 0 N--CA 1.469 0.491 0 C-N-CA 124.579 1.151 . . . . 0.0 111.876 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.2 -14.12 41.91 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 122.621 2.214 . . . . 0.0 112.828 169.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.2 tpt85 -70.52 -17.66 62.94 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.13 1.372 . . . . 0.0 113.123 169.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.84 22.81 22.47 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.474 1.511 . . . . 0.0 114.179 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -134.56 170.27 16.03 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.955 1.302 . . . . 0.0 111.844 -174.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -57.83 140.18 52.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.053 0.941 . . . . 0.0 111.692 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.28 78.09 1.14 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.451 1.501 . . . . 0.0 110.022 -171.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.7 144.12 30.45 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -169.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.8 tp -59.79 132.38 53.79 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.653 1.181 . . . . 0.0 109.246 169.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 97.8 m -130.7 118.85 21.52 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.292 1.037 . . . . 0.0 111.139 -169.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -61.54 137.38 94.8 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 126.305 1.842 . . . . 0.0 112.513 -177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.57 -13.78 20.15 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.441 2.761 . . . . 0.0 114.926 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.25 8.15 84.03 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -153.58 161.95 41.72 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.811 1.644 . . . . 0.0 111.732 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -89.77 165.73 13.98 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.007 0.923 . . . . 0.0 111.586 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 49.57 38.54 15.02 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.773 1.629 . . . . 0.0 113.813 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.4 m -136.2 141.17 35.14 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 125.562 1.545 . . . . 0.0 111.322 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -45.55 154.98 0.51 Allowed 'Trans proline' 0 C--N 1.353 0.804 1 C-N-CA 126.167 4.578 . . . . 0.0 115.49 169.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.3 t -110.89 153.96 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.065 1.346 . . . . 0.0 110.118 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.8 m -128.13 172.51 10.92 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.695 1.598 . . . . 0.0 110.938 -169.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.97 144.71 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.692 1.197 . . . . 0.0 111.42 175.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -149.54 158.98 37.31 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 124.921 1.288 . . . . 0.0 111.872 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -63.24 130.35 28.41 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 122.279 1.986 . . . . 0.0 110.527 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.6 tp -63.28 136.3 57.6 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.373 1.069 . . . . 0.0 111.428 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -130.36 -26.87 2.26 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.192 1.797 . . . . 0.0 112.021 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.64 4.68 19.32 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.451 1.5 . . . . 0.0 114.175 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.4 p -65.74 159.45 25.09 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 118.783 1.291 . . . . 0.0 113.209 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -62.66 -19.1 63.5 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -68.55 -27.21 65.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.907 0.883 . . . . 0.0 112.324 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -102.38 -7.46 21.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.9 1.68 . . . . 0.0 113.197 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.64 146.37 28.68 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.452 1.101 . . . . 0.0 111.456 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -138.31 170.48 15.95 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 122.471 1.129 . . . . 0.0 111.858 -169.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.4 mt -121.2 136.0 59.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 127.294 2.238 . . . . 0.0 107.126 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.3 tp -137.18 124.44 21.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.274 1.43 . . . . 0.0 109.727 -170.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -141.84 140.21 32.88 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.605 0.762 . . . . 0.0 111.134 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.7 t -65.74 139.37 58.35 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.833 0.453 . . . . 0.0 110.988 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -115.19 -47.27 2.86 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.289 1.036 . . . . 0.0 111.595 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.37 109.48 3.73 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.308 1.043 . . . . 0.0 111.059 170.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -57.94 -27.58 63.52 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.828 0.851 . . . . 0.0 111.101 168.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -60.62 -21.28 62.54 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.127 2.171 . . . . 0.0 113.574 174.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -130.21 10.84 5.4 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.869 1.668 . . . . 0.0 112.737 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 46.36 28.51 0.72 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.967 2.107 . . . . 0.0 113.858 -168.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 p -89.71 140.03 29.98 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.85 -1.156 . . . . 0.0 112.424 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -135.26 142.93 46.04 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.137 1.775 . . . . 0.0 111.322 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.0 p -78.33 148.5 33.75 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.032 0.533 . . . . 0.0 110.767 172.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.2 mm -128.67 130.16 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.547 1.539 . . . . 0.0 109.807 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.3 m -144.8 149.65 43.72 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 126.208 1.803 . . . . 0.0 110.232 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.91 148.1 31.45 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.007 2.471 . . . . 0.0 111.143 173.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.0 m -66.18 -25.48 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 120.757 -1.215 . . . . 0.0 113.199 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.67 -21.82 65.61 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.762 0.696 . . . . 0.0 114.389 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.3 m -143.7 66.75 15.54 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 125.73 1.612 . . . . 0.0 111.047 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -62.23 -13.19 30.72 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.894 2.396 . . . . 0.0 113.678 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -76.55 4.69 8.73 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.046 1.738 . . . . 0.0 114.297 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 94.6 p -139.19 175.29 9.68 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.595 1.543 . . . . 0.0 112.579 174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -138.53 171.49 14.28 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.357 1.463 . . . . 0.0 113.195 -169.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.8 mm -120.71 127.91 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.16 1.384 . . . . 0.0 110.364 176.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.84 -155.74 6.57 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 125.759 1.647 . . . . 0.0 110.968 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -143.25 145.06 32.41 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.492 1.146 . . . . 0.0 112.053 -172.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.66 -162.99 10.97 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.428 1.49 . . . . 0.0 113.26 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.16 136.51 23.87 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.174 1.39 . . . . 0.0 113.054 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.77 -4.48 63.49 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 124.738 1.161 . . . . 0.0 114.268 -173.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 48.54 54.71 10.09 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.425 1.89 . . . . 0.0 113.567 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.86 140.24 37.6 Favored Pre-proline 0 C--O 1.238 0.476 0 C-N-CA 127.454 2.301 . . . . 0.0 107.674 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.28 141.21 46.51 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.076 1.184 . . . . 0.0 109.278 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.1 m -133.5 151.6 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.348 1.459 . . . . 0.0 111.681 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.3 t -76.91 134.6 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.115 0.966 . . . . 0.0 110.858 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.2 mt -139.74 160.52 60.75 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 126.032 1.733 . . . . 0.0 111.825 -169.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.68 164.19 32.23 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 122.965 2.443 . . . . 0.0 111.983 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.71 120.51 6.73 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.43 2.087 . . . . 0.0 110.516 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -147.0 -90.91 0.09 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.0 0.92 . . . . 0.0 110.793 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -155.52 17.94 0.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.315 1.446 . . . . 0.0 113.096 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -67.36 136.33 54.62 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.486 -0.759 . . . . 0.0 111.99 -173.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.9 m -145.09 161.11 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.907 1.283 . . . . 0.0 112.545 -175.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -131.36 137.24 48.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.671 1.588 . . . . 0.0 110.737 169.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.1 m -68.49 129.67 40.6 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 169.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 44.3 mt -127.08 116.59 20.92 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.22 1.008 . . . . 0.0 108.693 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 m -131.6 128.29 38.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.813 0.845 . . . . 0.0 111.295 -169.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp -69.06 151.43 46.46 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.266 1.027 . . . . 0.0 112.147 177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.6 p -129.02 -176.62 3.92 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.128 1.771 . . . . 0.0 111.465 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.2 p -60.34 -15.89 29.8 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.66 18.17 0.24 Allowed Glycine 0 CA--C 1.534 1.253 0 N-CA-C 115.525 0.97 . . . . 0.0 115.525 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -177.07 -150.39 8.33 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.15 1.357 . . . . 0.0 112.061 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -133.66 168.22 19.08 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.694 1.998 . . . . 0.0 111.693 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -130.0 148.71 51.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 127.257 2.223 . . . . 0.0 109.968 174.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.85 122.94 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.779 1.231 . . . . 0.0 109.563 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -137.96 160.4 39.42 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.73 1.212 . . . . 0.0 112.675 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.35 -24.38 66.42 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 -172.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 124.93 -40.22 1.93 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.519 1.533 . . . . 0.0 113.077 -173.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -93.47 -3.05 53.7 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.298 1.439 . . . . 0.0 113.511 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.2 mmt85 70.16 14.51 7.67 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 127.609 2.364 . . . . 0.0 113.413 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.2 p -72.75 -23.79 60.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.747 1.219 . . . . 0.0 112.703 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.3 m -146.02 172.66 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.91 1.684 . . . . 0.0 111.833 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.0 m -143.82 155.18 44.05 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.076 2.151 . . . . 0.0 111.214 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 38.0 m0 -73.1 140.58 47.23 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 121.938 -0.477 . . . . 0.0 111.848 169.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.3 p -153.56 170.71 20.14 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.225 1.41 . . . . 0.0 112.547 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -117.88 164.88 14.39 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.821 1.648 . . . . 0.0 110.068 174.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -99.62 -32.84 10.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.669 0.787 . . . . 0.0 111.623 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -143.83 -0.8 1.02 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.482 1.913 . . . . 0.0 114.196 173.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 50.31 27.49 2.72 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.125 2.17 . . . . 0.0 115.9 -172.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 61.2 p -79.4 160.0 26.85 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 120.901 -1.124 . . . . 0.0 112.663 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.71 138.55 58.46 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.606 0.762 . . . . 0.0 112.152 172.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.03 -0.3 89.86 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.658 1.123 . . . . 0.0 114.757 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -76.28 154.17 35.36 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.798 1.299 . . . . 0.0 113.169 -176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -81.77 122.73 28.05 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.058 -1.026 . . . . 0.0 110.71 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.12 151.43 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.094 0.958 . . . . 0.0 111.011 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.3 m -134.83 168.42 19.09 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.7 1.6 . . . . 0.0 111.283 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.2 mt -132.77 145.12 34.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.007 1.323 . . . . 0.0 109.268 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.6 -161.28 34.99 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 123.813 0.721 . . . . 0.0 112.529 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.46 149.16 17.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 117.828 0.814 . . . . 0.0 111.956 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.68 116.38 2.47 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.39 1.476 . . . . 0.0 113.934 -172.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.84 157.23 37.86 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.4 t -87.66 -12.98 43.84 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -133.64 -37.86 0.92 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.48 1.112 . . . . 0.0 113.44 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.4 p -104.81 2.18 29.85 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.857 1.263 . . . . 0.0 114.26 -173.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.47 10.94 1.77 Allowed Glycine 0 CA--C 1.542 1.749 0 C-N-CA 125.888 1.708 . . . . 0.0 115.819 -176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -135.46 145.98 47.72 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.435 1.894 . . . . 0.0 111.225 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -138.06 178.51 7.07 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 126.949 2.1 . . . . 0.0 111.237 -168.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.31 138.09 29.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 124.169 0.987 . . . . 0.0 109.36 168.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.04 124.2 72.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 125.947 1.699 . . . . 0.0 107.215 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -147.93 152.5 37.65 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.535 1.134 . . . . 0.0 109.432 -170.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.74 155.58 38.94 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.046 -1.034 . . . . 0.0 112.909 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.133 1.773 . . . . 0.0 111.216 171.815 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.28 26.14 0.41 Allowed Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.272 0.939 . . . . 0.0 113.823 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -155.47 176.36 12.69 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.557 1.943 . . . . 0.0 111.266 -171.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -147.82 176.5 10.08 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.925 1.29 . . . . 0.0 112.255 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -154.94 165.69 35.92 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.889 1.276 . . . . 0.0 112.036 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -56.13 -17.34 6.9 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.132 1.773 . . . . 0.0 115.085 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -109.91 9.23 24.52 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.396 1.479 . . . . 0.0 113.407 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -134.5 -6.97 2.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.141 1.376 . . . . 0.0 114.191 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -131.41 -4.58 3.78 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.325 1.45 . . . . 0.0 113.992 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -128.04 7.58 6.07 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.977 1.311 . . . . 0.0 113.259 -175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 p -139.38 7.75 2.39 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.32 1.848 . . . . 0.0 113.527 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.46 16.51 0.17 Allowed Glycine 0 CA--C 1.539 1.553 0 C-N-CA 125.21 1.386 . . . . 0.0 114.963 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -143.72 21.91 1.8 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.338 1.455 . . . . 0.0 111.988 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.6 p -147.01 153.49 45.57 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.193 1.797 . . . . 0.0 111.733 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.15 164.02 33.9 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.198 2.599 . . . . 0.0 112.9 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.16 29.41 2.03 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.321 1.448 . . . . 0.0 112.615 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.5 t -69.55 144.41 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.817 1.647 . . . . 0.0 110.541 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.7 t -142.04 31.37 1.58 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 124.279 1.99 . . . . 0.0 114.375 -172.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.9 mt -62.67 169.78 2.91 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.717 2.007 . . . . 0.0 111.509 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 t -154.26 167.4 30.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 124.31 1.044 . . . . 0.0 110.087 173.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 125.06 22.7 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 122.091 -0.38 . . . . 0.0 111.506 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.2 -165.87 38.17 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 114.913 0.725 . . . . 0.0 114.913 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -99.71 124.8 45.32 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.236 1.014 . . . . 0.0 110.087 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -134.2 170.02 16.3 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.28 1.432 . . . . 0.0 112.508 -171.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 pt -125.07 152.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 126.242 1.817 . . . . 0.0 108.328 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.1 mt -128.94 119.33 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -137.85 147.8 44.83 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.279 0.631 . . . . 0.0 112.477 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -79.36 133.78 36.59 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.75 0.42 . . . . 0.0 111.234 -173.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.8 ttt-85 -61.63 -21.78 64.68 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.187 1.395 . . . . 0.0 114.343 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.8 -24.15 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.976 0.91 . . . . 0.0 112.497 174.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.4 mt 62.02 168.19 0.11 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.085 2.154 . . . . 0.0 113.871 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.2 t -77.6 146.76 73.78 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 124.783 1.233 . . . . 0.0 112.411 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.99 -19.02 30.62 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.525 2.817 . . . . 0.0 113.536 168.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.1 tpt85 -66.29 -18.51 65.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.026 1.73 . . . . 0.0 113.2 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.72 22.94 24.78 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.028 1.775 . . . . 0.0 113.948 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -138.7 167.16 22.58 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.866 1.267 . . . . 0.0 112.066 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -56.38 136.47 53.65 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.154 0.981 . . . . 0.0 113.197 176.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 29.4 tp -111.6 80.64 1.34 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.456 1.903 . . . . 0.0 110.871 -169.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.51 147.46 30.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.048 1.739 . . . . 0.0 114.287 -171.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.1 tp -60.25 136.73 58.12 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.207 1.403 . . . . 0.0 110.784 169.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 m -124.26 120.27 31.74 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.403 1.481 . . . . 0.0 111.473 -174.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -63.62 133.3 95.48 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 125.764 1.626 . . . . 0.0 111.39 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -74.83 -11.48 21.82 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.077 2.518 . . . . 0.0 114.587 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.15 8.93 84.8 Favored Glycine 0 CA--C 1.537 1.436 0 CA-C-O 119.14 -0.811 . . . . 0.0 114.92 -178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -156.1 161.56 40.37 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.196 1.398 . . . . 0.0 112.036 -174.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -88.96 164.51 15.08 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.131 0.972 . . . . 0.0 111.863 -173.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 47.3 mmt-85 50.57 34.57 9.79 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.874 1.67 . . . . 0.0 113.986 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.8 m -132.29 138.9 33.29 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 125.848 1.659 . . . . 0.0 110.653 -169.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.99 154.74 12.58 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.685 3.59 . . . . 0.0 115.229 172.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.9 t -100.92 156.66 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.839 1.256 . . . . 0.0 110.642 177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 52' ' ' VAL . 2.9 m -126.98 178.24 6.11 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.675 1.59 . . . . 0.0 110.694 -170.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -134.98 148.96 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.911 1.284 . . . . 0.0 111.406 176.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 27.5 m -158.84 162.79 25.87 Favored Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 125.08 1.352 . . . . 0.0 112.76 -177.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.67 127.62 16.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.53 2.153 . . . . 0.0 111.034 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.5 tp -65.2 140.22 58.73 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -137.26 10.64 3.01 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.986 1.315 . . . . 0.0 113.101 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.25 0.15 89.45 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.772 1.177 . . . . 0.0 114.948 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -64.66 142.51 58.4 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 118.678 1.239 . . . . 0.0 112.08 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.0 p -60.9 -14.13 20.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.037 1.335 . . . . 0.0 114.07 172.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -68.49 -21.55 64.6 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.201 -0.937 . . . . 0.0 112.626 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -118.28 9.5 12.54 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.975 1.31 . . . . 0.0 113.604 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -106.79 146.54 30.76 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.771 1.228 . . . . 0.0 110.894 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -138.94 173.96 11.01 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 122.478 1.133 . . . . 0.0 112.096 -168.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.7 mt -124.55 134.95 65.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 127.54 2.336 . . . . 0.0 106.948 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.02 124.88 22.6 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.376 1.47 . . . . 0.0 109.26 -170.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -146.39 139.32 25.52 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.069 0.548 . . . . 0.0 111.754 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.5 t -66.53 140.8 58.0 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.991 0.516 . . . . 0.0 111.592 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -114.85 -52.59 2.69 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.82 1.248 . . . . 0.0 111.223 175.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.86 110.32 5.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.77 1.228 . . . . 0.0 111.405 169.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.9 m -57.71 -24.7 58.19 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.956 0.903 . . . . 0.0 111.663 168.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -64.64 -21.97 66.86 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.009 2.124 . . . . 0.0 113.626 175.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.5 m -130.31 12.51 5.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.997 1.719 . . . . 0.0 112.686 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 42.95 35.33 0.73 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.623 1.969 . . . . 0.0 113.582 -169.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.5 p -87.58 139.28 30.7 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 120.76 -1.212 . . . . 0.0 111.709 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 43.4 m95 -135.94 143.57 44.99 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.57 1.548 . . . . 0.0 110.074 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 56.9 p -77.73 150.54 34.4 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.716 0.806 . . . . 0.0 110.793 173.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.9 mm -128.6 127.12 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.613 1.565 . . . . 0.0 109.44 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 35.6 m -143.79 148.11 41.39 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 125.835 1.654 . . . . 0.0 110.316 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.38 148.56 34.03 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.203 2.602 . . . . 0.0 111.172 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.5 m -66.79 -24.76 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.732 -1.23 . . . . 0.0 113.015 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.44 -23.9 74.34 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 123.938 0.78 . . . . 0.0 114.107 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.8 m -143.43 74.36 17.19 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 125.972 1.709 . . . . 0.0 110.368 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -61.81 -13.31 29.83 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.236 2.624 . . . . 0.0 113.192 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -89.38 9.58 25.68 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 128.52 2.728 . . . . 0.0 114.614 174.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.8 p -133.28 174.7 10.11 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.943 1.297 . . . . 0.0 112.009 170.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -141.36 170.07 16.42 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.882 1.273 . . . . 0.0 113.286 -170.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -120.48 128.95 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.164 1.386 . . . . 0.0 110.532 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.54 -159.61 8.22 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.652 1.596 . . . . 0.0 111.621 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -138.74 141.09 38.87 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.347 1.073 . . . . 0.0 111.956 -170.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.78 -163.73 10.85 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.447 1.499 . . . . 0.0 113.425 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.77 140.14 19.9 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.045 1.338 . . . . 0.0 113.314 -176.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.46 -4.74 73.62 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.686 1.136 . . . . 0.0 114.254 -173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 49.19 55.02 9.95 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.466 1.906 . . . . 0.0 114.333 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.0 m -133.8 149.05 70.8 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 126.103 1.761 . . . . 0.0 107.843 169.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.63 147.59 51.59 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.147 1.231 . . . . 0.0 109.877 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.26 153.02 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.74 1.616 . . . . 0.0 111.664 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.1 t -78.85 132.01 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.098 0.959 . . . . 0.0 111.158 176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.3 mt -137.91 161.8 57.83 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 126.312 1.845 . . . . 0.0 112.053 -169.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.43 165.76 29.48 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.093 2.528 . . . . 0.0 111.944 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.6 123.02 9.1 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.446 2.097 . . . . 0.0 110.45 177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -147.66 -88.79 0.09 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.719 0.808 . . . . 0.0 110.609 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -155.48 16.11 0.39 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.481 1.512 . . . . 0.0 112.954 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -65.9 132.7 49.28 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.502 -0.749 . . . . 0.0 111.936 -172.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.79 159.45 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.328 1.451 . . . . 0.0 111.522 -177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -129.3 145.98 51.27 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.157 1.383 . . . . 0.0 110.003 169.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.9 m -81.79 133.96 35.39 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.086 0.954 . . . . 0.0 109.735 173.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.45 132.7 54.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.041 1.336 . . . . 0.0 109.516 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 61.1 m -142.14 122.76 14.19 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.007 -1.058 . . . . 0.0 110.617 -173.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 18.5 mt -62.65 152.98 33.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.66 0.743 . . . . 0.0 112.65 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.9 p -126.17 -179.92 4.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.61 1.964 . . . . 0.0 109.808 171.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.5 m -61.38 -8.7 4.23 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.18 26.98 0.2 Allowed Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.229 0.919 . . . . 0.0 114.66 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.92 -151.72 11.02 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.946 1.26 . . . . 0.0 112.814 -172.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -131.73 170.21 15.13 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.011 2.124 . . . . 0.0 112.113 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -137.31 152.8 50.15 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.292 2.637 . . . . 0.0 109.127 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 mt -134.88 118.46 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.638 1.175 . . . . 0.0 109.176 -169.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -134.85 160.18 39.04 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -169.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -62.72 -25.98 68.45 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.626 1.97 . . . . 0.0 116.14 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 128.9 -32.99 3.17 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.054 1.312 . . . . 0.0 113.515 -173.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -113.72 9.86 17.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.298 1.839 . . . . 0.0 113.542 -178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 62.57 16.55 8.88 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.9 2.08 . . . . 0.0 113.98 178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.8 p -70.2 -27.49 64.54 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.716 0.806 . . . . 0.0 112.437 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.0 m -146.0 173.13 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.466 1.506 . . . . 0.0 112.061 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 t -141.77 154.19 45.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.292 2.237 . . . . 0.0 109.596 172.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -69.66 144.31 52.93 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.696 -0.627 . . . . 0.0 110.688 169.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.0 p -155.03 168.59 26.51 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.498 1.119 . . . . 0.0 112.171 176.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 73.4 mt -113.94 163.76 14.69 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.119 1.767 . . . . 0.0 109.564 171.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -97.13 -33.69 11.41 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.925 0.89 . . . . 0.0 111.793 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -136.57 -6.49 1.97 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.969 2.108 . . . . 0.0 112.123 171.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.1 27.74 11.91 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.17 1.788 . . . . 0.0 114.268 -171.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.8 p -78.03 157.21 29.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.22 1.008 . . . . 0.0 111.995 172.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.48 139.39 58.5 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.235 -0.916 . . . . 0.0 111.736 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.26 0.74 90.05 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.712 1.148 . . . . 0.0 114.703 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -73.48 144.94 46.02 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.666 1.233 . . . . 0.0 112.834 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -76.49 120.49 21.79 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 173.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.82 149.8 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.571 0.7 . . . . 0.0 111.382 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.1 t -130.2 166.66 19.81 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.999 1.72 . . . . 0.0 111.677 -169.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 68.8 mt -134.75 140.26 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.645 1.578 . . . . 0.0 109.184 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 171.32 -161.61 34.12 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 121.528 -0.733 . . . . 0.0 112.663 176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.17 152.86 12.83 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 117.667 0.734 . . . . 0.0 111.715 169.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -51.88 109.28 0.35 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.418 1.487 . . . . 0.0 113.121 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -67.99 142.92 55.79 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.787 0.835 . . . . 0.0 113.163 -173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.0 t -60.07 -20.57 58.73 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -135.74 -40.26 0.7 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.947 1.299 . . . . 0.0 113.006 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.6 t -91.0 1.26 57.21 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -172.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.77 14.69 1.93 Allowed Glycine 0 CA--C 1.542 1.75 0 C-N-CA 125.115 1.34 . . . . 0.0 116.003 -175.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -133.69 145.36 49.84 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.395 1.478 . . . . 0.0 111.476 -174.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -140.78 175.09 9.89 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.374 1.87 . . . . 0.0 110.613 -170.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.48 141.03 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.123 1.369 . . . . 0.0 108.977 169.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 mp -121.31 124.37 71.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.649 1.58 . . . . 0.0 107.167 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -149.0 154.24 39.07 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.687 1.195 . . . . 0.0 109.181 -169.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -68.68 154.46 41.9 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 120.928 -1.107 . . . . 0.0 112.577 -177.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.324 1.85 . . . . 0.0 111.374 171.226 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 111.182 0.067 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.15 3.9 0.27 Allowed Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.311 1.285 . . . . 0.0 116.311 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -134.89 2.95 3.17 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.268 1.427 . . . . 0.0 113.387 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -156.36 179.53 9.16 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.696 1.998 . . . . 0.0 110.693 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -145.35 37.75 1.13 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.023 1.329 . . . . 0.0 112.076 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -133.81 157.89 44.77 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.901 1.28 . . . . 0.0 113.102 -170.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -145.55 165.08 29.68 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.482 1.513 . . . . 0.0 111.511 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -129.36 11.66 5.89 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.975 1.71 . . . . 0.0 112.396 177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -154.01 168.56 26.03 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.356 2.262 . . . . 0.0 110.88 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -139.71 6.75 2.27 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.18 1.392 . . . . 0.0 113.686 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.3 m -66.24 -15.97 63.63 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.308 1.443 . . . . 0.0 114.84 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.93 18.77 0.48 Allowed Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.631 1.586 . . . . 0.0 113.906 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -148.52 172.59 14.25 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 127.375 2.27 . . . . 0.0 109.925 -178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.1 p -58.39 149.52 59.34 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -71.82 166.63 28.92 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.39 2.727 . . . . 0.0 112.607 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.5 19.13 5.25 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.822 1.249 . . . . 0.0 113.674 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.1 t -144.37 145.56 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.82 2.048 . . . . 0.0 109.758 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.0 t -149.02 12.36 0.85 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.085 1.354 . . . . 0.0 113.631 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.4 mt 55.91 178.71 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.478 1.911 . . . . 0.0 113.854 -172.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 t -159.66 168.91 24.88 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.92 1.288 . . . . 0.0 110.269 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.27 139.67 57.32 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.811 -0.555 . . . . 0.0 111.995 171.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.76 -163.45 35.25 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 123.916 0.769 . . . . 0.0 114.51 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -95.1 124.0 38.91 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.959 0.903 . . . . 0.0 109.77 170.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -133.45 173.25 11.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.552 1.541 . . . . 0.0 112.026 -172.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.4 pt -126.37 152.26 33.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 125.95 1.7 . . . . 0.0 108.542 169.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 mt -123.54 122.95 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -137.74 146.7 44.0 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.512 0.725 . . . . 0.0 110.836 177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -67.01 143.32 56.84 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -63.5 -23.54 67.44 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.882 -0.511 . . . . 0.0 112.212 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.7 t -83.98 112.86 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.453 1.501 . . . . 0.0 108.391 168.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.3 mp -69.36 165.69 20.2 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.0 1.72 . . . . 0.0 111.968 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.6 p -62.77 161.84 25.74 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 124.629 1.172 . . . . 0.0 113.296 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -57.32 -23.32 54.01 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.278 2.652 . . . . 0.0 113.758 169.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.7 tpt85 -77.25 -17.02 58.76 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.057 1.743 . . . . 0.0 113.32 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.16 25.98 15.38 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.098 1.332 . . . . 0.0 113.933 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -124.24 159.45 30.16 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.118 1.367 . . . . 0.0 111.922 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.4 128.65 32.59 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.758 1.223 . . . . 0.0 110.915 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.2 tp -100.2 75.58 1.83 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.437 1.095 . . . . 0.0 111.211 -169.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.39 149.81 28.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.981 1.712 . . . . 0.0 115.041 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 tp -62.38 137.02 58.18 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.261 1.424 . . . . 0.0 110.384 169.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 m -127.61 120.39 28.02 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.799 1.24 . . . . 0.0 111.287 -174.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -66.18 135.52 95.05 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.095 1.358 . . . . 0.0 112.218 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -75.1 -13.41 21.22 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.339 2.693 . . . . 0.0 114.666 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.41 7.87 81.82 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.1 0.857 . . . . 0.0 115.035 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.0 ptp180 -154.77 164.65 38.48 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.239 1.816 . . . . 0.0 111.382 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -98.89 165.78 11.6 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.894 1.278 . . . . 0.0 111.435 -173.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 47.38 43.46 15.38 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.938 1.695 . . . . 0.0 113.494 -173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.6 m -139.33 137.99 19.9 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 126.381 1.872 . . . . 0.0 109.852 -171.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.79 161.65 3.01 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.766 3.644 . . . . 0.0 115.597 173.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.46 148.55 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.875 1.27 . . . . 0.0 110.599 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.6 m -123.47 173.84 7.76 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.055 1.342 . . . . 0.0 111.039 -169.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.19 148.48 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.983 1.313 . . . . 0.0 111.533 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.2 m -154.34 160.21 31.16 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 124.153 0.981 . . . . 0.0 113.039 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.27 122.34 9.59 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.896 2.398 . . . . 0.0 110.575 170.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.58 136.54 57.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.379 1.471 . . . . 0.0 112.619 -175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -133.48 9.52 4.0 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.262 1.425 . . . . 0.0 112.41 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.82 8.09 60.1 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.147 1.356 . . . . 0.0 114.882 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.8 p -69.61 153.48 43.38 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.977 1.311 . . . . 0.0 112.914 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.3 m -62.07 -17.7 58.36 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -69.93 -23.4 63.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.878 1.271 . . . . 0.0 112.544 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -118.27 4.82 11.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.063 1.745 . . . . 0.0 113.162 -176.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.63 139.92 35.63 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.703 1.201 . . . . 0.0 110.774 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -133.74 171.08 14.62 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 122.756 1.265 . . . . 0.0 112.149 -169.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 89.1 mt -125.88 135.53 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 127.571 2.349 . . . . 0.0 106.657 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 34.0 tp -136.2 126.3 26.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 125.113 1.365 . . . . 0.0 109.064 -170.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -142.22 140.63 32.36 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.795 0.838 . . . . 0.0 110.833 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.8 t -65.64 141.04 58.53 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 122.853 0.461 . . . . 0.0 111.006 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -112.11 -52.87 2.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.437 1.095 . . . . 0.0 110.743 174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.97 109.28 4.68 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.591 1.156 . . . . 0.0 110.479 169.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.7 m -58.15 -25.25 61.25 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.948 0.899 . . . . 0.0 111.399 168.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -63.39 -21.52 66.33 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.0 2.12 . . . . 0.0 113.451 174.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.1 m -130.26 9.7 5.24 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.043 1.737 . . . . 0.0 113.105 178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 45.52 33.32 1.32 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.765 2.026 . . . . 0.0 114.217 -169.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.8 p -87.72 143.15 27.31 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.79 -1.193 . . . . 0.0 112.073 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -140.43 140.23 35.39 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.287 1.435 . . . . 0.0 111.052 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.6 p -77.94 142.24 38.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.498 0.719 . . . . 0.0 111.079 172.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.1 mm -123.91 124.81 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.172 1.389 . . . . 0.0 109.836 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.4 m -142.31 145.7 36.31 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 125.437 1.495 . . . . 0.0 109.661 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -77.76 150.08 27.03 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.73 2.287 . . . . 0.0 111.274 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.5 t -65.05 -30.55 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 121.216 -0.927 . . . . 0.0 111.764 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.18 -11.11 82.82 Favored Glycine 0 CA--C 1.538 1.498 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.3 m -155.49 63.67 3.74 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 125.525 1.53 . . . . 0.0 111.485 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -63.88 -19.24 66.5 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.994 3.129 . . . . 0.0 113.689 -173.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -68.11 -2.18 7.41 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 128.026 2.53 . . . . 0.0 114.553 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.4 m -132.24 166.58 21.54 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.602 1.961 . . . . 0.0 110.86 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -142.39 171.21 14.36 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.331 1.452 . . . . 0.0 112.946 -170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 41.8 mm -115.27 126.26 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.837 1.255 . . . . 0.0 110.721 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.43 -158.98 7.91 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.475 1.512 . . . . 0.0 111.676 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 8.5 t90 -139.59 140.41 37.04 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.355 1.062 . . . . 0.0 111.555 -170.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.01 -166.06 12.75 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.284 1.421 . . . . 0.0 113.193 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.7 137.19 20.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.258 1.423 . . . . 0.0 113.159 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.9 -6.95 64.7 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.779 1.181 . . . . 0.0 114.183 -172.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 48.88 56.76 7.23 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.552 1.941 . . . . 0.0 114.216 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.95 151.57 78.22 Favored Pre-proline 0 C--O 1.239 0.543 0 C-N-CA 126.292 1.837 . . . . 0.0 108.047 169.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.02 141.91 54.7 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 120.939 1.092 . . . . 0.0 109.626 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.27 152.71 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.372 1.469 . . . . 0.0 111.032 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 49.9 t -79.63 136.28 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.917 0.887 . . . . 0.0 111.07 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -140.84 165.19 31.32 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 126.674 1.99 . . . . 0.0 111.861 -170.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -63.64 176.43 2.27 Favored 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 123.558 2.838 . . . . 0.0 113.501 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -79.29 43.44 1.49 Allowed 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.78 2.987 . . . . 0.0 113.527 -178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -80.7 13.71 2.45 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.746 1.618 . . . . 0.0 114.407 -174.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 70.74 44.69 0.62 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.714 2.405 . . . . 0.0 113.588 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -64.25 143.8 57.62 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.741 0.817 . . . . 0.0 111.273 169.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.6 m -141.86 156.21 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.403 1.081 . . . . 0.0 112.399 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -127.2 140.95 51.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.075 1.35 . . . . 0.0 111.176 170.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.8 m -78.88 127.04 31.5 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.741 1.216 . . . . 0.0 109.149 172.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.3 mt -115.39 128.64 56.2 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.809 0.843 . . . . 0.0 109.575 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 95.1 m -131.34 118.27 20.07 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.243 1.017 . . . . 0.0 110.189 -169.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.7 tp -66.03 145.73 55.52 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.761 -0.587 . . . . 0.0 111.17 174.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.0 p -127.55 175.35 8.32 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.963 1.705 . . . . 0.0 110.527 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 72.5 p -57.83 -16.51 11.85 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -155.06 23.74 0.6 Allowed Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.629 1.109 . . . . 0.0 114.565 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.95 -149.83 9.48 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.877 1.227 . . . . 0.0 112.607 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -134.0 171.11 14.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.186 2.194 . . . . 0.0 111.574 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -136.78 154.46 50.55 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.364 2.266 . . . . 0.0 109.95 171.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.5 mt -134.45 121.04 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.133 1.373 . . . . 0.0 109.355 -169.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -137.0 158.3 44.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.567 1.147 . . . . 0.0 112.614 -170.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.3 -33.38 75.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 -171.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.21 -31.36 2.7 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.283 1.42 . . . . 0.0 113.772 -169.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -104.19 -2.21 26.07 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.539 1.536 . . . . 0.0 113.887 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 64.82 13.04 8.2 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.295 2.238 . . . . 0.0 114.128 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.4 p -69.98 -21.26 63.25 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.588 1.155 . . . . 0.0 112.824 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.89 169.6 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.486 1.515 . . . . 0.0 112.661 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.9 t -140.67 153.71 46.1 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.919 2.487 . . . . 0.0 109.66 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -69.9 144.8 52.35 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.455 -0.778 . . . . 0.0 110.137 168.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.7 p -149.34 171.6 16.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.378 1.071 . . . . 0.0 112.993 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.5 mt -125.15 165.7 17.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.108 1.763 . . . . 0.0 109.625 172.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -105.19 -32.71 8.53 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.904 0.882 . . . . 0.0 111.94 -169.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -140.24 -10.08 1.12 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.757 2.023 . . . . 0.0 112.662 172.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.68 27.13 12.15 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.569 1.548 . . . . 0.0 114.24 -170.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.9 p -78.31 157.62 29.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.415 1.086 . . . . 0.0 111.807 170.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.87 141.57 58.73 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.259 -0.901 . . . . 0.0 112.161 174.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.27 4.96 89.22 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.5 1.048 . . . . 0.0 114.458 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -75.13 137.45 41.38 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.769 1.228 . . . . 0.0 112.402 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -74.41 128.28 35.15 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.508 -0.745 . . . . 0.0 110.569 175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.5 t -64.23 150.71 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.229 0.612 . . . . 0.0 110.557 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.4 t -126.95 161.96 27.08 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.823 1.249 . . . . 0.0 111.796 -175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.7 mt -134.21 142.04 42.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.98 1.712 . . . . 0.0 108.78 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.84 -156.71 28.81 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 124.631 1.11 . . . . 0.0 110.716 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -58.77 166.43 1.91 Allowed 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.717 1.259 . . . . 0.0 111.685 169.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -56.35 157.01 5.27 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.06 0.944 . . . . 0.0 112.82 174.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.53 136.16 51.34 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.607 1.163 . . . . 0.0 112.312 -172.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.1 t -55.59 -26.84 45.98 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.254 1.822 . . . . 0.0 115.834 -169.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -130.16 -32.82 1.78 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.094 0.958 . . . . 0.0 113.385 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 96.6 p -103.87 -2.25 26.52 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -171.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.8 27.76 1.1 Allowed Glycine 0 CA--C 1.539 1.561 0 C-N-CA 125.955 1.74 . . . . 0.0 114.859 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -147.64 142.1 26.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.765 2.026 . . . . 0.0 110.943 -169.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -140.74 175.75 9.36 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.956 1.702 . . . . 0.0 111.21 -168.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -143.55 140.16 26.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 124.735 1.214 . . . . 0.0 109.299 169.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.62 125.05 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 125.677 1.591 . . . . 0.0 107.354 172.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -148.98 153.62 38.2 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.8 1.24 . . . . 0.0 109.673 -171.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -67.9 155.22 39.9 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.998 -1.064 . . . . 0.0 112.882 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.328 1.851 . . . . 0.0 111.217 171.154 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.9 -171.53 40.33 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 124.676 1.131 . . . . 0.0 112.619 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -135.08 9.12 3.5 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.887 1.275 . . . . 0.0 113.276 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -156.93 179.62 9.11 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.212 1.805 . . . . 0.0 111.552 -176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -132.16 10.59 4.55 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.478 1.511 . . . . 0.0 113.469 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -73.18 -21.25 60.72 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.508 1.123 . . . . 0.0 113.889 -178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -141.12 5.72 1.92 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.407 1.483 . . . . 0.0 113.184 176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -144.62 174.24 11.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.341 1.857 . . . . 0.0 111.426 -172.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -141.79 169.45 17.57 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.605 1.162 . . . . 0.0 111.633 176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.4 m80 54.65 16.64 1.42 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.304 1.841 . . . . 0.0 115.0 -174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.4 m -136.78 19.29 3.05 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.692 1.997 . . . . 0.0 112.307 -172.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.56 -20.47 0.07 OUTLIER Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.906 1.717 . . . . 0.0 113.858 -174.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -144.67 161.53 38.94 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.026 1.73 . . . . 0.0 111.224 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.4 p -153.27 159.05 32.66 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.848 1.659 . . . . 0.0 111.84 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -52.99 142.61 52.81 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.615 2.877 . . . . 0.0 114.165 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.59 31.36 0.98 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.623 1.169 . . . . 0.0 113.621 -176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.18 151.17 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.364 1.465 . . . . 0.0 110.609 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -141.63 -4.52 1.09 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.3 mt 58.37 173.67 0.06 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.855 2.062 . . . . 0.0 114.131 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.9 t -159.92 168.21 26.24 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.215 1.406 . . . . 0.0 109.861 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.85 137.2 57.62 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.653 -0.654 . . . . 0.0 112.176 174.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.73 -162.88 35.41 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.968 0.794 . . . . 0.0 114.604 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -97.14 124.91 41.32 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.215 1.006 . . . . 0.0 109.978 172.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -133.88 173.11 11.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.637 1.575 . . . . 0.0 112.235 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.8 pt -125.88 151.66 32.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 126.051 1.74 . . . . 0.0 108.452 170.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 mt -124.64 119.17 55.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 173.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -137.63 148.11 45.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.776 0.83 . . . . 0.0 110.581 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -72.79 149.11 43.92 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.176 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -61.81 -24.94 67.19 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.686 -0.633 . . . . 0.0 112.569 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 56.0 t -83.73 122.02 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 125.545 1.538 . . . . 0.0 109.671 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.96 168.39 17.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.812 1.645 . . . . 0.0 112.416 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 24.5 p -66.91 161.16 64.64 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.157 1.383 . . . . 0.0 113.159 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.1 -17.85 51.0 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.655 2.237 . . . . 0.0 113.096 169.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -73.93 -22.24 59.75 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.995 1.318 . . . . 0.0 112.781 169.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.67 24.33 9.39 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.156 1.36 . . . . 0.0 113.852 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.98 172.28 10.6 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.629 1.171 . . . . 0.0 111.903 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -54.69 144.75 21.05 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 121.409 -0.807 . . . . 0.0 110.584 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -119.85 83.11 1.99 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.828 1.251 . . . . 0.0 109.815 -168.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.38 150.83 19.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -168.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.3 tp -60.45 135.63 57.8 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.806 1.242 . . . . 0.0 110.032 169.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.9 m -129.97 121.06 25.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.803 1.241 . . . . 0.0 111.247 -173.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -65.03 136.29 96.69 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.956 1.302 . . . . 0.0 112.458 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.07 -13.31 21.3 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.51 2.807 . . . . 0.0 114.688 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.01 7.42 80.68 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 124.223 0.916 . . . . 0.0 115.071 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -153.92 166.59 32.48 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.351 1.86 . . . . 0.0 111.299 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -102.57 166.64 10.41 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.743 1.217 . . . . 0.0 111.545 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 51.15 40.93 27.04 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.773 1.629 . . . . 0.0 112.425 -174.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.9 m -141.16 137.89 17.26 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 126.139 1.776 . . . . 0.0 110.47 -169.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -52.71 158.17 6.49 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 124.736 3.624 . . . . 0.0 115.43 172.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 t -110.26 148.99 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.861 1.264 . . . . 0.0 110.74 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 52' ' ' VAL . 1.3 m -121.66 176.5 5.68 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.216 1.407 . . . . 0.0 111.494 -169.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.461 ' H ' HG22 ' A' ' 51' ' ' THR . 0.3 OUTLIER -131.34 146.04 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.109 1.364 . . . . 0.0 111.647 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.1 m -153.79 163.06 25.13 Favored Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 124.469 1.108 . . . . 0.0 113.303 -177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -60.49 124.38 14.98 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.394 2.73 . . . . 0.0 110.418 168.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.46 136.21 57.98 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.33 1.052 . . . . 0.0 111.786 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -132.81 7.72 4.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.023 1.329 . . . . 0.0 112.449 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.53 9.61 58.78 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.92 1.247 . . . . 0.0 114.592 -173.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.0 p -68.77 154.3 42.23 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.26 1.424 . . . . 0.0 112.729 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.4 p -62.54 -17.12 59.2 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -70.48 -24.41 62.86 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.858 1.263 . . . . 0.0 112.402 171.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.23 3.14 12.0 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.04 1.736 . . . . 0.0 113.235 -176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.89 140.26 32.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.563 1.145 . . . . 0.0 110.558 171.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -134.15 171.31 14.41 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.763 1.268 . . . . 0.0 111.7 -169.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.4 mt -125.92 136.28 61.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 127.052 2.141 . . . . 0.0 106.566 -175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.6 tp -137.41 124.47 21.53 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.1 1.36 . . . . 0.0 108.901 -169.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -142.62 134.26 26.67 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.768 0.827 . . . . 0.0 110.946 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.3 t -63.78 137.03 57.88 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.998 0.519 . . . . 0.0 110.853 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -112.79 -47.38 3.06 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.324 1.05 . . . . 0.0 111.691 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.46 111.46 4.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.302 1.441 . . . . 0.0 110.708 170.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.2 m -58.99 -24.32 62.61 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.987 0.915 . . . . 0.0 111.533 168.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -64.18 -21.82 66.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.872 2.069 . . . . 0.0 113.522 175.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 m -130.33 11.75 5.44 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.684 1.594 . . . . 0.0 112.853 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 44.09 32.26 0.63 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 126.592 1.957 . . . . 0.0 113.509 -169.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 p -87.11 139.82 30.18 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.163 -0.96 . . . . 0.0 111.876 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -135.44 141.92 45.5 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.636 1.574 . . . . 0.0 110.978 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 66.6 p -77.5 145.72 36.82 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.808 0.443 . . . . 0.0 110.849 172.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.8 mm -127.14 126.73 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.32 1.448 . . . . 0.0 109.673 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 57.1 m -144.01 147.94 40.0 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 126.103 1.761 . . . . 0.0 109.578 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.63 149.93 24.11 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.887 2.392 . . . . 0.0 111.445 175.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.91 -29.72 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.058 -1.026 . . . . 0.0 111.811 173.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.21 -13.97 81.12 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 115.424 0.929 . . . . 0.0 115.424 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 38.0 m -151.98 62.48 4.72 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 125.682 1.593 . . . . 0.0 111.536 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.13 -13.65 39.04 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.414 2.742 . . . . 0.0 114.034 -174.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -73.18 6.33 2.86 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.425 1.89 . . . . 0.0 114.063 170.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -138.89 166.31 24.79 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.295 1.838 . . . . 0.0 111.088 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -136.56 171.23 14.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.348 1.459 . . . . 0.0 113.089 -172.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 37.6 mm -120.9 130.62 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.143 1.377 . . . . 0.0 110.929 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.75 -156.15 6.9 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.917 1.722 . . . . 0.0 111.834 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -142.6 142.37 32.12 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.402 1.081 . . . . 0.0 111.518 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.22 -166.44 13.13 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.31 1.433 . . . . 0.0 113.401 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.2 138.65 20.13 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.085 1.354 . . . . 0.0 113.221 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.7 -6.57 67.58 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.724 1.154 . . . . 0.0 114.089 -172.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 49.67 56.54 7.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.578 1.951 . . . . 0.0 114.21 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.6 m -132.08 150.23 75.48 Favored Pre-proline 0 N--CA 1.47 0.551 0 C-N-CA 126.153 1.781 . . . . 0.0 108.127 169.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -67.94 142.38 56.73 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.192 1.261 . . . . 0.0 109.693 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.28 148.16 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.724 1.61 . . . . 0.0 111.096 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 41.2 t -77.73 138.8 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.938 0.895 . . . . 0.0 110.575 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.7 mt -140.53 161.74 53.05 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.31 1.844 . . . . 0.0 111.013 -171.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.12 164.83 30.56 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.94 2.427 . . . . 0.0 111.879 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.23 119.55 6.07 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.528 2.152 . . . . 0.0 110.47 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -147.5 -89.6 0.09 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.821 0.848 . . . . 0.0 110.977 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -155.91 17.25 0.37 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.117 1.367 . . . . 0.0 113.235 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -67.56 135.86 53.61 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.525 -0.735 . . . . 0.0 112.075 -173.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.7 m -145.03 159.83 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.034 1.334 . . . . 0.0 112.646 -175.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -129.55 136.28 49.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.538 1.535 . . . . 0.0 110.925 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.3 m -74.35 128.98 36.91 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 109.437 170.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -118.01 125.81 51.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.175 0.99 . . . . 0.0 109.335 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 53.0 m -130.52 118.32 20.91 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.272 1.029 . . . . 0.0 111.155 -169.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.99 148.39 51.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.641 0.776 . . . . 0.0 111.34 173.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.8 p -132.26 174.42 10.24 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.035 1.734 . . . . 0.0 110.35 175.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.8 m -61.67 -10.39 8.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.54 36.71 0.39 Allowed Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.396 0.998 . . . . 0.0 113.944 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.24 -166.57 34.72 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 124.793 1.187 . . . . 0.0 112.708 -177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -121.23 166.83 13.42 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.484 1.914 . . . . 0.0 111.293 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -135.09 152.31 51.54 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.592 1.557 . . . . 0.0 110.454 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.58 117.47 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.136 1.374 . . . . 0.0 109.263 -169.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -136.48 157.73 46.09 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.66 1.184 . . . . 0.0 112.373 -169.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -63.72 -31.06 72.12 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 -171.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.14 -26.14 3.27 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.313 1.435 . . . . 0.0 114.175 -169.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -113.62 1.21 14.86 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.112 1.765 . . . . 0.0 114.0 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.7 mmt180 64.32 12.87 7.57 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.453 2.301 . . . . 0.0 114.239 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.3 p -73.22 -22.37 60.45 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.163 0.985 . . . . 0.0 112.9 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 m -144.69 170.85 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.66 1.584 . . . . 0.0 112.437 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 17.5 t -144.27 150.43 37.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 129.215 3.006 . . . . 0.0 108.885 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.5 m0 -69.94 145.87 51.57 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.16 -0.962 . . . . 0.0 110.52 169.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 89.0 p -156.41 174.22 15.74 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.805 1.242 . . . . 0.0 112.575 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -120.35 171.87 8.21 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.144 1.777 . . . . 0.0 110.059 175.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -108.27 -31.83 7.72 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.968 1.307 . . . . 0.0 110.811 -175.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -142.83 -13.34 0.75 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 127.425 2.29 . . . . 0.0 112.96 169.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.93 22.04 8.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 126.615 1.966 . . . . 0.0 114.729 -170.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.7 p -70.7 158.28 36.53 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.64 1.176 . . . . 0.0 111.944 170.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.56 136.84 57.44 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.244 -0.91 . . . . 0.0 111.886 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.09 0.74 89.67 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.644 1.116 . . . . 0.0 114.367 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -72.32 138.86 47.62 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.806 1.303 . . . . 0.0 112.584 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -73.9 125.41 28.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.463 0.705 . . . . 0.0 110.26 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.0 153.56 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.596 0.713 . . . . 0.0 110.315 175.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 39.1 m -135.34 165.19 26.03 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.193 1.397 . . . . 0.0 111.572 -172.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 72.8 mt -134.07 142.2 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.262 1.425 . . . . 0.0 108.96 -175.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.91 179.54 48.02 Favored Glycine 0 N--CA 1.47 0.944 0 C-N-CA 124.602 1.096 . . . . 0.0 111.496 175.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.48 -40.83 62.8 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 119.005 1.402 . . . . 0.0 114.274 -173.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -169.6 174.11 6.02 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.857 2.463 . . . . 0.0 111.61 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.27 150.63 39.52 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.574 1.149 . . . . 0.0 111.908 169.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -83.06 -7.02 59.7 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -169.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -142.38 -40.93 0.34 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.205 1.002 . . . . 0.0 112.524 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.9 p -95.3 3.54 54.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.432 1.493 . . . . 0.0 114.212 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.29 22.91 0.61 Allowed Glycine 0 CA--C 1.544 1.87 0 C-N-CA 125.818 1.675 . . . . 0.0 115.802 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 11.5 tpp85 -147.58 143.98 28.14 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.836 1.655 . . . . 0.0 111.066 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -136.45 175.54 9.52 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.398 1.879 . . . . 0.0 111.338 -169.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.45 137.76 25.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 124.653 1.181 . . . . 0.0 109.373 169.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -116.01 124.24 72.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 125.916 1.686 . . . . 0.0 107.14 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -147.6 153.09 38.98 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.845 1.258 . . . . 0.0 109.497 -171.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -68.08 155.4 39.63 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.008 -1.057 . . . . 0.0 112.803 -176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.3 t . . . . . 0 C--O 1.252 1.21 0 C-N-CA 126.121 1.769 . . . . 0.0 111.292 171.879 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 111.472 0.175 . . . . 0.0 111.472 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.98 175.02 47.28 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.398 0.999 . . . . 0.0 113.466 177.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -139.8 0.47 1.8 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.914 1.285 . . . . 0.0 113.621 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -151.88 157.42 41.83 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.964 1.706 . . . . 0.0 110.301 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.7 t60 52.72 25.41 3.76 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.866 1.666 . . . . 0.0 114.667 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -142.13 4.97 1.67 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.531 1.532 . . . . 0.0 113.119 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -59.54 -21.52 60.37 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.906 -1.121 . . . . 0.0 113.9 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.0 m80 -54.68 -15.2 1.68 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.162 2.185 . . . . 0.0 114.534 170.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 65.2 t60 -98.3 -5.6 32.66 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.469 1.508 . . . . 0.0 114.029 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -136.31 -5.36 2.07 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 t -142.03 155.09 45.41 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.471 1.508 . . . . 0.0 111.886 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.67 27.66 0.11 Allowed Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.203 1.382 . . . . 0.0 113.881 -178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -132.89 7.4 4.03 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.143 1.377 . . . . 0.0 113.575 -169.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.4 m -137.38 155.53 75.56 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 126.281 1.832 . . . . 0.0 111.563 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.79 160.62 47.47 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.046 2.497 . . . . 0.0 113.588 -175.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.41 32.01 1.08 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.859 1.664 . . . . 0.0 111.985 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -137.62 167.04 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 126.597 1.959 . . . . 0.0 109.749 -169.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.0 t -127.63 18.99 6.78 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.68 1.592 . . . . 0.0 113.097 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.6 mt 62.29 164.88 0.1 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.012 2.525 . . . . 0.0 114.761 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.6 t -161.58 170.46 19.78 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.302 1.841 . . . . 0.0 109.232 174.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.03 134.12 54.39 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 121.564 -0.71 . . . . 0.0 112.308 173.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.08 -161.24 34.2 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.114 0.864 . . . . 0.0 114.311 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -100.49 125.8 46.85 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.125 0.97 . . . . 0.0 110.213 173.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -134.86 172.76 12.53 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.537 1.535 . . . . 0.0 112.514 -170.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 pt -125.97 154.69 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 126.461 1.904 . . . . 0.0 108.657 170.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.5 mt -129.92 118.92 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -141.61 153.37 44.73 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.68 0.792 . . . . 0.0 112.237 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -84.11 138.35 33.08 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.793 -0.567 . . . . 0.0 112.031 -172.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -63.36 -19.83 64.99 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.3 t -66.09 -25.71 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.908 0.883 . . . . 0.0 112.319 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.5 mt 59.77 170.64 0.08 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.82 2.048 . . . . 0.0 113.748 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.0 t -73.68 145.24 84.24 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 124.222 1.009 . . . . 0.0 111.449 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -64.6 -13.26 37.86 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.027 2.485 . . . . 0.0 112.913 169.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 -68.61 -16.8 63.97 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.977 1.311 . . . . 0.0 112.811 169.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.72 25.2 21.21 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.584 1.564 . . . . 0.0 113.7 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -133.44 173.67 11.24 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.77 1.228 . . . . 0.0 111.382 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -54.93 156.28 3.88 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.427 -0.796 . . . . 0.0 111.589 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.9 tp -130.04 71.19 1.44 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.681 1.193 . . . . 0.0 110.151 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.89 150.85 30.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.876 1.27 . . . . 0.0 113.12 -170.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.2 tp -61.44 139.56 58.19 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.256 1.022 . . . . 0.0 110.016 169.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.2 m -130.7 122.12 26.74 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.564 1.145 . . . . 0.0 111.584 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -64.24 135.52 96.37 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 124.637 1.175 . . . . 0.0 112.061 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.07 -13.68 21.2 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.428 2.752 . . . . 0.0 114.852 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.35 7.28 76.63 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.083 0.849 . . . . 0.0 114.957 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -156.01 164.46 38.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.583 1.553 . . . . 0.0 112.085 -174.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -90.77 164.47 14.09 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.442 1.097 . . . . 0.0 111.761 -174.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 49.48 39.38 16.59 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.843 1.657 . . . . 0.0 113.586 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.9 m -136.5 140.73 33.23 Favored Pre-proline 0 N--CA 1.474 0.768 0 C-N-CA 125.674 1.59 . . . . 0.0 111.198 -169.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -45.55 156.58 0.37 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 126.093 4.528 . . . . 0.0 115.277 169.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.92 150.74 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.719 1.207 . . . . 0.0 110.065 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.9 m -124.44 176.05 6.74 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.744 1.618 . . . . 0.0 110.265 -169.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.09 147.53 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-N 119.679 1.127 . . . . 0.0 112.1 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 m -150.84 160.83 31.63 Favored Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 124.94 1.296 . . . . 0.0 111.795 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -64.22 134.21 41.35 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.009 1.806 . . . . 0.0 111.613 170.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.6 tp -67.53 137.73 55.97 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.645 0.778 . . . . 0.0 111.515 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -138.29 8.81 2.7 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.864 1.265 . . . . 0.0 112.98 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.46 -7.07 58.89 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 125.058 1.313 . . . . 0.0 115.095 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -67.05 145.81 54.98 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.549 1.174 . . . . 0.0 111.827 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.4 p -60.33 -12.3 8.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.756 1.622 . . . . 0.0 114.96 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -68.66 -23.7 64.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.216 1.006 . . . . 0.0 112.36 174.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -114.76 4.5 14.98 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.573 1.549 . . . . 0.0 113.231 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -103.1 140.9 36.72 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.045 0.938 . . . . 0.0 111.126 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -134.14 170.56 15.49 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 122.83 1.3 . . . . 0.0 111.94 -169.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 84.0 mt -122.58 135.34 62.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 127.485 2.314 . . . . 0.0 106.208 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 29.3 tp -136.62 124.17 22.24 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.044 1.338 . . . . 0.0 108.561 -170.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -142.33 139.31 31.77 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.347 0.659 . . . . 0.0 111.048 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.1 t -64.59 138.55 58.47 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 122.966 0.506 . . . . 0.0 110.735 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -110.23 -53.03 2.72 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.453 1.101 . . . . 0.0 111.047 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.14 109.97 5.08 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.024 1.329 . . . . 0.0 110.648 169.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.4 m -57.73 -23.51 52.27 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.997 0.919 . . . . 0.0 111.748 168.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -65.21 -22.18 66.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.061 2.144 . . . . 0.0 113.439 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.0 m -130.32 12.03 5.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.145 1.778 . . . . 0.0 112.784 178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 42.74 34.96 0.64 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.938 2.095 . . . . 0.0 113.412 -169.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -86.03 143.96 27.83 Favored 'General case' 0 C--O 1.24 0.575 0 O-C-N 120.966 -1.084 . . . . 0.0 112.391 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -138.54 140.49 39.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.25 1.42 . . . . 0.0 111.068 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.8 p -77.84 146.36 35.75 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.206 0.603 . . . . 0.0 110.75 171.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.3 mm -130.79 120.46 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.284 1.433 . . . . 0.0 110.426 -174.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.9 m -141.71 148.77 51.04 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.367 1.467 . . . . 0.0 110.343 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.08 148.34 24.49 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.841 2.361 . . . . 0.0 111.674 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.2 t -68.28 -31.12 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 121.198 -0.939 . . . . 0.0 111.881 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -75.74 -23.56 72.23 Favored Glycine 0 CA--C 1.539 1.543 0 N-CA-C 114.875 0.71 . . . . 0.0 114.875 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.1 m -144.43 60.66 7.92 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 125.315 1.446 . . . . 0.0 112.352 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -62.69 -12.1 26.96 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 123.502 2.801 . . . . 0.0 114.143 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -75.63 14.46 0.63 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 126.812 2.045 . . . . 0.0 113.336 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 75.4 p -142.32 171.61 13.82 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.995 2.118 . . . . 0.0 111.289 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -144.08 167.03 23.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.946 1.299 . . . . 0.0 112.027 -173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 43.4 mm -118.38 131.74 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.517 1.127 . . . . 0.0 111.185 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -148.63 -157.72 7.69 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.952 1.739 . . . . 0.0 111.284 176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -141.59 145.19 34.76 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.265 1.032 . . . . 0.0 111.802 -174.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.4 -164.22 11.75 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.491 1.52 . . . . 0.0 112.955 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.62 138.3 23.11 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.957 1.303 . . . . 0.0 113.045 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.63 -3.51 63.18 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.684 1.135 . . . . 0.0 114.322 -173.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 47.56 55.19 8.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.295 1.838 . . . . 0.0 113.713 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.91 138.76 31.49 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 127.693 2.397 . . . . 0.0 107.45 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.27 142.48 55.34 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 N-CA-C 109.206 -1.113 . . . . 0.0 109.206 173.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.9 m -133.27 151.08 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.139 1.376 . . . . 0.0 111.627 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.19 136.53 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.753 0.821 . . . . 0.0 110.783 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.9 mt -139.41 163.76 43.29 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 127.154 2.182 . . . . 0.0 110.286 -171.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.16 159.31 53.67 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.153 1.902 . . . . 0.0 111.464 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -71.4 118.18 5.53 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.744 2.296 . . . . 0.0 110.294 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -145.47 -88.76 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.763 0.825 . . . . 0.0 111.018 -175.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -155.21 15.89 0.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.932 1.293 . . . . 0.0 113.387 -173.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -69.93 133.81 47.71 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.437 -0.789 . . . . 0.0 111.581 -175.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.0 m -141.8 160.99 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.422 1.089 . . . . 0.0 112.441 -174.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -129.06 134.85 48.27 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.339 1.456 . . . . 0.0 110.441 170.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.3 m -75.66 129.8 37.71 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.388 1.075 . . . . 0.0 109.406 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.1 mt -120.46 132.23 55.12 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.207 1.003 . . . . 0.0 109.786 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.1 m -133.2 118.26 18.42 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.194 0.998 . . . . 0.0 110.357 -170.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.28 137.27 58.23 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.862 1.265 . . . . 0.0 110.449 171.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 p -126.46 173.17 9.59 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.239 1.415 . . . . 0.0 111.798 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.4 m -58.13 -10.18 1.79 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.0 36.82 0.33 Allowed Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.128 1.347 . . . . 0.0 113.251 175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.78 -150.2 17.42 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-N 118.398 1.099 . . . . 0.0 114.148 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -132.83 169.59 16.52 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.949 2.499 . . . . 0.0 110.564 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -135.22 150.81 50.16 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.901 2.081 . . . . 0.0 109.451 171.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.1 mt -133.32 119.94 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.207 1.403 . . . . 0.0 109.515 -169.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -137.07 157.06 47.55 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.201 1.0 . . . . 0.0 112.552 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.09 -31.68 71.36 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.6 -40.28 1.63 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.798 1.666 . . . . 0.0 113.175 -172.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -80.3 -10.08 59.75 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.6 1.16 . . . . 0.0 113.946 173.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 67.39 12.95 9.18 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.798 2.039 . . . . 0.0 112.758 -173.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.5 p -73.24 -23.97 60.42 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.281 1.432 . . . . 0.0 112.692 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.3 m -142.83 170.39 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.863 1.665 . . . . 0.0 112.025 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.4 t -142.15 151.81 42.6 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 128.903 2.881 . . . . 0.0 109.359 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -70.02 143.55 52.51 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 119.153 0.888 . . . . 0.0 111.29 169.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.6 p -152.08 170.81 19.03 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.822 1.249 . . . . 0.0 112.969 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.0 mt -127.89 166.23 18.67 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.185 1.794 . . . . 0.0 110.111 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -109.02 -32.35 7.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.969 0.908 . . . . 0.0 111.689 -169.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -139.5 -10.89 1.21 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.436 1.894 . . . . 0.0 112.729 169.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.3 23.97 7.77 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.993 1.717 . . . . 0.0 114.685 -170.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.7 p -70.52 153.12 43.25 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.028 -1.045 . . . . 0.0 111.457 169.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.18 137.91 57.92 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.116 -0.99 . . . . 0.0 111.444 172.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.19 0.3 88.7 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 124.472 1.034 . . . . 0.0 114.251 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -69.56 142.38 53.61 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.873 1.337 . . . . 0.0 112.609 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -76.14 116.48 16.87 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.385 -0.822 . . . . 0.0 109.693 170.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.36 150.1 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.573 0.749 . . . . 0.0 111.59 174.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 57.5 m -129.81 169.54 15.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.591 1.556 . . . . 0.0 111.468 -169.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.6 mt -135.26 143.63 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 125.338 1.455 . . . . 0.0 108.862 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.35 179.12 47.49 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.672 1.13 . . . . 0.0 111.666 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.69 -41.98 61.84 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 119.092 1.446 . . . . 0.0 114.271 -172.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -168.81 172.28 7.93 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 127.915 2.486 . . . . 0.0 109.818 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.07 138.62 33.71 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.144 0.978 . . . . 0.0 112.436 169.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.0 t -62.97 -14.75 51.38 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -169.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -141.43 -36.89 0.43 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.38 1.072 . . . . 0.0 112.958 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.8 p -98.33 2.27 47.89 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.362 1.465 . . . . 0.0 114.529 -172.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.33 12.64 1.76 Allowed Glycine 0 CA--C 1.544 1.86 0 C-N-CA 125.547 1.546 . . . . 0.0 116.202 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -135.48 145.34 47.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.22 1.808 . . . . 0.0 111.364 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -139.35 175.87 9.19 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.335 1.454 . . . . 0.0 111.98 -169.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.65 138.99 38.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.764 1.225 . . . . 0.0 109.421 169.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.5 125.74 74.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 125.404 1.481 . . . . 0.0 107.276 171.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -148.93 153.99 38.78 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.798 1.239 . . . . 0.0 109.304 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -67.49 155.86 38.05 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 121.094 -1.004 . . . . 0.0 112.827 -177.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 C--O 1.253 1.247 0 C-N-CA 126.073 1.749 . . . . 0.0 111.278 172.223 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 119.234 -0.412 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 168.45 18.8 0.02 OUTLIER Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.595 0.998 . . . . 0.0 115.595 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.4 t60 52.11 26.2 3.71 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.163 1.785 . . . . 0.0 114.737 -173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -58.53 149.09 26.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.318 1.047 . . . . 0.0 111.528 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.8 m80 49.13 27.3 1.72 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.02 1.328 . . . . 0.0 113.924 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.5 p80 45.81 14.98 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 128.768 2.827 . . . . 0.0 116.48 -169.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -159.71 124.33 3.92 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.036 1.334 . . . . 0.0 111.836 -174.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -143.18 -2.26 1.01 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.909 1.284 . . . . 0.0 114.063 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.422 ' CD2' ' H ' ' A' ' 11' ' ' SER . 26.5 t60 -157.18 161.78 39.31 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.267 1.827 . . . . 0.0 110.29 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -60.99 -35.13 76.01 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.666 0.786 . . . . 0.0 112.787 175.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.422 ' H ' ' CD2' ' A' ' 9' ' ' HIS . 49.4 m 50.45 28.67 3.46 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.384 1.873 . . . . 0.0 114.948 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.21 21.66 0.57 Allowed Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.405 1.479 . . . . 0.0 113.856 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -63.49 -16.47 60.78 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.241 1.416 . . . . 0.0 113.485 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -147.74 155.73 44.8 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.988 2.115 . . . . 0.0 111.219 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.56 167.85 24.29 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.837 2.358 . . . . 0.0 112.13 172.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.16 31.07 2.17 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.872 1.269 . . . . 0.0 112.288 176.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.74 150.91 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.697 1.599 . . . . 0.0 109.909 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 t -133.8 -4.22 2.86 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.436 1.094 . . . . 0.0 113.662 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 80.7 mt 63.62 165.41 0.13 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.796 2.438 . . . . 0.0 114.69 177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 t -160.78 170.95 19.69 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.141 1.776 . . . . 0.0 109.414 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.22 133.1 49.92 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 121.631 -0.668 . . . . 0.0 111.656 170.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.25 -163.01 35.78 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.975 0.798 . . . . 0.0 114.183 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -98.63 125.64 43.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.826 0.851 . . . . 0.0 109.98 171.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -134.3 172.75 12.44 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.332 1.453 . . . . 0.0 112.284 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.0 pt -125.46 156.64 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 126.352 1.861 . . . . 0.0 109.058 171.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.8 mt -130.08 119.76 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -142.28 152.24 42.81 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.712 0.805 . . . . 0.0 112.346 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -84.3 137.81 33.25 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.871 -0.518 . . . . 0.0 111.736 -174.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -59.34 -19.54 47.41 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.3 t -67.3 -24.94 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.448 1.099 . . . . 0.0 112.834 175.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.9 mp 57.35 168.61 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.575 1.95 . . . . 0.0 113.846 -170.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 50.0 p -73.84 159.36 84.45 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.212 1.005 . . . . 0.0 112.372 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.95 -15.31 43.36 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.456 2.104 . . . . 0.0 112.612 169.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.7 tpt85 -74.61 -17.22 60.74 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.516 1.526 . . . . 0.0 113.042 171.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.71 23.64 17.85 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.066 1.317 . . . . 0.0 113.897 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -131.98 173.76 10.87 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.721 1.208 . . . . 0.0 111.972 -174.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -55.83 142.62 34.3 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.228 -0.92 . . . . 0.0 111.21 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 43.6 tp -118.53 76.51 1.09 Allowed 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.395 1.478 . . . . 0.0 109.737 -170.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.98 148.2 26.31 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -169.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.2 tp -59.3 135.25 57.59 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.006 1.323 . . . . 0.0 110.058 169.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 m -126.82 121.09 30.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.974 1.31 . . . . 0.0 110.877 -174.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -63.94 138.02 97.27 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.224 1.409 . . . . 0.0 111.913 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.03 -13.56 21.32 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.418 2.745 . . . . 0.0 114.845 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.87 4.43 72.42 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.481 1.039 . . . . 0.0 114.955 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.4 ptt-85 -156.14 172.95 17.55 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.294 1.838 . . . . 0.0 111.565 -176.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -101.04 168.79 9.37 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.837 1.255 . . . . 0.0 111.396 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 35.7 tpt85 50.04 35.08 9.15 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 127.002 2.121 . . . . 0.0 113.849 -176.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.9 m -133.67 141.73 41.18 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.693 1.597 . . . . 0.0 111.274 -169.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -45.72 160.27 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.859 1 C-N-CA 126.174 4.582 . . . . 0.0 115.259 169.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.4 t -116.11 154.73 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.606 1.162 . . . . 0.0 109.964 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 m -128.5 172.04 11.52 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.429 1.492 . . . . 0.0 110.857 -169.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.61 149.23 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.902 1.281 . . . . 0.0 111.478 176.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.6 m -157.14 161.36 29.57 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.402 1.081 . . . . 0.0 113.122 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.04 122.28 11.42 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.779 2.986 . . . . 0.0 111.449 169.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.9 tp -59.01 138.45 57.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.2 1.0 . . . . 0.0 111.81 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -132.71 5.15 3.94 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.944 1.298 . . . . 0.0 112.756 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.6 7.33 60.96 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.784 1.183 . . . . 0.0 114.742 -174.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.9 p -67.27 153.9 42.59 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.032 1.333 . . . . 0.0 112.541 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 57.7 p -62.49 -17.3 59.32 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -70.84 -22.3 62.34 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.552 1.141 . . . . 0.0 112.338 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -118.23 1.42 11.88 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.483 1.513 . . . . 0.0 113.638 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.34 146.08 27.38 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.522 1.129 . . . . 0.0 111.018 171.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -138.15 172.44 12.92 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.582 1.182 . . . . 0.0 111.901 -169.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 75.8 mt -119.6 136.79 55.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.847 2.459 . . . . 0.0 106.792 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.2 tp -135.99 128.21 29.98 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.132 1.373 . . . . 0.0 109.311 -173.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -144.09 140.67 29.61 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.875 0.87 . . . . 0.0 110.785 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.9 t -66.01 140.31 58.28 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.726 0.41 . . . . 0.0 110.758 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -109.68 -52.73 2.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.544 1.138 . . . . 0.0 110.47 173.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.17 108.48 4.27 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.48 1.112 . . . . 0.0 110.691 169.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.6 m -57.44 -25.5 59.74 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.964 0.906 . . . . 0.0 111.56 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -62.85 -20.51 65.17 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.052 2.141 . . . . 0.0 113.535 173.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -130.23 9.01 5.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.132 1.773 . . . . 0.0 112.671 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 47.5 29.28 1.34 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.372 1.869 . . . . 0.0 114.325 -169.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.9 p -87.48 144.73 26.58 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.686 -1.259 . . . . 0.0 112.193 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.5 m95 -139.43 142.62 37.42 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.576 1.55 . . . . 0.0 111.288 -176.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.2 p -81.28 149.64 28.89 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.414 0.685 . . . . 0.0 110.882 171.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.5 mm -133.59 124.97 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 125.509 1.524 . . . . 0.0 110.481 -173.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 m -142.83 153.27 60.86 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 125.889 1.676 . . . . 0.0 110.362 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.73 151.82 28.6 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.044 2.496 . . . . 0.0 111.199 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.9 -25.74 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.987 -1.071 . . . . 0.0 113.303 176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.11 -18.19 54.25 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 123.927 0.775 . . . . 0.0 114.727 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.9 m -141.31 60.3 11.84 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 125.514 1.526 . . . . 0.0 111.536 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -62.22 -17.1 55.07 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.796 2.997 . . . . 0.0 113.286 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -72.15 9.47 0.97 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 128.191 2.596 . . . . 0.0 113.384 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 49.8 p -137.79 169.24 18.13 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.165 2.186 . . . . 0.0 111.095 173.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -143.73 164.6 29.99 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.001 1.32 . . . . 0.0 111.566 -171.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -115.53 127.43 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.374 1.07 . . . . 0.0 111.154 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.49 -160.55 8.46 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.004 1.764 . . . . 0.0 111.367 177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -142.93 147.88 35.98 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.251 1.026 . . . . 0.0 111.917 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -153.06 -159.12 8.88 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.531 1.539 . . . . 0.0 112.92 178.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.3 141.14 19.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.736 1.214 . . . . 0.0 113.077 -177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.7 -4.24 72.17 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.613 1.102 . . . . 0.0 114.359 -173.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 46.99 53.87 9.97 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.139 1.775 . . . . 0.0 113.625 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.32 138.53 32.44 Favored Pre-proline 0 C--O 1.238 0.496 0 C-N-CA 127.6 2.36 . . . . 0.0 107.266 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -68.54 143.17 56.14 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 N-CA-C 108.844 -1.252 . . . . 0.0 108.844 173.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 18.3 m -132.62 148.41 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.951 1.301 . . . . 0.0 110.818 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 38.2 t -75.54 137.16 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.547 0.739 . . . . 0.0 110.159 173.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.3 mt -142.92 164.68 30.65 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.702 2.001 . . . . 0.0 110.399 -171.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.87 155.59 43.58 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.216 1.944 . . . . 0.0 110.982 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.95 125.09 17.16 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 123.431 2.754 . . . . 0.0 112.684 177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -145.12 -107.47 0.11 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.96 1.304 . . . . 0.0 109.107 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -143.56 20.06 1.85 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.174 1.789 . . . . 0.0 110.928 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -68.14 134.62 50.83 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.231 -0.918 . . . . 0.0 111.511 -174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.0 m -143.0 161.88 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.015 0.926 . . . . 0.0 112.065 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -129.96 134.36 47.41 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.017 1.327 . . . . 0.0 109.979 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 91.0 m -70.85 127.39 32.46 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.988 1.315 . . . . 0.0 108.743 169.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 54.1 mt -125.0 115.34 20.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.113 0.965 . . . . 0.0 109.027 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.7 m -136.62 133.68 36.55 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.49 0.716 . . . . 0.0 112.564 -169.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 39.9 tp -66.12 150.21 49.09 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.878 1.271 . . . . 0.0 112.602 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 p -136.89 175.81 9.28 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.663 1.585 . . . . 0.0 112.01 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.8 m -62.89 -4.97 2.44 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.75 19.64 0.21 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.455 1.026 . . . . 0.0 115.044 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.38 -156.87 28.32 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.682 1.135 . . . . 0.0 112.189 -171.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.6 170.55 9.9 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.943 2.097 . . . . 0.0 110.91 174.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -132.21 149.52 52.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.828 1.651 . . . . 0.0 110.952 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 32.4 mt -135.11 117.82 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.164 1.386 . . . . 0.0 109.203 -175.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -134.72 158.75 43.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.218 1.007 . . . . 0.0 111.942 -175.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.03 -21.98 66.53 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -171.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.51 -40.28 1.83 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.375 1.464 . . . . 0.0 112.716 -170.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -98.26 5.22 48.57 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.329 1.451 . . . . 0.0 113.836 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 58.14 14.49 2.78 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.256 2.222 . . . . 0.0 114.221 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.3 p -72.97 -23.2 60.63 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.012 0.925 . . . . 0.0 112.547 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.0 m -143.79 173.01 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.768 1.627 . . . . 0.0 112.284 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.3 t -144.23 150.82 38.55 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.78 2.832 . . . . 0.0 109.106 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 36.0 m0 -70.24 145.03 51.65 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.115 -0.99 . . . . 0.0 111.372 169.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 99.3 p -153.63 173.28 16.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.715 1.206 . . . . 0.0 112.418 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.8 mt -126.39 174.1 8.85 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.128 1.771 . . . . 0.0 109.687 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -115.66 -33.5 5.17 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.996 0.918 . . . . 0.0 111.111 -170.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -141.52 -10.66 0.93 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.46 1.904 . . . . 0.0 112.946 169.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.84 22.37 6.98 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.96 1.704 . . . . 0.0 114.824 -170.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.5 p -70.94 158.02 37.18 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.115 0.966 . . . . 0.0 111.826 170.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -67.0 139.98 57.7 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.132 -0.98 . . . . 0.0 112.01 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.87 2.75 88.85 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.345 0.974 . . . . 0.0 114.064 -178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -69.93 139.09 52.86 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.651 1.225 . . . . 0.0 112.148 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.75 120.09 19.82 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.358 -0.839 . . . . 0.0 109.746 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.18 150.73 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.436 0.694 . . . . 0.0 111.202 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 53.2 m -130.33 167.71 18.08 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.058 1.343 . . . . 0.0 111.561 -171.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 81.3 mt -134.94 145.14 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 125.291 1.436 . . . . 0.0 108.753 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.4 -179.86 47.95 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 124.89 1.234 . . . . 0.0 111.231 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.39 -39.48 60.92 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.217 1.508 . . . . 0.0 113.849 -175.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -169.96 175.4 5.14 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.889 2.476 . . . . 0.0 111.826 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.87 162.12 36.27 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.306 1.442 . . . . 0.0 111.687 169.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.4 t -92.7 -13.28 29.61 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -169.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -140.78 -32.49 0.57 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.541 1.137 . . . . 0.0 113.331 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.6 p -107.31 4.55 26.61 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.678 1.591 . . . . 0.0 114.045 -173.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.51 15.35 1.16 Allowed Glycine 0 CA--C 1.541 1.709 0 C-N-CA 126.348 1.928 . . . . 0.0 115.513 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -141.26 147.34 38.07 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.563 1.945 . . . . 0.0 110.353 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -141.1 177.48 8.04 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.21 1.804 . . . . 0.0 110.726 -169.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.9 p -142.23 142.61 27.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.025 0.93 . . . . 0.0 109.834 169.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.2 mp -119.44 126.98 75.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.544 1.538 . . . . 0.0 107.053 173.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -148.91 153.84 38.58 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.908 1.283 . . . . 0.0 109.088 -170.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -66.78 155.06 39.22 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.049 -1.032 . . . . 0.0 112.53 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.2 t . . . . . 0 C--O 1.252 1.194 0 C-N-CA 125.991 1.716 . . . . 0.0 111.239 172.635 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.78 175.5 41.51 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.669 1.128 . . . . 0.0 113.078 178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -132.55 2.17 3.78 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.654 1.182 . . . . 0.0 114.032 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 50.06 28.8 3.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 126.188 1.795 . . . . 0.0 114.262 -174.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -70.44 -5.12 26.19 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.051 1.74 . . . . 0.0 114.487 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -147.16 157.45 43.61 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.218 1.807 . . . . 0.0 111.039 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -148.81 -3.3 0.46 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -60.69 -15.05 24.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.564 1.545 . . . . 0.0 114.581 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -118.53 10.55 12.63 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.848 1.659 . . . . 0.0 113.211 -179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -140.01 -28.27 0.74 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -177.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.6 m -132.88 5.56 3.91 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.268 1.427 . . . . 0.0 113.561 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.14 18.3 0.54 Allowed Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.011 1.291 . . . . 0.0 114.563 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -65.43 132.85 50.0 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 118.242 1.021 . . . . 0.0 112.317 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.427 ' H ' ' CD ' ' A' ' 15' ' ' PRO . 21.8 t -159.57 -38.46 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.04 1.336 . . . . 0.0 114.182 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.427 ' CD ' ' H ' ' A' ' 14' ' ' SER . 51.7 Cg_exo -58.56 169.87 2.89 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.034 2.489 . . . . 0.0 114.654 171.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 51.39 33.03 9.33 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.418 1.487 . . . . 0.0 113.901 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.03 145.21 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 125.404 1.482 . . . . 0.0 110.547 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.1 t -141.36 13.0 2.17 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -170.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.7 mt 58.66 177.98 0.07 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.641 1.976 . . . . 0.0 113.499 -175.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 t -157.8 167.57 29.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.046 1.338 . . . . 0.0 110.207 173.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.14 135.6 53.79 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.928 -0.483 . . . . 0.0 111.275 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.6 -162.55 35.94 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 115.161 0.824 . . . . 0.0 115.161 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.96 119.7 35.93 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.946 1.298 . . . . 0.0 109.909 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -133.85 170.58 15.38 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.708 1.203 . . . . 0.0 112.468 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.8 pt -129.65 153.95 39.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 126.385 1.874 . . . . 0.0 108.763 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.7 mt -130.61 119.61 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -140.03 148.02 41.23 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.579 0.752 . . . . 0.0 111.639 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -75.72 137.46 40.64 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.592 -0.692 . . . . 0.0 111.213 -172.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -60.58 -29.23 69.05 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.39 1.076 . . . . 0.0 113.714 -175.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.77 -37.38 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.706 0.802 . . . . 0.0 111.669 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tp 55.9 175.12 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.316 1.846 . . . . 0.0 114.437 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.4 t -72.76 139.68 80.63 Favored Pre-proline 0 N--CA 1.473 0.68 0 O-C-N 120.646 -1.284 . . . . 0.0 111.221 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -65.55 -15.49 49.77 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.917 2.411 . . . . 0.0 113.019 171.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 49.0 tpt85 -76.41 -17.01 59.56 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.817 1.247 . . . . 0.0 113.185 171.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.51 -3.53 56.4 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.898 1.713 . . . . 0.0 114.553 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -78.24 153.23 32.07 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.413 1.107 . . . . 0.0 111.519 176.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -65.16 159.92 22.44 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.619 -0.676 . . . . 0.0 112.034 174.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.8 mt -130.61 68.75 1.46 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.32 1.448 . . . . 0.0 110.661 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.34 145.61 26.26 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.162 0.985 . . . . 0.0 112.44 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.51 132.18 50.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.922 0.889 . . . . 0.0 109.242 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.3 m -130.91 127.29 38.18 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.098 0.959 . . . . 0.0 110.826 -170.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.16 129.3 94.41 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.24 1.416 . . . . 0.0 111.142 -175.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.01 -11.08 19.72 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.078 2.519 . . . . 0.0 114.164 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.12 -4.28 52.08 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.5 1.047 . . . . 0.0 115.196 178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -160.72 166.88 27.99 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.067 1.433 . . . . 0.0 113.035 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -89.17 161.97 16.17 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.109 1.764 . . . . 0.0 111.039 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 56.07 38.32 29.78 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.067 1.747 . . . . 0.0 113.783 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 45.7 m -141.86 140.91 20.63 Favored Pre-proline 0 N--CA 1.477 0.878 0 C-N-CA 126.401 1.88 . . . . 0.0 109.685 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.91 148.66 71.03 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.043 2.495 . . . . 0.0 113.717 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.9 t -84.65 157.61 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.061 1.344 . . . . 0.0 110.653 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -126.0 171.49 10.74 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.416 1.486 . . . . 0.0 111.115 -171.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.8 p -127.59 139.08 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 121.01 -1.056 . . . . 0.0 111.3 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 m -161.18 168.93 10.66 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 124.536 1.134 . . . . 0.0 113.161 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.83 152.8 12.76 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.604 3.536 . . . . 0.0 114.304 169.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.02 134.95 51.29 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.083 1.753 . . . . 0.0 110.094 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -130.88 -10.93 3.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.817 1.647 . . . . 0.0 113.68 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.99 -4.28 16.43 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.655 1.598 . . . . 0.0 114.395 -175.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.0 t -63.07 165.13 7.41 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.036 1.418 . . . . 0.0 113.035 175.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.0 p -71.6 -15.18 62.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.66 1.184 . . . . 0.0 113.972 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -64.14 -31.33 72.49 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.417 1.008 . . . . 0.0 112.823 -178.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -113.22 4.84 16.69 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.356 1.462 . . . . 0.0 112.843 -173.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.66 145.52 27.51 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.718 1.207 . . . . 0.0 111.614 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -141.48 174.12 10.85 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.646 1.212 . . . . 0.0 111.743 -169.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 86.7 mt -125.7 136.72 59.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 126.921 2.089 . . . . 0.0 107.357 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.3 tp -134.63 129.65 35.22 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.648 1.579 . . . . 0.0 108.816 -171.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.9 mtt85 -146.29 131.4 18.33 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.308 0.643 . . . . 0.0 110.64 -174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -64.33 138.0 58.2 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.401 0.546 . . . . 0.0 111.068 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -115.1 -47.78 2.85 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.332 1.053 . . . . 0.0 111.605 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -149.68 110.46 4.3 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.487 1.115 . . . . 0.0 111.476 170.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.9 m -59.51 -24.69 63.86 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.957 0.903 . . . . 0.0 111.412 168.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -63.96 -21.4 66.47 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.915 2.086 . . . . 0.0 113.495 175.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -130.18 9.28 5.22 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.674 1.59 . . . . 0.0 112.852 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.5 m-20 46.02 33.7 1.76 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.533 1.933 . . . . 0.0 113.55 -169.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.0 p -93.37 138.62 31.53 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.001 -1.062 . . . . 0.0 112.031 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.7 m95 -134.69 145.13 48.24 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.204 1.802 . . . . 0.0 110.789 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.7 p -77.98 152.75 32.95 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.854 -0.529 . . . . 0.0 110.958 171.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.1 mm -129.11 130.11 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.568 1.547 . . . . 0.0 109.045 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.8 m -142.99 145.98 35.34 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.628 1.571 . . . . 0.0 110.612 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.06 146.77 32.83 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.185 2.59 . . . . 0.0 111.102 173.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.84 -24.98 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.943 -1.098 . . . . 0.0 113.427 174.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.4 -22.15 63.17 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 123.743 0.687 . . . . 0.0 114.197 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.2 m -143.04 64.91 15.02 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 126.144 1.777 . . . . 0.0 110.473 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -63.76 -15.37 48.49 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.197 2.598 . . . . 0.0 113.364 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -71.94 0.3 9.62 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.229 1.811 . . . . 0.0 113.918 169.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.4 m -131.01 173.63 10.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.916 1.686 . . . . 0.0 111.545 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -140.6 171.83 13.57 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.556 1.142 . . . . 0.0 113.474 -170.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -121.07 130.64 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.234 1.414 . . . . 0.0 110.587 176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.14 -158.26 7.66 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.8 1.667 . . . . 0.0 111.513 177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.5 t90 -142.42 145.35 33.71 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.351 1.075 . . . . 0.0 111.956 -173.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -150.62 -163.46 11.28 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.481 1.515 . . . . 0.0 112.942 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.83 138.17 24.53 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.904 1.281 . . . . 0.0 113.081 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.36 -6.78 61.52 Favored Glycine 0 CA--C 1.538 1.478 0 C-N-CA 124.821 1.2 . . . . 0.0 114.173 -173.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 48.17 56.22 7.67 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 126.417 1.887 . . . . 0.0 114.177 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.3 m -136.02 149.2 67.7 Favored Pre-proline 0 C--O 1.239 0.512 0 C-N-CA 126.511 1.924 . . . . 0.0 107.896 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -69.76 146.01 58.89 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.338 1.358 . . . . 0.0 110.073 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -133.27 150.01 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.966 1.706 . . . . 0.0 111.274 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.1 t -78.81 134.66 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.085 0.954 . . . . 0.0 110.179 175.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.7 mt -137.74 162.46 54.39 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.79 1.636 . . . . 0.0 112.243 -169.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.75 167.85 21.83 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.267 2.645 . . . . 0.0 111.828 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.86 127.03 12.5 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.318 2.012 . . . . 0.0 110.676 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -149.78 -93.32 0.07 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.789 0.836 . . . . 0.0 110.541 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -155.4 18.14 0.41 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.908 1.683 . . . . 0.0 112.343 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -66.04 135.4 54.59 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 121.73 -0.606 . . . . 0.0 111.64 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -144.99 160.8 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.968 1.307 . . . . 0.0 111.756 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -130.32 144.24 51.26 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.53 1.532 . . . . 0.0 110.537 170.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 90.1 m -76.31 134.83 39.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.163 1.385 . . . . 0.0 109.409 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.21 125.62 50.54 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.413 1.085 . . . . 0.0 109.478 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.8 m -132.3 117.0 17.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.672 0.789 . . . . 0.0 110.246 -170.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.9 tp -66.16 146.72 54.31 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.181 0.592 . . . . 0.0 111.109 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.1 p -127.59 -177.97 4.3 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.593 1.557 . . . . 0.0 111.627 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.0 p -59.48 -13.57 9.37 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 115.915 1.821 . . . . 0.0 115.915 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -164.13 25.85 0.19 Allowed Glycine 0 CA--C 1.533 1.207 0 N-CA-C 115.202 0.841 . . . . 0.0 115.202 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.55 -149.57 9.44 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.878 1.228 . . . . 0.0 112.273 -173.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -128.46 170.11 13.53 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.609 1.964 . . . . 0.0 111.781 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -137.05 153.59 50.57 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.976 2.511 . . . . 0.0 109.037 170.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.0 mt -133.56 127.88 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.807 1.243 . . . . 0.0 108.717 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -138.29 159.9 40.87 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.457 1.103 . . . . 0.0 112.734 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.45 -23.01 67.22 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 -169.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 125.86 -39.51 2.02 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.97 1.272 . . . . 0.0 113.102 -171.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -98.66 1.58 46.38 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.889 1.675 . . . . 0.0 113.732 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.6 mmm-85 66.39 13.17 9.1 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.1 2.16 . . . . 0.0 113.655 177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 72.8 p -74.84 -24.82 58.66 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.46 1.104 . . . . 0.0 112.683 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.2 m -143.46 174.25 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.738 1.615 . . . . 0.0 111.693 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 t -147.23 152.89 39.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.609 2.364 . . . . 0.0 110.176 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -70.01 143.43 52.57 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.543 -0.723 . . . . 0.0 111.413 171.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 81.3 p -153.26 172.14 17.45 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.807 1.243 . . . . 0.0 112.527 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -123.92 172.97 8.51 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.332 1.853 . . . . 0.0 110.207 174.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -119.44 -29.76 5.04 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.777 1.631 . . . . 0.0 112.065 -169.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -142.41 -8.7 0.86 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.995 1.718 . . . . 0.0 114.294 172.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 54.22 51.84 13.69 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.359 1.064 . . . . 0.0 113.649 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.5 p -126.99 167.1 16.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.887 0.875 . . . . 0.0 112.306 173.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -73.0 146.21 46.14 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 120.742 -1.224 . . . . 0.0 112.568 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.79 -8.49 69.21 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.44 1.019 . . . . 0.0 114.016 -176.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -61.28 157.34 16.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.621 1.968 . . . . 0.0 112.602 169.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -109.11 124.87 51.48 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.424 1.089 . . . . 0.0 109.231 171.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.6 p -60.0 148.19 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.731 0.813 . . . . 0.0 111.886 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.2 m -130.91 168.22 17.68 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.734 1.614 . . . . 0.0 112.087 -170.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 80.8 mt -133.91 143.87 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 125.401 1.48 . . . . 0.0 109.712 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.49 179.79 48.79 Favored Glycine 0 N--CA 1.471 1.021 0 C-N-CA 125.036 1.303 . . . . 0.0 111.655 172.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.75 -40.54 54.95 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 119.248 1.524 . . . . 0.0 114.542 -172.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -171.92 173.41 4.46 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.057 2.943 . . . . 0.0 108.942 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.64 137.94 33.98 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.242 -0.911 . . . . 0.0 112.785 169.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.6 t -61.84 -21.02 64.29 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.73 1.612 . . . . 0.0 115.303 -170.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -134.18 -38.01 0.87 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.509 1.124 . . . . 0.0 113.312 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 81.3 p -98.19 4.06 48.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.152 1.381 . . . . 0.0 114.626 -171.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.53 14.25 1.03 Allowed Glycine 0 CA--C 1.544 1.892 0 C-N-CA 126.017 1.77 . . . . 0.0 115.9 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -134.53 150.66 50.78 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.88 1.672 . . . . 0.0 111.915 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -141.41 175.6 9.53 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.996 2.118 . . . . 0.0 110.795 -169.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.86 138.46 34.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 125.03 1.332 . . . . 0.0 108.814 169.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.8 123.5 71.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.716 1.606 . . . . 0.0 106.768 176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -146.9 153.83 40.58 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.597 1.159 . . . . 0.0 109.168 -169.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -68.62 154.57 41.66 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.967 -1.083 . . . . 0.0 112.518 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.256 1.822 . . . . 0.0 111.405 171.902 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.78 173.82 46.34 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.464 1.031 . . . . 0.0 112.996 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -133.25 7.97 3.96 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.102 1.361 . . . . 0.0 113.189 -175.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -70.2 -15.68 62.97 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.786 1.634 . . . . 0.0 113.762 178.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.5 t60 -148.87 157.02 43.12 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.456 1.902 . . . . 0.0 110.706 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -144.57 163.88 32.59 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.639 1.576 . . . . 0.0 111.862 -174.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -123.4 3.1 9.1 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.873 1.269 . . . . 0.0 113.607 -175.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -143.43 160.5 40.46 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.374 1.869 . . . . 0.0 110.857 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -143.47 11.26 1.69 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.372 1.469 . . . . 0.0 112.85 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -152.97 168.39 25.98 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.478 1.911 . . . . 0.0 111.896 -169.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.2 m -132.72 6.52 4.03 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.12 1.368 . . . . 0.0 113.348 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.98 176.14 43.95 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.911 1.72 . . . . 0.0 112.393 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -142.64 1.97 1.37 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.521 1.129 . . . . 0.0 113.691 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.4 m -145.0 159.35 50.15 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 126.154 1.782 . . . . 0.0 111.231 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.61 139.02 39.57 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.727 2.951 . . . . 0.0 113.747 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.79 27.79 1.19 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.805 1.242 . . . . 0.0 113.194 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 t -78.53 152.74 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.804 1.641 . . . . 0.0 110.501 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.2 t -134.1 6.28 3.62 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.5 mt 57.95 174.38 0.06 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.969 2.107 . . . . 0.0 113.746 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 t -159.7 168.43 25.98 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.084 1.354 . . . . 0.0 109.879 173.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.53 131.83 48.18 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.854 -0.529 . . . . 0.0 111.632 171.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.55 -168.49 41.34 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 114.643 0.617 . . . . 0.0 114.643 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -94.49 125.75 39.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.043 0.937 . . . . 0.0 109.793 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -132.73 166.15 22.87 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.709 1.604 . . . . 0.0 111.887 -173.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.1 pt -117.69 151.1 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 125.489 1.516 . . . . 0.0 108.45 169.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 57.0 mt -130.33 113.43 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -136.47 143.39 43.82 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.439 1.095 . . . . 0.0 110.089 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -71.01 150.08 45.98 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 121.797 -0.564 . . . . 0.0 111.329 -172.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.0 tpt85 -63.83 -13.88 48.31 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.8 t -118.65 139.18 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 126.611 1.964 . . . . 0.0 108.889 169.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.9 mt -109.72 169.22 8.85 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.388 1.475 . . . . 0.0 113.398 -169.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.1 t -68.58 151.34 97.29 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.644 1.177 . . . . 0.0 111.889 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -61.35 -8.07 9.79 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.448 2.766 . . . . 0.0 113.833 169.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -62.1 -24.33 67.06 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.106 1.363 . . . . 0.0 112.302 169.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.54 30.38 27.36 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.844 1.212 . . . . 0.0 114.2 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.39 162.64 33.92 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.852 1.661 . . . . 0.0 110.294 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -54.34 142.02 28.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.618 0.767 . . . . 0.0 110.33 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -121.95 84.66 2.28 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.523 1.529 . . . . 0.0 110.684 -166.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.53 150.12 21.44 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.827 1.651 . . . . 0.0 115.045 -168.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.77 134.99 57.34 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.18 0.992 . . . . 0.0 109.14 169.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.2 m -135.4 125.38 25.84 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.216 1.007 . . . . 0.0 111.301 -173.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -67.0 140.42 96.04 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 126.551 1.94 . . . . 0.0 112.878 -174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -76.29 -15.64 17.89 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.705 2.937 . . . . 0.0 114.943 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.98 7.21 66.2 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.306 0.955 . . . . 0.0 115.076 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -156.97 167.04 31.67 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.515 1.926 . . . . 0.0 111.322 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -100.13 167.83 10.2 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.809 1.243 . . . . 0.0 111.267 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 50.85 38.91 21.12 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.672 1.589 . . . . 0.0 113.256 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.1 m -139.87 138.41 19.72 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 126.129 1.772 . . . . 0.0 110.557 -169.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.21 159.83 3.85 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 124.861 3.707 . . . . 0.0 115.542 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 t -114.0 149.64 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.107 1.363 . . . . 0.0 110.643 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 52' ' ' VAL . 2.8 m -125.2 174.42 8.11 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.268 1.427 . . . . 0.0 110.909 -169.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 51' ' ' THR . 0.3 OUTLIER -127.06 143.02 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.951 1.301 . . . . 0.0 111.365 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.3 m -152.99 162.51 26.21 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 124.302 1.041 . . . . 0.0 113.047 -173.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.34 150.57 40.62 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.446 2.764 . . . . 0.0 112.754 169.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.8 tp -108.14 134.19 51.35 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.864 1.266 . . . . 0.0 111.585 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -133.82 -26.88 1.52 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.823 2.049 . . . . 0.0 112.405 174.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.8 5.47 2.2 Favored Glycine 0 CA--C 1.537 1.464 0 N-CA-C 116.811 1.484 . . . . 0.0 116.811 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.3 p -72.83 165.28 25.19 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.899 1.849 . . . . 0.0 113.798 -175.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.3 m -70.04 -14.48 62.7 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.806 1.409 . . . . 0.0 114.806 -176.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -73.14 -25.34 60.79 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.974 0.91 . . . . 0.0 112.458 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.61 5.82 11.64 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 128.343 2.657 . . . . 0.0 112.23 -172.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.8 147.89 33.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.506 1.522 . . . . 0.0 110.257 172.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -134.96 171.66 14.1 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 122.886 1.326 . . . . 0.0 112.291 -168.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 87.3 mt -125.66 134.46 66.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 127.505 2.322 . . . . 0.0 106.249 -176.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.4 tp -137.13 123.38 20.56 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.067 1.347 . . . . 0.0 109.624 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -142.81 140.03 31.17 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.495 0.718 . . . . 0.0 111.388 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.3 t -65.5 142.43 58.14 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.355 0.662 . . . . 0.0 111.451 -176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -117.19 -52.74 2.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.749 1.219 . . . . 0.0 111.823 176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.2 111.24 5.32 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.3 1.04 . . . . 0.0 111.006 170.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.3 m -57.28 -24.35 54.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.887 0.875 . . . . 0.0 111.26 168.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -65.37 -21.6 66.7 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.924 2.089 . . . . 0.0 113.633 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.6 t -130.5 14.69 5.49 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.193 1.397 . . . . 0.0 112.898 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 43.89 34.56 0.92 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.24 1.816 . . . . 0.0 113.475 -169.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.1 p -88.0 143.23 27.21 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.995 -1.065 . . . . 0.0 112.106 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -139.17 143.22 38.04 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.328 1.451 . . . . 0.0 110.993 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 55.4 p -77.7 147.99 35.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.288 0.635 . . . . 0.0 110.723 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.0 mm -128.28 126.08 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.462 1.505 . . . . 0.0 109.397 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.0 m -143.34 146.46 36.24 Favored Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 125.791 1.637 . . . . 0.0 109.539 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.57 150.84 28.34 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.765 2.31 . . . . 0.0 111.53 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.49 -30.53 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 O-C-N 121.297 -0.877 . . . . 0.0 111.836 172.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.73 -14.89 78.99 Favored Glycine 0 CA--C 1.539 1.564 0 N-CA-C 115.595 0.998 . . . . 0.0 115.595 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.6 m -151.6 61.75 4.47 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 125.819 1.648 . . . . 0.0 111.56 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -62.8 -17.21 58.19 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 124.065 3.176 . . . . 0.0 113.669 -173.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -72.77 13.11 0.41 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 128.484 2.713 . . . . 0.0 114.238 169.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.8 p -141.46 171.34 14.19 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.731 2.012 . . . . 0.0 111.596 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -138.83 170.09 16.63 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.634 1.574 . . . . 0.0 112.469 -175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 39.3 mm -119.71 129.88 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.865 1.266 . . . . 0.0 110.897 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.75 -156.15 6.82 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.83 1.681 . . . . 0.0 111.693 178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -143.01 141.11 31.27 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.387 1.075 . . . . 0.0 111.526 -171.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.14 -166.78 13.0 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.36 1.457 . . . . 0.0 113.035 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.72 137.47 20.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.979 1.311 . . . . 0.0 113.164 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 98.32 -7.28 61.88 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.85 1.214 . . . . 0.0 114.094 -173.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 48.69 56.32 7.8 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.575 1.95 . . . . 0.0 114.298 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.64 151.02 77.4 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 126.2 1.8 . . . . 0.0 108.201 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.57 142.16 57.91 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.269 1.313 . . . . 0.0 109.84 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.2 m -132.34 148.92 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.615 1.566 . . . . 0.0 111.123 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.5 t -77.87 139.47 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.838 0.855 . . . . 0.0 110.602 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.67 161.67 57.28 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.666 1.986 . . . . 0.0 110.944 -172.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -69.65 164.88 32.79 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.703 2.269 . . . . 0.0 111.482 174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.0 123.44 10.02 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 122.455 2.103 . . . . 0.0 110.851 179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -147.72 -91.34 0.08 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.245 1.018 . . . . 0.0 110.482 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -156.01 18.34 0.37 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.524 1.53 . . . . 0.0 112.955 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -68.2 136.13 53.11 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.544 -0.722 . . . . 0.0 112.125 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.7 m -145.19 161.55 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.06 1.344 . . . . 0.0 112.537 -174.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -131.49 136.79 48.2 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.964 1.706 . . . . 0.0 110.571 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.6 m -71.92 131.58 43.17 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.098 0.959 . . . . 0.0 108.717 169.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.1 mt -123.52 128.19 49.41 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.096 0.958 . . . . 0.0 109.424 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.1 m -133.63 120.35 20.56 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.772 0.829 . . . . 0.0 110.586 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.83 146.82 54.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.065 0.546 . . . . 0.0 111.246 174.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -126.43 178.85 5.6 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.585 1.554 . . . . 0.0 110.818 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 69.0 p -60.23 -14.98 20.54 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -161.75 33.66 0.36 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.659 1.124 . . . . 0.0 114.088 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.61 -154.46 24.23 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.927 1.251 . . . . 0.0 112.909 -175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -126.71 170.93 11.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.272 2.229 . . . . 0.0 111.119 174.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -135.44 151.05 50.04 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.361 2.264 . . . . 0.0 109.255 170.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 26.9 mt -132.94 125.3 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.921 1.289 . . . . 0.0 108.778 -170.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -138.12 157.67 45.85 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.598 1.159 . . . . 0.0 112.648 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -60.72 -32.98 72.21 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -174.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.38 -40.28 1.64 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.9 1.714 . . . . 0.0 113.298 -172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -79.65 -13.1 59.73 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.598 1.159 . . . . 0.0 113.585 171.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 69.99 13.85 7.86 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.221 2.208 . . . . 0.0 112.796 -178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 58.2 p -71.99 -21.53 61.55 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.84 1.656 . . . . 0.0 112.856 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.0 m -144.97 170.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 126.071 1.749 . . . . 0.0 111.754 -176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.3 t -141.23 156.47 45.9 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.255 1.822 . . . . 0.0 110.838 171.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -70.05 140.17 52.76 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.595 -0.691 . . . . 0.0 111.345 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.8 p -151.64 172.15 16.52 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.438 1.095 . . . . 0.0 112.498 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -117.34 174.73 5.97 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.137 1.775 . . . . 0.0 109.794 174.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -112.16 -31.88 6.73 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.977 1.311 . . . . 0.0 110.648 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -142.7 -13.3 0.76 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 127.546 2.338 . . . . 0.0 112.734 169.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.96 20.53 6.83 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.75 2.02 . . . . 0.0 114.78 -171.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.7 p -70.86 155.78 40.37 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.571 1.148 . . . . 0.0 111.921 171.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -59.12 137.22 58.04 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.408 -0.807 . . . . 0.0 112.457 172.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 86.14 -1.83 87.63 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.98 1.276 . . . . 0.0 114.455 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -73.29 139.01 45.81 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.75 1.275 . . . . 0.0 112.823 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.36 127.0 32.16 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.528 -0.732 . . . . 0.0 110.266 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.36 152.07 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.117 0.567 . . . . 0.0 110.426 175.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 45.7 m -130.34 161.98 30.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.574 1.549 . . . . 0.0 111.563 -173.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 71.0 mt -131.87 143.73 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.377 1.471 . . . . 0.0 108.84 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 165.44 -157.64 30.19 Favored Glycine 0 N--CA 1.468 0.831 0 C-N-CA 123.73 0.681 . . . . 0.0 112.236 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -57.16 159.99 4.07 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 117.832 0.816 . . . . 0.0 112.063 169.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -54.43 148.77 11.35 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.784 1.234 . . . . 0.0 112.229 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -120.8 138.93 53.78 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.988 1.315 . . . . 0.0 112.939 -170.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.2 t -60.07 -21.75 61.85 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -169.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -131.45 -39.93 1.13 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 85.9 p -98.59 3.78 48.01 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -173.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.43 -3.18 31.09 Favored Glycine 0 CA--C 1.539 1.591 0 C-N-CA 124.492 1.044 . . . . 0.0 115.02 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -121.45 154.88 35.98 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.941 1.696 . . . . 0.0 111.21 178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -137.83 175.09 9.9 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.258 1.823 . . . . 0.0 111.155 -170.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.8 t -133.58 135.05 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 125.621 1.568 . . . . 0.0 107.956 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 47.6 mt -130.59 119.05 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -149.31 152.46 35.9 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.048 -1.433 . . . . 0.0 108.997 -168.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -68.93 154.4 42.11 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.167 -0.958 . . . . 0.0 112.587 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 C--O 1.254 1.311 0 C-N-CA 126.338 1.855 . . . . 0.0 111.422 172.324 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.0 15.32 0.09 OUTLIER Glycine 0 CA--C 1.538 1.483 0 N-CA-C 115.719 1.048 . . . . 0.0 115.719 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 53.16 15.75 0.67 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.082 2.153 . . . . 0.0 116.164 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -145.06 19.13 1.6 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.049 1.739 . . . . 0.0 111.819 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -137.54 14.42 2.96 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.211 1.404 . . . . 0.0 113.203 -169.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -129.59 3.84 5.05 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.216 1.807 . . . . 0.0 113.377 -170.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -132.75 -13.36 2.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.949 1.699 . . . . 0.0 114.115 -173.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -71.02 -9.81 58.68 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.587 1.155 . . . . 0.0 113.431 170.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -147.55 167.64 23.99 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.945 2.098 . . . . 0.0 111.179 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -155.54 167.05 31.64 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.397 1.479 . . . . 0.0 111.711 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 55.8 m -134.13 6.54 3.62 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.918 1.287 . . . . 0.0 113.933 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.9 29.4 0.42 Allowed Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.494 1.045 . . . . 0.0 114.536 -176.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -139.27 11.71 2.57 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.157 1.383 . . . . 0.0 113.295 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.1 m -63.59 157.91 62.75 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.723 1.209 . . . . 0.0 112.88 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.94 155.03 9.05 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.677 2.918 . . . . 0.0 114.042 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -133.25 24.08 4.14 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.012 1.325 . . . . 0.0 112.719 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.03 146.75 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.028 1.331 . . . . 0.0 110.646 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 t -150.65 33.64 0.62 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 123.304 1.526 . . . . 0.0 114.277 -174.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.9 mt -57.28 161.0 3.54 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.496 1.519 . . . . 0.0 111.584 168.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -157.49 167.49 30.05 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.494 1.118 . . . . 0.0 110.034 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.39 124.0 20.17 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.994 -0.441 . . . . 0.0 111.259 172.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.36 -166.05 37.83 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 114.825 0.69 . . . . 0.0 114.825 -175.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -101.53 123.91 46.33 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.198 0.999 . . . . 0.0 109.908 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -131.86 169.7 15.89 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.073 1.349 . . . . 0.0 112.454 -171.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.4 pt -123.52 152.01 28.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.992 1.717 . . . . 0.0 108.302 171.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.6 mt -126.83 121.2 57.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 176.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -136.66 147.07 46.64 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.118 0.967 . . . . 0.0 111.022 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -73.62 148.11 43.16 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.828 -0.545 . . . . 0.0 110.832 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.7 tpt85 -64.61 -16.64 63.04 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.0 t -112.77 140.43 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 126.084 1.754 . . . . 0.0 109.117 169.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 47.2 mt -109.99 167.52 10.11 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.284 1.433 . . . . 0.0 114.015 -168.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 t -69.74 151.04 96.55 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.814 1.246 . . . . 0.0 112.021 175.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.71 -9.71 12.25 Favored 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.578 2.852 . . . . 0.0 113.972 169.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -30.71 67.34 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.347 1.459 . . . . 0.0 112.127 169.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.49 21.95 25.47 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.939 1.257 . . . . 0.0 114.968 172.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -133.45 173.34 11.59 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.067 1.347 . . . . 0.0 111.056 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -54.33 148.17 12.17 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.505 0.722 . . . . 0.0 110.901 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -127.33 92.95 3.61 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.719 1.208 . . . . 0.0 109.949 -168.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -105.24 151.15 24.46 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -167.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.0 tp -57.37 132.33 52.76 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.111 1.365 . . . . 0.0 109.778 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.0 m -130.47 124.82 32.88 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.929 0.892 . . . . 0.0 111.479 -170.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -61.11 128.87 90.05 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 125.14 1.376 . . . . 0.0 111.404 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.67 -11.36 20.3 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.326 2.684 . . . . 0.0 114.208 -175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.87 -5.15 50.25 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.456 1.027 . . . . 0.0 115.104 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -160.02 168.28 25.97 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.903 1.351 . . . . 0.0 113.067 -173.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -88.7 167.7 13.12 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.085 1.754 . . . . 0.0 111.394 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 48.92 40.42 16.69 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.678 1.991 . . . . 0.0 113.466 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.6 m -141.04 137.16 16.64 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 126.062 1.745 . . . . 0.0 110.03 -172.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -51.73 141.86 42.92 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.309 3.34 . . . . 0.0 114.547 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.6 t -84.74 149.15 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.398 1.079 . . . . 0.0 110.509 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 52' ' ' VAL . 1.4 m -122.7 178.08 5.17 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.172 1.389 . . . . 0.0 110.595 -170.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.473 ' H ' HG22 ' A' ' 51' ' ' THR . 0.3 OUTLIER -130.27 148.61 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.695 1.198 . . . . 0.0 111.253 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.4 p -155.11 159.01 32.15 Favored Pre-proline 0 N--CA 1.471 0.578 0 C-N-CA 123.539 0.736 . . . . 0.0 112.792 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.71 128.41 30.21 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.569 2.179 . . . . 0.0 111.213 169.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.2 tp -61.92 131.51 49.97 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.391 1.076 . . . . 0.0 111.079 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -123.04 -19.36 6.1 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.587 1.155 . . . . 0.0 112.221 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.35 60.67 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.698 1.142 . . . . 0.0 113.261 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.5 t -67.74 162.26 24.21 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.066 1.346 . . . . 0.0 111.766 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.4 p -57.09 -18.74 15.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.62 1.168 . . . . 0.0 113.944 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.21 -32.88 74.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.685 1.194 . . . . 0.0 113.04 173.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -111.4 -0.65 16.23 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -177.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.42 146.48 24.73 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 122.33 1.062 . . . . 0.0 111.868 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -140.5 172.81 12.2 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.963 1.305 . . . . 0.0 111.427 -169.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.8 mt -123.03 135.19 63.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.072 2.149 . . . . 0.0 107.025 -177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.04 123.85 21.27 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.194 1.398 . . . . 0.0 109.17 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 -144.03 139.96 29.28 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.461 0.705 . . . . 0.0 111.922 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 t -66.32 139.2 58.03 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.014 0.526 . . . . 0.0 111.651 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -114.58 -52.79 2.69 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.649 1.18 . . . . 0.0 111.303 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.85 109.95 4.93 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.614 1.165 . . . . 0.0 111.34 171.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.4 m -57.92 -24.58 58.43 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.877 0.871 . . . . 0.0 111.65 168.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -64.11 -22.57 66.99 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.129 2.171 . . . . 0.0 113.641 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.7 m -130.31 12.25 5.5 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.772 1.629 . . . . 0.0 112.671 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 43.99 35.35 1.13 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.595 1.958 . . . . 0.0 113.487 -168.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 p -89.45 140.43 29.52 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.836 -1.165 . . . . 0.0 112.028 -178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -136.55 144.73 44.37 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.03 1.732 . . . . 0.0 110.14 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.2 p -77.68 149.81 34.61 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.404 0.682 . . . . 0.0 110.667 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.0 mm -128.55 126.81 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.563 1.545 . . . . 0.0 109.184 -178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 64.1 m -144.77 142.9 19.53 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.348 1.459 . . . . 0.0 110.105 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.04 145.38 35.4 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.983 2.455 . . . . 0.0 111.114 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.6 m -66.01 -23.1 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.708 -1.245 . . . . 0.0 112.733 172.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.09 -9.69 81.87 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.675 1.131 . . . . 0.0 114.625 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.8 t -152.35 66.03 6.28 Favored Pre-proline 0 N--CA 1.472 0.643 0 C-N-CA 125.048 1.339 . . . . 0.0 110.883 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.99 -18.18 61.45 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.265 2.643 . . . . 0.0 112.949 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -78.61 5.22 11.5 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.406 2.282 . . . . 0.0 114.096 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 m -130.87 171.91 12.63 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.372 1.869 . . . . 0.0 111.182 173.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -138.7 173.59 11.42 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.39 1.476 . . . . 0.0 112.915 -171.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.0 mm -121.67 129.79 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 125.232 1.413 . . . . 0.0 110.81 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.12 -156.85 7.13 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.76 1.648 . . . . 0.0 111.958 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -142.66 142.37 32.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.437 1.095 . . . . 0.0 111.646 -171.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.93 -165.13 12.0 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.303 1.43 . . . . 0.0 113.405 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.57 138.84 21.75 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.063 1.345 . . . . 0.0 113.217 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.69 -6.42 67.51 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.746 1.165 . . . . 0.0 114.097 -172.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 49.04 57.78 6.08 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.373 1.869 . . . . 0.0 113.932 -177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.65 149.7 72.77 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 126.101 1.761 . . . . 0.0 108.13 169.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.75 144.4 53.96 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.242 1.294 . . . . 0.0 109.643 174.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.88 146.96 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.577 1.551 . . . . 0.0 110.945 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.9 t -76.22 137.99 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 123.567 0.747 . . . . 0.0 109.887 171.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.9 mt -140.21 162.97 47.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.946 1.699 . . . . 0.0 112.194 -169.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.34 166.66 24.64 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 C-N-CA 123.252 2.635 . . . . 0.0 111.71 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.44 126.81 11.92 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.311 2.007 . . . . 0.0 110.909 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -148.62 -106.18 0.08 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.604 1.161 . . . . 0.0 109.413 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -145.25 21.58 1.54 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.422 1.889 . . . . 0.0 110.59 -177.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -66.73 133.5 50.31 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.226 -0.921 . . . . 0.0 111.774 -173.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.7 m -144.71 160.33 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.336 1.455 . . . . 0.0 111.994 -176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -130.06 145.66 51.69 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.611 1.564 . . . . 0.0 109.973 169.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -77.03 134.86 38.68 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.801 1.241 . . . . 0.0 109.583 171.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -117.66 126.06 51.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.644 1.177 . . . . 0.0 109.722 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 49.2 m -132.77 120.13 21.22 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.247 1.019 . . . . 0.0 110.284 -175.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 tp -65.33 146.6 54.72 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.203 0.601 . . . . 0.0 111.334 172.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.7 p -127.76 176.53 7.47 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.564 1.545 . . . . 0.0 111.497 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -60.51 -10.31 4.86 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.88 31.89 0.29 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.496 1.046 . . . . 0.0 114.064 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.38 -151.82 19.12 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 124.721 1.153 . . . . 0.0 113.02 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -131.64 170.22 15.07 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 128.007 2.523 . . . . 0.0 110.591 175.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -134.59 155.36 50.59 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.683 1.593 . . . . 0.0 111.076 169.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 19.1 mt -135.09 115.89 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.774 1.629 . . . . 0.0 108.98 -170.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -134.36 158.15 44.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.227 1.011 . . . . 0.0 112.866 -170.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -61.25 -18.1 56.72 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 117.938 2.569 . . . . 0.0 117.938 -169.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 120.27 -33.83 4.37 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.885 1.231 . . . . 0.0 113.279 -172.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -107.94 5.73 26.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.477 1.911 . . . . 0.0 113.18 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 9.8 mmm-85 63.19 16.98 9.84 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.148 2.179 . . . . 0.0 113.998 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 59.8 p -74.71 -27.91 60.59 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.235 1.014 . . . . 0.0 112.799 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.7 m -143.19 175.27 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.314 1.446 . . . . 0.0 111.735 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -144.41 150.98 38.6 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 128.449 2.7 . . . . 0.0 109.675 -177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -71.0 145.01 50.26 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.583 -0.698 . . . . 0.0 111.517 169.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.5 p -152.32 176.42 11.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.552 1.141 . . . . 0.0 112.557 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.7 mt -132.08 171.29 13.81 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.067 2.147 . . . . 0.0 109.861 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -111.68 -35.89 5.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.305 1.042 . . . . 0.0 111.159 -170.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -141.38 -10.95 0.94 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 127.079 2.152 . . . . 0.0 112.63 169.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.77 19.14 5.37 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.455 1.902 . . . . 0.0 115.134 -170.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.6 p -70.69 157.81 37.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.319 1.047 . . . . 0.0 112.148 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.52 137.54 58.15 Favored 'General case' 0 CA--C 1.546 0.808 0 O-C-N 121.372 -0.83 . . . . 0.0 112.612 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.14 -1.22 89.06 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.536 1.065 . . . . 0.0 114.564 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -69.21 141.47 54.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.66 1.184 . . . . 0.0 112.501 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -80.91 128.88 34.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.579 0.752 . . . . 0.0 110.424 174.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.08 151.62 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.429 0.692 . . . . 0.0 110.714 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.6 t -126.27 165.24 19.33 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.256 1.422 . . . . 0.0 111.539 -174.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 86.0 mt -135.68 140.48 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 125.608 1.563 . . . . 0.0 109.672 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.0 -179.49 48.9 Favored Glycine 0 N--CA 1.469 0.889 0 C-N-CA 124.9 1.238 . . . . 0.0 111.768 173.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -52.22 -41.05 62.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 119.034 1.417 . . . . 0.0 114.035 -173.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -168.62 172.17 8.25 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.809 2.444 . . . . 0.0 109.96 177.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.69 141.23 35.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.356 1.062 . . . . 0.0 112.547 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.5 t -60.43 -21.06 61.84 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 -169.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -134.3 -38.4 0.85 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.3 p -96.65 5.36 50.85 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.347 1.459 . . . . 0.0 114.354 -173.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.62 10.75 3.68 Favored Glycine 0 CA--C 1.542 1.764 0 C-N-CA 125.107 1.336 . . . . 0.0 115.658 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -136.22 149.1 48.4 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.85 2.06 . . . . 0.0 110.412 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -137.75 176.25 8.87 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.525 1.93 . . . . 0.0 112.022 -169.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.1 t -134.77 137.07 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 125.924 1.69 . . . . 0.0 108.509 171.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.0 mp -123.94 123.75 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.06 154.19 38.92 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.651 1.18 . . . . 0.0 108.989 -170.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -68.75 154.75 41.4 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 120.682 -1.261 . . . . 0.0 112.594 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.394 1.878 . . . . 0.0 111.462 171.328 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.76 178.46 45.6 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.736 1.16 . . . . 0.0 113.096 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -150.68 152.99 34.77 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.911 1.284 . . . . 0.0 111.866 178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -147.3 159.64 43.43 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.847 1.659 . . . . 0.0 111.392 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -131.11 -6.88 3.88 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.819 1.248 . . . . 0.0 113.279 175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -140.99 14.21 2.26 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.896 2.078 . . . . 0.0 113.099 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 44.79 30.86 0.58 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.818 2.447 . . . . 0.0 115.969 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -148.37 -177.85 5.99 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.347 1.459 . . . . 0.0 111.672 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.09 -0.3 1.02 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.1 p80 42.22 25.99 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.89 2.076 . . . . 0.0 115.996 -172.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 40.0 m 49.61 34.59 7.3 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.918 1.687 . . . . 0.0 114.012 -171.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.11 -156.71 8.27 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.458 1.504 . . . . 0.0 113.245 -174.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -147.86 145.96 28.89 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.752 1.221 . . . . 0.0 111.409 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.9 m -151.18 164.23 20.95 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.964 1.706 . . . . 0.0 111.099 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.68 161.14 4.67 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.532 2.821 . . . . 0.0 114.403 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -135.51 33.26 3.02 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.246 1.418 . . . . 0.0 112.381 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.04 146.65 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.035 1.734 . . . . 0.0 109.914 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.8 t -135.19 12.57 3.56 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.525 1.53 . . . . 0.0 112.871 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.6 mt 63.01 168.03 0.13 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.674 2.39 . . . . 0.0 114.031 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 t -160.08 170.07 22.03 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.662 1.585 . . . . 0.0 109.575 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.43 130.84 44.54 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.58 -0.7 . . . . 0.0 111.512 171.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.11 -163.02 36.52 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 121.623 -0.673 . . . . 0.0 114.627 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -98.41 124.33 43.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.049 0.939 . . . . 0.0 110.094 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -133.1 171.75 13.57 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.084 1.354 . . . . 0.0 112.679 -171.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.0 pt -125.72 153.32 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 126.368 1.867 . . . . 0.0 108.643 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.0 mt -129.13 120.04 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -138.69 149.32 44.99 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.876 0.871 . . . . 0.0 111.326 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -75.65 144.51 41.65 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.98 -0.45 . . . . 0.0 110.648 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -62.13 -15.04 42.92 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.4 t -108.18 102.03 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.37 1.468 . . . . 0.0 109.419 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.0 mp -63.52 156.66 25.71 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.789 1.635 . . . . 0.0 111.568 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 37.8 p -74.39 159.62 83.17 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.42 -15.52 8.73 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 124.242 3.295 . . . . 0.0 115.412 170.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.17 -28.75 69.35 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.506 1.922 . . . . 0.0 112.909 172.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.46 23.73 25.72 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.401 1.476 . . . . 0.0 114.387 176.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -135.44 162.01 33.84 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.313 1.445 . . . . 0.0 111.918 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -54.83 135.79 47.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.283 1.033 . . . . 0.0 110.966 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.4 tp -109.69 78.07 1.1 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.942 1.297 . . . . 0.0 111.386 -169.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.96 149.52 22.54 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.934 1.294 . . . . 0.0 113.665 -171.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.0 tp -58.17 135.2 57.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.001 1.32 . . . . 0.0 110.081 170.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.6 m -127.38 127.11 43.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.793 1.237 . . . . 0.0 111.276 -174.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -66.9 132.23 93.89 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.762 0.825 . . . . 0.0 111.654 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.27 -10.34 22.38 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.1 2.534 . . . . 0.0 114.348 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.4 10.81 85.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 123.994 0.807 . . . . 0.0 114.64 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -148.53 150.89 34.16 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.94 1.696 . . . . 0.0 111.046 -171.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -90.67 159.55 16.33 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.588 1.155 . . . . 0.0 111.005 -177.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 49.87 39.27 17.96 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.163 1.385 . . . . 0.0 112.969 -176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 97.3 m -135.03 137.52 27.27 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.907 1.683 . . . . 0.0 110.401 -169.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -53.41 152.92 18.97 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.514 3.476 . . . . 0.0 114.752 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.3 t -102.68 150.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.777 1.231 . . . . 0.0 110.801 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -122.76 172.85 8.13 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.159 1.383 . . . . 0.0 111.215 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.36 139.92 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.938 1.295 . . . . 0.0 111.352 176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.9 m -151.76 166.06 16.06 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.401 1.081 . . . . 0.0 112.962 -174.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.14 162.73 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 124.03 3.154 . . . . 0.0 114.113 169.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.5 tp -126.97 143.24 51.34 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.137 1.375 . . . . 0.0 111.485 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -145.68 -30.38 0.41 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.037 1.335 . . . . 0.0 113.579 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 144.94 -9.63 1.8 Allowed Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.259 1.409 . . . . 0.0 114.156 -174.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.4 t -64.21 140.35 58.86 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.825 1.313 . . . . 0.0 112.108 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.3 m -61.56 -12.63 16.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.584 1.554 . . . . 0.0 114.286 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -67.19 -22.49 65.73 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.162 -0.961 . . . . 0.0 112.027 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -106.69 1.78 25.32 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.998 1.719 . . . . 0.0 113.296 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.67 147.75 25.64 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 122.143 0.973 . . . . 0.0 111.489 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -141.31 169.77 16.97 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.54 1.136 . . . . 0.0 111.776 -169.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.18 138.79 42.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 126.729 2.012 . . . . 0.0 108.011 176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 39.7 tp -136.84 127.94 27.83 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.847 1.659 . . . . 0.0 109.459 -173.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -143.5 142.28 31.09 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.895 0.878 . . . . 0.0 111.374 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.6 t -66.65 142.15 57.55 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.099 0.56 . . . . 0.0 111.176 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -115.18 -52.6 2.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.291 1.036 . . . . 0.0 111.522 174.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.73 110.64 4.99 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.648 1.179 . . . . 0.0 111.306 171.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 51.7 m -58.43 -24.43 60.18 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.938 0.895 . . . . 0.0 111.447 168.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -64.1 -21.62 66.6 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.998 2.119 . . . . 0.0 113.421 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.8 m -130.29 10.89 5.37 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.9 1.68 . . . . 0.0 113.021 176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 44.5 33.93 1.0 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 126.491 1.916 . . . . 0.0 113.794 -169.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.1 p -89.63 144.61 25.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.859 0.864 . . . . 0.0 112.055 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.4 m95 -140.2 142.18 35.89 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.539 1.535 . . . . 0.0 110.838 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 48.0 p -77.83 146.61 35.62 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.012 0.525 . . . . 0.0 110.506 171.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.6 mm -128.02 125.93 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.402 1.481 . . . . 0.0 109.094 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.2 m -142.46 143.41 26.64 Favored Pre-proline 0 N--CA 1.471 0.612 0 C-N-CA 124.556 1.142 . . . . 0.0 110.391 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.93 140.7 42.66 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.061 2.507 . . . . 0.0 110.682 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.3 p -66.35 -25.65 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.27 -13.93 59.53 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.45 1.024 . . . . 0.0 114.752 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.5 m -140.45 61.44 16.41 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.421 1.488 . . . . 0.0 111.517 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -61.58 -17.43 54.12 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.659 2.906 . . . . 0.0 113.295 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -71.68 8.66 1.07 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 128.105 2.562 . . . . 0.0 114.079 169.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 71.9 m -141.1 172.19 13.02 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.504 2.321 . . . . 0.0 111.32 172.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -137.27 171.65 14.17 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.081 2.152 . . . . 0.0 112.045 -175.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -116.97 124.28 72.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.805 1.242 . . . . 0.0 110.36 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.48 -160.89 8.51 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.806 1.67 . . . . 0.0 111.891 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -139.92 140.01 36.31 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.65 1.18 . . . . 0.0 111.449 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -146.46 -166.82 12.4 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.2 1.381 . . . . 0.0 113.384 177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.0 137.95 20.33 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.073 1.349 . . . . 0.0 113.143 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.79 -7.08 62.86 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.735 1.159 . . . . 0.0 114.06 -172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 48.49 57.66 6.03 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.384 1.874 . . . . 0.0 113.829 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.87 149.74 71.39 Favored Pre-proline 0 N--CA 1.469 0.518 0 C-N-CA 126.176 1.79 . . . . 0.0 108.461 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.07 144.4 57.55 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.595 1.53 . . . . 0.0 110.042 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.38 145.6 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.73 1.612 . . . . 0.0 111.859 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.0 t -74.22 122.83 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.149 0.979 . . . . 0.0 110.346 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 mp -132.4 163.09 52.97 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.802 2.041 . . . . 0.0 110.481 -169.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.31 165.41 32.65 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 122.75 2.3 . . . . 0.0 111.97 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.3 126.12 20.52 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.04 2.494 . . . . 0.0 112.026 170.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -149.63 -90.75 0.07 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.087 0.955 . . . . 0.0 110.184 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -156.27 16.82 0.34 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.832 1.653 . . . . 0.0 112.513 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -66.27 132.6 48.77 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.324 0.65 . . . . 0.0 111.839 -171.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.0 m -144.21 160.69 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.093 1.357 . . . . 0.0 111.827 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -131.5 136.5 47.94 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.29 1.436 . . . . 0.0 110.411 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 61.7 m -72.73 132.87 44.2 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.542 1.137 . . . . 0.0 109.195 170.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 60.5 mt -124.17 73.68 1.25 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.844 0.857 . . . . 0.0 109.419 -174.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.0 m -74.59 125.27 28.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.369 1.067 . . . . 0.0 110.698 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.1 tp -69.05 146.4 52.67 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.267 0.627 . . . . 0.0 111.168 171.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.3 p -126.92 175.72 7.85 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.609 1.564 . . . . 0.0 111.009 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.1 m -59.72 -11.62 5.48 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.0 24.3 0.33 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.898 1.237 . . . . 0.0 114.42 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 172.19 -149.03 11.25 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 118.298 1.049 . . . . 0.0 112.895 -173.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -133.81 169.73 16.64 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.22 2.208 . . . . 0.0 111.894 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -136.14 145.89 46.31 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.082 2.153 . . . . 0.0 109.451 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.9 mt -125.7 122.87 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.401 1.08 . . . . 0.0 108.914 -171.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -139.27 157.68 45.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.344 1.058 . . . . 0.0 112.737 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -60.33 -29.74 69.08 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.914 1.686 . . . . 0.0 115.284 -173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 128.91 -40.07 1.76 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.892 1.711 . . . . 0.0 113.237 -173.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -79.9 -10.25 59.76 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.653 1.181 . . . . 0.0 113.927 173.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.0 mmm-85 68.52 12.8 8.83 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.848 2.059 . . . . 0.0 112.837 -174.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.8 p -74.12 -25.06 59.56 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.159 1.384 . . . . 0.0 112.512 -178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.2 m -144.31 171.35 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.908 1.683 . . . . 0.0 111.915 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.6 t -144.85 154.15 42.34 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.864 2.466 . . . . 0.0 109.938 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -69.95 145.45 51.88 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.62 -0.675 . . . . 0.0 111.603 170.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.9 p -150.32 177.04 10.33 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.112 0.965 . . . . 0.0 112.329 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.15 166.86 18.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.493 1.917 . . . . 0.0 109.354 172.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -110.01 -32.17 7.12 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.875 0.87 . . . . 0.0 112.023 -169.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -139.94 -10.13 1.16 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.677 1.991 . . . . 0.0 112.644 170.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.18 24.29 7.9 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.82 1.648 . . . . 0.0 114.302 -169.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.3 p -73.45 154.85 39.79 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.783 -1.198 . . . . 0.0 111.0 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -65.45 142.83 58.03 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.154 -0.967 . . . . 0.0 112.001 173.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.43 5.8 89.12 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.667 1.127 . . . . 0.0 114.297 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -75.4 137.69 41.19 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 118.783 1.291 . . . . 0.0 112.61 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -72.94 123.91 24.41 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.5 -0.75 . . . . 0.0 110.167 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.0 t -60.92 149.39 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.564 0.746 . . . . 0.0 110.623 177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 90.4 p -125.06 166.44 16.37 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.817 1.247 . . . . 0.0 112.384 -175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 84.8 mt -135.03 142.04 41.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.151 1.381 . . . . 0.0 109.185 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.37 177.96 46.65 Favored Glycine 0 N--CA 1.471 1.008 0 C-N-CA 124.728 1.156 . . . . 0.0 111.73 174.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.38 -40.15 48.86 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 119.087 1.443 . . . . 0.0 114.212 -173.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -168.97 174.45 6.36 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.661 2.784 . . . . 0.0 110.734 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.92 141.23 38.49 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.183 0.993 . . . . 0.0 111.627 169.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.0 t -62.86 -21.09 65.71 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -169.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -137.94 -35.21 0.64 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p -97.52 3.46 50.66 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.222 1.409 . . . . 0.0 114.19 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.95 17.83 1.23 Allowed Glycine 0 CA--C 1.542 1.767 0 C-N-CA 125.805 1.669 . . . . 0.0 115.805 -176.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -140.07 146.37 38.85 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.238 1.815 . . . . 0.0 110.766 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -140.4 175.85 9.26 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.812 1.245 . . . . 0.0 112.184 -169.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.1 p -140.85 138.87 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.856 1.262 . . . . 0.0 109.409 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.18 125.92 74.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 125.785 1.634 . . . . 0.0 107.144 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -149.13 154.2 38.86 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.866 1.266 . . . . 0.0 109.101 -171.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -67.86 155.43 39.39 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.86 -1.15 . . . . 0.0 112.663 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.7 t . . . . . 0 C--O 1.252 1.227 0 C-N-CA 126.127 1.771 . . . . 0.0 111.28 171.853 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.0 20.86 0.11 Allowed Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.754 1.169 . . . . 0.0 114.527 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -151.41 156.44 40.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.174 1.39 . . . . 0.0 111.895 -177.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -59.55 -17.0 28.9 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.344 1.858 . . . . 0.0 115.602 -174.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -111.63 2.66 17.41 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.882 1.273 . . . . 0.0 113.555 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -75.77 -12.42 60.18 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -134.68 -1.56 2.76 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.974 1.31 . . . . 0.0 113.642 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.0 m80 55.65 17.93 2.58 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.742 2.017 . . . . 0.0 116.097 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -125.7 13.4 8.03 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.8 1.64 . . . . 0.0 112.988 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -125.71 6.36 7.46 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.555 1.542 . . . . 0.0 113.049 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 82.7 p -133.66 -3.82 2.93 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.361 1.864 . . . . 0.0 113.672 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.51 172.92 40.04 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.843 1.687 . . . . 0.0 112.662 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -146.75 6.53 0.92 Allowed 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.884 1.274 . . . . 0.0 113.337 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 47.0 m -147.48 162.21 32.97 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 125.92 1.688 . . . . 0.0 111.594 -172.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -52.13 158.25 5.33 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.969 3.112 . . . . 0.0 114.907 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.32 34.15 1.08 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -170.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 p -143.15 157.44 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 126.132 1.773 . . . . 0.0 111.25 -171.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.3 t -146.57 11.31 1.12 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -176.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.8 mt 60.05 166.85 0.07 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.198 2.199 . . . . 0.0 114.151 -174.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.9 m -151.44 159.41 44.22 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.296 1.839 . . . . 0.0 109.231 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.41 136.27 56.94 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.307 -0.871 . . . . 0.0 111.505 174.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.62 -164.77 37.55 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 114.788 0.675 . . . . 0.0 114.788 -176.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -95.06 125.58 39.82 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.217 1.007 . . . . 0.0 110.213 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -134.62 172.26 13.19 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.694 1.598 . . . . 0.0 111.973 -172.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.2 pt -126.17 154.22 35.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 125.919 1.687 . . . . 0.0 108.535 170.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.9 mt -128.9 119.41 49.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -141.24 152.88 44.91 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.359 0.663 . . . . 0.0 111.655 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -88.43 133.32 34.15 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.029 -0.419 . . . . 0.0 111.289 -174.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -62.52 -18.69 62.49 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t -61.6 -27.34 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.298 1.039 . . . . 0.0 112.509 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.4 mt 58.85 168.88 0.06 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.698 1.999 . . . . 0.0 113.496 -171.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 26.7 p -70.59 159.73 84.03 Favored Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 121.016 -1.053 . . . . 0.0 112.129 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.45 -16.85 48.46 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.898 2.399 . . . . 0.0 112.929 171.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -73.31 -18.22 61.22 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.424 1.49 . . . . 0.0 112.689 170.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.51 25.78 17.43 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.012 1.291 . . . . 0.0 113.512 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -127.22 169.31 13.62 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.095 1.358 . . . . 0.0 112.202 -175.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -58.33 144.04 42.84 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.594 1.158 . . . . 0.0 111.467 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.3 tp -125.06 73.2 1.28 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.876 1.27 . . . . 0.0 111.236 -169.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.25 149.62 28.93 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.503 1.521 . . . . 0.0 114.014 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.0 tp -60.35 139.92 57.4 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.332 1.053 . . . . 0.0 109.598 169.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 m -132.34 123.41 26.76 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.216 1.006 . . . . 0.0 111.611 -174.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -60.18 129.65 88.74 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 126.4 1.88 . . . . 0.0 111.507 177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.14 -3.86 14.19 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.736 2.957 . . . . 0.0 115.12 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.78 9.03 87.43 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-N 119.046 0.839 . . . . 0.0 114.702 -176.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -144.75 164.59 30.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.156 1.382 . . . . 0.0 112.476 -170.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 -101.97 157.85 16.56 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.729 1.212 . . . . 0.0 109.841 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 49.27 33.72 5.49 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.022 1.329 . . . . 0.0 113.607 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.0 m -129.0 136.27 28.92 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 126.111 1.764 . . . . 0.0 110.083 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -51.6 149.18 19.11 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.771 3.647 . . . . 0.0 115.237 174.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 t -98.51 151.46 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.101 1.361 . . . . 0.0 110.819 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.7 m -122.14 175.78 6.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.22 1.408 . . . . 0.0 111.394 -169.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.68 139.94 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.801 1.24 . . . . 0.0 111.516 177.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.0 m -152.68 166.43 15.4 Favored Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 124.249 1.02 . . . . 0.0 113.326 -171.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.7 161.32 6.15 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.652 2.901 . . . . 0.0 113.127 168.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 34.3 tp -121.84 138.44 54.39 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.461 1.104 . . . . 0.0 111.74 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -139.53 -37.18 0.5 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.744 2.018 . . . . 0.0 112.363 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.82 3.77 1.07 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.908 1.242 . . . . 0.0 115.334 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.7 t -63.44 153.84 34.04 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.476 1.638 . . . . 0.0 112.381 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.7 p -70.52 -11.16 60.75 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 175.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -75.16 -23.62 57.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.29 0.95 . . . . 0.0 112.209 175.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.72 3.55 11.66 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.33 2.652 . . . . 0.0 112.259 -170.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.46 148.88 32.18 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.337 1.455 . . . . 0.0 110.315 173.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -136.24 172.98 12.22 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.699 1.238 . . . . 0.0 112.537 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.1 mt -129.83 135.18 61.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 126.735 2.014 . . . . 0.0 106.709 -175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.5 tp -134.65 128.8 33.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.349 1.459 . . . . 0.0 109.472 -169.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -143.06 130.6 21.2 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.782 0.833 . . . . 0.0 110.383 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.1 t -64.02 138.49 58.48 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.485 0.584 . . . . 0.0 111.287 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -115.27 -51.86 2.69 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.32 1.048 . . . . 0.0 111.471 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.43 109.35 4.45 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.255 1.022 . . . . 0.0 111.127 170.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.9 m -58.03 -25.99 61.87 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.841 0.857 . . . . 0.0 111.141 168.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -62.79 -20.62 65.18 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.151 2.18 . . . . 0.0 113.598 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 t -130.42 9.98 5.2 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.684 1.593 . . . . 0.0 112.996 175.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 47.46 32.59 2.4 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.986 1.714 . . . . 0.0 114.087 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -90.24 140.72 29.41 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 120.857 -1.152 . . . . 0.0 112.362 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.4 m95 -138.32 145.09 40.78 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.865 1.666 . . . . 0.0 110.791 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.2 p -77.89 150.14 34.15 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.642 -0.661 . . . . 0.0 110.974 173.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.3 mm -124.54 127.75 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.374 1.47 . . . . 0.0 109.274 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.3 m -140.33 143.76 34.57 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.85 1.66 . . . . 0.0 110.22 175.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.87 147.24 30.57 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 123.121 2.548 . . . . 0.0 111.637 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.47 -29.89 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 O-C-N 121.122 -0.986 . . . . 0.0 111.882 174.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.75 -26.1 73.58 Favored Glycine 0 CA--C 1.538 1.506 0 O-C-N 121.705 -0.622 . . . . 0.0 114.448 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -145.64 64.95 10.91 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.508 1.523 . . . . 0.0 111.587 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.95 -13.65 36.35 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.505 2.803 . . . . 0.0 113.938 -174.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -73.7 10.04 1.24 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.926 2.09 . . . . 0.0 113.979 169.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.9 p -138.53 174.64 10.32 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.417 1.487 . . . . 0.0 112.389 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -142.11 168.25 20.2 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.942 1.297 . . . . 0.0 113.024 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.1 mm -117.4 130.34 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.69 1.196 . . . . 0.0 110.849 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.35 -158.62 7.63 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.86 1.695 . . . . 0.0 111.69 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -142.25 141.95 32.55 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.452 1.101 . . . . 0.0 111.474 -173.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.39 -166.48 12.53 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.409 1.48 . . . . 0.0 113.184 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.45 138.15 22.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.016 1.326 . . . . 0.0 113.128 -176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 97.55 -6.56 63.06 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.731 1.158 . . . . 0.0 114.196 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 49.45 57.33 6.61 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.323 1.849 . . . . 0.0 113.976 -177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.7 149.34 71.73 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.327 1.851 . . . . 0.0 108.19 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.09 144.73 58.62 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.435 1.423 . . . . 0.0 109.712 173.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.1 m -134.35 150.01 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.782 1.633 . . . . 0.0 111.257 -176.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.1 t -76.83 136.28 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.262 0.625 . . . . 0.0 110.854 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.4 mt -134.63 158.3 75.39 Favored Pre-proline 0 C--O 1.239 0.549 0 C-N-CA 126.331 1.852 . . . . 0.0 111.65 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -60.59 164.89 12.42 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 122.649 2.233 . . . . 0.0 112.927 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -72.64 124.95 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 122.662 2.242 . . . . 0.0 110.665 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -147.99 -95.54 0.08 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.038 0.935 . . . . 0.0 110.354 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -155.24 21.06 0.42 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.163 1.785 . . . . 0.0 112.146 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -67.34 139.13 57.2 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.69 -0.631 . . . . 0.0 111.565 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.5 m -144.89 159.34 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.689 1.196 . . . . 0.0 112.047 -175.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -128.76 148.67 50.87 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.528 1.531 . . . . 0.0 110.251 169.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 79.2 m -76.51 132.88 39.82 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.963 1.305 . . . . 0.0 109.209 170.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -123.41 115.98 22.51 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.391 1.077 . . . . 0.0 108.954 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 55.4 m -134.09 128.78 34.89 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.67 0.788 . . . . 0.0 110.968 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.8 mt -63.0 153.37 34.05 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 175.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.8 p -127.89 178.63 6.04 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.496 1.918 . . . . 0.0 110.057 170.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.0 m -61.56 -8.25 4.15 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.17 37.85 0.26 Allowed Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.799 1.19 . . . . 0.0 113.578 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 165.57 -153.02 22.79 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.133 0.873 . . . . 0.0 113.231 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -132.26 169.25 16.73 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.718 2.407 . . . . 0.0 111.731 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -130.81 154.3 48.16 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.026 2.131 . . . . 0.0 110.295 170.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 18.4 mt -135.04 114.72 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.624 1.17 . . . . 0.0 109.176 -172.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -134.29 156.07 49.1 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.062 0.945 . . . . 0.0 112.312 -170.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -61.63 -30.16 70.52 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 -170.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 132.83 -40.5 1.6 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.855 1.693 . . . . 0.0 112.785 -172.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -84.39 -5.64 59.3 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.966 1.307 . . . . 0.0 113.888 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 57.17 18.13 3.97 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.752 2.021 . . . . 0.0 113.415 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 47.5 p -72.07 -24.54 61.53 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.394 1.077 . . . . 0.0 112.259 177.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.3 m -143.75 173.92 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 125.943 1.697 . . . . 0.0 111.982 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.4 t -146.39 152.48 39.14 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 128.409 2.683 . . . . 0.0 109.979 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -70.57 144.78 51.13 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.385 -0.822 . . . . 0.0 111.8 170.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.6 p -152.88 174.76 13.69 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.067 1.347 . . . . 0.0 112.273 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.3 mt -128.68 170.18 13.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.161 1.784 . . . . 0.0 110.199 176.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -109.03 -36.58 6.04 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.431 0.693 . . . . 0.0 111.864 -169.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -144.91 -0.15 0.92 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.091 1.756 . . . . 0.0 114.495 173.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 51.26 23.27 1.61 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.878 2.071 . . . . 0.0 116.122 -171.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.4 p -75.22 156.35 35.88 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 120.779 -1.201 . . . . 0.0 112.06 172.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.26 138.18 57.48 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.472 -0.767 . . . . 0.0 111.836 173.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.19 4.68 89.59 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.885 1.231 . . . . 0.0 114.422 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.6 146.96 30.95 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.198 1.499 . . . . 0.0 112.783 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -76.14 130.88 38.94 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.265 -0.897 . . . . 0.0 110.781 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.22 151.21 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.906 0.482 . . . . 0.0 110.453 173.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.8 m -129.9 164.45 24.15 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.464 1.506 . . . . 0.0 111.783 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 78.4 mt -133.56 143.27 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.305 1.442 . . . . 0.0 109.556 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.61 179.98 48.01 Favored Glycine 0 N--CA 1.471 0.976 0 C-N-CA 124.832 1.206 . . . . 0.0 111.745 174.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.79 -41.16 61.48 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 119.155 1.477 . . . . 0.0 114.27 -173.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -169.11 170.33 8.84 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.004 2.522 . . . . 0.0 109.906 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -141.42 130.61 23.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.155 0.982 . . . . 0.0 112.446 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.1 t -56.59 -28.75 61.04 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -122.36 -26.72 4.58 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.437 1.095 . . . . 0.0 113.856 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 72.9 p -116.48 0.02 12.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.757 1.223 . . . . 0.0 114.1 -171.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.14 33.88 0.65 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 126.619 2.057 . . . . 0.0 114.827 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.09 145.99 22.51 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.279 2.232 . . . . 0.0 110.597 -178.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -143.3 175.72 9.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.422 1.489 . . . . 0.0 111.556 -168.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.4 p -139.44 138.9 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.488 1.115 . . . . 0.0 109.643 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -120.76 125.02 73.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.135 0 C-N-CA 125.984 1.714 . . . . 0.0 107.11 175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -149.13 155.07 40.13 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.644 1.178 . . . . 0.0 109.08 -170.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -68.65 155.79 39.39 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.022 -1.049 . . . . 0.0 112.549 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.9 t . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.086 1.754 . . . . 0.0 111.301 171.856 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.83 3.69 0.97 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.262 0.934 . . . . 0.0 115.43 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -137.59 5.72 2.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.728 1.211 . . . . 0.0 114.034 -169.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -133.91 1.94 3.35 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -134.45 13.11 3.8 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.458 1.503 . . . . 0.0 113.443 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -132.88 20.28 4.15 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.902 1.681 . . . . 0.0 112.477 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -56.01 -18.9 10.64 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.618 1.567 . . . . 0.0 114.557 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -64.5 -24.75 67.72 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.553 1.541 . . . . 0.0 114.15 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -141.44 -8.61 0.98 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -138.59 172.58 12.67 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.908 1.683 . . . . 0.0 110.985 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.0 m 49.61 29.43 3.04 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.714 1.606 . . . . 0.0 114.811 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.69 -22.57 0.09 OUTLIER Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.566 1.079 . . . . 0.0 114.881 -171.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -128.39 0.24 5.66 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.975 1.31 . . . . 0.0 113.537 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.4 p -69.25 160.2 79.92 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.829 1.652 . . . . 0.0 112.907 172.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -52.4 144.88 38.61 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 123.952 3.101 . . . . 0.0 114.539 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.76 31.01 1.17 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.329 1.451 . . . . 0.0 112.249 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.6 p -65.19 151.22 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.938 1.295 . . . . 0.0 110.702 175.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -145.38 8.64 1.19 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt 62.03 161.13 0.07 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 127.508 2.323 . . . . 0.0 113.918 -175.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.2 m -152.5 165.33 35.44 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.366 1.867 . . . . 0.0 109.228 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.78 130.59 44.08 Favored 'General case' 0 CA--C 1.548 0.9 0 O-C-N 121.5 -0.75 . . . . 0.0 110.958 169.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.06 -165.31 38.66 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 114.721 0.648 . . . . 0.0 114.721 -175.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -95.64 122.99 38.99 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.168 0.987 . . . . 0.0 110.304 172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -133.98 174.74 10.15 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.246 1.418 . . . . 0.0 112.424 -172.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.0 pt -131.08 155.98 42.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 126.246 1.818 . . . . 0.0 108.936 171.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 mt -127.49 127.72 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -142.47 147.88 36.81 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.762 0.825 . . . . 0.0 111.564 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -78.06 133.44 37.91 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.92 -0.487 . . . . 0.0 111.043 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.3 ttt-85 -60.91 -25.51 66.8 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.4 t -63.93 -36.42 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.827 0.851 . . . . 0.0 112.36 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 mp 56.87 172.44 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.079 1.752 . . . . 0.0 115.308 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 39.3 t -87.61 139.2 31.47 Favored Pre-proline 0 N--CA 1.469 0.505 0 O-C-N 121.133 -0.979 . . . . 0.0 112.163 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.33 -15.98 12.51 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.993 3.129 . . . . 0.0 114.598 168.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.0 tpt85 -64.34 -19.16 65.27 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.14 1.776 . . . . 0.0 113.173 171.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.65 27.69 23.82 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.409 1.48 . . . . 0.0 113.709 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -140.06 152.56 46.3 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.897 1.279 . . . . 0.0 112.043 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -64.55 146.64 54.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.927 1.691 . . . . 0.0 113.363 -171.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.1 mt -115.48 75.79 0.96 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.144 1.778 . . . . 0.0 111.447 -175.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.81 150.25 29.25 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.4 tp -58.6 134.39 56.71 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.304 1.442 . . . . 0.0 109.529 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 m -127.07 125.28 41.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.741 1.216 . . . . 0.0 111.192 -175.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.435 ' CE1' ' HG3' ' A' ' 79' ' ' PRO . 38.3 t80 -66.19 138.63 96.12 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.842 1.257 . . . . 0.0 112.094 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -76.56 -15.16 17.57 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.132 2.555 . . . . 0.0 114.911 -177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 91.31 3.72 69.23 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.535 1.064 . . . . 0.0 115.012 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -155.31 179.91 8.71 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.681 1.993 . . . . 0.0 110.756 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -110.42 170.64 7.95 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.939 1.295 . . . . 0.0 111.158 -178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 50.63 40.75 24.6 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 126.411 1.884 . . . . 0.0 112.83 -174.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 m -140.87 141.59 24.95 Favored Pre-proline 0 N--CA 1.476 0.858 0 C-N-CA 126.14 1.776 . . . . 0.0 110.344 -169.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -52.95 163.31 2.13 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 125.293 3.995 . . . . 0.0 115.981 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.9 t -115.01 149.68 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.127 1.371 . . . . 0.0 110.857 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 m -127.8 176.0 7.9 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.301 1.441 . . . . 0.0 111.261 -168.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.7 m -123.43 156.29 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 120.965 -1.084 . . . . 0.0 112.045 170.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.3 m -153.0 167.05 14.15 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 124.946 1.298 . . . . 0.0 112.375 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.05 118.53 5.44 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.682 2.921 . . . . 0.0 111.671 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.9 tp -66.63 134.76 52.96 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.789 -0.569 . . . . 0.0 111.842 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -138.61 3.42 2.29 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.566 1.546 . . . . 0.0 113.712 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.5 0.67 86.28 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.943 1.258 . . . . 0.0 115.033 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.7 t -63.29 147.41 51.15 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.402 1.601 . . . . 0.0 112.401 175.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 18.7 m -59.53 -13.51 9.35 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.325 1.45 . . . . 0.0 114.405 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.03 -26.16 63.91 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.162 0.892 . . . . 0.0 112.371 171.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -118.63 0.89 11.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.906 1.682 . . . . 0.0 114.45 -175.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.16 145.48 27.96 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.617 1.167 . . . . 0.0 110.55 171.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -136.05 169.96 16.78 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 123.015 1.388 . . . . 0.0 112.546 -168.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 94.1 mt -117.54 137.15 52.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 128.578 2.751 . . . . 0.0 107.3 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.2 tp -134.65 128.99 34.16 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.573 1.549 . . . . 0.0 109.211 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -142.65 138.17 30.47 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.469 1.108 . . . . 0.0 110.732 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.8 t -67.81 141.26 56.55 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.947 0.499 . . . . 0.0 110.552 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -108.8 -51.25 2.91 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.623 1.169 . . . . 0.0 110.715 174.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.21 109.87 4.65 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.142 1.377 . . . . 0.0 110.595 169.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.9 m -56.96 -24.38 52.56 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.945 0.898 . . . . 0.0 111.745 168.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -65.21 -20.93 66.67 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.096 2.158 . . . . 0.0 113.589 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.5 t -130.8 14.59 5.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.838 1.655 . . . . 0.0 112.844 175.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 43.36 33.77 0.65 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.571 1.948 . . . . 0.0 114.113 -169.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -85.9 145.56 27.11 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 120.893 -1.129 . . . . 0.0 112.037 -177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 62.1 m95 -141.52 148.97 40.25 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.149 1.38 . . . . 0.0 111.58 -177.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.3 p -91.34 145.78 24.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.25 1.02 . . . . 0.0 110.641 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.8 mm -127.91 115.76 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 126.768 2.027 . . . . 0.0 110.257 -172.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.4 m -134.62 146.15 57.89 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 123.882 0.873 . . . . 0.0 110.712 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HG3' ' CE1' ' A' ' 42' ' ' TYR . 62.2 Cg_endo -70.8 146.59 54.17 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.729 2.286 . . . . 0.0 109.92 174.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.31 -22.06 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -96.82 -11.13 54.27 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 124.554 1.073 . . . . 0.0 115.241 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 24.5 m -144.22 62.0 9.68 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.954 1.302 . . . . 0.0 111.795 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.49 -17.1 46.15 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.109 3.206 . . . . 0.0 113.846 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -71.65 19.02 0.07 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 128.653 2.781 . . . . 0.0 114.497 169.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.6 p -142.31 164.96 28.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.044 1.738 . . . . 0.0 112.226 171.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -143.83 140.37 29.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.568 1.547 . . . . 0.0 111.09 -172.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 30.4 mm -85.04 132.25 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.79 -0.569 . . . . 0.0 111.086 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -144.1 -165.11 10.77 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.889 2.185 . . . . 0.0 112.021 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -144.04 141.62 30.2 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.387 1.075 . . . . 0.0 111.674 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.26 -163.55 11.05 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.319 1.438 . . . . 0.0 113.31 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.64 140.41 18.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.987 1.315 . . . . 0.0 113.207 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.93 -7.85 70.21 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 124.572 1.082 . . . . 0.0 114.012 -172.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 48.22 58.05 5.54 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.334 1.854 . . . . 0.0 113.853 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.2 m -133.25 149.25 72.03 Favored Pre-proline 0 C--O 1.24 0.564 0 C-N-CA 126.272 1.829 . . . . 0.0 107.458 169.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.47 145.29 58.37 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.298 1.142 . . . . 0.0 109.395 174.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.06 172.06 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.581 1.952 . . . . 0.0 109.797 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.6 p -119.51 136.25 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 O-C-N 121.323 -0.861 . . . . 0.0 111.215 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.6 mt -140.87 165.15 31.52 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 127.27 2.228 . . . . 0.0 110.474 -169.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -77.3 155.41 32.67 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.497 2.131 . . . . 0.0 111.643 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.39 124.85 12.61 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.194 3.263 . . . . 0.0 113.537 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -149.49 -88.85 0.08 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.616 1.166 . . . . 0.0 110.428 -176.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -154.89 8.84 0.31 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.23 1.412 . . . . 0.0 114.218 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -69.02 139.82 54.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.384 -0.822 . . . . 0.0 110.845 -175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.3 m -148.93 164.26 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.112 1.365 . . . . 0.0 111.417 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -129.47 131.36 46.67 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.121 1.369 . . . . 0.0 110.536 169.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.8 m -75.93 130.57 38.68 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.275 1.03 . . . . 0.0 109.559 169.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 48.7 mt -117.38 129.58 55.95 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.569 1.147 . . . . 0.0 109.447 -177.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 m -137.02 129.29 29.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.093 0.957 . . . . 0.0 110.228 -170.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.2 mt -65.68 153.62 41.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.697 0.76 . . . . 0.0 113.025 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.1 p -127.78 -179.22 4.83 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 126.024 1.73 . . . . 0.0 110.274 170.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 75.7 p -60.89 -12.81 12.26 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.0 29.45 0.29 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.422 1.011 . . . . 0.0 114.658 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 176.95 -153.06 13.01 Favored Glycine 0 CA--C 1.535 1.323 0 CA-C-N 118.386 1.093 . . . . 0.0 113.25 -173.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -131.58 169.74 15.7 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.108 2.163 . . . . 0.0 112.266 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -136.49 149.72 48.31 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.424 2.289 . . . . 0.0 109.462 173.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 24.9 mt -132.58 115.61 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.678 1.191 . . . . 0.0 109.106 -170.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -135.91 149.89 49.12 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.513 1.125 . . . . 0.0 111.649 -169.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -55.11 -34.12 63.43 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.082 0.953 . . . . 0.0 113.129 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.49 -29.83 2.85 Favored Glycine 0 N--CA 1.47 0.965 0 C-N-CA 125.856 1.693 . . . . 0.0 113.916 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -79.61 -6.02 56.23 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 174.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 60.59 12.92 3.88 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.474 2.31 . . . . 0.0 114.048 -170.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.3 p -65.75 -28.19 68.85 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.837 2.055 . . . . 0.0 112.761 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.0 m -144.89 171.06 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 126.014 1.725 . . . . 0.0 112.135 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.2 t -146.15 156.02 43.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.413 2.685 . . . . 0.0 110.032 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -72.23 145.25 48.09 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.49 -0.756 . . . . 0.0 111.866 171.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 78.7 p -154.41 177.18 11.44 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.056 1.342 . . . . 0.0 112.232 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -118.96 169.52 9.82 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.644 1.578 . . . . 0.0 110.211 173.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -95.26 -33.32 12.62 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.354 0.662 . . . . 0.0 111.979 -176.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 24.0 p30 -144.8 0.52 0.97 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.479 1.912 . . . . 0.0 114.42 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 52.08 26.54 3.88 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.864 2.066 . . . . 0.0 116.038 -172.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.5 p -82.6 160.16 22.57 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 120.965 -1.084 . . . . 0.0 112.246 172.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -64.14 141.46 58.76 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.303 -0.873 . . . . 0.0 111.93 172.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.28 1.19 89.52 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.178 0.894 . . . . 0.0 114.817 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -83.35 149.69 26.57 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 118.99 1.395 . . . . 0.0 113.45 -173.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -74.87 136.76 41.5 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.312 -0.867 . . . . 0.0 111.056 175.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.0 t -70.34 154.54 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.106 0.479 . . . . 0.0 110.568 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.4 t -131.58 164.92 24.79 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.342 1.857 . . . . 0.0 111.343 -177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 77.6 mt -136.8 140.27 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 125.572 1.549 . . . . 0.0 109.638 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.99 177.96 47.14 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 125.056 1.312 . . . . 0.0 111.44 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.09 36.48 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 119.315 1.557 . . . . 0.0 114.553 -171.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -170.28 171.25 6.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.561 2.744 . . . . 0.0 108.968 176.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.0 127.21 21.14 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.766 0.826 . . . . 0.0 111.176 170.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.9 t -60.67 -14.17 19.15 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.258 1.823 . . . . 0.0 115.682 -170.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -128.65 -38.85 1.68 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.356 1.063 . . . . 0.0 113.185 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 74.3 p -111.96 2.99 17.19 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -171.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.37 13.83 0.53 Allowed Glycine 0 CA--C 1.539 1.537 0 N-CA-C 116.327 1.291 . . . . 0.0 116.327 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -134.68 147.84 50.2 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.255 2.027 . . . . 0.0 111.074 -172.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 75.8 m95 -139.8 176.01 9.1 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.491 1.516 . . . . 0.0 112.371 -168.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 55.3 t -135.82 139.14 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.101 1.36 . . . . 0.0 109.099 170.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.7 125.7 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 169.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.19 154.67 39.48 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 124.477 1.111 . . . . 0.0 109.56 -171.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -68.11 155.79 38.82 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.043 -1.036 . . . . 0.0 112.606 -178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.6 t . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.131 1.772 . . . . 0.0 111.31 171.584 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.488 1.434 0 N-CA-C 110.784 -0.08 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.73 13.67 0.14 Allowed Glycine 0 CA--C 1.539 1.567 0 N-CA-C 115.372 0.909 . . . . 0.0 115.372 177.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -156.7 -175.31 5.36 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.187 1.795 . . . . 0.0 110.482 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -122.88 -1.56 8.86 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.699 1.6 . . . . 0.0 113.668 -174.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -140.77 168.49 19.67 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.321 1.849 . . . . 0.0 111.452 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -151.54 170.63 19.18 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.816 1.247 . . . . 0.0 111.34 174.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -142.43 -3.69 1.03 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.243 1.417 . . . . 0.0 114.643 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -134.98 -8.86 2.34 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.155 1.382 . . . . 0.0 113.809 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -130.06 -2.67 4.56 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.586 1.554 . . . . 0.0 113.766 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -149.83 163.03 39.12 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.419 1.487 . . . . 0.0 111.318 177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.6 m -144.56 144.28 31.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.613 1.565 . . . . 0.0 111.841 -177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.02 10.11 0.08 OUTLIER Glycine 0 CA--C 1.539 1.544 0 N-CA-C 115.903 1.121 . . . . 0.0 115.903 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -137.29 15.06 3.0 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.43 1.492 . . . . 0.0 112.302 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.585 ' H ' ' CD ' ' A' ' 15' ' ' PRO . 77.5 p -146.75 -23.48 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.606 1.962 . . . . 0.0 116.214 -174.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.585 ' CD ' ' H ' ' A' ' 14' ' ' SER . 87.7 Cg_exo -53.79 143.86 57.15 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 122.579 2.186 . . . . 0.0 113.836 169.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.59 15.52 1.61 Allowed 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 t -146.75 147.46 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.427 1.891 . . . . 0.0 110.156 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.1 t -143.19 11.33 1.75 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.605 1.562 . . . . 0.0 113.303 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.7 mt 58.35 170.58 0.06 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.245 2.218 . . . . 0.0 113.917 -173.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.0 m -161.56 162.05 30.05 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.704 2.002 . . . . 0.0 109.222 177.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.15 137.11 58.13 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.544 -0.722 . . . . 0.0 111.923 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.79 -160.11 32.89 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 123.901 0.762 . . . . 0.0 114.937 -177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -98.48 122.62 41.9 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.919 1.288 . . . . 0.0 110.616 173.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -134.65 172.71 12.56 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.773 1.229 . . . . 0.0 112.698 -171.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.7 pt -128.44 154.25 38.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 126.458 1.903 . . . . 0.0 108.57 170.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.3 mt -124.97 126.91 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 174.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -141.26 150.38 42.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.05 0.54 . . . . 0.0 112.156 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -77.07 134.98 38.61 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.589 -0.694 . . . . 0.0 111.298 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -61.48 -28.32 69.21 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.106 1.151 . . . . 0.0 114.106 -174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.41 -32.19 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.379 0.672 . . . . 0.0 112.042 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 83.5 mt 55.3 171.39 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.453 1.901 . . . . 0.0 114.208 -169.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.6 t -65.18 147.31 98.65 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 121.133 -0.979 . . . . 0.0 111.18 -175.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.13 -22.05 18.32 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.319 2.679 . . . . 0.0 114.14 169.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 -84.04 -14.32 50.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.846 1.258 . . . . 0.0 113.733 175.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.2 2.18 62.34 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.98 1.752 . . . . 0.0 114.289 -174.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -75.03 159.74 31.37 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.597 1.159 . . . . 0.0 112.203 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -61.97 156.03 22.16 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.805 0.842 . . . . 0.0 112.191 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.5 mt -130.65 66.84 1.51 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.48 1.512 . . . . 0.0 111.134 177.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.76 141.66 36.1 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.601 1.16 . . . . 0.0 112.857 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.57 128.21 36.02 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.039 0.936 . . . . 0.0 108.789 169.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.0 m -128.37 115.0 17.56 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.055 0.942 . . . . 0.0 110.801 -170.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -59.89 135.19 90.03 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 126.934 2.094 . . . . 0.0 112.086 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.89 -11.45 19.89 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.289 2.659 . . . . 0.0 114.602 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.63 8.83 82.37 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-O 119.079 -0.845 . . . . 0.0 115.119 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.8 ptt-85 -156.72 165.34 36.51 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.303 1.441 . . . . 0.0 112.134 -177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -87.74 166.6 14.52 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.436 1.095 . . . . 0.0 111.768 -174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 49.85 36.91 12.26 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.83 1.652 . . . . 0.0 113.839 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.8 m -135.97 138.55 27.97 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 126.228 1.811 . . . . 0.0 110.206 -169.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.3 160.57 4.63 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 124.94 3.76 . . . . 0.0 115.81 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.5 t -111.56 148.71 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.904 1.281 . . . . 0.0 110.724 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.3 m -123.36 167.24 14.06 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.256 1.422 . . . . 0.0 110.774 -169.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 p -121.48 138.25 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.167 0.987 . . . . 0.0 111.212 174.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.5 m -156.51 168.17 12.94 Favored Pre-proline 0 N--CA 1.479 1.015 0 C-N-CA 124.355 1.062 . . . . 0.0 112.882 -169.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -51.14 152.59 10.59 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.648 2.899 . . . . 0.0 114.286 169.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.4 tp -105.6 137.2 43.83 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.459 1.504 . . . . 0.0 110.45 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -135.23 -24.24 1.43 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.075 1.35 . . . . 0.0 112.751 172.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.18 5.83 9.35 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.199 1.381 . . . . 0.0 113.759 -178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.1 m -61.85 150.48 37.2 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.485 1.142 . . . . 0.0 111.532 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.2 p -61.8 -15.05 38.4 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -72.86 -24.01 60.82 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.355 1.062 . . . . 0.0 112.412 171.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -104.88 -9.33 18.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.519 1.927 . . . . 0.0 112.621 -174.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -102.62 142.0 34.5 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.596 1.158 . . . . 0.0 111.328 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -135.73 171.34 14.6 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.944 1.355 . . . . 0.0 112.111 -169.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 91.1 mt -126.17 136.45 60.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 127.024 2.13 . . . . 0.0 106.747 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.7 tp -136.84 126.53 25.46 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.948 1.299 . . . . 0.0 109.446 -169.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 35.2 mtp-105 -141.46 140.84 33.65 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.753 0.821 . . . . 0.0 111.121 175.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.0 t -65.24 141.56 58.59 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.908 0.483 . . . . 0.0 110.929 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -115.12 -51.27 2.72 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.434 1.094 . . . . 0.0 111.093 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.23 109.25 4.45 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.379 1.071 . . . . 0.0 110.996 169.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.2 m -59.18 -26.47 64.83 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.801 0.84 . . . . 0.0 111.166 168.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -60.99 -20.94 63.05 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.012 2.125 . . . . 0.0 113.398 172.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.0 m -130.26 6.32 4.91 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.308 1.843 . . . . 0.0 113.237 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 47.37 30.44 1.55 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.142 2.177 . . . . 0.0 114.281 -169.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.0 p -90.6 143.58 26.6 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.25 -0.907 . . . . 0.0 112.367 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -139.31 141.64 37.71 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.683 1.593 . . . . 0.0 111.104 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.5 p -77.87 147.71 34.98 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.711 -0.618 . . . . 0.0 111.06 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.0 mm -129.26 127.77 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.421 1.488 . . . . 0.0 109.71 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.0 m -142.84 142.38 22.25 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.197 1.399 . . . . 0.0 110.355 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.1 145.39 31.05 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.217 2.611 . . . . 0.0 111.314 176.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.53 -28.22 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.311 -0.868 . . . . 0.0 111.769 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.55 -24.96 76.17 Favored Glycine 0 CA--C 1.541 1.665 0 N-CA-C 114.868 0.707 . . . . 0.0 114.868 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 50.9 m -148.17 65.51 8.83 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 125.429 1.492 . . . . 0.0 111.614 -176.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -64.13 -17.9 61.47 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.843 3.028 . . . . 0.0 113.669 -173.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -69.96 -2.62 13.04 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 127.688 2.395 . . . . 0.0 114.636 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.2 m -132.8 174.72 10.02 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.372 1.869 . . . . 0.0 111.686 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -141.27 172.66 12.37 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.371 1.469 . . . . 0.0 113.164 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.1 mm -115.99 127.25 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.903 1.281 . . . . 0.0 110.413 175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.56 -157.48 7.18 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.489 1.519 . . . . 0.0 111.35 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -141.99 142.24 32.93 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.135 0.974 . . . . 0.0 111.665 -171.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.94 -165.25 12.1 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.361 1.458 . . . . 0.0 113.466 177.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.59 135.15 23.44 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.265 1.426 . . . . 0.0 113.049 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 100.23 -8.64 59.08 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.969 1.271 . . . . 0.0 114.012 -172.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 49.29 56.16 8.23 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.485 1.914 . . . . 0.0 113.949 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.9 m -133.89 150.43 74.5 Favored Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 126.266 1.826 . . . . 0.0 108.065 169.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.01 142.71 52.02 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 121.225 1.283 . . . . 0.0 109.721 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -135.05 151.5 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.815 1.646 . . . . 0.0 111.536 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.5 t -79.14 132.18 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.074 0.95 . . . . 0.0 111.044 175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -139.34 161.45 57.2 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 125.833 1.653 . . . . 0.0 112.193 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -65.04 174.06 5.26 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 123.277 2.652 . . . . 0.0 113.31 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.67 104.15 1.68 Allowed 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.779 2.319 . . . . 0.0 111.01 175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.405 ' HB3' ' CE2' ' A' ' 103' ' ' TYR . 65.2 t30 -143.46 13.51 1.77 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.657 1.183 . . . . 0.0 113.356 -177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 70.37 40.88 1.07 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.913 2.485 . . . . 0.0 113.773 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.405 ' CE2' ' HB3' ' A' ' 101' ' ' ASN . 90.7 m-85 -61.97 143.46 56.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.089 0.556 . . . . 0.0 110.887 169.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.92 156.55 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.206 1.002 . . . . 0.0 112.253 -177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -129.8 137.06 50.28 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.496 1.518 . . . . 0.0 110.448 172.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.9 m -71.0 134.23 46.98 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.698 1.199 . . . . 0.0 108.895 169.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 58.7 mt -126.24 73.93 1.41 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.878 0.871 . . . . 0.0 109.966 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 39.3 m -78.93 129.12 34.16 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.269 1.028 . . . . 0.0 111.116 -174.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.7 tp -71.2 145.83 49.44 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.455 0.702 . . . . 0.0 111.226 171.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.2 p -124.55 -177.17 3.72 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.741 1.616 . . . . 0.0 111.719 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 66.2 p -59.04 -13.44 6.74 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -165.22 25.96 0.18 Allowed Glycine 0 CA--C 1.533 1.197 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 178.55 -149.25 8.87 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.023 1.296 . . . . 0.0 112.127 -173.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -131.77 168.44 17.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.286 1.834 . . . . 0.0 112.024 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -134.15 142.43 47.46 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.393 2.277 . . . . 0.0 109.515 174.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.1 mt -124.37 121.78 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.419 1.088 . . . . 0.0 109.231 -171.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -138.17 158.04 45.09 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.194 1.398 . . . . 0.0 112.68 -171.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -59.8 -18.18 41.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 116.575 2.065 . . . . 0.0 116.575 -172.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 125.23 -35.71 3.01 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.916 1.722 . . . . 0.0 112.623 -169.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -110.17 4.18 20.82 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.503 1.921 . . . . 0.0 113.557 -170.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? 57.39 21.6 7.03 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.858 2.063 . . . . 0.0 113.781 -177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.1 p -77.62 -30.58 52.35 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.391 -0.818 . . . . 0.0 112.02 175.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.1 m -148.07 155.81 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.667 1.587 . . . . 0.0 111.959 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.1 t -130.5 153.37 48.89 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.577 1.951 . . . . 0.0 111.248 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 37.3 m0 -69.88 139.57 53.05 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.289 0.635 . . . . 0.0 111.812 171.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 88.1 p -147.76 175.06 11.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.929 1.292 . . . . 0.0 111.909 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.3 mt -125.43 151.33 46.35 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.53 1.532 . . . . 0.0 109.898 173.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -82.59 -33.56 27.97 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.179 0.992 . . . . 0.0 111.704 -169.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 29.9 m-80 -138.93 -6.21 1.45 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.674 1.99 . . . . 0.0 112.634 172.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.79 32.36 14.78 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.852 1.661 . . . . 0.0 114.243 -170.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.3 p -81.58 156.63 25.1 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.26 1.024 . . . . 0.0 111.509 170.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.84 139.59 57.77 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.252 -0.905 . . . . 0.0 111.674 172.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.67 86.0 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 125.125 1.345 . . . . 0.0 114.718 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -79.64 144.65 33.57 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.929 1.292 . . . . 0.0 113.25 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -75.7 128.44 35.21 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.854 -1.154 . . . . 0.0 110.655 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.9 t -63.95 148.53 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.182 0.593 . . . . 0.0 110.799 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.7 t -126.07 160.83 29.04 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.812 1.245 . . . . 0.0 111.779 -174.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.8 mt -134.22 140.86 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.823 1.649 . . . . 0.0 109.292 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 169.43 -159.73 32.69 Favored Glycine 0 N--CA 1.468 0.815 0 C-N-CA 123.776 0.703 . . . . 0.0 112.61 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.96 149.68 18.32 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 117.62 0.71 . . . . 0.0 111.764 169.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -52.63 119.09 4.14 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.482 1.513 . . . . 0.0 113.428 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.23 164.12 26.3 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.848 1.259 . . . . 0.0 114.174 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.2 t -93.65 -9.44 37.9 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.785 1.234 . . . . 0.0 114.229 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -142.11 -44.93 0.34 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.483 1.113 . . . . 0.0 113.028 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.8 p -91.61 1.93 56.81 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.6 5.09 6.07 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 126.414 1.959 . . . . 0.0 116.281 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -126.48 150.84 48.48 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.408 1.483 . . . . 0.0 112.252 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -142.16 175.98 9.33 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 127.389 2.276 . . . . 0.0 110.104 -169.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.65 139.7 28.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 124.354 1.062 . . . . 0.0 109.529 169.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -118.22 124.82 73.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 125.694 1.598 . . . . 0.0 107.15 174.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -147.74 153.44 39.26 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.644 1.178 . . . . 0.0 109.433 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -68.97 155.91 39.51 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.998 -1.064 . . . . 0.0 112.945 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 C--O 1.251 1.175 0 C-N-CA 126.221 1.808 . . . . 0.0 111.284 171.877 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 mmt . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.423 0.154 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.16 22.14 0.3 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.301 0.953 . . . . 0.0 114.527 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -154.91 171.66 19.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.262 1.825 . . . . 0.0 111.306 -177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -139.14 0.53 1.94 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.876 1.27 . . . . 0.0 113.272 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -152.52 167.67 28.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.905 1.682 . . . . 0.0 111.43 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -149.24 154.61 39.33 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.121 1.368 . . . . 0.0 110.882 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -148.79 151.37 34.67 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.906 1.283 . . . . 0.0 111.168 175.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -154.45 164.63 38.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.709 1.603 . . . . 0.0 111.142 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -150.01 148.15 28.7 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.31 1.044 . . . . 0.0 111.51 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -156.3 -33.6 0.09 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.461 1.504 . . . . 0.0 112.128 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 87.9 p -150.17 173.9 13.4 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.337 1.855 . . . . 0.0 111.578 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.87 -21.82 0.03 OUTLIER Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.048 0.832 . . . . 0.0 114.773 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -139.34 162.43 35.03 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.066 1.747 . . . . 0.0 110.905 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.0 p -152.43 160.62 31.01 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 125.409 1.484 . . . . 0.0 111.544 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -53.43 148.27 34.49 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.52 2.813 . . . . 0.0 114.164 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.01 31.64 1.13 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.884 1.273 . . . . 0.0 112.651 -173.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.19 143.21 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.547 1.539 . . . . 0.0 110.622 -172.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.7 p -129.26 1.87 5.15 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.064 1.746 . . . . 0.0 112.969 -171.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt 68.24 160.62 0.18 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 129.294 3.037 . . . . 0.0 113.165 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.1 m -151.45 159.53 44.15 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.668 1.987 . . . . 0.0 108.955 -179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.84 131.14 48.83 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.489 -0.757 . . . . 0.0 111.858 175.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.1 -163.11 36.86 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 -176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 -100.56 126.93 47.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.128 0.971 . . . . 0.0 110.345 174.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -136.05 172.3 13.21 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.238 1.415 . . . . 0.0 112.292 -170.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 pt -126.96 152.14 34.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 126.111 1.764 . . . . 0.0 108.518 172.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.1 mt -131.04 115.89 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -140.49 151.48 44.85 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.702 0.763 . . . . 0.0 112.408 -177.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -81.45 136.72 35.67 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.436 -173.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.8 mtp-105 -65.13 -18.22 65.12 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.9 t -66.23 -22.64 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.135 0.974 . . . . 0.0 112.375 173.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.4 mt 59.82 172.95 0.08 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.656 1.982 . . . . 0.0 113.718 -172.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.6 p -67.19 162.86 51.0 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.506 1.122 . . . . 0.0 112.024 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -68.23 -4.55 12.93 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 122.827 2.351 . . . . 0.0 112.961 170.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 45.9 tpt85 -100.76 -8.72 22.46 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.858 2.063 . . . . 0.0 113.32 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.4 24.42 28.81 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.489 1.042 . . . . 0.0 113.987 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.52 170.37 12.09 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.816 1.247 . . . . 0.0 111.836 -176.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -56.77 144.16 33.92 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.015 -1.053 . . . . 0.0 111.557 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.7 tp -125.11 72.98 1.26 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.328 1.451 . . . . 0.0 109.887 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.31 151.42 24.77 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 114.676 -1.147 . . . . 0.0 113.718 -170.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.8 tp -57.59 134.05 55.81 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.852 0.861 . . . . 0.0 108.897 168.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 85.6 m -134.54 126.05 28.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.864 0.865 . . . . 0.0 111.123 -170.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -60.49 130.3 89.93 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 126.518 1.927 . . . . 0.0 111.948 -176.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.32 -10.41 19.1 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.442 2.761 . . . . 0.0 114.465 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.53 -2.32 58.91 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.318 0.961 . . . . 0.0 115.152 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -160.28 171.22 19.54 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.082 1.353 . . . . 0.0 112.94 -172.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -96.51 169.14 10.1 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.403 1.881 . . . . 0.0 111.121 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 23.4 mmt-85 52.13 32.51 10.61 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 126.113 1.765 . . . . 0.0 114.022 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.1 m -137.11 138.13 24.69 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.301 1.441 . . . . 0.0 110.731 -169.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.7 155.38 10.59 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 124.567 3.512 . . . . 0.0 114.847 172.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 t -105.03 153.81 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.867 1.267 . . . . 0.0 110.542 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.8 m -125.42 171.06 10.77 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.197 1.399 . . . . 0.0 110.186 -170.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.64 141.66 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 120.911 -1.118 . . . . 0.0 112.047 175.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.1 m -153.12 166.16 16.1 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.052 0.941 . . . . 0.0 112.327 -171.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -53.86 164.79 2.2 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.648 2.898 . . . . 0.0 113.564 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tt -127.59 141.8 51.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.729 1.211 . . . . 0.0 111.785 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -143.36 -13.6 0.69 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.43 -8.35 8.94 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.096 1.332 . . . . 0.0 114.347 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.1 p -63.44 157.86 22.21 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.895 1.348 . . . . 0.0 113.302 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 p -64.22 -11.91 35.64 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -66.53 -36.32 82.4 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.207 1.003 . . . . 0.0 112.161 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.81 6.4 11.49 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.58 147.27 24.04 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.793 0.806 . . . . 0.0 111.652 172.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 81.8 m95 -138.61 172.09 13.4 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 122.661 1.22 . . . . 0.0 112.306 -169.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 74.2 mt -120.77 135.47 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.498 2.319 . . . . 0.0 107.066 -179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.0 tp -137.28 122.3 19.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.123 1.369 . . . . 0.0 109.544 -172.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -140.92 137.98 33.52 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.309 0.644 . . . . 0.0 111.633 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.5 t -64.46 138.94 58.69 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.124 0.569 . . . . 0.0 111.151 -176.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -115.17 -51.29 2.72 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.557 1.143 . . . . 0.0 111.339 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -146.52 109.96 4.81 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.583 1.153 . . . . 0.0 111.625 170.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.1 m -58.98 -23.72 62.02 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.025 0.93 . . . . 0.0 111.468 168.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.07 -21.69 66.62 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.075 2.15 . . . . 0.0 113.341 174.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.2 m -130.4 7.8 4.97 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.956 1.703 . . . . 0.0 113.002 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 46.56 34.87 2.6 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.667 1.987 . . . . 0.0 113.47 -168.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.6 p -92.34 142.76 27.1 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.531 -0.731 . . . . 0.0 112.275 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.8 m95 -138.73 144.15 39.37 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.86 1.664 . . . . 0.0 110.478 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.0 p -77.96 150.1 34.03 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.56 0.744 . . . . 0.0 111.018 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.8 mm -128.73 126.87 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.72 1.608 . . . . 0.0 109.479 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 m -144.92 145.93 29.35 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 125.701 1.601 . . . . 0.0 110.51 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.27 145.41 34.49 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.832 2.354 . . . . 0.0 110.831 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.5 m -65.22 -24.69 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.004 -1.06 . . . . 0.0 113.119 177.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.65 -17.96 60.94 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.062 0.839 . . . . 0.0 114.61 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 42.5 m -144.1 62.14 9.99 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 125.434 1.494 . . . . 0.0 110.962 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -61.8 -18.59 61.59 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.013 3.142 . . . . 0.0 113.423 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -71.35 9.33 0.81 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 128.314 2.645 . . . . 0.0 114.148 169.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 79.1 p -138.44 172.53 12.75 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.886 1.675 . . . . 0.0 111.966 174.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -141.44 169.75 17.02 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.167 1.387 . . . . 0.0 112.837 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 mm -115.97 128.48 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.932 1.293 . . . . 0.0 110.567 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.37 -160.77 8.55 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 125.778 1.656 . . . . 0.0 111.926 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -140.27 139.63 35.56 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.443 1.097 . . . . 0.0 111.468 -172.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.18 -164.85 11.39 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.383 1.468 . . . . 0.0 113.208 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.3 139.38 19.16 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.928 1.291 . . . . 0.0 113.084 -178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.3 -7.72 66.63 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.825 1.202 . . . . 0.0 114.13 -172.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 47.97 56.42 7.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.516 1.926 . . . . 0.0 113.974 -177.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.71 150.96 76.17 Favored Pre-proline 0 C--O 1.24 0.571 0 C-N-CA 126.112 1.765 . . . . 0.0 108.386 169.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.87 142.67 58.11 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 121.23 1.286 . . . . 0.0 109.762 173.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.8 m -132.84 150.46 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.681 1.592 . . . . 0.0 111.354 -177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 t -83.26 132.92 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.764 0.826 . . . . 0.0 110.816 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.6 mt -138.39 162.33 54.03 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 125.982 1.713 . . . . 0.0 112.384 -169.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -61.1 167.19 9.48 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.824 2.349 . . . . 0.0 113.302 174.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.66 125.98 10.46 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.735 2.29 . . . . 0.0 110.216 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -146.95 -106.25 0.09 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.806 1.242 . . . . 0.0 109.304 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -145.22 21.55 1.55 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.518 1.927 . . . . 0.0 110.471 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -66.53 133.75 51.0 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.386 -0.821 . . . . 0.0 111.385 -174.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.4 m -144.78 160.27 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 124.964 1.306 . . . . 0.0 111.812 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -130.84 148.77 52.66 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.406 1.482 . . . . 0.0 110.406 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.9 m -74.98 139.11 42.73 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.168 0.987 . . . . 0.0 109.262 169.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -123.59 73.92 1.22 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.143 0.977 . . . . 0.0 109.31 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 93.2 m -76.96 118.9 19.99 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.289 1.036 . . . . 0.0 110.594 -176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 17.8 tp -66.98 146.48 54.33 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.285 0.634 . . . . 0.0 111.156 170.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.2 p -125.42 -178.42 4.22 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.685 1.594 . . . . 0.0 111.233 178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.0 t -60.26 -18.48 49.3 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -158.7 28.2 0.42 Allowed Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.445 1.021 . . . . 0.0 114.465 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.63 -153.07 16.61 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.459 1.028 . . . . 0.0 113.018 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -133.1 168.71 18.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.87 2.068 . . . . 0.0 111.981 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -135.88 151.23 49.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.685 1.994 . . . . 0.0 110.412 171.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.7 mt -132.17 114.55 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.033 0.933 . . . . 0.0 109.949 -169.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -135.47 156.43 48.91 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.199 1.0 . . . . 0.0 111.973 -169.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -60.35 -31.23 70.12 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.457 1.503 . . . . 0.0 114.829 -173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 133.09 -40.76 1.56 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.658 2.075 . . . . 0.0 112.797 -174.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -81.37 -6.45 58.93 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.676 1.19 . . . . 0.0 114.05 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.9 mmt-85 59.18 16.08 4.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.962 2.105 . . . . 0.0 113.999 -170.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 46.5 p -69.73 -23.39 63.39 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.871 1.268 . . . . 0.0 112.265 178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.7 m -144.27 170.01 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.101 1.76 . . . . 0.0 111.701 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 t -142.38 156.83 45.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.729 2.012 . . . . 0.0 110.676 173.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.4 m0 -70.9 138.72 50.38 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.234 0.614 . . . . 0.0 111.354 170.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.9 p -149.29 173.0 13.97 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.549 1.14 . . . . 0.0 112.504 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.1 mt -123.97 173.59 8.13 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.911 1.684 . . . . 0.0 109.879 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -111.41 -33.73 6.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.079 0.952 . . . . 0.0 111.459 -171.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -140.98 -9.49 1.01 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.646 1.978 . . . . 0.0 112.683 171.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.71 24.28 8.81 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.055 1.742 . . . . 0.0 114.784 -169.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.2 p -71.88 154.75 41.04 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 121.19 -0.944 . . . . 0.0 111.181 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -69.2 143.43 54.0 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 120.887 -1.133 . . . . 0.0 111.764 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.07 4.2 89.65 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.481 1.038 . . . . 0.0 114.153 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -73.56 142.58 46.63 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.825 1.313 . . . . 0.0 112.46 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -77.62 111.37 13.31 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.437 -0.789 . . . . 0.0 109.777 172.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.6 p -54.7 149.09 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.895 0.878 . . . . 0.0 111.434 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.7 t -130.55 168.63 16.76 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.561 1.544 . . . . 0.0 112.008 -169.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 64.8 mt -134.74 141.73 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.041 1.736 . . . . 0.0 108.866 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 168.91 -162.97 36.77 Favored Glycine 0 CA--C 1.526 0.722 0 O-C-N 121.52 -0.737 . . . . 0.0 112.283 176.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.61 153.56 10.15 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 117.631 0.715 . . . . 0.0 111.803 169.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -53.51 122.3 9.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.664 1.186 . . . . 0.0 113.039 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.69 173.68 7.81 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.228 1.411 . . . . 0.0 113.703 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 t -105.15 -5.06 21.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.821 1.248 . . . . 0.0 114.355 -172.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -148.44 -41.04 0.16 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.353 1.061 . . . . 0.0 112.821 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 84.2 p -96.91 4.98 51.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.376 1.47 . . . . 0.0 114.487 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.87 2.66 16.09 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.908 1.242 . . . . 0.0 115.575 -174.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 -130.32 146.31 51.9 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.897 1.848 . . . . 0.0 111.134 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -136.97 174.36 10.7 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.875 1.27 . . . . 0.0 111.835 -168.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.5 p -138.53 139.14 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.757 1.223 . . . . 0.0 109.461 172.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.81 124.49 71.58 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 125.627 1.571 . . . . 0.0 107.067 176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.98 153.78 38.42 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.856 -170.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -67.9 155.57 39.12 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.074 -1.016 . . . . 0.0 112.429 -177.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.5 t . . . . . 0 C--O 1.252 1.205 0 C-N-CA 125.996 1.719 . . . . 0.0 111.228 172.429 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.17 10.5 0.22 Allowed Glycine 0 CA--C 1.538 1.508 0 N-CA-C 115.347 0.899 . . . . 0.0 115.347 177.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -154.26 169.76 22.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.253 1.821 . . . . 0.0 110.258 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 55.52 16.41 1.84 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.85 2.06 . . . . 0.0 115.307 -175.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -140.03 -4.63 1.34 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.973 1.709 . . . . 0.0 113.214 -176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -153.76 156.55 37.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.827 1.651 . . . . 0.0 110.845 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -148.22 19.85 1.09 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -171.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -134.22 169.95 16.43 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 120.99 -1.069 . . . . 0.0 112.772 -171.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -67.71 164.25 19.78 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.823 0.849 . . . . 0.0 112.314 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -148.76 155.7 41.34 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.257 1.423 . . . . 0.0 111.524 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.7 p -151.13 158.67 44.3 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.804 1.242 . . . . 0.0 112.958 -177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.94 25.85 0.06 OUTLIER Glycine 0 CA--C 1.538 1.472 0 C-N-CA 124.325 0.964 . . . . 0.0 114.651 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -143.69 21.4 1.82 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.034 1.334 . . . . 0.0 112.73 -171.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.2 m -141.21 148.85 53.07 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 125.536 1.534 . . . . 0.0 111.372 -175.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -73.51 158.72 47.42 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.116 2.544 . . . . 0.0 112.589 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.99 29.35 1.49 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.31 1.444 . . . . 0.0 112.263 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.57 147.02 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.581 1.552 . . . . 0.0 110.374 -174.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.7 t -133.83 8.73 3.85 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -175.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 92.5 mt 58.42 175.44 0.06 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.978 2.111 . . . . 0.0 113.967 -177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 t -159.94 170.1 22.07 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.29 1.436 . . . . 0.0 109.825 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.55 140.46 58.55 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 121.701 -0.625 . . . . 0.0 112.271 173.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.14 -162.37 33.15 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.203 0.906 . . . . 0.0 114.391 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -95.19 125.33 39.76 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.017 0.927 . . . . 0.0 110.174 170.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -134.19 170.87 15.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.367 1.467 . . . . 0.0 112.312 -172.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.8 pt -123.9 151.55 28.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 126.119 1.768 . . . . 0.0 108.361 170.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.1 mt -128.18 120.12 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -139.94 149.83 43.79 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.743 0.817 . . . . 0.0 112.061 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -75.9 136.39 40.11 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.655 -0.653 . . . . 0.0 111.79 -174.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 46.4 tpt85 -65.76 -15.47 62.88 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -174.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.5 t -70.35 -20.66 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.633 1.173 . . . . 0.0 112.489 172.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.5 mm? 61.13 167.87 0.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 127.108 2.163 . . . . 0.0 112.569 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.0 t -65.8 150.02 96.82 Favored Pre-proline 0 CA--C 1.539 0.556 0 O-C-N 121.191 -0.943 . . . . 0.0 111.072 171.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.61 -14.89 42.64 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.87 2.38 . . . . 0.0 112.97 169.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -71.39 -15.32 62.36 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.403 1.481 . . . . 0.0 113.104 169.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.07 27.74 36.36 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.744 1.64 . . . . 0.0 113.792 -175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -128.83 166.1 19.7 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.25 1.42 . . . . 0.0 111.514 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.04 141.22 54.57 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.437 0.695 . . . . 0.0 111.572 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 27.1 tp -122.39 74.4 1.17 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.094 1.758 . . . . 0.0 109.2 -169.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.29 147.13 29.07 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.352 1.461 . . . . 0.0 114.547 -169.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.1 tp -58.16 136.18 57.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.232 1.013 . . . . 0.0 109.148 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.1 m -132.94 121.94 23.57 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.982 0.913 . . . . 0.0 111.373 -171.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -60.01 130.96 89.27 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 127.526 2.331 . . . . 0.0 111.498 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.63 -8.58 19.44 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.6 2.866 . . . . 0.0 114.432 -177.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.02 -2.27 65.92 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.227 0.917 . . . . 0.0 114.958 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -156.46 169.85 23.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.084 1.354 . . . . 0.0 113.001 -173.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -99.46 159.28 15.13 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.345 1.858 . . . . 0.0 110.527 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 57.49 39.9 27.57 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.788 1.635 . . . . 0.0 113.402 -175.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 54.1 m -142.22 139.2 17.49 Favored Pre-proline 0 N--CA 1.478 0.925 0 C-N-CA 125.963 1.705 . . . . 0.0 110.733 -172.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -52.96 156.95 8.79 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 124.869 3.713 . . . . 0.0 115.389 172.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 t -105.29 156.81 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.947 1.299 . . . . 0.0 110.711 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.6 m -127.94 170.16 13.16 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.715 1.606 . . . . 0.0 110.644 -171.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.1 140.16 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.843 1.257 . . . . 0.0 111.425 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.4 m -152.82 164.21 21.04 Favored Pre-proline 0 N--CA 1.479 0.975 0 C-N-CA 124.513 1.125 . . . . 0.0 112.758 -172.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -53.6 159.35 6.67 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.735 2.957 . . . . 0.0 113.604 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.2 tp -116.46 140.41 49.4 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.654 1.182 . . . . 0.0 111.725 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -140.68 -37.55 0.45 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.633 1.973 . . . . 0.0 112.517 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 141.11 3.58 1.21 Allowed Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.82 1.2 . . . . 0.0 115.374 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.8 t -62.39 154.68 27.4 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.535 1.667 . . . . 0.0 112.388 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.4 p -68.95 -14.79 63.25 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 173.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.57 -22.72 60.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.202 0.91 . . . . 0.0 112.343 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -118.73 6.4 11.56 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 128.111 2.564 . . . . 0.0 112.687 -169.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -115.17 149.51 37.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.966 1.306 . . . . 0.0 110.896 174.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -136.83 171.87 13.85 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 123.008 1.385 . . . . 0.0 112.856 -168.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 79.6 mt -120.2 135.33 60.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 127.948 2.499 . . . . 0.0 106.472 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.0 tp -135.73 126.21 26.84 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.116 1.366 . . . . 0.0 109.101 -172.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -142.82 139.59 30.99 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.634 0.773 . . . . 0.0 110.899 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.4 t -65.31 140.19 58.67 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.934 0.494 . . . . 0.0 110.874 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -109.84 -52.74 2.74 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.608 1.163 . . . . 0.0 110.62 173.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -145.18 106.86 4.25 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.721 1.208 . . . . 0.0 110.841 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 m -51.81 -31.81 28.84 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.204 1.802 . . . . 0.0 114.604 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 71' ' ' ASN . 3.2 p30 -73.71 -18.04 61.05 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.504 2.322 . . . . 0.0 114.151 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.7 m -117.51 6.37 12.54 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.923 1.689 . . . . 0.0 113.073 171.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 43.97 33.44 0.77 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.018 2.127 . . . . 0.0 114.267 -169.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 p -87.44 145.42 26.29 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.722 -1.236 . . . . 0.0 112.04 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.5 m95 -141.24 141.72 33.99 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.999 1.319 . . . . 0.0 111.422 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 p -80.46 146.58 31.33 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.76 0.824 . . . . 0.0 111.225 171.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.0 mm -130.16 122.26 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.45 1.5 . . . . 0.0 111.037 -171.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.9 m -142.04 147.66 45.37 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 125.256 1.423 . . . . 0.0 110.894 178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.74 146.94 34.45 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.82 2.347 . . . . 0.0 110.977 175.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.0 m -65.6 -23.96 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.864 -1.148 . . . . 0.0 112.793 176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.87 -6.58 72.12 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.6 1.095 . . . . 0.0 114.889 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.3 t -152.81 67.39 6.52 Favored Pre-proline 0 N--CA 1.473 0.709 0 CA-C-N 118.565 1.182 . . . . 0.0 111.867 176.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -62.16 -13.35 31.43 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.686 2.257 . . . . 0.0 113.103 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -78.16 11.26 2.41 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.473 1.909 . . . . 0.0 113.447 169.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.5 m -136.89 169.29 18.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.5 1.92 . . . . 0.0 111.783 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -141.61 167.18 22.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.353 1.461 . . . . 0.0 111.842 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.8 mm -119.18 130.98 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.665 1.186 . . . . 0.0 110.89 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -149.0 -158.86 8.26 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.722 1.629 . . . . 0.0 111.676 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -140.54 143.54 35.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.457 1.103 . . . . 0.0 111.792 -172.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -148.9 -165.34 12.16 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.394 1.474 . . . . 0.0 113.018 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.92 139.71 21.66 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.914 1.286 . . . . 0.0 113.185 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.12 -5.71 65.97 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.762 1.173 . . . . 0.0 114.18 -172.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 48.38 55.85 8.31 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.6 1.96 . . . . 0.0 114.401 -178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -134.68 149.07 69.78 Favored Pre-proline 0 C--O 1.24 0.567 0 C-N-CA 126.291 1.837 . . . . 0.0 107.573 169.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.4 147.64 59.2 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.022 1.148 . . . . 0.0 109.802 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.32 149.93 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.743 1.617 . . . . 0.0 110.973 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 25.2 t -77.7 137.34 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.504 0.721 . . . . 0.0 110.368 173.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 93.9 mt -138.89 164.63 38.12 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.069 2.148 . . . . 0.0 110.677 -170.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -69.92 159.74 52.18 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 122.109 1.872 . . . . 0.0 111.178 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.23 119.84 6.57 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.031 2.487 . . . . 0.0 110.328 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -144.11 -88.46 0.12 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 110.752 -176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.8 p30 -156.09 14.59 0.33 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.102 1.361 . . . . 0.0 113.414 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -70.15 134.34 48.03 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.408 -0.808 . . . . 0.0 111.477 -174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.64 160.02 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.484 1.113 . . . . 0.0 112.344 -174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -128.07 135.07 49.32 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.989 1.316 . . . . 0.0 110.769 171.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 75.0 m -76.45 129.18 36.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.753 1.221 . . . . 0.0 109.391 172.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 42.4 mt -117.05 129.34 55.94 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.097 0.959 . . . . 0.0 109.793 -178.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 m -133.27 118.03 18.07 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.649 1.18 . . . . 0.0 110.212 -169.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 16.4 tp -65.07 147.27 53.77 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.246 0.618 . . . . 0.0 111.335 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.3 p -129.06 -178.84 4.8 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.509 1.524 . . . . 0.0 111.686 -178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 64.3 p -59.05 -15.0 11.31 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.933 1.827 . . . . 0.0 115.933 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.92 27.51 0.24 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.215 0.912 . . . . 0.0 114.64 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 174.42 -148.35 9.8 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.954 1.264 . . . . 0.0 112.155 -173.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -131.8 172.12 12.69 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.936 2.095 . . . . 0.0 111.547 176.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -137.82 152.98 49.67 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.774 2.43 . . . . 0.0 109.526 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 38.7 mt -133.71 126.47 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.309 1.444 . . . . 0.0 108.824 -170.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -140.3 159.43 42.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.643 1.177 . . . . 0.0 113.14 -172.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.71 -24.17 67.54 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -169.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.9 -37.13 2.1 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.613 1.102 . . . . 0.0 113.032 -170.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -117.38 12.17 14.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.478 1.911 . . . . 0.0 113.709 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 62.42 16.63 8.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.757 2.023 . . . . 0.0 114.185 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.9 p -72.16 -29.17 63.76 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.72 0.808 . . . . 0.0 112.534 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.0 m -145.85 177.45 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.494 1.517 . . . . 0.0 111.837 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t -148.97 153.05 37.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.648 2.379 . . . . 0.0 110.093 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -69.85 144.92 52.41 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.534 -0.729 . . . . 0.0 111.712 171.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 87.7 p -151.94 171.6 17.55 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.673 1.189 . . . . 0.0 112.734 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.4 mt -125.6 165.78 17.91 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.356 1.862 . . . . 0.0 110.015 174.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -104.8 -32.8 8.67 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.871 0.869 . . . . 0.0 112.144 -169.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -138.81 -8.33 1.4 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.661 1.984 . . . . 0.0 112.436 172.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.51 21.68 5.87 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.009 1.724 . . . . 0.0 114.621 -170.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.2 p -73.08 154.13 40.53 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.961 -1.087 . . . . 0.0 111.683 171.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -63.65 142.82 58.26 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.299 -0.876 . . . . 0.0 112.263 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.05 1.68 90.08 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 124.904 1.24 . . . . 0.0 114.479 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.93 141.76 45.96 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.741 1.27 . . . . 0.0 112.776 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -76.22 117.86 18.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.23 -0.919 . . . . 0.0 110.312 173.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.9 p -58.88 148.29 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.804 0.842 . . . . 0.0 111.57 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.3 t -128.68 167.73 16.8 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.586 1.555 . . . . 0.0 111.781 -169.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 79.7 mt -135.6 141.22 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.603 1.561 . . . . 0.0 109.582 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -179.41 179.86 48.82 Favored Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.944 1.259 . . . . 0.0 111.605 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.07 -40.41 58.29 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.221 1.51 . . . . 0.0 114.334 -173.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -171.63 173.14 4.75 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 128.844 2.858 . . . . 0.0 109.331 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.74 139.87 36.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.201 1.0 . . . . 0.0 112.629 169.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.6 t -60.98 -20.79 62.83 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -169.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -137.71 -38.88 0.58 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.465 1.106 . . . . 0.0 113.222 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 86.8 p -93.35 3.67 55.24 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.294 1.437 . . . . 0.0 114.606 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.23 15.66 1.37 Allowed Glycine 0 CA--C 1.543 1.799 0 C-N-CA 125.856 1.693 . . . . 0.0 115.763 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -134.73 152.46 51.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.916 1.686 . . . . 0.0 111.451 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -141.77 175.9 9.34 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.884 2.074 . . . . 0.0 110.594 -169.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.82 138.37 47.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 125.123 1.369 . . . . 0.0 108.588 170.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.77 123.29 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -149.0 154.01 38.73 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.922 1.289 . . . . 0.0 109.239 -171.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.58 155.85 39.2 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.907 -1.12 . . . . 0.0 112.701 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 C--O 1.252 1.211 0 C-N-CA 126.146 1.778 . . . . 0.0 111.276 171.415 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.01 174.87 42.92 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.526 1.06 . . . . 0.0 113.095 176.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -140.04 3.51 2.0 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.622 1.169 . . . . 0.0 113.548 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -61.3 -12.59 14.21 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.476 1.91 . . . . 0.0 115.077 -176.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -125.21 11.11 8.13 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.458 1.903 . . . . 0.0 112.608 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.4 m80 53.66 -167.76 0.07 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.854 2.062 . . . . 0.0 113.936 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -133.95 8.84 3.82 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.741 1.616 . . . . 0.0 112.943 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -152.52 170.61 19.74 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.373 1.869 . . . . 0.0 111.666 -173.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.0 p-80 -152.54 172.5 16.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.658 1.583 . . . . 0.0 111.749 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -147.58 162.65 38.67 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.948 1.299 . . . . 0.0 111.356 176.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.3 t -138.78 13.04 2.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.944 1.697 . . . . 0.0 112.677 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.99 25.54 2.23 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.709 1.623 . . . . 0.0 113.865 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.92 -13.36 61.66 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.997 1.319 . . . . 0.0 113.815 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.9 m 46.88 54.72 15.61 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 126.778 2.031 . . . . 0.0 115.134 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.41 179.61 4.92 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.567 2.844 . . . . 0.0 113.459 177.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 51.6 39.59 25.3 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.89 1.676 . . . . 0.0 113.593 -178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.8 t -59.1 138.75 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.05 1.34 . . . . 0.0 110.15 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.6 t -129.86 10.49 5.52 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -172.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt 60.16 170.85 0.08 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.429 2.292 . . . . 0.0 114.343 -177.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.7 m -149.69 163.16 38.7 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.315 1.846 . . . . 0.0 109.61 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.17 54.76 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.458 -0.776 . . . . 0.0 111.417 170.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.84 -164.3 36.9 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 123.914 0.768 . . . . 0.0 114.604 -178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -94.52 125.65 39.3 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.017 0.927 . . . . 0.0 110.232 170.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -134.64 171.12 14.79 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.428 1.491 . . . . 0.0 112.409 -171.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.7 pt -125.38 152.42 32.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.173 1.789 . . . . 0.0 108.445 170.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.9 mt -128.72 119.85 50.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -140.25 148.96 42.25 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.696 0.798 . . . . 0.0 112.555 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -78.7 135.06 37.07 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.903 -0.498 . . . . 0.0 111.544 -174.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -59.59 -22.84 62.34 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.089 1.356 . . . . 0.0 114.139 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.6 t -64.56 -24.33 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 124.172 0.989 . . . . 0.0 112.866 175.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 62.6 mt 60.85 169.76 0.09 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.856 2.062 . . . . 0.0 113.867 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.9 p -75.37 160.6 79.44 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.331 1.052 . . . . 0.0 112.762 -175.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.2 -16.72 44.71 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.596 2.197 . . . . 0.0 112.694 170.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -76.19 -16.76 59.78 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.53 1.532 . . . . 0.0 113.094 171.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.72 22.2 19.13 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.249 1.404 . . . . 0.0 114.113 177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.38 172.08 12.61 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.895 1.278 . . . . 0.0 112.708 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -57.08 127.55 32.52 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.419 1.088 . . . . 0.0 111.447 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 34.8 tp -105.41 79.24 1.45 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.675 1.59 . . . . 0.0 110.016 -173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.29 147.64 27.84 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.788 1.635 . . . . 0.0 114.203 -169.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.4 tp -59.64 138.36 57.76 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.163 1.385 . . . . 0.0 110.863 170.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 m -130.42 126.52 37.22 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.102 0.961 . . . . 0.0 111.93 -171.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -61.25 130.51 91.66 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 126.319 1.848 . . . . 0.0 111.657 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -77.41 -6.49 16.39 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.707 2.938 . . . . 0.0 114.878 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.76 -2.29 62.07 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-O 118.832 -0.982 . . . . 0.0 115.082 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -160.22 169.75 22.59 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 118.919 1.359 . . . . 0.0 112.863 -172.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -95.17 167.55 11.3 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.894 1.677 . . . . 0.0 111.405 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.8 tpt85 47.49 40.71 11.77 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 127.11 2.164 . . . . 0.0 113.694 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.6 m -139.76 140.61 25.21 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 125.159 1.384 . . . . 0.0 111.83 -169.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -44.53 150.18 0.84 Allowed 'Trans proline' 0 C--N 1.355 0.888 1 C-N-CA 126.338 4.692 . . . . 0.0 115.424 169.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.7 t -109.57 155.84 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.145 1.378 . . . . 0.0 110.699 179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 52' ' ' VAL . 2.9 m -126.74 176.06 7.53 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.753 1.621 . . . . 0.0 111.082 -169.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.409 ' H ' HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -130.62 145.74 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.049 1.34 . . . . 0.0 111.452 176.162 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.6 m -151.22 159.67 33.19 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.938 1.295 . . . . 0.0 111.945 -174.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -63.66 132.38 35.06 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 121.84 1.693 . . . . 0.0 110.758 169.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.69 138.73 57.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.161 1.384 . . . . 0.0 111.436 175.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -132.45 -22.34 2.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.946 1.298 . . . . 0.0 112.594 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.73 -1.82 32.12 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.944 1.735 . . . . 0.0 113.478 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 96.6 p -80.04 159.42 26.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.792 1.237 . . . . 0.0 113.076 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.3 m -60.19 -18.16 46.24 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -63.76 -35.26 80.0 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.04 0.936 . . . . 0.0 112.458 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . 0.31 0.0 OUTLIER -120.47 14.06 11.89 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -178.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.16 149.69 23.72 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.267 1.027 . . . . 0.0 111.707 170.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -139.47 171.53 14.13 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.635 1.207 . . . . 0.0 113.131 -169.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.8 mt -120.8 137.04 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 127.721 2.408 . . . . 0.0 107.351 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.5 tp -137.0 125.61 23.73 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.487 1.515 . . . . 0.0 109.491 -171.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -142.88 135.69 27.92 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.08 0.952 . . . . 0.0 110.999 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 t -63.87 140.23 58.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.321 0.649 . . . . 0.0 111.37 -178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -112.06 -52.89 2.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.421 1.088 . . . . 0.0 111.25 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -147.89 117.34 6.98 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.524 1.13 . . . . 0.0 111.087 169.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -36.18 80.82 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 112.936 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -61.26 -17.35 53.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.927 2.091 . . . . 0.0 114.883 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 54.7 m -123.99 8.32 8.67 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.143 1.777 . . . . 0.0 113.624 172.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 43.36 33.56 0.62 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.31 1.844 . . . . 0.0 114.545 -169.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 p -89.25 144.81 25.82 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 120.386 -1.446 . . . . 0.0 112.316 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -139.71 140.82 36.91 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.357 1.463 . . . . 0.0 111.297 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 67.4 p -79.02 148.3 32.55 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.015 0.526 . . . . 0.0 110.858 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.13 129.9 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.524 1.53 . . . . 0.0 109.362 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 25.0 m -145.63 145.98 27.74 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 125.641 1.576 . . . . 0.0 110.622 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.19 145.91 35.52 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.999 2.466 . . . . 0.0 111.043 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.7 m -65.71 -25.78 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.925 -1.109 . . . . 0.0 113.057 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.87 -23.44 61.86 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 123.858 0.742 . . . . 0.0 114.388 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 68.7 m -142.09 64.13 16.75 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.701 1.6 . . . . 0.0 111.112 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -61.3 -19.38 63.7 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.917 3.078 . . . . 0.0 113.244 -177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -71.19 9.0 0.82 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 128.234 2.614 . . . . 0.0 114.415 169.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.8 p -138.03 172.73 12.49 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.717 1.607 . . . . 0.0 112.345 173.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -137.98 171.6 14.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.917 1.687 . . . . 0.0 112.567 -171.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -120.39 126.7 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.15 1.38 . . . . 0.0 110.728 175.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.75 -158.59 7.6 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.874 1.702 . . . . 0.0 111.385 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -141.3 144.09 34.43 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.343 1.071 . . . . 0.0 111.763 -173.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.84 -165.2 12.29 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.494 1.521 . . . . 0.0 113.059 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.24 138.92 25.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.003 1.321 . . . . 0.0 113.257 -175.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.18 -1.63 67.62 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.607 1.099 . . . . 0.0 114.354 -173.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 48.52 55.67 8.65 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.236 1.815 . . . . 0.0 113.669 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.8 p -132.68 137.2 29.25 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 127.695 2.398 . . . . 0.0 107.479 174.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.31 143.29 47.76 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.112 -1.149 . . . . 0.0 109.112 174.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.13 147.13 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.178 1.391 . . . . 0.0 110.932 -172.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.3 t -74.64 138.87 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.423 0.689 . . . . 0.0 109.964 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 90.3 mt -142.31 163.55 38.8 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 125.826 1.65 . . . . 0.0 111.728 -169.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -69.92 165.77 30.02 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.05 2.5 . . . . 0.0 111.751 175.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.43 123.7 9.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.555 2.17 . . . . 0.0 110.924 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -147.07 -92.11 0.09 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.164 0.985 . . . . 0.0 110.511 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.4 p-10 -154.53 17.47 0.46 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.563 1.545 . . . . 0.0 112.794 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -67.48 134.69 51.81 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.605 0.762 . . . . 0.0 111.92 -172.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.5 m -145.73 161.45 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.059 1.344 . . . . 0.0 112.391 -175.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -129.75 138.19 50.96 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.466 1.506 . . . . 0.0 110.875 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.5 m -74.95 125.52 29.06 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.242 1.417 . . . . 0.0 109.228 171.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 40.1 mt -116.46 128.41 55.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.965 0.906 . . . . 0.0 109.876 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 88.0 m -134.89 121.77 21.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.911 0.884 . . . . 0.0 110.858 -169.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 tp -67.92 148.24 51.38 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.262 0.625 . . . . 0.0 111.448 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.0 p -129.39 -176.67 3.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.93 1.692 . . . . 0.0 111.452 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 74.1 p -58.56 -17.71 23.86 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 -176.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.68 29.37 0.24 Allowed Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.506 1.05 . . . . 0.0 114.017 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.48 -150.99 10.47 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.977 1.275 . . . . 0.0 112.172 -173.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -134.86 171.93 13.7 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.077 2.151 . . . . 0.0 111.536 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -137.83 154.49 49.51 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.52 1.928 . . . . 0.0 110.91 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 31.5 mt -135.32 118.53 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.084 1.354 . . . . 0.0 110.057 -169.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -134.9 157.96 45.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.218 1.007 . . . . 0.0 112.831 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -62.53 -26.76 68.73 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -169.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.48 -40.35 1.67 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.145 1.355 . . . . 0.0 113.143 -170.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -98.54 1.5 46.6 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.643 1.577 . . . . 0.0 113.641 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.2 mmm-85 65.22 12.84 8.34 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.942 2.097 . . . . 0.0 113.738 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.2 p -73.49 -23.84 60.1 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.46 1.104 . . . . 0.0 112.812 -178.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.6 m -143.3 173.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.552 1.541 . . . . 0.0 112.017 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.8 t -145.17 154.0 41.97 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.582 2.753 . . . . 0.0 109.767 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.7 m0 -72.32 145.24 47.94 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.401 -0.812 . . . . 0.0 111.491 170.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.0 p -154.84 162.14 41.21 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.362 1.065 . . . . 0.0 112.868 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 66.5 mt -109.91 170.55 8.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.797 1.639 . . . . 0.0 109.375 169.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -109.77 -31.74 7.33 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.224 1.01 . . . . 0.0 112.059 -169.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -135.83 -10.11 2.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.756 2.022 . . . . 0.0 112.081 169.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 55.65 27.98 11.36 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.98 1.712 . . . . 0.0 113.939 -170.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 19.1 p -75.47 155.6 36.07 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.222 1.009 . . . . 0.0 111.657 170.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -66.26 136.54 55.99 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.244 -0.91 . . . . 0.0 111.427 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 85.03 0.75 88.93 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.466 1.031 . . . . 0.0 114.536 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -71.17 142.72 50.68 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 118.807 1.303 . . . . 0.0 112.73 178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -75.1 119.87 19.85 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.302 -0.874 . . . . 0.0 110.06 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.4 p -62.47 150.34 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.521 0.729 . . . . 0.0 111.357 173.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 54.1 m -131.95 168.98 16.95 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.309 1.844 . . . . 0.0 111.293 -171.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 73.6 mt -134.63 143.71 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 125.05 1.34 . . . . 0.0 109.379 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.28 179.33 47.53 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 124.819 1.2 . . . . 0.0 111.743 174.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.31 -42.65 61.33 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 118.963 1.382 . . . . 0.0 114.291 -172.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -169.71 172.93 6.53 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.166 2.586 . . . . 0.0 109.559 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.51 135.02 33.05 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.168 0.987 . . . . 0.0 112.254 170.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.6 t -56.98 -24.56 54.32 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 126.273 1.829 . . . . 0.0 115.809 -169.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -130.83 -36.41 1.38 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.962 1.305 . . . . 0.0 112.826 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 t -96.3 1.14 51.71 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -171.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.83 26.37 0.77 Allowed Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.105 1.336 . . . . 0.0 115.948 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 88.4 mmt-85 -145.92 149.7 34.71 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.17 1.788 . . . . 0.0 111.594 -177.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -141.62 176.76 8.64 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.956 1.702 . . . . 0.0 111.826 -169.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.22 140.16 42.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 125.629 1.572 . . . . 0.0 108.807 169.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.18 123.59 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 169.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -148.98 153.32 37.77 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.599 1.16 . . . . 0.0 109.474 -170.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -68.09 155.01 40.47 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.945 -1.097 . . . . 0.0 112.736 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.3 t . . . . . 0 C--O 1.251 1.17 0 C-N-CA 126.317 1.847 . . . . 0.0 111.31 171.199 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 170.98 -15.6 0.06 OUTLIER Glycine 0 CA--C 1.538 1.504 0 N-CA-C 115.656 1.022 . . . . 0.0 115.656 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -145.77 161.92 38.83 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.737 1.615 . . . . 0.0 111.221 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -142.15 161.96 36.67 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.701 1.6 . . . . 0.0 111.963 -174.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -147.99 161.64 40.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.011 1.324 . . . . 0.0 111.806 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -146.22 158.23 43.87 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.377 1.471 . . . . 0.0 112.106 -173.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -120.64 -7.2 9.65 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.41 1.484 . . . . 0.0 113.462 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -131.48 7.17 4.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.902 2.081 . . . . 0.0 113.353 -173.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -141.85 -9.88 0.91 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.489 1.516 . . . . 0.0 114.03 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -134.8 -21.04 1.72 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.255 1.422 . . . . 0.0 114.009 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.1 m -132.96 13.57 4.31 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.712 1.605 . . . . 0.0 112.72 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.51 -172.47 44.57 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.803 1.668 . . . . 0.0 112.307 -174.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -141.52 9.0 2.0 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.818 1.647 . . . . 0.0 113.441 -178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.0 m -149.72 165.66 17.06 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.278 1.831 . . . . 0.0 111.298 -169.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.92 147.83 24.73 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.606 2.87 . . . . 0.0 114.119 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -144.07 41.69 1.4 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.836 1.254 . . . . 0.0 112.276 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 p -140.68 161.18 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 126.191 1.796 . . . . 0.0 111.38 -170.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.0 p -109.71 9.31 24.93 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.478 1.511 . . . . 0.0 113.518 -170.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 87.2 mt 66.73 167.88 0.23 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 129.044 2.938 . . . . 0.0 113.523 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.5 m -148.53 162.9 38.72 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.696 1.998 . . . . 0.0 109.3 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.8 137.24 56.48 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.399 -0.813 . . . . 0.0 111.495 172.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.14 -162.94 36.15 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 115.312 0.885 . . . . 0.0 115.312 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -94.02 121.85 35.92 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.01 1.324 . . . . 0.0 110.282 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -133.5 170.49 15.42 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.483 1.113 . . . . 0.0 112.801 -173.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.3 pt -125.26 154.74 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 126.353 1.861 . . . . 0.0 108.855 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.0 mt -130.24 120.15 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -145.49 160.53 41.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.777 0.831 . . . . 0.0 112.458 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -99.6 121.44 41.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.486 0.714 . . . . 0.0 110.871 -174.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -63.42 -14.73 53.54 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.8 t -60.57 -26.49 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.324 1.049 . . . . 0.0 112.358 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.4 mt 58.32 175.94 0.06 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.088 1.755 . . . . 0.0 112.666 -170.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.6 p -108.28 164.08 15.54 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 124.663 1.185 . . . . 0.0 113.514 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -55.68 -16.63 15.48 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 124.303 3.336 . . . . 0.0 115.18 169.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -63.75 -22.82 67.1 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.718 1.607 . . . . 0.0 112.604 171.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.7 24.79 37.45 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 125.528 1.537 . . . . 0.0 113.707 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -138.37 167.75 21.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.761 1.225 . . . . 0.0 112.179 -172.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -55.84 141.34 39.21 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.621 1.168 . . . . 0.0 111.519 173.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.1 tp -116.66 78.03 1.17 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 124.882 1.273 . . . . 0.0 110.414 -169.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.96 153.07 21.86 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.621 1.169 . . . . 0.0 113.368 -171.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.5 tp -62.1 136.15 57.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.608 1.163 . . . . 0.0 109.901 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.8 m -128.05 124.72 37.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.667 1.187 . . . . 0.0 111.644 -173.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -68.27 136.18 91.28 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 124.149 0.98 . . . . 0.0 112.315 -178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.04 -13.16 19.41 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.547 2.831 . . . . 0.0 115.015 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.93 5.79 73.15 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.324 0.964 . . . . 0.0 115.191 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptp85 -157.0 167.57 30.07 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.051 1.741 . . . . 0.0 111.78 -174.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -98.65 167.09 11.0 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.005 1.322 . . . . 0.0 111.453 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.6 tpt180 47.78 43.36 16.95 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.642 1.977 . . . . 0.0 113.079 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.0 m -141.07 138.96 18.46 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 125.407 1.483 . . . . 0.0 111.272 -169.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -46.5 157.06 0.5 Allowed 'Trans proline' 0 C--N 1.354 0.852 1 C-N-CA 126.121 4.547 . . . . 0.0 115.306 169.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.6 t -117.43 149.68 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.384 1.474 . . . . 0.0 109.774 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 m -124.89 174.97 7.6 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.097 1.359 . . . . 0.0 110.429 -169.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 m -127.02 144.33 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 120.902 -1.124 . . . . 0.0 111.602 172.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.4 m -148.38 166.02 16.67 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.803 1.241 . . . . 0.0 112.462 -176.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -53.58 163.26 2.82 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 123.79 2.993 . . . . 0.0 113.469 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.2 tp -126.26 143.73 51.04 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.794 1.238 . . . . 0.0 111.552 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -147.98 -32.33 0.27 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.328 1.451 . . . . 0.0 113.434 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.26 -9.65 0.83 Allowed Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.358 1.456 . . . . 0.0 114.365 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 33.9 t -63.08 139.65 58.79 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.979 1.39 . . . . 0.0 111.916 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.7 p -63.99 -11.05 25.22 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.387 1.475 . . . . 0.0 114.353 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.99 -20.08 64.99 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.487 1.04 . . . . 0.0 112.095 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -109.07 3.94 22.56 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.482 1.913 . . . . 0.0 113.282 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -101.29 144.58 29.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 122.125 0.964 . . . . 0.0 111.687 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -139.54 173.66 11.31 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 122.899 1.333 . . . . 0.0 112.123 -169.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 77.0 mt -122.75 135.44 62.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 127.746 2.418 . . . . 0.0 106.745 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.0 tp -137.04 124.53 22.12 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.978 1.311 . . . . 0.0 109.379 -172.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -142.77 138.57 30.55 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.403 0.681 . . . . 0.0 111.196 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.8 t -64.53 139.41 58.76 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.967 0.507 . . . . 0.0 110.984 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -114.21 -51.01 2.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.528 1.131 . . . . 0.0 110.762 174.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.23 107.71 4.1 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.172 0.989 . . . . 0.0 111.208 169.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 61.6 m -58.27 -25.94 62.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.987 0.915 . . . . 0.0 111.311 168.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -62.24 -21.6 65.3 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.095 2.158 . . . . 0.0 113.399 173.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.4 m -130.37 9.1 5.11 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.913 1.685 . . . . 0.0 113.026 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 47.0 32.1 1.76 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.014 2.126 . . . . 0.0 114.23 -169.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 p -92.55 142.49 27.34 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.158 -0.964 . . . . 0.0 112.319 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -139.06 144.54 38.82 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 126.072 1.749 . . . . 0.0 110.653 -177.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.0 p -77.85 148.5 34.64 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.182 0.593 . . . . 0.0 110.82 172.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.5 mm -128.17 126.86 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.572 1.549 . . . . 0.0 109.417 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.9 m -143.9 148.91 44.21 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 125.541 1.536 . . . . 0.0 109.785 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.51 150.76 28.47 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 123.031 2.487 . . . . 0.0 111.055 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.03 -26.38 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.023 -1.048 . . . . 0.0 113.552 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.84 -20.79 55.1 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.738 0.685 . . . . 0.0 114.485 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.6 m -142.39 61.13 11.23 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 125.635 1.574 . . . . 0.0 111.526 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -61.31 -17.16 51.39 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.69 2.926 . . . . 0.0 113.178 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -72.87 13.55 0.37 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 128.591 2.756 . . . . 0.0 113.481 168.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.8 p -144.0 170.13 16.51 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.428 2.291 . . . . 0.0 111.119 173.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -139.65 170.71 15.4 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.217 1.807 . . . . 0.0 111.979 -174.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.4 mm -117.1 126.79 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.732 1.213 . . . . 0.0 110.77 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.79 -158.67 7.63 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 126.072 1.796 . . . . 0.0 111.328 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -144.96 144.77 31.23 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.178 0.989 . . . . 0.0 111.897 -174.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.03 -161.13 9.83 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.573 1.558 . . . . 0.0 113.116 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.18 137.7 21.8 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.921 1.288 . . . . 0.0 113.018 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.56 -5.83 64.9 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.724 1.154 . . . . 0.0 114.248 -172.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 47.49 52.65 12.12 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.402 1.881 . . . . 0.0 113.719 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.8 p -128.84 141.39 41.51 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 127.213 2.205 . . . . 0.0 107.478 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -66.54 140.12 55.98 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 N-CA-C 108.944 -1.214 . . . . 0.0 108.944 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.53 148.02 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.327 1.451 . . . . 0.0 111.275 -175.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.0 t -77.26 137.42 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 123.577 0.751 . . . . 0.0 110.426 173.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.0 mt -141.0 161.76 51.93 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.209 1.803 . . . . 0.0 110.799 -171.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.32 162.5 38.33 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 122.555 2.17 . . . . 0.0 111.291 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.96 127.77 27.48 Favored 'Trans proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.15 2.566 . . . . 0.0 113.02 177.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -149.3 -107.82 0.07 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.203 1.401 . . . . 0.0 108.994 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -143.83 21.22 1.8 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.535 1.934 . . . . 0.0 110.581 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -65.82 131.99 47.63 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.339 -0.85 . . . . 0.0 111.677 -173.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.5 m -143.56 161.24 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.437 1.495 . . . . 0.0 111.335 -177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -130.83 152.27 50.35 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.214 1.406 . . . . 0.0 110.135 169.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.4 m -77.03 135.58 38.66 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 125.158 1.383 . . . . 0.0 109.294 170.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -126.09 73.78 1.39 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.246 1.018 . . . . 0.0 109.137 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 26.8 m -83.92 127.16 33.66 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.3 1.04 . . . . 0.0 111.015 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 19.1 tp -69.58 147.36 50.83 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.727 0.811 . . . . 0.0 111.405 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.1 p -129.91 175.53 8.79 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.381 1.473 . . . . 0.0 111.791 178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 75.9 p -62.88 -11.5 18.69 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.65 17.22 1.63 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.76 1.171 . . . . 0.0 115.291 -178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.63 -137.22 4.99 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 118.645 1.222 . . . . 0.0 112.498 -174.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -133.6 169.07 17.54 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 127.421 2.288 . . . . 0.0 111.336 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -131.39 147.39 52.56 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.304 1.842 . . . . 0.0 110.43 172.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 17.8 mt -130.53 114.01 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.055 0.942 . . . . 0.0 110.022 -170.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -136.89 151.99 49.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.86 1.264 . . . . 0.0 111.433 -169.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.0 -31.37 62.99 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -175.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 135.55 -40.11 1.59 Allowed Glycine 0 N--CA 1.471 1.019 0 C-N-CA 125.221 1.391 . . . . 0.0 112.649 -171.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -79.77 -5.76 55.96 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.913 1.285 . . . . 0.0 114.214 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? 57.1 14.14 1.87 Allowed 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 126.998 2.119 . . . . 0.0 114.26 -169.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.8 p -69.46 -26.54 64.63 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.625 1.97 . . . . 0.0 113.501 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.5 m -143.88 168.71 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 126.005 1.722 . . . . 0.0 111.322 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.6 t -140.93 156.88 46.0 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.157 1.783 . . . . 0.0 110.863 172.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -71.52 138.74 49.13 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.18 0.592 . . . . 0.0 111.148 170.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 98.3 p -147.94 172.97 13.35 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.344 1.058 . . . . 0.0 112.552 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.92 149.18 46.18 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.077 1.351 . . . . 0.0 110.001 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -82.55 -34.41 27.8 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.433 0.693 . . . . 0.0 111.285 -171.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -141.0 -7.83 1.05 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.33 1.852 . . . . 0.0 112.785 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 56.45 28.16 13.25 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.816 1.646 . . . . 0.0 114.319 -170.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 32.0 p -76.81 157.84 31.26 Favored 'General case' 0 N--CA 1.474 0.725 0 O-C-N 120.987 -1.071 . . . . 0.0 111.39 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -71.24 144.51 50.05 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.074 -1.016 . . . . 0.0 112.036 175.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.11 0.83 84.1 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.423 1.011 . . . . 0.0 114.395 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -70.01 149.4 47.75 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.964 1.306 . . . . 0.0 112.579 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -83.91 114.22 21.52 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.991 -1.068 . . . . 0.0 109.774 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.7 p -56.96 146.09 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 111.353 175.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 7.3 t -124.94 165.8 17.45 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.99 1.316 . . . . 0.0 111.957 -169.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.8 mt -134.98 143.06 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.725 1.61 . . . . 0.0 108.81 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 164.66 -157.81 30.33 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.076 0.846 . . . . 0.0 111.85 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.54 157.51 5.15 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.664 0.732 . . . . 0.0 111.91 169.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -57.84 153.08 14.59 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.33 1.052 . . . . 0.0 112.691 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -113.24 171.24 7.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.911 1.685 . . . . 0.0 112.738 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.3 t -107.2 -3.45 19.81 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -170.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -145.82 -43.93 0.21 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.384 1.073 . . . . 0.0 112.536 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 86.2 p -95.48 -0.3 52.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -174.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.52 -3.71 27.76 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.5 1.524 . . . . 0.0 115.924 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 84.9 mmt-85 -125.66 152.58 45.03 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 119.524 1.662 . . . . 0.0 111.541 -174.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -137.59 175.48 9.56 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.656 1.583 . . . . 0.0 111.947 -168.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.0 p -138.41 139.62 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.7 1.2 . . . . 0.0 109.857 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.9 mp -122.45 124.51 70.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 125.968 1.707 . . . . 0.0 106.95 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -149.07 154.03 38.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.104 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -68.24 155.16 40.28 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.102 -0.999 . . . . 0.0 112.62 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 75.6 t . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.077 1.751 . . . . 0.0 111.313 171.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 tpp . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.9 173.89 45.44 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.907 1.241 . . . . 0.0 112.699 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 50.2 m80 57.57 6.22 0.4 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 127.019 2.127 . . . . 0.0 116.182 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -147.4 159.92 43.14 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 127.169 2.188 . . . . 0.0 110.802 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.2 m80 -133.61 -2.68 3.01 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.863 1.265 . . . . 0.0 113.771 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -155.54 152.67 29.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.327 1.851 . . . . 0.0 110.626 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -145.33 154.81 42.72 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.397 1.479 . . . . 0.0 111.743 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -141.17 2.1 1.67 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.938 1.295 . . . . 0.0 114.317 -177.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -64.07 160.74 17.45 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.932 1.293 . . . . 0.0 113.15 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -65.79 -12.09 51.33 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.697 1.599 . . . . 0.0 114.989 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.8 t -55.16 153.35 6.88 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.314 1.446 . . . . 0.0 113.323 173.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.41 -175.7 43.98 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.978 1.275 . . . . 0.0 113.366 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -147.52 170.65 16.99 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.85 1.66 . . . . 0.0 111.905 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.2 m -138.87 151.68 68.84 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.228 1.411 . . . . 0.0 111.924 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.11 173.58 13.43 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.727 2.951 . . . . 0.0 112.471 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.34 27.31 9.75 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.872 1.269 . . . . 0.0 113.43 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -162.71 156.52 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 127.916 2.486 . . . . 0.0 110.707 -177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 t -149.97 29.8 0.73 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 123.58 1.657 . . . . 0.0 114.81 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.3 mt -69.09 172.39 6.85 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.295 2.238 . . . . 0.0 111.826 169.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 t -154.18 169.53 23.38 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.945 1.298 . . . . 0.0 109.841 171.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.88 139.43 58.76 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 173.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.89 -161.34 32.29 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.267 0.937 . . . . 0.0 114.374 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -98.93 125.61 44.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.077 0.951 . . . . 0.0 110.111 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -134.28 172.47 12.83 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.572 1.549 . . . . 0.0 112.239 -171.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.4 pt -127.04 154.58 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 126.477 1.911 . . . . 0.0 108.62 171.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.66 123.77 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -141.36 150.22 42.15 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.362 0.665 . . . . 0.0 112.485 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -84.82 134.56 34.3 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.192 0.597 . . . . 0.0 111.635 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -64.83 -13.59 56.49 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.6 t -67.73 -24.68 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 119.447 1.022 . . . . 0.0 112.399 171.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 11.1 mp 58.38 166.89 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.898 2.079 . . . . 0.0 113.97 -170.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.0 p -69.64 161.45 74.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 124.626 1.17 . . . . 0.0 112.362 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -66.96 -16.21 49.03 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 122.491 2.127 . . . . 0.0 113.004 170.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -74.29 -20.15 60.23 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.28 1.432 . . . . 0.0 112.894 169.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.5 24.42 14.03 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 125.004 1.287 . . . . 0.0 113.923 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -128.94 171.22 12.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.048 1.339 . . . . 0.0 112.259 -174.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -54.86 137.32 45.49 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.377 1.071 . . . . 0.0 111.367 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.3 tp -116.6 79.63 1.35 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.355 1.462 . . . . 0.0 110.27 -169.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.72 145.17 29.73 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -169.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -59.39 130.95 49.42 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.803 1.241 . . . . 0.0 109.201 168.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 94.1 m -128.52 117.37 21.18 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.436 1.094 . . . . 0.0 110.909 -170.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -59.87 134.3 89.77 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.512 1.925 . . . . 0.0 112.141 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.59 -10.46 18.68 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.497 2.798 . . . . 0.0 114.795 -176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.21 6.19 81.85 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 119.01 -0.883 . . . . 0.0 115.254 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 ptp85 -157.7 163.24 38.37 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.94 1.37 . . . . 0.0 112.241 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -90.8 165.62 13.55 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.318 1.047 . . . . 0.0 111.631 -175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 53.4 mmt-85 50.67 35.77 12.53 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.308 1.843 . . . . 0.0 113.707 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.0 m -134.06 138.96 31.78 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 125.385 1.474 . . . . 0.0 111.319 -169.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -46.62 153.15 1.32 Allowed 'Trans proline' 0 C--N 1.354 0.817 1 C-N-CA 125.973 4.449 . . . . 0.0 115.238 169.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.05 147.75 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.687 1.195 . . . . 0.0 110.388 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 m -120.95 173.02 7.5 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.377 1.471 . . . . 0.0 111.347 -168.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -126.47 143.91 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.875 1.27 . . . . 0.0 111.446 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.1 m -151.41 159.84 32.79 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 125.136 1.374 . . . . 0.0 111.478 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -62.55 132.95 40.22 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.241 1.961 . . . . 0.0 110.779 173.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.1 tp -63.79 137.28 57.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.284 1.034 . . . . 0.0 111.308 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -135.93 -24.03 1.32 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.298 1.439 . . . . 0.0 112.811 177.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.14 5.96 22.81 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.147 1.356 . . . . 0.0 114.037 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.3 t -62.48 147.93 47.29 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.425 1.113 . . . . 0.0 111.788 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.8 m -58.24 -20.29 40.81 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.097 0.959 . . . . 0.0 113.53 172.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.87 -20.98 65.18 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.927 0.891 . . . . 0.0 112.853 173.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -104.29 -1.54 26.87 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.145 1.778 . . . . 0.0 112.617 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -105.95 138.81 41.5 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.807 1.243 . . . . 0.0 111.517 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -136.0 170.43 16.02 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.745 1.218 . . . . 0.0 111.873 -169.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 81.0 mt -124.69 136.87 59.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 126.514 1.926 . . . . 0.0 107.358 -176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.6 tp -136.51 126.51 26.02 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.383 1.473 . . . . 0.0 109.506 -169.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -144.25 138.05 27.72 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.15 0.98 . . . . 0.0 110.788 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 t -63.84 141.87 58.61 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.933 0.493 . . . . 0.0 111.529 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -113.4 -52.27 2.77 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.505 1.122 . . . . 0.0 110.76 173.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.43 107.49 4.02 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.276 1.03 . . . . 0.0 110.971 169.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.1 m -57.96 -26.56 62.45 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.939 0.896 . . . . 0.0 111.369 168.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -61.7 -20.81 63.89 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.091 2.156 . . . . 0.0 113.664 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.8 m -130.36 9.39 5.16 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.242 1.817 . . . . 0.0 112.949 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 47.23 28.55 1.02 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.291 2.236 . . . . 0.0 114.734 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -88.53 142.33 27.79 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.592 -1.318 . . . . 0.0 112.443 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -138.45 141.7 39.47 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.932 1.693 . . . . 0.0 110.891 -177.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 78.2 p -77.88 147.57 35.03 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.148 0.579 . . . . 0.0 110.758 172.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.6 mm -128.49 131.41 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.42 1.488 . . . . 0.0 109.507 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.1 m -144.54 148.33 39.75 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 125.918 1.687 . . . . 0.0 110.549 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.9 145.89 28.95 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.121 2.547 . . . . 0.0 111.322 173.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.34 -28.76 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 O-C-N 121.189 -0.945 . . . . 0.0 112.003 174.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -72.43 -25.3 74.63 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 123.738 0.685 . . . . 0.0 114.753 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.1 m -144.59 67.37 14.23 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.451 1.5 . . . . 0.0 111.554 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.82 -13.46 37.2 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.416 2.744 . . . . 0.0 113.658 -177.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -73.99 1.99 9.68 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.976 1.71 . . . . 0.0 114.002 170.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.9 m -132.74 173.56 11.23 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.7 1.6 . . . . 0.0 111.782 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -137.4 172.43 12.99 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.453 1.501 . . . . 0.0 112.775 -174.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.9 mm -119.28 123.02 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.098 1.359 . . . . 0.0 110.14 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.45 -161.43 9.75 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.981 1.753 . . . . 0.0 111.144 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -142.07 143.2 32.97 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 118.383 1.092 . . . . 0.0 111.703 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -149.68 -162.32 10.36 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.092 1.33 . . . . 0.0 113.35 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.08 137.71 21.2 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.17 1.388 . . . . 0.0 113.058 -177.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.48 -5.71 65.03 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.771 1.177 . . . . 0.0 114.167 -171.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 47.99 55.91 7.99 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.256 1.822 . . . . 0.0 113.563 -178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.89 141.12 33.76 Favored Pre-proline 0 N--CA 1.468 0.457 0 C-N-CA 127.262 2.225 . . . . 0.0 107.658 174.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -66.43 144.18 72.54 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.142 1.228 . . . . 0.0 109.836 174.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.24 145.13 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.521 1.528 . . . . 0.0 111.992 -172.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.2 t -74.19 119.2 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.194 0.997 . . . . 0.0 110.361 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 mp -129.95 164.64 39.07 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.842 2.057 . . . . 0.0 111.457 -169.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.04 166.34 27.03 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.154 2.569 . . . . 0.0 112.339 -177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.85 121.05 7.02 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.335 2.023 . . . . 0.0 110.374 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -148.11 -90.94 0.08 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.762 0.825 . . . . 0.0 110.827 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -155.81 17.75 0.38 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.648 1.579 . . . . 0.0 112.727 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -66.47 137.2 56.66 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.583 -0.698 . . . . 0.0 111.802 -174.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.0 m -144.53 160.46 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.788 1.235 . . . . 0.0 112.231 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -129.6 138.0 51.02 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.644 1.578 . . . . 0.0 110.145 169.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.7 m -71.4 127.51 32.8 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.67 1.188 . . . . 0.0 108.793 169.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.8 mt -125.92 115.76 20.45 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.192 0.997 . . . . 0.0 108.739 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.8 m -136.52 134.49 37.61 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.733 0.813 . . . . 0.0 111.261 -169.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 12.7 tp -69.66 152.11 45.09 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.008 1.323 . . . . 0.0 112.14 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 p -131.61 -178.75 5.0 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.096 1.758 . . . . 0.0 111.373 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 79.6 p -60.54 -13.0 11.46 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.82 24.45 0.26 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.274 0.94 . . . . 0.0 114.885 177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 176.02 -147.6 8.76 Favored Glycine 0 CA--C 1.532 1.097 0 CA-C-N 118.147 0.974 . . . . 0.0 113.112 -173.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -132.02 167.26 20.0 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.082 2.153 . . . . 0.0 111.233 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -122.27 155.12 36.57 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.923 2.089 . . . . 0.0 109.964 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 29.6 mt -134.84 117.15 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.01 1.724 . . . . 0.0 108.276 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -134.91 157.21 47.44 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.732 1.213 . . . . 0.0 111.633 -173.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -60.96 -25.69 67.01 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 130.93 -40.36 1.66 Allowed Glycine 0 CA--C 1.534 1.238 0 C-N-CA 126.003 1.763 . . . . 0.0 112.425 -169.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -98.82 4.4 47.59 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 114.06 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 58.08 14.56 2.76 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.282 2.233 . . . . 0.0 114.352 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 66.4 p -71.13 -24.74 62.34 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.164 0.985 . . . . 0.0 112.597 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.6 m -143.78 172.9 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.867 1.667 . . . . 0.0 111.988 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.0 t -143.74 150.99 39.43 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 129.462 3.105 . . . . 0.0 108.816 -178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -73.51 144.84 45.99 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.41 -0.806 . . . . 0.0 111.507 170.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 93.1 p -154.07 173.98 15.3 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.447 1.099 . . . . 0.0 112.322 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.7 mt -121.11 170.51 9.48 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.841 2.056 . . . . 0.0 109.503 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -105.06 -33.87 8.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.025 0.93 . . . . 0.0 111.9 -169.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -139.33 -8.51 1.3 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.015 2.126 . . . . 0.0 112.456 170.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 57.8 24.53 10.87 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 126.211 1.805 . . . . 0.0 114.521 -171.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 23.5 p -73.26 158.76 34.55 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 111.736 169.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.72 142.91 54.86 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.21 -0.931 . . . . 0.0 112.009 174.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 77.02 6.23 85.74 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.659 1.123 . . . . 0.0 114.444 -177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -77.74 137.16 38.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.826 1.313 . . . . 0.0 112.498 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -71.95 134.35 45.91 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.369 -0.832 . . . . 0.0 110.834 174.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.48 155.59 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 121.462 0.649 . . . . 0.0 110.962 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.6 t -127.11 159.21 34.89 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.359 1.464 . . . . 0.0 110.91 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.97 137.07 47.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 125.468 1.507 . . . . 0.0 108.736 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 178.48 178.46 47.87 Favored Glycine 0 N--CA 1.471 0.976 0 C-N-CA 124.674 1.13 . . . . 0.0 111.44 177.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -50.87 -41.34 57.98 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 119.265 1.532 . . . . 0.0 114.19 -173.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -167.62 176.0 6.7 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.944 2.498 . . . . 0.0 111.382 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -140.12 140.08 35.95 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.332 1.053 . . . . 0.0 111.88 169.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 12.6 t -62.85 -22.59 66.79 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -171.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -134.01 -35.42 0.95 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.959 1.304 . . . . 0.0 113.076 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.0 t -97.8 2.8 49.83 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.812 1.245 . . . . 0.0 114.323 -171.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.91 17.6 1.26 Allowed Glycine 0 CA--C 1.544 1.865 0 C-N-CA 125.4 1.476 . . . . 0.0 116.27 -174.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -140.45 149.23 42.3 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.135 1.774 . . . . 0.0 112.142 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -140.89 178.17 7.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.717 2.007 . . . . 0.0 111.18 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.2 141.22 26.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.77 1.228 . . . . 0.0 109.286 169.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.33 123.62 71.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 C-N-CA 125.575 1.55 . . . . 0.0 106.939 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -145.94 153.19 40.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.665 1.186 . . . . 0.0 109.482 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -67.45 155.28 39.41 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 121.04 -1.038 . . . . 0.0 112.774 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 77.1 t . . . . . 0 C--O 1.251 1.177 0 C-N-CA 126.171 1.789 . . . . 0.0 111.309 172.228 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.44 174.95 43.38 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.331 0.967 . . . . 0.0 113.664 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 -139.25 5.05 2.26 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.369 1.467 . . . . 0.0 113.909 -176.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 67.5 t60 -63.85 157.04 25.67 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.624 1.17 . . . . 0.0 112.761 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -149.65 159.78 44.05 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.252 1.421 . . . . 0.0 110.947 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -133.96 -3.89 2.82 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.159 1.384 . . . . 0.0 113.887 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -132.29 -9.4 3.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.679 1.192 . . . . 0.0 114.096 -175.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -149.68 134.2 17.54 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.28 1.432 . . . . 0.0 110.574 173.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -137.61 -8.33 1.67 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -62.45 -11.82 18.21 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.204 1.802 . . . . 0.0 114.761 -175.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.3 m -130.57 18.38 5.25 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.213 1.805 . . . . 0.0 112.526 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.09 14.35 0.76 Allowed Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.671 1.129 . . . . 0.0 115.431 -174.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -149.46 158.32 44.07 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.055 1.742 . . . . 0.0 110.98 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.7 p -151.76 161.53 29.28 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.195 1.398 . . . . 0.0 112.244 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.39 151.07 24.39 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.679 2.919 . . . . 0.0 114.596 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.77 23.44 4.28 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.431 1.492 . . . . 0.0 112.869 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 p -68.64 161.56 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.804 2.042 . . . . 0.0 111.097 171.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.2 t -144.66 12.17 1.47 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.7 mt 55.73 176.93 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.537 1.935 . . . . 0.0 113.828 -172.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -160.76 169.28 23.07 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.095 1.358 . . . . 0.0 109.928 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.16 133.07 50.75 Favored 'General case' 0 CA--C 1.548 0.865 0 O-C-N 121.855 -0.528 . . . . 0.0 111.703 170.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.24 -164.99 37.95 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 123.841 0.734 . . . . 0.0 114.5 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -97.07 126.48 42.25 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.982 0.913 . . . . 0.0 110.318 171.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.15 172.05 13.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.56 1.544 . . . . 0.0 112.442 -170.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.6 pt -127.17 156.73 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 126.472 1.909 . . . . 0.0 108.763 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.8 mt -128.38 126.75 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.91 151.82 39.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.316 0.646 . . . . 0.0 111.735 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -86.2 138.36 31.93 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.75 -0.594 . . . . 0.0 112.038 -173.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.8 mmm180 -62.05 -19.08 62.52 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -177.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t -69.4 -24.41 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-N 119.269 0.941 . . . . 0.0 112.936 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 mp 58.59 166.35 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.684 1.994 . . . . 0.0 114.178 -170.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.7 t -73.28 145.99 86.21 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 124.392 1.077 . . . . 0.0 111.936 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -56.27 -19.49 28.06 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.611 2.874 . . . . 0.0 113.754 168.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -67.8 -18.7 64.94 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.848 1.659 . . . . 0.0 113.348 172.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.23 26.62 13.63 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.853 1.692 . . . . 0.0 113.983 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -134.32 160.58 37.49 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.727 1.211 . . . . 0.0 111.918 -171.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -54.67 129.37 36.42 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.086 1.355 . . . . 0.0 111.323 176.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 24.3 tp -98.73 79.89 2.48 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.731 1.213 . . . . 0.0 110.552 -172.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.78 141.23 36.48 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.574 1.149 . . . . 0.0 113.987 -169.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.561 HD12 ' CZ2' ' A' ' 63' ' ' TRP . 0.6 OUTLIER -60.99 125.04 22.28 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.326 1.45 . . . . 0.0 107.957 169.001 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.406 ' N ' HD13 ' A' ' 40' ' ' LEU . 87.7 m -126.33 124.64 40.74 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.344 1.058 . . . . 0.0 112.054 -169.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.59 134.37 95.99 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.905 2.082 . . . . 0.0 111.885 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -75.83 -10.8 19.99 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.366 2.71 . . . . 0.0 114.462 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.89 6.16 76.38 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.962 -0.91 . . . . 0.0 115.262 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.3 ptt-85 -157.17 166.66 32.59 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 119.005 1.402 . . . . 0.0 112.278 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 41.0 mm-40 -89.36 165.42 14.38 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.388 1.075 . . . . 0.0 111.828 -174.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 45.95 43.64 10.57 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.582 1.953 . . . . 0.0 113.497 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 m -138.31 139.01 23.91 Favored Pre-proline 0 N--CA 1.475 0.807 0 C-N-CA 125.507 1.523 . . . . 0.0 110.813 -169.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -45.84 157.81 0.33 Allowed 'Trans proline' 0 C--N 1.355 0.881 1 C-N-CA 126.279 4.653 . . . . 0.0 115.483 169.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.15 151.02 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.316 1.446 . . . . 0.0 110.42 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.2 m -130.92 170.28 14.65 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.174 1.39 . . . . 0.0 110.339 -169.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.8 m -130.12 146.54 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 120.993 -1.067 . . . . 0.0 112.075 175.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.9 m -150.6 160.41 32.72 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.642 1.177 . . . . 0.0 112.223 -174.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.06 128.03 27.39 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.46 2.774 . . . . 0.0 111.75 169.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 tp -64.11 136.22 57.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.481 0.713 . . . . 0.0 111.042 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -134.47 -26.89 1.39 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.206 1.403 . . . . 0.0 112.606 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.8 8.76 13.32 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.293 1.425 . . . . 0.0 113.938 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.5 t -66.98 160.13 27.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.596 1.198 . . . . 0.0 111.941 176.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.5 m -73.6 -16.28 61.25 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.088 0.955 . . . . 0.0 111.665 -176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -77.26 -16.73 58.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.064 1.745 . . . . 0.0 112.829 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -101.5 -5.45 25.19 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.02 1.728 . . . . 0.0 112.343 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -107.97 143.23 36.93 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.991 1.316 . . . . 0.0 111.735 -174.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.561 ' CZ2' HD12 ' A' ' 40' ' ' LEU . 90.3 m95 -136.4 168.12 20.05 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.542 1.163 . . . . 0.0 112.333 -169.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.2 mt -121.56 134.82 63.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.92 2.088 . . . . 0.0 106.654 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.1 tp -134.79 126.82 29.66 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.49 1.516 . . . . 0.0 109.655 -169.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 69.7 mtm180 -143.0 140.25 30.94 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.146 0.978 . . . . 0.0 110.894 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.7 t -65.92 140.23 58.32 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.707 0.403 . . . . 0.0 111.132 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -112.87 -51.2 2.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.414 1.086 . . . . 0.0 111.026 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.62 108.7 4.41 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.469 1.107 . . . . 0.0 110.93 169.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 70.1 m -58.08 -26.59 62.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.83 0.852 . . . . 0.0 111.188 168.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -61.36 -20.6 63.18 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.136 2.174 . . . . 0.0 113.51 173.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 t -130.48 6.92 4.86 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.851 1.66 . . . . 0.0 113.401 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 48.1 31.29 2.44 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.26 1.824 . . . . 0.0 114.035 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.5 p -89.03 143.46 26.84 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.266 -0.896 . . . . 0.0 111.848 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -138.53 141.61 39.32 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.443 1.497 . . . . 0.0 110.795 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 40.9 p -78.02 147.44 34.82 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.092 0.557 . . . . 0.0 110.678 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.2 mm -127.63 128.09 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.48 1.512 . . . . 0.0 109.302 -176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.1 m -142.16 141.01 20.23 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 125.674 1.59 . . . . 0.0 110.5 178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.09 143.41 32.33 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.853 2.369 . . . . 0.0 111.224 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.86 -28.8 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 O-C-N 121.297 -0.877 . . . . 0.0 111.631 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -79.17 -10.51 86.01 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 115.492 0.957 . . . . 0.0 115.492 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 29.4 m -156.4 68.05 4.6 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.846 1.658 . . . . 0.0 110.469 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -63.55 -17.84 61.76 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.789 2.992 . . . . 0.0 113.5 -173.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -76.24 6.15 5.91 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 127.848 2.459 . . . . 0.0 114.657 171.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 67.7 m -131.23 175.31 9.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.977 1.711 . . . . 0.0 112.088 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -139.06 171.99 13.5 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.546 1.538 . . . . 0.0 113.28 -172.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 42.7 mm -120.17 130.79 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.272 1.429 . . . . 0.0 110.601 174.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.47 -157.63 7.34 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.645 1.593 . . . . 0.0 111.422 175.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -141.7 142.61 33.33 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.24 1.016 . . . . 0.0 111.848 -172.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.94 -163.21 10.57 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.247 1.403 . . . . 0.0 113.381 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.2 139.96 22.43 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.011 1.324 . . . . 0.0 113.136 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.46 -2.29 73.83 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.512 1.053 . . . . 0.0 114.292 -173.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 48.7 56.34 7.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.18 1.792 . . . . 0.0 113.41 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 3.7 p -133.83 136.88 27.34 Favored Pre-proline 0 C--O 1.238 0.49 0 C-N-CA 127.548 2.339 . . . . 0.0 107.751 176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.75 142.77 59.13 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.202 1.268 . . . . 0.0 109.462 173.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 15.4 m -135.03 149.29 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.023 1.329 . . . . 0.0 111.472 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 t -76.22 134.93 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 123.851 0.861 . . . . 0.0 110.402 174.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.5 mt -141.17 161.62 52.27 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.649 1.58 . . . . 0.0 112.039 -169.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.9 165.65 29.18 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 123.062 2.508 . . . . 0.0 111.765 176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.62 124.07 9.97 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.5 2.133 . . . . 0.0 110.702 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -148.01 -89.61 0.08 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.076 0.95 . . . . 0.0 110.592 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.0 p-10 -154.82 15.95 0.43 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.431 1.493 . . . . 0.0 112.901 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -67.01 134.36 51.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.425 0.69 . . . . 0.0 111.906 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.4 m -144.92 161.03 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.949 1.3 . . . . 0.0 112.069 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 85.6 m95 -130.99 137.61 49.31 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.252 1.421 . . . . 0.0 110.762 169.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 94.9 m -72.19 131.74 43.17 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.899 1.28 . . . . 0.0 108.705 169.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.7 mt -121.94 73.49 1.09 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 122.071 0.938 . . . . 0.0 109.324 -176.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 93.3 m -73.42 119.47 17.7 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.755 1.222 . . . . 0.0 110.656 -174.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 28.7 tp -68.41 147.63 51.8 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.077 0.551 . . . . 0.0 111.271 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.0 p -133.82 177.05 8.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.987 1.715 . . . . 0.0 110.515 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.9 m -59.88 -12.69 8.18 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -171.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -162.93 31.25 0.28 Allowed Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.761 1.172 . . . . 0.0 114.096 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 168.29 -160.62 34.22 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.976 1.274 . . . . 0.0 112.072 -174.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -127.92 172.11 11.19 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.255 1.822 . . . . 0.0 112.075 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -136.69 150.18 48.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.21 1.804 . . . . 0.0 110.099 170.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 46.1 mt -129.1 114.84 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.103 0.961 . . . . 0.0 109.516 -169.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -134.8 155.74 50.08 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.124 0.969 . . . . 0.0 112.248 -169.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -61.86 -28.99 69.88 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 131.68 -40.6 1.61 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.063 1.792 . . . . 0.0 112.756 -172.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.08 -5.2 59.35 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.974 1.309 . . . . 0.0 113.983 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? 57.11 17.86 3.74 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.623 1.969 . . . . 0.0 113.374 -169.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 49.0 p -71.02 -24.46 62.37 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.195 0.998 . . . . 0.0 112.168 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.9 m -144.26 173.68 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 126.006 1.723 . . . . 0.0 112.162 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.4 t -146.14 154.81 42.21 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.481 2.712 . . . . 0.0 110.044 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -73.19 142.04 47.37 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.464 -0.773 . . . . 0.0 111.777 170.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 91.7 p -152.92 170.47 20.29 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.025 1.33 . . . . 0.0 112.63 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.81 156.06 31.36 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.954 1.302 . . . . 0.0 110.386 173.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -89.93 -31.47 17.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.281 0.632 . . . . 0.0 111.501 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -138.07 -4.12 1.74 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.556 1.542 . . . . 0.0 113.639 172.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 49.85 27.26 2.26 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.303 1.841 . . . . 0.0 114.452 -169.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.6 p -76.33 161.0 29.09 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.899 0.88 . . . . 0.0 111.471 174.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.72 142.39 51.47 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 120.911 -1.118 . . . . 0.0 111.359 169.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.41 5.79 82.79 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.322 0.963 . . . . 0.0 114.019 -173.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -71.53 140.57 49.95 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.906 1.283 . . . . 0.0 111.858 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.56 111.19 14.36 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 170.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 p -58.32 147.39 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.634 0.73 . . . . 0.0 111.175 172.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 33.3 m -134.22 171.54 14.11 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.76 1.624 . . . . 0.0 111.399 -169.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 70.0 mt -134.34 143.69 37.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 124.983 1.313 . . . . 0.0 109.231 -173.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.03 179.04 47.22 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.895 1.236 . . . . 0.0 111.65 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.47 -42.47 61.62 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 119.091 1.445 . . . . 0.0 114.266 -172.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -169.3 174.28 6.18 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.266 2.626 . . . . 0.0 111.027 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -142.46 141.83 32.23 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.185 0.994 . . . . 0.0 111.866 169.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 t -66.26 -18.61 65.46 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -170.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -138.62 -43.66 0.49 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.194 0.998 . . . . 0.0 113.293 -178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.8 p -86.07 0.49 53.31 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.081 1.352 . . . . 0.0 114.381 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.95 19.68 0.96 Allowed Glycine 0 CA--C 1.541 1.666 0 C-N-CA 126.505 2.002 . . . . 0.0 116.622 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -144.94 149.78 35.83 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-N 120.069 1.935 . . . . 0.0 112.057 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -139.4 177.71 7.73 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.988 1.715 . . . . 0.0 112.368 -169.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.3 p -140.78 139.93 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.831 1.252 . . . . 0.0 109.607 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 5.3 mp -119.17 125.87 74.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 C-N-CA 125.821 1.648 . . . . 0.0 107.192 172.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -148.58 153.76 38.81 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.646 1.178 . . . . 0.0 109.46 -170.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -67.71 155.11 39.99 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.921 -1.112 . . . . 0.0 112.775 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.0 t . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.145 1.778 . . . . 0.0 111.323 171.908 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 tpp . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -169.48 16.18 0.06 OUTLIER Glycine 0 CA--C 1.539 1.575 0 N-CA-C 116.154 1.222 . . . . 0.0 116.154 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -141.95 0.76 1.42 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 118.702 1.251 . . . . 0.0 113.996 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -142.42 162.01 36.56 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.22 1.408 . . . . 0.0 111.56 -177.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -138.26 16.19 2.79 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.94 1.296 . . . . 0.0 112.722 -173.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 62.52 2.54 0.93 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.194 2.197 . . . . 0.0 114.627 -169.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.3 p80 -149.33 172.34 15.05 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.917 2.087 . . . . 0.0 110.72 171.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -136.87 -4.62 1.96 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.197 1.399 . . . . 0.0 113.516 174.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -63.96 -19.31 65.05 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.297 1.439 . . . . 0.0 114.333 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -127.69 16.98 6.92 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.819 1.648 . . . . 0.0 112.221 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.8 m 55.24 -10.92 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 129.484 3.114 . . . . 0.0 119.088 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.84 14.23 0.03 OUTLIER Glycine 0 CA--C 1.537 1.45 0 N-CA-C 116.7 1.44 . . . . 0.0 116.7 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -140.58 168.07 20.67 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.058 1.429 . . . . 0.0 111.66 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.9 m -60.7 155.1 53.32 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 124.432 1.093 . . . . 0.0 112.542 174.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.0 134.78 43.37 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.639 2.893 . . . . 0.0 114.402 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.4 27.13 0.93 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.137 1.375 . . . . 0.0 112.69 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.19 151.41 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.738 1.215 . . . . 0.0 110.648 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 t -143.92 13.66 1.68 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.6 mt 59.62 166.9 0.06 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.286 2.235 . . . . 0.0 113.973 -173.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.2 m -150.73 160.17 44.03 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.073 1.749 . . . . 0.0 109.382 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.52 131.14 45.66 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.652 -0.655 . . . . 0.0 111.362 171.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.93 -166.11 39.43 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 114.968 0.747 . . . . 0.0 114.968 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -95.52 124.1 39.39 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.231 1.012 . . . . 0.0 110.037 172.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -133.17 171.83 13.48 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.098 1.359 . . . . 0.0 112.259 -173.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.7 pt -124.57 153.05 31.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.888 1.675 . . . . 0.0 108.431 170.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.7 mt -128.49 118.97 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -138.56 149.6 45.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.504 0.669 . . . . 0.0 112.212 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -77.6 136.58 38.27 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.04 -0.413 . . . . 0.0 111.463 -173.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -64.94 -24.28 67.47 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -175.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.3 t -65.98 -38.25 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.819 0.847 . . . . 0.0 112.489 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 37' ' ' LYS . 73.3 mt 54.48 173.25 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.104 1.761 . . . . 0.0 114.66 -169.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 99.0 p -100.72 163.91 17.19 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.685 1.194 . . . . 0.0 112.068 176.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.2 -2.61 6.04 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.335 2.69 . . . . 0.0 114.363 170.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -73.41 -13.4 61.07 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.979 1.312 . . . . 0.0 113.967 172.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.25 14.1 75.17 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.431 172.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -133.05 167.31 20.54 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.974 1.309 . . . . 0.0 113.014 -175.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.413 ' HA ' HD22 ' A' ' 31' ' ' LEU . 97.9 mttt -60.78 156.3 17.41 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.802 1.241 . . . . 0.0 113.136 -175.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.3 mt -124.37 72.84 1.21 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.125 1.77 . . . . 0.0 109.8 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.46 142.86 33.86 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.445 1.098 . . . . 0.0 113.292 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.8 tp -56.74 135.76 55.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.857 0.863 . . . . 0.0 109.218 169.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 90.5 m -132.26 122.55 25.35 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.266 1.026 . . . . 0.0 110.827 -173.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -64.07 138.13 97.32 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 127.128 2.171 . . . . 0.0 111.907 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -74.06 -12.1 23.51 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.299 2.666 . . . . 0.0 114.933 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.29 7.26 86.94 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.006 0.812 . . . . 0.0 114.76 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.2 ptp85 -154.09 166.42 33.11 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.947 1.699 . . . . 0.0 111.764 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.5 mm-40 -93.83 164.69 13.02 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.936 0.894 . . . . 0.0 111.812 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.6 tpt85 46.68 40.12 8.12 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.816 2.046 . . . . 0.0 114.032 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.7 m -133.98 142.1 42.15 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 125.563 1.545 . . . . 0.0 111.057 -169.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -44.67 156.28 0.24 Allowed 'Trans proline' 0 C--N 1.354 0.828 1 C-N-CA 126.003 4.469 . . . . 0.0 115.589 169.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.88 158.43 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.798 1.239 . . . . 0.0 110.207 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -128.71 170.28 13.48 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.698 1.599 . . . . 0.0 110.971 -169.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 9.8 p -125.49 142.29 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.833 1.253 . . . . 0.0 111.257 172.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 m -159.04 168.49 12.3 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.711 1.204 . . . . 0.0 113.004 -175.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -49.97 161.56 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.677 3.585 . . . . 0.0 114.857 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 19.3 tp -123.01 132.26 54.05 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.739 1.216 . . . . 0.0 111.343 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -134.19 -29.27 1.27 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.922 2.089 . . . . 0.0 112.27 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.53 4.09 1.98 Allowed Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.642 1.417 . . . . 0.0 116.642 169.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.8 p -71.0 165.1 24.19 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.056 1.928 . . . . 0.0 113.391 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.2 m -69.02 -16.98 63.85 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.29 -24.84 62.23 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.022 0.828 . . . . 0.0 112.28 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.62 6.28 11.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 128.084 2.554 . . . . 0.0 112.409 -169.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.99 148.07 39.27 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.979 1.312 . . . . 0.0 110.745 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -137.51 174.02 11.04 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 122.69 1.233 . . . . 0.0 112.901 -168.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 92.8 mt -122.96 139.15 50.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 127.194 2.198 . . . . 0.0 107.09 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 45.7 tp -137.31 123.22 20.14 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.409 1.483 . . . . 0.0 109.044 -173.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -144.13 138.34 28.12 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.507 0.723 . . . . 0.0 111.117 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.2 t -65.96 139.33 58.23 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.734 0.414 . . . . 0.0 111.002 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -111.93 -50.61 2.9 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.809 1.244 . . . . 0.0 110.282 174.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.01 106.9 3.97 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.432 1.093 . . . . 0.0 110.84 169.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 69.4 m -58.05 -25.5 61.3 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.959 0.903 . . . . 0.0 111.506 168.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -63.73 -20.99 66.18 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.022 2.129 . . . . 0.0 113.495 174.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.2 m -130.1 9.02 5.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 126.126 1.77 . . . . 0.0 112.644 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 45.87 32.69 1.36 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 127.422 2.289 . . . . 0.0 114.217 -169.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.5 p -91.62 140.95 29.23 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.919 -1.113 . . . . 0.0 112.091 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -136.84 144.89 43.86 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.878 1.671 . . . . 0.0 110.733 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.1 p -77.78 150.64 34.29 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.192 0.597 . . . . 0.0 110.965 170.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.9 mm -130.44 129.73 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.976 1.71 . . . . 0.0 108.519 -177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.1 p -151.98 155.09 33.4 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.171 0.988 . . . . 0.0 111.866 174.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.88 146.05 29.19 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 122.994 2.462 . . . . 0.0 110.841 178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.49 -24.26 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.851 -1.156 . . . . 0.0 113.072 176.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.71 -19.54 57.89 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.033 0.825 . . . . 0.0 114.728 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 63.0 m -142.22 62.58 13.9 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 125.66 1.584 . . . . 0.0 111.266 -178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -63.36 -13.98 39.37 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.268 2.645 . . . . 0.0 113.491 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -74.08 6.84 3.1 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.293 1.837 . . . . 0.0 114.001 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -129.75 175.54 8.75 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.637 1.575 . . . . 0.0 111.331 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -141.0 167.96 20.94 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.618 1.567 . . . . 0.0 111.07 -172.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 40.7 mm -122.23 128.04 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.296 1.038 . . . . 0.0 110.552 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.77 -159.18 7.88 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.985 1.755 . . . . 0.0 111.243 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -143.83 148.32 35.36 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.595 1.197 . . . . 0.0 111.996 -174.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.51 -160.36 9.56 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.397 1.475 . . . . 0.0 112.968 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -52.46 138.35 27.68 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.832 1.253 . . . . 0.0 112.959 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 96.6 -3.59 63.32 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.612 1.101 . . . . 0.0 114.284 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 47.67 54.21 10.14 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.106 1.762 . . . . 0.0 113.602 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.98 138.44 30.68 Favored Pre-proline 0 C--O 1.239 0.513 0 C-N-CA 127.53 2.332 . . . . 0.0 107.473 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.78 144.45 59.41 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.292 1.328 . . . . 0.0 109.284 174.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.5 m -134.01 149.87 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.253 1.421 . . . . 0.0 111.343 -174.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.96 134.26 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.01 0.924 . . . . 0.0 110.677 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 98.0 mt -139.23 162.1 53.86 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.586 1.555 . . . . 0.0 110.784 -172.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.69 161.14 45.02 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.34 2.027 . . . . 0.0 111.574 176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -72.33 119.75 6.34 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.564 2.176 . . . . 0.0 110.307 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -146.49 -82.64 0.13 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.309 1.044 . . . . 0.0 110.793 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -154.72 10.48 0.35 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.005 1.322 . . . . 0.0 113.945 -177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -67.39 128.65 37.21 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.391 -0.818 . . . . 0.0 111.776 -175.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.4 m -143.6 163.76 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.757 1.623 . . . . 0.0 111.234 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -130.47 145.78 51.9 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.034 1.333 . . . . 0.0 110.332 171.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 99.2 m -74.94 134.96 41.43 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.848 1.259 . . . . 0.0 109.222 169.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -119.85 123.85 44.66 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.389 1.075 . . . . 0.0 109.49 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.3 m -135.09 127.17 29.81 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.952 0.901 . . . . 0.0 110.491 -169.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.1 153.24 41.41 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.795 0.807 . . . . 0.0 113.049 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.7 p -127.99 -177.45 4.13 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.422 1.889 . . . . 0.0 110.15 171.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 78.1 p -60.9 -14.59 23.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -163.61 30.71 0.26 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.51 1.052 . . . . 0.0 114.142 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 177.49 -149.78 9.61 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 124.795 1.188 . . . . 0.0 112.537 -173.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -132.64 170.19 15.57 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.972 2.109 . . . . 0.0 112.358 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -134.73 152.12 51.51 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.306 2.643 . . . . 0.0 108.805 170.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 23.2 mt -132.46 125.13 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.826 1.251 . . . . 0.0 108.242 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -137.25 160.09 40.03 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.246 1.018 . . . . 0.0 112.342 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -63.67 -22.19 66.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 -170.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 126.87 -40.5 1.77 Allowed Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.614 1.578 . . . . 0.0 112.725 -171.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -98.38 5.67 47.96 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.94 1.696 . . . . 0.0 113.401 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 57.11 18.04 3.86 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 127.156 2.182 . . . . 0.0 114.227 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p -74.37 -24.6 59.18 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.251 -0.905 . . . . 0.0 112.384 178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.1 m -143.73 174.61 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.661 1.584 . . . . 0.0 112.104 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.1 t -148.45 154.36 39.77 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.96 2.504 . . . . 0.0 110.111 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -70.29 143.59 52.02 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.386 -0.821 . . . . 0.0 111.802 172.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.1 p -151.54 172.46 15.97 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.154 1.382 . . . . 0.0 112.621 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.0 mt -128.81 177.59 6.96 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.338 1.855 . . . . 0.0 110.095 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -123.93 -31.93 3.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.258 1.423 . . . . 0.0 111.332 -169.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -143.41 -5.54 0.84 Allowed 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 173.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 53.17 34.61 17.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.692 1.597 . . . . 0.0 114.786 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.4 p -90.98 160.78 15.45 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 121.323 -0.861 . . . . 0.0 111.946 171.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -70.06 142.98 52.61 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 120.756 -1.215 . . . . 0.0 112.139 173.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.49 -0.5 87.83 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.535 1.064 . . . . 0.0 114.24 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -63.76 142.99 58.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.102 1.761 . . . . 0.0 112.443 174.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -85.54 116.78 24.05 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.144 -0.972 . . . . 0.0 109.759 170.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.3 p -58.82 152.92 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.24 1.016 . . . . 0.0 112.214 177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 58.6 m -130.26 168.88 16.17 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.536 1.534 . . . . 0.0 111.767 -170.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 93.2 mt -136.65 143.38 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.217 1.407 . . . . 0.0 109.535 -177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 178.93 178.2 48.03 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 125.03 1.3 . . . . 0.0 111.905 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.59 -42.5 44.75 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 119.258 1.529 . . . . 0.0 114.562 -172.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -167.28 176.31 6.8 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 129.091 2.956 . . . . 0.0 108.374 172.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -139.53 137.93 35.87 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.228 -0.92 . . . . 0.0 112.364 169.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.2 t -59.93 -21.53 61.25 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.958 1.703 . . . . 0.0 115.218 -169.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -134.34 -36.51 0.89 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.399 1.08 . . . . 0.0 113.613 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 78.1 p -103.41 2.44 33.87 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.86 10.81 1.44 Allowed Glycine 0 CA--C 1.541 1.672 0 C-N-CA 125.294 1.426 . . . . 0.0 115.377 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -131.51 142.67 50.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.849 1.66 . . . . 0.0 109.921 -169.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -139.41 175.89 9.18 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.692 1.597 . . . . 0.0 111.85 -168.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.71 139.56 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.848 1.259 . . . . 0.0 109.403 169.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.42 125.49 73.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.731 1.613 . . . . 0.0 107.088 175.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -149.07 153.91 38.5 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 124.733 1.213 . . . . 0.0 108.974 -170.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -68.63 155.6 39.71 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.923 -1.111 . . . . 0.0 112.497 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 79.6 t . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.107 1.763 . . . . 0.0 111.279 171.807 . . . . . . . . 0 0 . 1 stop_ save_